"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,DE,B,DE 1276732 B,028-178-973-424-702,1968-09-05,1968,DE G0044834 A,1965-10-01,US 40073564 A,1964-10-01,Anzeigeschaltung fuer einen Stereo-Rundfunkempfaenger,,GEN ELECTRIC,ELIAS WILLIAM HUBERT,,https://lens.org/028-178-973-424-702,Patent Application,no,3,0,3,3,0,H04B1/1653;;H04B1/1653,H04B1/16,,0,0,,,,DISCONTINUED
2,US,A,US 3417341 A,079-772-325-116-711,1968-12-17,1968,US 64571367 A,1967-06-13,US 64571367 A,1967-06-13,Composite am-fm intermediate frequency amplifier,,GEN ELECTRIC,ELIAS WILLIAM H,,https://lens.org/079-772-325-116-711,Granted Patent,no,0,2,1,1,0,H03F3/68;;H03F3/68;;H03F3/191;;H03F3/191,H03F3/191;;H03F3/68,330/28,0,0,,,,EXPIRED
3,EP,B1,EP 0026842 B1,082-048-195-825-181,1985-08-28,1985,EP 80105186 A,1980-09-01,US 7417779 A,1979-09-10,LOW INDUCTANCE ELECTROLYTIC CAPACITOR,,"SANGAMO WESTON, INC.","ELIAS, WILLIAM H.",,https://lens.org/082-048-195-825-181,Granted Patent,yes,0,0,7,7,0,H01G9/06;;H01G9/06,H01G4/245;;H01G9/008;;H01G9/048;;H01G9/06,,0,0,,,,EXPIRED
4,EP,A2,EP 0026842 A2,163-866-910-555-290,1981-04-15,1981,EP 80105186 A,1980-09-01,US 7417779 A,1979-09-10,Low inductance electrolytic capacitor.,A capacitor which includes a case containing a capacitor element with a pair of overlapping tabs extending therefrom. A header for sealing the case carries a pair of leads. Each tab is welded to one of the leads with an insulator interposed between the tabs.,SANGAMO WESTON,ELIAS WILLIAM H,,https://lens.org/163-866-910-555-290,Patent Application,yes,0,1,7,7,0,H01G9/06;;H01G9/06,H01G4/245;;H01G9/008;;H01G9/048;;H01G9/06,,0,0,,,,EXPIRED
5,US,B2,US 9114739 B2,074-323-710-198-316,2015-08-25,2015,US 201313894410 A,2013-05-14,US 201313894410 A;;US 201261646359 P,2012-05-14,Child car seat with height adjustable head rest and adjustment mechanism for same,"A child car seat has a seat back with an upper end and a head rest coupled to the seat back near the upper end. The head rest is vertically adjustable along the seat back between a raised position and a lowered position. The car seat has an adjustment mechanism with an actuator and a lock element. The lock element is movable between a locked condition preventing vertical adjustment of the head rest and an unlocked condition permitting vertical adjustment of the head rest. The actuator is actuable to reconfigure the adjustment mechanism between a locked arrangement blocking the lock element in the locked condition, a released arrangement unblocking the lock element from the locked condition, and an unlocked arrangement whereby the lock element is in the unlocked condition.",CONWAY WILLIAM ELIAS;;GRACO CHILDRENS PROD INC,CONWAY WILLIAM ELIAS,GRACO CHILDREN'S PRODUCTS INC (2013-07-08),https://lens.org/074-323-710-198-316,Granted Patent,yes,15,8,2,2,0,B60N2/2851;;B60N2/2851;;B60N2/2863;;B60N2/2863,B60N2/28,,0,0,,,,ACTIVE
6,GB,A,GB 189913247 A,127-227-376-773-805,1900-03-24,1900,GB 189913247D A,1899-06-26,GB 189913247T A,1899-06-26,Improvements in and connected with Mining Caps or Cartridges.,"13,247. Miller, W. E. June 26. Blasting-fuzes.-Fuzes and detonators, Fig. 2, are connected by an elastic protector 3 to prevent moisture from entering. The protectors are conveniently rolled upon themselves and carried on a stick 6, Fig. 5, from which they can be readily slipped upon the case 1 and then unrolled over the fuze 2.",MILLER WILLIAM ELIAS,MILLER WILLIAM ELIAS,,https://lens.org/127-227-376-773-805,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
7,US,A,US 3294916 A,181-686-619-960-367,1966-12-27,1966,US 40073564 A,1964-10-01,US 40073564 A,1964-10-01,Stereophonic indicator and automatic switching means,,GEN ELECTRIC,HUBERT ELIAS WILLIAM,,https://lens.org/181-686-619-960-367,Granted Patent,no,6,5,3,3,0,H04B1/1653;;H04B1/1653,H04B1/16,,0,0,,,,EXPIRED
8,US,A,US 1051493 A,185-740-018-228-496,1913-01-28,1913,US 1911/0653351 A,1911-10-07,US 1911/0653351 A,1911-10-07,WASHING DEVICE.,,ELIAS WILLIAM M,ELIAS WILLIAM M,,https://lens.org/185-740-018-228-496,Granted Patent,no,0,0,1,1,0,D06F1/08;;D06F1/08,,,0,0,,,,EXPIRED
9,US,A,US 5801917 A,034-638-849-659-135,1998-09-01,1998,US 65708696 A,1996-06-03,US 65708696 A,1996-06-03,Capacitor for an implantable cardiac defibrillator,"A capacitor and a method for making the capacitor using ultrasonic welding to join the cathode layers together are provided. The capacitor includes a housing defining a chamber with a step provided at an inner portion of the housing. A plurality of capacitor layers each including a cathode foil, a separator and an anode foil, each having alignment holes therein to precisely fit with alignment elements housing, is positioned within the chamber, with the alignment holes mating with the alignment elements. The housing is electrically conductive for connection to the cathode foils. Each cathode foil includes a cathode tab which extends away from the foil. The cathode tabs are pressed together and ultrasonically welded to the housing step abutting the periphery of the interior of the housing.",PACESETTER INC,ELIAS WILLIAM H,PACESETTER INC (1997-05-15);;VENTRITEX INC (1996-05-31),https://lens.org/034-638-849-659-135,Granted Patent,yes,8,107,2,2,0,A61N1/3956;;A61N1/3956,A61N1/39,361/535;;361/508;;361/512;;361/516;;361/517;;361/537;;361/528;;361/532,0,0,,,,EXPIRED
10,DE,D1,DE 3071033 D1,060-009-649-926-99X,1985-10-03,1985,DE 3071033 T,1980-09-01,US 7417779 A,1979-09-10,LOW INDUCTANCE ELECTROLYTIC CAPACITOR,,SANGAMO WESTON,ELIAS WILLIAM H,,https://lens.org/060-009-649-926-99X,Granted Patent,no,0,0,7,7,0,H01G9/06;;H01G9/06,H01G4/245;;H01G9/008;;H01G9/048;;H01G9/06,,0,0,,,,EXPIRED
11,US,A,US 717595 A,138-198-652-735-872,1903-01-06,1903,US 1902/0122628 A,1902-09-08,US 1902/0122628 A,1902-09-08,PEN-CLEANER.,,MILLER WILLIAM ELIAS,MILLER WILLIAM ELIAS,,https://lens.org/138-198-652-735-872,Granted Patent,no,0,0,1,1,0,B43K13/00;;B43K13/00,,,0,0,,,,EXPIRED
12,US,A,US 781218 A,093-705-658-480-439,1905-01-31,1905,US 1904/0205598 A,1904-04-29,US 1904/0205598 A,1904-04-29,RAIL-TIE PLATE.,,MILLER WILLIAM ELIAS,MILLER WILLIAM ELIAS,,https://lens.org/093-705-658-480-439,Granted Patent,no,0,0,1,1,0,E01B13/02;;E01B13/02,,,0,0,,,,EXPIRED
13,CA,A,CA 1157539 A,102-431-274-614-644,1983-11-22,1983,CA 359928 A,1980-09-09,US 7417779 A,1979-09-10,LOW INDUCTANCE ELECTROLYTIC CAPACITOR TYPE 350,"Capacitor and Element Therefor An electrolytic capacitor having a low equivalent series inductance (ESL) and equivalent series resistance (ESR) includes a case containing cylindrically rolled cathode, anode and spacer films. Tabs abut the cathode and anode films and are connected to leads which are spaced apart across the diameter of a header used to close the open end of the case. The tabs in the finished capacitor are circumferentially spaced proximate and parallel to each other. They are bent over so that they are also parallel to the diameter of the header on which the leads are spaced. The tabs are of unequal length, the longer tab being attached to the lead furthest from the point on the circumference of the capacitor element where the tabs are attached and the shorter tab being attached to the other lead. An insulator is disposed between the tabs. In one embodiment a conductive header is utilized and one of the leads is insulated therefrom.",SANGAMO WESTON,ELIAS WILLIAM H,,https://lens.org/102-431-274-614-644,Granted Patent,no,0,0,7,7,0,H01G9/06;;H01G9/06,H01G4/245;;H01G9/008;;H01G9/048;;H01G9/06,334-21,0,0,,,,EXPIRED
14,EP,A3,EP 0026842 A3,006-842-062-137-547,1982-05-05,1982,EP 80105186 A,1980-09-01,US 7417779 A,1979-09-10,LOW INDUCTANCE ELECTROLYTIC CAPACITOR,A capacitor which includes a case containing a capacitor element with a pair of overlapping tabs extending therefrom. A header for sealing the case carries a pair of leads. Each tab is welded to one of the leads with an insulator interposed between the tabs.,"SANGAMO WESTON, INC.","ELIAS, WILLIAM H.",,https://lens.org/006-842-062-137-547,Search Report,yes,10,0,7,7,0,H01G9/06;;H01G9/06,H01G4/245;;H01G9/008;;H01G9/048;;H01G9/06,,0,0,,,,EXPIRED
15,US,A,US 4298906 A,008-194-736-331-814,1981-11-03,1981,US 7417779 A,1979-09-10,US 7417779 A,1979-09-10,Capacitor and element therefor,A capacitor which includes a case containing a capacitor element with a pair of unequal length overlapping tabs extending therefrom. A header for sealing the case carries a pair of leads. Each tab is welded to one of the leads with an insulator interposed between the tabs.,SANGAMO WESTON,ELIAS WILLIAM H,CORNELL-DUBLILIER MARKETING INC. (1987-05-07);;CORNELL-DUBIILIER MARKETING INC (1987-05-07),https://lens.org/008-194-736-331-814,Granted Patent,yes,7,17,7,7,0,H01G9/06;;H01G9/06,H01G9/008;;H01G4/245;;H01G9/048;;H01G9/06,361/433,0,0,,,,EXPIRED
16,CA,A,CA 796088 A,070-626-082-066-170,1968-10-08,1968,CA 796088D A,,CA 796088T A,,UNIVERSAL DISPOSABLE CARTRIDGE FOR PARENTERAL ADMINISTRATION OF DRUGS,,AMERICAN HOME PROD,ELIAS WILLIAM F,,https://lens.org/070-626-082-066-170,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
17,US,A,US 817601 A,092-441-914-386-503,1906-04-10,1906,US 1905/0268359 A,1905-07-06,US 1905/0268359 A,1905-07-06,TRAP.,,GRANT WILSON;;WERD WILLIAM ELIAS,WERD WILLIAM ELIAS,,https://lens.org/092-441-914-386-503,Granted Patent,no,0,5,1,1,0,A01M23/34;;A01M23/34,,,0,0,,,,EXPIRED
18,US,A1,US 2013/0320725 A1,025-797-629-468-224,2013-12-05,2013,US 201313894410 A,2013-05-14,US 201313894410 A;;US 201261646359 P,2012-05-14,Child Car Seat with Height Adjustable Head Rest and Adjustment Mechanism for Same,"A child car seat has a seat back with an upper end and a head rest coupled to the seat back near the upper end. The head rest is vertically adjustable along the seat back between a raised position and a lowered position. The car seat has an adjustment mechanism with an actuator and a lock element. The lock element is movable between a locked condition preventing vertical adjustment of the head rest and an unlocked condition permitting vertical adjustment of the head rest. The actuator is actuable to reconfigure the adjustment mechanism between a locked arrangement blocking the lock element in the locked condition, a released arrangement unblocking the lock element from the locked condition, and an unlocked arrangement whereby the lock element is in the unlocked condition.",CONWAY WILLIAM ELIAS,CONWAY WILLIAM ELIAS,GRACO CHILDREN'S PRODUCTS INC (2013-07-08),https://lens.org/025-797-629-468-224,Patent Application,yes,12,37,2,2,0,B60N2/2851;;B60N2/2851;;B60N2/2863;;B60N2/2863,B60N2/28,297/256.11,0,0,,,,ACTIVE
19,US,A,US 5908151 A,052-311-832-978-007,1999-06-01,1999,US 93918197 A,1997-09-29,US 93918197 A;;US 65708696 A,1996-06-03,Capacitor for an implantable cardiac defibrillator,"A capacitor and a method for making the capacitor using ultrasonic welding to join the cathode layers together are provided. The capacitor includes a housing defining a chamber with a step provided at an inner portion of the housing. A plurality of capacitor layers each including a cathode foil, a separator and an anode foil, each having alignment holes therein to precisely fit with alignment elements housing, is positioned within the chamber, with the alignment holes mating with the alignment elements. The housing is electrically conductive for connection to the cathode foils. Each cathode foil includes a cathode tab which extends away from the foil. The cathode tabs are pressed together and ultrasonically welded to the housing step abutting the periphery of the interior of the housing.",PACESETTER INC,ELIAS WILLIAM H,,https://lens.org/052-311-832-978-007,Granted Patent,yes,5,102,2,2,0,A61N1/3956;;A61N1/3956,A61N1/39,228/110.1;;228/179.1;;228/190,0,0,,,,EXPIRED
20,US,A,US 3380452 A,162-765-739-824-921,1968-04-30,1968,US 41500564 A,1964-12-01,US 41500564 A,1964-12-01,Universal disposable cartridge for parenteral administration of drugs,,AMERICAN HOME PROD,ELIAS WILLIAM F,,https://lens.org/162-765-739-824-921,Granted Patent,no,5,4,1,1,0,A61M5/28;;A61M5/28,A61M5/28,128/221,0,0,,,,EXPIRED
21,CA,A,CA 461548 A,119-891-252-420-528,1949-12-06,1949,CA 461548D A,,CA 461548T A,,SWIVEL VALVE JOINT,,ELIAS WILLIAM M,ELIAS WILLIAM M,,https://lens.org/119-891-252-420-528,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
22,US,A,US 636919 A,158-267-267-433-060,1899-11-14,1899,US 1899/0717937 A,1899-05-23,US 1899/0717937 A,1899-05-23,DEVICE FOR APPLYING PROTECTORS TO FULMINATING-CAPS FOR EXPLOSIVE CHARGES.,,MILLER WILLIAM ELIAS,MILLER WILLIAM ELIAS,,https://lens.org/158-267-267-433-060,Granted Patent,no,0,1,1,1,0,F42D1/08;;F42D1/08;;Y10T29/53657;;Y10T29/53657;;Y10T29/53665;;Y10T29/53665,,,0,0,,,,EXPIRED
23,CA,A,CA 234088 A,152-575-541-900-888,1923-09-11,1923,CA 234088D A,,CA 234088T A,,SHOE,,ELIAS DAVID WILLIAM,ELIAS DAVID WILLIAM,,https://lens.org/152-575-541-900-888,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
24,CA,A,CA 107735 A,170-930-622-453-262,1907-10-01,1907,CA 107735D A,1907-04-09,CA 107735T A,1907-04-09,TRAP,,WERD WILLIAM ELIAS;;VINTON RICHARD K;;RICKETTS GEORGE W,WERD WILLIAM ELIAS,,https://lens.org/170-930-622-453-262,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
25,CA,A,CA 788031 A,191-226-272-060-030,1968-06-18,1968,CA 788031D A,,CA 788031T A,,STEREOPHONIC INDICATOR AND AUTOMATIC SWITCHING MEANS,,GEN ELECTRIC,ELIAS WILLIAM H,,https://lens.org/191-226-272-060-030,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
26,CA,A,CA 839964 A,186-575-021-371-963,1970-04-21,1970,CA 839964D A,,CA 839964T A,,COMPOSITE AM-FM INTERMEDIATE FREQUENCY AMPLIFIER,,GEN ELECTRIC,ELIAS WILLIAM H,,https://lens.org/186-575-021-371-963,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
27,US,A,US 2416785 A,042-340-082-013-58X,1947-03-04,1947,US 59926645 A,1945-06-13,US 59926645 A,1945-06-13,Bobbin arbor,,CELANESE CORP,ELIAS DETWILER WILLIAM,,https://lens.org/042-340-082-013-58X,Granted Patent,no,2,14,1,1,0,B65H54/543;;B65H2701/31;;B65H2402/20;;B65H54/543;;B65H2701/31;;B65H2402/20,B65H54/54,,0,0,,,,EXPIRED
28,US,A,US 1502408 A,148-186-783-349-634,1924-07-22,1924,US 65857423 A,1923-08-21,US 65857423 A,1923-08-21,Liquid measurer and can filler,,ELIAS SORENSEN WILLIAM,ELIAS SORENSEN WILLIAM,,https://lens.org/148-186-783-349-634,Granted Patent,no,0,0,1,1,0,G01F11/28;;G01F11/28,G01F11/28,,0,0,,,,EXPIRED
29,US,A,US 2481733 A,191-087-473-755-181,1949-09-13,1949,US 4361648 A,1948-08-11,US 4361648 A,1948-08-11,Swivel valve joint,,ELIAS WILLIAM M,ELIAS WILLIAM M,,https://lens.org/191-087-473-755-181,Granted Patent,no,4,3,1,1,0,F16L29/02;;F16L29/02;;F16K5/0207;;F16K5/0207;;Y10T137/87917;;Y10T137/87917;;Y10T137/88102;;Y10T137/88102,F16K5/02;;F16L29/02,,0,0,,,,EXPIRED
30,US,A,US 2748451 A,071-391-990-116-746,1956-06-05,1956,US 28605352 A,1952-05-05,US 28605352 A;;GB 1033251 A,1951-05-02,Gear transmissions,,C V A JIGS MOULDS & TOOLS LTD,REGINALD PULMAN WILLIAM ELIAS,,https://lens.org/071-391-990-116-746,Granted Patent,no,3,2,1,2,0,B23B3/16;;B23B3/16;;B23Q5/34;;B23Q5/34;;B23Q2705/187;;B23Q2705/187;;F16H27/10;;F16H27/10;;F16H1/203;;F16H1/203;;Y10T29/5163;;Y10T29/5163;;Y10T74/19679;;Y10T74/19679,B23B3/16;;B23B3/18;;B23Q5/34;;F16H1/20;;F16H27/10,,0,0,,,,EXPIRED
31,AU,A,AU 1973/054800 A,191-331-376-748-344,1974-10-24,1974,AU 1973/054800 A,1973-04-19,US 24532172 A,1972-04-19,CATHODE RAY TUBE DEFLECTING YOKE,,GTE SYLVANIA INC,ELIAS WILLIAM;;CLEVELAND GEORGE,,https://lens.org/191-331-376-748-344,Patent Application,no,0,0,6,6,0,H04N3/16;;H04N3/16;;H03K4/62;;H03K4/62,H03K4/62;;H04N3/16,,0,0,,,,DISCONTINUED
32,US,A,US 2676385 A,024-136-835-762-171,1954-04-27,1954,US 23739151 A,1951-07-18,GB 2676385X A,1950-07-27,Work-locating stop mechanism for automatic lathes,,C V A JIGS MOULDS & TOOLS LTD,REGINALD PULMAN WILLIAM ELIAS,,https://lens.org/024-136-835-762-171,Granted Patent,no,4,1,2,2,0,B23Q16/00;;B23Q16/00,B23B9/04;;B23Q16/00,,0,0,,,,EXPIRED
33,US,A,US 1217582 A,126-181-664-035-017,1917-02-27,1917,US 8844116 A,1916-04-03,US 8844116 A,1916-04-03,ELECTRIC-LIGHT SHADE.,,ELIAS GEORGE;;MENDEL WILLIAM,ELIAS GEORGE;;MENDEL WILLIAM,,https://lens.org/126-181-664-035-017,Granted Patent,no,0,0,1,1,0,F21V17/00;;F21V17/00,,,0,0,,,,EXPIRED
34,GB,A,GB 2425630 A,139-512-499-573-086,2006-11-01,2006,GB 0613074 A,2004-12-29,US 2004/0043966 W;;US 53262903 P,2003-12-29,Electronic bartering,"An electronic bartering system and method for facilitating a trade of a first item owned by a first user for a second item owned by a second user when the first user and the second user are connected to a network. The electronic bartering system and method receives a request from the first user, allows the second user to access items owned by the first user, receives a response from the second user, and receives an acceptance from the first user. The request identifies the second item and is a potential trade request. The response identifies the first item and is a trade offer. The trade comprises the potential trade request, the trade offer, and the acceptance. Completion of the trade further includes receiving a confirmation from both the first user and the second user.",ZUNAFISH VENTURES INC,BLOOM WILLIAM;;ELIAS DANEIEL,,https://lens.org/139-512-499-573-086,Patent Application,no,2,0,6,6,0,G06Q30/02;;G06Q30/02;;G06Q30/0603;;G06Q30/0603;;G06Q30/08;;G06Q30/08;;G06Q40/04;;G06Q40/04,G06Q30/00,G4A AUXB          UXB,0,0,,,,DISCONTINUED
35,US,A,US 2763365 A,113-372-692-433-960,1956-09-18,1956,US 28858752 A,1952-05-19,GB 2763365X A,1951-05-18,Work feeding mechanism for automatic machine tools,,C V A JIGS MOULDS & TOOLS LTD,REGINALD PULMAN WILLIAM ELIAS,,https://lens.org/113-372-692-433-960,Granted Patent,no,6,3,1,1,0,B23B13/00;;B23B13/00,B23B13/00,,0,0,,,,EXPIRED
36,WO,A3,WO 2005/065386 A3,148-060-446-560-777,2006-01-05,2006,US 2004/0043966 W,2004-12-29,US 53262903 P,2003-12-29,ELECTRONIC BARTERING,"An electronic bartering system and method for facilitating a trade of a first item owned by a first user for a second item owned by a second user when the first user and the second user are connected to a network. The electronic bartering system and method receives a request from the first user, allows the second user to access items owned by the first user, receives a response from the second user, and receives an acceptance from the first user. The request identifies the second item and is a potential trade request. The response identifies the first item and is a trade offer. The trade comprises the potential trade request, the trade offer, and the acceptance. Completion of the trade further includes receiving a confirmation from both the first user and the second user.",ZUNAFISH VENTURES INC;;BLOOM WILLIAM;;ELIAS DANIEL,BLOOM WILLIAM;;ELIAS DANIEL,,https://lens.org/148-060-446-560-777,Search Report,yes,2,0,6,6,0,G06Q30/02;;G06Q30/02;;G06Q30/0603;;G06Q30/0603;;G06Q30/08;;G06Q30/08;;G06Q40/04;;G06Q40/04,G06Q30/00,,0,0,,,,PENDING
37,US,A,US 2654271 A,036-784-293-278-393,1953-10-06,1953,US 28605552 A,1952-05-05,GB 2654271X A,1951-05-02,Indexing mechanism for turrets of automatic machine tools,,C V A JIGS MOULDS & TOOLS LTD,REGINALD PULMAN WILLIAM ELIAS,,https://lens.org/036-784-293-278-393,Granted Patent,no,1,1,1,1,0,B23Q5/34;;B23Q2705/187;;Y10T74/1441;;Y10T74/1406;;Y10T74/1429;;Y10T74/1441;;Y10T74/1406;;Y10T74/1429;;B23Q5/34;;B23Q2705/187,B23Q5/34,,0,0,,,,EXPIRED
38,US,A,US 2730371 A,088-185-105-097-141,1956-01-10,1956,US 23723851 A,1951-07-17,GB 1787250 A,1950-07-17,"Operating mechanism for chucks, clutches and like devices",,C V A JIGS MOULDS & TOOLS LTD,REGINALD PULMAN WILLIAM ELIAS,,https://lens.org/088-185-105-097-141,Granted Patent,no,10,4,2,2,0,Y10T279/17521;;B23B31/2072;;Y10T279/17521;;B23B31/2072,B23B31/20,,0,0,,,,EXPIRED
39,US,A1,US 2016/0287825 A1,045-339-004-315-786,2016-10-06,2016,US 201615042163 A,2016-02-12,US 201615042163 A;;US 201313737944 A;;IB 2012052077 W;;US 201161506210 P,2011-07-11,ENDOBRONCHIAL TUBE WITH INTEGRATED IMAGE SENSOR AND A CLEANING NOZZLE ARRANGEMENT,An endobronchial tube which contains an integrated camera and light source and a cleaning nozzle arrangement disposed within dedicated peripheral lumen within the tube's wall.,ETVIEW LTD,DAHER ELIAS;;EDELMAN WILLIAM,AMBU A/S (2017-09-28);;ETVIEW LTD (2016-02-17),https://lens.org/045-339-004-315-786,Patent Application,yes,0,4,23,23,0,A61M16/0463;;A61M16/0463;;A61B1/00018;;A61B1/00082;;A61B1/00091;;A61B1/00091;;A61B1/00094;;A61B1/00124;;A61B1/012;;A61B1/015;;A61B1/05;;A61B1/051;;A61B1/0676;;A61B1/0684;;A61B1/07;;A61B1/12;;A61B1/126;;A61B1/126;;A61B1/2676;;A61B1/2676;;A61B1/313;;A61M15/00;;A61M15/00;;A61M16/0057;;A61M16/04;;A61M16/04;;A61M16/0404;;A61M16/0404;;A61M16/0434;;A61M16/044;;A61M16/0459;;A61M16/0459;;A61M16/0461;;A61M16/0465;;A61M16/0486;;A61M16/0486;;A61M16/0488;;A61M16/0833;;A61M16/0833;;A61M16/104,A61M16/04;;A61B1/00;;A61B1/015;;A61B1/05;;A61B1/06;;A61B1/07;;A61B1/12;;A61B1/267,,0,0,,,,DISCONTINUED
40,US,A,US 2754699 A,005-580-993-831-437,1956-07-17,1956,US 28605452 A,1952-05-05,US 28605452 A,1952-05-05,Indexing mechanism for the turrets of automatic machine tools,,C V A JIGS MOULDS & TOOLS LTD,REGINALD PULMAN WILLIAM ELIAS,,https://lens.org/005-580-993-831-437,Granted Patent,no,5,3,2,2,0,B23Q16/065;;Y10T74/14;;Y10T74/19879;;Y10T74/14;;Y10T74/19879;;B23Q16/065,B23Q16/06,,0,0,,,,EXPIRED
41,US,A1,US 2007/0124228 A1,123-208-922-874-728,2007-05-31,2007,US 58339504 A,2004-12-29,US 58339504 A;;US 53262903 P;;US 2004/0043966 W,2003-12-29,Electronic bartering,"An electronic bartering system and method for facilitating a trade of a first item owned by a first user for a second item owned by a second user when the first user and the second user are connected to a network. The electronic bartering system and method receives a request from the first user, allows the second user to access items owned by the first user, receives a response from the second user, and receives an acceptance from the first user The request identifies the second item and is a potential trade request. The response identifies the first item and is a trade offer The trade comprises the potential trade request, the trade offer, and the acceptance. Completion of the trade further includes receiving a confirmation from both the first user and the second user",ELIAS DANIEL;;BLOOM WILLIAM,ELIAS DANIEL;;BLOOM WILLIAM,ZUNAFISH VENTURES INC (2006-05-04),https://lens.org/123-208-922-874-728,Patent Application,yes,2,73,6,6,0,G06Q30/02;;G06Q30/02;;G06Q30/0603;;G06Q30/0603;;G06Q30/08;;G06Q30/08;;G06Q40/04;;G06Q40/04,G06Q30/00,705/37,0,0,,,,DISCONTINUED
42,CA,A1,CA 2550645 A1,189-982-003-557-163,2005-06-20,2005,CA 2550645 A,2004-12-29,US 53262903 P;;US 2004/0043966 W,2003-12-29,ELECTRONIC BARTERING,"An electronic bartering system and method for facilitating a trade of a firs t item owned by a first user for a second item owned by a second user when the first user and the second user are connected to a network. The electronic bartering system and method receives a request from the first user, allows t he second user to access items owned by the first user, receives a response fro m the second user, and receives an acceptance from the first user. The request identifies the second item and is a potential trade request. The response identifies the first item and is a trade offer. The trade comprises the potential trade request, the trade offer, and the acceptance. Completion of the trade further includes receiving a confirmation from both the first user and the second user.",ZUNAFISH VENTURES INC,BLOOM WILLIAM;;ELIAS DANIEL,,https://lens.org/189-982-003-557-163,Patent Application,no,0,2,6,6,0,G06Q30/02;;G06Q30/02;;G06Q30/0603;;G06Q30/0603;;G06Q30/08;;G06Q30/08;;G06Q40/04;;G06Q40/04,G06Q30/00,,0,0,,,,DISCONTINUED
43,WO,A2,WO 2005/065386 A2,016-408-370-747-823,2005-07-21,2005,US 2004/0043966 W,2004-12-29,US 53262903 P,2003-12-29,ELECTRONIC BARTERING,"An electronic bartering system and method for facilitating a trade of a first item owned by a first user for a second item owned by a second user when the first user and the second user are connected to a network. The electronic bartering system and method receives a request from the first user, allows the second user to access items owned by the first user, receives a response from the second user, and receives an acceptance from the first user. The request identifies the second item and is a potential trade request. The response identifies the first item and is a trade offer. The trade comprises the potential trade request, the trade offer, and the acceptance. Completion of the trade further includes receiving a confirmation from both the first user and the second user.",ZUNAFISH VENTURES INC;;BLOOM WILLIAM;;ELIAS DANIEL,BLOOM WILLIAM;;ELIAS DANIEL,,https://lens.org/016-408-370-747-823,Patent Application,yes,0,5,6,6,0,G06Q30/02;;G06Q30/02;;G06Q30/0603;;G06Q30/0603;;G06Q30/08;;G06Q30/08;;G06Q40/04;;G06Q40/04,G06Q30/00,,0,0,,,,PENDING
44,US,A,US 3024520 A,060-960-091-097-818,1962-03-13,1962,US 65661257 A,1957-05-02,GB 3024520X A,1956-05-03,Turret operating mechanism for automatic machine tools,,ERIC ARON,REGINALD PULMAN WILLIAM ELIAS,,https://lens.org/060-960-091-097-818,Granted Patent,no,2,4,1,1,0,B23B3/16;;B23B3/16;;B23Q5/34;;B23Q5/34;;B23Q2705/182;;B23Q2705/182;;Y10T29/5161;;Y10T29/5161,B23B3/16;;B23Q5/34,,0,0,,,,EXPIRED
45,CA,A,CA 112174 A,002-131-575-458-235,1908-06-02,1908,CA 112174D A,1908-03-26,CA 112174T A,1908-03-26,TONGS,,WERD WILLIAM ELIAS;;KOONTZ WILLIAM MARSHALL,WERD WILLIAM ELIAS;;KOONTZ WILLIAM MARSHALL,,https://lens.org/002-131-575-458-235,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
46,US,A,US 893854 A,035-337-560-236-358,1908-07-21,1908,US 1907/0395038 A,1907-09-28,US 1907/0395038 A,1907-09-28,SUCTION APPARATUS FOR PNEUMATIC CLEANING SYSTEMS.,,VACUUM ENGINEERING COMPANY,LOCKE WILLIAM;;DUNN ELIAS B,,https://lens.org/035-337-560-236-358,Granted Patent,no,0,1,1,1,0,F04B7/04;;F04B7/04;;Y10T137/7838;;Y10T137/7838,,,0,0,,,,EXPIRED
47,US,A,US 893853 A,054-644-438-041-978,1908-07-21,1908,US 1906/0305015 A,1906-03-09,US 1906/0305015 A,1906-03-09,APPARATUS FOR REMOVING DUST BY PNEUMATIC SUCTION.,,VACUUM ENGINEERING COMPANY,LOCKE WILLIAM;;DUNN ELIAS B,,https://lens.org/054-644-438-041-978,Granted Patent,no,0,0,1,1,0,A47L15/13;;A47L15/13,,,0,0,,,,EXPIRED
48,US,A,US 4711524 A,088-336-810-452-087,1987-12-08,1987,US 77327685 A,1985-09-06,US 77327685 A,1985-09-06,Combustor fiberscope,A fiberscope for the viewing of the interior of an operating engine combur is provided with a fused coherent fiber bundle as an image conduit to transmit the image of said interior through the wall of the combustor. Illumination may be provided through the use of a second optical fiber or bundle and a coherent light source aligned with the image conduit.,US NAVY,MOREY WILLIAM W;;SNITZER ELIAS,UNITED STATES CORPORATION (1985-06-13);;NAVY THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF THE (1985-08-16),https://lens.org/088-336-810-452-087,Granted Patent,yes,4,26,1,1,0,G02B23/26;;G02B23/26,G02B23/26,G2J JE            JE,0,0,,,,EXPIRED
49,US,A,US 2939601 A,096-318-210-617-686,1960-06-07,1960,US 68007157 A,1957-08-26,US 68007157 A,1957-08-26,Container structure,,EVANS WILLIAM I;;ELIAS BLANCO,EVANS WILLIAM I;;ELIAS BLANCO,,https://lens.org/096-318-210-617-686,Granted Patent,no,6,5,1,1,0,B65D9/12;;B65D13/00;;B65D9/12;;B65D13/00,B65D6/00;;B65D13/00,,0,0,,,,EXPIRED
50,US,A,US 919606 A,040-245-955-478-610,1909-04-27,1909,US 1906/0316057 A,1906-05-10,US 1906/0316057 A,1906-05-10,PNEUMATIC SUCTION CLEANING APPARATUS.,,VACUUM ENGINEERING COMPANY,LOCKE WILLIAM;;DUNN ELIAS B,,https://lens.org/040-245-955-478-610,Granted Patent,no,0,12,1,1,0,A47L11/4044;;A47L11/4044;;Y10T137/698;;Y10T137/698,,,0,0,,,,EXPIRED
51,US,A,US 2905212 A,000-334-568-590-323,1959-09-22,1959,US 68876257 A,1957-10-07,US 68876257 A,1957-10-07,Mortising machine,,EVANS WILLIAM I;;ELIAS BLANCO,EVANS WILLIAM I;;ELIAS BLANCO,,https://lens.org/000-334-568-590-323,Granted Patent,no,8,3,1,1,0,B23B47/287;;B27F5/02;;Y10T408/563;;Y10T408/34;;Y10T408/55;;Y10T408/567;;Y10T408/563;;Y10T408/34;;Y10T408/55;;Y10T408/567;;B23B47/287;;B27F5/02,B23B47/28;;B27F5/02,,0,0,,,,EXPIRED
52,GB,A,GB 190810211 A,013-824-452-410-478,1908-08-20,1908,GB 190810211D A,1908-05-11,US 1908/010211X A,1907-05-09,Improvements in Insulators for Telegraph Wires and the like.,"10,211. Pollock, G., and Werd, W. E. May 9, 1907, [date applied for under Section 91 of Patents &c. Act, 1907]. Insulators particularly for telegraph wires are made with a base-plate 20 into which a base-block 11 is placed which engages the hooked ends 24 of clamping members 22 which embrace the bearing- blocks 23 and force them into contact with the wire 16 when the cap 17 is screwed down on to the screwed taper nipple 27. The base-plates are bolted to the post &c. and may be arranged to hold the clamps 22 at various inclinations. The clamps and bearing-blocks may be grooved and ribbed respectively so as to prevent relative displacement, and the shoulder 25 serves as a fulcrum when drawing the clamps together. Base-plates may be made to hold one or more insulators, and the device may be constructed in metal, porcelain, or wood.",POLLOCK GEORGE;;WERD WILLIAM ELIAS,POLLOCK GEORGE;;WERD WILLIAM ELIAS,,https://lens.org/013-824-452-410-478,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
53,US,A,US 2837789 A,013-543-447-453-958,1958-06-10,1958,US 50544355 A,1955-05-02,US 50544355 A,1955-05-02,Joining spindle,,EVANS WILLIAM I;;ELIAS BLANCO,EVANS WILLIAM I;;ELIAS BLANCO,,https://lens.org/013-543-447-453-958,Granted Patent,no,7,1,1,1,0,B27M3/008;;F16B12/24;;Y10T29/49936;;Y10T403/447;;F16B2200/40;;F16B2200/67;;Y10T29/49936;;Y10T403/447;;F16B2200/40;;F16B12/24;;B27M3/008;;F16B2200/67,B27M3/00;;F16B12/24,,0,0,,,,EXPIRED
54,US,A,US 3109698 A,121-378-716-956-561,1963-11-05,1963,US 18451062 A,1962-04-02,US 18451062 A,1962-04-02,Method for making high tenacity regenerated cellulose staple fiber,,COURTAULDS NORTH AMERICA INC,ELIAS KLEIN;;RICHARDSON WILLIAM C,,https://lens.org/121-378-716-956-561,Granted Patent,no,1,6,2,2,0,D01F2/08;;D01F11/02;;D01F11/02;;D01F2/08,D01F2/06;;D01F2/08,,0,0,,,,EXPIRED
55,GB,A,GB 190623018 A,108-108-892-121-028,1907-07-25,1907,GB 190623018D A,1906-10-17,GB 190623018T A,1906-10-17,"Improvements in connection with the Air Supply to Steamboiler, and other, Furnaces.","23,018. Wallace, W. C., and Middleton, E. Oct. 17. Forced and exhaust draught furnaces.-Relates to apparatus in which, in order to prevent outrush or inrush of air through the furnace door, two fans are provided, one to force air into the furnace, and the other to withdraw the combustion products from the furnace chamber and pass them into the chimney, and in which also air-heating arrangements are provided. As shown in Fig. 1, the two fans a, a<2> are mounted upon the same spindle in a casing B, and are separated by a rotary partition c. The fan a draws the combustion products from the furnace chamber through a tubular air-heater F, which may be of the form described in Specification No. 8723,. A.D. 1900, or No. 29,066, A.D. 1904, and discharges them into the chimney through an outlet b<3>. The fan a<2> forces air through a flue a into the air-heater, and on into the furnace. A damper-controlled by-pass flue H may be provided, through which a portion of the products of combustion is returned into the furnace. The fans may be mounted in separate casings, either upon the sime spindle, or independently, and their blades may be adjustable to allow of properly proportioning the two draughts.",WALLACE WILLIAM CARLILE;;MIDDLETON ELIAS,WALLACE WILLIAM CARLILE;;MIDDLETON ELIAS,,https://lens.org/108-108-892-121-028,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
56,US,A,US 2656299 A,037-864-649-885-781,1953-10-20,1953,US 3629448 A,1948-06-30,US 3629448 A,1948-06-30,Penicillin compositions,,AMERICAN HOME PROD,WILLIAM ELIAS;;JOSEPH MERRION HOWARD,,https://lens.org/037-864-649-885-781,Granted Patent,no,3,7,1,1,0,A61K31/43;;A61K31/43,A61K31/43,,0,0,,,,EXPIRED
57,CA,A,CA 985778 A,099-609-799-470-03X,1976-03-16,1976,CA 169043 A,1973-04-18,US 24532172 A,1972-04-19,ISOLATED HORIZONTAL AND VERTICAL OUTPUT CIRCUITRY HAVING A COMMON WINDING,,GTE SYLVANIA INC,ELIAS WILLIAM;;WAYBRIGHT GEORGE C,,https://lens.org/099-609-799-470-03X,Granted Patent,no,0,0,6,6,0,H04N3/16;;H04N3/16;;H03K4/62;;H03K4/62,H03K4/62;;H04N3/16,350-104,0,0,,,,EXPIRED
58,US,A,US 2585304 A,019-875-457-607-665,1952-02-12,1952,US 75489847 A,1947-06-16,US 75489847 A,1947-06-16,Rod to plate joint structure,,EVANS WILLIAM I;;ELIAS BLANCO,EVANS WILLIAM I;;ELIAS BLANCO,,https://lens.org/019-875-457-607-665,Granted Patent,no,7,11,1,1,0,A01K47/06;;B65D9/34;;F16B12/12;;Y10T403/472;;Y10T403/46;;Y10T403/472;;Y10T403/46;;B65D9/34;;A01K47/06;;F16B12/12,A01K47/06;;B27F1/00;;F16B12/12,,0,0,,,,EXPIRED
59,CA,A,CA 550866 A,056-312-481-947-240,1957-12-31,1957,CA 550866D A,,CA 550866T A,,ANTIBIOTIC COMPOSITIONS,,AMERICAN HOME PROD,ELIAS WILLIAM;;MERRION HOWARD J,,https://lens.org/056-312-481-947-240,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
60,CA,A,CA 110911 A,068-679-767-800-873,1908-03-24,1908,CA 110911D A,1907-12-21,CA 110911T A,1907-12-21,LANTERN SLIDE MOVING DEVICE,,SOUTHARD ELIAS B;;FREDERICK WILLIAM,SOUTHARD ELIAS B;;FREDERICK WILLIAM,,https://lens.org/068-679-767-800-873,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
61,CA,A,CA 110055 A,179-472-716-786-780,1908-02-04,1908,CA 110055D A,1907-09-30,CA 110055T A,1907-09-30,SUCTION APPARATUS FOR PNEUMATIC CLEANING SYSTEMS,,LOCKE WILLIAM;;DUNN LOCKE VACUUM CLEANING COMPANY;;DUNN ELIAS B,LOCKE WILLIAM;;DUNN ELIAS B,,https://lens.org/179-472-716-786-780,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
62,BE,A,BE 594179 A,034-465-671-729-526,1960-12-16,1960,BE 594179 A,1960-08-18,US 83455959 A,1959-08-18,Procédé pour la fabrication de fibres de cellulose régénérée et produit obtenu,,COURTAULDS INC,RICHARDSON WILLIAM CULLEN;;KLEIN ELIAS,,https://lens.org/034-465-671-729-526,Granted Patent,no,0,0,3,4,0,D01F2/08,D01F2/06,,0,0,,,,EXPIRED
63,CA,A,CA 110054 A,100-095-937-639-824,1908-02-04,1908,CA 110054D A,1907-09-30,CA 110054T A,1907-09-30,APPARATUS FOR REMOVING DUST,,DUNN LOCKE VACUUM CLEANING COMPANY;;LOCKE WILLIAM;;DUNN ELIAS B,LOCKE WILLIAM;;DUNN ELIAS B,,https://lens.org/100-095-937-639-824,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
64,CA,A,CA 649458 A,106-574-841-422-803,1962-10-02,1962,CA 649458D A,,CA 649458T A,,CONTAINER STRUCTURE,,BLANCO ELIAS;;EVANS WILLIAM I,EVANS WILLIAM I;;BLANCO ELIAS,,https://lens.org/106-574-841-422-803,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
65,FR,A,FR 386913 A,139-773-362-858-318,1908-06-26,1908,FR 386913D A,1908-02-04,FR 386913T A,1908-02-04,Perfectionnements dans l'alimentation d'air dans les foyers de chaudières à vapeur et autres,,WILLIAM CARLILE WALLACE;;ELIAS MIDDLETON,WALLACE WILLIAM CARLILE;;MIDDLETON ELIAS,,https://lens.org/139-773-362-858-318,Granted Patent,no,0,0,1,1,0,F23L17/00;;F23L2700/001,F23L17/00,"XV, 2",0,0,,,,EXPIRED
66,US,A,US 2464743 A,175-852-027-362-738,1949-03-15,1949,US 58939045 A,1945-04-20,US 58939045 A,1945-04-20,Article construction,,EVANS WILLIAM I;;ELIAS BLANCO,EVANS WILLIAM I;;ELIAS BLANCO,,https://lens.org/175-852-027-362-738,Granted Patent,no,8,11,1,1,0,F16B12/12;;F16B12/12;;Y10T29/49826;;Y10T29/49826;;Y10T403/46;;Y10T403/46,F16B12/12,,0,0,,,,EXPIRED
67,US,A,US 4302970 A,069-779-086-225-302,1981-12-01,1981,US 14834380 A,1980-05-09,US 14834380 A,1980-05-09,Optical temperature probe employing rare earth absorption,"A temperature probe formed by an optical fiber having a core fabricated from a glass host doped with a trivalent rare earth is positioned at the location temperature is to be measured. One of the rare earth elements, europium, has low lying energy levels that have significant population changes over certain desirable temperature ranges, i.e., related to the population of this particular energy level transition is monitored to determine the temperature at the location of the temperature probe. A simplified embodiment of a temperature measuring device incorporating the optical temperature probe includes at least one LED, or equivalent, to generate light into the input end of the optical fiber. The preselected wavelength of light that corresponds to the absorption line of interest experiences a change in strength as function of temperature. A detector at the output end measures changes in strength of the absorbed light by normalizing to an unabsorbed wavelength of light.",UNITED TECHNOLOGIES CORP,SNITZER ELIAS;;GLENN WILLIAM H,,https://lens.org/069-779-086-225-302,Granted Patent,yes,4,33,1,1,0,G01K11/32;;G01K11/32,G01K11/32,73339R,0,0,,,,EXPIRED
68,CA,A,CA 110990 A,075-675-397-467-297,1908-03-24,1908,CA 110990D A,1907-10-21,CA 110990T A,1907-10-21,CLAMP INSULATOR,,POLLOCK GEORGE;;WERD WILLIAM ELIAS,POLLOCK GEORGE;;WERD WILLIAM ELIAS,,https://lens.org/075-675-397-467-297,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
69,US,A,US 719081 A,012-830-993-448-334,1903-01-27,1903,US 1901/0071125 A,1901-08-07,US 1901/0071125 A,1901-08-07,EXTENSION-LADDER HOOK.,,JOSEPH CHESEBROUGH,BURBRIDGE WILLIAM A;;CHESEBROUGH ELIAS,,https://lens.org/012-830-993-448-334,Granted Patent,no,0,0,1,1,0,E06C1/12;;E06C1/12,,,0,0,,,,EXPIRED
70,US,A,US 919369 A,008-836-832-110-693,1909-04-27,1909,US 1907/0395037 A,1907-09-28,US 1907/0395037 A,1907-09-28,SUCTION APPARATUS FOR PNEUMATIC CLEANING SYSTEMS.,,VACUUM ENGINEERING COMPANY,LOCKE WILLIAM;;DUNN ELIAS B,,https://lens.org/008-836-832-110-693,Granted Patent,no,0,0,1,1,0,F04B7/04;;F04B7/04,,,0,0,,,,EXPIRED
71,EP,A2,EP 0025902 A2,005-535-150-175-029,1981-04-01,1981,EP 80105187 A,1980-09-01,US 7417579 A,1979-09-10,Low inductance electrolytic capacitor.,A capacitor which includes a case containing a capacitor element with multiple tabs extending therefrom is provided with a header which carries a pair of terminal members. Each of the terminal members has a pair of parallel connector leads extending out of the header connected by terminal portions inside the case. Each of the terminal portions includes portions parallel and non-parallel to corresponding terminal portions of the other terminal member and each of the tabs is welded to the outside of a parallel terminal portion.,SANGAMO WESTON,ELIAS WILLIAM H;;GRANGER HAROLD M,,https://lens.org/005-535-150-175-029,Patent Application,yes,0,1,7,7,0,H01G9/06;;H01G9/06,H01G4/236;;H01G9/008;;H01G9/06;;H01G9/10;;H01G9/14,,0,0,,,,EXPIRED
72,GB,A,GB 190200435 A,025-834-732-641-830,1902-08-14,1902,GB 190200435D A,1902-01-07,GB 190200435T A,1902-01-07,An Improved Joint for Sewer and other Pipes and the like,"435. Wright, E. G., and Wright, W. H. Jan. 7. Joint - making packing.- In joints for sewer, gas, water, and other pipes and for electric conduits, a collar or packing- ring A, Fig. 2, consisting of natural, compressed, or granulated cork covered with a coating of bitumen cement, is employed to make the joint tight. The packing-ring A is inserted into the socket C<2> of the pipe C, and the spigot B is then forced home. According to the Provisional Specification, the cork is prepared by steaming and rolling.",WRIGHT ELIAS GEORGE;;WRIGHT WILLIAM HENRY,WRIGHT ELIAS GEORGE;;WRIGHT WILLIAM HENRY,,https://lens.org/025-834-732-641-830,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
73,FR,A1,FR 2547063 A1,038-547-611-770-505,1984-12-07,1984,FR 8408401 A,1984-05-29,US 49927383 A,1983-05-31,PROCEDE ET APPAREIL POUR REDUIRE LES ERREURS DUES A L'EFFET GROENINGEN DANS LES MESURES DE RESISTIVITE D'UNE FORMATION TERRESTRE,"<P>SELON CE PROCEDE, ON DESCEND UNE SONDE 12 QUI COMPORTE PLUSIEURS ELECTRODES DE MESURE DE TENSION M, M, M, M, A, A ET PLUSIEURS ELECTRODES EMETTRICES DE COURANT A, A, A, A, A AU MOYEN D'UN CABLE CONDUCTEUR 16 AUQUEL LA SONDE EST ATTACHEE PAR L'INTERMEDIAIRE D'UN CABLE ISOLE 32. DEUX ELECTRODES DE REFERENCE N, N SONT DISPOSEES AU-DESSUS DE LA SONDE. UN COURANT D'ANALYSE ET AU MOINS DEUX COURANTS DE FOCALISATION SONT EMIS A DES FREQUENCES OU A DES TEMPS DIFFERENTS ET ON UTILISE LES TENSIONS INDUITES POUR CALCULER DES SERIES CORRESPONDANTES D'IMPEDANCES DE TRANSFERT AU MOYEN DESQUELLES ON PEUT CALCULER LA RESISTIVITE APPARENTE DE LA FORMATION SANS AVOIR A MODIFIER LE COURANT DE FOCALISATION. ON MESURE LA TENSION PRODUITE PAR LE PREMIER COURANT DE FOCALISATION ENTRE LA PREMIERE ELECTRODE DE REFERENCE N ET LA SONDE ET LA TENSION PRODUITE PAR LE SECOND COURANT DE FOCALISATION, A TRES BASSE FREQUENCE, ENTRE LES DEUX ELECTRODES DE REFERENCE ET ON COMBINE CES TENSIONS POUR OBTENIR UNE TENSION DE MESURE DANS LAQUELLE L'ERREUR INDUITE PAR L'EFFET GROENINGEN EST REDUITE.</P>",GEARHART IND INC,CHEMALI ROLAND ELIAS;;DIRK WILLIAM CHARLES,,https://lens.org/038-547-611-770-505,Patent Application,no,2,0,9,10,0,G01V3/24,G01V3/24,,0,0,,,,EXPIRED
74,US,A,US 4134310 A,094-036-949-847-625,1979-01-16,1979,US 78788377 A,1977-04-15,US 78788377 A,1977-04-15,Hydromechanical transmission with hydrodynamic drive,"This transmission has a first planetary gear assembly having first input means connected to an input shaft, first output means, and first reaction means, and a second planetary gear assembly having second input means connected to the first input means, second output means, and second reaction means connected directly to the first reaction means by a reaction shaft. First clutch means, when engaged, connect the first output means to an output shaft in a high driving range. A hydrodynamic drive is used; for example, a torque converter, which may or may not have a stationary case, has a pump connected to the second output means, a stator grounded by an overrunning clutch to the case, and a turbine connected to an output member, and may be used in a starting phase. Alternatively, a fluid coupling or other type of hydrodynamic drive may be used. Second clutch means, when engaged, for connecting the output member to the output shaft in a low driving range. A variable-displacement hydraulic unit is mechanically connected to the input shaft, and a fixed-displacement hydraulic unit is mechanically connected to the reaction shaft. The hydraulic units are hydraulically connected together so that when one operates as a pump the other acts as a motor, and vice versa. Both clutch means are connected to the output shaft through a forward-reverse shift arrangement. It is possible to lock out the torque converter after the starting phase is over.",ORSHANSKY TRANSMISSION CORP,ORSHANSKY JR ELIAS;;WESELOH WILLIAM E,,https://lens.org/094-036-949-847-625,Granted Patent,yes,7,10,1,1,0,F16H47/04;;F16H2037/0886;;F16H2037/104;;F16H2037/106;;F16H47/04;;F16H2037/104;;F16H2037/0886;;F16H2037/106,F16H47/04,74/687,0,0,,,,EXPIRED
75,CA,A,CA 1152170 A,141-468-127-458-067,1983-08-16,1983,CA 359930 A,1980-09-09,US 7417579 A,1979-09-10,LOW INDUCTANCE ELECTROLYTIC CAPACITOR TYPE 200,"#0077A/8209 File 48.264 CAPACITOR AND HEADER THEREFOR A capacitor which includes a case containing a capacitor element with multiple tabs extending therefrom is provided with a header which carries a pair of terminal members. Each of the terminal members has a pair of parallel connector leads extending out of the header connected by terminal portions inside the case. Each of the terminal portions includes portions parallel and nonparallel to corresponding terminal portions of the other terminal member and each of the tabs is welded to the outside of a parallel terminal portion.",SANGAMO WESTON,ELIAS WILLIAM H;;GRANGER HAROLD M,,https://lens.org/141-468-127-458-067,Granted Patent,no,0,0,7,7,0,H01G9/06;;H01G9/06,H01G4/236;;H01G9/008;;H01G9/06;;H01G9/10;;H01G9/14,334-20,0,0,,,,EXPIRED
76,DE,A1,DE 2815831 A1,147-291-727-692-962,1978-10-19,1978,DE 2815831 A,1978-04-12,US 78776777 A,1977-04-15,GETRIEBEANORDNUNG MIT HYDROSTATISCHER ANFAHRSTUFE UND ZWEI HYDROMECHANISCHEN GANGSTUFEN,,ORSHANSKY TRANSMISSION CORP,WESELOH WILLIAM EDWIN;;ORSHANSKY JUN ELIAS,,https://lens.org/147-291-727-692-962,Patent Application,no,0,1,8,8,0,F16H47/04;;F16H2037/0886;;F16H2037/107;;F16H47/04;;F16H2037/0886;;F16H2037/107,F16H47/04,,0,0,,,,DISCONTINUED
77,ZA,B,ZA 200907146 B,029-942-288-151-870,2010-06-30,2010,ZA 200907146 A,2009-10-14,ZA 200907146 A,2009-10-14,Cap gripper,,FILMATIC PACKAGING SYSTEMS PTY,OCHSE WILLIAM LENNOX;;KAMFER ELIAS LOURENS,,https://lens.org/029-942-288-151-870,Granted Patent,no,0,0,1,1,0,,B67B/,,0,0,,,,ACTIVE
78,CA,A,CA 623644 A,093-705-609-846-254,1961-07-11,1961,CA 623644D A,,CA 623644T A,,FUEL NOZZLE,,GEN MOTORS CORP,JACOBITZ WILLIAM G;;SCHEIBE ELIAS W,,https://lens.org/093-705-609-846-254,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
79,CA,A,CA 492608 A,163-717-077-777-651,1953-05-05,1953,CA 492608D A,,CA 492608T A,,PREPARATION OF AROMATIC ALDEHYDES FROM CO,,DU PONT,TABET GEORGES ELIAS;;CRESHAM WILLIAM FRANKLIN,,https://lens.org/163-717-077-777-651,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
80,EP,B1,EP 0585590 B1,022-122-121-218-588,1997-12-29,1997,EP 93111705 A,1993-07-21,US 93932692 A,1992-09-02,"(Alpha, omega) phenylethynyl siloxane monomers, oligomers, and polymers thereof",,HUGHES AIRCRAFT CO,DOUGHERTY THOMAS K;;ELIAS WILLIAM E,,https://lens.org/022-122-121-218-588,Granted Patent,yes,1,0,7,7,0,C07F7/0836;;C07F7/0896;;C08G77/045;;C08G77/20;;C08G77/455;;C07F7/0838;;C07F7/1804;;C07F7/0896;;C08G77/045;;C08G77/20;;C07F7/0836;;C08G77/455;;C07F7/1804;;C07F7/0838,C07F7/08;;C07F7/18;;C08F38/00;;C08F290/00;;C08F299/08;;C08G77/04;;C08G77/20;;C08G77/22;;C08G77/455,,2,0,,,"POLYMER BULLETIN vol. 23 , 1990 pages 439 - 445 MANTECON, A. ET AL. 'DIETHYNYL TERMINATED SILOXANE BASES (BISAZOMETHINE SCHIFF BASE). PREPARATION AND POLYMERIZATION';;CHEMICAL ABSTRACTS, vol. 105, no. 16, 20 October 1986, Columbus, Ohio, US; abstract no. 135021q, MAUDGAL, S. ET AL. 'SILOXANE CONTAINING ADDITION POLYIMIDES. II. ACETYLENE-TERMINATED POLYIMIDES' page 49 ; & SAMPE Q vol. 16, no. 1 , 1984 pages 6 - 12",EXPIRED
81,FR,A,FR 403657 A,035-325-239-168-944,1909-11-11,1909,FR 403657D A,1909-06-04,GB 403657X A,1908-08-21,"Perfectionnements apportés aux dispositifs pour opérer la désinfection constante de tubes porte-voix, embouchures de téléphones ou organes similaires",,GEORGES WILLIAM GIBBERD;;OWEN AUBREY ELIAS,GIBBERD GEORGES WILLIAM;;ELIAS OWEN AUBREY,,https://lens.org/035-325-239-168-944,Granted Patent,no,0,0,1,1,0,H04R1/12,H04R1/12,"XII, 4",0,0,,,,EXPIRED
82,US,A,US 3083303 A,079-673-325-331-442,1963-03-26,1963,US 82113059 A,1959-06-18,US 82113059 A,1959-06-18,Diode input nor circuit including positive feedback,,AMPEX,KNOWLES WILLIAM S;;ELIAS ARTHUR J,,https://lens.org/079-673-325-331-442,Granted Patent,no,7,18,1,1,0,H03K19/013;;H03K19/084;;H03K19/084;;H03K19/013,H03K19/013;;H03K19/084,,0,0,,,,EXPIRED
83,EP,A3,EP 0025902 A3,103-278-696-815-866,1982-05-12,1982,EP 80105187 A,1980-09-01,US 7417579 A,1979-09-10,LOW INDUCTANCE ELECTROLYTIC CAPACITOR,A capacitor which includes a case containing a capacitor element with multiple tabs extending therefrom is provided with a header which carries a pair of terminal members. Each of the terminal members has a pair of parallel connector leads extending out of the header connected by terminal portions inside the case. Each of the terminal portions includes portions parallel and non-parallel to corresponding terminal portions of the other terminal member and each of the tabs is welded to the outside of a parallel terminal portion.,"SANGAMO WESTON, INC.","ELIAS, WILLIAM H.;;GRANGER, HAROLD M.",,https://lens.org/103-278-696-815-866,Search Report,yes,4,0,7,7,0,H01G9/06;;H01G9/06,H01G4/236;;H01G9/008;;H01G9/06;;H01G9/10;;H01G9/14,,0,0,,,,EXPIRED
84,GB,A,GB 2141237 A,102-710-324-759-158,1984-12-12,1984,GB 8413679 A,1984-05-29,US 49927383 A,1983-05-31,Method and apparatus for reducing Groeningen effect errors in resistivity measurements of an earth formation,"In a method and apparatus for reducing ""Groeningen"" effect and other anomaly induced errors in resistivity measurements of an earth formation, a sonde 12 having a plurality of voltage measuring electrodes M1l--- and current emitting electrodes A1l--- suspended in a borehole by a conductive cable 16 to which the sonde is attached by a length of insulated cable 32; and two reference electrodes N,N1 are disposed above the sonde 12. A survey current and at least two focusing currents are emitted from the sonde at different respective frequencies; and various voltages induced by each current are measured and utilized to calculate a corresponding set of transfer impedances for that current, and hence the relationships of focusing currents to survey current which is necessary to properly focus the sonde. With these relationships thus defined, the apparent resistivity of the formation may be expressed as a function of the transfer impedances and the currents without the necessity of actually altering the amount of focusing current. One of the focusing currents is operated at a very low frequency to minimise the effect of a resistive anomaly and, by measuring the voltages induced by that current between widely spaced electrodes, the sonde may be operated at a faster rate than would otherwise be possible. <IMAGE>",GEARHART IND INC,CHEMALI ROLAND ELIAS;;DIRK WILLIAM CHARLES,,https://lens.org/102-710-324-759-158,Patent Application,no,0,5,9,10,0,G01V3/24,G01V3/24,G1N NCLC          CLC;;G1N N18A2A        CLC;;G1N N19B2Q        CLC;;G1N N19B4         CLC;;G1N N19D1X        CLC;;G1N N19D10        CLC,0,0,,,,EXPIRED
85,EP,A1,EP 0034107 A1,097-151-016-503-129,1981-08-19,1981,EP 81630002 A,1981-01-06,US 12045080 A,1980-02-11,Optical encoder using time domain multi-plexer.,"An optical encoder having a single light source and single light receiver transcribes signal information imprinted on an optical mask in the form of light transmissive or opaque regions in a plurality of signal bit locations into a serial, real time optical pulse signal in which the presence or absence of an optical pulse in each of a plurality of successive pulse window time intervals defines the signal state of successive signal bit locations, by multiplexing a light source pulse into a temporal array of secondary light pulses, one for each signal bit of the optical mask and each presented to the associated signal bit in a related one of successive pulse window time intervals, the optical receiver detecting the presence or absence of a secondary light pulse in each successive interval and providing signal manifestation in the form of electrical signal bits corresponding to the signal state of the data word imprinted on the optical mask.",UNITED TECHNOLOGIES CORP,SNITZER ELIAS;;GREEN WILLIAM JACKSON JR,,https://lens.org/097-151-016-503-129,Patent Application,yes,1,12,2,2,0,G01D5/268;;G01D5/34792;;H03M1/26;;G01D5/34792,H04B10/00;;G01D5/249;;G01D5/26;;G01D5/347;;G01D5/36;;H03M1/00;;H04B10/275;;H04B10/524;;H04B10/80;;H04J14/08,,0,0,,,,DISCONTINUED
86,FR,A1,FR 2547064 A1,117-221-490-138-469,1984-12-07,1984,FR 8408402 A,1984-05-29,US 49927483 A,1983-05-31,PROCEDE ET APPAREIL POUR L'EXPLORATION DE FORMATIONS GEOLOGIQUES DANS DES TROUS DE SONDE,"<P>ON DESCEND DANS UN PUITS 14 UNE SONDE 12 QUI COMPORTE DES ELECTRODES DE MESURE DE TENSION M, M, M, M, M, M ET AU MOINS UNE ELECTRODE EMETTRICE DE COURANT A QUI EMET ALTERNATIVEMENT UN COURANT D'ANALYSE ET UN COURANT DE FOCALISATION. LES TENSIONS ENGENDREES PAR CES COURANTS AUX ELECTRODES DE MESURE SONT MESUREES ET, A PARTIR DE CES TENSIONS ET DES COURANTS EMIS, ON CALCULE DES IMPEDANCES DE TRANSFERT AU MOYEN DESQUELLES ON PEUT CALCULER LA QUANTITE DE COURANT NECESSAIRE POUR FOCALISER CORRECTEMENT LA SONDE. LA RELATION ENTRE LES COURANTS D'ANALYSE ET DE FOCALISATION ETANT AINSI DEFINIE, ON PEUT EXPRIMER LA RESISTANCE APPARENTE DE LA FORMATION SOUS FORME D'UNE FONCTION DES IMPEDANCES DE TRANSFERT SANS AVOIR A MODIFIER LE COURANT DE FOCALISATION POUR FOCALISER EFFECTIVEMENT LA SONDE.</P>",GEARHART IND INC,CHEMALI ROLAND ELIAS;;DIRK WILLIAM CHARLES,,https://lens.org/117-221-490-138-469,Patent Application,no,0,3,4,4,0,G01V3/24,G01V3/24,,0,0,,,,DISCONTINUED
87,BE,A,BE 619471 A,192-386-812-322-193,1962-12-27,1962,BE 619471 A,1962-06-27,US 6177460 A,1960-10-10,Stabilisation des fluides organiques contre la décomposition due aux radiations,,MONSANTO CHEMICALS,YANKO WILLIAM HARRY;;GUTZKE MARK ELIAS,,https://lens.org/192-386-812-322-193,Granted Patent,no,0,0,2,2,0,G21C5/123;;Y02E30/30;;G21C5/123;;Y02E30/30,G21C5/12,,0,0,,,,EXPIRED
88,CA,A,CA 44004 A,010-573-436-501-035,1893-08-22,1893,CA 44004D A,,CA 44004T A,,WEATHER STRIP,,HUMPHREY WILLIAM S;;CANNON ELLIS ELIAS,HUMPHREY WILLIAM S;;CANNON ELLIS ELIAS,,https://lens.org/010-573-436-501-035,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
89,GB,A,GB 969275 A,028-886-414-371-779,1964-09-09,1964,GB 1750462 A,1962-05-07,GB 1750462 A,1962-05-07,Stabilization of organic fluids against radiation decomposition,A coolant and moderator for a neutronic power reactor comprises a mixture of a polyphenyl or polyphenyl ether and a hydrogenated polyphenyl. Many compounds of the above nature given.,MONSANTO CO,GUTZKE MARK ELIAS;;YANKO WILLIAM HARRY,,https://lens.org/028-886-414-371-779,Granted Patent,no,0,0,1,3,0,G21C5/123;;Y02E30/30,G21C5/12,G6C CLF           CLF;;G6C C39Y          CLF;;G6C C40X          CLF;;G6C C46Y          CLF;;G6C C464          CLF;;G6C C498          CLF;;G6C C50Y          CLF;;G6C C534          CLF,0,0,,,,EXPIRED
90,FR,A,FR 398344 A,046-981-365-656-601,1909-06-02,1909,FR 398344D A,1909-01-08,FR 398344T A,1909-01-08,"Roue à jante flexible et mobile, avec amortisseurs entre la jante et le moyeu",,ELIAS BERNHARD ANDERSON;;FRED WILLIAM BURGI,ANDERSON ELIAS BERNHARD;;BURGI FRED WILLIAM,,https://lens.org/046-981-365-656-601,Granted Patent,no,0,0,1,1,0,B60B9/06,B60B9/06,"X, 1",0,0,,,,EXPIRED
91,US,B2,US 8267604 B2,062-622-919-282-927,2012-09-18,2012,US 50026709 A,2009-07-09,US 50026709 A;;US 7958708 P,2008-07-10,Sheet discharge assembly for a printer,"A printer for printing individual sheets from a continuous feed roll includes a housing configured for receipt of a feed roll of sheet material, and a print mechanism disposed within the housing, whereby the sheet material is conveyed within the housing to print mechanism. A sheet separating device is disposed within the housing downstream of the print mechanism to separate the sheet material into individual printed sheets. A discharge assembly is disposed downstream of the sheet separating device and defines a gap through which the sheet material is advanced. At least one protruding member is disposed in the gap at a position so as to contact and deflect the sheet material and to impart a curved transverse profile to a trailing edge of a first individual sheet held in the gap. In this manner, a leading edge of a subsequent sheet bisects the curved trailing edge of the first sheet and pushes the first sheet out of the gap as the second sheet is advanced through the print mechanism.",CONWAY WILLIAM ELIAS;;HOLBROOK JAMES JONATHAN;;SCIENT GAMES INT INC,CONWAY WILLIAM ELIAS;;HOLBROOK JAMES JONATHAN,SCIENTIFIC GAMES LLC (2021-10-26);;SCIENTIFIC GAMES INTERNATIONAL INC (2009-07-20),https://lens.org/062-622-919-282-927,Granted Patent,yes,12,0,2,2,0,B41J11/70;;B41J15/04;;G07B1/00;;B41J15/04;;G07B1/00;;B41J11/70,B41J29/02;;B41J29/00;;B65H29/52;;B65H29/70,400/621;;400/645,1,0,,,"http://www.scientificgames.com/sections/lottery-systems/lottery-terminals.aspx (WAVE), Jun. 2008.",ACTIVE
92,DE,D1,DE 3071287 D1,054-676-292-874-593,1986-01-23,1986,DE 3071287 T,1980-09-01,US 7417579 A,1979-09-10,LOW INDUCTANCE ELECTROLYTIC CAPACITOR,,SANGAMO WESTON,ELIAS WILLIAM H;;GRANGER HAROLD M,,https://lens.org/054-676-292-874-593,Granted Patent,no,0,0,7,7,0,H01G9/06;;H01G9/06,H01G4/236;;H01G9/008;;H01G9/06;;H01G9/10;;H01G9/14,,0,0,,,,EXPIRED
93,CA,A,CA 1095741 A,073-943-914-067-239,1981-02-17,1981,CA 300978 A,1978-04-12,US 78776777 A,1977-04-15,TRANSMISSION WITH A FIRST-STAGE HYDROSTATIC MODE AND TWO HYDROMECHANICAL STAGES,"TRANSMISSION WITH A FIRST-STAGE HYDROSTATIC MODE AND TWO HYDROMECHANICAL STAGES A power transmission having two planetary assemblies, each having at least one carrier with planet gears, at least one sun gear, and at least one ring gear. A speed-varying module is connected in driving relation to the input shaft and in driving relationship to the sun gear or gears of the first planetary assembly. The speed-varying means may comprise a pair of hydraulic units hydraulically interconnected so that one serves as a pump while the other serves as a motor and vice versa, one of the units having a variable stroke and being connected in driving relation to the input shaft, the other unit, which may have a fixed stroke, being connected in driving relation to the sun gear. The input shaft is also connectable by a first clutch to a carrier of the first planetary assembly and by a second clutch to a sun gear of the second planetary assembly. A brake grounds the first carrier in the first range and in reverse and causes drive to be delivered to the output through a ring gear of the first planetary assembly in a hydrostatic mode. The carrier of the second planetary assembly being connected in driving relationship to the ring gear, and in all ranges these two elements transmit the drive to the output shaft.",ORSHANSKY TRANSMISSION CORP,ORSHANSKY JR ELIAS;;WESELOH WILLIAM E,,https://lens.org/073-943-914-067-239,Granted Patent,no,0,0,8,8,0,F16H47/04;;F16H2037/0886;;F16H2037/107;;F16H47/04;;F16H2037/0886;;F16H2037/107,F16H47/04,74-117,0,0,,,,EXPIRED
94,US,B1,US 9230013 B1,095-929-627-940-75X,2016-01-05,2016,US 201313788914 A,2013-03-07,US 201313788914 A,2013-03-07,Suffix searching on documents,"Embodiments of a system for searching text indices for suffixes are disclosed. Embodiments may include a suffix searching module at a computer configured to receive a query and identify the query as a suffix query, extract a suffix from an identified suffix query and reverse an order of characters in the suffix, and search a secondary index for terms corresponding to the reverse-ordered suffix, the secondary index comprising one or more lists of reverse-ordered terms from a primary index; a search reconfiguration module operably coupled to the suffix searching module and configured to receive from the suffix searching module found terms corresponding to the reverse-ordered suffix and reverse an order of the characters of the found terms; and a search module configured to implement a search of a primary index using reverse-ordered found terms received from the search reconfiguration module.",STOREDIQ INC;;IBM,PONVERT ELIAS;;KALTER WILLIAM;;SZALAY JOZSEF,INTERNATIONAL BUSINESS MACHINES CORPORATION (2014-02-12);;STOREDIQ INC (2013-03-04),https://lens.org/095-929-627-940-75X,Granted Patent,yes,23,1,1,1,0,G06F16/316;;G06F16/316,G06F17/30,,0,0,,,,ACTIVE
95,US,A,US 2963282 A,099-208-493-668-222,1960-12-06,1960,US 65671957 A,1957-05-02,US 65671957 A,1957-05-02,Fuel nozzle,,GEN MOTORS CORP,JACOBITZ WILLIAM G;;SCHEIBE ELIAS W,,https://lens.org/099-208-493-668-222,Granted Patent,no,7,4,1,1,0,F02M69/04;;F02M69/04,F02M69/04,,0,0,,,,EXPIRED
96,US,A,US 4894413 A,192-695-827-012-752,1990-01-16,1990,US 10714487 A,1987-10-09,US 10714487 A,1987-10-09,Polybutadiene-epoxy-anhydride laminating resins,Improvement in the method for preparing resin compositions for use as a laminate material in printed wiring boards wherein the resin composition is formed by mixing an epoxy-anhydride prepolymer with maleated polybutadiene and a suitable solvent. The improvement involves preparing the epoxy-anhydride prepolymer using a two step procedure instead of a single step. The two step procedure prevents uncontrolled exothermic reactions from occurring during preparation of commercial quantities of the epoxy-anhydride prepolymer and increases the versatility of the process since different anhydrides can be used in each of the two steps.,HUGHES AIRCRAFT CO,CATSIFF EPHRAIM H;;ELIAS WILLIAM E,HUGHES AIRCRAFT COMPANY A DE. CORP (1987-10-09);;HE HOLDINGS INC. A DELAWARE CORP (1997-12-17);;RAYTHEON COMPANY (1997-12-17),https://lens.org/192-695-827-012-752,Granted Patent,yes,3,8,1,1,0,B32B15/14;;C08G59/42;;C08J5/043;;C08L63/00;;H05K1/0326;;C08J5/241;;C08J5/249;;C08J5/043;;B32B15/14;;C08G59/42;;C08L63/00;;H05K1/0326;;C08J5/241;;C08J5/249,B32B15/14;;C08G59/42;;C08J5/04;;C08J5/24;;C08L63/00;;H05K1/03,525/65;;525/117,0,0,,,,EXPIRED
97,EP,A1,EP 0585590 A1,060-128-593-772-072,1994-03-09,1994,EP 93111705 A,1993-07-21,US 93932692 A,1992-09-02,"(Alpha, omega) phenylethynyl siloxane monomers, oligomers, and polymers thereof.","Novel acetylene-terminated silicone monomers with (a) silane (Si-H) functionalities, (b) silanol (Si-OH) functionalities, or (c) (alpha,omega)phenylethynyl terminated siloxanes, and a novel synthetic route. The (alpha,omega)phenylethynyl-terminated siloxane monomers are prepared, starting with 1,3-bromobenzene, which is converted to 3-TMS-ethynylbromobenzene, where TMS represents the trimethylsilyl group, by reacting 1,3-dibromobenzene with trimethylsilylacetylene and triethylamine in the presence of a palladium catalyst. The 3-bromo-TMS protected phenyl acetylene is then reacted with an alkyllithium compound, such as n-butyllithium, or with magnesium to form the corresponding lithio or Grignard compound, respectively, followed by reaction with a halogenated compound, such as chlorodimethylsilane, to form 3-trimethylsilyl-ethynylphenyldimethyl silane. Next, the TMS protected ethynylphenyl silane is subjected to deprotection and methanolysis of the Si-H bond to form 3-ethynylphenyldimethyl methoxy silane, employing methanol. This silane is then hydrolyzed to form the corresponding silanol. Finally, the silanol is then condensed by known methods to form the disiloxane. The disiloxane monomer can be reacted with a cyclic siloxane, having ≧3 silicon atoms, each independently substituted with hydrogen, C₁ to C₆ alkyl, phenyl, or phenyl substituted with one or more alkyl or halogen groups, to form oligomers. Both monomers and oligomers form thermoset polymers by heating to a temperature of at least about 250°C.",HUGHES AIRCRAFT CO,DOUGHERTY THOMAS K;;ELIAS WILLIAM E,,https://lens.org/060-128-593-772-072,Patent Application,yes,1,0,7,7,0,C07F7/0836;;C07F7/0896;;C08G77/045;;C08G77/20;;C08G77/455;;C07F7/0838;;C07F7/1804;;C07F7/0896;;C08G77/045;;C08G77/20;;C07F7/0836;;C08G77/455;;C07F7/1804;;C07F7/0838,C07F7/08;;C07F7/18;;C08F38/00;;C08F290/00;;C08F299/08;;C08G77/04;;C08G77/20;;C08G77/22;;C08G77/455,,2,1,108-035-174-927-380,10.1007/bf00294875,"MANTECON, A. ET AL.: ""DIETHYNYL TERMINATED SILOXANE BASES (BISAZOMETHINE SCHIFF BASE). PREPARATION AND POLYMERIZATION"", POLYMER BULLETIN, vol. 23, 1990, pages 439 - 445;;CHEMICAL ABSTRACTS, vol. 105, no. 16, 20 October 1986, Columbus, Ohio, US; abstract no. 135021q, MAUDGAL, S. ET AL.: ""SILOXANE CONTAINING ADDITION POLYIMIDES. II. ACETYLENE-TERMINATED POLYIMIDES"" page 49",EXPIRED
98,US,A,US 4114475 A,158-849-165-683-659,1978-09-19,1978,US 78776677 A,1977-04-15,US 78776677 A,1977-04-15,"Hydromechanical transmission with three simple planetary assemblies, one sun gear being mounted on the output shaft and the other two on a common shaft connected to an input-driven hydraulic module","A power transmission having three simple planetary assemblies, each having its own carrier and its own planet, sun, and ring gears. A speed-varying module is connected in driving relation to the input shaft and in driving relationship to the sun gears of the first two planetary assemblies, these two sun gears being connected together on a common shaft. The speed-varying means may comprise a pair of hydraulic units hydraulically interconnected so that one serves as a pump while the other serves as a motor and vice versa, one of the units having a variable stroke and being connected in driving relation to the input shaft, the other unit, which may have a fixed stroke, being connected in driving relation to the sun gears. The input shaft is also connected to drive the second ring gear and, furthermore is clutchable to the carrier of the third planetary assembly. A brake grounds the first carrier in the first range and in reverse and causes drive to be delivered to the output through the first ring gear in a hydrostatic mode. The carrier of the second planetary assembly drives the ring gear of the third planetary assembly, which is clutchable to the output shaft, and the sun gear of the third planetary assembly is mounted rigidly to the output shaft.",ORSHANSKY TRANSMISSION CORP,ORSHANSKY JR ELIAS;;WESELOH WILLIAM E,,https://lens.org/158-849-165-683-659,Granted Patent,yes,5,7,1,1,0,F16H47/04;;F16H2037/0886;;F16H2037/107;;F16H47/04;;F16H2037/107;;F16H2037/0886,F16H47/04,74/687,0,0,,,,EXPIRED
99,US,A,US 4134311 A,047-589-017-038-727,1979-01-16,1979,US 81370577 A,1977-07-07,US 81370577 A,1977-07-07,Hydromechanical transmission with two planetary assemblies that are clutchable to both the input and output shafts,"A power transmission having two planetary assemblies, each having its own carrier and its own planet, sun, and ring gears. A speed-varying module is connected in driving relation to the input shaft and in driving relationship to the two sun gears, which are connected together. The speed-varying means may comprise a pair of hydraulic units hydraulically interconnected so that one serves as a pump while the other serves as a motor and vice versa, one of the units having a variable stroke and being connected in driving relation to the input shaft, the other unit, which may have a fixed stroke, being connected in driving relation to the sun gears. A brake grounds the first carrier in the first range and in reverse and causes drive to be delivered to the output shaft through the first ring gear in a hydrostatic mode, the first ring gear being rigidly connected to the output shaft. The input shaft also is clutchable to either the carrier or the ring gear of the second planetary assembly. The output shaft is also clutchable to the carrier of the second planetary assembly when the input is clutched to the ring gear of the second planetary assembly, and is clutchable to the ring gear of the second planetary assembly when the input is clutched to the carrier thereof.",ORSHANSKY TRANSMISSION CORP,ORSHANSKY JR ELIAS;;WESELOH WILLIAM E,,https://lens.org/047-589-017-038-727,Granted Patent,yes,2,13,1,1,0,F16H47/04;;F16H47/04;;F16H2037/0886;;F16H2037/0886;;F16H2037/107;;F16H2037/107,F16H47/04,74/687,0,0,,,,EXPIRED
100,AU,A,AU 1977/023797 A,060-632-655-620-844,1978-01-19,1978,AU 1976/023797 A,1976-12-21,AU 856376 A,1976-12-21,PRESSURISED BLEEDING DEVICE,,GODFREY G R,GODFREY GEOFFREY RUSSELL;;ELIAS WILLIAM BARJAM,,https://lens.org/060-632-655-620-844,Patent Application,no,0,0,1,1,0,,B60S5/00;;F15B21/04,,0,0,,,,DISCONTINUED
101,DE,B,DE 1266889 B,103-232-497-621-897,1968-04-25,1968,DE M0053667 A,1962-07-23,DE M0053667 A;;GB 1750462 A,1962-05-07,"Mischung aus Polyphenylen und hydrierten Polyphenylen zur Verwendung als Kuehlmittel, Moderator oder hydraulische Fluessigkeit in Kernreaktoren",,MONSANTO CO,YANKO WILLIAM HARRY;;GUTZKE MARK ELIAS,,https://lens.org/103-232-497-621-897,Patent Application,no,0,0,1,3,0,G21C5/123;;Y02E30/30,G21C5/12,,1,0,,,None,DISCONTINUED
102,WO,A1,WO 2000/023667 A1,110-183-160-845-508,2000-04-27,2000,AU 1995/099008 W,1999-10-15,AU 1998/089317 A,1998-10-16,METHOD OF TREATING CONCRETE FOUNDATIONS FOR THE PREVENTION OF TERMITE INTRUSION,"A method of treating a section of concrete foundations, footings or piers (2) in such a way as to convert that section into a barrier against all forms of Subterranean Termite attack. This is accomplished by the use of a specially manufactured membrane (4) to be used in either conjunction with or replacement of the normal damproof membrane as used in the normal building procedure when a concrete section has to be poured. This membrane (4) is constructed in such a way as to hold in suspension a non-biodegradable termiticide that has been sprayed onto the face of the membrane (4), until the concrete (2) has been poured. The termiticide then becomes embedded between the concrete (2) and the membrane (4). Now when the concrete (2) begins to cure, the non-biodegradable termiticide will begin to absorb from out of the spongelike layer of the membrane (4) into the adjoining face of the concrete (2). This sectional area of the concrete structure has now become a permanent non-destructible barrier to all forms of subterranean termites.",BRIEN VINCENT WILLIAM O;;ELIAS STEPHEN PAUL,O'BRIEN VINCENT WILLIAM;;ELIAS STEPHEN PAUL,,https://lens.org/110-183-160-845-508,Patent Application,yes,8,0,3,4,0,A01M1/245;;A01M2200/011;;E04B1/72,A01M1/24;;E04B1/72,,0,0,,,,PENDING
103,DE,T2,DE 3587641 T2,164-037-362-398-930,1994-02-17,1994,DE 3587641 T,1985-07-31,US 64049084 A,1984-08-13,"VERTEILTER, GEMÄSS RAUMAUFLÖSUNG AUFGESTELLTER DEHNUNGSMESSER MIT OPTISCHER FASER.",,UNITED TECHNOLOGIES CORP,MELTZ GERALD;;GLENN WILLIAM;;SNITZER ELIAS,,https://lens.org/164-037-362-398-930,Granted Patent,no,0,0,8,11,0,G01L1/242;;G01B11/16;;G01D5/35383;;G01K5/52,G01L1/24;;G01B11/16;;G01D5/353;;G01K5/52;;G01K11/12,,0,0,,,,EXPIRED
104,DE,A1,DE 1521848 A1,184-525-421-516-932,1969-06-04,1969,DE 1521848 A,1964-01-13,US 25099763 A,1963-01-14,Verfahren zur Umwandlung von organischen Verbindungen in Gegenwart von Wasserstoff,,MONSANTO CO,GLENN JUHL WILLIAM;;ELIAS ROSENBERGER FREDERICK,,https://lens.org/184-525-421-516-932,Patent Application,no,0,4,3,3,0,B01J19/02;;B01J2219/0277;;C07C4/16;;C10G47/00;;C10G47/22,B01J19/02;;C07C4/16,,0,0,,,,PENDING
105,US,A,US 5078173 A,101-577-055-963-583,1992-01-07,1992,US 71526491 A,1991-06-14,US 71526491 A,1991-06-14,Droop compensated bypass valve,"A droop compensated bypass valve for use with a metering system having a high pressure fluid supply line, a metering valve connected to the high pressure supply line, and a low pressure supply line connected to the metering valve. The bypass valve includes a body defining a valve chamber, a piston slidably mounted in the valve chamber and including a head dividing the chamber into high and low pressure volumes, the high pressure volume being connected to the high pressure fluid supply line and the low pressure volume being connected to the low pressure supply line. The valve body includes a bypass line connecting the high pressure volume to a low pressure fluid source. A spring urges the piston toward the high pressure volume against high pressure fluid pressure from the high pressure line to cover and progressively shut off the bypass line. The piston includes an orifice therethrough connecting the high and low pressure volumes, and a diaphragm, connected to the spring, which deflects as the piston is displaced toward the low pressure volume thereby progressively closing the piston orifice such that a pressure diferential across the piston varies with the spring force exerted against the piston, thereby compensating for variations in the force applied by the spring as the piston changes position in the chamber.",GEN ELECTRIC,SPENCER WILLIAM R;;LEVINE ELIAS L,GENERAL ELECTRIC COMPANY A NEW YORK CORPORATION (1991-05-28),https://lens.org/101-577-055-963-583,Granted Patent,yes,11,15,2,2,0,F02C7/232;;G05D16/10;;G05D16/028;;Y10T137/2597;;Y10T137/2597;;F02C7/232;;G05D16/10;;G05D16/028,F02C7/232;;G05D7/00;;G05D16/10,137/117,0,0,,,,EXPIRED
106,FR,A,FR 991338 A,097-751-951-148-067,1951-10-04,1951,FR 991338D A,1949-07-23,NZ 991338X A;;NZ 2697972X A;;NZ 663494X A,1949-03-01,Cultivateur du type rotatif,,A A CORBAN & SONS LTD,MCINTOSH WILLIAM NEIL;;ATAYA GEORGE ELIAS,,https://lens.org/097-751-951-148-067,Granted Patent,no,0,0,3,5,0,A01B33/00;;A01B33/00,A01B33/00,,0,0,,,,EXPIRED
107,DE,T2,DE 69315916 T2,099-949-840-370-796,1998-08-27,1998,DE 69315916 T,1993-07-21,US 93932692 A,1992-09-02,"(Alpha, Omega)Phenylethinylsiloxanmonomere und daraus hergestellte Oligomere und Polymere",,HUGHES AIRCRAFT CO,DOUGHERTY THOMAS K;;ELIAS WILLIAM E,"RAYTHEON CO., LEXINGTON, MASS., US (2005-04-28)",https://lens.org/099-949-840-370-796,Granted Patent,no,0,0,7,7,0,C07F7/0836;;C07F7/0896;;C08G77/045;;C08G77/20;;C08G77/455;;C07F7/0838;;C07F7/1804;;C07F7/0896;;C08G77/045;;C08G77/20;;C07F7/0836;;C08G77/455;;C07F7/1804;;C07F7/0838,C07F7/08;;C07F7/18;;C08F38/00;;C08F290/00;;C08F299/08;;C08G77/04;;C08G77/20;;C08G77/22;;C08G77/455,,0,0,,,,EXPIRED
108,US,A,US 4352147 A,113-852-243-065-042,1982-09-28,1982,US 23209981 A,1981-02-06,US 23209981 A;;US 97416378 A,1978-12-28,Capacitor for high vibration environments having a controlled gas reservoir,"An electrolytic capacitor capable of withstanding high vibration environments includes a cylindrical capacitor case having an open end and a closed end, and cylindrically rolled alternate wraps of electrolyte impregnated paper and metal foil films with tabs abutting the foil films to electrically connect each of the foil films to a terminal. With the paper film on the outside of the cylindrical roll, the roll's outside diameter is tightly controlled to provide a snug fit when inserted in the case while the inside diameter of the roll is sized to provide a cylindrical volume in cubic inches equal to approximately 1.2 times the actual capacitance in farads times the desired rated voltage in volts so as to prevent a large pressure rise due to gas generation during capacitor operation. The paper films are axially longer than the other films towards the open end of the case while one of the foil films is axially longer towards the closed end of the case than the other films. When a cap and seal assembly is forced into the case to seal the open end, the terminals extend through the cap with one insulated and the other uninsulated from the cap. At the same time, the paper films are crushed against the cap to prevent flexing of the tabs between the foil films and the cap while the long foil film which is connected to the uninsulated terminal is crushed against the closed end of the capacitor case to allow heat transfer between the foil and the case.",SANGAMO WESTON,ELIAS WILLIAM H;;GRANGER HAROLD M,CORNELL-DUBLILIER MARKETING INC. (1987-05-07);;CORNELL-DUBIILIER MARKETING INC (1987-05-07),https://lens.org/113-852-243-065-042,Granted Patent,yes,11,10,1,1,0,H01G9/00;;H01G9/00,H01G9/00,361/433,0,0,,,,EXPIRED
109,GB,A,GB 190817612 A,192-053-640-803-525,1908-12-17,1908,GB 190817612D A,1908-08-21,GB 190817612T A,1908-08-21,"Improvements in and relating to Means for the Constant Disinfection of Speaking Tubes, Telephone Mouth-pieces or the like.","17,612. Gibberd, G. W., and Elias, O. A. Aug. 21. Speaking-tubes.-The mouthpieces of telephones, speakmg-tubes, &c. are disinfected by providing at the back of the mouthpiece holes c, which communicate with a box B on the outside of the mouthpiece containing antiseptic. In a modification shown in Fig. 7, the disinfectant is contained in a flask B'.",GIBBERD GEORGE WILLIAM;;ELIAS OWEN AUBREY,GIBBERD GEORGE WILLIAM;;ELIAS OWEN AUBREY,,https://lens.org/192-053-640-803-525,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
110,NO,B,NO 159322 B,075-254-084-102-208,1988-09-05,1988,NO 842169 A,1984-05-30,US 49927383 A,1983-05-31,FREMGANGSMAATE OG INNRETNING FOR REDUKSJON AV ANOMALIFORAARSAKEDE FEIL VED RESISTIVITETSMAALINGER I EN JORDFORMASJON.,,GEARHART IND INC,CHEMALI ROLAND ELIAS;;DIRK WILLIAM CHARLES,,https://lens.org/075-254-084-102-208,Unknown,no,0,0,9,10,0,G01V3/24,G01V3/24,,0,0,,,,EXPIRED
111,CH,A,CH 48282 A,097-511-833-638-02X,1910-10-01,1910,CH 48282D A,1909-06-04,CH 48282T A,1909-06-04,Dispositif de désinfection des embouchures des appareils pour la transmission de la parole,,GIBBERD GEORGE WILLIAM;;ELIAS OWEN AUBREY,GEORGE WILLIAM GIBBERD;;OWEN AUBREY ELIAS,,https://lens.org/097-511-833-638-02X,Granted Patent,no,0,0,1,1,0,,,120B,0,0,,,,EXPIRED
112,NO,C,NO 159322 C,131-690-700-815-480,1988-12-14,1988,NO 842169 A,1984-05-30,US 49927383 A,1983-05-31,FREMGANGSMAATE OG INNRETNING FOR REDUKSJON AV ANOMALIFORAARSAKEDE FEIL VED RESISTIVITETSMAALINGER I EN JORDFORMASJON.,,GEARHART IND INC,CHEMALI ROLAND ELIAS;;DIRK WILLIAM CHARLES,,https://lens.org/131-690-700-815-480,Granted Patent,no,0,0,9,10,0,G01V3/24,G01V3/24,,0,0,,,,EXPIRED
113,NO,L,NO 842170 L,167-292-480-625-361,1984-12-03,1984,NO 842170 A,1984-05-30,US 49927483 A,1983-05-31,FREMGANGSMAATE OG INNRETNING FOR UNDERSOEKELSE AV GEOLOGISKE FORMASJONER I BOREHULL,,GEARHART IND INC,CHEMALI ROLAND ELIAS;;DIRK WILLIAM CHARLES,,https://lens.org/167-292-480-625-361,Abstract,no,0,0,4,4,0,G01V3/24,G01V3/24,,0,0,,,,DISCONTINUED
114,US,A,US 4258585 A,028-685-225-744-58X,1981-03-31,1981,US 90221678 A,1978-05-02,US 90221678 A,1978-05-02,Four-range hydromechanical transmission with hydrostatic steering module,"A hydromechanical transmission especially suited to track-laying vehicles. A series of planetary assemblies are provided in conjunction with a hydrostatic driving module and a hydrostatic steering module. Every range may operate in both forward and reverse modes, and the change between forward and reverse can be made in any range. Efficient operation in moving straight ahead or back and on turns is assured.",ORSHANSKY TRANSMISSION CORP,ORSHANSKY JR ELIAS;;WESELOH WILLIAM E,,https://lens.org/028-685-225-744-58X,Granted Patent,yes,12,23,2,2,0,B62D11/18;;B62D11/18;;F16H47/02;;F16H47/02;;F16H47/04;;F16H47/04;;F16H2037/0886;;F16H2037/0886;;F16H2037/108;;F16H2037/108;;Y10T74/19033;;Y10T74/19033,F16H47/02;;F16H47/04,74/687,0,0,,,,EXPIRED
115,NO,L,NO 842169 L,134-625-433-535-22X,1984-12-03,1984,NO 842169 A,1984-05-30,US 49927383 A,1983-05-31,FREMGANGSMAATE OG INNRETNING FOR REDUKSJON AV ANOMALIFORAARSAKEDE FEIL VED MOTSTANDSMAALINGER PAA EN JORDFORMASJON,,GEARHART IND INC,CHEMALI ROLAND ELIAS;;DIRK WILLIAM CHARLES,,https://lens.org/134-625-433-535-22X,Abstract,no,0,0,9,10,0,G01V3/24,G01V3/24,,0,0,,,,EXPIRED
116,GB,A,GB 190902388 A,145-952-358-741-02X,1910-02-01,1910,GB 190902388D A,1909-02-01,GB 190902388T A,1909-02-01,Improvements in Connecting-links more especially intended for Joining Together Chains and Chain Cables.,"2388. Thompson, W. G. R., and Middleton, E. Feb. 1. Shackles.-Relates to connecting-links of the kind described in Specification 7951/06, and consists in-providing increased bearing-surfaces. The two parts A, B, Fig. 1, of the link are identical. Each has an undercut projection C of rectangular or approximately - rectangular cross - section, and a correspondingly - formed recess to receive the projection on the other part. The recesses are preferably fully open at the ends; but they may be partially closed by a strip D<2>, Fig. 7, which permits engagement from one side only. A stay-piece F, Fig. 7, formed with ribs f which slide in grooves g may be provided. The parts A, B are retained in position by pins E.",THOMPSON WILLIAM GEORGE REEVE;;MIDDLETON ELIAS,THOMPSON WILLIAM GEORGE REEVE;;MIDDLETON ELIAS,,https://lens.org/145-952-358-741-02X,Patent Application,no,0,2,1,1,0,F16G15/02,F16G15/02,,0,0,,,,DISCONTINUED
117,US,A,US 981243 A,169-287-706-258-557,1911-01-10,1911,US 1910/0579404 A,1910-08-29,US 1910/0579404 A,1910-08-29,MINING-BIT.,,BITTENBENDER WILLIAM W;;BITTENBENDER ELIAS G,BITTENBENDER WILLIAM W;;BITTENBENDER ELIAS G,,https://lens.org/169-287-706-258-557,Granted Patent,no,0,1,1,1,0,E21B10/44;;E21B10/44,,,0,0,,,,EXPIRED
118,US,A,US 4314313 A,015-669-060-969-390,1982-02-02,1982,US 7417579 A,1979-09-10,US 7417579 A,1979-09-10,Single and dual low inductance capacitor and header therefor,A capacitor which includes a case containing a capacitor element with multiple tabs extending therefrom is provided with a header which carries a pair of terminal members. Each of the terminal members has a pair of parallel connector leads extending out of the header connected by terminal portions inside the case. Each of the terminal portions includes portions parallel and nonparallel to corresponding terminal portions of the other terminal member and each of the tabs is welded to the outside of a parallel terminal portion.,SANGAMO WESTON,ELIAS WILLIAM H;;GRANGER HAROLD M,CORNELL-DUBLILIER MARKETING INC. (1987-05-07);;CORNELL-DUBIILIER MARKETING INC (1987-05-07),https://lens.org/015-669-060-969-390,Granted Patent,yes,7,4,7,7,0,H01G9/06;;H01G9/06,H01G9/008;;H01G4/236;;H01G9/06;;H01G9/10;;H01G9/14,361/433,0,0,,,,EXPIRED
119,US,A,US 3988949 A,086-903-509-146-545,1976-11-02,1976,US 49673774 A,1974-08-12,US 49673774 A;;US 47871974 A,1974-06-12,Split-torque power transmission,"A relatively inexpensive simplified type of split-torque power transmission. A simple planetary gear assembly is employed having a carrier connected to the input with a set of planet gears, a ring gear, and a sun gear. Suitable speed-varying means are used, such as two variable-stroke hydraulic units, each having rotary shafts and driving relation therewith, the two units being hydraulically connected together so that one serves as a pump while the other serves as a motor, and vice versa. Two gear trains respectively connect the ring gear to the first rotary shaft and the sun gear to the second rotary shaft. A first clutch means connects the first rotary shaft in driving relation to the output means, and a second clutch means connects the second rotary shaft in driving relation to the output shaft. A three-range transmission and a four-range transmission are also shown.",ORSHANSKY TRANSMISSION CORP,WESELOH WILLIAM E;;ORSHANSKY JR ELIAS,,https://lens.org/086-903-509-146-545,Granted Patent,yes,7,47,8,8,0,F16H47/04;;F16H47/04;;F16H3/72;;F16H3/72;;F16H2037/0873;;F16H2037/0873;;F16H2037/106;;F16H2037/106,F16H3/72;;F16H37/02;;F16H47/04,74/687,0,0,,,,EXPIRED
120,US,A,US 5329036 A,074-711-910-727-539,1994-07-12,1994,US 93932692 A,1992-09-02,US 93932692 A,1992-09-02,"(alpha, omega)phenylethynyl siloxane monomers, oligomers, and polymers thereof","Novel acetylene-terminated silicone monomers with (a) silane (Si--H) functionalities, (b) silanol (Si--OH) functionalities, or (c) (alpha,omega)phenylethynyl terminated siloxanes, and a novel synthetic route. The (alpha,omega)phenylethynyl-terminated siloxane monomers are prepared, starting with 1,3-bromobenzene, which is converted to 3-TMS-ethynylbromobenzene, where TMS represents the trimethylsilyl group, by reacting 1,3-dibromobenzene with trimethylsilylacetylene and triethylamine in the presence of a palladium catalyst. The 3-bromo-TMS protected phenyl acetylene is then reacted with an alkyllithium compound, such as n-butyllithium, or with magnesium to form the corresponding lithio or Grignard compound, respectively, followed by reaction with a halogenated compound, such as chlorodimethylsilane, to form 3-trimethylsilyl-ethynylphenyldimethyl silane. Next, the TMS protected ethynylphenyl silane is subjected to deprotection and methanolysis of the Si--H bond to form 3-ethynylphenyldimethyl methoxy silane, employing methanol. This silane is then hydrolyzed to form the corresponding silanol. Finally, the silanol is then condensed by known methods to form the disiloxane. The disiloxane monomer can be reacted with a cyclic siloxane, having .gtoreq.3 silicon atoms, each independently substituted with hydrogen, C.sub.1 to C.sub.6 alkyl, phenyl, or phenyl substituted with one or more alkyl or halogen groups, to form oligomers. Both monomers and oligomers form thermoset polymers by heating to a temperature of at least about 250.degree. C.",HUGHES AIRCRAFT CO,DOUGHERTY THOMAS K;;ELIAS WILLIAM E,HUGHES AIRCRAFT COMPANY A CORP. OF DE (1992-08-26);;HE HOLDINGS INC. A DELAWARE CORP (1997-12-17);;HE HOLDINGS INC (1995-12-08);;RAYTHEON COMPANY (1997-12-17),https://lens.org/074-711-910-727-539,Granted Patent,yes,4,6,7,7,0,C07F7/0836;;C07F7/0896;;C08G77/045;;C08G77/20;;C08G77/455;;C07F7/0838;;C07F7/1804;;C07F7/0896;;C08G77/045;;C08G77/20;;C07F7/0836;;C08G77/455;;C07F7/1804;;C07F7/0838,C07F7/08;;C07F7/18;;C08F38/00;;C08F290/00;;C08F299/08;;C08G77/04;;C08G77/20;;C08G77/22;;C08G77/455,556/453;;528/32,3,2,108-035-174-927-380;;171-488-489-056-563,10.1007/bf00294875;;10.1002/polb.1991.090290204,"Mantecon et al Diethynyl terminated siloxane bases (bisazomethine schiff base), Polymer Bulletin, vol. 23, 1990, pp. 439 445.;;Maud gal et al Siloxane containing addition polyimides. II. Acetylene Terminated polyimides, Chemical Abstracts, vol. 105, No. 16, Oct. 20, 1986, abstract No. 135021q.;;Y. Nagase et al, Chemical Modification of Poly(substitued acetylene). I. Syntheis and Gas Permeability of Poly(1 trimethylsilyl 1 propyne)/Poly(dimethylsiloxane) Graft Copolymer , in Journal of Polymer Science, Part B: Polymer Physics, vol. 29, pp. 171 179 (1991).",EXPIRED
121,EP,A1,EP 1053373 A1,110-032-477-485-979,2000-11-22,2000,EP 99970705 A,1999-10-15,AU 1995/099008 W;;AU 1998/089317 A,1998-10-16,METHOD OF TREATING CONCRETE FOUNDATIONS FOR THE PREVENTION OF TERMITE INTRUSION,,BRIEN VINCENT WILLIAM O;;ELIAS STEPHEN PAUL,O'BRIEN VINCENT WILLIAM;;ELIAS STEPHEN PAUL,,https://lens.org/110-032-477-485-979,Patent Application,yes,0,0,3,4,0,A01M1/245;;A01M2200/011;;E04B1/72,A01M1/24;;E04B1/72,,1,0,,,See references of WO 0023667A1,DISCONTINUED
122,GB,B,GB 2141237 B,157-903-679-308-328,1986-10-22,1986,GB 8413679 A,1984-05-29,US 49927383 A,1983-05-31,METHOD AND APPARATUS FOR REDUCING GROENINGEN EFFECT ERRORS IN RESISTIVITY MEASUREMENTS OF AN EARTH FORMATION,,GEARHART IND INC,CHEMALI ROLAND ELIAS;;DIRK WILLIAM CHARLES,,https://lens.org/157-903-679-308-328,Granted Patent,no,0,0,9,10,0,G01V3/24,G01V3/24,G1N19B2Q;;G1N19B4;;G1N19D10;;G1N19D1X,0,0,,,,EXPIRED
123,CA,A,CA 121414 A,150-989-624-218-89X,1909-10-26,1909,CA 121414D A,1909-05-28,CA 121414T A,1909-05-28,MOUTHPIECE FOR TELEPHONE TRANSMITTERS,,GIBBERD GEORGE WILLIAM;;ELIAS OWEN AUBREY,GIBBERD GEORGE WILLIAM;;ELIAS OWEN AUBREY,,https://lens.org/150-989-624-218-89X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
124,CA,A,CA 1064732 A,165-592-459-270-318,1979-10-23,1979,CA 301008 A,1978-04-12,US 78785177 A,1977-04-14,HYDROMECHANICAL TRANSMISSION,"HYDROMECHANICAL TRANSMISSION A power transmission having three planetary assemblies, each having its own carrier and its own planet, sun, and ring gears. A speed-varying module is connected in driving relation to the input shaft and in driving relationship to the three sun gears, all of which are connected together. The speed-varying means may comprise a pair of hydraulic units hydraulically interconnected so that one serves as a pump while the other serves as a motor and vice versa, one of the units having a variable stroke and being connected in driving relation to the input shaft, the other unit, which may have a fixed stroke, being connected in driving relation to the sun gears. The input shaft also drives the carrier of the third planetary assembly. A brake grounds the first carrier in the first range and in reverse and causes drive to be delivered to the output through the first ring gear in a hydrostatic mode. The carrier of the third planetary assembly drives the ring gear of the second planetary assembly, and a first clutching means connects the second carrier with the output in a second range, the brake for grounding the first carrier then being released. A second clutching means enables the third ring gear to drive the output shaft in a third range.",ORSHANSKY TRANSMISSION CORP,ORSHANSKY ELIAS JR;;WESELOH WILLIAM E,,https://lens.org/165-592-459-270-318,Granted Patent,no,0,0,2,2,0,F16H47/04;;F16H2037/0886;;F16H2037/107;;F16H47/04;;F16H2037/0886;;F16H2037/107,F16H47/04,74-117,0,0,,,,EXPIRED
125,GB,A,GB 2141549 A,181-719-658-628-939,1984-12-19,1984,GB 8413678 A,1984-05-29,US 49927483 A,1983-05-31,Method and apparatus for exploration of geological formations in boreholes,"For investigating geological formations penetrated by a borehole, a sonde 12 having a plurality of voltage measuring electrodes M0L - - - - - M2U and at least one current emitting electrode A0 is provided and adapted to be lowered into a borehole 14. During exploration, a selected survey current is periodically emitted from the current emitting electrode and selected voltages at various voltage measuring electrodes are recorded. A transfer impedance is calculated utilizing each of these selected voltages and the selected survey current. A selected focusing current is also periodically emitted and similar voltages and transfer impedances are measured and calculated. By utilizing the transfer impedance calculated for the survey current and the focusing current, the amount of focusing current necessary to properly focus the sonde is calculated and with the relationship of focusing current and survey current thus defined, the apparent resistivity of the geological formation may be expressed as a function of the transfer impedances without the necessity of continuously altering the focusing current to focus the sonde. <IMAGE>",GEARHART IND INC,CHEMALI ROLAND ELIAS;;DIRK WILLIAM CHARLES,,https://lens.org/181-719-658-628-939,Patent Application,no,4,3,4,4,0,G01V3/24,G01V3/24,G1N NCLC          CLC;;G1N N18A2A        CLC;;G1N N19B2Q        CLC;;G1N N19B4         CLC,0,0,,,,DISCONTINUED
126,US,A,US 4261226 A,183-520-074-541-711,1981-04-14,1981,US 2972379 A,1979-04-13,US 2972379 A,1979-04-13,Transmission with a first-stage hydrostatic mode and two hydromechanical stages,"A power transmission having two planetary assemblies, each having at least one carrier with planet gears, at least one sun gear, and at least one ring gear. A speed-varying module is connected in driving relation to the input shaft and in driving relationship to the sun gear or gears of the first planetary assembly. The speed-varying means may comprise a pair of hydraulic units hydraulically interconnected so that one serves as a pump while the other serves as a motor and vice versa, one of the units having a variable stroke and being connected in driving relation to the input shaft, the other unit, which may have a fixed stroke, being connected in driving relation to the sun gear. The input shaft is also connected directly to a sun gear of the second planetary assembly and is further connectable by a clutch to a carrier of the first planetary assembly. Another clutch enables connecting the carrier of the first planetary assembly to a ring gear of the second planetary assembly. A brake grounds the first carrier in the first range and in reverse and causes drive to be delivered to the output through a ring gear of the first planetary assembly in a hydrostatic mode. The carrier of the second planetary assembly is connected in rigid driving relationship to that first ring gear, and in all ranges these two elements transmit the drive to the output shaft.",ORSHANSKY TRANSMISSION CORP,ORSHANSKY JR ELIAS;;WESELOH WILLIAM E,,https://lens.org/183-520-074-541-711,Granted Patent,yes,10,13,1,1,0,F16H47/04;;F16H47/04;;F16H2037/0886;;F16H2037/0886;;F16H2037/107;;F16H2037/107,F16H47/04,74/687,0,0,,,,EXPIRED
127,US,A,US 979467 A,199-893-675-776-009,1910-12-27,1910,US 1909/0499048 A,1909-05-28,US 1909/0499048 A,1909-05-28,TELEPHONE-MOUTHPIECE.,,GIBBERD GEORGE WILLIAM;;ELIAS OWEN AUBREY,GIBBERD GEORGE WILLIAM;;ELIAS OWEN AUBREY,,https://lens.org/199-893-675-776-009,Granted Patent,no,0,0,1,1,0,H04R1/12;;H04R1/12,,,0,0,,,,EXPIRED
128,FR,B1,FR 2547063 B1,033-162-710-446-955,1993-04-30,1993,FR 8408401 A,1984-05-29,US 49927383 A,1983-05-31,PROCEDE ET APPAREIL POUR REDUIRE LES ERREURS DUES A L'EFFET GROENINGEN DANS LES MESURES DE RESISTIVITE D'UNE FORMATION TERRESTRE,,GEARHART IND INC,CHEMALI ROLAND ELIAS;;DIRK WILLIAM CHARLES,,https://lens.org/033-162-710-446-955,Granted Patent,no,0,0,9,10,0,G01V3/24,G01V3/24,,0,0,,,,EXPIRED
129,EP,B1,EP 0025902 B1,035-770-517-437-522,1985-12-11,1985,EP 80105187 A,1980-09-01,US 7417579 A,1979-09-10,LOW INDUCTANCE ELECTROLYTIC CAPACITOR,,"SANGAMO WESTON, INC.","ELIAS, WILLIAM H.;;GRANGER, HAROLD M.",,https://lens.org/035-770-517-437-522,Granted Patent,yes,0,0,7,7,0,H01G9/06;;H01G9/06,H01G4/236;;H01G9/008;;H01G9/06;;H01G9/10;;H01G9/14,,0,0,,,,EXPIRED
130,CA,A,CA 1020776 A,054-955-051-441-844,1977-11-15,1977,CA 228207 A,1975-06-02,US 47871974 A;;US 49673774 A,1974-06-12,SPLIT-TORQUE POWER TRANSMISSION,,ORSHANSKY TRANSMISSION CORP,WESELOH WILLIAM E;;ORSHANSKY ELIAS JR,,https://lens.org/054-955-051-441-844,Granted Patent,no,0,0,8,8,0,F16H47/04;;F16H47/04;;F16H3/72;;F16H3/72;;F16H2037/0873;;F16H2037/0873;;F16H2037/106;;F16H2037/106,F16H3/72;;F16H37/02;;F16H47/04,74-104,0,0,,,,EXPIRED
131,DE,A1,DE 2525888 A1,142-465-877-847-099,1976-01-02,1976,DE 2525888 A,1975-06-10,US 47871974 A;;US 49673774 A,1974-06-12,LEISTUNGSVERZWEIGTES GETRIEBE,,ORSHANSKY TRANSMISSION CORP,WESELOH WILLIAM EDWIN;;ORSHANSKY JUN ELIAS,,https://lens.org/142-465-877-847-099,Patent Application,no,0,0,8,8,0,F16H47/04;;F16H47/04;;F16H3/72;;F16H3/72;;F16H2037/0873;;F16H2037/0873;;F16H2037/106;;F16H2037/106,F16H3/72;;F16H37/02;;F16H47/04,,0,0,,,,DISCONTINUED
132,EP,A1,EP 0518594 A1,135-130-179-711-647,1992-12-16,1992,EP 92305232 A,1992-06-08,US 71526491 A,1991-06-14,Droop compensated bypass valve.,"A droop compensated bypass valve (50) for use with a metering system (10) having a high pressure fluid supply line (14), a metering valve (16) connected to the high pressure supply line, and a low pressure supply line (18) connected to the metering valve. The bypass valve includes a body (52) defining a valve chamber (54), a piston (56) slidably mounted in the valve chamber and including a head (58) dividing the chamber into high and low pressure volumes (60,62), the high pressure volume being connected to the high pressure fluid supply line (64) and the low pressure volume being connected to the low pressure supply line (66). The valve body includes a bypass line (88) connecting the high pressure volume to a low pressure fluid source. A spring (70) urges the piston toward the high pressure volume against high pressure fluid pressure from the high pressure line to cover and progressively shut off the bypass line. The piston includes an orifice (84) therethrough connecting the high and low pressure volumes, and a diaphragm (74), connected to the spring, which deflects as the piston is displaced toward the low pressure volume thereby progressively closing the piston orifice such that a pressure differential across the piston varies with the spring force exerted against the piston, thereby compensating for variations in the force applied by the spring as the piston changes position in the chamber.",GEN ELECTRIC,SPENCER WILLIAM RALPH;;LEVINE ELIAS LIONEL,,https://lens.org/135-130-179-711-647,Patent Application,yes,2,11,2,2,0,F02C7/232;;G05D16/10;;G05D16/028;;Y10T137/2597;;Y10T137/2597;;F02C7/232;;G05D16/10;;G05D16/028,F02C7/232;;G05D7/00;;G05D16/10,,0,0,,,,DISCONTINUED
133,US,A,US 4196644 A,142-267-701-794-838,1980-04-08,1980,US 90221178 A,1978-05-02,US 90221178 A,1978-05-02,Hydromechanical transmission with compound planetary assembly,"A power transmission having three distinct ranges: (1) hydrostatic, (2) simple power-split hydromechanical, and (3) compound power-split hydromechanical. A single compound planetary assembly has two sun gears, two ring gears, and a single carrier with two sets of elongated planet gears. The two sun gears may be identical in size, and the two ring gears may be identical in size. A speed-varying module in driving relationship to the first sun gear is clutchable, in turn, to (1) the input shaft and (2) the second sun gear. The speed-varying means may comprise a pair of hydraulic units hydraulically interconnected so that one serves as a pump while the other serves as a motor and vice versa, one of the units having a variable stroke and being the one clutchable to either the input shaft or to the second sun gear. The other unit, which may have a fixed stroke, is connected in driving relation to the first sun gear. A brake grounds the carrier in the first range and in reverse and causes drive to be delivered to the output shaft through the first ring gear in a hydrostatic mode, the first ring gear being rigidly connected to the output shaft. The input shaft is also clutchable to the second ring gear of the compound planetary assembly.",ORSHANSKY TRANSMISSION CORP,ORSHANSKY ELIAS JR;;WESELOH WILLIAM E,,https://lens.org/142-267-701-794-838,Granted Patent,yes,4,10,1,1,0,F16H47/04;;F16H2037/0886;;F16H2037/107;;F16H47/04;;F16H2037/107;;F16H2037/0886,F16H47/04,74/687,0,0,,,,EXPIRED
134,GB,A,GB 190900467 A,142-597-472-463-913,1909-12-16,1909,GB 190900467D A,1909-01-07,GB 190900467T A,1909-01-07,An Improved Spring Wheel.,"467. Andersen, E. B., and Burgi, F. W. Jan. 7. Spring wheels with continuous outer rigid ring and helical springs or pneumatic cushions. -A wide hub-disk 2, Figs. 1 and 2, is formed with apertures 12, through which pass bolts 11 connecting plates 7 secured to the rim. The outer edges of the plates clamp the tyre 9 which rests on a rim 8 supported by transverse bolts 10. The periphery of the hub is widened to support the fixed inner ends of cushions which bear against the rim in all positions. Dished plates 5 are bolted to the hub and partly enclose the cushions, comprising telescopic members, the pistons of which are secured to the hub. As shown, helical springs butting against heads 16<a> are used, but these may be replaced by enclosed pneumatic cushions.",ANDERSON ELIAS BERNHARD;;BURGI FRED WILLIAM,ANDERSON ELIAS BERNHARD;;BURGI FRED WILLIAM,,https://lens.org/142-597-472-463-913,Patent Application,no,0,1,1,1,0,B60B9/26,B60B9/26,,0,0,,,,DISCONTINUED
135,DE,D1,DE 69315916 D1,021-591-634-892-960,1998-02-05,1998,DE 69315916 T,1993-07-21,US 93932692 A,1992-09-02,"(Alpha, Omega)Phenylethinylsiloxanmonomere und daraus hergestellte Oligomere und Polymere",,HUGHES AIRCRAFT CO,DOUGHERTY THOMAS K;;ELIAS WILLIAM E,"RAYTHEON CO., LEXINGTON, MASS., US (2005-04-28)",https://lens.org/021-591-634-892-960,Granted Patent,no,0,0,7,7,0,C07F7/0836;;C07F7/0896;;C08G77/045;;C08G77/20;;C08G77/455;;C07F7/0838;;C07F7/1804;;C07F7/0896;;C08G77/045;;C08G77/20;;C07F7/0836;;C08G77/455;;C07F7/1804;;C07F7/0838,C07F7/08;;C07F7/18;;C08F38/00;;C08F290/00;;C08F299/08;;C08G77/04;;C08G77/20;;C08G77/22;;C08G77/455,,0,0,,,,EXPIRED
136,US,A1,US 2010/0008710 A1,005-279-345-049-663,2010-01-14,2010,US 50026709 A,2009-07-09,US 50026709 A;;US 7958708 P,2008-07-10,Sheet Discharge Assembly for a Printer,"A printer for printing individual sheets from a continuous feed roll includes a housing configured for receipt of a feed roll of sheet material, and a print mechanism disposed within the housing, whereby the sheet material is conveyed within the housing to print mechanism. A sheet separating device is disposed within the housing downstream of the print mechanism to separate the sheet material into individual printed sheets. A discharge assembly is disposed downstream of the sheet separating device and defines a gap through which the sheet material is advanced. At least one protruding member is disposed in the gap at a position so as to contact and deflect the sheet material and to impart a curved transverse profile to a trailing edge of a first individual sheet held in the gap. In this manner, a leading edge of a subsequent sheet bisects the curved trailing edge of the first sheet and pushes the first sheet out of the gap as the second sheet is advanced through the print mechanism.",SCIENT GAMES INT INC,CONWAY WILLIAM ELIAS;;HOLBROOK JAMES JONATHAN,SCIENTIFIC GAMES LLC (2021-10-26);;SCIENTIFIC GAMES INTERNATIONAL INC (2009-07-20),https://lens.org/005-279-345-049-663,Patent Application,yes,12,6,2,2,0,B41J11/70;;B41J15/04;;G07B1/00;;B41J15/04;;G07B1/00;;B41J11/70,B41J33/00,400/223,0,0,,,,ACTIVE
137,AU,A,AU 1974/067609 A,021-768-081-046-561,1975-10-09,1975,AU 1974/067609 A,1974-04-05,US 41878673 A,1973-11-23,PORTABLE MATERIAL RESLURRING APPARATUS,,MARCONA CORP,GHUSN ABDALLAH ELIAS;;ARCHIBALD WILLIAM RICHARD,,https://lens.org/021-768-081-046-561,Patent Application,no,0,0,16,18,0,B65G53/30,B65G53/30,,0,0,,,,DISCONTINUED
138,US,A,US 641717 A,035-537-370-248-557,1900-01-23,1900,US 1898/0700849 A,1898-12-31,US 1898/0700849 A,1898-12-31,WEB-FEEDING MECHANISM.,,GERTRUDE PRINCE COOMBS;;MILLER WILLIAM V;;DUNN ELIAS B,MILLER WILLIAM V;;DUNN ELIAS B,,https://lens.org/035-537-370-248-557,Granted Patent,no,0,0,1,1,0,G03B1/18;;G03B1/18,,,0,0,,,,EXPIRED
139,US,A,US 4116089 A,091-999-617-716-808,1978-09-26,1978,US 78785177 A,1977-04-14,US 78785177 A,1977-04-14,Hydromechanical transmission,"A power transmission having three planetary assemblies, each having its own carrier and its own planet, sun, and ring gears. A speed-varying module is connected in driving relation to the input shaft and in driving relationship to the three sun gears, all of which are connected together. The speed-varying means may comprise a pair of hydraulic units hydraulically interconnected so that one serves as a pump while the other serves as a motor and vice versa, one of the units having a variable stroke and being connected in driving relation to the input shaft, the other unit, which may have a fixed stroke, being connected in driving relation to the sun gears. The input shaft also drives the carrier of the third planetary assembly. A brake grounds the first carrier in the first range and in reverse and causes drive to be delivered to the output through the first ring gear in a hydrostatic mode. The carrier of the third planetary assembly drives the ring gear of the second planetary assembly, and a first clutching means connects the second carrier with the output in a second range, the brake for grounding the first carrier then being released. A second clutching means enables the third ring gear to drive the output shaft in a third range.",ORSHANSKY TRANSMISSION CORP,ORSHANSKY ELIAS JR;;WESELOH WILLIAM E,,https://lens.org/091-999-617-716-808,Granted Patent,yes,3,11,2,2,0,F16H47/04;;F16H2037/0886;;F16H2037/107;;F16H47/04;;F16H2037/0886;;F16H2037/107,F16H47/04,74/687,0,0,,,,EXPIRED
140,DE,D1,DE 3587641 D1,094-173-181-556-847,1993-12-02,1993,DE 3587641 T,1985-07-31,US 64049084 A,1984-08-13,"VERTEILTER, GEMÄSS RAUMAUFLÖSUNG AUFGESTELLTER DEHNUNGSMESSER MIT OPTISCHER FASER.",,UNITED TECHNOLOGIES CORP,MELTZ GERALD;;GLENN WILLIAM;;SNITZER ELIAS,,https://lens.org/094-173-181-556-847,Granted Patent,no,0,0,8,11,0,G01L1/242;;G01B11/16;;G01D5/35383;;G01K5/52,G01L1/24;;G01B11/16;;G01D5/353;;G01K5/52;;G01K11/12,,0,0,,,,EXPIRED
141,AU,A,AU 2000/011392 A,104-870-082-754-99X,2000-05-08,2000,AU 2000/011392 A,1999-10-15,AU 1998/089317 A;;AU 1995/099008 W;;AU 2000/011392 A,1998-10-16,Method of treating concrete foundations for the prevention of termite intrusion,,ELIAS STEPHEN PAUL;;OBRIEN VINCENT WILLIAM,O'BRIEN VINCENT WILLIAM;;ELIAS STEPHEN PAUL,,https://lens.org/104-870-082-754-99X,Patent Application,no,0,0,1,4,0,,A01M1/24;;E04B1/72,,0,0,,,,DISCONTINUED
142,US,A,US 4168637 A,140-271-543-237-698,1979-09-25,1979,US 78776777 A,1977-04-15,US 78776777 A,1977-04-15,Transmission with a first-stage hydrostatic mode and two hydromechanical stages,"A power transmission having two planetary assemblies, each having at least one carrier with planet gears, at least one sun gear, and at least one ring gear. A speed-varying module is connected in driving relation to the input shaft and in driving relationship to the sun gear or gears of the first planetary assembly. The speed-varying means may comprise a pair of hydraulic units hydraulically interconnected so that one serves as a pump while the other serves as a motor and vice versa, one of the units having a variable stroke and being connected in driving relation to the input shaft, the other unit, which may have a fixed stroke, being connected in driving relation to the sun gear. The input shaft is also connectable by a first clutch to a carrier of the first planetary assembly and by a second clutch to a sun gear of the second planetary assembly. A brake grounds the first carrier in the first range and in reverse and causes drive to be delivered to the output through a ring gear of the first planetary assembly in a hydrostatic mode. The carrier of the second planetary assembly being connected in driving relationship to that ring gear, and in all ranges these two elements transmit the drive to the output shaft.",ORSHANSKY TRANSMISSION CORP,ORSHANSKY JR ELIAS;;WESELOH WILLIAM E,,https://lens.org/140-271-543-237-698,Granted Patent,yes,8,15,8,8,0,F16H47/04;;F16H2037/0886;;F16H2037/107;;F16H47/04;;F16H2037/0886;;F16H2037/107,F16H47/04,74/687,0,0,,,,EXPIRED
143,US,A,US 4761073 A,069-405-816-345-642,1988-08-02,1988,US 91589186 A,1986-10-03,US 91589186 A;;US 64049084 A,1984-08-13,"Distributed, spatially resolving optical fiber strain gauge","A distributed, spatially resolving optical fiber strain gauge in which the core of the optical fiber is written with periodic grating patterns effective for transmitting and reflecting light injected into the core. Spectral shifts in the transmitted and reflected light indicate the intensity of strain or temperature variations at positions of the grating corresponding to the associated wavelengths of injected light.",UNITED TECHNOLOGIES CORP,MELTZ GERALD;;GLENN WILLIAM H;;SNITZER ELIAS,,https://lens.org/069-405-816-345-642,Granted Patent,yes,8,187,1,11,0,G01B11/16;;G01D5/35383;;G01K5/52;;G01L1/242;;G01L1/242;;G01B11/16;;G01K5/52;;G01D5/35383,G01B11/16;;G01D5/353;;G01K5/52,356/32;;73/800;;250/227,1,1,054-867-069-869-398,20396175;;10.1364/ao.21.003059,"S. K. Yao et al, Applied Optics, vol. 21, pp. 3059 3060, (1982).",EXPIRED
144,CA,A,CA 129054 A,170-933-279-794-038,1910-11-01,1910,CA 129054D A,1909-09-10,CA 129054T A,1909-09-10,APPARATUS FOR BESSEMERIZING COPPER MATTES,,PEIRCE SMITH CONVERTER COMPANY;;PIERCE WILLIAM H;;SMITH ELIAS A C,PIERCE WILLIAM H;;SMITH ELIAS A C,,https://lens.org/170-933-279-794-038,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
145,JP,A,JP 2023089266 A,059-401-624-983-390,2023-06-27,2023,JP 2023069966 A,2023-04-21,JP 2019528645 A;;US 201662427293 P;;US 2017/0063561 W,2016-11-29,APPARATUS AND METHOD FOR EDGE PROCESSING OF SHEET-LIKE SUBSTRATE,"To provide an alternative apparatus and a method for finishing an edge of a glass sheet by combining with a discharged cooling agent.SOLUTION: A finishing member is rotatably maintained in a chamber of a shroud. The shroud includes a wall part 52 terminated at a long edge for defining a part of a slot. The slot is structured so as to receive an end part of a sheet-like substrate, and facilitates a mutual action between the end part and the finishing member. The wall part 52 further defines nozzle passages 90a, 90b, 90c, 92a, 92b, 92c terminated at an opening of the long edge. Tubular members 80, 110a, 110b, 110c, 112a, 112b, 112c protrude from the long edges 60, 62, and define a passage which is in fluid communication with the nozzle passages 90a, 90b, 90c, 92a, 92b, 92c. A cooling agent discharged to the nozzle passages 90a, 90b, 90c, 92a, 92b, 92c is jetted to the finishing member through the tubular members even when a cross flow by vacuum exists.SELECTED DRAWING: Figure 3",CORNING INC,JAMES WILLIAM BROWN;;WAYMING LEE;;PANIDES ELIAS,,https://lens.org/059-401-624-983-390,Patent Application,no,0,0,10,10,0,B24B55/02;;B24B9/10;;B24B9/10;;B24B55/02;;B24B55/06;;B24B9/10;;B24B55/02,B24B55/02;;B24B55/06,,0,0,,,,PENDING
146,WO,A1,WO 1986/001286 A1,112-228-485-955-026,1986-02-27,1986,US 8501450 W,1985-07-31,US 64049084 A,1984-08-13,"DISTRIBUTED, SPATIALLY RESOLVING OPTICAL FIBER STRAIN GAUGE","A distributed, spatially resolving optical fiber strain gauge (13) in which the core (19) of the optical fiber (15) is written with periodic grating patterns (16) effective for transmitting and reflecting light injected into the core (19). Spectral shifts in the transmitted and reflected light indicate the intensity of strain or temperature variations at positions of the grating (16) corresponding to the associated wavelength of injected light.",UNITED TECHNOLOGIES CORP,MELTZ GERALD;;GLENN WILLIAM H;;SNITZER ELIAS,,https://lens.org/112-228-485-955-026,Patent Application,yes,2,33,8,11,0,G01L1/242;;G01B11/16;;G01D5/35383;;G01K5/52,G01L1/24;;G01B11/16;;G01D5/353;;G01K5/52;;G01K11/12,G1A AA5           CDL(F);;G1A AA6           CDL(F);;G1A AA7           CDL(F);;G1A ACD           CDL(F);;G1A ACEW          CEW;;G1A AG1           CDL(F);;G1A AG4           CDL(F);;G1A AG7           CDL(F);;G1A AP17          CDL(F);;G1A AP6           CDL(F);;G1A AR7           CDL(F);;G1A AS4           CDL(F);;G1A AT14          CDL(F);;G1A AT23          CDL(F);;G1A AT5           CDL(F);;G1A AT8           CDL(F);;U1S S2166;;U1S S2171,1,0,,,See also references of EP 0192659A4,PATENTED
147,EP,A1,EP 0192659 A1,114-564-636-172-981,1986-09-03,1986,EP 85903956 A,1985-07-31,US 64049084 A,1984-08-13,"DISTRIBUTED, SPATIALLY RESOLVING OPTICAL FIBER STRAIN GAUGE.",Sur l'âme (19) de la fibre optique (15) de cette jauge de contrainte (13) sont inscrits des motifs de réseau périodique (16) efficaces pour transmettre et réfléchir la lumière injectée dans l'âme (19). Des décalages spectraux de la lumière transmise et de la lumière réfléchie indiquent l'intensité des variations de contrainte ou de température en des positions du réseau (16) correspondant à la longueur d'onde de la lumière injectée.,UNITED TECHNOLOGIES CORP,MELTZ GERALD;;GLENN WILLIAM H;;SNITZER ELIAS,,https://lens.org/114-564-636-172-981,Patent Application,yes,0,0,8,11,0,G01L1/242;;G01B11/16;;G01D5/35383;;G01K5/52,G01L1/24;;G01B11/16;;G01D5/353;;G01K5/52;;G01K11/12,,0,0,,,,EXPIRED
148,CN,A,CN 110087830 A,127-164-180-684-696,2019-08-02,2019,CN 201780073900 A,2017-11-29,US 201662427293 P;;US 2017/0063561 W,2016-11-29,APPARATUS AND METHOD FOR EDGE PROCESSING OF SUBSTRATE SHEET,"An apparatus for processing an edge of a substrate sheet is provided. The apparatus includes a finishing member, a shroud, and a tubular member. The finishing member is rotatably maintained within a chamber of the shroud. The shroud includes a wall segment terminating at a major edge that defines a portion of a slot. The slot is configured to receive the edge of the substrate sheet, facilitating interface of the edge with the finishing member. The wall segment further defines a nozzle passageway that terminates at an opening in the major edge. The tubular member projects from the major edge and defines a passage in fluid communication with the nozzle passageway. Cooling agent delivered to the nozzle passageway is injected onto the finishing member via the tubular member even in the presence of vacuum induced cross-flow. In some embodiments, a spatial arrangement of the tubular member is adjustable.",CORNING INC,BROWN JAMES WILLIAM;;LI WEIMING;;PANIDES ELIAS,,https://lens.org/127-164-180-684-696,Patent Application,no,16,0,10,10,0,B24B55/02;;B24B9/10;;B24B9/10;;B24B55/02;;B24B55/06;;B24B9/10;;B24B55/02,B24B9/10;;B24B55/02;;B24B55/06,,0,0,,,,PENDING
149,US,B1,US 10457159 B1,156-790-839-050-836,2019-10-29,2019,US 201615250906 A,2016-08-29,US 201615250906 A;;US 201414231728 A;;US 90881610 A,2010-10-20,Power share converter for connecting multiple energy storage systems,"A system comprises a plurality of power converters, a plurality of energy storage systems, a first common node, a second common node, and zero-reference voltage node. Each power converter is coupled between one energy storage system and the first and second common nodes. The system operates to regulate power between the power converters and the first and second common nodes. Each power converter is a bi-directional power converter and each energy storage system is a battery pack. In one example, the first common node is regulated to a voltage VSPAN, and the second common node is regulated to a voltage VSCN which is the mean of all voltages output by the battery packs. In another example, the first common node is regulated to a voltage −VSPAN, and the second common node is regulated to a voltage +VSPAN. No power converter processes more than voltage VSPAN yielding high-efficiency power conversion.",MOTIV POWER SYSTEMS INC,CASTELAZ JIM MICHAEL;;STEIN ELIAS;;TREICHLER WILLIAM,MOTIV POWER SYSTEMS INC (2016-08-30),https://lens.org/156-790-839-050-836,Granted Patent,yes,3,6,1,1,0,B60L3/12;;B60L53/22;;B60L1/02;;B60L58/18;;B60L2210/10;;B60L2210/10;;B60L2240/547;;B60L2240/549;;H02J7/1423;;H02J7/34;;H02M1/0058;;H02M1/007;;H02M1/346;;H02M3/158;;H02M3/1582;;H02M7/487;;H02M7/53871;;H02P27/06;;H02P29/66;;Y02T10/70;;Y02T10/7072;;Y02T10/72;;Y02T10/92;;Y02T90/14,H02J1/10;;B60L1/02;;B60L53/22;;H02J3/06;;H02J3/46;;H02P27/06;;H02P29/66,,0,0,,,,ACTIVE
150,US,A1,US 2016/0243031 A1,091-136-604-180-166,2016-08-25,2016,US 201615148574 A,2016-05-06,US 201615148574 A;;US 201615057711 A;;US 201414461242 A;;US 201414227819 A;;US 201361958170 P,2013-07-22,PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF,"Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.",IMPRIMIS PHARMACEUTICALS INC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2018-12-27);;HARROW IP LLC (2019-11-01),https://lens.org/091-136-604-180-166,Patent Application,yes,12,16,1,52,0,A61K38/08;;A61K45/06;;A61K47/10;;A61K9/1641;;A61F9/008;;A61F9/00827;;A61K31/496;;A61K31/58;;A61F2009/00872;;A61F2009/00853;;A61K9/0048;;A61K31/4709;;A61K31/573;;A61K47/32;;A61K38/14;;A61K31/196;;A61K9/0048;;A61K31/4709;;A61K31/573;;A61K47/32;;A61K38/14;;A61K31/196;;A61K38/08;;A61K47/10;;A61F2009/00872;;A61K9/1641;;A61F2009/00853;;A61F9/008;;A61F9/00827;;A61K31/496;;A61K31/58;;A61K45/06,A61K9/00;;A61K31/196;;A61K31/4709;;A61K31/573;;A61K38/08;;A61K38/14;;A61K47/32,,2,2,052-698-748-877-456;;052-698-748-877-456,10.1089/jop.1993.9.167;;8345289;;10.1089/jop.1993.9.167;;8345289,Huerva. Levels of Vancomycin in Aqueous Humor After Topical Eye Drops Administration. 11/1993.;;Huerva. Levels of Vancomycin in Aqueous Humor After Topical Eye Drops Administration. 11/1993.,DISCONTINUED
151,WO,A1,WO 2018/102327 A1,157-178-357-201-035,2018-06-07,2018,US 2017/0063561 W,2017-11-29,US 201662427293 P,2016-11-29,APPARATUS AND METHOD FOR EDGE PROCESSING OF A SUBSTRATE SHEET,"An apparatus for processing an edge of a substrate sheet. The apparatus includes a finishing member, a shroud, and a tubular member. The finishing member is rotatably maintained within a chamber of the shroud. The shroud includes a wall segment terminating at a major edge that defines a portion of a slot. The slot is configured to receive the edge of the substrate sheet, facilitating interface of the edge with the finishing member. The wall segment further defines a nozzle passageway that terminates at an opening in the major edge. The tubular member projects from the major edge and defines a passage in fluid communication with the nozzle passageway. Cooling agent delivered to the nozzle passageway is injected onto the finishing member via the tubular member even in the presence of vacuum induced cross-flow. In some embodiments, a spatial arrangement of the tubular member is adjustable.",CORNING INC,BROWN JAMES WILLIAM;;LI WEIMING;;PANIDES ELIAS,,https://lens.org/157-178-357-201-035,Patent Application,yes,5,0,10,10,0,B24B55/02;;B24B9/10;;B24B9/10;;B24B55/02;;B24B55/06;;B24B9/10;;B24B55/02,B24B9/10;;B24B55/02;;B24B55/06,,0,0,,,,PENDING
152,US,A,US 4725110 A,104-722-809-994-210,1988-02-16,1988,US 92551286 A,1986-10-27,US 92551286 A;;US 64048984 A,1984-08-13,Method for impressing gratings within fiber optics,"A method of establishing a dielectric periodic index of refraction phase grating upon the core of an optical waveguide by intense angled application of several transverse beams of ultraviolet light, enabling the establishment of a distributed, spatially resolving optical fiber strain gauge.",UNITED TECHNOLOGIES CORP,GLENN WILLIAM H;;MELTZ GERALD;;SNITZER ELIAS,,https://lens.org/104-722-809-994-210,Granted Patent,yes,7,282,10,10,0,G02B5/18;;G02B5/18;;G02B6/02133;;G02B6/02133;;G02B6/022;;G02B6/022;;G02B6/02204;;G02B6/02204;;G02B6/124;;G02B6/124;;Y10S359/90;;Y10S359/90,G01J1/02;;G01K11/12;;G01L1/00;;G02B5/18;;G02B6/00;;G02B6/02;;G02B6/124;;G02B6/34,G2J JGFG          JGFG,5,4,121-749-265-631-636;;073-838-210-667-215;;097-298-438-816-543;;054-867-069-869-398,10.1063/1.88166;;10.1063/1.89881;;10.1364/ol.3.000066;;19684698;;20396175;;10.1364/ao.21.003059,"Tomlinson et al., Applied Physics Letters vol. 26, No. 6, Mar. 1975, pp. 303 306.;;Photosensitivity in Optical Fiber Waveguides: Application to Reflection Filter Fabrication K. O. Hill et al, Appl. Phys. Letter 32(10), May 15, 1978.;;Photosensitive Phenomena in Optical Fibers, J. LaPierre et al.;;Narrow Band Bragg Reflectors in Optical Fibers, B. S. Kawasaki et al, Optics Letters, vol. 3, No. 2, Aug. 1978.;;S. K. Yao et al, Applied Optics, vol. 21, pp. 3059 3060, (1982).",EXPIRED
153,EP,A4,EP 0191063 A4,005-134-079-819-348,1988-05-25,1988,EP 85904033 A,1985-07-31,US 64048984 A,1984-08-13,METHOD FOR IMPRESSING GRATING WITHIN FIBER OPTICS.,,UNITED TECHNOLOGIES CORP,GLENN WILLIAM H;;MELTZ GERALD;;SNITZER ELIAS,,https://lens.org/005-134-079-819-348,Search Report,no,0,0,10,10,0,G02B5/18;;G02B5/18;;G02B6/02133;;G02B6/02133;;G02B6/022;;G02B6/022;;G02B6/02204;;G02B6/02204;;G02B6/124;;G02B6/124;;Y10S359/90;;Y10S359/90,G01J1/02;;G01K11/12;;G01L1/00;;G02B5/18;;G02B6/00;;G02B6/02;;G02B6/124;;G02B6/34,,0,0,,,,EXPIRED
154,US,A,US 4807950 A,008-051-288-482-230,1989-02-28,1989,US 12283087 A,1987-11-19,US 12283087 A;;US 64048984 A,1984-08-13,Method for impressing gratings within fiber optics,"An optical fiber has a dielectric periodic index of refraction phase grating established in its core by intense angled application of several transverse beams of ultraviolet light, enabling the establishment of a distributed, spatially resolving optical fiber strain gauge.",UNITED TECHNOLOGIES CORP,GLENN WILLIAM H;;MELTZ GERALD;;SNITZER ELIAS,,https://lens.org/008-051-288-482-230,Granted Patent,yes,2,247,10,10,0,G02B5/18;;G02B5/18;;G02B6/02133;;G02B6/02133;;G02B6/022;;G02B6/022;;G02B6/02204;;G02B6/02204;;G02B6/124;;G02B6/124;;Y10S359/90;;Y10S359/90,G01J1/02;;G01K11/12;;G01L1/00;;G02B5/18;;G02B6/00;;G02B6/02;;G02B6/124;;G02B6/34,G2J JGFG          JGFG,1,1,097-298-438-816-543,10.1364/ol.3.000066;;19684698,"Kawasaki et al., Narrow Band Bragg Reflectors in Optical Fibers , Optics Letters, vol. 3, No. 2, Aug. 1978.",EXPIRED
155,EP,B1,EP 0191063 B1,032-974-081-091-377,1992-05-13,1992,EP 85904033 A,1985-07-31,US 64048984 A,1984-08-13,METHOD FOR IMPRESSING GRATING WITHIN FIBER OPTICS,,UNITED TECHNOLOGIES CORPORATION,"GLENN, WILLIAM, H.;;MELTZ, GERALD;;SNITZER, ELIAS",,https://lens.org/032-974-081-091-377,Granted Patent,yes,4,1,10,10,0,G02B5/18;;G02B5/18;;G02B6/02133;;G02B6/02133;;G02B6/022;;G02B6/022;;G02B6/02204;;G02B6/02204;;G02B6/124;;G02B6/124;;Y10S359/90;;Y10S359/90,G01J1/02;;G01K11/12;;G01L1/00;;G02B5/18;;G02B6/00;;G02B6/02;;G02B6/124;;G02B6/34,,0,0,,,,EXPIRED
156,US,B1,US 6453035 B1,108-016-560-924-563,2002-09-17,2002,US 3327898 A,1998-03-02,US 3327898 A,1998-03-02,Method and apparatus for providing virtual private network services over public switched telephone network,"
    A method of providing a Private Telephone Network over a Public Telephone Network is described. A Private Network is a telecommunications service which has controlled access, and is generally provided to customers having two or more geographic locations. A Private Network is provided by embedding originating customer site identification and a Private Network Routing Code into an Initial Address Message at the originating End Office associated with the originating customer site. This Initial Address Message is routed to a Service Switching Point by the Private Network Routing Code. At the Service Switching Point, reference is made to databases defining the members of the Private Network, and a destination End Office identification and a destination customer site identification associated with the destination customer site is embedded into the Initial Address Message. The Initial Address Message is then routed to the destination End Office Switch by a Public Network Routing Number associated with the destination End Office Switch. This will permit a Private Network to be provided over a Public Telephone Network, taking advantage of the inherent redundancy and reliability of the Public Telephone Network. 
",STENTOR RESOURCE CT INC,PSARRAS ELIAS;;CARKNER R WILLIAM;;COTTON MARC,STENTOR RESOURCE CENTRE INC (1998-02-23),https://lens.org/108-016-560-924-563,Granted Patent,yes,24,49,1,1,0,H04M7/009;;H04M2207/12;;H04Q3/0029;;H04Q3/0029;;H04M2207/12;;H04M7/009,H04M7/00;;H04Q3/00,379/221.08;;379/220.01;;379/221.09;;379/221.12,1,0,,,"""Evolution in Business Networking"" Davis et al Business Services Portfolio; Telesis 1988 three; pp. 23-31.",EXPIRED
157,WO,A1,WO 1986/001303 A1,049-364-599-817-055,1986-02-27,1986,US 8501451 W,1985-07-31,US 64048984 A,1984-08-13,METHOD FOR IMPRESSING GRATING WITHIN FIBER OPTICS,"A method of establishing a dielectric periodic index of refraction phase grating (16) upon the core (19) of an optical waveguide (15) by intense angled application of several tranverse beams (99) of ultraviolet light, enabling the establishment of a distributed, spatially resolving optical fiber strain gauge (13).",UNITED TECHNOLOGIES CORP,GLENN WILLIAM H;;MELTZ GERALD;;SNITZER ELIAS,,https://lens.org/049-364-599-817-055,Patent Application,yes,4,61,10,10,0,G02B5/18;;G02B5/18;;G02B6/02133;;G02B6/02133;;G02B6/022;;G02B6/022;;G02B6/02204;;G02B6/02204;;G02B6/124;;G02B6/124;;Y10S359/90;;Y10S359/90,G01J1/02;;G01K11/12;;G01L1/00;;G02B5/18;;G02B6/00;;G02B6/02;;G02B6/124;;G02B6/34,G1A AA5           CA;;G1A AA7           CA;;G1A ACA           CA;;G1A AG18          CA;;G1A AG7           CA;;G1A AP17          CA;;G1A AP6           CA;;G1A AR7           CA;;G1A AS4           CA;;G1A AT14          CA;;G1A AT15          CA;;G1A AT5           CA;;G2J JGF           JGF;;G2J JGFG          JGFG;;U1S S1915;;U1S S2171,0,0,,,,PATENTED
158,EP,B1,EP 0192659 B1,057-851-475-182-375,1993-10-27,1993,EP 85903956 A,1985-07-31,US 64049084 A,1984-08-13,"DISTRIBUTED, SPATIALLY RESOLVING OPTICAL FIBER STRAIN GAUGE.",,UNITED TECHNOLOGIES CORP,MELTZ GERALD;;GLENN WILLIAM H;;SNITZER ELIAS,,https://lens.org/057-851-475-182-375,Granted Patent,yes,7,0,8,11,0,G01L1/242;;G01B11/16;;G01D5/35383;;G01K5/52,G01L1/24;;G01B11/16;;G01D5/353;;G01K5/52;;G01K11/12,,1,0,,,"APPLIED OPTICS, vol. 21, no. 17, 1st September 1982, pages 3059-3060, Optical Society of America; S.K. YAO et al.: ""Microbending loss in a single-mode fiber in the pure-bend loss regime""",EXPIRED
159,US,A,US 4806012 A,022-493-550-019-715,1989-02-21,1989,US 12282687 A,1987-11-19,US 12282687 A;;US 64049084 A;;US 91589186 A,1984-08-13,"Distributed, spatially resolving optical fiber strain gauge","A distributed, spatially resolving optical fiber strain gauge in which the core of the optical fiber is written with periodic grating patterns effective for transmitting and reflecting light injected into the core. Spectral shifts in the transmitted and reflected light indicate the intensity of strain or temperature variations at positions of the grating corresponding to the associated wavelengths of injected light.",UNITED TECHNOLOGIES CORP,MELTZ GERALD;;GLENN WILLIAM H;;SNITZER ELIAS,,https://lens.org/022-493-550-019-715,Granted Patent,yes,9,117,1,11,0,G01K5/52;;G01K5/52;;G01B11/16;;G01B11/16;;G01D5/35383;;G01D5/35383,G01B11/16;;G01D5/353;;G01K5/52,356/32;;73/800,1,1,054-867-069-869-398,20396175;;10.1364/ao.21.003059,"S. K. Yao et al., Applied Optics, vol. 21, pp. 3059 3060, 1982.",EXPIRED
160,US,A,US 942346 A,147-490-210-980-058,1909-12-07,1909,US 1908/0438286 A,1908-06-13,US 1908/0438286 A,1908-06-13,METHOD OF AND CONVERTER VESSEL FOR BESSEMERIZING COPPER MATTE.,,PEIRCE WILLIAM H;;SMITH ELIAS A C,PEIRCE WILLIAM H;;SMITH ELIAS A C,,https://lens.org/147-490-210-980-058,Granted Patent,no,0,5,1,1,0,C21C5/48;;C21C5/48,,,0,0,,,,EXPIRED
161,EP,A1,EP 0191063 A1,005-446-123-895-093,1986-08-20,1986,EP 85904033 A,1985-07-31,US 64048984 A,1984-08-13,METHOD FOR IMPRESSING GRATING WITHIN FIBER OPTICS.,Procédé de formation d'un réseau diélectrique périodique de variation de phase de l'indice de réfraction (16) dans le noyau (19) d'un guide d'ondes optiques (15) par l'application oblique de plusieurs faisceaux transversaux intenses (99) de lumière ultraviolette. Ce procédé permet d'obtenir une jauge de contrainte (13) à fibre optique à résolution spatiale servant à mesurer les répartitions de contraintes.,UNITED TECHNOLOGIES CORP,GLENN WILLIAM H;;MELTZ GERALD;;SNITZER ELIAS,,https://lens.org/005-446-123-895-093,Patent Application,yes,0,1,10,10,0,G02B5/18;;G02B5/18;;G02B6/02133;;G02B6/02133;;G02B6/022;;G02B6/022;;G02B6/02204;;G02B6/02204;;G02B6/124;;G02B6/124;;Y10S359/90;;Y10S359/90,G01J1/02;;G01K11/12;;G01L1/00;;G02B5/18;;G02B6/00;;G02B6/02;;G02B6/124;;G02B6/34,,1,0,,,See references of WO 8601303A1,EXPIRED
162,US,A,US 3656840 A,070-109-195-818-695,1972-04-18,1972,US 3656840D A,1970-06-26,US 5025970 A,1970-06-26,MAGNIFYING SPECIMEN VIEWER,"A container for housing a specimen to be studied. A specimen, such as an insect, is mounted on a disk. The disk, acting as a piston, is mounted on a shaft having a knob on the opposite end thereof. The shaft extends through the bottom of a housing and the disk slides, as a piston, within the housing. The top of the housing is a lens element. The distance between the lens element and the specimen to be observed is controlled by positioning the piston within the housing by means of the knob resting outside the housing.",KIMTEC INC,SMITH WILLIAM G;;FRIANT ELIAS S JR,,https://lens.org/070-109-195-818-695,Granted Patent,no,2,46,1,1,0,G02B27/06;;G02B27/06,G02B27/06,G2J JVAX          JVAX,1,0,,,"Roles of Detonation Waves & Autoignition in Spark Ignition Engine, SAE Quarterly Trans. 98, (1/1947)",EXPIRED
163,CA,A,CA 450541 A,099-507-651-722-096,1948-08-17,1948,CA 450541D A,,CA 450541T A,,MANUFACTURE AND APPLICATION OF SYNTHETIC RUBBER-LIKE MATERIALS,,CANADIAN IND,MORGAN WILLIAM MCGILLIVRAY;;GUDGEON HERBERT;;ISAACS ELIAS,,https://lens.org/099-507-651-722-096,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
164,TW,B,TW I808065 B,117-175-391-509-047,2023-07-11,2023,TW 106140693 A,2017-11-23,US 201662427293 P,2016-11-29,Apparatus and method for edge processing of a substrate sheet,,CORNING INC,BROWN JAMES WILLIAM;;LI WEIMING;;PANIDES ELIAS,,https://lens.org/117-175-391-509-047,Granted Patent,no,6,0,10,10,0,B24B55/02;;B24B9/10;;B24B9/10;;B24B55/02;;B24B55/06;;B24B9/10;;B24B55/02,,,0,0,,,,ACTIVE
165,US,A,US 2378140 A,128-876-169-913-971,1945-06-12,1945,US 46200042 A,1942-10-14,GB 2378140X A,1941-07-04,"Synthetic rubberlike materials comprising butadiene -1, 3 -interpolymers",,ICI LTD,HERBERT GUDGEON;;ELIAS ISAACS;;MCGILLIVRAY MORGAN WILLIAM,,https://lens.org/128-876-169-913-971,Granted Patent,no,0,1,1,1,0,C08F236/04;;Y10S526/911;;C08F236/04;;Y10S526/911,C08F236/04,,0,0,,,,EXPIRED
166,KR,A,KR 20190082980 A,147-830-293-364-856,2019-07-10,2019,KR 20197018851 A,2017-11-29,US 201662427293 P;;US 2017/0063561 W,2016-11-29,기판 시트의 에지 프로세싱을 위한 장치 및 방법,"기판 시트의 에지 프로세싱 장치이다. 상기 장치는 피니싱 부재, 슈라우드, 및 튜브형 부재를 포함한다. 상기 피니싱 부재는 상기 슈라우드의 챔버 내에서 회전 가능하도록 유지된다. 슈라우드는 슬롯의 일부분을 정의하는 주 에지에서 종료되는 월 세그먼트를 포함한다. 상기 슬롯은 상기 피니싱 부재와 상기 에지의 인터페이스를 용이하게 하며, 유리 시트의 에지를 슬라이딩 가능하게 수취하도록 구성된다. 상기 월 세그먼트는 상기 주 에지 내의 개구부에서 종료되는 노즐 통로를 더욱 정의한다. 상기 튜브형 부재는 상기 주 에지로부터 돌출하고 상기 노즐 통로와 유체 연통되는 통로를 정의한다. 상기 노즐 통로로 이송되는 냉각재는 진공 유도된 크로스-흐름의 존재 하에서도 상기 튜브형 부재를 경유하여 상기 피니싱 부재 상으로 주입된다. 일부 실시예들에서, 상기 튜브형 부재의 공간적 배열은 조절 가능하다.",CORNING INC,BROWN JAMES WILLIAM;;LI WEIMING;;PANIDES ELIAS,,https://lens.org/147-830-293-364-856,Patent Application,no,4,0,10,10,0,B24B55/02;;B24B9/10;;B24B9/10;;B24B55/02;;B24B55/06;;B24B9/10;;B24B55/02,B24B9/10;;B24B55/02;;B24B55/06,,0,0,,,,ACTIVE
167,EP,A4,EP 0192659 A4,197-777-562-704-681,1990-10-10,1990,EP 85903956 A,1985-07-31,US 64049084 A,1984-08-13,"DISTRIBUTED, SPATIALLY RESOLVING OPTICAL FIBER STRAIN GAUGE",,UNITED TECHNOLOGIES CORPORATION,"MELTZ, GERALD;;GLENN, WILLIAM, H.;;SNITZER, ELIAS",,https://lens.org/197-777-562-704-681,Search Report,no,5,0,8,11,0,G01L1/242;;G01B11/16;;G01D5/35383;;G01K5/52,G01L1/24;;G01B11/16;;G01D5/353;;G01K5/52;;G01K11/12,,2,1,054-867-069-869-398,20396175;;10.1364/ao.21.003059,"APPLIED OPTICS, vol. 21, no. 17, 1st September 1982, pages 3059-3060, Optical Society of America; S.K. YAO et al.: ""Microbending loss in a single-mode fiber in the pure-bend loss regime"";;See also references of WO 8601286A1",EXPIRED
168,US,A1,US 2019/0291232 A1,107-543-560-912-683,2019-09-26,2019,US 201716463618 A,2017-11-29,US 2017/0063561 W;;US 201662427293 P,2016-11-29,APPARATUS AND METHOD FOR EDGE PROCESSING OF A SUBSTRATE SHEET,"An apparatus for processing an edge of a substrate sheet. The apparatus includes a finishing member, a shroud, and a tubular member. The finishing member is rotatably maintained within a chamber of the shroud. The shroud includes a wall segment terminating at a major edge that defines a portion of a slot. The slot is configured to receive the edge of the substrate sheet, facilitating interface of the edge with the finishing member. The wall segment further defines a nozzle passageway that terminates at an opening in the major edge. The tubular member projects from the major edge and defines a passage in fluid communication with the nozzle passageway. Cooling agent delivered to the nozzle passageway is injected onto the finishing member via the tubular member even in the presence of vacuum induced cross-flow. In some embodiments, a spatial arrangement of the tubular member is adjustable.",CORNING INC,BROWN JAMES WILLIAM;;LI WEIMING;;PANIDES ELIAS,CORNING INCORPORATED (2019-03-15),https://lens.org/107-543-560-912-683,Patent Application,yes,0,0,10,10,0,B24B55/02;;B24B9/10;;B24B9/10;;B24B55/02;;B24B55/06;;B24B9/10;;B24B55/02,B24B9/10;;B24B55/02,,0,0,,,,DISCONTINUED
169,US,A1,US 2016/0157708 A1,164-240-063-825-481,2016-06-09,2016,US 201615042160 A,2016-02-12,US 201615042160 A;;US 201313819743 A;;IB 2012052077 W;;US 201161506210 P,2011-07-11,ENDOBRONCHIAL TUBE WITH INTEGRATED IMAGE SENSOR,"An endobronchial tube comprising at least two lumens of different lengths for selectively associating with a patient about at least two locations relative to the Tracheal Carina. said tube comprising: a first lumen having an open distal end that associates proximally to the Carina within the Trachea, with a first inflatable cuff; a second lumen having an open distal end that extends distally, past the Carina and associates within one of the Left Bronchial branch and Right Bronchial branch with a second inflatable cuff; a dedicated image sensor lumen spanning the length of said first lumen, the dedicated image sensor lumen comprising an image sensor and illumination source disposed adjacent to the distal end of said first lumen, and configured to provide an image of the Tracheal bifurcation of the Tracheal Carina, the openings of the Left Bronchial branch, and the opening Right Bronchial branch; and at least one dedicated cleaning lumen disposed parallel with said dedicated image sensor lumen along the length of said endobronchial tube and wherein said cleaning lumen is configured to forms a cleaning nozzle at the distal end, wherein said cleaning nozzle is directed toward said image sensor lumen at its distal end.",DAHER ELIAS;;SCHUH MATTHIAS BENEDIKT;;EDELMAN WILLIAM;;ETVIEW LTD,DAHER ELIAS;;SCHUH MATTHIAS BENEDIKT;;EDELMAN WILLIAM,AMBU A/S (2017-09-28);;ETVIEW LTD (2016-02-17),https://lens.org/164-240-063-825-481,Patent Application,yes,2,5,23,23,0,A61M16/0463;;A61M16/0463;;A61B1/00018;;A61B1/00082;;A61B1/00091;;A61B1/00091;;A61B1/00094;;A61B1/00124;;A61B1/012;;A61B1/015;;A61B1/05;;A61B1/051;;A61B1/0676;;A61B1/0684;;A61B1/07;;A61B1/12;;A61B1/126;;A61B1/126;;A61B1/2676;;A61B1/2676;;A61B1/313;;A61M15/00;;A61M15/00;;A61M16/0057;;A61M16/04;;A61M16/04;;A61M16/0404;;A61M16/0404;;A61M16/0434;;A61M16/044;;A61M16/0459;;A61M16/0459;;A61M16/0461;;A61M16/0465;;A61M16/0486;;A61M16/0486;;A61M16/0488;;A61M16/0833;;A61M16/0833;;A61M16/104,A61B1/267;;A61B1/00;;A61B1/015;;A61B1/05;;A61B1/06;;A61M16/04,,0,0,,,,DISCONTINUED
170,GR,B,GR 871344 B,000-781-863-939-473,1988-02-17,1988,GR 870101344 A,1987-09-01,US 92325186 A,1986-10-27,METHOD FOR SELECTIVELY FORMING SMALL DIAMETER HOLES IN POLYMIDE/ KEVLAR SUBSTRATES,,HUGHES AIRCRAFT CO,RICHARD LEYDEN N;;ROBERT LAWRENCE;;WILLIAM ELIAS E,,https://lens.org/000-781-863-939-473,Granted Patent,no,0,0,8,9,0,,H05K3/00;;C08J9/00;;H05K/;;H05K3/26,,0,0,,,,EXPIRED
171,CA,A,CA 989516 A,025-161-783-315-898,1976-05-18,1976,CA 149541 A,1972-08-16,US 17515971 A,1971-08-26,SIGNAL GENERATING CIRCUIT FOR A DEFLECTION SYSTEM,,GTE SYLVANIA INC,ELIAS WILLIAM;;VALDES SILVERIO A;;WAYBRIGHT GEORGE C,,https://lens.org/025-161-783-315-898,Granted Patent,no,0,0,3,3,0,H03K4/725;;H03K4/725,H03K4/72,350-85,0,0,,,,EXPIRED
172,US,A1,US 2015/0143260 A1,090-164-959-218-284,2015-05-21,2015,US 201314082937 A,2013-11-18,US 201314082937 A,2013-11-18,State-Machine-Driven User-Interface Interactions,"In one embodiment, a method includes receiving, by a client computing device, an input associated with a user interface of an application. The user interface may include multiple elements. The client computing device may transition from a first state of the application to a second state of the application based on the input. The client computing device may then determine one or more listeners associated with the application that are registered to receive information when the second state of the application is entered. The client computing device may provide information associated with the second state of the application to one or more of the listeners, and the listeners may implement one or more changes to one or more elements of the user interface in response to the transition to the second state of the application.",FACEBOOK INC,BAILEY WILLIAM S;;YUEN JENNY;;ELIAS VICTOR GONÇALVES,META PLATFORMS INC (2013-08-18),https://lens.org/090-164-959-218-284,Patent Application,yes,15,23,1,1,0,G06Q50/01;;G06Q50/01;;H04M1/72436;;H04M1/72436,H04L29/06,715/753,1,0,,,"Hoffman, Chris, ""5 Cool Uses for Androids Daydream Mode"", 8/29/2013, How-To Geek, All pages",DISCONTINUED
173,EP,C0,EP 3935357 C0,161-570-285-889-344,2023-10-18,2023,EP 20765897 A,2020-03-02,SE 1950273 A;;SE 2020050229 W,2019-03-02,ASSEMBLY FOR SPECTROPHOTOMETRIC MEASUREMENTS OF TURBID SAMPLES USING A POLYCHROMATIC RECTANGULAR LIGHT SHEET,,SPEC IMAGING AB,BERROCAL EDOUARD;;CHAZE WILLIAM;;KRISTENSSON ELIAS;;ZOUEU JÉRÉMIE,,https://lens.org/161-570-285-889-344,Unknown,no,0,0,11,11,0,G01N21/255;;G01N21/49;;G01N21/645;;G01N2021/6463;;G01N2201/0691;;G01N2201/0635;;G01N2201/0675;;G01N21/4738;;G01N21/4795;;G01N21/49;;G01N21/532;;G01N21/255;;G01N21/31;;G01J3/0229;;G01J3/2846;;G01J3/433;;G01J3/0229;;G01J3/433;;G01N21/31;;G01N21/4738;;G01N2021/6463;;G01N2201/0635,G01N21/31;;G01N21/25;;G01N21/49;;G01N21/64,,0,0,,,,ACTIVE
174,AU,B2,AU 2016/280161 B2,102-464-534-054-112,2019-02-21,2019,AU 2016/280161 A,2016-06-16,US 201562182130 P;;US 2016/0037893 W,2015-06-19,Pharmaceutical compositions for anesthesiological applications,"Pharmaceutical compositions and methods are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, a beta-blocker and antiemetic. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",MELT PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,"HARROW HEALTH, INC. (2019-01-31);;MELT PHARMACEUTICALS, INC. (2019-07-04)",https://lens.org/102-464-534-054-112,Granted Patent,no,4,0,16,31,0,A61K45/06;;A61K9/2031;;A61P23/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K31/5513;;A61P23/02;;A61P23/00;;A61K9/0056;;A61K9/2031;;A61K31/135;;A61K31/138;;A61K31/5517;;A61K45/06;;A61K2300/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K45/06;;A61P23/00;;A61K9/2031,A61P23/00;;A61K9/00;;A61K9/20;;A61K31/00;;A61K31/5513;;A61K31/5517,,0,0,,,,ACTIVE
175,CA,C,CA 2989319 C,063-600-672-725-659,2019-02-05,2019,CA 2989319 A,2016-06-16,US 201562182130 P;;US 2016/0037893 W,2015-06-19,PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS,"Pharmaceutical compositions and methods are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, a beta-blocker and antiemetic. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",IMPRIMIS PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,,https://lens.org/063-600-672-725-659,Granted Patent,no,0,0,16,31,0,A61K45/06;;A61K9/2031;;A61P23/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K31/5513;;A61P23/02;;A61P23/00;;A61K9/0056;;A61K9/2031;;A61K31/135;;A61K31/138;;A61K31/5517;;A61K45/06;;A61K2300/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K45/06;;A61P23/00;;A61K9/2031,A61K31/5517,,0,0,,,,ACTIVE
176,KR,A,KR 20210128430 A,084-146-808-667-633,2021-10-26,2021,KR 20217029224 A,2020-03-02,SE 1950273 A;;SE 2020050229 W,2019-03-02,다색 직사각형 광 시트를 사용한 탁한 샘플의 분광 광도 측정을 위한 어셈블리,"매질의 하나 이상의 광학 파라미터의 측정을 위한 어셈블리가 개시된다. 어셈블리는 광 시트 생성기, 광 강도 변조기, 샘플을 위한 홀더 및 광학 센서로 구성된다. 광 시트 생성기는 제1 공간 차원에서 확장되는 광 스펙트럼을 포함하는 다색 광 시트를 제공하도록 구성되며, 다색 광 시트는 제2 공간 차원에서 전파 경로를 갖는다. 광 시트 생성기는 백색 광을 제공하도록 구성된 광원, 제1 공간 차원에서 백색 광을 확산시켜 광 스펙트럼을 제공하도록 구성된 분산 요소, 및 확산된 백색 광의 제한에 의해 다색 광 시트를 제공하도록 구성된 제1 공간 차원에서 확장되는 광학 슬릿을 포함한다. 광 강도 변조기는 제1 공간 차원에서 주기적인(또는 실질적으로 주기적인) 패턴을 갖는 강도 변조를 다색 광 시트에 적용하여 강도 변조된 다색 광 시트를 제공하도록 구성된다. 매질의 샘플을 위한 홀더는 강도 변조된 다색 광 시트가 샘플을 조명할 수 있도록 구성된다. 광학 센서는 하나 이상의 광학 파라미터를 제공하기 위해 광 스펙트럼에 걸쳐 샘플을 빠져나오는 광의 강도를 기록하도록 구성된다. 매질의 하나 이상의 광학 파라미터를 측정하기 위한 어셈블리를 사용하는 방법이 또한 개시되어 있다.",SPEC IMAGING AB,BERROCAL EDOUARD;;CHAZE WILLIAM;;KRISTENSSON ELIAS;;ZOUEU JEREMIE,,https://lens.org/084-146-808-667-633,Patent Application,no,0,0,11,11,0,G01N21/255;;G01N21/49;;G01N21/645;;G01N2021/6463;;G01N2201/0691;;G01N2201/0635;;G01N2201/0675;;G01N21/4738;;G01N21/4795;;G01N21/49;;G01N21/532;;G01N21/255;;G01N21/31;;G01J3/0229;;G01J3/2846;;G01J3/433;;G01J3/0229;;G01J3/433;;G01N21/31;;G01N21/4738;;G01N2021/6463;;G01N2201/0635,G01N21/47;;G01J3/02;;G01J3/28;;G01J3/433;;G01N21/25;;G01N21/31;;G01N21/49;;G01N21/53,,0,0,,,,PENDING
177,US,A1,US 2018/0177797 A1,170-196-776-082-683,2018-06-28,2018,US 201815903615 A,2018-02-23,US 201815903615 A;;US 201615184768 A;;US 201562182130 P,2015-06-19,PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ANESTHESIOLOGICAL APPLICATIONS,"Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",IMPRIMIS PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2018-12-27);;MELT PHARMACEUTICALS INC (2019-03-14),https://lens.org/170-196-776-082-683,Patent Application,yes,0,13,2,31,0,A61K31/5517;;A61K31/5517;;A61K9/0056;;A61K9/0056;;A61K9/2031;;A61K9/2031;;A61K31/135;;A61K31/135;;A61K31/138;;A61K31/4178;;A61K31/4178;;A61K45/06;;A61K45/06;;A61K2300/00;;A61P23/00;;A61P23/00,A61K31/5517;;A61K9/00;;A61K9/20;;A61K31/138;;A61K45/06;;A61P23/00,,0,0,,,,ACTIVE
178,US,A,US 5926357 A,018-115-879-926-326,1999-07-20,1999,US 87627497 A,1997-06-16,US 87627497 A;;US 56746095 A,1995-12-05,Aluminum electrolytic capacitor for implantable medical device,"An aluminum electrolytic capacitor with an aluminum housing defining a chamber, and having a feed-through aperture providing communication with the chamber from outside of the housing. A number of aluminum anode layers are positioned within the chamber, and a feed-through member formed of a first conductive material occupies the feed-through aperture. The feed-through member has an inner end extending into the chamber, an outer end extending externally from the housing, and an insulative sleeve encompassing an intermediate portion of the feed-through member and directly contacting the housing at the feed-through aperture to prevent electrical contact between the feed-through member and the housing. A connection element formed of a second different conductive material is attached to the inner end of feed-through member and spaced apart from the housing. A compressible insulative gasket may be positioned between the housing and the connection element to provide insulation and a fluid seal.",PACESETTER INC,ELIAS WILLIAM H;;FAYRAM TIMOTHY A;;MCCALL SCOTT,PACESETTER INC (1997-05-15),https://lens.org/018-115-879-926-326,Granted Patent,yes,3,124,1,1,0,H01G9/00;;H01G9/008;;H01G9/10;;H01G9/008;;H01G9/10;;H01G9/00,H01G9/00;;H01G9/008;;H01G9/10,361/302;;361/520;;361/538;;361/540;;29/25.03;;607/5,0,0,,,,EXPIRED
179,EP,A1,EP 3310439 A1,071-523-940-749-74X,2018-04-25,2018,EP 16812447 A,2016-06-16,US 201562182130 P;;US 2016/0037893 W,2015-06-19,PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS,,IMPRIMIS PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,"HARROW HEALTH, INC. (2019-03-20);;MELT PHARMACEUTICALS, INC. (2019-11-13)",https://lens.org/071-523-940-749-74X,Patent Application,yes,0,0,16,31,0,A61K45/06;;A61K9/2031;;A61P23/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K31/5513;;A61P23/02;;A61P23/00;;A61K9/0056;;A61K9/2031;;A61K31/135;;A61K31/138;;A61K31/5517;;A61K45/06;;A61K2300/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K45/06;;A61P23/00;;A61K9/2031,A61P23/00;;A61K9/00;;A61K9/20;;A61K31/00;;A61K31/5513;;A61K31/5517,,0,0,,,,PENDING
180,EP,B1,EP 3935357 B1,146-022-039-495-146,2023-10-18,2023,EP 20765897 A,2020-03-02,SE 1950273 A;;SE 2020050229 W,2019-03-02,ASSEMBLY FOR SPECTROPHOTOMETRIC MEASUREMENTS OF TURBID SAMPLES USING A POLYCHROMATIC RECTANGULAR LIGHT SHEET,,SPEC IMAGING AB,BERROCAL EDOUARD;;CHAZE WILLIAM;;KRISTENSSON ELIAS;;ZOUEU JÉRÉMIE,,https://lens.org/146-022-039-495-146,Granted Patent,yes,8,0,11,11,0,G01N21/255;;G01N21/49;;G01N21/645;;G01N2021/6463;;G01N2201/0691;;G01N2201/0635;;G01N2201/0675;;G01N21/4738;;G01N21/4795;;G01N21/49;;G01N21/532;;G01N21/255;;G01N21/31;;G01J3/0229;;G01J3/2846;;G01J3/433;;G01J3/0229;;G01J3/433;;G01N21/31;;G01N21/4738;;G01N2021/6463;;G01N2201/0635,G01N21/31;;G01N21/25;;G01N21/49;;G01N21/64,,3,0,,,"KIEFER J: ""Using a supercontinuum light source for instantaneous excitation-emission fluorescence mapping"", MEASUREMENT SCIENCE AND TECHNOLOGY, IOP, BRISTOL, GB, vol. 28, no. 6, 7 April 2017 (2017-04-07), page 67001, XP020316697, ISSN: 0957-0233, DOI: 10.1088/1361-6501/AA6361 [retrieved on 2017-04-07];;MCGREGOR T ET AL: ""Laser-based volumetric flow visualization by digital color imaging of a spectrally coded volume"", REVIEW OF SCIENTIFIC INSTRUMENTS, AMERICAN INSTITUTE OF PHYSICS, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747, vol. 79, no. 1, 30 January 2008 (2008-01-30), pages 13710-13710, XP012114558, ISSN: 0034-6748, DOI: 10.1063/1.2825462;;KRISTENSSON E AND BERROCAL E: ""Crossed patterned structured illumination for the analysis and velocimetry of transient turbid media"", SCIENTIFIC REPORTS, vol. 8, no. 1, 6 August 2018 (2018-08-06), XP055581732, DOI: 10.1038/s41598-018-30233-y",ACTIVE
181,CA,A,CA 285553 A,189-162-713-211-577,1928-12-11,1928,CA 285553D A,,CA 285553T A,,ELECTROLYTIC PRODUCTION OF ZINC,,METALS EXTRACTION CORP LTD,FIELD SAMUEL;;PETERSSON ELIAS FREDERICK;;HARRIS WILLIAM EWART,,https://lens.org/189-162-713-211-577,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
182,EP,A4,EP 3310439 A4,030-782-023-277-043,2019-02-20,2019,EP 16812447 A,2016-06-16,US 201562182130 P;;US 2016/0037893 W,2015-06-19,PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS,,IMPRIMIS PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,"HARROW HEALTH, INC. (2019-03-20);;MELT PHARMACEUTICALS, INC. (2019-11-13)",https://lens.org/030-782-023-277-043,Search Report,no,5,0,16,31,0,A61K45/06;;A61K9/2031;;A61P23/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K31/5513;;A61P23/02;;A61P23/00;;A61K9/0056;;A61K9/2031;;A61K31/135;;A61K31/138;;A61K31/5517;;A61K45/06;;A61K2300/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K45/06;;A61P23/00;;A61K9/2031,A61K31/5513;;A61K9/00;;A61K9/20;;A61K31/00;;A61K31/135;;A61K31/138;;A61K31/5517;;A61K45/06;;A61P23/00,,5,3,065-967-627-463-438;;107-280-595-655-38X;;021-042-981-094-128,10.1016/j.ejps.2013.02.024;;23500040;;20060467;;10.1016/j.ejps.2009.12.011;;22363361;;pmc3283976;;10.4103/1735-3327.92925,"HOLM RENÉ ET AL: ""In vitro,ex vivoandin vivoexamination of buccal absorption of metoprolol with varying pH in TR146 cell culture, porcine buccal mucosa and Göttingen minipigs"", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, ELSEVIER, AMSTERDAM, NL, vol. 49, no. 2, 14 March 2013 (2013-03-14), pages 117 - 124, XP028531159, ISSN: 0928-0987, DOI: 10.1016/J.EJPS.2013.02.024;;WANG Y ET AL: ""Improving sublingual delivery of weak base compounds using pHmax concept: Application to propranolol"", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, ELSEVIER, AMSTERDAM, NL, vol. 39, no. 4, 19 February 2010 (2010-02-19), pages 272 - 278, XP026878352, ISSN: 0928-0987, [retrieved on 20100108];;GOLPAYEGANI MOJTABA VAHID ET AL: ""Comparison of oral Midazolam-Ketamine and Midazolam-Promethazine as sedative agents in pediatric dentistry"", DENTAL RESEARCH JOURNALIRANJAN 2012,, vol. 9, no. 1, 31 December 2011 (2011-12-31), pages 36 - 40, XP009509891, ISSN: 2008-0255;;ROSENBERG M ET AL: ""General anesthesia"", ANESTHESIA PROGRESS, ALLEN PRESS, US, vol. 38, no. 4-5, 1 January 1991 (1991-01-01), pages 172 - 186, XP009509876, ISSN: 0003-3006;;See also references of WO 2016205533A1",PENDING
183,US,A1,US 2016/0367566 A1,062-889-059-169-272,2016-12-22,2016,US 201615184768 A,2016-06-16,US 201615184768 A;;US 201562182130 P,2015-06-19,PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS,"Pharmaceutical compositions and methods are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, a β-blocker and antiemetic. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",IMPRIMIS PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2018-12-27);;MELT PHARMACEUTICALS INC (2019-03-14),https://lens.org/062-889-059-169-272,Patent Application,yes,3,1,16,31,0,A61K45/06;;A61K9/2031;;A61P23/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K31/5513;;A61P23/02;;A61P23/00;;A61K9/0056;;A61K9/2031;;A61K31/135;;A61K31/138;;A61K31/5517;;A61K45/06;;A61K2300/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K45/06;;A61P23/00;;A61K9/2031,A61K31/5517;;A61K9/00;;A61K31/135;;A61K31/138,,2,2,065-434-868-121-912;;125-460-862-602-786,10.1093/bja/aeh268;;15377583;;7486180;;10.1097/00000542-199511000-00007,"Chia et al (British Journal of Anaesthesia, 2004, 93(6), 799-805);;Davis et al (Anesthesiology, 1995, 83, 956-960)",ACTIVE
184,US,A,US 5319652 A,003-909-720-998-934,1994-06-07,1994,US 1094493 A,1993-01-29,US 1094493 A,1993-01-29,Super luminescent light source,"A fiber superfluorescent light source is disclosed which suppresses laser cillations without interfering with the pump light or the super luminescence. In a preferred embodiment of the invention, the fiber superfluorescent light source comprises a laser diode array for providing a pump beam at a wavelength of 0.81 microns, a first fiber doped with neodymium activator ions and being responsive to the pump beam for providing a spontaneous emission at a wavelength of 1.06 microns, and a second fiber optically coupled between the laser diode array and the first fiber for passing the pump beam therethrough to the first fiber to enable the first fiber to spontaneously emit light at the 1.06 micron wavelength and for suppressing backemissions of the 1.06 micron wavelength from the first fiber toward the laser diode array to prevent back reflection from the laser diode array and oscillations in the first fiber.",US ARMY,MOELLER ROBERT P;;BURNS WILLIAM K;;SNITZER ELIAS,UNITED STATES OF AMERICA THE AS REPRESENTED BY THE SECRETARY OF THE NAVY (1993-02-27);;NAVY THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE (1993-03-08),https://lens.org/003-909-720-998-934,Granted Patent,yes,5,41,1,1,0,G02B6/03633;;G02B6/03633;;G02B6/2551;;G02B6/2551;;G02B6/4203;;G02B6/4203;;G02B6/421;;G02B6/421;;H01S3/0064;;H01S3/0064;;H01S3/06795;;H01S3/06795;;H01S3/1611;;H01S3/1611,G02B6/036;;G02B6/255;;G02B6/42;;H01S3/00;;H01S3/067;;H01S3/16,312/6;;385/98;;385/123;;385/126;;385/127;;385/128;;385/15;;385/27;;385/28,0,0,,,,EXPIRED
185,HK,A1,HK 1253720 A1,009-805-640-043-240,2019-06-28,2019,HK 18112868 A,2018-10-10,US 201562182130 P,2015-06-19,PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS,,HARROW HEALTH INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,,https://lens.org/009-805-640-043-240,Patent Application,no,0,0,16,31,0,A61K45/06;;A61K9/2031;;A61P23/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K31/5513;;A61P23/02;;A61P23/00;;A61K9/0056;;A61K9/2031;;A61K31/135;;A61K31/138;;A61K31/5517;;A61K45/06;;A61K2300/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K45/06;;A61P23/00;;A61K9/2031,A61P/;;A61K/,,0,0,,,,PENDING
186,DE,A1,DE 2241660 A1,084-123-344-165-771,1973-03-15,1973,DE 2241660 A,1972-08-24,US 17515971 A,1971-08-26,ABLENKSYSTEM FUER EINE KATHODENSTRAHLROEHRE,,GTE SYLVANIA INC,ELIAS WILLIAM;;VALDES SILVERIO A;;WAYBRIGHT GEORGE C,,https://lens.org/084-123-344-165-771,Patent Application,no,0,0,3,3,0,H03K4/725;;H03K4/725,H03K4/72,,0,0,,,,DISCONTINUED
187,EP,A1,EP 3935357 A1,106-292-268-352-092,2022-01-12,2022,EP 20765897 A,2020-03-02,SE 1950273 A;;SE 2020050229 W,2019-03-02,ASSEMBLY FOR SPECTROPHOTOMETRIC MEASUREMENTS OF TURBID SAMPLES USING A POLYCHROMATIC RECTANGULAR LIGHT SHEET,,SPEC IMAGING AB,BERROCAL EDOUARD;;CHAZE WILLIAM;;KRISTENSSON ELIAS;;ZOUEU JÉRÉMIE,,https://lens.org/106-292-268-352-092,Patent Application,yes,0,0,11,11,0,G01N21/255;;G01N21/49;;G01N21/645;;G01N2021/6463;;G01N2201/0691;;G01N2201/0635;;G01N2201/0675;;G01N21/4738;;G01N21/4795;;G01N21/49;;G01N21/532;;G01N21/255;;G01N21/31;;G01J3/0229;;G01J3/2846;;G01J3/433;;G01J3/0229;;G01J3/433;;G01N21/31;;G01N21/4738;;G01N2021/6463;;G01N2201/0635,G01J3/00;;G01N21/17;;G01N21/31,,0,0,,,,ACTIVE
188,ES,A6,ES 2005383 A6,099-358-307-283-876,1989-03-01,1989,ES 8702868 A,1987-10-08,US 92325186 A,1986-10-27,METHOD OF SELECTIVELY FORMING SMALL HOLES IN POLYIMIDE/KEVLAR SUBSTRATE,"Formation of holes of predetermined size and shape in a polyimide/polyamide substrate with a metallic layer(s) adhesively joined thereto, comprises (a) forming an opening(s) in the metallic layer to expose the polyimide/polyamide material (b) contacting (I) to expose the opening with hot conc. H2SO4 at at least 185 deg.C for a time sufficient to form a hole(s) in the polyimide/polyamide layer, and then removing the substrate and washing with H2O, and (c) contacting the substrate with a liq. having medium to smooth any rough edges of the hole(s). A method for forming at least one hole above comprises affixing a mask(s) to a side(s) of the substrate. The mask has an opening(s) of predetermined size and shape.",HUGHES AIRCRAFT CO,LEYDEN RICHARD N;;LAWRENCE ROBERT;;ELIAS WILLIAM E,,https://lens.org/099-358-307-283-876,Granted Patent,no,0,0,8,9,0,,H05K3/00;;C08J9/00;;H05K/;;H05K3/26,,0,0,,,,EXPIRED
189,DK,D0,DK 529787 D0,177-979-252-506-751,1987-10-09,1987,DK 529787 A,1987-10-09,US 92325186 A,1986-10-27,FREMGANGSMAADE TIL SELEKTIV DANNELSE AF HULLER MED LILLE DIAMETER I POLYIMID/KEVLAR-UNDERLAG,,HUGHES AIRCRAFT CO,LEYDEN RICHARD N;;LAWRENCE ROBERT;;ELIAS WILLIAM E,,https://lens.org/177-979-252-506-751,Patent Application,no,0,0,8,9,0,,H05K3/00;;C08J9/00;;H05K/;;H05K3/26,,0,0,,,,DISCONTINUED
190,US,B2,US 10166240 B2,014-797-790-231-494,2019-01-01,2019,US 201815903529 A,2018-02-23,US 201815903529 A;;US 201615184768 A;;US 201562182130 P,2015-06-19,Pharmaceutical compositions and methods for anesthesiological applications,"Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",IMPRIMIS PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2018-12-27);;MELT PHARMACEUTICALS INC (2019-03-14),https://lens.org/014-797-790-231-494,Granted Patent,yes,10,2,2,31,0,A61K31/135;;A61K31/4178;;A61K31/5517;;A61K9/2031;;A61K45/06;;A61P23/00;;A61K9/0056;;A61K31/5517;;A61K31/138;;A61K9/2031;;A61K2300/00;;A61K45/06;;A61P23/00;;A61K9/0056;;A61K31/4178;;A61K31/135,A61K31/138;;A61K9/00;;A61K9/20;;A61K31/5517;;A61K45/06;;A61P23/00,,9,5,006-634-789-624-833;;027-264-776-988-749;;125-460-862-602-786;;042-813-959-756-919;;042-180-451-830-180,10.1586/ern.11.52;;21539491;;pmc3227310;;22144928;;10.4103/1658-354x.87270;;7486180;;10.1097/00000542-199511000-00007;;10.1517/14656560902978446;;19601699;;28473800;;10.3389/fneur.2017.00141;;pmc5397512,"Ramaiah et al, Expert Rev. Neurother. 11(5), 755-763 (Year: 2011).;;Tobias et al, Saudi J Anaesth., Oct.-Dec.; 5(4): 395-410 (Year: 2011).;;PCT/US2016/037893 International Search Report and Written Opinion dated Sep. 7, 2016.;;Chia et al. “Role of β-blockade in anaesthesia and postoperative pain management after hysterectomy,” British Journal of Anaesthesia, 2004, 93(6):799-805.;;Davis et al. “Effect of Antiemetic Therapy on Recovery and Hospital Discharge Time.” Anesthesiology, 1995, 83:956-960.;;McLean et al. “The pharmacological treatment of nystagmus: a review,” Expert Opinion on Pharmacotherapy, 2009, 10(11)1805-1816.;;MacDonald et al. “Central Positional Nystagmus: A Systematic Literature Review,” Frontiers in Neurology, Apr. 2017, 8:1-11.;;JP2017-566010 Office Action dated Jun. 5, 2018.;;KR10-2018-7000815 Office Action dated Aug. 2, 2018.",ACTIVE
191,US,B1,US 6270616 B1,009-891-965-622-666,2001-08-07,2001,US 10901198 A,1998-07-01,US 10901198 A;;US 54914195 A,1995-10-27,"Metal-filled, plateable structural adhesives for cyanate ester composites","A family of adhesives is provided for bonding cyanate ester composite articles together which is also plateable with metal once chemically etched. The adhesives comprise a polymeric matrix and a filler of metal powder or metal flakes. The polymeric matrix comprises at least one polyepoxide resin and at least one curing agent. In practice, the present adhesive is applied to the surface of cyanate ester composite articles to be bonded and is allowed to cure in air at a temperature less than 125.degree. C. Thereafter, the surface of the assembly is chemically etched and then plated with metal. The present adhesives enable the complete coverage of the cyanate ester composite assembly with the plated metal, including the adhesive bondlines. A cyanate ester resin structure assembled with the present adhesive composition may, upon plating, replace certain metallic components in such applications as aircraft, spacecraft, and automobiles given its highly conductive and comprehensive metallic coating.",HUGHES ELECTRONICS CORP,PUNSLY BRIAN M;;WALLACE ANDRE;;ELIAS WILLIAM E,HUGHES ELECTRONICS CORPORATION (1998-08-28),https://lens.org/009-891-965-622-666,Granted Patent,yes,4,9,8,8,0,C09J163/00;;C09J163/00;;C08L63/00;;C08L63/00;;C08L2666/54;;C08L2666/54;;C09J179/04;;C09J179/04;;Y10T428/31515;;Y10T428/31515,C09J163/00;;C09J179/04,156/330;;523/458;;428/414,0,0,,,,EXPIRED
192,US,B2,US 10391102 B2,069-439-141-500-207,2019-08-27,2019,US 201815995875 A,2018-06-01,US 201815995875 A;;US 201815903529 A;;US 201615184768 A;;US 201815903615 A;;US 201562182130 P,2015-06-19,Pharmaceutical compositions and methods for anesthesiological applications,"Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",MELT PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2018-12-27);;MELT PHARMACEUTICALS INC (2019-03-14),https://lens.org/069-439-141-500-207,Granted Patent,yes,16,0,2,31,0,A61K9/02;;A61K9/06;;A61K9/08;;A61K9/2031;;A61K31/5517;;A61K31/135;;A61K9/0031;;A61K45/06;;A61K31/138;;A61K47/22;;A61K9/0014;;A61P23/02;;A61K47/10;;A61K47/26;;A61K9/0043;;A61K9/0019;;A61K47/44;;A61K47/42;;A61K47/34;;A61K31/5517;;A61K31/135;;A61K9/0031;;A61K45/06;;A61K31/138;;A61K47/22;;A61K9/0014;;A61P23/02;;A61K47/10;;A61K47/26;;A61K9/0043;;A61K9/0019;;A61K47/44;;A61K47/42;;A61K9/0053;;A61K47/34;;A61K9/02;;A61K9/2031;;A61K9/08;;A61K9/06,A61K47/42;;A61K9/00;;A61K31/135;;A61K31/138;;A61K31/5517;;A61K45/06;;A61K47/10;;A61K47/22;;A61K47/26;;A61K47/34;;A61K47/44;;A61P23/02,,17,11,011-194-032-772-660;;022-167-810-687-485;;125-460-862-602-786;;006-634-789-624-833;;027-264-776-988-749;;042-813-959-756-919;;042-180-451-830-180;;065-967-627-463-438;;107-280-595-655-38X;;021-042-981-094-128;;137-519-590-588-683,8025055;;10.1136/bjo.77.8.529;;pmc504592;;pmc2007493;;15675259;;7486180;;10.1097/00000542-199511000-00007;;10.1586/ern.11.52;;21539491;;pmc3227310;;22144928;;10.4103/1658-354x.87270;;10.1517/14656560902978446;;19601699;;28473800;;10.3389/fneur.2017.00141;;pmc5397512;;10.1016/j.ejps.2013.02.024;;23500040;;20060467;;10.1016/j.ejps.2009.12.011;;22363361;;pmc3283976;;10.4103/1735-3327.92925;;pmc2190299;;1819969,"Louon et al. (British Journal of Ophthalmology , 1993,77:529-530.;;Roelofse et al. (Anesth Prog. 51, 2004 pp. 114-121).;;Rudnic (Chapter 92, Oral solid dosage forms, Remington, 1995, pp. 1615-1649).;;PCT/US2016/037893 International Search Report and Written Opinion dated Sep. 7, 2016.;;Chia et al. “Role of β-blockade in anaesthesia and postoperative pain management after hysterectomy,” British Journal of Anaesthesia, 2004, 93(6):799-805.;;Davis et al. “Effect of Antiemetic Therapy on Recovery and Hospital Discharge Time.” Anesthesiology, 1995, 83:956-960.;;Ramaiah et al. “Pediatric procedural sedation and analgesia outside the operating room: anticipating, avoiding and managing complications,” Expert Rev. Neurother, 2011, 11(5):755-763.;;Tobias et al. “Procedural sedation: A review of sedative agents, monitoring, and management of complications,” Saudi J Anaesth., 2011, 5(4):395-410.;;McLean et al. “The pharmacological treatment of nystagmus: a review,” Expert Opinion on Pharmacotherapy, 2009, 10(11):1805-1816.;;MacDonald et al. “Central Positional Nystagmus: A Systematic Literature Review,” Frontiers in Neurology, Apr. 2017, 8:1-11.;;JP2017-566010 Office Action dated Jun. 5, 2018.;;KR10-2018-7000815 Office Action dated Aug. 2, 2018.;;Holm et al. “In vitro, ex vivo and in vivo examination of buccal absorption of metoprolol with varying pH in TR146 cell culture, porcine buccal mucosa and Gottingen minipigs,” European Journal of Pharmaceutical Sciences, 2013, 49:117-124.;;Wang et al. “Improving sublingual delivery of weak base compounds using pHmax concept: Application to propranolol,” European Journal of Pharmaceutical Sciences, 2010, 39:272-278.;;Golpayegani et al. “Comparison of oral Midazolam-Ketamine and Midazolam-Promethazine as sedative agents in pediatric dentistry,” Dental Research Journal, Jan. 2012, 9(1):36-40.;;Rosenberg et al. “General Anesthesia,” Anesth Prog, 1991, 38:172-186.;;EP16812447.7 Extended European Search Report dated Jan. 17, 2019.",ACTIVE
193,US,A1,US 2018/0271877 A1,083-278-432-221-884,2018-09-27,2018,US 201815995875 A,2018-06-01,US 201815995875 A;;US 201815903529 A;;US 201615184768 A;;US 201815903615 A;;US 201562182130 P,2015-06-19,PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ANESTHESIOLOGICAL APPLICATIONS,"Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",IMPRIMIS PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2018-12-27);;MELT PHARMACEUTICALS INC (2019-03-14),https://lens.org/083-278-432-221-884,Patent Application,yes,0,5,2,31,0,A61K9/02;;A61K9/06;;A61K9/08;;A61K9/2031;;A61K31/5517;;A61K31/135;;A61K9/0031;;A61K45/06;;A61K31/138;;A61K47/22;;A61K9/0014;;A61P23/02;;A61K47/10;;A61K47/26;;A61K9/0043;;A61K9/0019;;A61K47/44;;A61K47/42;;A61K47/34;;A61K31/5517;;A61K31/135;;A61K9/0031;;A61K45/06;;A61K31/138;;A61K47/22;;A61K9/0014;;A61P23/02;;A61K47/10;;A61K47/26;;A61K9/0043;;A61K9/0019;;A61K47/44;;A61K47/42;;A61K9/0053;;A61K47/34;;A61K9/02;;A61K9/2031;;A61K9/08;;A61K9/06,A61K31/5517;;A61K9/00;;A61K31/135;;A61K31/138;;A61K45/06,,0,0,,,,ACTIVE
194,TW,A,TW 201829119 A,189-750-002-178-476,2018-08-16,2018,TW 106140693 A,2017-11-23,US 201662427293 P,2016-11-29,Apparatus and method for edge processing of a substrate sheet,"An apparatus for processing an edge of a substrate sheet. The apparatus includes a finishing member, a shroud, and a tubular member. The finishing member is rotatably maintained within a chamber of the shroud. The shroud includes a wall segment terminating at a major edge that defines a portion of a slot. The slot is configured to receive the edge of the substrate sheet, facilitating interface of the edge with the finishing member. The wall segment further defines a nozzle passageway that terminates at an opening in the major edge. The tubular member projects from the major edge and defines a passage in fluid communication with the nozzle passageway. Cooling agent delivered to the nozzle passageway is injected onto the finishing member via the tubular member even in the presence of vacuum induced cross-flow. In some embodiments, a spatial arrangement of the tubular member is adjustable.",CORNING INC,BROWN JAMES WILLIAM;;LI WEI-MING;;PANIDES ELIAS,,https://lens.org/189-750-002-178-476,Patent of Addition,no,0,0,10,10,0,B24B55/02;;B24B9/10;;B24B9/10;;B24B55/02;;B24B55/06;;B24B9/10;;B24B55/02,B24B9/08;;B24B55/02,,0,0,,,,ACTIVE
195,US,A1,US 2018/0177796 A1,192-483-228-299-056,2018-06-28,2018,US 201815903529 A,2018-02-23,US 201815903529 A;;US 201615184768 A;;US 201562182130 P,2015-06-19,PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ANESTHESIOLOGICAL APPLICATIONS,"Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",IMPRIMIS PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2018-12-27);;MELT PHARMACEUTICALS INC (2019-03-14),https://lens.org/192-483-228-299-056,Patent Application,yes,0,2,2,31,0,A61K31/135;;A61K31/4178;;A61K31/5517;;A61K9/2031;;A61K45/06;;A61P23/00;;A61K9/0056;;A61K31/5517;;A61K31/138;;A61K9/2031;;A61K2300/00;;A61K45/06;;A61P23/00;;A61K9/0056;;A61K31/4178;;A61K31/135,A61K31/5517;;A61K9/00;;A61K9/20;;A61K31/138;;A61K45/06;;A61P23/00,,0,0,,,,ACTIVE
196,DK,A,DK 529787 A,120-391-921-545-497,1988-04-28,1988,DK 529787 A,1987-10-09,US 92325186 A,1986-10-27,FREMGANGSMAADE TIL SELEKTIV DANNELSE AF HULLER MED LILLE DIAMETER I POLYIMID/KEVLAR-UNDERLAG,,HUGHES AIRCRAFT CO,LEYDEN RICHARD N;;LAWRENCE ROBERT;;ELIAS WILLIAM E,,https://lens.org/120-391-921-545-497,Patent Application,no,0,0,8,9,0,,H05K3/00;;C08J9/00;;H05K/;;H05K3/26,,0,0,,,,DISCONTINUED
197,CN,A,CN 113508281 A,197-665-184-097-784,2021-10-15,2021,CN 202080017975 A,2020-03-02,SE 1950273 A;;SE 2020050229 W,2019-03-02,ASSEMBLY FOR SPECTROPHOTOMETRIC MEASUREMENTS OF TURBID SAMPLES USING A POLYCHROMATIC RECTANGULAR LIGHT SHEET,"An assembly for measurements of one or more optical parameters of a medium is disclosed. The assembly comprises a light sheet generator, a light intensity modulator, a holder for a sample, and an optical sensor. The light sheet generator is configured to provide a polychromatic light sheet comprising a light spectrum extending in a first spatial dimension, wherein the polychromatic light sheet has a propagation path in a second spatial dimension. The light sheet generator comprises a light source configured to provide white light, a dispersive element configured to spread the white light in the first spatial dimension to provide the light spectrum, and an optical slit extending in the first spatial dimension configured to provide the polychromatic light sheet by limitation of the spread white light. The light intensity modulator is configured to provide an intensity modulated polychromatic light sheet by applying -to the polychromatic light sheet -an intensity modulation having a periodical (or substantially periodical) pattern in the first spatial dimension. The holder for a sample of the medium is configured to enable the intensity modulated polychromatic light sheet to illuminate the sample. The optical sensor is configured to record intensity of light exiting the sample over the light spectrum for provision of the one or more optical parameters. A method of using the assembly for measuring one or more optical parameters of a medium is also disclosed.",SPEC IMAGE COMPANY,BERROCAL EDOUARD;;CHAZE WILLIAM;;KRISTENSSON ELIAS;;ZOUEU JEREMIE,,https://lens.org/197-665-184-097-784,Patent Application,no,0,0,11,11,0,G01N21/255;;G01N21/49;;G01N21/645;;G01N2021/6463;;G01N2201/0691;;G01N2201/0635;;G01N2201/0675;;G01N21/4738;;G01N21/4795;;G01N21/49;;G01N21/532;;G01N21/255;;G01N21/31;;G01J3/0229;;G01J3/2846;;G01J3/433;;G01J3/0229;;G01J3/433;;G01N21/31;;G01N21/4738;;G01N2021/6463;;G01N2201/0635,G01J3/00;;G01N21/17;;G01N21/31,,0,0,,,,PENDING
198,WO,A1,WO 2020/180233 A1,013-618-297-969-724,2020-09-10,2020,SE 2020050229 W,2020-03-02,SE 1950273 A,2019-03-02,ASSEMBLY FOR SPECTROPHOTOMETRIC MEASUREMENTS OF TURBID SAMPLES USING A POLYCHROMATIC RECTANGULAR LIGHT SHEET,"An assembly for measurements of one or more optical parameters of a medium is disclosed. The assembly comprises a light sheet generator, a light intensity modulator, a holder for a sample, and an optical sensor. The light sheet generator is configured to provide a polychromatic light sheet comprising a light spectrum extending in a first spatial dimension, wherein the polychromatic light sheet has a propagation path in a second spatial dimension. The light sheet generator comprises a light source configured to provide white light, a dispersive element configured to spread the white light in the first spatial dimension to provide the light spectrum, and an optical slit extending in the first spatial dimension configured to provide the polychromatic light sheet by limitation of the spread white light. The light intensity modulator is configured to provide an intensity modulated polychromatic light sheet by applying –to the polychromatic light sheet –an intensity modulation having a periodical (or substantially periodical) pattern in the first spatial dimension. The holder for a sample of the medium is configured to enable the intensity modulated polychromatic light sheet to illuminate the sample. The optical sensor is configured to record intensity of light exiting the sample over the light spectrum for provision of the one or more optical parameters. A method of using the assembly for measuring one or more optical parameters of a medium is also disclosed.",BERROCAL EDOUARD;;CHAZE WILLIAM;;KRISTENSSON ELIAS;;ZOUEU JEREMIE,BERROCAL EDOUARD;;CHAZE WILLIAM;;KRISTENSSON ELIAS;;ZOUEU JÉRÉMIE,,https://lens.org/013-618-297-969-724,Patent Application,yes,7,1,11,11,0,G01N21/255;;G01N21/49;;G01N21/645;;G01N2021/6463;;G01N2201/0691;;G01N2201/0635;;G01N2201/0675;;G01N21/4738;;G01N21/4795;;G01N21/49;;G01N21/532;;G01N21/255;;G01N21/31;;G01J3/0229;;G01J3/2846;;G01J3/433;;G01J3/0229;;G01J3/433;;G01N21/31;;G01N21/4738;;G01N2021/6463;;G01N2201/0635,G01J3/00;;G01N21/17;;G01N21/31,,1,0,,,See also references of EP 3935357A4,PENDING
199,EP,A4,EP 3935357 A4,040-610-008-482-673,2022-10-05,2022,EP 20765897 A,2020-03-02,SE 1950273 A;;SE 2020050229 W,2019-03-02,ASSEMBLY FOR SPECTROPHOTOMETRIC MEASUREMENTS OF TURBID SAMPLES USING A POLYCHROMATIC RECTANGULAR LIGHT SHEET,,SPEC IMAGING AB,BERROCAL EDOUARD;;CHAZE WILLIAM;;KRISTENSSON ELIAS;;ZOUEU JÉRÉMIE,,https://lens.org/040-610-008-482-673,Search Report,no,1,0,11,11,0,G01N21/255;;G01N21/49;;G01N21/645;;G01N2021/6463;;G01N2201/0691;;G01N2201/0635;;G01N2201/0675;;G01N21/4738;;G01N21/4795;;G01N21/49;;G01N21/532;;G01N21/255;;G01N21/31;;G01J3/0229;;G01J3/2846;;G01J3/433;;G01J3/0229;;G01J3/433;;G01N21/31;;G01N21/4738;;G01N2021/6463;;G01N2201/0635,G01N21/31;;G01N21/25;;G01N21/49;;G01N21/64,,4,3,017-912-618-493-265;;021-303-731-950-991;;055-986-766-744-783,10.1088/1361-6501/aa6361;;10.1063/1.2825462;;18248042;;10.1038/s41598-018-30233-y;;pmc6079086;;30082685,"KIEFER J: ""Using a supercontinuum light source for instantaneous excitation-emission fluorescence mapping"", MEASUREMENT SCIENCE AND TECHNOLOGY, IOP, BRISTOL, GB, vol. 28, no. 6, 7 April 2017 (2017-04-07), pages 67001, XP020316697, ISSN: 0957-0233, [retrieved on 20170407], DOI: 10.1088/1361-6501/AA6361;;MCGREGOR T ET AL: ""Laser-based volumetric flow visualization by digital color imaging of a spectrally coded volume"", REVIEW OF SCIENTIFIC INSTRUMENTS, AMERICAN INSTITUTE OF PHYSICS, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747, vol. 79, no. 1, 30 January 2008 (2008-01-30), pages 13710 - 13710, XP012114558, ISSN: 0034-6748, DOI: 10.1063/1.2825462;;KRISTENSSON E AND BERROCAL E: ""Crossed patterned structured illumination for the analysis and velocimetry of transient turbid media"", SCIENTIFIC REPORTS, vol. 8, no. 1, 6 August 2018 (2018-08-06), XP055581732, DOI: 10.1038/s41598-018-30233-y;;See also references of WO 2020180233A1",ACTIVE
200,WO,A1,WO 2019/231858 A1,053-842-692-941-147,2019-12-05,2019,US 2019/0034034 W,2019-05-24,US 201815995875 A,2018-06-01,PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ANESTHESIOLOGICAL APPLICATIONS,"Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMD A antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",MELT PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,,https://lens.org/053-842-692-941-147,Patent Application,yes,6,0,1,31,0,A61K31/5517;;A61K45/06;;A61K31/135;;A61K31/4178;;A61K9/0056;;A61K9/02;;A61K9/0043;;A61K9/06;;A61K9/0014;;A61K9/006;;A61K47/10,A61K31/138;;A61K31/5517;;A61K45/06,,7,7,065-860-902-641-375;;081-566-868-488-006;;015-266-812-972-714;;134-466-981-037-576;;101-177-786-334-438;;155-653-387-694-528;;013-031-291-124-875,pmc3950446;;24665234;;10.4103/1658-354x.125904;;10.1111/j.1460-9592.1995.tb00307.x;;7489470;;1443705;;10.1213/00000539-199212000-00003;;10.1093/bja/81.5.702;;10215313;;11759137;;10.1111/j.1460-9592.2007.02388.x;;18095966;;10.1111/j.1600-0722.1994.tb01468.x;;7817152,"KHATAVKAR ET AL.: ""Comparison of nasal Midazolam with Ketamine versus nasal Midazolam as a premedication in children"", SAUDI JOURNAL OF ANESTHESIA, vol. 8, 1 January 2014 (2014-01-01), pages 17 - 21, XP055659592, ISSN: 1658-354X, DOI: 10.4103/1658-354X.125904;;WARNER ET AL.: ""Ketamine plus Midazolam, a Most Effective Paediatric Oral Premedicant"", PEDIATRIC ANESTHESIA, vol. 5, no. 5, 1995, pages 293 - 295, XP055659597;;BEEBE ET AL.: ""Effectiveness of Preoperative Sedation With Rectal Midazolam, Ketamine, or Their Combination in Young Children"", ANESTHESIA & ANALGESIA, vol. 75, no. 6, 1992;;KATZ, R I ET AL.: ""Haemodynamic Stability and Ketamine-Alfentanil Anaesthetic Induction"", BRITISH JOURNAL OF ANAESTHESIA, vol. 81, no. 5, 1998, pages 702 - 706, XP055659605, ISSN: 0007-0912, DOI: 10.1093/bja/81.5.702;;SMITH ET AL.: ""Prevention of Vomiting After General Anesthesia for Pediatric Ophthalmic Surgery"", AMERICAN ASSOCIATION OF NURSE ANESTHETISTS JOURNAL, vol. 69, no. 1, 2001, pages 39 - 43, XP055659615;;NOVAK ET AL.: ""Sedation with Ketamine and Low-Dose Midazolam for Short-Term Procedures Requiring Pharyngeal Manipulation in Young Children"", PEDIATRIC ANESTHESIA, vol. 18, no. 1, 2008, pages 48 - 54, XP055659617, ISSN: 1155-5645, DOI: 10.1111/j.1460-9592.2007.02388.x;;LOKKEN ET AL.: ""Conscious Sedation by Rectal Administration of Midazolam or Midazolam plus Ketamine as Alternatives to General Anesthesia for Dental Treatment of Uncooperative Children"", SCAND J DENT RES, vol. 102, no. 5, 1994, pages 274 - 280, XP055659624, ISSN: 0029-845x",PENDING
201,US,A,US 4889585 A,058-952-742-736-651,1989-12-26,1989,US 20501088 A,1988-05-31,US 20501088 A;;US 92325186 A,1986-10-27,Method for selectively forming small diameter holes in polyimide/Kevlar substrates,"Methods for forming small diameter holes in polyimide/Kelvar.RTM. substrates utilize hot concentrated sulfuric acid and then honing, as necessary, with liquid abradant slurries to smooth uneven edges of the openings.",HUGHES AIRCRAFT CO,LEYDEN RICHARD N;;LAWRENCE ROBERT;;ELIAS WILLIAM E,,https://lens.org/058-952-742-736-651,Granted Patent,yes,10,7,1,9,0,H01L21/31133;;H05K1/0346;;H05K1/0366;;H05K3/002;;H05K3/0041;;H05K3/0055;;H05K3/427;;H05K2201/0154;;H05K2201/0278;;H05K2203/0554;;H05K2203/0789;;H01L21/31133;;H05K3/002;;H05K3/427;;H05K2201/0278;;H05K2203/0554;;H05K3/0055;;H05K3/0041;;H05K1/0366;;H05K2201/0154;;H05K1/0346;;H05K2203/0789,H01L21/311;;H05K1/03;;H05K3/00;;H05K3/42,156/630;;156/644;;156/652;;156/656;;156/668;;252/79.2;;134/22.1;;134/34,3,0,,,"Lee and Neville, Handbook of Epoxy Resins, McGraw Hill Book Company, 1967, pp. 22 8 to 22 65.;;Markstein, Low TCE Metals and Fibers . . . SMT Substrates , Electronic Packaging & Production, Jan. 1985, pp. 52 59.;;Brooks, C. T., Kevlar as the Reinforcing Fiber in Printed Wiring Broad Materials , p. 32.",EXPIRED
202,GB,A,GB 189714805 A,118-065-160-859-188,1897-08-28,1897,GB 189714805D A,1897-06-18,NZ 189714805X A,1897-03-20,An Improved Screw Propeller Blade.,"14,805. Baggstom, E., Guthridge, W. P and Langley, A. E. March 20, [date claimed under Sec. 103 of Patents &c. Act, A.D. 1883]. Screw propellers.-The blades are curved or set backward in a plane perpendicular to the propeller shaft, and the amount and character of this curvature varies according to the pitch and general design of the propeller. The blades may also be curved in the plane passing through the shaft.",BAGGSTROM ELIAS;;GUTHRIDGE WILLIAM PHILIP;;LANGLEY ARTHUR EDWARD,BAGGSTROM ELIAS;;GUTHRIDGE WILLIAM PHILIP;;LANGLEY ARTHUR EDWARD,,https://lens.org/118-065-160-859-188,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
203,US,B2,US 9918993 B2,155-280-497-246-209,2018-03-20,2018,US 201615184768 A,2016-06-16,US 201615184768 A;;US 201562182130 P,2015-06-19,Pharmaceutical compositions for anesthesiological applications,"Pharmaceutical compositions and methods are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, a β-blocker and antiemetic. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",IMPRIMIS PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2018-12-27);;MELT PHARMACEUTICALS INC (2019-03-14),https://lens.org/155-280-497-246-209,Granted Patent,yes,4,6,16,31,0,A61K45/06;;A61K9/2031;;A61P23/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K31/5513;;A61P23/02;;A61P23/00;;A61K9/0056;;A61K9/2031;;A61K31/135;;A61K31/138;;A61K31/5517;;A61K45/06;;A61K2300/00;;A61K31/5517;;A61K31/135;;A61K31/138;;A61K9/0056;;A61K45/06;;A61P23/00;;A61K9/2031,A61K31/5517;;A61K9/00;;A61K31/135;;A61K31/138;;A61K45/06,,3,2,065-434-868-121-912;;125-460-862-602-786,10.1093/bja/aeh268;;15377583;;7486180;;10.1097/00000542-199511000-00007,"Chia et al (British Journal of Anaesthesia, 2004, 93(6), 799-805).;;Davis et al (Anesthesiology, 1995, 83, 956-960).;;PCT/US2016/037893 International Search Report and Written Opinion dated Sep. 7, 2016.",ACTIVE
204,US,B2,US 10179136 B2,093-945-850-765-170,2019-01-15,2019,US 201815903615 A,2018-02-23,US 201815903615 A;;US 201615184768 A;;US 201562182130 P,2015-06-19,Pharmaceutical compositions and methods for anesthesiological applications,"Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",IMPRIMIS PHARMACEUTICALS INC,BERDAHL JOHN;;WILEY WILLIAM F;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2018-12-27);;MELT PHARMACEUTICALS INC (2019-03-14),https://lens.org/093-945-850-765-170,Granted Patent,yes,10,1,2,31,0,A61K31/5517;;A61K31/5517;;A61K9/0056;;A61K9/0056;;A61K9/2031;;A61K9/2031;;A61K31/135;;A61K31/135;;A61K31/138;;A61K31/4178;;A61K31/4178;;A61K45/06;;A61K45/06;;A61K2300/00;;A61P23/00;;A61P23/00,A61K31/138;;A61K9/00;;A61K9/20;;A61K31/5517;;A61K45/06;;A61P23/00,,9,5,125-460-862-602-786;;006-634-789-624-833;;027-264-776-988-749;;042-813-959-756-919;;042-180-451-830-180,7486180;;10.1097/00000542-199511000-00007;;10.1586/ern.11.52;;21539491;;pmc3227310;;22144928;;10.4103/1658-354x.87270;;10.1517/14656560902978446;;19601699;;28473800;;10.3389/fneur.2017.00141;;pmc5397512,"PCT/US2016/037893 International Search Report and Written Opinion dated Sep. 7, 2016.;;Chia et al. “Role of β-blockade in anaesthesia and postoperative pain management after hysterectomy,” British Journal of Anaesthesia, 2004, 93(6):799-805.;;Davis et al. “Effect of Antiemetic Therapy on Recovery and Hospital Discharge Time.” Anesthesiology, 1995, 83:956-960.;;Ramaiah et al. “Pediatric procedural sedation and analgesia outside the operating room: anticipating, avoiding and managing complications,” Expert Rev. Neurother, 2011, 11(5):755-763.;;Tobias et al. “Procedural sedation: A review of sedative agents, monitoring, and management of complications,” Saudi J Anaesth., 2011, 5(4):395-410.;;Mclean et al. “The pharmacological treatment of nystagmus: a review,” Expert Opinion on Pharmacotherapy, 2009, 10(11):1805-1816.;;Macdonald et al. “Central Positional Nystagmus: A Systematic Literature Review,” Frontiers in Neurology, Apr. 2017, 8:1-11.;;JP2017-566010 Office Action dated Jun. 5, 2018.;;KR10-2018-7000815 Office Action dated Aug. 2, 2018.",ACTIVE
205,DE,T2,DE 69212352 T2,074-107-236-369-221,1997-01-16,1997,DE 69212352 T,1992-02-19,US 66964691 A,1991-03-14,Implantierbarer Defibrillator mit verbesserten Kondensatoren,,VENTRITEX INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;MARQUIT TIMOTHY A,,https://lens.org/074-107-236-369-221,Granted Patent,no,0,0,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,,0,0,,,,EXPIRED
206,CA,A1,CA 2176684 A1,016-421-012-968-075,1996-11-18,1996,CA 2176684 A,1996-05-15,US 44313495 A,1995-05-17,CAPACITOR FOIL WITH ENHANCED SURFACE AREA,"An improved electrolytic capacitor is provided by producing an anode foil which has areas which are not subject to stress during manufacturing being highly etched and those areas which are subject to stress during manufacturing being lightly etched or not etched at all. The process of the invention provides an etch mask to cover during the etch process those portions of the anode foil which will be subjected to stress during construction of the capacitor. The highly etched areas, which are very brittle, provide increased capacitance and thus improved energy density. For layered or stacked capacitors, a weld tab is covered with the etch mask to allow connection of the anode layers. Additionally, strong edges may be maintained thereby reducing the possibility of cracking that would normally occur during the stamping and assembly operations. For flat or oval capacitors made by rolling or winding the capacitor element on a large arbor, and then flattening the element by compressing it in a press, high stress occurs at the sharp bends resulting in cracking or breaking if the foil is not flexible. The method of the invention allows high gain foil to be used in the flat areas, while masking strengthens the locations where the sharp bends occur, thereby improving the capacitance.",VENTRITEX INC;;PHILIPS ELECTRONICS NA,ELIAS WILLIAM H;;STRANGE THOMAS F;;STEVENS JAMES I,,https://lens.org/016-421-012-968-075,Patent Application,no,0,0,8,8,0,H01G9/055;;H01G9/055,H01G9/04;;H01G9/055,,0,0,,,,DISCONTINUED
207,DE,D1,DE 69628527 D1,050-586-915-921-268,2003-07-10,2003,DE 69628527 T,1996-10-26,US 54914195 A,1995-10-27,Verwendung von metallbeschichtbare Strukturklebstoffe zum Kleben von Kompositen aus Cyanatestern.,,HUGHES ELECTRONICS CORP,PUNSLY BRIAN M;;WALLACE ANDRE R;;ELIAS WILLIAM E,,https://lens.org/050-586-915-921-268,Granted Patent,no,0,0,8,8,0,C09J163/00;;C09J163/00;;C08L63/00;;C08L63/00;;C08L2666/54;;C08L2666/54;;C09J179/04;;C09J179/04;;Y10T428/31515;;Y10T428/31515,C09J163/00;;C09J179/04,,0,0,,,,EXPIRED
208,KR,B1,KR 960001499 B1,073-432-035-253-444,1996-01-31,1996,KR 930011157 A,1993-06-18,US 90129792 A,1992-06-19,INORGAMIC OXIDANT COMPOSITIONS FOR REMOVING CONTAMINANTS,"A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxy-acid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGE RICHARD C;;STANFORD THOMAS B,,https://lens.org/073-432-035-253-444,Granted Patent,no,0,0,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,C23G1/14;;H05K3/34;;H05K3/26,,0,0,,,,EXPIRED
209,WO,A2,WO 2015/134715 A2,119-130-094-694-884,2015-09-11,2015,US 2015/0018895 W,2015-03-05,US 201461949297 P,2014-03-07,SYSTEMS AND METHODS FOR NON-INVASIVE FLUID FLOW MEASUREMENT,"A device (10) is capable of sensing the flow of fluid in a system (14) and can be affixed to the outside of the system, pipe or conduit directly. The device (10) does not require invasive installation (i.e. no changes to the system have to be made). This makes the invention particularly suited for a retro-fit or other application in existing systems (14). The device may include a sensor (22) capable of detecting vibrations and a microprocessor capable of processing the information collected from the sensor. The device (10) can be capable of transmitting the information over a wireless or wired connection via a radio (44) to a collector station or otherwise. It can be powered by various means such as a battery pack, main facility power, and or solar power (24). The on-board microprocessor (40) may use a series of algorithms to translate vibrational data to flow data (60).",LAGOON SYSTEMS INC,ELIAS ERIC J;;HEIDT NATHANIEL W;;WIEBE WILLIAM E,,https://lens.org/119-130-094-694-884,Patent Application,yes,0,9,2,2,0,G01F1/8409;;G01F1/666,G01L13/06,,0,0,,,,PENDING
210,EP,B1,EP 0743662 B1,173-295-387-877-039,2004-08-11,2004,EP 96107901 A,1996-05-17,US 44313495 A,1995-05-17,Capacitor foil with enhanced surface area,,PACESETTER INC;;PHILIPS ELECTRONICS NA,ELIAS WILLIAM H;;STRANGE THOMAS F;;STEVENS JAMES I,"PHILIPS ELECTRONICS NORTH AMERICA CORPORATION (2001-10-17);;PACESETTER, INC. (2001-10-17)",https://lens.org/173-295-387-877-039,Granted Patent,yes,1,0,8,8,0,H01G9/055;;H01G9/055,H01G9/04;;H01G9/055,,0,0,,,,EXPIRED
211,US,A1,US 2015/0238685 A1,181-244-663-400-06X,2015-08-27,2015,US 201314429592 A,2013-09-18,US 201314429592 A;;US 201261703191 P;;US 201361874741 P;;US 2013/0060404 W,2012-09-19,Method and System for Enhanced Imaging Visualization of Deep Brain Anatomy Using Infusion,"Provided is a method and system for delivering a diagnostic agent to a site in the brain of a subject for imaging at least a portion of the brain site on a medical imaging system. The method and system includes a catheter device with associated lumens having diagnostic agent ports for delivering the diagnostic agent (e.g., infusate) through the lumens and advancing the diagnostic agent so as to exit out from the lumens to at least a portion of the brain site and while sealing a portion of the brain site thereby preventing the exited diagnostic agent from travelling proximally beyond the sealing location, and at the same time imaging at least a portion of the brain site during at least a portion of the sealing duration so that the brain site can be visualized on a medical imaging system. The diagnostic agent (infusate) is able to highlight borders and internal patterns of the deep structures of the brain thereby enabling direct targeting. Ultimately this leads to reduced complications, enhanced therapy, and the elimination of the need for awake surgery. The method and system provides the capability heretofore not possible to visualize the small, often indistinct regions, which will greatly improve clinical outcomes with therapeutic interventions.",ELIAS WILLIAM J;;BOND AARON E;;GILLIES GEORGE T;;UNIV VIRGINIA PATENT FOUND,ELIAS WILLIAM J;;BOND AARON E;;GILLIES GEORGE T,UNIVERSITY OF VIRGINIA PATENT FOUNDATION (2013-12-03);;UNIVERSITY OF VIRGINIA (2013-10-13),https://lens.org/181-244-663-400-06X,Patent Application,yes,4,20,5,5,0,A61M25/10;;A61B5/0042;;A61B5/055;;A61M25/007;;A61M25/0127;;A61M25/1002;;A61M31/005;;A61M2025/0042;;A61M2025/105;;A61M2025/1052;;A61M2025/1093;;G01R33/285;;A61B6/032;;A61B6/12;;A61B6/481;;A61B6/501;;A61M25/10;;A61B5/0042;;A61B5/055;;A61M25/007;;A61M25/0127;;A61M25/1002;;A61M31/005;;A61M2025/0042;;A61M2025/105;;A61M2025/1052;;A61M2025/1093;;G01R33/285;;A61B6/032;;A61B6/12;;A61B6/481;;A61B6/501;;A61M5/007;;A61M25/0026;;A61M2025/0037;;A61N1/36139,A61B5/055;;A61M5/00;;A61M25/00;;A61M25/10;;A61N1/36,,0,0,,,,ACTIVE
212,US,A1,US 2019/0070356 A1,196-898-582-529-352,2019-03-07,2019,US 201816181498 A,2018-11-06,US 201816181498 A;;US 2013/0060404 W;;US 201361874741 P;;US 201261703191 P,2012-09-19,Method and System for Enhanced Imaging Visualization of Deep Brain Anatomy Using Infusion,"Provided is a method and system for delivering a diagnostic agent to a site in the brain of a subject for imaging at least a portion of the brain site on a medical imaging system. The method and system includes a catheter device with associated lumens having diagnostic agent ports for delivering the diagnostic agent (e.g., infusate) through the lumens and advancing the diagnostic agent so as to exit out from the lumens to at least a portion of the brain site and while sealing a portion of the brain site thereby preventing the exited diagnostic agent from travelling proximally beyond the sealing location, and at the same time imaging at least a portion of the brain site during at least a portion of the sealing duration so that the brain site can be visualized on a medical imaging system. The diagnostic agent (infusate) is able to highlight borders and internal patterns of the deep structures of the brain thereby enabling direct targeting. Ultimately this leads to reduced complications, enhanced therapy, and the elimination of the need for awake surgery. The method and system provides the capability heretofore not possible to visualize the small, often indistinct regions, which will greatly improve clinical outcomes with therapeutic interventions.",UNIV VIRGINIA PATENT FOUNDATION,ELIAS WILLIAM J;;BOND AARON E;;GILLIES GEORGE T,UNIVERSITY OF VIRGINIA PATENT FOUNDATION (2013-12-03);;UNIVERSITY OF VIRGINIA (2013-10-13),https://lens.org/196-898-582-529-352,Patent Application,yes,0,4,5,5,0,A61M25/10;;A61B5/0042;;A61B5/055;;A61M25/007;;A61M25/0127;;A61M25/1002;;A61M31/005;;A61M2025/0042;;A61M2025/105;;A61M2025/1052;;A61M2025/1093;;G01R33/285;;A61B6/032;;A61B6/12;;A61B6/481;;A61B6/501;;A61M25/10;;A61B5/0042;;A61B5/055;;A61M25/007;;A61M25/0127;;A61M25/1002;;A61M31/005;;A61M2025/0042;;A61M2025/105;;A61M2025/1052;;A61M2025/1093;;G01R33/285;;A61B6/032;;A61B6/12;;A61B6/481;;A61B6/501;;A61M5/007;;A61M25/0026;;A61M2025/0037;;A61N1/36139,A61M5/00;;A61B5/00;;A61B5/055;;A61B6/00;;A61B6/03;;A61B6/12;;A61M25/00;;A61M25/01;;A61M25/10;;A61M31/00;;A61N1/36;;G01R33/28,,0,0,,,,ACTIVE
213,DE,D1,DE 69308647 D1,043-374-465-680-920,1997-04-17,1997,DE 69308647 T,1993-06-14,US 90129792 A,1992-06-19,Anorganische oxydierende Zusammensetzungen zur Entfernung von Verunreinigungen,"A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxy-acid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGE RICHARD C;;STANFORD THOMAS B,,https://lens.org/043-374-465-680-920,Granted Patent,no,0,0,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,H05K3/34;;C23G1/14;;H05K3/26,,0,0,,,,EXPIRED
214,DE,T2,DE 69633090 T2,080-828-033-382-458,2005-07-28,2005,DE 69633090 T,1996-05-17,US 44313495 A,1995-05-17,Kondensatorfolie mit hoher spezifischer Oberfläche,,PACESETTER INC;;PHILIPS ELECTRONICS NA,ELIAS WILLIAM H;;STRANGE THOMAS F;;STEVENS JAMES I,,https://lens.org/080-828-033-382-458,Granted Patent,no,0,0,8,8,0,H01G9/055;;H01G9/055,H01G9/04;;H01G9/055,,0,0,,,,EXPIRED
215,GB,A,GB 190124425 A,084-339-448-204-723,1902-05-29,1902,GB 190124425D A,1901-12-02,GB 190124425T A,1901-12-02,"Improvements in, or relating to, Buckets, Pails, and other Hollow-ware.","24,425. Roberts, C. W., Cooper, E. E.,' and Cooper, D. W., [trading as Wollescote Galvanizing Co.]. Dec. 2. Metal, sheet, seaming and joining.- Relates to buckets, pails, cans, milkchurns, pans, and other hollow-ware, in which the bottom a:nd foot-ring are combined or made in one piece and connected to the body-part by turning or closing the edge of one part over the edge of the other. The foot-ring is formed with a circumferential groove which has for its outer wall a double thickness of metal b<4>. Into this groove is placed the flanged or beaded mouth end of the body a, which is there enclosed internally and externally by the walls of the groove. The attachment is completed by closing the double thickness of metal over the flange a<2> of the body. As a modification, both the inner and outer walls of the groove are formed of a double thickness, in which case the outer double wall may be closed over the edge of the bucket body, the other wall being left standing ; or both vertical walls may be closed over a wired or beaded edge of the body.",ROBERTS CALEB WILLIAM;;COOPER EBENEZER ELIAS;;COOPER DAVID WALTER,ROBERTS CALEB WILLIAM;;COOPER EBENEZER ELIAS;;COOPER DAVID WALTER,,https://lens.org/084-339-448-204-723,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
216,EP,B1,EP 0205947 B1,115-994-653-945-962,1989-01-04,1989,EP 86107014 A,1986-05-23,US 74759885 A,1985-06-24,METHOD OF SMOOTHING THE SURFACE OF A CERAMIC SUBSTRATE,,INTERNATIONAL BUSINESS MACHINES CORPORATION,"ELIAS, KENNETH LAMBERT;;MARTIN, STUART ROBB;;SLATTERY, WILLIAM JOHN",,https://lens.org/115-994-653-945-962,Granted Patent,yes,0,0,7,8,0,C04B41/4572;;H05K1/0306;;H05K3/0011;;C04B41/4572;;H05K3/0011;;H05K1/0306,C04B41/87;;C04B41/45;;H05K1/03;;H05K3/00,,2,0,,,"MANUFACTURING TECHNOLOGY NOTE - US ARMY MATERIEL DEVELOPMENT AND READINESS COMMAND, April 1983, report no. AMMRC-TR-80-36, filing code 71E-018, Alexandria, Virginia, US; ""Silicon nitride coatings on silica substrates"";;CHEMICAL ABSTRACTS, vol. 57, no. 10, September 1982, page 318, abstract no. 77349f, Columbus, Ohio, US; J. JANCA et al.: ""Plasma-chemical deposition of silicon nitride films""",EXPIRED
217,CN,A,CN 1034259 A,039-200-804-347-352,1989-07-26,1989,CN 88106587 A,1988-09-07,US 14379288 A,1988-01-14,BIMODAL SWIRLER INJECTOR FOR GAS TURBINE COMBUSTOR,,GEN ELECTRIC,VINSON JOHN WILLIAM;;HOWELL STEPHEN JOHN;;LAMPES ELIAS HARRY,,https://lens.org/039-200-804-347-352,Patent Application,no,0,8,18,18,0,F23C7/002;;F23D17/00;;F23R3/14;;F23R3/34;;Y02T50/60;;F23D17/00;;F23R3/34;;F23R3/14;;F23C7/002;;Y02T50/60,F02C7/232;;F23C7/00;;F23D17/00;;F23R3/14;;F23R3/34,,0,0,,,,EXPIRED
218,US,A,US 4692098 A,059-276-958-324-109,1987-09-08,1987,US 78750385 A,1985-10-15,US 78750385 A;;US 29787481 A,1981-08-31,Airfoil for high efficiency/high lift fan,Airfoil for vehicle fan which operates in low Reynolds number and varying turbulent conditions having a discontinuity formed on the suction surface thereof adjacent to its leading edge to trigger early formation of a laminar flow bubble so that sufficient suction surface remains downstream of the air bubble whereby air circumventing the bubble can reattach to the suction surface for sufficient pressure recovery for high lift and low drag performance.,GEN MOTORS CORP,RAZINSKY ELIAS H;;ROBERTS WILLIAM B;;LONGHOUSE RICHARD E,ITT AUTOMOTIVE ELECTRICAL SYSTEMS INC (1994-03-31);;GENERAL MOTORS CORPORATION DETROIT MICHIGAN A CORP OF DE (1985-09-20),https://lens.org/059-276-958-324-109,Granted Patent,yes,9,27,1,7,0,F04D29/384;;F04D29/681;;Y10S415/914;;Y10S416/02;;F04D29/384;;F04D29/681;;Y10S415/914;;Y10S416/02,F04D29/38,416223R;;416/237;;X416DIG 2;;416/243;;X415DIG 1,1,0,,,"Journal of Engineering for Power, 4 1975, pp. 261 274.",EXPIRED
219,AU,B2,AU 650818 B2,092-799-971-062-587,1994-06-30,1994,AU 1993/041217 A,1993-06-11,US 90129792 A,1992-06-19,Inorganic oxidant compositions for removing contaminants,"A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxy-acid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGE RICHARD C;;STANFORD THOMAS B,,https://lens.org/092-799-971-062-587,Granted Patent,no,3,0,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,H05K3/34;;C23G1/14;;H05K3/26,,0,0,,,,EXPIRED
220,CN,B,CN 1018384 B,134-424-093-424-935,1992-09-23,1992,CN 88106587 A,1988-09-07,US 14379288 A,1988-01-14,BIMODAL SWIRLER INJECTOR FOR GAS TURBINE COMBUSTOR,,GEN ELECTRIC,VINSON JOHN WILLIAM;;HOWELL STEPHEN JOHN;;LAMPES ELIAS HARRY,,https://lens.org/134-424-093-424-935,Patent Application,no,0,0,18,18,0,F23C7/002;;F23D17/00;;F23R3/14;;F23R3/34;;Y02T50/60;;F23D17/00;;F23R3/34;;F23R3/14;;F23C7/002;;Y02T50/60,F02C7/232;;F23C7/00;;F23D17/00;;F23R3/14;;F23R3/34,,0,0,,,,EXPIRED
221,DE,A1,DE 3227997 A1,042-721-136-088-958,1983-03-10,1983,DE 3227997 A,1982-07-23,US 29787481 A,1981-08-31,SCHAUFEL FUER LUEFTER VON LANDFAHRZEUGEN,,GEN MOTORS CORP,RAZINSKY ELIAS HIRSH;;ROBERTS WILLIAM BYRON;;LONGHOUSE RICHARD EDWARD,,https://lens.org/042-721-136-088-958,Patent Application,no,1,0,6,7,0,F04D29/384,F04D29/38;;F04D29/68,,0,0,,,,EXPIRED
222,US,B2,US 10159782 B2,062-261-268-594-618,2018-12-25,2018,US 201314429592 A,2013-09-18,US 201314429592 A;;US 201261703191 P;;US 201361874741 P;;US 2013/0060404 W,2012-09-19,Method and system for enhanced imaging visualization of deep brain anatomy using infusion,"Provided is a method and system for delivering a diagnostic agent to a site in the brain of a subject for imaging at least a portion of the brain site on a medical imaging system. The method and system includes a catheter device with associated lumens having diagnostic agent ports for delivering the diagnostic agent (e.g., infusate) through the lumens and advancing the diagnostic agent so as to exit out from the lumens to at least a portion of the brain site and while sealing a portion of the brain site thereby preventing the exited diagnostic agent from travelling proximally beyond the sealing location, and at the same time imaging at least a portion of the brain site during at least a portion of the sealing duration so that the brain site can be visualized on a medical imaging system. The diagnostic agent (infusate) is able to highlight borders and internal patterns of the deep structures of the brain thereby enabling direct targeting. Ultimately this leads to reduced complications, enhanced therapy, and the elimination of the need for awake surgery. The method and system provides the capability heretofore not possible to visualize the small, often indistinct regions, which will greatly improve clinical outcomes with therapeutic interventions.",ELIAS WILLIAM J;;BOND AARON E;;GILLIES GEORGE T;;UNIV VIRGINIA PATENT FOUNDATION,ELIAS WILLIAM J;;BOND AARON E;;GILLIES GEORGE T,UNIVERSITY OF VIRGINIA PATENT FOUNDATION (2013-12-03);;UNIVERSITY OF VIRGINIA (2013-10-13),https://lens.org/062-261-268-594-618,Granted Patent,yes,85,4,5,5,0,A61M25/10;;A61B5/0042;;A61B5/055;;A61M25/007;;A61M25/0127;;A61M25/1002;;A61M31/005;;A61M2025/0042;;A61M2025/105;;A61M2025/1052;;A61M2025/1093;;G01R33/285;;A61B6/032;;A61B6/12;;A61B6/481;;A61B6/501;;A61M25/10;;A61B5/0042;;A61B5/055;;A61M25/007;;A61M25/0127;;A61M25/1002;;A61M31/005;;A61M2025/0042;;A61M2025/105;;A61M2025/1052;;A61M2025/1093;;G01R33/285;;A61B6/032;;A61B6/12;;A61B6/481;;A61B6/501;;A61M5/007;;A61M25/0026;;A61M2025/0037;;A61N1/36139,A61B5/055;;A61B5/00;;A61B6/00;;A61B6/03;;A61B6/12;;A61M5/00;;A61M25/00;;A61M25/01;;A61M25/10;;A61M31/00;;A61N1/36;;G01R33/28,,48,44,025-436-075-770-54X;;019-837-589-695-401;;002-154-516-131-453;;017-864-558-610-576;;018-211-497-893-135;;010-318-113-512-823;;037-315-113-227-826;;166-982-437-010-515;;023-042-472-834-936;;123-261-250-568-05X;;005-824-206-707-479;;012-898-797-523-967;;025-076-573-169-961;;033-498-203-758-54X;;070-767-623-822-485;;005-672-609-080-164;;026-698-144-036-485;;027-390-894-379-503;;034-857-530-497-541;;036-272-578-633-724;;046-792-685-913-66X;;020-300-680-711-842;;086-731-007-693-09X;;002-024-637-029-038;;055-384-190-448-931;;054-182-351-237-210;;088-421-309-373-832;;000-975-142-042-477;;001-148-148-771-555;;077-336-525-929-166;;087-568-570-461-481;;078-687-047-868-776;;008-082-006-772-347;;069-559-717-258-908;;001-447-676-601-242;;013-269-517-688-762;;002-678-405-898-317;;037-666-099-701-791;;003-528-760-802-669;;069-263-694-910-12X;;038-147-649-040-062;;154-753-776-781-061;;089-330-668-020-118;;038-585-674-487-966,10.1063/1.3077262;;10.1088/0957-4484/15/1/018;;10.1109/68.752527;;10.1109/68.720261;;10.1049/el:19961529;;10.1109/leos.2005.1548202;;26848911;;10.3171/2015.10.jns151154;;10.1109/2944.788420;;10.1063/1.121709;;10.1016/j.wneu.2010.06.008;;21299996;;10.3171/2012.1.peds11391;;22462711;;19782522;;10.1016/j.jvs.2009.07.072;;10.1109/leos.1998.737802;;10.1109/68.669218;;10.3171/jns.2004.101.2.0314;;15309925;;10.1023/b:neon.0000041874.02554.b3;;15527083;;10.1002/mds.22080;;18442130;;17977271;;10.3171/jns-07/11/0983;;10.3171/2008.7.17625;;18821828;;10.1016/j.neuroimage.2011.10.049;;22036683;;10.1088/0967-3334/33/12/2003;;23151433;;10.1371/journal.pone.0056266;;pmc3574132;;23457542;;10.1109/lpt.2005.856400;;10.1109/lpt.2005.849975;;10.1212/01.wnl.0000194272.79084.7e;;16434672;;18824788;;10.1088/1478-3975/5/3/036010;;23215793;;10.3109/08941939.2012.677967;;16055972;;10.3233/thc-2005-13403;;20488320;;10.1016/j.jvs.2010.01.033;;10.1159/000331269;;22104373;;10.1063/1.3626469;;16429411;;10.1002/ana.20737;;22791029;;pmc4104674;;10.1227/neu.0b013e3182672ac9;;21548744;;10.3171/2011.4.jns102075;;10.3171/2011.7.jns11250;;21854118;;17557455;;16703895;;10.3171/jns.2006.104.5.845;;10.3171/jns-07/11/0998;;17977273;;10.3109/03091902.2011.645943;;22316101;;10.1007/s10544-012-9684-1;;22892642;;10.1213/ane.0b013e31824cb835;;22451591;;19272871;;10.1109/tbme.2008.2009527;;pmc2995881;;20861152;;10.1093/brain/awq239;;22120376;;10.1016/j.wneu.2011.05.051,"Allison, S.W. et al., “Temperature-dependent fluorescence decay lifetimes of the phosphor Y3(Al0.5Ga0.5)5O12:Ce 1%”, Journal of Applied Physics, 2009), pp. 036105-1-036105-3, vol. 105, Issue 3, Published by AIP Publishing, United States.;;Bauman, M.A. et al., “Physical Characterization of Neurocatheter Performance in a Brain Phantom Gelatin with Nanoscale Porosity: Stead-State and Oscillatory Flows,” Nanotechnology, 2004, pp. 92-97, vol. 15, Published by IOP Publishing Ltd, UK.;;Bond, A.E. et al., “43 GHz Modulation Bandwidth Packaged InGaAsP MQW EA Modulators with Integrated Mode Converters”, Proceedings of ECOC'99, 25th European Conference on Optical Communication, Sep. 26-30, 1999, Nice, France, pp. 14-15 (2 pages) Suppl., Published by OSA Publishing, United States.;;Bond, A.E. et al., “Aperture Dependent Loss Analysis in Vertical-Cavity Surface-Emitting Lasers”, IEEE Photonics Technology Letters, Apr. 1999, pp. 397-399, vol. 11, No. 4, Published by IEEE Publications, United States.;;Bond, A.E. et al., “Aperture Placement Effects in Oxide-Defined Vertical-Cavity Surface-Emitting Lasers”, IEEE Photonics Technology Letters, Oct. 1998, pp. 1362-1364, vol. 10, No. 10, Published by IEEE Publications, United States.;;Bond, A.E. et al., “Backgating reduction in MESFETs using an AIAs native oxide buffer layer”, Electronics Letters, Nov. 21, 1996, pp. 2271-2273, vol. 32, No. 24, Published by the Institution of Engineering and Technology, UK.;;Bond, A. et al., “Challenges in Optoelectronic Component Packaging for Next Generation Pluggable Modules”, IEEE conference Publications, 2005 IEEE LEOS Annual Meeting Conference Proceedings, Lasers and Electro-Optics Society 18th Annual Meeting Sydney, Australia, Oct. 2005, pp. 706-707, Published by IEEE Publications, United States.;;Bond, A.E. et al., “Convection-enhanced delivery improves MRI visualization of basal ganglia for stereotactic surgery”, Journal of Neurosurgery, 2016, pp. 1080-1086, vol. 125, Issue 5, Published by the American Association of Neurological Surgeons, United States.;;Bond, A.E. et al., “Design of Low-Loss Single-Mode Vertical-Cavity Surface-Emitting Lasers”, IEEE Journal of Selected Topics in Quantum Electronics, May/Jun. 1999, pp. 574-581, vol. 5, No. 3, Published by IEEE Publications, United States.;;Bond, A.E. et al., “Monolithically integrated surface and substrate emitting vertical cavity lasers for smart pixels”, Applied Physics Letters, Jul. 6, 1998, pp. 19-21, vol. 73, No. 1, Published by AIP Publishing, United States.;;Bond, A.E. et al., “Operative Strategies for Minimizing Hearing Loss and other major Complications Associated with Microvascular Decompression for Trigeminal Neuralgia”, World Neurosurgery, Jul. 2010, pp. 172-177, vol. 74, No. 1, Published by Elsevier, Amsterdam, Netherlands.;;Bond, A.E. et al., “Spinal arachnoid cysts in the pediatric population: report of 31 cases and a review of the literature”, Journal of Neurosurgery: Pediatrics, Apr. 2012, pp. 432-441, vol. 9, No. 4, Published by the American Association of Neurological Surgeons, United States.;;Bond, A.E. et al., “The Influence of Stents on the Performance of an Ultrasonic Navigation System for Endovascular Procedures,” Journal of Vascular Surgery, Nov. 2009, pp. 1143-1148, vol. 50, No. 5, Published by Elsevier, Amsterdam, Netherlands.;;Bond, A.E., “Ultralow threshold monolithically integrated surface and substrate emitting vertical cavity surface emitting lasers with properties controlled by oxide aperture placement,” Conference Proceedings Publications, Lasers and Electro-Optics Society Annual Meeting, IEEE Lasers and Electro-Optics Society 1998 Annual Meetings, Dec. 1-4, 1998, pp. 208-209, vol. 1, Orlando, FL, USA, Published by IEEE Publications, United States.;;Bond, A.E. et al., “Vertical-Cavity Surface-Emitting Lasers with Spatially Adjustable DBR Reflectivity to Enable Free-Space Photonic Repeaters”, IEEE Photonics Technology Letters, May 1998, pp. 636-638, vol. 10, No. 5, Published by IEEE Publications, United States.;;Chen, M.Y. et al., “Intratumoral Administration and Convection-Enhanced Delivery,” in Newton, H., ed., Handbook of Brain Tumor Chemotherapy, 2006, Chap. 20, pp. 295-304, Academic Press, New York, USA.;;Chen, Z., et al., “A realistic brain tissue phantom for intraparenchymal infusion studies”, Journal of Neurosurgery, 2004, pp. 314-322, vol. 101, Issue 2, Published by the American Association of Neurological Surgeons, United States.;;Chiocca, E.A et al., “Neurosurgical Delivery of Chemotherapeutics, Targeted Toxins, Genetic and Viral Therapies in Neuro-Oncology,” Journal of Neuro-Oncology, 2004, pp. 101-117, vol. 69, Published by Springer Science+Business Media, Germany.;;Elias, W.J. et al., “Dexmedetomidine and arousal affect subthalamic neurons”, Movement Disorders, 2008, pp. 1317-1320, vol. 23, No. 9, Published by Wiley-Liss, United States.;;Elias, W.J. et al., “Cortical and subcortical brain shift during stereotactic procedures”, Journal of Neurosurgery, 2007, pp. 983-988, vol. 107, Issue 5, Published by the American Association of Neurological Surgeons, United States.;;Elias, W.J. et al., “Focused ultrasound surgery”, Neurosurg Focus, Jan. 2012, Introduction (1 page), vol. 32, Issue 1, Published by the American Association of Neurological Surgeons, United States.;;Elias, W.J. et al., “Sulcal and ventricular trajectories in stereotactic surgery”, Journal of Neurosurgery, Feb. 2009, pp. 201-207, vol. 110, Issue 2, Published by the American Association of Neurological Surgeons, United States.;;Elias, W.J. et al., “Validation of connectivity-based thalamic segmentation with direct electrophysiologic recordings from human sensory thalamus”, Neuroimage, 2012, pp. 2025-2034, vol. 59, Issue 3, Published by Elsevier, Amsterdam, Netherlands.;;Flouty, O. et al., “A New Device Concept for Directly Modulating Spinal Cord Pathways: Initial in vivo Experimental Results,” Physiological Measurement, 2012, pp. 2003-2015, vol. 33, No. 12, Published by IOP Publishing Ltd, UK.;;Flouty, O.E. et al., “Intracranial Somatosensory Responses with Direct Spinal Cord Stimulation in Anesthetized Sheep,” PLOS ONE, Feb. 2013, e56266 (11 pgs.), vol. 8, Issue 2, Published by Public Library of Science, United States.;;Foulk, H. et al., “Broad Temperature Operation and Widely Tunable High Dynamic Range High-Speed Amplified Electroabsorption Modulator”, IEEE Photonics Technology Letters, Oct. 2005, pp. 2191-2193, vol. 17, No. 10, Published by IEEE Publications, United States.;;Frateschi, N.C. et al., “Uncooled Performance of 10-Gb/s Laser Modules With InGaAlAs—InP and InGaAsP—InP MQW Electroabsorption Modulators Integrated With Semiconductor Amplifiers”, IEEE Photonics Technology Letters, Jul. 2005, pp. 1378-1380, vol. 17, No. 7, Published by IEEE Publications, United States.;;Frysinger, R.C., et al., “Bipolar Deep Brain Stimulation Permits Routine EKG, EEG, and Polysomnography”, Neurology, Jan. 2006, pp. 268-270, vol. 66, No. 2, Published by the American Academy of Neurology, United States.;;Gevertz, J.L. et al., “Simulating Tumor Growth in Confined Heterogeneous Environments” Physical Biology, 2008, 036010 (10 pgs.), vol. 5, No. 3, Published by IOP Publishing Ltd, UK.;;Gibson-Corley, K.N. et al., “Ovine Tests of a Novel Spinal Cord Neuromodulator and Dentate Ligament Fixation Method,” Journal of Investigative Surgery, 2012, pp. 366-374, vol. 25, No. 6, Published by Informa Healthcare, United States.;;Gillies, G.T. et al., “Positive Pressure Infusion of Therapeutic Agents into Brain Tissues: Mathematical and Experimental Simulations,” Technology and Health Care, 2005, pp. 235-243, vol. 13, Published by IOS Press, Amsterdam, Netherlands.;;Han, S. et al., “Comparison of Ultrasound and CT Scan Determined AAA Diameters Following Endovascular AAA Repair,” Society for Clinical Vascular Surgery 37th Annual Symposium, Mar. 18-21, 2009, Ft. Lauderdale, FL, USA, Published by the Society for Clinical Vascular Surgery.;;Han, S.M. et al., “Ultrasound-determined diameter measurements are more accurate than axial computed tomography after endovascular aortic aneurysm repair”, Journal of Vascular Surgery, Jun. 2010, pp. 1381-1389, vol. 51, No. 6, Published by Elsevier, Amsterdam, Netherlands.;;Hilliard, J.D. et al., “Effective Subthalamic Nucleus Deep Brain Stimulation Sites May Differ for Tremor, Bradykinesia and Gait Disturbances in Parkinson's Disease”, Stereotactic and Functional Neurosurgery, 2011, pp. 357-364, vol. 89, No. 6, Published by Karger Publishing, Basel, Switzerland.;;Howard III, M.A. et al., “Intradural Approach to Selective Stimulation in the Spinal Cord for Treatment of Intractable Pain: Design Principles and Wireless Protocol” Journal of Applied Physics, 2011, pp. 044702-01-044702-12, vol. 110, Issue 2, Published by AIP Publishing, United States.;;Lang, A.E., et al., “Randomized Controlled Trial of Intraputamenal Glial Cell Line-Derived Neurotrophic Factor Infusion in Parkinson Disease”, Ann Neurol, 2006, pp. 459-466, vol. 59, Published by John Wiley & Sons, United States.;;Medel, R. et al., “Magnetic Resonance-Guided Focused Ultrasound Surgery: Part 2: A Review of Current and Future Applications”, Neurosurgery, Oct. 2012, pp. 755-763, vol. 71, No. 4, Published by Oxford University Press, Oxford, England, UK.;;Pouratian, N. et al., “Comprehensive analysis of risk factors for seizures after deep brain stimulation surgery”, Journal of Neurosurgery, Aug. 2011, pp. 310-315, vol. 115, Issue 2, Published by the American Association of Neurological Surgeons, United States.;;Pouratian, N. et al., “Multi-institutional evaluation of deep brain stimulation targeting using probabilistic connectivity-based thalamic segmentation”, Journal of Neurosurgery, Nov. 2011, pp. 995-1004, vol. 115, Issue 5, Published by the American Association of Neurological Surgeons, United States.;;Quigg, M. et al., “Acute Insomnia Following Surgery of the Ventralis Intermedius Nucleus of the Thalamus for Tremor”, Journal of Clinical Sleep Medicine, 2007, pp. 58-59, vol. 3, No. 1, Published by the American Academy of Sleep Medicine, United States.;;Quigg, M. et al., “Conduction aphasia as a function of the dominant posterior perisylvian cortex”, Journal of Neurosurgery, May 2006, pp. 845-848, vol. 104, Issue 5, Published by the American Association of Neurological Surgeons, United States.;;Sansur, C.A. et al., “Incidence of symptomatic hemorrhage after stereotactic electrode placement”, Journal of Neurosurgery, Nov. 2007, pp. 998-1003, vol. 107, Issue 5, Published by the American Association of Neurological Surgeons, United States.;;Song, S.-H. et al., “Inductively Coupled Microfluidic Pressure Meter for in vivo Monitoring of Cerebrospinal Fluid Shunt Function”, Journal of Medical Engineering & Technology, 2012, pp. 156-162, vol. 36, Issue 3, Published by Informa Healthcare, United States.;;Song, S.-H. et al., “Power and Signal Transmission Protocol for a Contactless Subdural Spinal Cord Stimulation Device”, Biomedical Microdevices, 2013, pp. 27-36, vol. 15, Published by Kluwer Academic Publishers, Boston.;;Thiele, R.H. et al., “Manipulation of Hyperbaric Lidocaine Using a Weak Magnetic Field: A Pilot Study”, Anesthesia & Analgesia, Jun. 2012, pp. 1365-1367, vol. 114, No. 6, Published by Lippincott Williams & Wilkins, Netherlands.;;Tucker-Schwartz, J.M. et al., “Pressure-Frequency Sensing Subxiphoid Access System for Use in Percutaneous Cardiac Electrophysiology: Prototype Design and Pilot Study Results”, IEEE Transactions on Biomedical Engineering, Apr. 2009, pp. 1160-1168, vol. 56, No. 4, Published by IEEE Publications, United States.;;Wylie, S.A. et al, “Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease”, Brain A Journal of Neurology, 2010, pp. 3611-3624, vol. 133, Published by Oxford University Press, Oxford, England, UK.;;Zada, G. et al., “Incidence Trends in the Anatomic Location of Primary Malignant Brain Tumors in the United States: 1992-2006”, World Neurosurgery, Mar. 2012, pp. 518-524, vol. 77, No. 3, Published by Elsevier, Amsterdam, Netherlands.",ACTIVE
223,EP,B1,EP 3188861 B1,065-157-668-497-672,2018-04-04,2018,EP 15744772 A,2015-07-02,US 201462045112 P;;US 201462060234 P;;US 201414542150 A;;US 2015/0039034 W,2014-09-03,METHOD FOR FORMING LANTHANIDE NANOPARTICLES,,RAYTHEON CO,ELIAS WILLIAM E;;CONRAD THEODORE J;;CHOW JAMES R,,https://lens.org/065-157-668-497-672,Granted Patent,yes,1,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,B01J19/12;;B22F1/054;;B22F9/24;;B33Y10/00;;B33Y80/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B9/14;;F28D21/00;;F28F13/18;;F28F19/02;;F28F21/02,,1,0,,,"Nader Shehata ET AL: ""Reduced erbium-doped ceria nanoparticles: one nano-host applicable for simultaneous optical down- and up-conversions"", Nanoscale Research Letters, 13 May 2014 (2014-05-13), pages 1-6, XP055212916, Boston DOI: 10.1186/1556-276X-9-231 Retrieved from the Internet: URL:http://www.ncbi.nlm.nih.gov/pubmed/249 40173 [retrieved on 2015-09-11]",ACTIVE
224,IT,A0,IT 8821907 A0,102-016-687-032-759,1988-09-13,1988,IT 2190788 A,1988-09-13,US 14379288 A,1988-01-14,INIETTORE VORTICIZZATORE BIMODALE PER COMBUSTORE DI TURBINA A GAS.,,GEN ELECTRIC,VINSON JOHN WILLIAM;;HOWELL STEPHEN JOHN;;LAMPES ELIAS HARRY,,https://lens.org/102-016-687-032-759,Patent Application,no,0,0,18,18,0,F23C7/002;;F23D17/00;;F23R3/14;;F23R3/34;;Y02T50/60;;F23D17/00;;F23R3/34;;F23R3/14;;F23C7/002;;Y02T50/60,F23C7/00;;F02C7/232;;F23D17/00;;F23R3/14;;F23R3/34,,0,0,,,,EXPIRED
225,EP,A3,EP 0499134 A3,171-789-984-748-347,1993-02-03,1993,EP 92101941 A,1992-02-06,US 65486691 A,1991-02-12,FLUXLESS SOLDER,"A fluxless solder for application to metal surfaces which include contaminants such as metal oxides. The fluxless solder includes a reducing agent which reacts with interfering metal oxides to form essentially inert compounds which require no further cleaning. Reducing agents, such as lithium, calcium, strontium and cesium are disclosed for use in lead-tin solders, in amounts ranging from about 0,5 to 10 atom percent. Various methods for forming the fluxless solder are also disclosed.",HUGHES AIRCRAFT COMPANY,"HOLLAND, WILSON A.;;ELIAS, WILLIAM E.;;DUANE, FRANCIS O.",,https://lens.org/171-789-984-748-347,Search Report,yes,4,0,6,6,0,B23K35/26;;B23K35/26;;B23K35/262;;B23K35/262,B23K1/20;;B23K35/26;;B23K35/40;;C22B1/16;;C22B5/04;;C22C24/00,,0,0,,,,DISCONTINUED
226,EP,A1,EP 0205947 A1,032-875-483-319-203,1986-12-30,1986,EP 86107014 A,1986-05-23,US 74759885 A,1985-06-24,Method of smoothing the surface of a ceramic substrate.,"A method of planarizing or smoothing the surface (30) of a ceramic substrate (20) by deposition of a silicon nitride layer (32). The silicon nitride in addition to planarizing the surface forms an alpha particle barrier. The substrates suitable for planarization with silicon nitride in accordance with the method of the present invention are sintered oxide particles (22) which are bonded with a silicon bonding phase (24). The silicon content of the silicon bonding phase is greater than the silicon content of the aggregate of the oxide particles. The silicon nitride is preferably deposited by plasma enhanced chemical vapor deposition, and the silicon bonding phase is preferably a glass.",IBM,ELIAS KENNETH LAMBERT;;MARTIN STUART ROBB;;SLATTERY WILLIAM JOHN,,https://lens.org/032-875-483-319-203,Patent Application,yes,0,0,7,8,0,C04B41/4572;;H05K1/0306;;H05K3/0011;;C04B41/4572;;H05K3/0011;;H05K1/0306,C04B41/87;;C04B41/45;;H05K1/03;;H05K3/00,,2,0,,,"MANUFACTURING TECHNOLOGY NOTE - US ARMY MATERIEL DEVELOPMENT AND READINESS COMMAND, April 1983, report no. AMMRC-TR-80-36, filing code 71E-018, Alexandria, Virginia, US; ""Silicon nitride coatings on silica substrates"";;CHEMICAL ABSTRACTS, vol. 57, no. 10, September 1982, page 318, abstract no. 77349f, Columbus, Ohio, US; J. JANCA et al.: ""Plasma-chemical deposition of silicon nitride films"", & KONF. CESK. FYZ., [SB. PREDNASEK], 7th 1981, 1(1), paper no. 89, 2pp",EXPIRED
227,FR,A1,FR 2637113 A1,039-324-058-726-645,1990-03-30,1990,FR 8906913 A,1989-05-26,US 24805488 A,1988-09-23,ELEMENT COMBUSTIBLE NUCLEAIRE A LIT DE PARTICULES MUNI D'UNE FRITTE EXTERIEURE PORTEUSE DE COMBUSTIBLE,"<P>L'invention concerne un élément combustible pour réacteur à lit de particules.</P><P>Des frittes intérieure 12 et extérieure 14 poreuses définissent entre elles un espace annulaire. Une multiplicité de particules combustibles sphériques forment un lit combustible 16 dans l'espace annulaire. La fritte extérieure porte de la matière fissile de façon que sa dilatation thermique corresponde sensiblement à celle du lit 16, ceci pour réduire la contrainte subie par la fritte extérieure.</P><P>Application notamment aux réacteurs à lit de particules refroidis par gaz.</P>",BABCOCK & WILCOX CO,BINGHAM BILLY ELIAS;;DEMARS RICHARD VAIL;;PETTUS WILLIAM GOWER,,https://lens.org/039-324-058-726-645,Patent Application,no,2,0,5,5,0,G21C1/07;;Y02E30/30,G21C3/22;;G21C1/07;;G21C3/60,,1,0,,,"ENERGIE NUCLEAIRE. vol. 14, no. 3, juin 1972, RUEIL-MALMAISON FR pages 161 - 167; J M YELLOWLEES: ""ASSEMBLAGE DE COMBUSTIBLE POUR REACTEURS RAPIDES REFROIDIS AU GAZ""",EXPIRED
228,CA,A,CA 1205709 A,094-484-891-296-507,1986-06-10,1986,CA 398169 A,1982-03-11,US 29787481 A,1981-08-31,AIRFOIL FOR HIGH EFFICIENCY/HIGH LIFT FAN,AIRFOIL FOR HIGH EFFICIENCY/HIGH LIFT FAN Airfoil for vehicle fan which operates in low Reynolds number and varying turbulent conditions having a discontinuity formed on the suction surface thereof adjacent to its leading edge to trigger formation of a laminar flow bubble so that sufficient suction surface remains downstream of the air bubble whereby air circumventing the bubble can reattach to the suction surface for sufficient pressure recovery for high lift and low drag performance.,GEN MOTORS CORP,RAZINSKY ELIAS H;;ROBERTS WILLIAM B;;LONGHOUSE RICHARD E,,https://lens.org/094-484-891-296-507,Granted Patent,no,0,0,6,7,0,F04D29/384,F04D29/38;;F04D29/68,123-153,0,0,,,,EXPIRED
229,EP,A3,EP 0770656 A3,118-668-248-450-531,1997-08-27,1997,EP 96117201 A,1996-10-26,US 54914195 A,1995-10-27,"Metal-filled, plateable structural adhesive for cyanate ester composites","A plateable adhesive for bonding cyanate ester composites together comprises a combination of the following components, (a) a polymer mixture comprising (i) at least one polyepoxide resin and (ii) a substantially stoichiometric amount of a curing agent; and (b) a filler comprising a metal, said metal capable of being activated by an acid, said metal present in said plateable adhesive in an amount not exceeding that at which said plateable adhesive exhibits an electrical resistivity of about 1 ohm·cm.",HUGHES AIRCRAFT CO,PUNSLY BRIAN M;;WALLACE ANDRE R;;ELIAS WILLIAM E,HUGHES ELECTRONICS CORPORATION (1998-12-16),https://lens.org/118-668-248-450-531,Search Report,yes,6,0,8,8,0,C09J163/00;;C09J163/00;;C08L63/00;;C08L63/00;;C08L2666/54;;C08L2666/54;;C09J179/04;;C09J179/04;;Y10T428/31515;;Y10T428/31515,C09J163/00;;C09J179/04,,1,0,,,"DATABASE WPI Section Ch Week 9036, Derwent World Patents Index; Class A21, AN 90-270675, XP002028390",EXPIRED
230,ES,T3,ES 2093188 T3,104-820-205-512-718,1996-12-16,1996,ES 92301349 T,1992-02-19,US 66964691 A,1991-03-14,DESFIBRILADOR CARDIACO IMPLANTABLE CON CONDENSADORES MEJORADOS.,"SE PRESENTA UN DESFIBRILADOR CARDIACO IMPLANTABLE QUE TIENE UNA FUENTE DE ENERGIA, UN CAPACITOR Y MEDIOS ACOPLADOS A LA FUENTE DE ENERGIA PARA CARGAR EL CAPACITOR. EL CAPACITOR CONSTA DE UNA ESTRUCTURA ESTRATIFORME PLANA DE PLACAS ANODICAS, PLACAS CATODICAS Y DE MEDIOS PARA SEPARAR LAS PLACAS ANODICAS DE LAS CATODICAS. UNA ENVOLTURA POLIMERICA QUE CONTIENE ELECTROLITOS RODEA A LA ESTRUCTURA ESTRATIFORME. UNOS MEDIOS DE CONTACTO ELECTRICOS SE EXTIENDEN DESDE LOS ANODOS Y LOS CATODOS HACIA EL EXTERIOR DEL ENVOLVENTE.",VENTRITEX INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;MARQUIT TIMOTHY A,,https://lens.org/104-820-205-512-718,Granted Patent,no,0,0,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,,0,0,,,,EXPIRED
231,DE,A1,DE 3919286 A1,195-568-488-234-453,1990-03-29,1990,DE 3919286 A,1989-06-13,US 24805488 A,1988-09-23,"Nuclear fuel element for particle bed reactor - with fuel bed in annular space between porous external frit contg. fissile material, and internal fit",A novel fuel element for a particle bed reactor comprises a fuel bed enclosed in the annular space between a fissile material -contg. porous external frit and a concentric porous internal frit. USE/ADVANTAGE - The fuel element is used esp. in gas cooled particle bed nuclear reactors. Fission heat causes expansion of the external frit to reduce any stresses produced by thermal expansion of the fuel bed.,BABCOCK & WILCOX CO,BINGHAM BILLY ELIAS;;DEMARS RICHARD VAIL;;PETTUS WILLIAM GOWER,,https://lens.org/195-568-488-234-453,Patent Application,no,4,0,5,5,0,G21C1/07;;Y02E30/30,G21C3/22;;G21C1/07;;G21C3/60,,0,0,,,,DISCONTINUED
232,WO,A3,WO 2015/134715 A3,023-773-127-842-926,2015-12-10,2015,US 2015/0018895 W,2015-03-05,US 201461949297 P,2014-03-07,SYSTEMS AND METHODS FOR NON-INVASIVE FLUID FLOW MEASUREMENT,"A device (10) is capable of sensing the flow of fluid in a system (14) and can be affixed to the outside of the system, pipe or conduit directly. The device (10) does not require invasive installation (i.e. no changes to the system have to be made). This makes the invention particularly suited for a retro-fit or other application in existing systems (14). The device may include a sensor (22) capable of detecting vibrations and a microprocessor capable of processing the information collected from the sensor. The device (10) can be capable of transmitting the information over a wireless or wired connection via a radio (44) to a collector station or otherwise. It can be powered by various means such as a battery pack, main facility power, and or solar power (24). The on-board microprocessor (40) may use a series of algorithms to translate vibrational data to flow data (60).",LAGOON SYSTEMS INC,ELIAS ERIC J;;HEIDT NATHANIEL W;;WIEBE WILLIAM E,,https://lens.org/023-773-127-842-926,Search Report,yes,6,0,2,2,0,G01F1/8409;;G01F1/666,G01F1/00,,0,0,,,,PENDING
233,WO,A1,WO 2016/036437 A1,050-673-620-971-597,2016-03-10,2016,US 2015/0039034 W,2015-07-02,US 201462045112 P;;US 201462060234 P;;US 201414542150 A,2014-09-03,METHOD FOR FORMING LANTHANIDE NANOPARTICLES,"A method includes exposing (210) a non-aqueous solution (310) to ultraviolet illumination, where the non-aqueous solution (310) includes one or more lanthanide elements and one or more photo-initiators. The method also includes producing (212) lanthanide nanoparticles (100-102) using the non-aqueous solution (310). The non-aqueous solution (310) could be formed by mixing a first non-aqueous solution (302) including the one or more lanthanide elements and a second non-aqueous solution (304) including the one or more photo-initiators. The non-aqueous solution (310) could include one or more metallic salts, where each metallic salt includes at least one lanthanide element. The one or more metallic salts could include erbium chloride, and the one or more photo-initiators could include benzophenone. The non-aqueous solution (310) could include an organic solvent, such as an alcohol.",RAYTHEON CO,ELIAS WILLIAM E;;CONRAD THEODORE J;;CHOW JAMES R,,https://lens.org/050-673-620-971-597,Patent Application,yes,2,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,B22F1/054;;B22F9/24;;B41J2/01;;C09D11/52,,1,1,020-241-579-969-243,10.1186/1556-276x-9-231;;pmc4038360;;24940173,"NADER SHEHATA ET AL: ""Reduced erbium-doped ceria nanoparticles: one nano-host applicable for simultaneous optical down- and up-conversions"", NANOSCALE RESEARCH LETTERS, 13 May 2014 (2014-05-13), Boston, pages 1 - 6, XP055212916, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pubmed/24940173> [retrieved on 20150911], DOI: 10.1186/1556-276X-9-231",PENDING
234,US,A,US 5139704 A,073-008-772-371-253,1992-08-18,1992,US 65486691 A,1991-02-12,US 65486691 A,1991-02-12,FLUXLESS SOLDER,"A fluxless solder for application to metal surfaces which include contaminants such as metal oxides. The fluxless solder includes a reducing agent which reacts with interfering metal oxides to form essentially inert compounds which require no further cleaning. Reducing agents, such as lithium, calcium, strontium and cesium are disclosed for use in lead-tin solders, in amounts ranging from about 0.5 to 10 atom percent. Various methods for forming the fluxless solder are also disclosed.",HUGHES AIRCRAFT CO,HOLLAND WILSON A;;ELIAS WILLIAM E;;DUANE FRANCIS O,HUGHES AIRCRAFT COMPANY (1991-04-22);;HE HOLDINGS INC (1997-12-16);;RAYTHEON COMPANY (1997-12-17),https://lens.org/073-008-772-371-253,Granted Patent,yes,8,7,6,6,0,B23K35/26;;B23K35/26;;B23K35/262;;B23K35/262,B23K1/20;;B23K35/26;;B23K35/40;;C22B1/16;;C22B5/04;;C22C24/00,252/521;;252/512,0,0,,,,EXPIRED
235,FR,B1,FR 2637113 B1,074-952-538-568-611,1991-08-23,1991,FR 8906913 A,1989-05-26,US 24805488 A,1988-09-23,ELEMENT COMBUSTIBLE NUCLEAIRE A LIT DE PARTICULES MUNI D'UNE FRITTE EXTERIEURE PORTEUSE DE COMBUSTIBLE,,BABCOCK & WILCOX CO,BINGHAM BILLY ELIAS;;DEMARS RICHARD VAIL;;PETTUS WILLIAM GOWER,,https://lens.org/074-952-538-568-611,Granted Patent,no,0,0,5,5,0,G21C1/07;;Y02E30/30,G21C3/22;;G21C1/07;;G21C3/60,,0,0,,,,EXPIRED
236,FR,B1,FR 2626043 B1,083-311-914-065-919,1993-06-11,1993,FR 8811692 A,1988-09-07,US 14379288 A,1988-01-14,DISPOSITIF DE FORMATION DE TURBULENCES-INJECTEUR DE CARBURANT POUR ENSEMBLE DE COMBUSTION DANS UNE TURBINE A GAZ,,GEN ELECTRIC,VINSON JOHN WILLIAM;;HOWELL STEPHEN JOHN;;LAMPES ELIAS HARRY,,https://lens.org/083-311-914-065-919,Granted Patent,no,0,0,18,18,0,F23C7/002;;F23D17/00;;F23R3/14;;F23R3/34;;Y02T50/60;;F23D17/00;;F23R3/34;;F23R3/14;;F23C7/002;;Y02T50/60,F23C7/00;;F23D17/00;;F23R3/14;;F23R3/34;;F02C7/232,,0,0,,,,EXPIRED
237,EP,A2,EP 0503778 A2,114-917-497-983-848,1992-09-16,1992,EP 92301349 A,1992-02-19,US 66964691 A,1991-03-14,Implantable cardiac defribrillator with improved capacitors.,"An implantable cardiac defibrillator is provided having an energy source, a capacitor, and means coupled to the energy source for charging the capacitor. The capacitor comprises a planar layered structure of anode plates, cathode plates and means separating the anode plates and cathode plates. A polymeric envelope containing electrolyte encloses the layered structure. Electrical contact means extend from the anodes and cathodes to outside the envelope.",VENTRITEX INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;MARQUIT TIMOTHY A,,https://lens.org/114-917-497-983-848,Patent Application,yes,0,5,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,,0,0,,,,EXPIRED
238,CH,A,CH 365086 A,119-850-428-582-387,1962-10-31,1962,CH 4484357 A,1957-04-10,US 62742656 A;;US 57763556 A,1956-04-12,Verfahren zur Herstellung von Äthern epoxysubstituierter Phenole,,BATAAFSCHE PETROLEUM,ROBERT WILLIAM MARTIN;;CALVIN ELIAS PANNELL;;CARL GODFREY SCHWARZER,,https://lens.org/119-850-428-582-387,Granted Patent,no,0,0,2,8,0,C08G59/245;;C08G59/245;;C07D303/24;;C07D303/24;;C07D303/28;;C07D303/28;;C08G59/3218;;C08G59/3218,C07D303/24;;C07D303/28;;C08G59/24;;C08G59/32,"12Q,14/04",0,0,,,,EXPIRED
239,US,A,US 2697972 A,133-905-138-834-446,1954-12-28,1954,US 9316649 A,1949-05-13,NZ 2697972X A;;NZ 663494X A;;NZ 991338X A,1949-03-01,Rotary type cultivator implement,,A A CORBAN & SONS LTD;;WILLIAM NEIL MCINTOSH;;GEORGE ELIAS ATAYA,NEIL MCINTOSH WILLIAM;;ELIAS ATAYA GEORGE;;ASSID CORBAN NAJIB,,https://lens.org/133-905-138-834-446,Granted Patent,no,4,0,3,5,0,A01B33/00;;A01B33/00,A01B33/00,,0,0,,,,EXPIRED
240,GB,A,GB 189805485 A,125-442-120-015-807,1898-06-25,1898,GB 189805485D A,1898-03-05,GB 189805485T A,1898-03-05,Improvements in Apparatus for Taking and Projecting Photographs.,"5485. Miller, W. V., Rice, G. P., and Dunn, E. B. March 5. Kinematographic apparatus.-Relates to an intermittent feed for the ribbon, which is locked at the end of each movement. In the plan shown in Fig. 1, the ribbon A is fed downwards by a pair of toothed wheels D, D<1> which gear into perforations in the side of the ribbon. The wheels D, D' are moved forward step by step by a lever G, G<1> on the hollow axis F which is oscillated by a cam groove I<1>. The teeth on G<1> are thrown out of and into gear with the wheels D, D', and also alternately with a stop on the opposite side of the wheels, by a cam P acting through a double bellcrank lever N. The two cams I and P are so arranged that the wheels D, D' are fed on during one quarter of a revolution, and remain looked for the rest of the time.",MILLER WILLIAM VELLETTE;;RICE GEORGE PERCIVAL;;DUNN ELIAS BOUND,MILLER WILLIAM VELLETTE;;RICE GEORGE PERCIVAL;;DUNN ELIAS BOUND,,https://lens.org/125-442-120-015-807,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
241,CA,C,CA 2188345 C,140-862-135-565-355,2003-08-05,2003,CA 2188345 A,1996-10-21,US 54914195 A,1995-10-27,"METAL-FILLED, PLATEABLE STRUCTURAL ADHESIVES FOR CYANATE ESTER COMPOSITES","A family of adhesives is provided for bonding cyanate ester composite articl es to- gether which is also plateable with metal once chemically etched. The adhesives comprise a polymeric matrix and a filler of metal powder or metal flakes. The polymeric matrix com- prises at least one polyepoxide resin and a curing agent. In practice, the present adhesive is applied to the surface of cyanate ester composite articles to be bonded and is allowed to cure at room temperature. Thereafter, the surface of the assembly is chemically etched and then plated with metal. The present adhesives enable the complete coverage o f the cyanate ester composite assembly with the plated metal, including the adhesive bondlines. A cyanate ester resin structure assembled with the present adhesive composition may, upon plating, replace certain metallic components in such applications as aircraft, spacecraft, and auto- mobiles given its highly conductive and comprehensive metallic coating.</SDO AB>",HUGHES AIRCRAFT CO,PUNSLY BRIAN M;;WALLACE ANDRE R;;ELIAS WILLIAM E,,https://lens.org/140-862-135-565-355,Granted Patent,no,0,0,8,8,0,C09J163/00;;C09J163/00;;C08L63/00;;C08L63/00;;C08L2666/54;;C08L2666/54;;C09J179/04;;C09J179/04;;Y10T428/31515;;Y10T428/31515,C09J163/00;;C09J179/04,,0,0,,,,EXPIRED
242,EP,A1,EP 3188861 A1,145-698-989-732-823,2017-07-12,2017,EP 15744772 A,2015-07-02,US 201462045112 P;;US 201462060234 P;;US 201414542150 A;;US 2015/0039034 W,2014-09-03,METHOD FOR FORMING LANTHANIDE NANOPARTICLES,,RAYTHEON CO,ELIAS WILLIAM E;;CONRAD THEODORE J;;CHOW JAMES R,,https://lens.org/145-698-989-732-823,Patent Application,yes,0,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,B22F1/054;;B22F9/24;;B41J2/01;;C09D11/52,,0,0,,,,ACTIVE
243,CA,A1,CA 2188345 A1,000-630-237-492-59X,1997-04-28,1997,CA 2188345 A,1996-10-21,US 54914195 A,1995-10-27,"METAL-FILLED, PLATEABLE STRUCTURAL ADHESIVES FOR CYANATE ESTER COMPOSITES","A family of adhesives is provided for bonding cyanate ester composite articles t o-gether which is also plateable with metal once chemically etched. The adhesives comprise a polymeric matrix and a filler of metal powder or metal flakes. The polymeric mat rix comprises at least one polyepoxide resin and a curing agent. In practice, the prese nt adhesive is applied to the surface of cyanate ester composite articles to be bonded and is a llowed to cure at room temperature. Thereafter, the surface of the assembly is chemically etched and then plated with metal. The present adhesives enable the complete coverage of th e cyanate ester resin assembly with the plated metal, including the adhesive bondlines. A cyanate ester resin structure assembled with the present adhesive composition may, upon plating, replace certain metallic components in such applications as aircraft, spacecraft , and automobiles given its highly conductive and comprehensive metallic coating.",HUGHES AIRCRAFT CO,PUNSLY BRIAN M;;WALLACE ANDRE R;;ELIAS WILLIAM E,,https://lens.org/000-630-237-492-59X,Patent Application,no,0,0,8,8,0,C09J163/00;;C09J163/00;;C08L63/00;;C08L63/00;;C08L2666/54;;C08L2666/54;;C09J179/04;;C09J179/04;;Y10T428/31515;;Y10T428/31515,C09J163/00;;C09J179/04,,0,0,,,,EXPIRED
244,BR,A,BR 9302421 A,008-426-540-943-827,1994-03-22,1994,BR 9302421 A,1993-06-21,US 90129792 A,1992-06-19,COMPOSICAO E METODO PARA REMOVER CONTAMINANTES DE UM SUBSTRATO SOLIDO ESCOLHIDO,"A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxy-acid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGES RICHARD C;;STANFORD THOMAS B,,https://lens.org/008-426-540-943-827,Patent Application,no,0,0,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,H05K3/34;;C23G1/14;;H05K3/26,,0,0,,,,PENDING
245,US,B2,US 10555952 B2,032-795-052-277-03X,2020-02-11,2020,US 201816021973 A,2018-06-28,US 201816021973 A;;US 201815995875 A;;US 201815903529 A;;US 201615184768 A;;US 201815903615 A;;US 201562182130 P,2015-06-19,Pharmaceutical compositions and methods for anesthesiological applications,"Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",MELT PHARMACEUTICALS INC,BAUM MARK;;BERDAHL JOHN;;WILEY WILLIAM;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2019-03-09);;MELT PHARMACEUTICALS INC (2019-03-14),https://lens.org/032-795-052-277-03X,Granted Patent,yes,21,0,2,31,0,A61K45/06;;A61K31/4178;;A61K9/02;;A61K9/06;;A61K9/08;;A61K9/2031;;A61K31/5517;;A61K47/22;;A61K47/26;;A61K47/34;;A61K47/42;;A61K47/44;;A61K9/0053;;A61K9/0043;;A61K9/0031;;A61K9/0019;;A61K9/0014;;A61P23/02;;A61K31/138;;A61K47/10;;A61K31/135;;A61K31/5517;;A61K31/403;;A61K47/22;;A61K47/26;;A61K47/34;;A61K47/42;;A61K47/44;;A61K9/0053;;A61K9/0043;;A61K9/0031;;A61K9/0019;;A61K9/0014;;A61P23/02;;A61K2300/00;;A61K31/138;;A61K47/10;;A61K45/06;;A61K31/4178;;A61K9/06;;A61K9/2031;;A61K9/02;;A61K9/08;;A61K31/135,A61K31/5517;;A61K9/00;;A61K9/02;;A61K9/06;;A61K9/08;;A61K9/20;;A61K31/135;;A61K31/138;;A61K31/403;;A61K31/4178;;A61K45/06;;A61K47/10;;A61K47/22;;A61K47/26;;A61K47/34;;A61K47/42;;A61K47/44;;A61P23/02,,26,17,042-813-959-756-919;;125-460-862-602-786;;006-634-789-624-833;;027-264-776-988-749;;065-967-627-463-438;;107-280-595-655-38X;;021-042-981-094-128;;137-519-590-588-683;;011-194-032-772-660;;022-167-810-687-485;;015-266-812-972-714;;134-466-981-037-576;;065-860-902-641-375;;013-031-291-124-875;;155-653-387-694-528;;101-177-786-334-438;;081-566-868-488-006,10.1517/14656560902978446;;19601699;;7486180;;10.1097/00000542-199511000-00007;;10.1586/ern.11.52;;21539491;;pmc3227310;;22144928;;10.4103/1658-354x.87270;;10.1016/j.ejps.2013.02.024;;23500040;;20060467;;10.1016/j.ejps.2009.12.011;;22363361;;pmc3283976;;10.4103/1735-3327.92925;;pmc2190299;;1819969;;8025055;;10.1136/bjo.77.8.529;;pmc504592;;pmc2007493;;15675259;;1443705;;10.1213/00000539-199212000-00003;;10.1093/bja/81.5.702;;10215313;;pmc3950446;;24665234;;10.4103/1658-354x.125904;;10.1111/j.1600-0722.1994.tb01468.x;;7817152;;10.1111/j.1460-9592.2007.02388.x;;18095966;;11759137;;10.1111/j.1460-9592.1995.tb00307.x;;7489470,"McLean et al, Expert Opinion on Pharmacotherapy, 10:11, 1805-1816 (Year: 2009).;;Macdonald et al, Front. Neurol., vol. 8, Apr. 20, 2017, pp. 1-11 (Year: 2017).;;PCT/US2016/037893 International Search Report and Written Opinion dated Sep. 7, 2016.;;Chia et al. “Role of β-blockade in anaesthesia and postoperative pain management after hysterectomy,” British Journal of Anaesthesia, 2004, 93(6):799-805.;;Davis et al. “Effect of Antiemetic Therapy on Recovery and Hospital Discharge Time.” Anesthesiology, 1995, 83:956-960.;;Ramaiah et al. “Pediatric procedural sedation and analgesia outside the operating room: anticipating, avoiding and managing complications,” Expert Rev. Neurother, 2011, 11(5):755-763.;;Tobias et al. “Procedural sedation: A review of sedative agents, monitoring, and management of complications,” Saudi J Anaesth., 2011, 5(4):395-410.;;JP2017-566010 Office Action dated Jun. 5, 2018.;;KR10-2018-7000815 Office Action dated Aug. 2, 2018.;;EP16812447.7 Extended European Search Report dated Jan. 17, 2019.;;Holm et al. “In vitro, ex vivo and in vivo examination of buccal absorption of metoprolol with varying pH in TR146 cell culture, porcine buccal mucosa and Gottingen minipigs,” European Journal of Pharmaceutical Sciences, 2013, 49:117-124.;;Wang et al. “Improving sublingual delivery of weak base compounds using pHmax concept: Application to propranolol,” European Journal of Pharmaceutical Sciences, 2010, 39:272-278.;;Golpayegani et al. “Comparison of oral Midazolam-Ketamine and Midazolam-Promethazine as sedative agents in pediatric dentistry,” Dental Research Journal, Jan. 2012, 9(1):36-40.;;Rosenberg et al. “General Anesthesia,” Anesth Prog, 1991, 38:172-186.;;JP2017-566010 Office Action dated Sep. 25, 2018.;;Louon et al. “Sedation with nasal ketamine and midazolam for cryotherapy in retinopathy of prematurity,” British Journal of Ophthalmology, 1993, 77:529-530.;;Roelofse et al. “Intranasal Sufentanil/Midazolam Versus Ketamine/Midazolam for Analgesia/Sedation in the Pediatric Population Prior to Undergoing Multiple Dental Extractions Under General Anesthesia: A Prospective, Double-Blind, Randomized Comparison,” Anesth Prog, 2004, 51:114-121.;;Rudnic et al. “Chapter 92: Oral Solid Dosage Forms,” Remington: The Science and Practice of Pharmacy, 1995, 1615-1649.;;Beebe et al. “Effectiveness of Preoperative Sedation with Rectal Midazolam, Ketamine, or Their Combination in Young Children,” Anesthesia & Analgesia, Dec. 1992, 75(6):880-884.;;Katz et al. “Haemodynamic Stability and Ketamine-Alfentanil Anaesthetic Induction,” British Journal of Anaesthesia, 1998, 81:702-706.;;Khatavkar et al. “Comparison of Nasal Midazolam with Ketamine versus Nasal Midazolam as a Premedication in Children,” Saudi Journal of Anesthesia, 2014, 8(1):17-21.;;Lokken et al. “Conscious Sedation by Rectal Administration of Midazolam or Midazolam Plus Ketamine as Alternatives to General Anesthesia for Dental Treatment of Uncooperative Children,” European Journal of Oral Sciences, Oct. 1994, 102(5):274-280.;;Novak et al. “Sedation with Ketamine and Low-Dose Midazolam for Short-Term Procedures Requiring Pharyngeal Manipulation in Young Children,” Paediatric Anaesthesia, Jan. 2008, 18(1):48-54.;;Smith et al. “Prevention of Vomiting after General Anesthesia for Pediatric Ophthalmic Surgery,” AANA Journal, Feb. 2001, 69(1):39-43.;;Warner et al. “Ketamine Plus Midazolam, a Most Effective Paediatric Oral Premedicant,” Paediatric Anaesthesia, 1995, 5(5):293-295.;;PCT/US2019/034034 International Search Report and Written Opinion dated Sep. 17, 2019.",ACTIVE
246,EP,A1,EP 0574858 A1,044-512-202-721-005,1993-12-22,1993,EP 93109469 A,1993-06-14,US 90129792 A,1992-06-19,Inorganic oxidant compositions for removing contaminants.,"A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxy-acid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGE RICHARD C;;STANFORD THOMAS B,,https://lens.org/044-512-202-721-005,Patent Application,yes,5,11,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,H05K3/34;;C23G1/14;;H05K3/26,,0,0,,,,EXPIRED
247,DE,D1,DE 3661625 D1,122-393-344-113-919,1989-02-09,1989,DE 3661625 T,1986-05-23,US 74759885 A,1985-06-24,METHOD OF SMOOTHING THE SURFACE OF A CERAMIC SUBSTRATE,,IBM,ELIAS KENNETH LAMBERT;;MARTIN STUART ROBB;;SLATTERY WILLIAM JOHN,,https://lens.org/122-393-344-113-919,Granted Patent,no,0,0,7,8,0,C04B41/4572;;H05K1/0306;;H05K3/0011;;C04B41/4572;;H05K3/0011;;H05K1/0306,C04B41/87;;C04B41/45;;H05K1/03;;H05K3/00,,0,0,,,,EXPIRED
248,CA,A,CA 1257154 A,000-228-428-615-438,1989-07-11,1989,CA 497009 A,1985-12-05,US 74759885 A,1985-06-24,PLANARIZED CERAMIC SUBSTRATES,"PLANARIZED CERAMIC SUBSTRATES A method of planarizing or smoothing the surface of a ceramic substrate by deposition of a silicon nitride layer. The silicon nitride in addition to planarizing the surface forms an alpha particle barrier. The substrates suitable for planarization with silicon nitride in accordance with the method of the present invention are sintered oxide particles which are bonded with a silicon bonding phase. The silicon content of the silicon bonding phase is greater than the silicon content of the aggregate of the oxide particles. The silicon nitride is preferably deposited by plasma enhanced chemical vapor deposition, and the silicon bonding phase is preferably a glass.",IBM,ELIAS KENNETH L;;MARTIN STUART R;;SLATTERY WILLIAM J,,https://lens.org/000-228-428-615-438,Granted Patent,no,0,0,7,8,0,C04B41/4572;;H05K1/0306;;H05K3/0011;;C04B41/4572;;H05K3/0011;;H05K1/0306,C04B41/87;;C04B41/45;;H05K1/03;;H05K3/00,117-85,0,0,,,,EXPIRED
249,CA,A1,CA 2055910 A1,085-929-892-204-216,1992-08-13,1992,CA 2055910 A,1991-11-20,US 65486691 A,1991-02-12,FLUXLESS SOLDER,,HUGHES AIRCRAFT COMPANY,"HOLLAND, WILSON A.;;ELIAS, WILLIAM E.;;DUANE, FRANCIS O.",,https://lens.org/085-929-892-204-216,Patent Application,no,0,1,6,6,0,B23K35/26;;B23K35/26;;B23K35/262;;B23K35/262,B23K1/20;;B23K35/26;;B23K35/40;;C22B1/16;;C22B5/04;;C22C24/00,,0,0,,,,EXPIRED
250,GB,B,GB 2214630 B,159-966-721-959-249,1991-11-13,1991,GB 8821461 A,1988-09-13,US 14379288 A,1988-01-14,SWIRLER AND FUEL INJECTOR FOR A GAS TURBINE COMBUSTOR,,GEN ELECTRIC,VINSON JOHN WILLIAM;;HOWELL STEPHEN JOHN;;LAMPES ELIAS HARRY,,https://lens.org/159-966-721-959-249,Granted Patent,no,0,1,18,18,0,F23C7/002;;F23D17/00;;F23R3/14;;F23R3/34;;Y02T50/60;;F23D17/00;;F23R3/34;;F23R3/14;;F23C7/002;;Y02T50/60,F23C7/00;;F02C7/232;;F23D17/00;;F23R3/14;;F23R3/34,F4T TAH           TAH;;F4T TAL           TAL;;F4T T101          TAH;;F4T T101          TAL;;F4T T1110         TAH;;F4T T1110         TAL;;F4T T1112         TAH;;F4T T1112         TAL;;F4T T1113         TAH;;F4T T1113         TAL;;F4T T1120         TAH;;F4T T1120         TAL;;U1S S1987,0,0,,,,EXPIRED
251,GB,A,GB 2214630 A,009-977-887-810-270,1989-09-06,1989,GB 8821461 A,1988-09-13,US 14379288 A,1988-01-14,BIOMODAL SWIRLER INJECTOR FOR A GAS TURBINE COMBUSTOR,,GEN ELECTRIC,VINSON JOHN WILLIAM;;HOWELL STEPHEN JOHN;;LAMPES ELIAS HARRY,,https://lens.org/009-977-887-810-270,Patent Application,no,0,9,18,18,0,F23C7/002;;F23D17/00;;F23R3/14;;F23R3/34;;Y02T50/60;;F23D17/00;;F23R3/34;;F23R3/14;;F23C7/002;;Y02T50/60,F23C7/00;;F23D17/00;;F02C7/232;;F23R3/14;;F23R3/34,F4T TAH           TAH;;F4T TAL           TAL;;F4T T101          TAH;;F4T T101          TAL;;F4T T1110         TAH;;F4T T1110         TAL;;F4T T1112         TAH;;F4T T1112         TAL;;F4T T1113         TAH;;F4T T1113         TAL;;F4T T1120         TAH;;F4T T1120         TAL;;U1S S1987,0,0,,,,EXPIRED
252,IT,B,IT 1227060 B,068-348-602-746-585,1991-03-14,1991,IT 2190788 A,1988-09-13,US 14379288 A,1988-01-14,INIETTORE VORTICIZZATORE BIMODALE PER COMBUSTORE DI TURBINA A GAS.,,GEN ELECTRIC,VINSON JOHN WILLIAM;;HOWELL STEPHEN JOHN;;LAMPES ELIAS HARRY,,https://lens.org/068-348-602-746-585,Granted Patent,no,0,0,18,18,0,F23C7/002;;F23D17/00;;F23R3/14;;F23R3/34;;Y02T50/60;;F23D17/00;;F23R3/34;;F23R3/14;;F23C7/002;;Y02T50/60,F23C7/00;;F02C7/232;;F23D17/00;;F23R3/14;;F23R3/34,,0,0,,,,EXPIRED
253,EP,A2,EP 0770656 A2,086-181-093-860-566,1997-05-02,1997,EP 96117201 A,1996-10-26,US 54914195 A,1995-10-27,"Metal-filled, plateable structural adhesive for cyanate ester composites","A plateable adhesive for bonding cyanate ester composites together comprises a combination of the following components, (a) a polymer mixture comprising (i) at least one polyepoxide resin and (ii) a substantially stoichiometric amount of a curing agent; and (b) a filler comprising a metal, said metal capable of being activated by an acid, said metal present in said plateable adhesive in an amount not exceeding that at which said plateable adhesive exhibits an electrical resistivity of about 1 ohm·cm.",HUGHES AIRCRAFT CO,PUNSLY BRIAN M;;WALLACE ANDRE R;;ELIAS WILLIAM E,HUGHES ELECTRONICS CORPORATION (1998-12-16),https://lens.org/086-181-093-860-566,Patent Application,yes,1,0,8,8,0,C09J163/00;;C09J163/00;;C08L63/00;;C08L63/00;;C08L2666/54;;C08L2666/54;;C09J179/04;;C09J179/04;;Y10T428/31515;;Y10T428/31515,C09J163/00;;C09J179/04,,0,0,,,,EXPIRED
254,US,A1,US 2016/0059320 A1,107-492-965-030-622,2016-03-03,2016,US 201414542150 A,2014-11-14,US 201414542150 A;;US 201462045112 P;;US 201462060234 P,2014-09-03,METHOD FOR FORMING LANTHANIDE NANOPARTICLES,"A method includes exposing a non-aqueous solution to ultraviolet illumination, where the non-aqueous solution includes one or more lanthanide elements and one or more photo-initiators. The method also includes producing lanthanide nanoparticles using the non-aqueous solution. The non-aqueous solution could be formed by mixing a first non-aqueous solution including the one or more lanthanide elements and a second non-aqueous solution including the one or more photo-initiators. The non-aqueous solution could include one or more metallic salts, where each metallic salt includes at least one lanthanide element. The one or more metallic salts could include erbium chloride, and the one or more photo-initiators could include benzophenone. The non-aqueous solution could include an organic solvent, such as an alcohol.",RAYTHEON CO,ELIAS WILLIAM E;;CONRAD THEODORE J;;CHOW JAMES R,RAYTHEON COMPANY (2014-10-31),https://lens.org/107-492-965-030-622,Patent Application,yes,8,3,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,B22F9/24;;B22F1/054,,2,0,,,"""Bonding in metals and semiconductors,"" part 5, available online at http://www.chem1.com/acad/webtext/chembond/cb10.html;;Encyclopedia Britannica, ""Nanoparticle,"" available at https://www.britannica.com/science/nanoparticle, pages 1-2",ACTIVE
255,GB,B,GB 2104975 B,000-068-141-338-752,1984-10-17,1984,GB 8221246 A,1982-07-22,US 29787481 A,1981-08-31,AIRFOILS FOR LAND VEHICLE FANS,,GEN MOTORS CORP,RAZINSKY ELIAS HIRSH;;LONGHOUSE RICHARD EDWARD;;ROBERTS WILLIAM BYRON,,https://lens.org/000-068-141-338-752,Granted Patent,no,0,0,6,7,0,F04D29/384,F04D29/38;;F04D29/68,F1V104;;F1VCS;;F2R;;U1S1968;;U1S2006;;U1SF1V;;U1SF2R,0,0,,,,EXPIRED
256,GB,A,GB 189404508 A,103-022-372-293-177,1894-12-22,1894,GB 189404508D A,1894-03-03,GB 189404508T A,1894-03-03,"Improvements in Means for Uniting Together the Terminal Ends of the Hoops of Metallic Buckets, Casks, and other Hollow Articles.",,ROBERTS CALEB WILLIAM;;COOPER EBENEZER ELIAS;;COOPER DAVID WALTER,ROBERTS CALEB WILLIAM;;COOPER EBENEZER ELIAS;;COOPER DAVID WALTER,,https://lens.org/103-022-372-293-177,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
257,EP,B1,EP 0770656 B1,098-192-936-110-368,2003-06-04,2003,EP 96117201 A,1996-10-26,US 54914195 A,1995-10-27,"Use of a metal-filled, plateable structural adhesive for bonding cyanate ester composites together.",,HUGHES ELECTRONICS CORP,PUNSLY BRIAN M;;WALLACE ANDRE R;;ELIAS WILLIAM E,HUGHES ELECTRONICS CORPORATION (1998-12-16),https://lens.org/098-192-936-110-368,Granted Patent,yes,6,0,8,8,0,C09J163/00;;C09J163/00;;C08L63/00;;C08L63/00;;C08L2666/54;;C08L2666/54;;C09J179/04;;C09J179/04;;Y10T428/31515;;Y10T428/31515,C09J163/00;;C09J179/04,,1,0,,,"DATABASE WPI Section Ch, Week 9036 Derwent Publications Ltd., London, GB; Class A21, AN 90-270675 XP002028390 & JP 02 189 329 A (NITTO DENKO CORP) , 25 July 1990",EXPIRED
258,DE,B,DE 1109887 B,151-282-591-615-772,1961-06-29,1961,DE N0013523 A,1957-04-10,US 57763556 A,1956-04-12,Verfahren zur Herstellung von Kunststoffen durch Aushaerten von mehrere Epoxydgruppen aufweisenden Phenolaethern,,BATAAFSCHE PETROLEUM,MARTIN ROBERT WILLIAM;;PANNELL CALVIN ELIAS;;SCHWARZER CARL GODFREY,,https://lens.org/151-282-591-615-772,Patent Application,no,0,0,6,8,0,C07D303/24;;C07D303/24;;C07D303/28;;C07D303/28;;C08G59/245;;C08G59/245;;C08G59/3218;;C08G59/3218,C07D301/28;;C07D303/24;;C07D303/28;;C08G59/24;;C08G59/32,,1,0,,,None,DISCONTINUED
259,US,B1,US 6411005 B1,173-866-937-588-554,2002-06-25,2002,US 50259100 A,2000-02-11,US 50259100 A,2000-02-11,System to improve the torque smoothness of an electric machine,"
    A stator for an induction machine comprises a cylindrical core that has a plurality of inner and outer slots and a plurality of toroidal coils wound about the core and laid in the inner and outer slots. Each toroidal coil occupies a single inner slot and is laid in the adjacent associated outer slot to minimize the distance the coils extend from the end faces of the core thereby minimizing the length of the induction machine. The coils are encapsulated in a material that fills any voids to provide a thermal path for uniform heat dissipation. In operation, a controller is coupled to three current sensors and detects the current of only three phases. These phases are then used to calculate the current of the adjacent six phases, thereby, allowing for better control of the electric machine. 
",FORD GLOBAL TECH INC,STRANGAS ELIAS G;;KELLY JOHN WILLIAM;;MILLER JOHN MICHAEL,FORD GLOBAL TECHNOLOGIES INC (2000-01-24);;FORD MOTOR COMPANY (2000-01-18),https://lens.org/173-866-937-588-554,Granted Patent,yes,17,7,1,1,0,H02K19/34;;H02K19/34;;H02K1/16;;H02K1/16;;H02K19/10;;H02K19/10;;H02K29/06;;H02K29/06,H02K1/16;;H02K19/10;;H02K19/34;;H02K29/06,310/254;;310/164;;310/216;;318/801;;318/254,0,0,,,,EXPIRED
260,GB,A,GB 189818973 A,042-897-580-108-520,1898-11-12,1898,GB 189818973D A,1898-09-06,GB 189818973T A,1898-09-06,"Improvements in Fastening or Connecting together the Ends of the Foot Rings or Hoops of Buckets, Cans, and other analogous articles.","18,973. Roberts, C. W., Cooper, E. E., and Cooper, D. W., [trading as Wollescote Galvanizing Co.]. Sept. 6. Milk cans.-The ends of sheet-metal strips for forming the foot rings or hoops are fastened together by forming a tongue or hook b, Fig. 9, on one end, which is passed through a slot c in the other end and rests in a pocket c<1>. When placed together and pressed, a flush joint is formed as shown in Fig. 10. The pocket may be omitted, and the flush joint formed by pressure after engagement.",ROBERTS CALEB WILLIAM;;COOPER EBENEZER ELIAS;;COOPER DAVID WALTER,ROBERTS CALEB WILLIAM;;COOPER EBENEZER ELIAS;;COOPER DAVID WALTER,,https://lens.org/042-897-580-108-520,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
261,US,B2,US 10421127 B2,049-770-182-273-316,2019-09-24,2019,US 201414542150 A,2014-11-14,US 201414542150 A;;US 201462045112 P;;US 201462060234 P,2014-09-03,Method for forming lanthanide nanoparticles,"A method includes exposing a non-aqueous solution to ultraviolet illumination, where the non-aqueous solution includes one or more lanthanide elements and one or more photo-initiators. The method also includes producing lanthanide nanoparticles using the non-aqueous solution. The non-aqueous solution could be formed by mixing a first non-aqueous solution including the one or more lanthanide elements and a second non-aqueous solution including the one or more photo-initiators. The non-aqueous solution could include one or more metallic salts, where each metallic salt includes at least one lanthanide element. The one or more metallic salts could include erbium chloride, and the one or more photo-initiators could include benzophenone. The non-aqueous solution could include an organic solvent, such as an alcohol.",RAYTHEON CO,ELIAS WILLIAM E;;CONRAD THEODORE J;;CHOW JAMES R,RAYTHEON COMPANY (2014-10-31),https://lens.org/049-770-182-273-316,Granted Patent,yes,25,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,B22F9/24;;B01J19/12;;B22F1/054;;B33Y10/00;;B33Y80/00;;B41J2/01;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B9/14;;F28D21/00;;F28F13/18;;F28F19/02;;F28F21/02,,20,6,039-074-524-113-928;;035-751-470-828-388;;109-118-925-190-931;;002-354-482-087-963;;121-886-040-964-860;;020-241-579-969-243,15352782;;10.1021/cr030027b;;10.1021/la9705827;;10.1016/s0009-2614(03)00073-3;;14709034;;10.1021/ja037933q;;10.1016/s1010-6030(99)00146-x;;10.1186/1556-276x-9-231;;pmc4038360;;24940173,"“Bonding in metals and semiconductors,” part 5, available online at http://www.chem1.com/acad/webtext/chembond/cb10.html.;;Encyclopedia Britannica, “Nanoparticle,” available at https://www.britannica.com/science/nanoparticle, pp. 1-2.;;Shehata et al, “:Control of oxygen vacancies and Ce+3 concentrations in doped ceria nanoparticles via the selection of lanthanide elernent,”J. Nanopart. Res. (20112) vol. 14:1173 (Year: 2012).;;Conrad; et al. “Cryocooler Regenerator Containing One or More Carbon-Based Anisotropic Thermal Layers”; U.S. Appl. No. 14/151,408; 23 pages.;;Cushing, et al.; “Recent Advances in the Liquid-Phase Syntheses of Inorganic Nanoparticles”; Chemical Review: 104, No. 9; 2004; 54 pages.;;Eustis, Susie; “Gold and Silver Nanoparticles: Characterization of their Interesting Optical Properties and the Mechanism of their Photochemical Formation”; 2006; 290 pages.;;Kapoor, S.; “Preparation, Characterization, and Surface Modification of Silver Particles”; Langmuir 14.5; 1998; 5 pages.;;Kapoor, et al.; “Photochemical Formation of Copper Nanoparticles in poly (N-Vinylpyrrolidone)”, Chemical Physics Letters; 370.1; 2003; 5 pages.;;Kometani, et al.; “Laser Flash Photolysis Study of the Photochemical Formation of Colloidal Ag Nanoparticles in the Presence of Benzophenone.” PCCP; 4.20; (2002); 6 pages.;;Korchev, et al.; “Polymer-Initiated Photogeneration of Silver Nanoparticles in SPEEK/PVA Films: Direct Metal Photopatterning”; J. Am. Chem. Soc.; 126.1; 2004; 2 pages.;;Mooney, et al.; “Nanocrystalline Co 30 Fe 70 Alloy Synthesized by Alkalide Reduction”; Journal of Materials Chemistry; 19.5; 2009; 6 pages.;;Nelson, et al.; “Solution Synthesis of Gadolinium Nanoparticies”; Journal of the American Chemical Society: 124.12 ; 2002; 5 pages.;;Nelson, et at.; “Dysprosium Nanoparticles Synthesized by Alkalide Reduction”; Journal of Materials Chemistry; 13.4; 2003; 4 pages.;;Sato, et al.; “Sensitized Photoreduction of Silver Ions in the Presence of Acetophenone”; Journal of Photochemistry and Photobiology A: Chemistry; 127.1; 1999; 5 pages.;;Nader Shehata, et al., “Reduced erbium-doped ceria nanoparticles: one nano-host applicable for simultaneous optical down- and up-conversions”, Nanoscale Research Letters, May 13, 2014, 6 pages.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration dated Sep. 22, 2015 in connection with International Patent Application No. PCT/US2015/039034.;;Zivkovic; “Ternary Nanomaterials: Synthesis by Alkalide Reduction and Characterization”; UMI Dissertation Publishing; Jan. 31, 2010; 221 pages.;;Japanese Patent Office, Notification of Reasons for Refusal in Application No. JP 2017-512042 dated Mar. 30, 2018, 17 pages.;;Japanese Patent Office, Decision of Refusal in Application No. JP 2017-512042 dated Oct. 9, 2018, 12 pages.;;“Notice of Reason(s) for Rejection” from Japanese Patent Office in Counterpart Application No. JP 2017-512041 dated May 29, 2018, 8 pages.",ACTIVE
262,DE,D1,DE 69212352 D1,070-813-394-158-123,1996-08-29,1996,DE 69212352 T,1992-02-19,US 66964691 A,1991-03-14,Implantierbarer Defibrillator mit verbesserten Kondensatoren,,VENTRITEX INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;MARQUIT TIMOTHY A,,https://lens.org/070-813-394-158-123,Granted Patent,no,0,0,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,,0,0,,,,EXPIRED
263,AT,T1,AT E140631 T1,083-745-338-714-21X,1996-08-15,1996,AT 92301349 T,1992-02-19,US 66964691 A,1991-03-14,IMPLANTIERBARER DEFIBRILLATOR MIT VERBESSERTEN KONDENSATOREN,,VENTRITEX INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;MARQUIT TIMOTHY A,,https://lens.org/083-745-338-714-21X,Granted Patent,no,0,0,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,,0,0,,,,DISCONTINUED
264,EP,A3,EP 0503778 A3,079-763-359-300-061,1993-01-13,1993,EP 92301349 A,1992-02-19,US 66964691 A,1991-03-14,IMPLANTABLE CARDIAC DEFRIBRILLATOR WITH IMPROVED CAPACITORS,"An implantable cardiac defibrillator is provided having an energy source, a capacitor, and means coupled to the energy source for charging the capacitor. The capacitor comprises a planar layered structure of anode plates, cathode plates and means separating the anode plates and cathode plates. A polymeric envelope containing electrolyte encloses the layered structure. Electrical contact means extend from the anodes and cathodes to outside the envelope.","VENTRITEX, INC.","PLESS, BENJAMIN D.;;ELIAS, WILLIAM H.;;MARQUIT, TIMOTHY A.",,https://lens.org/079-763-359-300-061,Search Report,yes,4,0,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,,0,0,,,,EXPIRED
265,DE,A1,DE 3830185 A1,120-283-722-833-412,1989-07-27,1989,DE 3830185 A,1988-09-06,US 14379288 A,1988-01-14,VERWIRBELUNGS- UND BRENNSTOFFEINSPRITZVORRICHTUNG FUER EINE GASTURBINENBRENNKAMMER,,GEN ELECTRIC,VINSON JOHN WILLIAM;;HOWELL STEPHEN JOHN;;LAMPES ELIAS HARRY,,https://lens.org/120-283-722-833-412,Patent Application,no,0,2,18,18,0,F23C7/002;;F23D17/00;;F23R3/14;;F23R3/34;;Y02T50/60;;F23D17/00;;F23R3/34;;F23R3/14;;F23C7/002;;Y02T50/60,F02C7/232;;F23C7/00;;F23D17/00;;F23R3/14;;F23R3/34,,0,0,,,,DISCONTINUED
266,US,A,US 4977220 A,145-234-456-468-69X,1990-12-11,1990,US 48592590 A,1990-02-20,US 48592590 A;;US 27467688 A,1988-11-21,"Epoxy end-capped diolefin derivatives, polymers thereof, and processes for forming same","Epoxy end-capped oligomers of 1,3-diolefin compounds of Formula I ##STR1## These oligomers are formed by: (a) reacting a 1,3-diolefin compound having 4 to 12 carbon atoms per molecule with a difunctional initiator comprising anionic reactive sites to form an intermediate living oligomer comprising two anionic end groups; and (b) reacting the intermediate living oligomer with a halohydrin compound to epoxidize the two anionic end groups and form the desired oligomer. The oligomers are subsequently reacted with an epoxidizing agent to form a polymer having epoxy-derived linkages at regular intervals along the chain of the polymer.",HUGHES AIRCRAFT CO,DOUGHERTY THOMAS K;;OLDHAM SUSAN L;;ELIAS WILLIAM E,RAYTHEON COMPANY A CORPORATION OF DELAWARE (1997-12-17);;HE HOLDINGS INC. A CORPORATION OF DELAWARE (1995-12-08),https://lens.org/145-234-456-468-69X,Granted Patent,yes,9,17,1,1,0,C08G59/027;;C08G59/027;;C08C19/40;;C08C19/40;;C08C19/44;;C08C19/44;;C08G59/02;;C08G59/02,C08C19/40;;C08C19/44;;C08G59/02;;C08G59/34,525/332.3;;549/512;;525/359.2;;528/393,3,0,,,"Makromol. Chem., vol. 179, pp. 551 555, Beinert et al.;;Polymer Preprints, vol. 26, No. 1, Apr. 1985, pp. 241 243, Broske et al.;;J. Polymer Science, vol. 20, pp. 2809 2817, Kennedy et al.",EXPIRED
267,CA,C,CA 2055910 C,174-123-233-802-400,1994-09-27,1994,CA 2055910 A,1991-11-20,US 65486691 A,1991-02-12,FLUXLESS SOLDER,"A fluxless solder for application to metal surfaces which include contaminants such as metal oxides. The fluxless solder includes a reducing agent which reacts with interfering metal oxides to form essentially inert compounds which require no further cleaning. Reducing agents, such as lithium, calcium, strontium and cesium are disclosed for use in lead-tin solders, in amounts ranging from about 0.5 to 10 atom percent. Various methods for forming the fluxless solder are also disclosed.",HUGHES AIRCRAFT CO,HOLLAND WILSON A;;ELIAS WILLIAM E;;DUANE FRANCIS O,,https://lens.org/174-123-233-802-400,Granted Patent,no,0,0,6,6,0,B23K35/26;;B23K35/26;;B23K35/262;;B23K35/262,B23K1/20;;B23K35/26;;B23K35/40;;C22B1/16;;C22B5/04;;C22C24/00,,0,0,,,,EXPIRED
268,EP,B1,EP 0503778 B1,061-762-843-587-094,1996-07-24,1996,EP 92301349 A,1992-02-19,US 66964691 A,1991-03-14,Implantable cardiac defribrillator with improved capacitors,,VENTRITEX INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;MARQUIT TIMOTHY A,,https://lens.org/061-762-843-587-094,Granted Patent,yes,4,4,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,,0,0,,,,EXPIRED
269,US,A,US 5131388 A,094-582-415-122-214,1992-07-21,1992,US 66964691 A,1991-03-14,US 66964691 A,1991-03-14,IMPLANTABLE CARDIAC DEFIBRILLATOR WITH IMPROVED CAPACITORS,"An implantable cardiac defibrillator is provided having an energy source, a capacitor, and means coupled to the energy source for charging the capacitor. The capacitor comprises a planar layered structure of anode plates, cathode plates and means separating the anode plates and cathode plates. A polymeric envelope containing electrolyte encloses the layered structure. Electrical contact means extend from the anodes and cathodes to outside the envelope.",VENTRITEX INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;MARGUIT TIMOTHY A,VENTRITEX INC. A CORP. OF CA (1991-03-01);;PACESETTER INC (1997-05-15),https://lens.org/094-582-415-122-214,Granted Patent,yes,1,460,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,128419D,1,1,014-235-519-768-388,10.1016/s0146-2806(89)80005-2;;2692974,"Implantable Cardioverters and Defibrillators (Current Problems in Cardiology, vol. XIV, No. 12, Dec. 1989).",EXPIRED
270,US,B2,US 11241526 B2,109-682-308-550-310,2022-02-08,2022,US 201816181498 A,2018-11-06,US 201816181498 A;;US 2013/0060404 W;;US 201361874741 P;;US 201261703191 P,2012-09-19,Method and system for enhanced imaging visualization of deep brain anatomy using infusion,"Provided is a method and system for delivering a diagnostic agent to a site in the brain of a subject for imaging at least a portion of the brain site on a medical imaging system. The method and system includes a catheter device with associated lumens having diagnostic agent ports for delivering the diagnostic agent (e.g., infusate) through the lumens and advancing the diagnostic agent so as to exit out from the lumens to at least a portion of the brain site and while sealing a portion of the brain site thereby preventing the exited diagnostic agent from travelling proximally beyond the sealing location, and at the same time imaging at least a portion of the brain site during at least a portion of the sealing duration so that the brain site can be visualized on a medical imaging system. The diagnostic agent (infusate) is able to highlight borders and internal patterns of the deep structures of the brain thereby enabling direct targeting. Ultimately this leads to reduced complications, enhanced therapy, and the elimination of the need for awake surgery. The method and system provides the capability heretofore not possible to visualize the small, often indistinct regions, which will greatly improve clinical outcomes with therapeutic interventions.",UNIV VIRGINIA PATENT FOUNDATION,ELIAS WILLIAM J;;BOND AARON E;;GILLIES GEORGE T,UNIVERSITY OF VIRGINIA PATENT FOUNDATION (2013-12-03);;UNIVERSITY OF VIRGINIA (2013-10-13),https://lens.org/109-682-308-550-310,Granted Patent,yes,9,0,5,5,0,A61M25/10;;A61B5/0042;;A61B5/055;;A61M25/007;;A61M25/0127;;A61M25/1002;;A61M31/005;;A61M2025/0042;;A61M2025/105;;A61M2025/1052;;A61M2025/1093;;G01R33/285;;A61B6/032;;A61B6/12;;A61B6/481;;A61B6/501;;A61M25/10;;A61B5/0042;;A61B5/055;;A61M25/007;;A61M25/0127;;A61M25/1002;;A61M31/005;;A61M2025/0042;;A61M2025/105;;A61M2025/1052;;A61M2025/1093;;G01R33/285;;A61B6/032;;A61B6/12;;A61B6/481;;A61B6/501;;A61M5/007;;A61M25/0026;;A61M2025/0037;;A61N1/36139,A61M5/00;;A61B5/00;;A61B5/055;;A61B6/00;;A61B6/03;;A61B6/12;;A61M25/00;;A61M25/01;;A61M25/10;;A61M31/00;;A61N1/36;;G01R33/28,,0,0,,,,ACTIVE
271,US,A,US 5660737 A,111-650-254-718-610,1997-08-26,1997,US 44313495 A,1995-05-17,US 44313495 A,1995-05-17,Process for making a capacitor foil with enhanced surface area,"An improved electrolytic capacitor is provided by producing an anode foil which has areas which are not subject to stress during manufacturing being highly etched and those areas which are subject to stress during manufacturing being lightly etched or not etched at all. The process of the invention provides an etch mask to cover during the etch process those portions of the anode foil which will be subjected to stress during construction of the capacitor. The highly etched areas, which are very brittle, provide increased capacitance and thus improved energy density. For layered or stacked capacitors, a weld tab is covered with the etch mask to allow connection of the anode layers. Additionally, strong edges may be maintained thereby reducing the possibility of cracking that would normally occur during the stamping and assembly operations. For flat or oval capacitors made by rolling or winding the capacitor element on a large arbor, and then flattening the element by compressing it in a press, high stress occurs at the sharp bends resulting in cracking or breaking if the foil is not flexible. The method of the invention allows high gain foil to be used in the flat areas, while masking strengthens the locations where the sharp bends occur, thereby improving the capacitance.",VENTRITEX INC,ELIAS WILLIAM H;;STRANGE THOMAS F;;STEVENS JAMES I,PACESETTER INC (1997-05-15);;VENTRITEX INC (1997-03-11),https://lens.org/111-650-254-718-610,Granted Patent,yes,11,176,8,8,0,H01G9/055;;H01G9/055,H01G9/04;;H01G9/055,216/6;;216/33;;216/47,1,1,014-235-519-768-388,10.1016/s0146-2806(89)80005-2;;2692974,"Implantable Cardioverters and Defibrillators , Troup, Current Problemsin Cardiology, Dec. 1989, pp. 704 713.",EXPIRED
272,CA,C,CA 2061344 C,193-984-431-622-658,1997-02-25,1997,CA 2061344 A,1992-02-17,US 66964691 A,1991-03-14,IMPLANTABLE CARDIAC DEFIBRILLATOR WITH IMPROVED CAPACITORS,"An implantable cardiac defibrillator is provided having an energy source, a capacitor, and means coupled to the energy source for charging the capacitor. The capacitor comprises a planar layered structure of anode plates, cathode plates and means separating the anode plates and cathode plates. A polymeric envelope containing electrolyte encloses the layered structure. Electrical contact means extend from the anodes and cathodes to outside the envelope.",VENTRITEX INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;MARQUIT TIMOTHY A,,https://lens.org/193-984-431-622-658,Granted Patent,no,0,0,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,,0,0,,,,EXPIRED
273,US,A1,US 2018/0303847 A1,030-925-273-181-234,2018-10-25,2018,US 201816021973 A,2018-06-28,US 201816021973 A;;US 201815995875 A;;US 201815903529 A;;US 201615184768 A;;US 201815903615 A;;US 201562182130 P,2015-06-19,PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ANESTHESIOLOGICAL APPLICATIONS,"Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.",IMPRIMIS PHARMACEUTICALS INC,BAUM MARK;;BERDAHL JOHN;;WILEY WILLIAM;;SAADEH DENNIS ELIAS,HARROW HEALTH INC (2019-03-09);;MELT PHARMACEUTICALS INC (2019-03-14),https://lens.org/030-925-273-181-234,Patent Application,yes,0,1,2,31,0,A61K45/06;;A61K31/4178;;A61K9/02;;A61K9/06;;A61K9/08;;A61K9/2031;;A61K31/5517;;A61K47/22;;A61K47/26;;A61K47/34;;A61K47/42;;A61K47/44;;A61K9/0053;;A61K9/0043;;A61K9/0031;;A61K9/0019;;A61K9/0014;;A61P23/02;;A61K31/138;;A61K47/10;;A61K31/135;;A61K31/5517;;A61K31/403;;A61K47/22;;A61K47/26;;A61K47/34;;A61K47/42;;A61K47/44;;A61K9/0053;;A61K9/0043;;A61K9/0031;;A61K9/0019;;A61K9/0014;;A61P23/02;;A61K2300/00;;A61K31/138;;A61K47/10;;A61K45/06;;A61K31/4178;;A61K9/06;;A61K9/2031;;A61K9/02;;A61K9/08;;A61K31/135,A61K31/5517;;A61K9/00;;A61K47/10;;A61K47/22;;A61K47/26;;A61K47/34;;A61K47/42;;A61K47/44;;A61P23/02,,2,1,042-813-959-756-919,10.1517/14656560902978446;;19601699,"Macdonald et al, Front. Neurol., Vol. 8, 20 April 2017, pages 1-11 (Year: 2017);;McLean et al, Expert Opinion on Pharmacotherapy, 10:11, 1805-1816 (Year: 2009)",ACTIVE
274,FR,A1,FR 2626043 A1,067-947-139-981-978,1989-07-21,1989,FR 8811692 A,1988-09-07,US 14379288 A,1988-01-14,DISPOSITIF DE FORMATION DE TURBULENCES-INJECTEUR DE CARBURANT POUR ENSEMBLE DE COMBUSTION DANS UNE TURBINE A GAZ,"<P>Un dispositif de formation de turbulences-injecteur de carburant perfectionné 47 pour ensemble de combustion de turbine à gaz emploie une injection de carburant primaire dans une zone de combustion à circulation primaire 98 alimentée par un anneau intérieur 54 d'air tourbillonnant pour des valeurs élevées du rapport air/carburant lors de la marche à faible puissance. Un écoulement de carburant secondaire à étagement sélectif est introduit dans l'anneau extérieur 52 en aval du dispositif 60 de formation de turbulences dans l'air secondaire, fournissant une zone de circulation secondaire 106 pour la combustion avec des débits plus élevés du carburant mais avec des rapports plus faibles entre air et carburant lors de la marche à haute puissance. L'écoulement du carburant secondaire peut être injecté séparément dans l'anneau extérieur par l'intermédiaire de moyens de conduit 64 s'étendant à travers les ailettes 96 du dispositif 58 de formation de turbulences dans l'air primaire.</P><P>Application aux ensembles de combustion des moteurs à turbine à gaz.</P>",GEN ELECTRIC,VINSON JOHN WILLIAM;;HOWELL STEPHEN JOHN;;LAMPES ELIAS HARRY,,https://lens.org/067-947-139-981-978,Patent Application,no,5,13,18,18,0,F23C7/002;;F23D17/00;;F23R3/14;;F23R3/34;;Y02T50/60;;F23D17/00;;F23R3/34;;F23R3/14;;F23C7/002;;Y02T50/60,F23C7/00;;F23D17/00;;F23R3/14;;F23R3/34;;F02C7/232,,0,0,,,,EXPIRED
275,AT,T1,AT E150097 T1,076-482-573-907-024,1997-03-15,1997,AT 93109469 T,1993-06-14,US 90129792 A,1992-06-19,ANORGANISCHE OXYDIERENDE ZUSAMMENSETZUNGEN ZUR ENTFERNUNG VON VERUNREINIGUNGEN,"A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxy-acid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGE RICHARD C;;STANFORD THOMAS B,,https://lens.org/076-482-573-907-024,Granted Patent,no,0,0,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,H05K3/34;;C23G1/14;;H05K3/26,,0,0,,,,EXPIRED
276,US,A,US 4761332 A,083-227-615-907-424,1988-08-02,1988,US 93726587 A,1987-02-24,US 93726587 A;;US 74759885 A,1985-06-24,Planarized ceramic substrates,"A method of planarizing or smoothing the surface of a ceramic substrate by deposition of a silicon nitride layer. The silicon nitride in addition to planarizing the surface forms an alpha particle barrier. The substrates suitable for planarization with silicon nitride in accordance with the method of the present invention are sintered oxide particles which are bonded with a silicon bonding phase. The silicon content of the silicon bonding phase is greater than the silicon content of the aggregate of the oxide particles. The silicon nitride is preferably deposited by plasma enhanced chemical vapor deposition, and the silicon bonding phase is preferably a glass.",IBM,ELIAS KENNETH L;;MARTIN STUART R;;SLATTERY WILLIAM J,,https://lens.org/083-227-615-907-424,Granted Patent,yes,6,14,1,8,0,C04B41/4572;;H05K1/0306;;H05K3/0011;;Y10T428/259;;Y10T428/2993;;Y10T428/252;;Y10T428/259;;Y10T428/2993;;Y10T428/252;;C04B41/4572;;H05K3/0011;;H05K1/0306,C04B41/45;;H05K1/03;;H05K3/00,428/325;;428/331;;428/404;;428/446;;428/698;;428/701,0,0,,,,EXPIRED
277,EP,B1,EP 0574858 B1,124-685-503-079-787,1997-03-12,1997,EP 93109469 A,1993-06-14,US 90129792 A,1992-06-19,Inorganic oxidant compositions for removing contaminants,"A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxy-acid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGE RICHARD C;;STANFORD THOMAS B,,https://lens.org/124-685-503-079-787,Granted Patent,yes,5,0,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,H05K3/34;;C23G1/14;;H05K3/26,,0,0,,,,EXPIRED
278,IN,B,IN 170055 B,139-935-370-034-027,1992-02-01,1992,IN 700CA1988 A,1988-08-22,US 14379288 A,1988-01-14,A COMBINED SWIRLER AND FUEL INJECTOR FOR A GAS TURBINE COMBUSTOR,,GEN ELECTRIC,VINSON JOHN WILLIAM;;HOWELL STEPHEN JOHN;;LAMPES ELIAS HARRY,,https://lens.org/139-935-370-034-027,Granted Patent,no,0,0,18,18,0,F23C7/002;;F23D17/00;;F23R3/14;;F23R3/34;;Y02T50/60;;F23D17/00;;F23R3/34;;F23R3/14;;F23C7/002;;Y02T50/60,F23C7/00;;F02C7/232;;F23D17/00;;F23R3/14;;F23R3/34,,0,0,,,,EXPIRED
279,GB,A,GB 2104975 A,158-086-686-723-019,1983-03-16,1983,GB 8221246 A,1982-07-22,US 29787481 A,1981-08-31,Airfoils for land vehicle fans,The airfoil 30 is operable in low Reynolds number and varying turbulent conditions and has a discontinuity 32 with a sharp forward edge 36 formed on the curved suction surface 42 of the airfoil adjacent to the leading edge 34 to trigger formation of a laminar flow separation bubble so that sufficient suction surface remains downstream of the air bubble for air circumventing the bubble to re-attach to the suction surface and thereby provide sufficient pressure recovery for high lift and low drag performance. <IMAGE>,GEN MOTORS CORP,RAZINSKY ELIAS HIRSH;;LONGHOUSE RICHARD EDWARD;;ROBERTS WILLIAM BYRON,,https://lens.org/158-086-686-723-019,Patent Application,no,0,7,6,7,0,F04D29/384,F04D29/38;;F04D29/68,F1V VCS           VCS;;F1V V104          VCS;;F2R R             R;;F2R RD            RZ;;F2R RP            RZ;;U1S S1968;;U1S S2006,0,0,,,,EXPIRED
280,CA,A1,CA 2061344 A1,187-765-426-571-182,1992-09-15,1992,CA 2061344 A,1992-02-17,US 66964691 A,1991-03-14,IMPLANTABLE CARDIAC DEFIBRILLATOR WITH IMPROVED CAPACITORS,,VENTRITEX INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;MARQUIT TIMOTHY A,,https://lens.org/187-765-426-571-182,Patent Application,no,0,0,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,,0,0,,,,EXPIRED
281,WO,A1,WO 2014/047179 A1,041-144-428-775-561,2014-03-27,2014,US 2013/0060404 W,2013-09-18,US 201261703191 P;;US 201361874741 P,2012-09-19,METHOD AND SYSTEM FOR ENHANCED IMAGING VISUALIZATION OF DEEP BRAIN ANATOMY USING INFUSION,"Provided is a method and system for delivering a diagnostic agent to a site in the brain of a subject for imaging at least a portion of the brain site on a medical imaging system. The method and system includes a catheter device with associated lumens having diagnostic agent ports for delivering the diagnostic agent (e.g., infusate) through the lumens and advancing the diagnostic agent so as to exit out from the lumens to at least a portion of the brain site and while sealing a portion of the brain site thereby preventing the exited diagnostic agent from travelling proximally beyond the sealing location, and at the same time imaging at least a portion of the brain site during at least a portion of the sealing duration so that the brain site can be visualized on a medical imaging system. The diagnostic agent (infusate) is able to highlight borders and internal patterns of the deep structures of the brain thereby enabling direct targeting. Ultimately this leads to reduced complications, enhanced therapy, and the elimination of the need for awake surgery. The method and system provides the capability heretofore not possible to visualize the small, often indistinct regions, which will greatly improve clinical outcomes with therapeutic interventions.",UNIV VIRGINIA PATENT FOUND;;ELIAS WILLIAM J;;BOND AARON E;;GILLIES GEORGE T,ELIAS WILLIAM J;;BOND AARON E;;GILLIES GEORGE T,,https://lens.org/041-144-428-775-561,Patent Application,yes,6,12,5,5,0,A61M25/10;;A61B5/0042;;A61B5/055;;A61M25/007;;A61M25/0127;;A61M25/1002;;A61M31/005;;A61M2025/0042;;A61M2025/105;;A61M2025/1052;;A61M2025/1093;;G01R33/285;;A61B6/032;;A61B6/12;;A61B6/481;;A61B6/501;;A61M25/10;;A61B5/0042;;A61B5/055;;A61M25/007;;A61M25/0127;;A61M25/1002;;A61M31/005;;A61M2025/0042;;A61M2025/105;;A61M2025/1052;;A61M2025/1093;;G01R33/285;;A61B6/032;;A61B6/12;;A61B6/481;;A61B6/501;;A61M5/007;;A61M25/0026;;A61M2025/0037;;A61N1/36139,A61M25/10,,0,0,,,,PENDING
282,US,A,US 4659585 A,038-559-194-345-871,1987-04-21,1987,US 74759885 A,1985-06-24,US 74759885 A,1985-06-24,Planarized ceramic substrates,"A method of planarizing or smoothing the surface of a ceramic substrate by deposition of a silicon nitride layer. The silicon nitride in addition to planarizing the surface forms an alpha particle barrier. The substrates suitable for planarization with silicon nitride in accordance with the method of the present invention are sintered oxide particles which are bonded with a silicon bonding phase. The silicon content of the silicon bonding phase is greater than the silicon content of the aggregate of the oxide particles. The silicon nitride is preferably deposited by plasma enhanced chemical vapor deposition, and the silicon bonding phase is preferably a glass.",IBM,ELIAS KENNETH L;;MARTIN STUART R;;SLATTERY WILLIAM J,INTERNATIONAL BUSINESS MACHINES CORPORATION A CORP OF NEW YORK (1985-06-21),https://lens.org/038-559-194-345-871,Granted Patent,yes,6,7,7,8,0,C04B41/4572;;H05K1/0306;;H05K3/0011;;C04B41/4572;;H05K3/0011;;H05K1/0306,C04B41/45;;H05K1/03;;C04B41/87;;H05K3/00,427/5;;427/94;;427/269;;427/126.4;;427/126.3;;427/193;;427/199;;427/50;;427/99;;427/39;;427/9,0,0,,,,EXPIRED
283,AU,A,AU 1996/052362 A,062-904-878-656-915,1996-11-28,1996,AU 1996/052362 A,1996-05-17,US 44313495 A,1995-05-17,Capacitor foil with enhanced surface area,,PHILIPS ELECTRONICS NORTH AMERICA CORP;;VENTRITEX INC,ELIAS WILLIAM H;;STRANGE THOMAS F;;STEVENS JAMES I,,https://lens.org/062-904-878-656-915,Patent Application,no,0,0,8,8,0,H01G9/055;;H01G9/055,H01G9/04;;H01G9/055,,0,0,,,,DISCONTINUED
284,DK,T3,DK 0503778 T3,178-239-744-499-52X,1996-10-28,1996,DK 92301349 T,1992-02-19,US 66964691 A,1991-03-14,Implanterbar hjertedefibrillator med forbedret kondensator,,VENTRITEX INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;MARQUIT TIMOTHY A,,https://lens.org/178-239-744-499-52X,Granted Patent,no,0,0,11,11,0,A61N1/375;;A61N1/3956;;A61N1/3956;;A61N1/375,A61N1/375;;A61N1/39,,0,0,,,,EXPIRED
285,EP,A2,EP 0499134 A2,198-376-291-383-554,1992-08-19,1992,EP 92101941 A,1992-02-06,US 65486691 A,1991-02-12,Fluxless solder.,"A fluxless solder for application to metal surfaces which include contaminants such as metal oxides. The fluxless solder includes a reducing agent which reacts with interfering metal oxides to form essentially inert compounds which require no further cleaning. Reducing agents, such as lithium, calcium, strontium and cesium are disclosed for use in lead-tin solders, in amounts ranging from about 0,5 to 10 atom percent. Various methods for forming the fluxless solder are also disclosed.",HUGHES AIRCRAFT CO,HOLLAND WILSON A;;ELIAS WILLIAM E;;DUANE FRANCIS O,,https://lens.org/198-376-291-383-554,Patent Application,yes,0,2,6,6,0,B23K35/26;;B23K35/26;;B23K35/262;;B23K35/262,B23K1/20;;B23K35/26;;B23K35/40;;C22B1/16;;C22B5/04;;C22C24/00,,0,0,,,,DISCONTINUED
286,US,A,US 2966442 A,055-650-964-046-522,1960-12-27,1960,US 61088156 A,1956-09-20,US 61088156 A,1956-09-20,Antibiotic compositions,,AMERICAN HOME PROD,ELIAS WILLIAM F;;JOSEPH MERRION HOWARD;;APAT JOSEPH K,,https://lens.org/055-650-964-046-522,Granted Patent,no,3,10,1,1,0,A61K31/43;;A61K31/43,A61K31/43,,0,0,,,,EXPIRED
287,DE,T2,DE 69628527 T2,070-815-479-047-851,2004-04-29,2004,DE 69628527 T,1996-10-26,US 54914195 A,1995-10-27,Verwendung von metallbeschichtbare Strukturklebstoffe zum Kleben von Kompositen aus Cyanatestern.,,HUGHES ELECTRONICS CORP,PUNSLY BRIAN M;;WALLACE ANDRE R;;ELIAS WILLIAM E,,https://lens.org/070-815-479-047-851,Granted Patent,no,0,0,8,8,0,C09J163/00;;C09J163/00;;C08L63/00;;C08L63/00;;C08L2666/54;;C08L2666/54;;C09J179/04;;C09J179/04;;Y10T428/31515;;Y10T428/31515,C09J163/00;;C09J179/04,,0,0,,,,EXPIRED
288,EP,A1,EP 0743662 A1,119-036-029-024-314,1996-11-20,1996,EP 96107901 A,1996-05-17,US 44313495 A,1995-05-17,Capacitor foil with enhanced surface area,"An improved electrolytic capacitor (50) is provided by producing an anode foil (10) which has areas (16) which are not subject to stress during manufacturing being highly etched and those areas (18) which are subject to stress during manufacturing being lightly etched or not etched at all. The process of the invention provides an etch mask (12) to cover during the etch process those portions (18) of the anode foil (10) which will be subjected to stress during construction of the capacitor (50). The highly etched areas (16), which are very brittle, provide increased capacitance and thus improved energy density. For layered or stacked capacitors, a weld tab (14) is covered with the etch mask (12) to allow connection of the anode layers (10). Additionally, strong edges may be maintained thereby reducing the possibility of cracking that would normally occur during the stamping and assembly operations. For flat or oval capacitors (50) made by rolling or winding the capacitor element on a large arbor, and then flattening the element by compressing it in a press, high stress occurs at the sharp bends (60) resulting in cracking or breaking if the foil (10) is not flexible. The method of the invention allows high gain foil to be used in the flat areas (62), while masking strengthens the locations where the sharp bends (60) occur, thereby improving the capacitance.",VENTRITEX INC;;PHILIPS ELECTRONICS NA,ELIAS WILLIAM H;;STRANGE THOMAS F;;STEVENS JAMES I,"PACESETTER, INC. (2001-10-17);;PHILIPS ELECTRONICS NORTH AMERICA CORPORATION (2001-10-17)",https://lens.org/119-036-029-024-314,Patent Application,yes,1,5,8,8,0,H01G9/055;;H01G9/055,H01G9/04;;H01G9/055,,0,0,,,,EXPIRED
289,DE,D1,DE 69633090 D1,128-843-627-532-180,2004-09-16,2004,DE 69633090 T,1996-05-17,US 44313495 A,1995-05-17,Kondensatorfolie mit hoher spezifischer Oberfläche,,PACESETTER INC;;PHILIPS ELECTRONICS NA,ELIAS WILLIAM H;;STRANGE THOMAS F;;STEVENS JAMES I,,https://lens.org/128-843-627-532-180,Granted Patent,no,0,0,8,8,0,H01G9/055;;H01G9/055,H01G9/04;;H01G9/055,,0,0,,,,EXPIRED
290,AU,A,AU 1993/041217 A,134-898-393-568-708,1994-01-13,1994,AU 1993/041217 A,1993-06-11,US 90129792 A,1992-06-19,Inorganic oxidant compositions for removing contaminants,"A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxy-acid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGE RICHARD C;;STANFORD THOMAS B,,https://lens.org/134-898-393-568-708,Patent Application,no,0,0,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,H05K3/34;;C23G1/14;;H05K3/26,,0,0,,,,EXPIRED
291,US,A,US 3351527 A,174-046-620-051-591,1967-11-07,1967,US 40090664 A,1964-10-01,US 40090664 A,1964-10-01,Stabilized benzathine penicillin compositions,,AMERICAN HOME PROD,APAT JOSEPH K;;BRADY JOSEPH E;;ELIAS WILLIAM F,,https://lens.org/174-046-620-051-591,Granted Patent,no,6,14,1,1,0,A61K9/0019;;A61K31/43;;A61K9/0019;;A61K31/43,A61K9/00;;A61K31/43,,0,0,,,,EXPIRED
292,AU,A,AU 1971/037515 A,023-229-655-619-569,1973-07-05,1973,AU 1971/037515 A,1971-12-31,CA 101921 A,1971-01-04,UNIVERSAL DRILLING RIG,,HEATH & SHERWOOD DRILLING LTD,HOKANSON LYLE WILLIAM;;SAVAGE JAMES RYRIE;;SMITH ELIAS PETER;;LEVANGIE GILBERT;;KLAAS WILLIAM,,https://lens.org/023-229-655-619-569,Patent Application,no,0,0,4,4,0,E21B3/02;;E21B15/00;;E21B3/02,E21B3/02;;E21B7/02;;E21B15/00,,0,0,,,,DISCONTINUED
293,WO,A1,WO 2023/283714 A1,065-383-262-514-474,2023-01-19,2023,BR 2022050259 W,2022-07-13,BR 102021013829 A,2021-07-13,MACHINING FLUID,"A machining fluid is described that contains a metal nanomaterial that acts synergistically with synthetic lubricants in the formulation, with the nanomaterial acting as a colubricant after degradation of the synthetic lubricant and also allowing for the concentration of synthetic lubricants to be decreased, there to be no need for emulsifiers, and a lower concentration of biocides and alkalizing amines to be required.",BONDMANN QUIM LTDA,CANTO DA ROSA GUILHERME;;COUTO CAVALCANTE ELIAS;;PASSINI VIANA WILLIAM,,https://lens.org/065-383-262-514-474,Patent Application,yes,7,0,1,1,0,B82Y30/00;;C10M125/04;;C10M173/02;;C10N2040/20;;C10N2010/02,B82Y30/00;;C10M173/02;;C10M125/04;;C10N10/02;;C10N40/20,,0,0,,,,PENDING
294,JP,A,JP 2015051635 A,020-032-279-042-306,2015-03-19,2015,JP 2014182128 A,2014-09-08,US 89116507 P,2007-02-22,COMPOSITE ARTICLE HAVING EXCELLENT FIRE RESISTANCE,"PROBLEM TO BE SOLVED: To provide a composite article having excellent fire resistance, that is substantially more cost effective to fabricate, is lighter in weight, and also maintains excellent structural integrity even after a breach forms in the composite article, and that also does not emit as much smoke and toxic gases as composite articles including primarily carbon-based materials.SOLUTION: A composite article 10 includes a first window layer 12 formed from a vitreous material and a reinforced silicone layer 14 disposed adjacent to the first window layer 12. The reinforced silicone layer 14 includes a cured silicone composition and a fiber reinforcing agent. Due to the presence of the cured silicone composition in the reinforced silicone layer 14, the composite article 10 exhibits excellent fire resistance and does not emit as much smoke and toxic gases as composite articles 10 including primarily carbon-based materials. Further, due to the presence of the fiber reinforcing agent in the reinforced silicone layer 14, the composite article 10 maintains excellent structural integrity even after a breach is formed in the composite article 10 due to heat.",DOW CORNING,KATSOULIS DIMITRIS ELIAS;;WILLIAM ROBERT O'BRIEN;;AARON SEITZ;;ZHU BIZHONG,,https://lens.org/020-032-279-042-306,Patent Application,no,3,1,8,22,0,B32B17/10018;;B32B17/10036;;B32B17/10366;;B32B17/1055;;B32B25/20;;C08J2483/00;;B32B17/10798;;Y10T442/60;;Y10T442/30;;Y10T428/31663;;C08J7/0427;;C08J7/05;;C08J7/043;;C08J7/046;;B32B17/10036;;B32B17/10366;;B32B17/10798;;B32B25/20;;C03C17/30;;B32B2307/3065;;B32B2305/74;;B32B17/10018;;C03C27/10;;C08J7/0427;;C08J7/043;;C08J7/046;;C08J7/05;;C08J2483/00;;Y10T442/60;;Y10T442/30;;Y10T428/31663;;B32B17/10018;;B32B17/10036;;B32B17/10366;;B32B25/20;;B32B17/1055;;C08J2483/00;;B32B17/10798;;C08J7/0427;;C08J7/043;;C08J7/046;;C08J7/05,B32B17/10;;C03C27/12;;C08J7/043;;C08J7/046;;C08J7/05;;C08K3/00;;C08L83/05;;C08L83/07,,0,0,,,,PENDING
295,EP,A1,EP 2125362 A1,042-258-773-746-907,2009-12-02,2009,EP 08725877 A,2008-02-21,US 2008/0002287 W;;US 89116507 P,2007-02-22,COMPOSITE ARTICLE HAVING EXCELLENT FIRE RESISTANCE,,DOW CORNING,KATSOULIS DIMITRIS ELIAS;;O'BRIEN WILLIAM ROBERT;;SEITZ AARON;;ZHU BIZHONG,,https://lens.org/042-258-773-746-907,Patent Application,yes,0,0,8,22,0,B32B17/10018;;B32B17/10036;;B32B17/10366;;B32B17/1055;;B32B25/20;;C08J2483/00;;B32B17/10798;;Y10T442/60;;Y10T442/30;;Y10T428/31663;;C08J7/0427;;C08J7/05;;C08J7/043;;C08J7/046;;B32B17/10036;;B32B17/10366;;B32B17/10798;;B32B25/20;;C03C17/30;;B32B2307/3065;;B32B2305/74;;B32B17/10018;;C03C27/10;;C08J7/0427;;C08J7/043;;C08J7/046;;C08J7/05;;C08J2483/00;;Y10T442/60;;Y10T442/30;;Y10T428/31663;;B32B17/10018;;B32B17/10036;;B32B17/10366;;B32B25/20;;B32B17/1055;;C08J2483/00;;B32B17/10798;;C08J7/0427;;C08J7/043;;C08J7/046;;C08J7/05,B32B17/10;;B32B25/20;;C03C17/30;;C03C27/12;;C08J7/043;;C08J7/046;;C08J7/05,,0,0,,,,DISCONTINUED
296,US,B2,US 11637417 B2,078-167-473-812-565,2023-04-25,2023,US 201816123471 A,2018-09-06,US 201816123471 A,2018-09-06,System and method for analyzing survivability of an infrastructure link,A method for analyzing survivability of an infrastructure link includes determining an optimal path arrangement of the infrastructure link between two geographic locations; and determining a risk index associated with the determined optimal path arrangement based on one or more quantified cost factors and one or more quantified risk factors associated with the determined optimal path arrangement. The risk index represents a survivability of the infrastructure link.,UNIV CITY HONG KONG,ZUKERMAN MOSHE;;WANG ZENGFU;;WANG QING;;MORAN WILLIAM;;TAHCHI ELIAS,CITY UNIVERSITY OF HONG KONG (2018-08-14),https://lens.org/078-167-473-812-565,Granted Patent,yes,17,0,2,2,0,G06F16/29;;H02G1/00;;H02G1/10;;H02G1/06;;G06Q10/20;;G06Q50/08;;G06F16/29;;H02G1/06;;G06Q10/0635;;G06Q10/047,G06Q10/06;;G06F16/29;;G06Q10/04;;G06Q10/047;;G06Q10/0635;;H02G1/06,,1,1,027-968-064-447-843,10.1109/jlt.2017.2711658,"Z. Wang, Q. Wang, M. Zukerman and B. Moran, “A Seismic Resistant Design Algorithm for Laying and Shielding of Optical Fiber Cables,” IEEE/OSA Journal of Lightwave Technology, vol. 35, No. 14, pp. 3060-3074, Jul. 2017.",ACTIVE
297,WO,A1,WO 2008/103407 A1,190-332-505-077-785,2008-08-28,2008,US 2008/0002287 W,2008-02-21,US 89116507 P,2007-02-22,COMPOSITE ARTICLE HAVING EXCELLENT FIRE RESISTANCE,"A composite article includes a first window layer formed from a vitreous material and a reinforced silicone layer disposed adjacent the first window layer. The reinforced silicone layer includes a cured silicone composition and a fiber reinforcement. Due to the presence of the cured silicone composition in the reinforced silicone layer, the composite article exhibits excellent fire resistance and will not emit as much smoke and toxic gases as composite articles including primarily carbon-based materials. Further, due to the presence of the fiber reinforcement in the reinforced silicone layer, the composite article maintains excellent structural integrity even after a breach is formed in the composite article due to heat. As such, the composite articles of the subject invention may be suitable for load-bearing applications that are not possible with existing composite articles.",DOW CORNING;;KATSOULIS DIMITRIS ELIAS;;O'BRIEN WILLIAM ROBERT;;SEITZ AARON;;ZHU BIZHONG,KATSOULIS DIMITRIS ELIAS;;O'BRIEN WILLIAM ROBERT;;SEITZ AARON;;ZHU BIZHONG,,https://lens.org/190-332-505-077-785,Patent Application,yes,9,5,8,22,0,B32B17/10018;;B32B17/10036;;B32B17/10366;;B32B17/1055;;B32B25/20;;C08J2483/00;;B32B17/10798;;Y10T442/60;;Y10T442/30;;Y10T428/31663;;C08J7/0427;;C08J7/05;;C08J7/043;;C08J7/046;;B32B17/10036;;B32B17/10366;;B32B17/10798;;B32B25/20;;C03C17/30;;B32B2307/3065;;B32B2305/74;;B32B17/10018;;C03C27/10;;C08J7/0427;;C08J7/043;;C08J7/046;;C08J7/05;;C08J2483/00;;Y10T442/60;;Y10T442/30;;Y10T428/31663;;B32B17/10018;;B32B17/10036;;B32B17/10366;;B32B25/20;;B32B17/1055;;C08J2483/00;;B32B17/10798;;C08J7/0427;;C08J7/043;;C08J7/046;;C08J7/05,B32B17/10;;B32B25/20;;C03C17/30;;C03C27/12;;C08J7/043;;C08J7/046;;C08J7/05,,0,0,,,,PENDING
298,DE,A1,DE 1454857 A1,179-490-347-740-558,1969-02-27,1969,DE 1454857 A,1964-09-15,US 31000763 A,1963-09-19,Polytetrafluor-AEthylen-Presspulver,,PENNSALT CHEMICALS CORP,BAXTER BLACK MATTHEW;;ELIAS FAUST ELLSWORTH;;BARNHART WILLIAM;;NERSCH RAYMOND,,https://lens.org/179-490-347-740-558,Patent Application,no,0,0,6,7,0,B29B9/00;;B29B9/00;;C08J3/12;;C08J3/12;;C08J3/124;;C08J3/124;;C08J2327/18;;C08J2327/18;;Y10T428/2982;;Y10T428/2982,B29B9/00;;C08J3/12,,0,0,,,,EXPIRED
299,CN,A,CN 101652245 A,174-700-907-643-328,2010-02-17,2010,CN 200880010410 A,2008-02-21,US 2008/0002287 W;;US 89116507 P,2007-02-22,Composite article having excellent fire resistance,"A composite article includes a first window layer formed from a vitreous material and a reinforced silicone layer disposed adjacent the first window layer. The reinforced silicone layer includes a cured silicone composition and a fiber reinforcement. Due to the presence of the cured silicone composition in the reinforced silicone layer, the composite article exhibits excellent fire resistance andwill not emit as much smoke and toxic gases as composite articles including primarily carbon-based materials. Further, due to the presence of the fiber reinforcement in the reinforced silicone layer,the composite article maintains excellent structural integrity even after a breach is formed in the composite article due to heat. As such, the composite articles of the subject invention may be suitable for load-bearing applications that are not possible with existing composite articles.",DOW CORNING US,ELIAS KATSOULIS DIMITRIS;;ROBERT O'BRIEN WILLIAM;;AARON SEITZ;;BIZHONG ZHU,,https://lens.org/174-700-907-643-328,Patent Application,no,0,3,8,22,0,B32B17/10018;;B32B17/10036;;B32B17/10366;;B32B17/1055;;B32B25/20;;C08J2483/00;;B32B17/10798;;Y10T442/60;;Y10T442/30;;Y10T428/31663;;C08J7/0427;;C08J7/05;;C08J7/043;;C08J7/046;;B32B17/10036;;B32B17/10366;;B32B17/10798;;B32B25/20;;C03C17/30;;B32B2307/3065;;B32B2305/74;;B32B17/10018;;C03C27/10;;C08J7/0427;;C08J7/043;;C08J7/046;;C08J7/05;;C08J2483/00;;Y10T442/60;;Y10T442/30;;Y10T428/31663;;B32B17/10018;;B32B17/10036;;B32B17/10366;;B32B25/20;;B32B17/1055;;C08J2483/00;;B32B17/10798;;C08J7/0427;;C08J7/043;;C08J7/046;;C08J7/05,B32B17/10;;C08J7/043;;C08J7/046;;C08J7/05,,0,0,,,,DISCONTINUED
300,US,A1,US 2020/0083679 A1,129-811-585-525-862,2020-03-12,2020,US 201816123471 A,2018-09-06,US 201816123471 A,2018-09-06,SYSTEM AND METHOD FOR ANALYZING SURVIVABILITY OF AN INFRASTRUCTURE LINK,A method for analyzing survivability of an infrastructure link includes determining an optimal path arrangement of the infrastructure link between two geographic locations; and determining a risk index associated with the determined optimal path arrangement based on one or more quantified cost factors and one or more quantified risk factors associated with the determined optimal path arrangement. The risk index represents a survivability of the infrastructure link.,UNIV CITY HONG KONG,ZUKERMAN MOSHE;;WANG ZENGFU;;WANG QING;;MORAN WILLIAM;;TAHCHI ELIAS,CITY UNIVERSITY OF HONG KONG (2018-08-14),https://lens.org/129-811-585-525-862,Patent Application,yes,5,5,2,2,0,G06F16/29;;H02G1/00;;H02G1/10;;H02G1/06;;G06Q10/20;;G06Q50/08;;G06F16/29;;H02G1/06;;G06Q10/0635;;G06Q10/047,H02G1/06;;G06F16/29,,0,0,,,,ACTIVE
301,ZA,B,ZA 933599 B,009-866-563-352-320,1993-12-13,1993,ZA 933599 A,1993-05-24,US 90129792 A,1992-06-19,Inorganic oxidant compositions for removing contaminants,"A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxy-acid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGE RICHARD C JR;;STANDORD THOMAS B,,https://lens.org/009-866-563-352-320,Granted Patent,no,0,0,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,C23G1/14;;H05K3/34;;H05K3/26,,0,0,,,,EXPIRED
302,CA,A1,CA 2096452 A1,114-560-401-526-062,1993-12-20,1993,CA 2096452 A,1993-05-18,US 90129792 A,1992-06-19,INORGANIC OXIDANT COMPOSITIONS FOR REMOVING CONTAMINANTS,"INORGANIC OXIDANT COMPOSITIONS FOR REMOVING CONTAMINANTS A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxyacid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGE RICHARD C JR;;STANFORD THOMAS B,,https://lens.org/114-560-401-526-062,Patent Application,no,0,0,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,H05K3/34;;C23G1/14;;H05K3/26,,0,0,,,,DISCONTINUED
303,MX,A,MX 9303675 A,150-306-767-502-542,1994-01-31,1994,MX 9303675 A,1993-06-18,US 90129792 A,1992-06-19,COMPOSICIONES INORGANICAS OXIDANTES PARA REMOVER CONTAMINANTES.,"A composition for removing contaminants from a chosen solid substrate while avoiding negative environmental impact comprises: (a) an oxidizer selected from the group of (1) oxidizing agents which generate hydrogen peroxide upon dissolution in water, the oxidizing agent present in an amount sufficient to generate from about 0.01 percent by weight of hydrogen peroxide based on the composition up to the solubility limit of the oxidizing agent in the composition, and (2) salts of halogen oxy-acids, present in an amount from about 0.01 percent by weight of the composition up to the solubility limit of the salt of the halogen oxy-acid in the composition; (b) an alkaline compound in sufficient amount to provide a pH of 7.0 or higher in the composition; (c) about 0.01 to 5.0 percent by weight of a chosen wetting agent which is unreactive with the oxidizer and the alkaline compound; and (d) deionized water as the balance of said composition. Optionally, the composition may further comprise about 0.01 to 10.0 percent by weight of a chosen materials protective agent. In operation, the solid substrate having contaminants thereon is exposed to the above-noted composition whereby the contaminants are removed from the substrate and are converted into non-toxic and non-hazardous products. In an alternative embodiment, contaminant removal is further enhanced by exposing the composition and the contaminants on the substrate to ultraviolet radiation.",HUGHES AIRCRAFT CO,ELIAS WILLIAM E;;GEORGE RICHARD C JR;;STANFORD THOMAS B,,https://lens.org/150-306-767-502-542,Patent Application,no,0,0,13,13,0,C23G1/14;;H05K3/26;;C11D7/02,C23G1/14;;H05K3/34;;H05K3/26,,0,0,,,,DISCONTINUED
304,DE,B2,DE 2525888 B2,084-544-632-846-841,1979-04-12,1979,DE 2525888 A,1975-06-10,US 47871974 A;;US 49673774 A,1974-06-12,DE 2525888 B2,,"ORSHANSKY TRANSMISSION CORP., NEW YORK, N.Y. (V.ST.A.)","WESELOH, WILLIAM EDWIN, SAN DIEGO;;ORSHANSKY JUN., ELIAS, SAN FRANCISCO",,https://lens.org/084-544-632-846-841,Patent Application,no,0,4,8,8,0,F16H47/04;;F16H47/04;;F16H3/72;;F16H3/72;;F16H2037/0873;;F16H2037/0873;;F16H2037/106;;F16H2037/106,F16H3/72;;F16H37/02;;F16H47/04,,0,0,,,,DISCONTINUED
305,US,A,US 4206596 A,062-363-519-163-036,1980-06-10,1980,US 94235678 A,1978-09-14,US 94235678 A,1978-09-14,Dual shaft gasifier spool for two shaft gas turbine engine,"A gas turbine engine for vehicular road type operation includes a gasifier spool and a power turbine spool driven by gases from a gas turbine engine combustor and wherein the gasifier spool includes first and second shaft portions thereon one of which is connected to the gasifier compressor and the other of which is connected to the gasifier turbine. A clutch and brake controlled planetary gear set cooperate to define a rotor speed responsive lock-up assembly for controlling relative rotation of the two shaft portions of the gasifier spool and include means responsive to compressor discharge pressure and a first speed of the gasifier turbine shaft portion to control engagement of a clutch and control release of a planetary gear set brake band to cause both shaft portions of the gasifier spool to either rotate as a single unit or at a predetermined speed difference for maintaining optimal, aerodynamically improved incidence angles of gas flow across the gasifier turbine blades during both part load vehicle operation and full road load vehicle operation.",GEN MOTORS CORP,KUZIAK WILLIAM R JR;;RAZINSKY ELIAS H;;YU MASON K,,https://lens.org/062-363-519-163-036,Granted Patent,yes,4,10,1,1,0,F02C7/36;;F02C7/36;;F05D2260/4023;;F05D2260/4023;;Y10S74/05;;Y10S74/05,F02C7/36,060039160R,0,0,,,,EXPIRED
306,DE,A1,DE 1760404 A1,126-922-407-929-197,1972-03-23,1972,DE 1760404 A,1968-05-14,US 63983967 A,1967-05-19,Verfahren zur Herstellung eines Schuhoberteils und vorgeformten Rohlings fuer einen Schuhoberteil,,UNION CARBIDE CORP,RECTOR HAIN ELIAS WILLIAM;;HERBERT HART HENRY;;RONALD COSNER ROBERT,,https://lens.org/126-922-407-929-197,Patent Application,no,0,0,5,5,0,A43B11/00;;B29C43/12;;B29C51/28,A43B11/00;;B29C43/12;;B29C51/28,,0,0,,,,PENDING
307,US,A,US 5823495 A,073-849-704-988-135,1998-10-20,1998,US 79707097 A,1997-02-10,US 79707097 A,1997-02-10,Mounting apparatus for a high power mobile radio,"A mounting apparatus for securing a mobile radio includes a mounting tray (102) having a flat surface (104), radio housing attachment wings (106) and a pair of radio receiving portions (108). The flat surface has recessed fastening locations (110) for attaching the mounting tray to a surface using screws or bolts. A rubber pad (114) is affixed to the inside of each attachment wing (106) such that an opening (115) in the pad is aligned with an opening (112) in the attachment wing. The radio receiving portions (108) each have a cut-out (109) for receiving the rear of the mobile radio. A high tensile strength spring (118) is riveted (130) to the flat surface (104) of the tray and has an L-shaped end (122) prevents the spring from deforming if an unexpectedly large force is applied to the top of the radio. Together, these features act to dampen any vibrations, etc. which could damage internal radio circuitry.",MOTOROLA INC,JOSS STEVE M;;ROBERTSON JR WILLIAM H;;MALLAR ELIAS R,MOTOROLA SOLUTIONS INC (1997-02-06),https://lens.org/073-849-704-988-135,Granted Patent,yes,3,38,1,1,0,B60R11/0205;;B60R11/0205;;B60R2011/0066;;B60R2011/0066;;B60R2011/0073;;B60R2011/0073,B60R11/00;;B60R11/02,248/309.1;;248/27.1;;361/825;;455/89;;455/90,0,0,,,,EXPIRED
308,US,A,US 4788268 A,146-650-409-944-277,1988-11-29,1988,US 4601287 A,1987-05-05,US 4601287 A,1987-05-05,Method for preparation of epoxysilicone compounds and allyl-terminated silicone compounds,"Epoxysilicone compounds are prepared by first reacting a dibromobenzene compound with magnesium in anhydrous ether solvent to form a Grignard reagent and subsequently reacting the Grignard reagent with allyl bromide to form a (bromophenyl)propene compound. Next, the (bromophenyl)propene compound is converted to the corresponding Grignard reagent, which is then reacted with a compound of the formula I below ##STR1## where n=1 to 6, R.sub.1 and R.sub.2 are each chosen from the group consisting of a C.sub.1 to C.sub.4 alkyl group, a substituted aryl group, and an unsubstituted aryl group. in tetrahydrofuran solvent to form an allyl-terminated silicone compound of formula II below ##STR2## Finally, the allyl-terminated silicone compound is reacted with a chosen epoxidizing agent to form the epoxysilicone compound of formula III below. ##STR3##",HUGHES AIRCRAFT CO,LAU KREISLER S Y;;OLDHAM SUSAN L;;ELIAS WILLIAM E,HE HOLDINGS INC. A DELAWARE CORP (1997-12-17);;HUGHES AIRCRAFT COMPANY LOS ANGELES CALIFORNIA A DE. CORP (1987-04-30);;RAYTHEON COMPANY (1997-12-17),https://lens.org/146-650-409-944-277,Granted Patent,yes,2,25,1,1,0,C07F7/0889;;C08G59/306;;C08G77/045;;C08G77/045;;C08G59/306;;C07F7/0889,C07F7/08;;C08G59/30;;C08G77/04,528/27;;549/215;;528/10;;528/32;;556/480,0,0,,,,EXPIRED
309,US,B2,US 9972814 B2,080-996-484-111-545,2018-05-15,2018,US 201615224074 A,2016-07-29,US 201615224074 A;;US 201213445866 A,2012-04-12,Embedded optics in modular assemblies,"An enhanced multi object potting fixture for exposure to a curing modality that sets an adhesive includes a fixture housing supporting a plurality of objects, the fixture housing having a wall defining a plurality of bonding wells with each the bonding well receiving a first portion of one of the objects, each the bonding well including an aperture in the wall proximate the first portion wherein each bonding well includes a target zone for selective cure of the adhesive to inhibit the adhesive from exiting the aperture; and a fixture enhancement structure integrated into the wall concentrating the curing modality in each the target zone.",TESLA MOTORS INC;;TESLA INC,HACHTMANN BRIAN DEAN;;RIEGEL MARK;;HEGEMAN DAVID ELIAS;;BISHOP WILLIAM CHRISTOPHER;;BEECHER WILLIAM VUCICH,TESLA INC (2012-04-10),https://lens.org/080-996-484-111-545,Granted Patent,yes,9,1,8,8,0,B29C2035/0827;;B29C35/0894;;Y02E60/10;;H01M50/213;;H01M50/264;;H01M50/227;;B32B3/26;;H01M2220/20;;B29C2035/0827;;H01M50/213;;H01M50/227;;H01M50/264;;B29C35/0894;;B29C65/4845;;B29C66/301;;B29C66/5324;;B29C66/73343;;B29L2031/3468,B29C35/08;;B29C65/00;;B29C65/48;;B29L31/34;;B32B3/26;;H01M50/213;;H01M50/227;;H01M50/264,,1,0,,,"State Intellectual Property Office; Office Action and Search Report; CN Application No. 201310336455.6; dated Mar. 2, 2017; 9 pgs.",ACTIVE
310,CN,A,CN 103560116 A,188-981-667-133-530,2014-02-05,2014,CN 201310336455 A,2013-04-12,US 201213445866 A,2012-04-12,Embedded optics in modular assemblies,"An enhanced multiobject potting fixture for exposure to a curing modality that sets an adhesive includes a fixture housing supporting a plurality of objects, the fixture housing having a wall defining a plurality of bonding wells with each the bonding well receiving a first portion of one of the objects, each the bonding well including an aperture in the wall proximate the first portion wherein each bonding well includes a target zone for selective cure of the adhesive to inhibit the adhesive from exiting the aperture; and a fixture enhancement structure integrated into the wall concentrating the curing modality in each the target zone.",TESLA MOTORS INC,BRIAN DEAN HACHTMANN;;MARK RIEGEL;;DAVID ELIAS HEGEMAN;;WILLIAM CHRISTOPHER BISHOP;;WILLIAM VUCICH BEECHER,,https://lens.org/188-981-667-133-530,Patent Application,no,7,4,8,8,0,B29C2035/0827;;B29C35/0894;;Y02E60/10;;H01M50/213;;H01M50/264;;H01M50/227;;B32B3/26;;H01M2220/20;;B29C2035/0827;;H01M50/213;;H01M50/227;;H01M50/264;;B29C35/0894;;B29C65/4845;;B29C66/301;;B29C66/5324;;B29C66/73343;;B29L2031/3468,H01L23/31;;H01L21/52;;H01L21/56;;H01M50/213;;H01M50/227;;H01M50/264,,0,0,,,,ACTIVE
311,JP,A,JP 2013243123 A,041-983-024-061-05X,2013-12-05,2013,JP 2013082806 A,2013-04-11,US 201213445866 A,2012-04-12,OPTICAL ELEMENTS EMBEDDED IN MODULAR ASSEMBLIES,"PROBLEM TO BE SOLVED: To provide an improved multiobject potting fixture for irradiating curing means that sets a photocurable adhesive.SOLUTION: An enhanced multiobject potting fixture comprises: a fixture housing supporting a plurality of objects, the fixture housing having a wall defining a plurality of bonding wells, each of the bonding well receiving a first portion of one of the objects, each of the bonding well including an aperture in the wall proximate to the first portion, and each of the bonding well including a target zone for selective cure of the adhesive to inhibit the adhesive from exiting the aperture; and a fixture enhancement structure integrated into the wall and concentrating the curing means in each of the target zones. The plurality of objects include battery cells. The curing means includes an ultraviolet (UV) radiation field. The fixture enhancement structure optically concentrates the UV radiation field in each of the target zones.",TESLA MOTORS INC,BRIAN DEAN HACHTMANN;;MARK RIEGEL;;DAVID ELIAS HEGEMAN;;WILLIAM CHRISTOPHER BISHOP;;WILLIAM VUCICH BEECHER,,https://lens.org/041-983-024-061-05X,Patent Application,no,3,9,8,8,0,B29C2035/0827;;B29C35/0894;;Y02E60/10;;H01M50/213;;H01M50/264;;H01M50/227;;B32B3/26;;H01M2220/20;;B29C2035/0827;;H01M50/213;;H01M50/227;;H01M50/264;;B29C35/0894;;B29C65/4845;;B29C66/301;;B29C66/5324;;B29C66/73343;;B29L2031/3468,C09J5/00;;H01M50/213;;H01M50/227;;H01M50/264,,0,0,,,,ACTIVE
312,US,B2,US 9403296 B2,002-789-153-817-841,2016-08-02,2016,US 201213445866 A,2012-04-12,US 201213445866 A,2012-04-12,Embedded optics in modular assemblies,"An enhanced multiobject potting fixture for exposure to a curing modality that sets an adhesive includes a fixture housing supporting a plurality of objects, the fixture housing having a wall defining a plurality of bonding wells with each the bonding well receiving a first portion of one of the objects, each the bonding well including an aperture in the wall proximate the first portion wherein each bonding well includes a target zone for selective cure of the adhesive to inhibit the adhesive from exiting the aperture; and a fixture enhancement structure integrated into the wall concentrating the curing modality in each the target zone.",HACHTMANN BRIAN DEAN;;RIEGEL MARK;;HEGEMAN DAVID ELIAS;;BISHOP WILLIAM CHRISTOPHER;;BEECHER WILLIAM VUCICH;;TELSA MOTORS INC,HACHTMANN BRIAN DEAN;;RIEGEL MARK;;HEGEMAN DAVID ELIAS;;BISHOP WILLIAM CHRISTOPHER;;BEECHER WILLIAM VUCICH,TESLA INC (2012-04-10),https://lens.org/002-789-153-817-841,Granted Patent,yes,22,1,8,8,0,B29C2035/0827;;B29C35/0894;;Y02E60/10;;H01M50/213;;H01M50/264;;H01M50/227;;B32B3/26;;H01M2220/20;;B29C2035/0827;;H01M50/213;;H01M50/227;;H01M50/264;;B29C35/0894;;B29C65/4845;;B29C66/301;;B29C66/5324;;B29C66/73343;;B29L2031/3468,B29C35/08;;B32B3/24;;B32B3/26;;H01M50/213;;H01M50/227;;H01M50/264,,2,1,060-770-670-800-291,10.1016/s0141-3910(00)00081-1,"""Light scattering"", Wikipedia, archived Mar. 2, 2011, web.archive.org/web/20110302010749/http://en.wikipedia.org/wiki/Light-scattering.;;R Ramani, C Ranganathaiah, Degradation of acrylonitrile-butadiene-styrene and polycarbonate by UV irradiation, Polymer Degradation and Stability, vol. 69, Issue 3, Sep. 1, 2000, pp. 347-354, ISSN 0141-3910, www.sciencedirect.com/science/article/pii/S0141391000000811.",ACTIVE
313,US,A1,US 2013/0270749 A1,178-799-138-083-95X,2013-10-17,2013,US 201213445866 A,2012-04-12,US 201213445866 A,2012-04-12,EMBEDDED OPTICS IN MODULAR ASSEMBLIES,"An enhanced multiobject potting fixture for exposure to a curing modality that sets an adhesive includes a fixture housing supporting a plurality of objects, the fixture housing having a wall defining a plurality of bonding wells with each the bonding well receiving a first portion of one of the objects, each the bonding well including an aperture in the wall proximate the first portion wherein each bonding well includes a target zone for selective cure of the adhesive to inhibit the adhesive from exiting the aperture; and a fixture enhancement structure integrated into the wall concentrating the curing modality in each the target zone.",HACHTMANN BRIAN DEAN;;RIEGEL MARK;;HEGEMAN DAVID ELIAS;;BISHOP WILLIAM CHRISTOPHER;;BEECHER WILLIAM VUCICH;;TESLA MOTORS INC,HACHTMANN BRIAN DEAN;;RIEGEL MARK;;HEGEMAN DAVID ELIAS;;BISHOP WILLIAM CHRISTOPHER;;BEECHER WILLIAM VUCICH,TESLA INC (2012-04-10),https://lens.org/178-799-138-083-95X,Patent Application,yes,9,15,8,8,0,B29C2035/0827;;B29C35/0894;;Y02E60/10;;H01M50/213;;H01M50/264;;H01M50/227;;B32B3/26;;H01M2220/20;;B29C2035/0827;;H01M50/213;;H01M50/227;;H01M50/264;;B29C35/0894;;B29C65/4845;;B29C66/301;;B29C66/5324;;B29C66/73343;;B29L2031/3468,B29C45/14;;B29C35/08;;H01M50/213;;H01M50/227;;H01M50/264,264/496;;425/123;;264/279,2,1,060-770-670-800-291,10.1016/s0141-3910(00)00081-1,"""Light scattering"", Wikipedia, archived 2 March 2011, web.archive.org/web/20110302010749/http://en.wikipedia.org/wiki/Light_scattering;;R Ramani, C Ranganathaiah, Degradation of acrylonitrile-butadiene-styrene and polycarbonate by UV irradiation, Polymer Degradation and Stability, Volume 69, Issue 3, 1 September 2000, Pages 347-354, ISSN 0141-3910, www.sciencedirect.com/science/article/pii/S0141391000000811",ACTIVE
314,CN,A,CN 103458949 A,057-456-143-633-31X,2013-12-18,2013,CN 201280014338 A,2012-03-15,IB 2012051221 W;;US 201161466488 P,2011-03-23,Pulse oximetry in respiratory therapy patient interface,"Provided are systems and methods for utilizing blood oxygenation information with respiratory therapy. These systems and methods may provide respiratory therapy to a patient (119), which may include providing a flow of gas to a patient via a patient interface. Blood oxygenation information for the patient is then obtained. The blood oxygenation information is then used to adjust the respiratory therapy, advance a diagnosis for the patient, or for other purposes.",KONINKL PHILIPS ELECTRONICS NV,LOTZ GARY WILLIAM;;DIACOPOULOS ELIAS GEORGE;;MECHLENBURG DOUGLAS;;DUFF WINSLOW KEVIN,,https://lens.org/057-456-143-633-31X,Patent Application,no,9,2,5,5,0,A61B5/4836;;A61B5/4836;;A61B5/14551;;A61M16/0003;;A61M16/0003;;A61M16/0057;;A61M16/024;;A61M16/024;;A61M16/06;;A61M16/06;;A61M16/0875;;A61M16/10;;A61M16/10;;A61M2016/0027;;A61M2016/0027;;A61M2016/0036;;A61M2016/0036;;A61M2202/0208;;A61M2202/0208;;A61M2205/3553;;A61M2205/3553;;A61M2205/3584;;A61M2205/3584;;A61M2205/502;;A61M2205/502;;A61M2205/52;;A61M2205/52;;A61M2230/06;;A61M2230/06;;A61M2230/205;;A61M2230/205,A61M16/00;;A61M16/06,,0,0,,,,DISCONTINUED
315,US,B2,US 7367880 B2,041-898-257-097-567,2008-05-06,2008,US 88881504 A,2004-07-08,US 88881504 A,2004-07-08,Method and apparatus for monitoring characteristics of a flow path having solid components flowing therethrough,"A method and apparatus is provided for monitoring a flow path having plurality of different solid components flowing therethrough. For example, in the harvesting of a plant material, many factors surrounding the threshing, separating or cleaning of the plant material and may lead to the inadvertent inclusion of the component being selectively harvested with residual plant materials being discharged or otherwise processed. In accordance with the present invention the detection of the selectively harvested component within residual materials may include the monitoring of a flow path of such residual materials by, for example, directing an excitation signal toward of flow path of material and then detecting a signal initiated by the presence of the selectively harvested component responsive to the excitation signal. The detected signal may be used to determine the presence or absence of a selected plant component within the flow path of residual materials.",BATTELLE ENERGY ALLIANCE LLC,HOSKINSON REED L;;SVOBODA JOHN M;;BAUER WILLIAM F;;ELIAS GRACY,BATTELLE ENERGY ALLIANCE LLC (2005-02-01);;BECHTEL BWXT IDAHO LLC (2004-09-24),https://lens.org/041-898-257-097-567,Granted Patent,yes,40,25,3,3,0,A01D41/1277;;A01D41/1271,A01F12/44,460/5;;X 56 102 R;;460/4,0,0,,,,INACTIVE
316,IT,B,IT 1119391 B,121-145-093-613-847,1986-03-10,1986,IT 6898979 A,1979-10-11,US 97047378 A,1978-12-18,DISPOSITIVO STAMPANTE A GETTI DI GOCCE,,MEAD CORP,CHA CHARLES L;;DENLINGER GEORGE WILLIAM;;PIPKORN DAVID N;;SPYROU ELIAS,,https://lens.org/121-145-093-613-847,Granted Patent,no,0,0,13,14,0,B41J2/025;;G01D15/18;;B41J2/025;;G01D15/18,B41J2/025;;G01D15/18,,0,0,,,,EXPIRED
317,WO,A1,WO 2012/127370 A1,133-468-916-077-507,2012-09-27,2012,IB 2012051221 W,2012-03-15,US 201161466488 P,2011-03-23,PULSE OXIMETRY IN RESPIRATORY THERAPY PATIENT INTERFACE,"Provided are systems and methods for utilizing blood oxygenation information with respiratory therapy. These systems and methods may provide respiratory therapy to a patient (119), which may include providing a flow of gas to a patient via a patient interface. Blood oxygenation information for the patient is then obtained. The blood oxygenation information is then used to adjust the respiratory therapy, advance a diagnosis for the patient, or for other purposes.",KONINKL PHILIPS ELECTRONICS NV;;LOTZ GARY WILLIAM;;DIACOPOULOS ELIAS GEORGE;;MECHLENBURG DOUGLAS;;DUFF WINSLOW KEVIN,LOTZ GARY WILLIAM;;DIACOPOULOS ELIAS GEORGE;;MECHLENBURG DOUGLAS;;DUFF WINSLOW KEVIN,,https://lens.org/133-468-916-077-507,Patent Application,yes,6,13,5,5,0,A61M16/06;;A61M16/10;;A61M2016/0027;;A61M2016/0036;;A61M2202/0208;;A61M2205/3553;;A61M2205/3584;;A61M2205/502;;A61M2205/52;;A61M2230/06;;A61M2230/205;;A61M16/0003;;A61M16/024;;A61B5/4836;;A61M16/06;;A61M2205/52;;A61M2016/0036;;A61M2205/502;;A61M2230/205;;A61M2202/0208;;A61M2205/3553;;A61M2016/0027;;A61M2230/06;;A61M16/10;;A61M2205/3584;;A61M16/0003;;A61M16/024;;A61B5/14551;;A61B5/4836;;A61M16/0057;;A61M16/0875,A61M16/00;;A61M16/06,,0,0,,,,PENDING
318,AU,A1,AU 2018/241068 A1,144-892-482-779-465,2019-04-04,2019,AU 2018/241068 A,2018-10-03,US 201715708404 A,2017-09-19,"Electronic Toolset to Locate, Read, Adjust, and Confirm Adjustment in an Implantable Bodily Fluid Drainage System Without Recalibrating Following Adjustment","Abstract 5 A method of using an electronic toolset for locating, reading, adjusting and confirming adjustment of an implantable bodily fluid drainage system without requiring recalibration following adjustment from a current valve setting to a new valve setting using an electronic toolset including an adjustment tool having a magnetic element and an indicator tool including a sensor array. The need to remove the electronic toolset from the patient to 10 recalibrate or zero the sensor array prior to confirming the new valve setting is eliminated. This is realized by disposing a ferromagnetic system component of the indicator tool in a magnet shield cage made of a metallic alloy to prevent magnetic fields produced by a magnetic element in the adjustment tool during the adjusting step from influencing the sensor array. qLL. LLr.",INTEGRA LIFESCIENCES SWITZERLAND SARL,BODEN THOMAS;;D'AOUST PATRICIA;;ARAZAWA ALEXANDER;;ELIAS ADAM;;WARD WILLIAM JACOB,,https://lens.org/144-892-482-779-465,Patent Application,no,0,0,4,4,0,G01R33/0076;;A61M27/006;;G01R35/005;;A61M27/006;;A61M2205/3515;;A61M2205/3317;;A61M2205/50;;A61M2205/583;;A61M2205/70;;A61M2205/103;;A61M2205/3331;;A61M2205/6054;;G01R33/0076;;G01R35/005,A61B5/06;;A61M27/00,,0,0,,,,ACTIVE
319,GB,A,GB 1027153 A,060-266-398-650-032,1966-04-27,1966,GB 756362 A,1962-02-27,GB 756362 A,1962-02-27,Improvements in and relating to the manufacture of regenerated cellulose fibres fromviscose,"1,027,153. Making viscose rayon staple fibres. COURTAULDS (NORTH AMERICA) Inc. Feb. 26, 1963 [Feb. 27, 1962], No. 7563/62. Heading B5B. Viscose rayon staple fibres are made by extruding a viscose containing 5-9% cellulose and a caustic soda to cellulose ratio of from 0À6: 1 to 1À5: 1, the cellulose having an average D.P. of at least 300 and the viscose having a gamma number of at least 80 and a ball-fall viscosity of at least 100 seconds, into an aqueous coagulating bath containing a percentage by weight of sulphuric acid which is (0À77 C + 0À92) 0À5, where C represents the percentage of caustic soda in the viscose, 6-15% sodium sulphate, 0-1% zinc sulphate and 0À5-1À5% formaldehyde, the temperature of the bath being 10 to 50 C. and the filaments having an immersion period in the bath of <SP>1</SP>/ 3 to 9 seconds, stretching the filaments in contact with a dilute aqueous solution of sulphuric acid at a temperature above 90 C. to increase their length by between 150 and 280 or even up to 350% and cutting and relaxing the stretched filaments only after their gamma number has fallen below 10. The fibres have a high initial wet modulus, tenacities greater than 5 g.p.d., the product of their tenacity expressed in g.p.d. and their extensibility expressed as their percentage elongation is at least 30 which is a measure of the performances to be expected in the carding or drawing operations of the cotton system. A high initial wet modulus is defined as a modulus greater than 15 grams per denier per 100% extension measured at 5% extension. The ball fall viscosity is defined as the time in seconds taken for a # inch diameter steel ball to fall through 20 cms. of the viscose. The gamma number of the filaments is determined by freezing them to inhibit regeneration, dissolving them in an inert liquid, and then proceeding in the manner used for determining the gamma number of viscose.",COURTAULDS NORTH AMERICA INC,WISE HAROLD FRANKLYN;;KLEIN ELIAS;;NELSON DONALD SMITH;;RICHARDSON WILLIAM CULLEN,,https://lens.org/060-266-398-650-032,Granted Patent,no,0,0,2,3,0,D01F2/08;;Y10S264/27;;D01F2/08;;Y10S264/27,D01F2/06,B5B B31Y          43;;B5B B312          43;;B5B B392          43;;B5B B404          43;;B5B B525          43;;B5B B526          43;;B5B B528          43;;B5B B608          43,0,0,,,,EXPIRED
320,US,B2,US 10906446 B2,097-712-878-544-976,2021-02-02,2021,US 201916373735 A,2019-04-03,US 201916373735 A,2019-04-03,Convenience assembly,A convenience assembly includes a work surface coupled to a support structure by a mounting structure. A switch protrudes from the support structure toward an underside of the mounting structure. A switch-actuation assembly is positioned between the support structure and the work surface and is movable between raised and lowered positions relative to the switch to indicate a rotational position of the work surface relative to the support structure.,FORD GLOBAL TECH LLC,GAINES DAVID WILLIAM;;KULHAWIK BENJAMIN;;SANTILLAN GUTIERREZ DIEGO;;ELIAS RAUL JAVIER,FORD GLOBAL TECHNOLOGIES LLC (2019-04-01),https://lens.org/097-712-878-544-976,Granted Patent,yes,38,4,4,4,0,B60N2/90;;B60N3/00;;B60N3/102;;B60R7/043;;B60N3/002;;B60N3/004;;B60N2/206;;B60N3/004;;B60N3/002,B60N3/00,,0,0,,,,ACTIVE
321,US,A1,US 2006/0009269 A1,145-254-100-464-637,2006-01-12,2006,US 88881504 A,2004-07-08,US 88881504 A,2004-07-08,Method and apparatus for monitoring characteristics of a flow path having solid components flowing therethrough,"A method and apparatus is provided for monitoring a flow path having plurality of different solid components flowing therethrough. For example, in the harvesting of a plant material, many factors surrounding the threshing, separating or cleaning of the plant material and may lead to the inadvertent inclusion of the component being selectively harvested with residual plant materials being discharged or otherwise processed. In accordance with the present invention the detection of the selectively harvested component within residual materials may include the monitoring of a flow path of such residual materials by, for example, directing an excitation signal toward of flow path of material and then detecting a signal initiated by the presence of the selectively harvested component responsive to the excitation signal. The detected signal may be used to determine the presence or absence of a selected plant component within the flow path of residual materials.",HOSKINSON REED L;;SVOBODA JOHN M;;BAUER WILLIAM F;;ELIAS GRACY,HOSKINSON REED L;;SVOBODA JOHN M;;BAUER WILLIAM F;;ELIAS GRACY,BATTELLE ENERGY ALLIANCE LLC (2005-02-01);;BECHTEL BWXT IDAHO LLC (2004-09-24),https://lens.org/145-254-100-464-637,Patent Application,yes,37,27,3,3,0,A01D41/1277;;A01D41/1271,A01D75/18,460/2,0,0,,,,INACTIVE
322,WO,A1,WO 2017/034975 A1,109-040-922-619-328,2017-03-02,2017,US 2016/0047754 W,2016-08-19,US 201562208317 P;;US 201662279194 P;;US 201662346175 P,2015-08-21,METHODS AND APPARATUS FOR PROCESSING GLASS,"Methods and apparatus for processing a glass ribbon can include a glass former to draw a glass ribbon from a quantity of molten material in a draw direction along a draw plane of the glass former. In some embodiments, the apparatus can include a baffle with an inner surface facing the draw plane and an elongated gas port oriented to distribute an outer curtain of gas to pass over an outer surface of the baffle before passing over a downstream edge of the baffle. In some embodiments, the apparatus can include a gas dispenser including a gas outlet oriented to dispense a gas stream in the draw direction along the draw plane and a glass separator oriented to separate a glass sheet from the glass ribbon along a separation path transverse to the draw direction along a width of the glass ribbon.",CORNING INC,BROWN JAMES WILLIAM;;LUO WEIWEI;;PANIDES ELIAS;;ZHANG JINGRU;;ZHOU NAIYUE,,https://lens.org/109-040-922-619-328,Patent Application,yes,5,4,9,28,0,B08B3/022;;C03B33/0215;;C03B33/033;;C03B33/093;;C03B35/167;;C03B35/246;;C03B17/064;;C03B17/067;;B65G2249/04;;C03B17/064;;C03B5/182;;C03B18/20;;Y02P40/57,C03B17/06;;C03B5/182;;C03B18/20,,0,0,,,,PENDING
323,US,A1,US 2014/0076317 A1,047-119-396-130-091,2014-03-20,2014,US 201214006469 A,2012-03-15,US 201214006469 A;;US 201161466488 P;;IB 2012051221 W,2011-03-23,PULSE OXIMETRY IN RESPIRATORY THERAPY PATIENT INTERFACE,"Provided are systems and methods for utilizing blood oxygenation information with respiratory therapy. These systems and methods may provide respiratory therapy to a patient ( 119 ), which may include providing a flow of gas to a patient via a patient interface. Blood oxygenation information for the patient is then obtained. The blood oxygenation information is then used to adjust the respiratory therapy, advance a diagnosis for the patient, or for other purposes.",LOTZ GARY WILLIAM;;DIACOPOULOS ELIAS GEORGE;;MECHLENBURG DOUGLAS;;DUFF WINSLOW KEVIN;;KONINKL PHILIPS NV,LOTZ GARY WILLIAM;;DIACOPOULOS ELIAS GEORGE;;MECHLENBURG DOUGLAS;;DUFF WINSLOW KEVIN,KONINKLIJKE PHILIPS ELECTRONICS N V (2013-08-16),https://lens.org/047-119-396-130-091,Patent Application,yes,1,6,5,5,0,A61B5/4836;;A61B5/4836;;A61B5/14551;;A61M16/0003;;A61M16/0003;;A61M16/0057;;A61M16/024;;A61M16/024;;A61M16/06;;A61M16/06;;A61M16/0875;;A61M16/10;;A61M16/10;;A61M2016/0027;;A61M2016/0027;;A61M2016/0036;;A61M2016/0036;;A61M2202/0208;;A61M2202/0208;;A61M2205/3553;;A61M2205/3553;;A61M2205/3584;;A61M2205/3584;;A61M2205/502;;A61M2205/502;;A61M2205/52;;A61M2205/52;;A61M2230/06;;A61M2230/06;;A61M2230/205;;A61M2230/205,A61B5/00;;A61B5/1455;;A61M16/00;;A61M16/06;;A61M16/08,128/204.23,0,0,,,,DISCONTINUED
324,US,A1,US 2005/0232847 A1,062-849-736-225-061,2005-10-20,2005,US 82857104 A,2004-04-20,US 82857104 A,2004-04-20,Method for diluting hypochlorite,"This invention relates to methods of diluting hypochlorite and hypochlorous acid compositions to produce stable compositions. These compositions can be used to treat allergen containing surfaces, hard surfaces, food contact surfaces, hospital surfaces, food surfaces, kitchen surfaces, bathroom surfaces, human surfaces, animal surfaces, military equipment, transportation equipment, children's items, plant surfaces, seeds, outdoor surfaces, soft surfaces, air, wounds, and medical instruments.",BROMBERG STEVEN E;;SHAHEEN ELIAS A;;SMITH WILLIAM L;;VIEIRA KENNETH,BROMBERG STEVEN E;;SHAHEEN ELIAS A;;SMITH WILLIAM L;;VIEIRA KENNETH,CLOROX COMPANY THE (2004-04-15),https://lens.org/062-849-736-225-061,Patent Application,yes,20,23,1,25,0,A01N59/00;;A01N59/00;;A61L2/23;;A61L2/23;;C01B11/068;;C01B11/068;;C01B11/04;;C01B11/04,A61L2/18;;B01J20/16;;C01B11/04;;C01B11/06,423/473,0,0,,,,DISCONTINUED
325,US,A,US 5451769 A,106-373-472-470-912,1995-09-19,1995,US 17959894 A,1994-01-05,US 17959894 A,1994-01-05,Circular electrode geometry metal-semiconductor-metal photodetectors,"A high speed, metal-semiconductor-metal photodetector includes a pair of generally circular, electrically conductive electrodes formed on an optically active semiconductor layer. Various embodiments of the invention include a spiral, intercoiled electrode geometry and an electrode geometry having substantially circular, concentric electrodes which are interposed. These electrode geometries result in photodetectors with lower capacitances, dark currents and lower inductance which reduces the ringing seen in the optical pulse response.",US ARMY,MCADOO JAMES A;;TOWE ELIAS;;BISHOP WILLIAM L;;WANG LIANG-GUO,NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (NASA) THE (1994-01-05);;NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (NASA) UNITED STATES OF AMERICA THE (1995-09-11),https://lens.org/106-373-472-470-912,Granted Patent,yes,13,37,1,1,0,H01L31/1085;;H01L31/1085,H01L31/108,250/214.1;;257/457;;257/459,0,0,,,,EXPIRED
326,EP,A1,EP 2688623 A1,169-436-291-022-206,2014-01-29,2014,EP 12713345 A,2012-03-15,US 201161466488 P;;IB 2012051221 W,2011-03-23,PULSE OXIMETRY IN RESPIRATORY THERAPY PATIENT INTERFACE,,KONINKL PHILIPS NV,LOTZ GARY WILLIAM;;DIACOPOULOS ELIAS GEORGE;;MECHLENBURG DOUGLAS;;DUFF WINSLOW KEVIN,,https://lens.org/169-436-291-022-206,Patent Application,yes,0,0,5,5,0,A61B5/4836;;A61B5/4836;;A61B5/14551;;A61M16/0003;;A61M16/0003;;A61M16/0057;;A61M16/024;;A61M16/024;;A61M16/06;;A61M16/06;;A61M16/0875;;A61M16/10;;A61M16/10;;A61M2016/0027;;A61M2016/0027;;A61M2016/0036;;A61M2016/0036;;A61M2202/0208;;A61M2202/0208;;A61M2205/3553;;A61M2205/3553;;A61M2205/3584;;A61M2205/3584;;A61M2205/502;;A61M2205/502;;A61M2205/52;;A61M2205/52;;A61M2230/06;;A61M2230/06;;A61M2230/205;;A61M2230/205,A61M16/00;;A61M16/06,,1,0,,,See references of WO 2012127370A1,DISCONTINUED
327,US,A1,US 2007/0231247 A1,049-455-417-910-683,2007-10-04,2007,US 76225407 A,2007-06-13,US 76225407 A;;US 82857104 A;;US 80652204 A,2004-03-23,Method for Diluting Hypochlorite,"This invention relates to methods of diluting hypochlorite and hypochlorous acid compositions with purified water to produce stable compositions. These compositions can be used to treat allergen containing surfaces, hard surfaces, food contact surfaces, hospital surfaces, food surfaces, kitchen surfaces, bathroom surfaces, human surfaces, animal surfaces, military equipment, transportation equipment, children's items, plant surfaces, seeds, outdoor surfaces, soft surfaces, air, wounds, and medical instruments.",BROMBERG STEVEN E;;SHAHEEN ELIAS A;;SMITH WILLIAM L;;VIEIRA KENNETH,BROMBERG STEVEN E;;SHAHEEN ELIAS A;;SMITH WILLIAM L;;VIEIRA KENNETH,THE CLOROX COMPANY (2007-05-07),https://lens.org/049-455-417-910-683,Patent Application,yes,30,54,8,25,0,A61L2/18;;A61L2/18;;A61L2202/24;;A61L2202/24;;A61P17/00;;A61P31/02;;C11D1/00;;C09K3/00,C01B11/04;;A61L2/18,423/473,0,0,,,,DISCONTINUED
328,AU,B2,AU 2018/241068 B2,137-050-388-297-457,2023-08-24,2023,AU 2018/241068 A,2018-10-03,US 201715708404 A,2017-09-19,"Electronic Toolset to Locate, Read, Adjust, and Confirm Adjustment in an Implantable Bodily Fluid Drainage System Without Recalibrating Following Adjustment","Abstract 5 A method of using an electronic toolset for locating, reading, adjusting and confirming adjustment of an implantable bodily fluid drainage system without requiring recalibration following adjustment from a current valve setting to a new valve setting using an electronic toolset including an adjustment tool having a magnetic element and an indicator tool including a sensor array. The need to remove the electronic toolset from the patient to 10 recalibrate or zero the sensor array prior to confirming the new valve setting is eliminated. This is realized by disposing a ferromagnetic system component of the indicator tool in a magnet shield cage made of a metallic alloy to prevent magnetic fields produced by a magnetic element in the adjustment tool during the adjusting step from influencing the sensor array. qLL. LLr.",INTEGRA LIFESCIENCES SWITZERLAND SARL,BODEN THOMAS;;D'AOUST PATRICIA;;ARAZAWA ALEXANDER;;ELIAS ADAM;;WARD WILLIAM JACOB,,https://lens.org/137-050-388-297-457,Granted Patent,no,2,0,4,4,0,G01R33/0076;;A61M27/006;;G01R35/005;;A61M27/006;;A61M2205/3515;;A61M2205/3317;;A61M2205/50;;A61M2205/583;;A61M2205/70;;A61M2205/103;;A61M2205/3331;;A61M2205/6054;;G01R33/0076;;G01R35/005,A61B5/06;;A61M27/00,,0,0,,,,ACTIVE
329,CA,A,CA 726612 A,170-153-127-422-65X,1966-01-25,1966,CA 726612D A,,CA 726612T A,,MANUFACTURE OF REGENERATED CELLULOSE FIBERS FROM VISCOSE,,COURTAULDS NORTH AMERICA,RICHARDSON WILLIAM C;;KLEIN ELIAS;;NELSON DONALD S;;WISE HAROLD F,,https://lens.org/170-153-127-422-65X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
330,US,A1,US 2020/0317105 A1,157-876-373-066-222,2020-10-08,2020,US 201916373735 A,2019-04-03,US 201916373735 A,2019-04-03,CONVENIENCE ASSEMBLY,A convenience assembly includes a work surface coupled to a support structure by a mounting structure. A switch protrudes from the support structure toward an underside of the mounting structure. A switch-actuation assembly is positioned between the support structure and the work surface and is movable between raised and lowered positions relative to the switch to indicate a rotational position of the work surface relative to the support structure.,FORD GLOBAL TECH LLC,GAINES DAVID WILLIAM;;KULHAWIK BENJAMIN;;SANTILLAN GUTIERREZ DIEGO;;ELIAS RAUL JAVIER,FORD GLOBAL TECHNOLOGIES LLC (2019-04-01),https://lens.org/157-876-373-066-222,Patent Application,yes,6,0,4,4,0,B60N2/90;;B60N3/00;;B60N3/102;;B60R7/043;;B60N3/002;;B60N3/004;;B60N2/206;;B60N3/004;;B60N3/002,B60N3/00,,0,0,,,,ACTIVE
331,TW,B,TW I700131 B,159-247-155-899-278,2020-08-01,2020,TW 105126581 A,2016-08-19,US 201562208317 P;;US 201662279194 P;;US 201662346175 P,2015-08-21,Methods and apparatus for processing glass,,CORNING INC,BROWN JAMES WILLIAM;;LUO WEIWEI;;PANIDES ELIAS;;ZHANG JINGRU;;ZHOU NAIYUE,,https://lens.org/159-247-155-899-278,Granted Patent,no,6,0,9,28,0,B08B3/022;;C03B33/0215;;C03B33/033;;C03B33/093;;C03B35/167;;C03B35/246;;C03B17/064;;C03B17/067;;B65G2249/04;;C03B17/064;;C03B5/182;;C03B18/20;;Y02P40/57,,,0,0,,,,ACTIVE
332,KR,A,KR 20180033603 A,009-458-553-007-731,2018-04-03,2018,KR 20187008115 A,2016-08-19,US 201562208317 P;;US 201662279194 P;;US 201662346175 P;;US 2016/0047754 W,2015-08-21,유리 가공 방법 및 장치,"유리 리본 가공 방법들 및 장치는 유리 성형기의 드로우 평면을 따라 드로우 방향으로 소정량의 용융 물질로부터 유리 리본을 드로하는 유리 성형기를 포함할 수 있다. 일부 실시예들에서, 상기 장치는 상기 드로우 평면을 향하는 내표면을 가지는 차단막, 및 차단막의 하류 엣지 상을 통과하기 전에 차단막의 외부 표면 상을 통과하도록 외부 가스 커튼을 분사하도록 배향된 긴 가스 포트를 포함할 수 있다. 일부 실시예들에서, 상기 장치는 상기 드로우 평면을 따라 상기 드로우 방향으로 가스 스트림을 분사하도록 배향된 가스 출구를 포함하는 가스 디스펜서, 및 상기 유리 리본의 폭을 따라 상기 드로우 방향을 가로지르는 분리 경로를 따라 상기 유리 리본으로부터 유리 시트를 분리하도록 배향된 유리 분리기를 포함할 수 있다.",CORNING INC,BROWN JAMES WILLIAM;;LUO WEIWEI;;PANIDES ELIAS;;ZHANG JINGRU;;ZHOU NAIYUE,,https://lens.org/009-458-553-007-731,Patent Application,no,2,0,9,28,0,B08B3/022;;C03B33/0215;;C03B33/033;;C03B33/093;;C03B35/167;;C03B35/246;;C03B17/064;;C03B17/067;;B65G2249/04;;C03B17/064;;C03B5/182;;C03B18/20;;Y02P40/57,C03B17/06;;C03B5/182;;C03B18/20,,0,0,,,,ACTIVE
333,IT,A0,IT 7968989 A0,063-254-556-714-400,1979-10-11,1979,IT 6898979 A,1979-10-11,US 97047378 A,1978-12-18,DISPOSITIVO STAMPANTE A GETTI DI GOCCE,,MEAD CORP,CHA CHARLES L;;DENLINGER GEORGE WILLIAM;;PIPKORN DAVID N;;SPYROU ELIAS,,https://lens.org/063-254-556-714-400,Patent Application,no,0,0,13,14,0,B41J2/025;;G01D15/18;;B41J2/025;;G01D15/18,B41J2/025;;G01D15/18,,0,0,,,,EXPIRED
334,CN,A,CN 108137369 A,110-531-701-483-254,2018-06-08,2018,CN 201680061071 A,2016-08-19,US 201562208317 P;;US 201662279194 P;;US 201662346175 P;;US 2016/0047754 W,2015-08-21,METHODS AND APPARATUS FOR PROCESSING GLASS,"Methods and apparatus for processing a glass ribbon can include a glass former to draw a glass ribbon from a quantity of molten material in a draw direction along a draw plane of the glass former. Insome embodiments, the apparatus can include a baffle with an inner surface facing the draw plane and an elongated gas port oriented to distribute an outer curtain of gas to pass over an outer surfaceof the baffle before passing over a downstream edge of the baffle. In some embodiments, the apparatus can include a gas dispenser including a gas outlet oriented to dispense a gas stream in the draw direction along the draw plane and a glass separator oriented to separate a glass sheet from the glass ribbon along a separation path transverse to the draw direction along a width of the glass ribbon.",CORNING INC,BROWN JAMES WILLIAM;;LUO WEIWEI;;PANIDES ELIAS;;ZHANG JINGRU;;ZHOU NAIYUE,,https://lens.org/110-531-701-483-254,Patent Application,no,5,2,9,28,0,B08B3/022;;C03B33/0215;;C03B33/033;;C03B33/093;;C03B35/167;;C03B35/246;;C03B17/064;;C03B17/067;;B65G2249/04;;C03B17/064;;C03B5/182;;C03B18/20;;Y02P40/57,C03B17/06;;C03B5/182;;C03B18/20,,0,0,,,,ACTIVE
335,DE,A1,DE 2949170 A1,186-372-666-085-876,1980-06-26,1980,DE 2949170 A,1979-12-06,US 97047378 A,1978-12-18,TINTENSTRAHLDRUCKER,,MEAD CORP,CHA CHARLES L;;DENLINGER GEORGE WILLIAM;;PIPKORN DAVID N;;SPYROU ELIAS,,https://lens.org/186-372-666-085-876,Patent Application,no,0,0,13,14,0,B41J2/025;;G01D15/18;;B41J2/025;;G01D15/18,B41J2/025;;G01D15/18,,0,0,,,,DISCONTINUED
336,US,A,US 3226461 A,029-548-162-154-253,1965-12-28,1965,US 26084763 A,1963-02-25,GB 756362 A,1962-02-27,Manufacture of regenerated cellulose fibers from viscose,,COURTAULDS NORTH AMERICA INC,WISE HAROLD F;;ELIAS KLEIN;;NELSON DONALD S;;RICHARDSON WILLIAM C,,https://lens.org/029-548-162-154-253,Granted Patent,no,4,9,2,3,0,D01F2/08;;Y10S264/27;;D01F2/08;;Y10S264/27,D01F2/06,,0,0,,,,EXPIRED
337,CH,A,CH 285693 A,034-380-534-218-647,1952-09-30,1952,CH 285693D A,1949-08-02,NZ 285693X A;;NZ 100549X A,1949-03-01,Cultivateur du type rotatif.,,A A CORBAN & SONS LIMITED;;MCINTOSH WILLIAM NEIL;;ATAYA GEORGE ELIAS,LIMITED A A CORBAN SONS;;WILLIAM NEIL MCINTOSH;;GEORGE ELIAS ATAYA,,https://lens.org/034-380-534-218-647,Granted Patent,no,0,0,1,1,0,A01B39/166,A01B39/16,2A,0,0,,,,EXPIRED
338,DE,A1,DE 102020108964 A1,115-235-542-819-835,2020-10-08,2020,DE 102020108964 A,2020-03-31,US 201916373735 A,2019-04-03,KOMFORTBAUGRUPPE,"Diese Offenbarung stellt eine Komfortbaugruppe bereit. Eine Komfortbaugruppe beinhaltet eine Arbeitsfläche, die durch eine Befestigungsstruktur an eine Trägerstruktur gekoppelt ist. Ein Schalter ragt von der Trägerstruktur in Richtung einer Unterseite der Befestigungsstruktur hervor. Eine Schalterbetätigungsbaugruppe ist zwischen der Trägerstruktur und der Arbeitsfläche positioniert und ist zwischen einer aufgestellten und abgesenkten Position in Bezug auf den Schalter beweglich, um eine Drehposition der Arbeitsfläche in Bezug auf die Trägerstruktur anzugeben.",FORD GLOBAL TECH LLC,GAINES DAVID WILLIAM;;KULHAWIK BENJAMIN;;SANTILLAN GUTIERREZ DIEGO;;ELIAS RAUL JAVIER,,https://lens.org/115-235-542-819-835,Patent Application,no,0,0,4,4,0,B60N2/90;;B60N3/00;;B60N3/102;;B60R7/043;;B60N3/002;;B60N3/004;;B60N2/206;;B60N3/004;;B60N3/002,B60N3/00;;B60N2/32;;B60N2/90;;B60N3/08;;B60N3/10,,0,0,,,,PENDING
339,EP,A1,EP 3632498 A1,184-379-090-451-923,2020-04-08,2020,EP 18198455 A,2018-10-03,EP 18198455 A,2018-10-03,"ELECTRONIC TOOLSET TO LOCATE, READ, ADJUST, AND CONFIRM ADJUSTMENT IN AN IMPLANTABLE BODILY FLUID DRAINAGE SYSTEM WITHOUT RECALIBRATING FOLLOWING ADJUSTMENT","A method of using an electronic toolset for locating, reading, adjusting and confirming adjustment of an implantable bodily fluid drainage system without requiring recalibration following adjustment from a current valve setting to a new valve setting using an electronic toolset including an adjustment tool having a magnetic element and an indicator tool including a sensor array. The need to remove the electronic toolset from the patient to recalibrate or zero the sensor array prior to confirming the new valve setting is eliminated. This is realized by disposing a ferromagnetic system component of the indicator tool in a magnet shield cage (1715, 1720) made of a metallic alloy to prevent magnetic fields produced by a magnetic element in the adjustment tool during the adjusting step from influencing the sensor array.
",INTEGRA LIFESCIENCES SWITZERLAND SARL,BODEN JR THOMAS;;D'AOUST PATRICIA;;ARAZAWA ALEXANDER;;ELIAS ADAM;;WARD WILLIAM,,https://lens.org/184-379-090-451-923,Patent Application,yes,9,0,1,1,0,G01R33/0076;;G01R33/02;;A61M27/006,A61M27/00;;G01R33/02,,0,0,,,,PENDING
340,US,A1,US 2008/0171582 A1,196-719-390-191-004,2008-07-17,2008,US 5548908 A,2008-03-26,US 5548908 A;;US 88881504 A,2004-07-08,METHOD AND APPARATUS FOR MONITORING CHARACTERISTICS OF A FLOW PATH HAVING SOLID COMPONENTS FLOWING THERETHROUGH,"A method and apparatus is provided for monitoring a flow path having plurality of different solid components flowing therethrough. For example, in the harvesting of a plant material, many factors surrounding the threshing, separating or cleaning of the plant material and may lead to the inadvertent inclusion of the component being selectively harvested with residual plant materials being discharged or otherwise processed. In accordance with the present invention the detection of the selectively harvested component within residual materials may include the monitoring of a flow path of such residual materials by, for example, directing an excitation signal toward of flow path of material and then detecting a signal initiated by the presence of the selectively harvested component responsive to the excitation signal. The detected signal may be used to determine the presence or absence of a selected plant component within the flow path of residual materials.",BATTELLE ENERGY ALLIANCE LLC,HOSKINSON REED L;;SVOBODA JOHN M;;BAUER WILLIAM F;;ELIAS GRACY,,https://lens.org/196-719-390-191-004,Patent Application,yes,45,7,3,3,0,A01D41/1277;;A01D41/1271,A01D75/18,460/2,0,0,,,,DISCONTINUED
341,US,A,US 5922215 A,109-573-291-874-921,1999-07-13,1999,US 73265196 A,1996-10-15,US 73265196 A,1996-10-15,Method for making anode foil for layered electrolytic capacitor and capacitor made therewith,"A method for making anode foil plates for use with layered electrolytic capacitors and capacitors made with such plates. A high purity aluminum foil is provided for generation of anode foil plates. Sheets of the foil are highly etched to provide a very high surface area. Following the etch process, the foil is partially cut or punched into plates from the etched sheets in the general shape of the finished capacitor housing with a portion remaining connected to the supporting foil. The supporting foil with the partially punched-out etched plates are subjected to a forming process by applying a voltage to the plates in the presence of an electrolyte to provide formed anode foil plates with edges which do not have to be reformed during capacitor aging and which do not have any particulates at cut edges. The formed anode plates are layered with cathode plates and separators in a capacitor housing with an electrolyte to provide a finished capacitor.",PACESETTER INC,PLESS BENJAMIN D;;ELIAS WILLIAM H;;PARLER SAM;;MCCALL J SCOTT,PACESETTER INC (1997-05-15);;VENTRITEX INC (1996-10-11),https://lens.org/109-573-291-874-921,Granted Patent,yes,9,108,1,1,0,A61N1/3956;;A61N1/3956;;H01G9/0029;;H01G9/0029;;H01G9/00;;H01G9/00,A61N1/39;;H01G9/00,216/6;;216/33;;216/102;;216/52;;361/522;;361/529,0,0,,,,EXPIRED
342,CN,A,CN 111791777 A,142-704-743-077-661,2020-10-20,2020,CN 202010247778 A,2020-03-31,US 201916373735 A,2019-04-03,CONVENIENCE ASSEMBLY,A convenience assembly includes a work surface coupled to a support structure by a mounting structure. A switch protrudes from the support structure toward an underside of the mounting structure. A switch-actuation assembly is positioned between the support structure and the work surface and is movable between raised and lowered positions relative to the switch to indicate a rotational position ofthe work surface relative to the support structure.,FORD GLOBAL TECH LLC,GAINES DAVID WILLIAM;;KULHAWIK BENJAMIN;;SANTILLAN GUTIERREZ DIEGO;;ELIAS RAUL JAVIER,,https://lens.org/142-704-743-077-661,Patent Application,no,0,0,4,4,0,B60N2/90;;B60N3/00;;B60N3/102;;B60R7/043;;B60N3/002;;B60N3/004;;B60N2/206;;B60N3/004;;B60N3/002,B60N2/90;;B60N3/00;;B60N3/10;;B60R7/04,,0,0,,,,PENDING
343,CA,A1,CA 3019407 A1,190-095-042-758-309,2020-04-02,2020,CA 3019407 A,2018-10-02,CA 3019407 A,2018-10-02,"ELECTRONIC TOOLSET TO LOCATE, READ, ADJUST, AND CONFIRM ADJUSTMENT IN AN IMPLANTABLE BODILY FLUID DRAINAGE SYSTEM WITHOUT RECALIBRATING FOLLOWING ADJUSTMENT","A method of using an electronic toolset for locating, reading, adjusting and confirming adjustment of an implantable bodily fluid drainage system without requiring recalibration following adjustment from a current valve setting to a new valve setting using an electronic toolset including an adjustment tool having a magnetic element and an indicator tool including a sensor array. The need to remove the electronic toolset from the patient to recalibrate or zero the sensor array prior to confirming the new valve setting is eliminated. This is realized by disposing a ferromagnetic system component of the indicator tool in a magnet shield cage made of a metallic alloy to prevent magnetic fields produced by a magnetic element in the adjustment tool during the adjusting step from influencing the sensor array.",INTEGRA LIFESCIENCES SWITZERLAND SARL,THOMAS BODEN;;D'AOUST PATRICIA;;ARAZAWA ALEXANDER;;ELIAS ADAM;;WARD WILLIAM JACOB,,https://lens.org/190-095-042-758-309,Patent Application,no,0,0,1,1,0,A61M27/006,A61M27/00;;A61M99/00,,0,0,,,,PENDING
344,US,A1,US 2019/0083762 A1,078-951-357-052-166,2019-03-21,2019,US 201715708404 A,2017-09-19,US 201715708404 A,2017-09-19,"Electronic Toolset to Locate, Read, Adjust, and Confirm Adjustment in an Implantable Bodily Fluid Drainage System Without Recalibrating Following Adjustment","A method of using an electronic toolset for locating, reading, adjusting and confirming adjustment of an implantable bodily fluid drainage system without requiring recalibration following adjustment from a current valve setting to a new valve setting using an electronic toolset including an adjustment tool having a magnetic element and an indicator tool including a sensor array. The need to remove the electronic toolset from the patient to recalibrate or zero the sensor array prior to confirming the new valve setting is eliminated. This is realized by disposing a ferromagnetic system component of the indicator tool in a magnet shield cage made of a metallic alloy to prevent magnetic fields produced by a magnetic element in the adjustment tool during the adjusting step from influencing the sensor array.",DEPUY SYNTHES PRODUCTS INC,BODEN JR THOMAS;;D'AOUST PATRICIA;;ARAZAWA ALEXANDER;;ELIAS ADAM;;WARD WILLIAM JACOB,INTEGRA LIFESCIENCES SWITZERLAND SARL (2017-10-02);;DEPUY SYNTHES PRODUCTS INC (2017-09-20),https://lens.org/078-951-357-052-166,Patent Application,yes,3,0,4,4,0,G01R33/0076;;A61M27/006;;G01R35/005;;A61M27/006;;A61M2205/3515;;A61M2205/3317;;A61M2205/50;;A61M2205/583;;A61M2205/70;;A61M2205/103;;A61M2205/3331;;A61M2205/6054;;G01R33/0076;;G01R35/005,A61M27/00,,0,0,,,,ACTIVE
345,JP,A,JP 2020054727 A,113-823-550-500-064,2020-04-09,2020,JP 2018188990 A,2018-10-04,JP 2018188990 A,2018-10-04,"ELECTRONIC TOOL SET FOR IDENTIFYING, READING, ADJUSTING AND CONFIRMING POSITION OF ADJUSTMENT OF BODY FLUID DRAINAGE SYSTEM WHICH CAN BE IMPLANTED WITHOUT RE-CALIBRATION AFTER ADJUSTMENT","To provide an electronic tool set capable of identifying, reading, adjusting, and confirming a position of adjustment of a body fluid drainage system which can be implanted without necessity of re-calibration after adjustment from a current valve setting to a novel valve setting using an electronic tool set comprising an adjustment tool having a magnet element and an indicator tool having a sensor array.SOLUTION: According to the present invention, necessity for removing an electronic tool set from a patient for re-calibration or zero reset of a sensor array before confirming a novel valve setting, is dissolved. The invention is achieved by providing a ferromagnetic system component of an indicator tool in a magnetic shield cage which is formed of a metal alloy for preventing an affection of a magnetic field generated by a magnet element in an adjustment tool in an adjusting step to the sensor array.SELECTED DRAWING: Figure 14",INTEGRA LIFESCIENCES SWITZERLAND SARL,THOMAS BODEN JR;;PATRICIA D'AOUST;;ALEXANDER ARAZAWA;;ADAM ELIAS;;WILLIAM JACOB WARD,,https://lens.org/113-823-550-500-064,Patent Application,no,3,0,2,2,0,,A61M27/00;;A61M1/00,,0,0,,,,ACTIVE
346,US,A,US 5391329 A,116-324-614-463-841,1995-02-21,1995,US 10988493 A,1993-08-23,US 10988493 A,1993-08-23,Process for making a solid optical limiter containing a graded distribution of reverse saturable material,"An improved process is provided for making optical limiters having a graded axial distribution of a reverse saturable absorber compound, such as a buckminsterfullerene, in a host matrix, such as polymethyl methacrylate or polycarbonate. The process of the invention includes: (a) dissolving the reverse saturable absorber and the host matrix in a suitable solvent to form a solution having a preselected ratio of reverse saturable absorber to host matrix; (b) casting the solution onto a surface to form a film; (c) evaporating the solvent to form a free-standing film; (d) performing steps (a)-(c) for each different desired ratio of reverse saturable absorber to host matrix; (e) stacking the free-standing films in a desired order; and (f) hot-pressing the stack to form the optical limiter having a graded distribution of the reverse saturable absorber in the host matrix. If desired, the stack of films can be placed in a die for hot-pressing. The films can be pre-cut to the shape of the die.",HUGHES AIRCRAFT CO,DOUGHERTY THOMAS K;;ELIAS WILLIAM E;;KOST ALAN R;;KLEIN MARVIN B,HUGHES AIRCRAFT COMPANY (1993-07-08);;HE HOLDINGS INC. A DELAWARE CORP (1997-12-17);;RAYTHEON COMPANY (1997-12-17),https://lens.org/116-324-614-463-841,Granted Patent,yes,6,23,1,1,0,B29D11/00634;;B32B27/08;;B32B2307/40;;B32B2551/00;;B32B27/302;;B32B27/308;;B32B2325/00;;B32B27/365;;B32B2369/00;;B32B27/08;;B29D11/00634,B29D11/00;;B32B27/08,B5N N195          S           1X;;B5N N195          S           11;;B5N N195          S           12;;B5N N195          S           13;;B5N N195          S           21;;B5N N195          S           22;;B5N N196          S           1X;;B5N N196          S           11;;B5N N196          S           12;;B5N N196          S           13;;B5N N196          S           21;;B5N N196          S           22;;B5N N200          S           22;;B5N N207          S           1X;;B5N N207          S           11;;B5N N207          S           12;;B5N N207          S           13;;B5N N207          S           21;;B5N N207          S           22;;B5N N21Y          S           1X;;B5N N21Y          S           11;;B5N N21Y          S           12;;B5N N21Y          S           13;;B5N N21Y          S           21;;B5N N21Y          S           22;;B5N N223          S           1X;;B5N N223          S           11;;B5N N223          S           12;;B5N N223          S           13;;B5N N223          S           21;;B5N N223          S           22;;B5N N225          S           1X;;B5N N225          S           11;;B5N N225          S           12;;B5N N225          S           13;;B5N N225          S           21;;B5N N237          S           1X;;B5N N237          S           11;;B5N N237          S           12;;B5N N237          S           13;;B5N N237          S           21;;B5N N24X          S           1X;;B5N N24X          S           11;;B5N N24X          S           12;;B5N N24X          S           13;;B5N N24X          S           21;;B5N N255          S           1X;;B5N N255          S           11;;B5N N255          S           12;;B5N N255          S           13;;B5N N255          S           21;;B5N N255          S           22;;B5N N257          S           1X;;B5N N257          S           11;;B5N N257          S           12;;B5N N257          S           13;;B5N N257          S           21;;B5N N259          S           1X;;B5N N259          S           11;;B5N N259          S           12;;B5N N259          S           13;;B5N N259          S           21;;B5N N259          S           22;;B5N N261          S           22;;B5N N263          S           1X;;B5N N263          S           11;;B5N N263          S           12;;B5N N263          S           13;;B5N N263          S           21;;B5N N281          S           1X;;B5N N281          S           11;;B5N N281          S           12;;B5N N281          S           13;;B5N N281          S           21;;B5N N283          S           1X;;B5N N283          S           11;;B5N N283          S           12;;B5N N283          S           13;;B5N N283          S           21;;B5N N287          S           1X;;B5N N287          S           11;;B5N N287          S           12;;B5N N287          S           13;;B5N N287          S           21;;B5N N295          S           22;;B5N N30X          S           22;;B5N N33X          S           1X;;B5N N33X          S           11;;B5N N33X          S           12;;B5N N33X          S           13,0,0,,,,EXPIRED
347,US,B2,US 11072023 B2,040-125-101-110-373,2021-07-27,2021,US 201715423961 A,2017-02-03,US 201715423961 A;;US 2015/0037993 W;;US 201462045112 P;;US 201462060234 P;;US 201414542150 A,2014-09-03,Cryocooler containing additively-manufactured heat exchanger,"An apparatus includes a heat exchanger configured to transfer heat to a fluid and to absorb heat from the fluid as the fluid flows between a warm end and a cold end of a cryocooler. The heat exchanger includes at least one section having a substrate of at least one allotropic form of carbon and a layer of nanoparticles on or over the substrate. The heat exchanger could include multiple sections, and each section could include one of multiple substrates and one of multiple layers of nanoparticles. The heat exchanger can further include pores through the multiple sections of the heat exchanger, where the pores are configured to allow the fluid to flow through the heat exchanger and to contact the substrates and the layers of nanoparticles. The nanoparticles could include at least one lanthanide element or alloy, and the substrate could include carbon nanotubes or graphene.",RAYTHEON CO,CONRAD THEODORE J;;CHOW JAMES R;;ARMIENTO CRAIG A;;ELIAS WILLIAM E,RAYTHEON COMPANY (2016-12-07),https://lens.org/040-125-101-110-373,Granted Patent,yes,28,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,F25B9/14;;B01J19/12;;B22F1/054;;B22F9/24;;B33Y10/00;;B33Y80/00;;B41J2/01;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F28D21/00;;F28F13/18;;F28F19/02;;F28F21/02,,25,6,121-886-040-964-860;;039-074-524-113-928;;035-751-470-828-388;;109-118-925-190-931;;002-354-482-087-963;;020-241-579-969-243,10.1016/s1010-6030(99)00146-x;;15352782;;10.1021/cr030027b;;10.1021/la9705827;;10.1016/s0009-2614(03)00073-3;;14709034;;10.1021/ja037933q;;10.1186/1556-276x-9-231;;pmc4038360;;24940173,"Japanese Patent Office, Notification of Reasons for Refusal in Application No. JP 2017-512042 dated Mar. 30, 2018, 17 pages.;;Japanese Patent Office, Decision of Refusal in Application No. JP 2017-512042 dated Oct. 9, 2018, 12 pages.;;Foreign Communication from a Related Counterpart Application, PCT Application No. PCT/US2015/037933, International Search Report dated Sep. 30, 2015, 4 pages.;;Foreign Communication from a Related Counterpart Application, PCT Application No. PCT/US2015/037933, Written Opinion of the International Searching Authority dated Sep. 30, 2015, 6 pages.;;Zivkovic, O.; “Ternary Nanomaterials: Synthesis by Alkalide Reduction and Characterization”; 2010; 221 pages.;;Sato, et al.; “Sensitized Photoreduction of Silver Ions in the Presence of Acetophenone”; Journal of Photochemistry and Photobiology A: Chemistry; 127.1; 1999; 5 pages;;Conrad, et al. “Cryocooler Regenerator Containing One or More Carbon-Based Anisotropic Thermal Layers”; U.S. Appl. No. 14/151,408; 23 pages.;;Cushing, et al.; “Recent Advances in the Liquid-Phase Syntheses of Inorganic Nanoparticles”; Chemical Review; 104, No. 9; 2004; 54 pages.;;Eustis, Susie; “Gold and Silver Nanoparticles: Characterization of their Interesting Optical Properties and the Mechanism of their Photochemical Formation”; 2006; 290 pages.;;Kapoor, S.; “Preparation, Characterization, and Surface Modification of Silver Particles”; Langmuir 14.5; 1998; 5 pages.;;Kapoor, et al.; “Photochemical Formation of Copper Nanoparticles in poly (N-Vinylpyrrolidone)”; Chemical Physics Letters; 370.1; 2003; 5 pages.;;Kometani, et al.; “Laser Flash Photolysis Study of the Photochemical Formation of Colloidal Ag Nanoparticles in the Presence of Benzophenone.” PCCP; 4.20; (2002); 6 pages.;;Korchev, et al.; “Polymer-Initiated Photogeneration of Silver Nanoparticles in SPEEK/PVA Films: Direct Metal Photopatterning”; J. Am. Chem. Soc.; 126.1; 2004; 2 pages.;;Mooney, et al.; “Nanocrystalline Co 30 Fe 70 Alloy Synthesized by Alkalide Reduction”; Journal of Materials Chemistry; 19; 2009; 6 pages.;;Nelson, et al.; “Solution Synthesis of Gadolinium Nanoparticles”; Journal of the American Chemical Society; 124.12 ; 2002; 5 pages.;;Nelson, et al.; “Dysprosium Nanoparticles Synthesized by Alkalide Reduction”; Journal of Materials Chemistry; 13; 2003; 4 pages.;;Nader Shehata, et al., “Reduced erbium-doped ceria nanoparticles: one nano-host applicable for simultaneous optical down-and up-conversions”, Nanoscale Research Letters, May 13, 2014, 6 pages.;;Foreign Communication from a Related Counterpart Application, PCT Application No. PCT/US2015/039034, International Search Report and Written Opinion of the International Searching Authority dated Sep. 22, 2015, 11 pages.;;Foreign Communication from a Related Counterpart Application, PCT Application No. PCT/US2015/037933, Preliminary Report on Patentability dated Mar. 16, 2017, 8 pages.;;Examination report No. 1 for standard patent application dated Nov. 12, 2019 in connection with Australian Patent Application No. 2015312420, 4 pages.;;Office Action dated Nov. 5, 2019 in connection with Japanese Patent Application No. 2017-512042, 6 pages.;;Japanese Patent Office, Notice of Reasons for Refusal in connection with counterpart Japanese Patent Application No. 2019-010185 dated Jan. 28, 2020, 20 pages.;;Official Action in connection with counterpart Israeli Patent Application No. 249815 dated Jun. 22, 2020, 4 pages;;Office Action dated Sep. 8, 2020 in connection with counterpart Japanese Patent Application No. 2019-010185, 13 pages.;;Office Action dated Aug. 16, 2020 in connection with counterpart Israeli Patent Application No. 250488, 10 pages.",ACTIVE
348,CN,A,CN 104972924 A,080-046-393-366-703,2015-10-14,2015,CN 201510159123 A,2015-04-03,US 201414245925 A,2014-04-04,METHOD AND SYSTEM FOR VEHICLE BATTERY ENVIRONMENT CONTROL,"The invention relates to a method and system for vehicle battery environment control. Methods and system for controlling conditions within an enclosure housing a vehicle propulsion energy source are described. In one example, vehicle windows, vents, and shades may be operated to reduce an amount of energy used to maintain conditions within an enclosure housing a vehicle propulsion source. The systems and methods may be at least incorporated into electric and hybrid vehicles.",FORD GLOBAL TECH LLC,MALONE MARK DOUGLAS;;MANSUR WILLIAM NAJIB;;ROBERTS DANIEL PAUL;;SAVAYA BONNIE ELIAS,,https://lens.org/080-046-393-366-703,Patent Application,no,4,0,3,3,0,B60H1/004;;B60L58/26;;B60H1/004;;B60H1/0075;;B60H1/0075;;B60J1/00;;B60J7/02;;B60J7/0573;;B60J7/0573;;B60K1/04;;B60L58/26;;E05F15/695;;E05F15/695;;E05F15/71;;E05F15/71;;Y02T10/70,B60L11/18,,0,0,,,,DISCONTINUED
349,JP,A,JP 2019066178 A,134-929-626-240-746,2019-04-25,2019,JP 2019010185 A,2019-01-24,US 201462045112 P;;US 201462060234 P;;US 201414542150 A,2014-09-03,CRYOCOOLER CONTAINING ADDITIVELY-MANUFACTURED HEAT EXCHANGER,"To provide an additively-manufactured heat exchanger.SOLUTION: A heat exchanger includes at least one section (118, 218) that has a substrate (302) of at least one allotropic form of carbon and a layer (304) of nanoparticles on the substrate. The heat exchanger could include multiple sections (118, 218), and each section could include one of multiple substrates (302) and one of multiple layers (304) of nanoparticles. The heat exchanger can further include pores (602) in the multiple sections of the heat exchanger, the pores being configured to allow a fluid to flow through the heat exchanger and to contact with the substrates and the layers of nanoparticles. The nanoparticles could include at least one lanthanide element or alloy, and the substrate could include carbon nanotubes (402) or graphene (500).SELECTED DRAWING: Figure 1",RAYTHEON CO,THEODORE J CONRAD;;JAMES R CHOW;;CRAIG A ARMIENTO;;WILLIAM E ELIAS,,https://lens.org/134-929-626-240-746,Patent Application,no,8,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,F25B9/00;;B22F1/054;;F28F21/02,,0,0,,,,ACTIVE
350,DE,D1,DE 69109646 D1,155-088-699-591-537,1995-06-14,1995,DE 69109646 T,1991-12-03,US 63130890 A;;US 63130690 A;;US 74267191 A;;US 74267291 A,1990-12-21,Eingekapselte Aluminiumzusammensetzungen.,,DOW CORNING,CONWAY LORI JEAN;;SMITH JANET MARY;;KATSOULIS DIMITRIS ELIAS;;SCHULZ WILLIAM JAMES,,https://lens.org/155-088-699-591-537,Granted Patent,no,0,0,5,9,0,A61K8/28;;A61K8/11;;A61K8/26;;A61K2800/412;;A61Q15/00,A61K8/26;;A61K8/11;;A61K8/20;;A61K8/28;;A61K8/36;;A61K8/37;;A61Q15/00,,0,0,,,,EXPIRED
351,US,A1,US 2015/0283914 A1,118-738-785-466-599,2015-10-08,2015,US 201414245925 A,2014-04-04,US 201414245925 A,2014-04-04,METHOD AND SYSTEM FOR VEHICLE BATTERY ENVIRONMENT CONTROL,"Methods and system for controlling conditions within an enclosure housing a vehicle propulsion energy source are described. In one example, vehicle windows, vents, and shades may be operated to reduce an amount of energy used to maintain conditions within an enclosure housing a vehicle propulsion source. The systems and methods may be at least incorporated into electric and hybrid vehicles.",FORD GLOBAL TECH LLC,MALONE MARK DOUGLAS;;MANSUR WILLIAM NAJIB;;ROBERTS DANIEL PAUL;;SAVAYA BONNIE ELIAS,FORD GLOBAL TECHNOLOGIES LLC (2014-04-02),https://lens.org/118-738-785-466-599,Patent Application,yes,14,24,3,3,0,B60H1/004;;B60L58/26;;B60H1/004;;B60H1/0075;;B60H1/0075;;B60J1/00;;B60J7/02;;B60J7/0573;;B60J7/0573;;B60K1/04;;B60L58/26;;E05F15/695;;E05F15/695;;E05F15/71;;E05F15/71;;Y02T10/70,B60L11/18;;B60J1/00;;B60J7/02;;B60K1/04,,0,0,,,,DISCONTINUED
352,WO,A1,WO 2005/084557 A1,119-513-555-488-724,2005-09-15,2005,US 2005/0006519 W,2005-03-02,US 54931704 P,2004-03-02,COMPACT MULTI-USE LANCING DEVICE,"A multi-use micro-sampling or lancing device (10) having an outer housing (12), a lancet holder (32) that engages a lancet (30) and constrains the lancet along a controlled and predefined path of travel during the lancing stroke, and a drive mechanism with a pair of opposed, off axis torsion springs (80,82) working in tandem to drive and return the lancet holder through its lancing stroke.",FACET TECHNOLOGIES LLC;;KOEPPEL BRADLEY;;CONWAY WILLIAM ELIAS;;VANHIEL BRIAN;;GRIFFIS JACK;;BUENGER DAVID R,KOEPPEL BRADLEY;;CONWAY WILLIAM ELIAS;;VANHIEL BRIAN;;GRIFFIS JACK;;BUENGER DAVID R,,https://lens.org/119-513-555-488-724,Patent Application,yes,3,15,12,12,0,A61B5/15186;;A61B5/150022;;A61B5/150412;;A61B5/150442;;A61B5/150541;;A61B5/150618;;A61B5/150717;;A61B5/15113;;A61B5/15117;;A61B5/1513;;A61B5/1519;;A61B5/15194;;A61B5/15194;;A61B5/15186;;A61B5/1519;;A61B5/150412;;A61B5/1513;;A61B5/150618;;A61B5/150541;;A61B5/150442;;A61B5/15113;;A61B5/150022;;A61B5/15117;;A61B5/150717,A61B5/15;;A61B17/14,,0,0,,,,PENDING
353,EP,A1,EP 3041944 A1,153-568-203-039-061,2016-07-13,2016,EP 14841848 A,2014-09-06,US 201361874752 P;;US 2014/0054434 W,2013-09-06,"CONVERSION OF GLYCEROL TO 1,3-PROPANEDIOL UNDER HALOALKALINE CONDITIONS",,UNIV MISSOURI,MORMILE MELANIE ROSE;;ROUSH DANIEL WILLIAM;;ELIAS DWAYNE ALEXANDER;;SITTON OLIVER CLIFFORD,,https://lens.org/153-568-203-039-061,Patent Application,yes,0,0,6,6,7,C12P7/18;;C12P7/18,C12P7/18;;C12N1/21,,0,0,,,,DISCONTINUED
354,CA,A1,CA 2558437 A1,163-614-224-566-685,2005-09-15,2005,CA 2558437 A,2005-03-02,US 54931704 P;;US 2005/0006519 W,2004-03-02,COMPACT MULTI-USE LANCING DEVICE,,FACET TECHNOLOGIES LLC,VANHIEL BRIAN;;GRIFFIS JACK;;CONWAY WILLIAM ELIAS;;KOEPPEL BRADLEY;;BUENGER DAVID R,,https://lens.org/163-614-224-566-685,Patent Application,no,0,0,12,12,0,A61B5/15194;;A61B5/15194;;A61B5/150022;;A61B5/150022;;A61B5/150412;;A61B5/150412;;A61B5/150442;;A61B5/150442;;A61B5/150541;;A61B5/150541;;A61B5/150618;;A61B5/150618;;A61B5/150717;;A61B5/150717;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15186;;A61B5/15186;;A61B5/1519;;A61B5/1519,A61B17/14;;A61B5/15,,0,0,,,,ACTIVE
355,US,B2,US 9328360 B2,062-431-199-487-972,2016-05-03,2016,US 201414479292 A,2014-09-06,US 201414479292 A;;US 201361874752 P,2013-09-06,"Conversion of glycerol to 1,3-propanediol under haloalkaline conditions","A method of producing 1,3-propanediol. The method comprises fermenting a haloalkaliphilic species of Halanaerobium with a source of glycerol into 1,3-propanediol, at a pH of greater than about 10 and at a salt concentration of greater than about 5% w/v. Furthermore, with supplementation of vitamin B 12 , the yield of 1,3-propanediol to glycerol can be increased.",UNIV MISSOURI,MORMILE MELANIE ROSE;;ROUSH DANIEL WILLIAM;;ELIAS DWAYNE ALEXANDER;;SITTON OLIVER CLIFFORD,THE CURATORS OF THE UNIVERSITY OF MISSOURI (2014-08-26),https://lens.org/062-431-199-487-972,Granted Patent,yes,7,0,6,6,7,C12P7/18;;C12P7/18,C12P7/18,,13,8,096-204-451-285-429;;043-837-246-425-581;;007-790-772-896-93X;;060-302-283-024-934;;049-131-666-602-111;;024-737-333-405-530;;102-786-606-028-768;;095-938-633-307-904,12013433;;10.1007/s007920100229;;16267554;;10.1038/nature04056;;10.4319/lo.1972.17.2.0315;;10.1016/j.biortech.2010.06.066;;20615687;;10.1016/j.ijhydene.2013.06.119;;pmc3133330;;10.1128/jb.05209-11;;21602336;;20804793;;10.1016/j.jbiotec.2010.08.014;;pmc19596;;9023339;;10.1073/pnas.94.3.814,"Kivisto et al., Journal of Biotechnology 158:242-247, available online Nov. 6, 2011.;;Brown et al., Genbank accession No. CP002304, 2011.;;The 2012 ATCC catalog.;;Van Gerpen, J., Improvement of Crop Plants for Industrial End Uses, Chapter 10, pp. 281-289, P. Ranalli Editor, 2007.;;Cayol et al., Extremophiles 6:131-134, 2002.;;Croft et al., Nature 438:90-93, 2005.;;Ohwada et al., Limnology and Oceanography 17(2):315-320, 1972.;;Kivisto et al., Bioresource Technology 101:8671-8677, 2010.;;Kivisto et al., ""Non-sterile process for biohydrogen and 1,3-propanediol production from raw glycerol,"" International Journal of Hydrogen Energy, Jul. 26, 2013, vol. 38, Issue No. 27, 11749-11755.;;International Search Report and Written Opinion mailed Dec. 23, 2014 in corresponding PCT/US2014/054434 filed Sep. 6, 2014.;;Brown et al., ""Complete Genome Sequence of the Haloalkaliphilic, Hydrogen-Producing Bacterium Halanaerobium hydrogeniformans,"" Journal of Bacteriology, Jul. 2011, vol. 193, No. 14, 3682-3683.;;Kivisto et al., ""Halophilic anaerobic fermentative bacteria,"" Journal of Biotechnology 152 (2011) 114-124.;;McAdams et al., ""Stochastic mechanisms in gene expression"", Proc. Natl. Acad. Sci. USA 94 (1997) 814-819, vol. 94.",INACTIVE
356,TW,A,TW 202248152 A,181-893-185-634-469,2022-12-16,2022,TW 111117606 A,2022-05-11,US 202163188155 P,2021-05-13,Methods and apparatus for manufacturing a glass ribbon,"A glass manufacturing apparatus includes a forming apparatus forming a glass ribbon. An enclosure is positioned downstream from the forming apparatus and includes a first chamber, a first end defining an inlet opening, and a second end defining an outlet opening. A first enclosure wall of the enclosure includes an enclosure wall opening defining a gas travel path from the first chamber to an exterior of the enclosure. A ribbon travel path extends through the first chamber. A first conduit extends along a first side of the enclosure and includes a second chamber. A gas opening provides fluid communication between the first chamber and the second chamber. A first gas source is in fluid communication with the second chamber. The first gas source delivers a first gas to the first chamber through the second chamber. Methods of manufacturing a glass ribbon are provided.",CORNING INC,BROWN JAMES WILLIAM;;GAO FENG;;HILL KEITH MITCHELL;;PANIDES ELIAS;;ZHOU NAIYUE,,https://lens.org/181-893-185-634-469,Patent of Addition,no,0,0,4,4,0,C03B35/16;;C03B35/14;;C03B17/064;;C03B35/246,C03B17/06,,0,0,,,,PENDING
357,DE,B,DE 1023791 B,185-330-091-521-726,1958-02-06,1958,DE T0005714 A,1952-02-06,SE 1023791X A,1951-02-06,Schaltungsanordnung fuer einen selbsttaetigen Streckenblock mit Gleisstromkreisen,,ERICSSON TELEFON AB L M,HANSEN WALTER WESSEL;;AHLBERG CURT FREDRIK;;ANDSJOE ERIK ELIAS;;HOFSTROEM ALF WILLIAM,,https://lens.org/185-330-091-521-726,Patent Application,no,3,0,1,1,0,B61L23/166,B61L23/16,,0,0,,,,DISCONTINUED
358,WO,A1,WO 2022/240676 A1,060-295-356-796-001,2022-11-17,2022,US 2022/0028049 W,2022-05-06,US 202163188155 P,2021-05-13,METHODS AND APPARATUS FOR MANUFACTURING A GLASS RIBBON,"A glass manufacturing apparatus includes a forming apparatus forming a glass ribbon. An enclosure is positioned downstream from the forming apparatus and includes a first chamber, a first end defining an inlet opening, and a second end defining an outlet opening. A first enclosure wall of the enclosure includes an enclosure wall opening defining a gas travel path from the first chamber to an exterior of the enclosure. A ribbon travel path extends through the first chamber. A first conduit extends along a first side of the enclosure and includes a second chamber. A gas opening provides fluid communication between the first chamber and the second chamber. A first gas source is in fluid communication with the second chamber. The first gas source delivers a first gas to the first chamber through the second chamber. Methods of manufacturing a glass ribbon are provided.",CORNING INC,BROWN JAMES WILLIAM;;GAO FENG;;HILL KEITH MITCHELL;;PANIDES ELIAS;;ZHOU NAIYUE,,https://lens.org/060-295-356-796-001,Patent Application,yes,3,0,4,4,0,C03B35/16;;C03B35/14;;C03B17/064;;C03B35/246,C03B35/14;;C03B17/06;;C03B35/16;;C03B35/24,,0,0,,,,PENDING
359,AU,A,AU 1988/014044 A,066-806-401-309-947,1988-10-06,1988,AU 1988/014044 A,1988-03-31,US 3452787 A,1987-04-03,PHOTODETECTOR ASSEMBLY FOR A LASER SCANNING APPARATUS,,DU PONT,LEE JERALD DANA;;ELIAS JOHN GREER;;WOLF WILLIAM EDWARD;;ROCKNEY BENNETT HANSON,,https://lens.org/066-806-401-309-947,Patent Application,no,0,0,5,14,0,H04N1/0635;;H04N1/028;;H04N1/0281;;H04N1/0657;;H04N1/0664,G03B42/02;;G02B26/10;;H04N1/028;;H04N1/06;;H04N1/113,,0,0,,,,EXPIRED
360,US,A,US 1109832 A,131-649-653-304-850,1914-09-08,1914,US 1913/0783172 A,1913-08-05,US 1913/0783172 A,1913-08-05,"APPARATUS FOR DISPENSING GASOLENE, &C.",,W B LINN,GRAHAM ELIAS;;DELL HAZEL;;TURNER WILLIAM C;;FOSTER HOMER;;GRANT HARVEY M,,https://lens.org/131-649-653-304-850,Granted Patent,no,0,3,1,1,0,G01F11/28;;G01F11/28,,,0,0,,,,EXPIRED
361,AU,B2,AU 608586 B2,013-494-317-021-50X,1991-04-11,1991,AU 1988/014044 A,1988-03-31,US 3452787 A,1987-04-03,PHOTODETECTOR ASSEMBLY FOR A LASER SCANNING APPARATUS,,DU PONT,LEE JERALD DANA;;ELIAS JOHN GREER;;WOLF WILLIAM EDWARD;;ROCKNEY BENNETT HANSON,,https://lens.org/013-494-317-021-50X,Granted Patent,no,1,1,5,14,0,H04N1/0635;;H04N1/028;;H04N1/0281;;H04N1/0657;;H04N1/0664,G03B42/02;;G02B26/10;;H04N1/028;;H04N1/06;;H04N1/113,,0,0,,,,EXPIRED
362,EP,B1,EP 3189287 B1,111-339-858-230-868,2018-03-21,2018,EP 15745287 A,2015-06-26,US 201462045112 P;;US 201462060234 P;;US 201414542150 A;;US 2015/0037993 W,2014-09-03,CRYOCOOLER CONTAINING ADDITIVELY-MANUFACTURED HEAT EXCHANGER,,RAYTHEON CO,CONRAD THEODORE J;;CHOW JAMES R;;ARMIENTO CRAIG A;;ELIAS WILLIAM E,,https://lens.org/111-339-858-230-868,Granted Patent,yes,4,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,F25B9/00;;B22F1/054;;B22F9/24;;B41J2/01;;C09D11/52;;F25B9/14;;F28D21/00;;F28F13/18;;F28F19/02,,0,0,,,,ACTIVE
363,EP,A4,EP 3041944 A4,025-538-625-345-917,2017-04-05,2017,EP 14841848 A,2014-09-06,US 201361874752 P;;US 2014/0054434 W,2013-09-06,"CONVERSION OF GLYCEROL TO 1,3-PROPANEDIOL UNDER HALOALKALINE CONDITIONS",,UNIV MISSOURI,MORMILE MELANIE ROSE;;ROUSH DANIEL WILLIAM;;ELIAS DWAYNE ALEXANDER;;SITTON OLIVER CLIFFORD,,https://lens.org/025-538-625-345-917,Search Report,no,0,0,6,6,0,C12P7/18;;C12P7/18,C12P7/18;;C12N1/21,,4,3,049-131-666-602-111;;082-357-498-675-837;;016-133-095-203-097,10.1016/j.ijhydene.2013.06.119;;10.3389/fmicb.2012.00093;;pmc3325762;;22509174;;24645484;;10.1080/09593330.2013.858186,"KIVISTÖ ANNIINA ET AL: ""Non-sterile process for biohydrogen and 1,3-propanediol production from raw glycerol"", INTERNATIONAL JOURNAL OF HYDROGEN ENERGY, vol. 38, no. 27, 26 July 2013 (2013-07-26), pages 11749 - 11755, XP028694438, ISSN: 0360-3199, DOI: 10.1016/J.IJHYDENE.2013.06.119;;MATTHEW B. BEGEMANN ET AL: ""A Streamlined Strategy for Biohydrogen Production with Halanaerobium hydrogeniformans, an Alkaliphilic Bacterium"", FRONTIERS IN MICROBIOLOGY, vol. 3, 1 January 2012 (2012-01-01), XP055346881, DOI: 10.3389/fmicb.2012.00093;;VARUN G. PAUL ET AL: ""Ability of a haloalkaliphilic bacterium isolated from Soap Lake, Washington to generate electricity at pH 11.0 and 7% salinity"", ENVIRONMENTAL TECHNOLOGY, vol. 35, no. 8, 18 April 2014 (2014-04-18), GB, pages 1003 - 1011, XP055346877, ISSN: 0959-3330, DOI: 10.1080/09593330.2013.858186;;See also references of WO 2015035266A1",DISCONTINUED
364,CA,A,CA 123648 A,054-666-947-565-101,1910-02-08,1910,CA 123648D A,1909-10-06,CA 123648T A,1909-10-06,STEAM ENGINE,,HEIN JACOB J;;CONKELL ELIAS W;;HAMMERLY WILLIAM A;;WEIDA JAMES B,HEIN JACOB J;;CONKELL ELIAS W;;HAMMERLY WILLIAM A;;WEIDA JAMES B,,https://lens.org/054-666-947-565-101,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
365,WO,A1,WO 2016/036435 A1,087-506-928-565-629,2016-03-10,2016,US 2015/0037993 W,2015-06-26,US 201462045112 P;;US 201462060234 P;;US 201414542150 A,2014-09-03,CRYOCOOLER CONTAINING ADDITIVELY-MANUFACTURED HEAT EXCHANGER,"An apparatus includes a heat exchanger (112, 212) configured to transfer heat to a fluid and to absorb heat from the fluid as the fluid flows between a warm end (106) and a cold end (108) of a cryocooler (100). The heat exchanger includes at least one section (118, 218) having a substrate (302) of at least one allotropic form of carbon and a layer (304) of nanoparticles on or over the substrate. The heat exchanger could include multiple sections (118, 218), and each section could include one of multiple substrates (302) and one of multiple layers (304) of nanoparticles. The heat exchanger can further include pores (602) through the multiple sections of the heat exchanger, where the pores are configured to allow the fluid to flow through the heat exchanger and to contact the substrates and the layers of nanoparticles. The nanoparticles could include at least one lanthanide element or alloy, and the substrate could include carbon nanotubes (402) or graphene (500).",RAYTHEON CO,CONRAD THEODORE J;;CHOW JAMES R;;ARMIENTO CRAIG A;;ELIAS WILLIAM E,,https://lens.org/087-506-928-565-629,Patent Application,yes,5,2,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,F25B9/00;;B22F1/054;;B22F9/24;;B41J2/01;;C09D11/52;;F25B9/14;;F28D21/00;;F28F13/18;;F28F19/02,,0,0,,,,PENDING
366,GB,A,GB 190917860 A,142-971-243-247-640,1909-12-16,1909,GB 190917860D A,1909-07-31,GB 190917860T A,1909-07-31,Improvements in Duplex Steam Engines.,"17,860. Conkell, E. W., Hein, J. J., Hammerly, W. A., and Weida, J. B. July 31. Tappet gears; slide valves; arrangement and disposition of valves.-The cylinders 1, 2 contain double-ended pistons 16, 17, 18, 19 which are provided with tappets to operate internal distributing-valves 27. The cylinders are provided with ports 6 ... 15. The ports 7, 8 in the cylinder 1 are connected to the ports 11, 14 in the cylinder 2, and the ports 12, 13 in the cylinder 2 are connected to the ports 6, 9 in the cylinder 1; the central ports 10, 15 are connected to the exhaust. The steam is supplied to the interior of the pistons through the pipe 31. During the reciprocation of one piston, the interior valve which is moved by that piston controls the admission and exhaust to the ends of the adjacent cylinder.",CONKELL ELIAS WILSON;;HEIN JACOB JOHN;;HAMMERLY WILLIAM ANTON;;WEIDA JAMES BUTZ,CONKELL ELIAS WILSON;;HEIN JACOB JOHN;;HAMMERLY WILLIAM ANTON;;WEIDA JAMES BUTZ,,https://lens.org/142-971-243-247-640,Patent Application,no,0,0,1,1,0,F01B17/04;;F01B2170/0429,F01B17/04,,0,0,,,,DISCONTINUED
367,CA,C,CA 2558437 C,167-734-103-837-049,2010-09-14,2010,CA 2558437 A,2005-03-02,US 54931704 P;;US 2005/0006519 W,2004-03-02,COMPACT MULTI-USE LANCING DEVICE,"A multi-use micro-sampling or lancing device (10) having an outer housing (12), a lancet holder (32) that engages a lancet (30) and constrains the lancet along a controlled and predefined path of travel during the lancing stroke, and a drive mechanism with a pair of opposed, off axis torsion springs (80,82) working in tandem to drive and return the lancet holder through its lancing stroke.",FACET TECHNOLOGIES LLC,KOEPPEL BRADLEY;;CONWAY WILLIAM ELIAS;;VANHIEL BRIAN;;GRIFFIS JACK;;BUENGER DAVID R,,https://lens.org/167-734-103-837-049,Granted Patent,no,0,0,12,12,0,A61B5/15186;;A61B5/150022;;A61B5/150412;;A61B5/150442;;A61B5/150541;;A61B5/150618;;A61B5/150717;;A61B5/15113;;A61B5/15117;;A61B5/1513;;A61B5/1519;;A61B5/15194;;A61B5/15194;;A61B5/15186;;A61B5/1519;;A61B5/150412;;A61B5/1513;;A61B5/150618;;A61B5/150541;;A61B5/150442;;A61B5/15113;;A61B5/150022;;A61B5/15117;;A61B5/150717,A61B17/14;;A61B5/15,,0,0,,,,ACTIVE
368,US,A,US 2391480 A,017-686-049-553-471,1945-12-25,1945,US 47268243 A,1943-01-18,US 47268243 A,1943-01-18,Laboratory hammer mill,,US AGRICULTURE,ROSS WILLIAM H;;SHIPLEY ELIAS S;;MULLINS JOSEPH F;;HARDESTY JOHN O,,https://lens.org/017-686-049-553-471,Granted Patent,no,0,10,1,1,0,B02C13/26;;B02C13/26,B02C13/26,,0,0,,,,EXPIRED
369,AU,B2,AU 2015/312420 B2,146-543-745-711-305,2020-01-23,2020,AU 2015/312420 A,2015-06-26,US 201414542150 A;;US 201462045112 P;;US 201462060234 P;;US 2015/0037993 W,2014-09-03,Cryocooler containing additively-manufactured heat exchanger,"An apparatus includes a heat exchanger (112, 212) configured to transfer heat to a fluid and to absorb heat from the fluid as the fluid flows between a warm end (106) and a cold end (108) of a cryocooler (100). The heat exchanger includes at least one section (118, 218) having a substrate (302) of at least one allotropic form of carbon and a layer (304) of nanoparticles on or over the substrate. The heat exchanger could include multiple sections (118, 218), and each section could include one of multiple substrates (302) and one of multiple layers (304) of nanoparticles. The heat exchanger can further include pores (602) through the multiple sections of the heat exchanger, where the pores are configured to allow the fluid to flow through the heat exchanger and to contact the substrates and the layers of nanoparticles. The nanoparticles could include at least one lanthanide element or alloy, and the substrate could include carbon nanotubes (402) or graphene (500).",RAYTHEON CO,CONRAD THEODORE J;;CHOW JAMES R;;ARMIENTO CRAIG A;;ELIAS WILLIAM E,,https://lens.org/146-543-745-711-305,Granted Patent,no,2,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,F25B9/00;;B22F1/054;;B22F9/24;;B41J2/01;;C09D11/52;;F25B9/14;;F28D21/00;;F28F13/18;;F28F19/02,,0,0,,,,ACTIVE
370,CA,A,CA 71333 A,159-956-081-227-875,1901-05-14,1901,CA 71333D A,1901-04-20,CA 71333T A,1901-04-20,ROLLER FOR BLINDS,,DIMANT ELIAS;;MIDDLETON TOD HARRY;;DUGINS WILLIAM FRANCIS;;PERCIVAL GARRETT JOHN JAMES,DIMANT ELIAS;;MIDDLETON TOD HARRY;;DUGINS WILLIAM FRANCIS;;PERCIVAL GARRETT JOHN JAMES,,https://lens.org/159-956-081-227-875,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
371,WO,A1,WO 2015/035266 A1,006-258-105-057-828,2015-03-12,2015,US 2014/0054434 W,2014-09-06,US 201361874752 P,2013-09-06,"CONVERSION OF GLYCEROL TO 1,3-PROPANEDIOL UNDER HALOALKALINE CONDITIONS","A method of producing 1,3-propanediol. The method comprises fermenting a haloalkaliphilic species of Halanaerobium with a source of glycerol into 1,3-propanediol, at a pH of greater than about 10 and at a salt concentration of greater than about 5% w/v. Furthermore, with supplementation of vitamin B 12 , the yield of 1,3-propanediol to glycerol can be increased.",UNIV MISSOURI,MORMILE MELANIE ROSE;;ROUSH DANIEL WILLIAM;;ELIAS DWAYNE ALEXANDER;;SITTON OLIVER CLIFFORD,,https://lens.org/006-258-105-057-828,Patent Application,yes,4,1,6,6,7,C12P7/18;;C12P7/18,C12P7/18;;C12N1/21,,3,2,014-794-615-255-639;;049-131-666-602-111,10.1016/j.jbiotec.2011.10.013;;22085971;;10.1016/j.ijhydene.2013.06.119,"KIVISTO, ANNIINA ET AL.: ""1,3-propanediol production and tolerance of a halophilic fermentative bacterium, Halanaerobium saccharolyticum subsp. saccharolyticum"", JOURNAL OF BIOTECHNOLOGY, vol. 158, no. 4, 2012, pages 242 - 247, XP055322468;;KIVISTO, ANNIINA ET AL.: ""Non-sterile process for biohydrogen and 1,3-propanediol production from raw glycerol"", INTERNATIONAL JOURNAL OF HYDROGEN ENERGY, vol. 38, no. 27, 26 July 2013 (2013-07-26), pages 11749 - 11755, XP028694438;;See also references of EP 3041944A4",PENDING
372,EP,A1,EP 3189287 A1,020-717-712-896-639,2017-07-12,2017,EP 15745287 A,2015-06-26,US 201462045112 P;;US 201462060234 P;;US 201414542150 A;;US 2015/0037993 W,2014-09-03,CRYOCOOLER CONTAINING ADDITIVELY-MANUFACTURED HEAT EXCHANGER,,RAYTHEON CO,CONRAD THEODORE J;;CHOW JAMES R;;ARMIENTO CRAIG A;;ELIAS WILLIAM E,,https://lens.org/020-717-712-896-639,Patent Application,yes,0,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,F25B9/00;;B22F1/054;;B22F9/24;;B41J2/01;;C09D11/52;;F25B9/14;;F28D21/00;;F28F13/18;;F28F19/02,,0,0,,,,ACTIVE
373,DE,A1,DE 1618652 A1,089-573-622-871-271,1972-04-20,1972,DE 1618652 A,1967-02-14,US 52704966 A,1966-02-14,Verfahren zur Hydrodesalkylierung von alkylsubstituierten aromatischen Kohlenwasserstoffen,,MONSANTO CO,GLENN JUHL WILLIAM;;ROBERT KNOX WALTER;;EUGENE KOONS RUSSELL;;ELIAS ROSENBERGER FREDERICK,,https://lens.org/089-573-622-871-271,Patent Application,no,0,0,6,6,0,C07C4/16;;C07C4/16;;C10G47/22;;C10G47/22,C07C4/16,,0,0,,,,DISCONTINUED
374,US,A,US 4814606 A,065-366-713-670-720,1989-03-21,1989,US 16000288 A,1988-02-24,US 16000288 A;;US 3452787 A;;US 79853985 A,1985-11-15,Photodetector assembly for a laser scanning apparatus,"A laser scanning apparatus is characterized by a curved film-receiving field with a conforming photodetector assembly. In one embodiment, the photodetector assembly comprises a plurality of semiconductor elements. In other embodiments, the photodetector assembly includes a photodetector device mounted in light transmissive engagement with a transparent block for receiving light passed through a radiographic film.",DU PONT,LEE JERALD D;;ELIAS JOHN G;;ROCKNEY BENNETT H;;WOLF WILLIAM E,E. I. DU PONT DE NEMOURS AND CO (1988-02-03),https://lens.org/065-366-713-670-720,Granted Patent,yes,17,5,1,14,0,H04N1/028;;H04N1/0281;;H04N1/0313;;H04N1/0635;;H04N1/0657;;H04N1/0664;;H04N2201/0404;;H04N1/0635;;H04N1/0281;;H04N2201/0404;;H04N1/0657;;H04N1/0664;;H04N1/028;;H04N1/0313,H04N1/028;;H04N1/031;;H04N1/06,250/235;;358/292,0,0,,,,EXPIRED
375,EP,A3,EP 0285122 A3,094-676-647-836-387,1991-02-20,1991,EP 88105158 A,1988-03-30,US 3452787 A,1987-04-03,PHOTODETECTOR ASSEMBLY FOR A LASER SCANNING APPARATUS,"A laser scanning apparatus is characterized by a curved film-receiving field with a conforming photodetector assembly. In one embodiment, the photodetector assembly comprises a plurality of semiconductor elements. In other embodiments, the photodetector assembly includes a photodetector device mounted in light transmissive engagement with a transparent block for receiving light passed through a radiographic film.  ",E.I. DU PONT DE NEMOURS AND COMPANY,"LEE, JERALD DANA;;ELIAS, JOHN GREER;;WOLF, WILLIAM EDWARD;;ROCKNEY, BENNETT HANSON",,https://lens.org/094-676-647-836-387,Search Report,yes,3,0,5,14,0,H04N1/0635;;H04N1/028;;H04N1/0281;;H04N1/0657;;H04N1/0664,G03B42/02;;G02B26/10;;H04N1/028;;H04N1/06;;H04N1/113,,0,0,,,,DISCONTINUED
376,US,A1,US 2015/0072388 A1,117-748-536-412-920,2015-03-12,2015,US 201414479292 A,2014-09-06,US 201414479292 A;;US 201361874752 P,2013-09-06,"CONVERSION OF GLYCEROL TO 1,3-PROPANEDIOL UNDER HALOALKALINE CONDITIONS","A method of producing 1,3-propanediol. The method comprises fermenting a haloalkaliphilic species of Halanaerobium with a source of glycerol into 1,3-propanediol, at a pH of greater than about 10 and at a salt concentration of greater than about 5% w/v. Furthermore, with supplementation of vitamin B 12 , the yield of 1,3-propanediol to glycerol can be increased.",UNIV MISSOURI,MORMILE MELANIE ROSE;;ROUSH DANIEL WILLIAM;;ELIAS DWAYNE ALEXANDER;;SITTON OLIVER CLIFFORD,THE CURATORS OF THE UNIVERSITY OF MISSOURI (2014-08-26),https://lens.org/117-748-536-412-920,Patent Application,yes,3,0,6,6,7,C12P7/18;;C12P7/18,C12P7/18,435/158,8,4,096-204-451-285-429;;043-837-246-425-581;;007-790-772-896-93X;;060-302-283-024-934,12013433;;10.1007/s007920100229;;16267554;;10.1038/nature04056;;10.4319/lo.1972.17.2.0315;;10.1016/j.biortech.2010.06.066;;20615687,"Kivisto et al., Journal of Biotechnology 158:242-247, available online 11/6/2011;;Brown et al., Genbank accession number CP002304, 2011;;The 2012 ATCC catalog;;Van Gerpen, J., Improvement of Crop Plants for Industrial End Uses, Chapter 10, pages 281-289, P. Ranalli Editor, 2007;;Cayol et al., Extremophiles 6:131-134, 2002;;Croft et al., Nature 438:90-93, 2005;;Ohwada et al., Limnology and Oceanography 17(2):315-320, 1972;;Kivisto et al., Bioresource Technology 101:8671-8677, 2010",INACTIVE
377,US,B2,US 10850080 B2,140-883-511-214-974,2020-12-01,2020,US 201715708404 A,2017-09-19,US 201715708404 A,2017-09-19,"Electronic toolset to locate, read, adjust, and confirm adjustment in an implantable bodily fluid drainage system without recalibrating following adjustment","A method of using an electronic toolset for locating, reading, adjusting and confirming adjustment of an implantable bodily fluid drainage system without requiring recalibration following adjustment from a current valve setting to a new valve setting using an electronic toolset including an adjustment tool having a magnetic element and an indicator tool including a sensor array. The need to remove the electronic toolset from the patient to recalibrate or zero the sensor array prior to confirming the new valve setting is eliminated. This is realized by disposing a ferromagnetic system component of the indicator tool in a magnet shield cage made of a metallic alloy to prevent magnetic fields produced by a magnetic element in the adjustment tool during the adjusting step from influencing the sensor array.",INTEGRA LIFESCIENCES SWITZERLAND SARL,BODEN JR THOMAS;;D'AOUST PATRICIA;;ARAZAWA ALEXANDER;;ELIAS ADAM;;WARD WILLIAM JACOB,INTEGRA LIFESCIENCES SWITZERLAND SARL (2017-10-02);;DEPUY SYNTHES PRODUCTS INC (2017-09-20),https://lens.org/140-883-511-214-974,Granted Patent,yes,98,0,4,4,0,G01R33/0076;;A61M27/006;;G01R35/005;;A61M27/006;;A61M2205/3515;;A61M2205/3317;;A61M2205/50;;A61M2205/583;;A61M2205/70;;A61M2205/103;;A61M2205/3331;;A61M2205/6054;;G01R33/0076;;G01R35/005,A61M27/00;;G01R33/00;;G01R35/00,,3,0,,,"Copending, co-owned U.S. Appl. No. 15/708,496, filed Sep. 19, 2017.;;Copending, co-owned U.S. Appl. No. 15/708,549, filed Sep. 19, 2017.;;Copending, co-owned U.S. Appl. No. 15/708,600, filed Sep. 19, 2017.",ACTIVE
378,EP,A2,EP 0285122 A2,189-570-268-571-410,1988-10-05,1988,EP 88105158 A,1988-03-30,US 3452787 A,1987-04-03,Photodetector assembly for a laser scanning apparatus.,"A laser scanning apparatus is characterized by a curved film-receiving field with a conforming photodetector assembly. In one embodiment, the photodetector assembly comprises a plurality of semiconductor elements. In other embodiments, the photodetector assembly includes a photodetector device mounted in light transmissive engagement with a transparent block for receiving light passed through a radiographic film.  ",DU PONT,LEE JERALD DANA;;ELIAS JOHN GREER;;WOLF WILLIAM EDWARD;;ROCKNEY BENNETT HANSON,,https://lens.org/189-570-268-571-410,Patent Application,yes,0,1,5,14,0,H04N1/0635;;H04N1/028;;H04N1/0281;;H04N1/0657;;H04N1/0664,G03B42/02;;G02B26/10;;H04N1/028;;H04N1/06;;H04N1/113,,0,0,,,,DISCONTINUED
379,EP,A1,EP 1722692 A1,008-213-452-407-021,2006-11-22,2006,EP 05724126 A,2005-03-02,US 2005/0006519 W;;US 54931704 P,2004-03-02,COMPACT MULTI-USE LANCING DEVICE,,FACET TECHNOLOGIES LLC,KOEPPEL BRADLEY;;CONWAY WILLIAM ELIAS;;VANHIEL BRIAN;;GRIFFIS JACK;;BUENGER DAVID R,,https://lens.org/008-213-452-407-021,Patent Application,yes,0,0,12,12,0,A61B5/15194;;A61B5/15194;;A61B5/150022;;A61B5/150022;;A61B5/150412;;A61B5/150412;;A61B5/150442;;A61B5/150442;;A61B5/150541;;A61B5/150541;;A61B5/150618;;A61B5/150618;;A61B5/150717;;A61B5/150717;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15186;;A61B5/15186;;A61B5/1519;;A61B5/1519,A61B5/151;;A61B5/15;;A61B17/14,,0,0,,,,ACTIVE
380,CN,A,CN 105531373 A,016-083-805-312-78X,2016-04-27,2016,CN 201480049297 A,2014-09-06,US 2014/0054434 W;;US 201361874752 P,2013-09-06,"Conversion of glycerol to 1,3-propanediol under haloalkaline conditions","A method of producing 1,3-propanediol. The method comprises fermenting a haloalkaliphilic species of Halanaerobium with a source of glycerol into 1,3-propanediol, at a pH of greater than about 10 and at a salt concentration of greater than about 5% w/v. Furthermore, with supplementation of vitamin B12, the yield of 1,3-propanediol to glycerol can be increased.",UNIV MISSOURI,MORMILE MELANIE ROSE;;ROUSH DANIEL WILLIAM;;ELIAS DWAYNE ALEXANDER;;SITTON OLIVER CLIFFORD,,https://lens.org/016-083-805-312-78X,Patent Application,no,4,0,6,6,0,C12P7/18;;C12P7/18,C12P7/18;;C12N1/21,,2,2,049-131-666-602-111;;082-357-498-675-837,10.1016/j.ijhydene.2013.06.119;;10.3389/fmicb.2012.00093;;pmc3325762;;22509174,"ANNIINA KIVISTO ET AL.: ""Non-sterile process for biohydrogen and 1,3-propanediol production from raw glycerol."", 《INTERNATIONAL JOURNAL OF HYDROGEN ENERGY》;;MATTHEW B.BEGEMANN ET AL.: ""A streamlined strategy for biohydrogen production with Halanaerobium hydrogeniformans，an alkaliphilic bacterium."", 《FRONTIERS IN MICROBIOLOGY》",DISCONTINUED
381,KR,A,KR 20240007280 A,085-984-371-037-397,2024-01-16,2024,KR 20237043175 A,2022-05-06,US 202163188155 P;;US 2022/0028049 W,2021-05-13,유리 리본을 제조하는 방법 및 장치,"유리 제조 장치는 유리 리본을 형성하는 성형 장치를 포함한다. 인클로저는 성형 장치로부터 하류에 위치하며, 제1 챔버, 입구 개구를 형성하는 제1 단부, 및 출구 개구를 형성하는 제2 단부를 포함한다. 인클로저의 제1 인클로저 벽은 상기 제1 챔버로부터 인클로저의 외부로의 가스 이동 경로를 정의하는 인클로저 벽 개구를 포함한다. 리본 이동 경로가 제1 챔버를 통해 연장된다. 제1 도관은 인클로저의 제1 측면을 따라 연장되며, 제2 챔버를 포함한다. 가스 개구는 제1 챔버와 제2 챔버 사이에 유체 연통을 제공한다. 제1 가스 소스는 상기 제2 챔버와 유체 연통한다. 제1 가스 소스는 제2 챔버를 통해 제1 챔버로 제1 가스를 전달한다. 유리 리본을 제조하는 방법들이 제공된다.",CORNING INC,BROWN JAMES WILLIAM;;GAO FENG;;HILL KEITH MITCHELL;;PANIDES ELIAS;;ZHOU NAIYUE,,https://lens.org/085-984-371-037-397,Patent Application,no,0,0,4,4,0,C03B35/16;;C03B35/14;;C03B17/064;;C03B35/246,C03B35/24;;C03B17/06;;C03B35/16,,0,0,,,,PENDING
382,AU,A1,AU 2015/312420 A1,088-380-802-530-936,2016-12-22,2016,AU 2015/312420 A,2015-06-26,US 201414542150 A;;US 201462045112 P;;US 201462060234 P;;US 2015/0037993 W,2014-09-03,Cryocooler containing additively-manufactured heat exchanger,"An apparatus includes a heat exchanger (112, 212) configured to transfer heat to a fluid and to absorb heat from the fluid as the fluid flows between a warm end (106) and a cold end (108) of a cryocooler (100). The heat exchanger includes at least one section (118, 218) having a substrate (302) of at least one allotropic form of carbon and a layer (304) of nanoparticles on or over the substrate. The heat exchanger could include multiple sections (118, 218), and each section could include one of multiple substrates (302) and one of multiple layers (304) of nanoparticles. The heat exchanger can further include pores (602) through the multiple sections of the heat exchanger, where the pores are configured to allow the fluid to flow through the heat exchanger and to contact the substrates and the layers of nanoparticles. The nanoparticles could include at least one lanthanide element or alloy, and the substrate could include carbon nanotubes (402) or graphene (500).",RAYTHEON CO,CONRAD THEODORE J;;CHOW JAMES R;;ARMIENTO CRAIG A;;ELIAS WILLIAM E,,https://lens.org/088-380-802-530-936,Patent Application,no,0,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,F25B9/00;;B22F1/054;;B22F9/24;;B41J2/01;;C09D11/52;;F25B9/14;;F28D21/00;;F28F13/18;;F28F19/02,,0,0,,,,ACTIVE
383,EP,B1,EP 1722692 B1,021-509-627-037-581,2017-08-23,2017,EP 05724126 A,2005-03-02,US 2005/0006519 W;;US 54931704 P,2004-03-02,COMPACT MULTI-USE LANCING DEVICE,,FACET TECH LLC,KOEPPEL BRADLEY;;CONWAY WILLIAM ELIAS;;VANHIEL BRIAN;;GRIFFIS JACK;;BUENGER DAVID R,,https://lens.org/021-509-627-037-581,Granted Patent,yes,8,0,12,12,0,A61B5/15186;;A61B5/150022;;A61B5/150412;;A61B5/150442;;A61B5/150541;;A61B5/150618;;A61B5/150717;;A61B5/15113;;A61B5/15117;;A61B5/1513;;A61B5/1519;;A61B5/15194;;A61B5/15194;;A61B5/15186;;A61B5/1519;;A61B5/150412;;A61B5/1513;;A61B5/150618;;A61B5/150541;;A61B5/150442;;A61B5/15113;;A61B5/150022;;A61B5/15117;;A61B5/150717,A61B5/151;;A61B5/15;;A61B17/14,,0,0,,,,ACTIVE
384,FR,A,FR 405449 A,053-024-634-517-626,1909-12-30,1909,FR 405449D A,1909-07-22,FR 405449T A,1909-07-22,Perfectionnements apportés aux machines à vapeur à deux cylindres,,ELIAS WILSON CONKELL;;JACOB JOHN HEIN;;WILLIAM ANTON HAMMERLY;;JAMES BUTZ WEIDA,CONKELL ELIAS WILSON;;HEIN JACOB JOHN;;HAMMERLY WILLIAM ANTON;;WEIDA JAMES BUTZ,,https://lens.org/053-024-634-517-626,Granted Patent,no,0,0,1,1,0,F01B17/04;;F01B2170/0423,F01B17/04,"V, 2",0,0,,,,EXPIRED
385,EP,A4,EP 1722692 A4,062-228-437-184-472,2010-01-27,2010,EP 05724126 A,2005-03-02,US 2005/0006519 W;;US 54931704 P,2004-03-02,COMPACT MULTI-USE LANCING DEVICE,,FACET TECHNOLOGIES LLC,KOEPPEL BRADLEY;;CONWAY WILLIAM ELIAS;;VANHIEL BRIAN;;GRIFFIS JACK;;BUENGER DAVID R,,https://lens.org/062-228-437-184-472,Search Report,no,5,0,12,12,0,A61B5/15186;;A61B5/150022;;A61B5/150412;;A61B5/150442;;A61B5/150541;;A61B5/150618;;A61B5/150717;;A61B5/15113;;A61B5/15117;;A61B5/1513;;A61B5/1519;;A61B5/15194;;A61B5/15194;;A61B5/15186;;A61B5/1519;;A61B5/150412;;A61B5/1513;;A61B5/150618;;A61B5/150541;;A61B5/150442;;A61B5/15113;;A61B5/150022;;A61B5/15117;;A61B5/150717,A61B17/14;;A61B5/15,,1,0,,,See also references of WO 2005084557A1,ACTIVE
386,US,A,US 5007708 A,090-851-806-129-576,1991-04-16,1991,US 22457188 A,1988-07-26,US 22457188 A,1988-07-26,"Technique for producing antireflection grating surfaces on dielectrics, semiconductors, and metals","A method of forming an antireflection rectangular-groove surface-relief grating on a lossy substrate exposed to incident waves of transverse electric or transverse magnetic or combination of polarizations and any angle of incidence in a lossless medium. The required thickness and complex refractive index of a single homogeneous layer on a lossy substrate to produce zero reflectivity is first computed using an impedance matching approach. The filling factor and groove depth of the rectangular groove surface-relief grating that is equivalent to the single homogeneous layer in the long-wavelength limit are then calculated. The surface-relief grating is then formed on the lossy substrate by reactive ion etching, electron beam lithography, or holography.",GEORGIA TECH RES INST,GAYLORD THOMAS K;;GLYTSIS ELIAS N;;MOHARAM M GAMAL;;BAIRD WILLIAM E,GEORGIA TECH RESEARCH CORPORATION (1988-08-15),https://lens.org/090-851-806-129-576,Granted Patent,yes,7,90,1,1,0,G02B1/118;;G02B5/1809;;G02B6/124;;G03F7/001;;Y10S359/90;;G02B1/118;;G02B5/1809;;G02B6/124;;G03F7/001;;Y10S359/90,G02B5/18;;G02B6/124;;G03F7/00,G2J JB7Q          JB7Q,0,0,,,,EXPIRED
387,DE,T2,DE 69109646 T2,191-957-644-316-586,1996-01-25,1996,DE 69109646 T,1991-12-03,US 63130890 A;;US 63130690 A;;US 74267191 A;;US 74267291 A,1990-12-21,Eingekapselte Aluminiumzusammensetzungen.,,DOW CORNING,CONWAY LORI JEAN;;SMITH JANET MARY;;KATSOULIS DIMITRIS ELIAS;;SCHULZ WILLIAM JAMES,,https://lens.org/191-957-644-316-586,Granted Patent,no,0,0,5,9,0,A61K8/28;;A61K8/11;;A61K8/26;;A61K2800/412;;A61Q15/00,A61K8/26;;A61K8/11;;A61K8/20;;A61K8/28;;A61K8/36;;A61K8/37;;A61Q15/00,,0,0,,,,EXPIRED
388,US,A9,US 2018/0180329 A9,038-265-470-074-171,2018-06-28,2018,US 201715423961 A,2017-02-03,US 201715423961 A;;US 2015/0037993 W;;US 201462045112 P;;US 201462060234 P;;US 201414542150 A,2014-09-03,CRYOCOOLER CONTAINING ADDITIVELY-MANUFACTURED HEAT EXCHANGER,"An apparatus includes a heat exchanger configured to transfer heat to a fluid and to absorb heat from the fluid as the fluid flows between a warm end and a cold end of a cryocooler. The heat exchanger includes at least one section having a substrate of at least one allotropic form of carbon and a layer of nanoparticles on or over the substrate. The heat exchanger could include multiple sections, and each section could include one of multiple substrates and one of multiple layers of nanoparticles. The heat exchanger can further include pores through the multiple sections of the heat exchanger, where the pores are configured to allow the fluid to flow through the heat exchanger and to contact the substrates and the layers of nanoparticles. The nanoparticles could include at least one lanthanide element or alloy, and the substrate could include carbon nanotubes or graphene.",RAYTHEON CO,CONRAD THEODORE J;;CHOW JAMES R;;ARMIENTO CRAIG A;;ELIAS WILLIAM E,RAYTHEON COMPANY (2016-12-07),https://lens.org/038-265-470-074-171,Amended Application,yes,0,0,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,F25B9/14;;B22F1/054;;B22F9/24;;B33Y10/00;;B33Y80/00;;B41J2/01;;F28F13/18;;F28F21/02,,0,0,,,,ACTIVE
389,US,A,US 5391460 A,131-749-651-917-416,1995-02-21,1995,US 8954493 A,1993-07-12,US 8954493 A,1993-07-12,Resin composition and process for investment casting using stereolithography,"A resin composition for investment casting contains a moderate boiling temperature liquid inert diluent, having a boiling point in the range of about 200.degree. to 300.degree. C. The presence of the liquid inert diluent allows the resin to be used as a pattern, or model, in investment casting by preventing breaking of the mold during burnout of the resin. Any of the conventional resins suitable for stereolithography may be employed in the practice of the invention. To the resin is added a moderate boiling point solvent in the amount of about 5 to 30 wt %. Use of the moderate boiling point solvent in conjunction with the resin allows the pattern to shrink and crack at moderate temperature before final burnout. The shrinkage occurs faster and at a lower temperature as compared to the prior art.",HUGHES AIRCRAFT CO,DOUGHERTY THOMAS K;;ELIAS WILLIAM E;;THELANDER TIMOTHY C;;BHAVNANI MAHESH N,HUGHES AIRCRAFT COMPANY (1993-07-07);;OL SECURITY LIMITED LIABILITY COMPANY (2012-07-30);;HE HOLDINGS INC. A DELAWARE CORP (1997-12-17);;RAYTHEON COMPANY (1997-12-17),https://lens.org/131-749-651-917-416,Granted Patent,yes,4,25,1,1,0,B22C1/08;;G03F7/0037;;G03F7/0048;;B33Y10/00;;B33Y70/00;;B33Y10/00;;B33Y70/00;;B22C1/08;;G03F7/0037;;G03F7/0048,B22C1/08;;G03F7/00;;G03F7/004,430/269;;522/79;;164/526;;164/527,1,0,,,"Payne, Organic Coating Technology , vol. 1, John Wiley & Sons, Inc., New York, 1954, pp. 256, 257.",EXPIRED
390,DE,A1,DE 102015104392 A1,146-988-137-482-053,2015-10-08,2015,DE 102015104392 A,2015-03-24,US 201414245925 A,2014-04-04,Verfahren und System zur Kontrolle der Fahrzeugbatterieumgebung,"Verfahren und System zum Steuern von Bedingungen innerhalb eines Einschlusses, der eine Fahrzeugantriebsenergiequelle aufnimmt, sind beschrieben. Bei einem Beispiel können Fahrzeugfenster, Belüftungsschlitze und Verdunkelungen betätigt werden, um eine Energiemenge zu verringern, die verwendet wird, um Bedingungen innerhalb eines Einschlusses, der eine Fahrzeugantriebsquelle aufnimmt, aufrecht zu erhalten. Die Systeme und Verfahren können mindestens in elektrische und Hybridfahrzeuge eingebaut werden.",FORD GLOBAL TECH LLC,MALONE MARK DOUGLAS;;MANSUR WILLIAM NAJIB;;ROBERTS DAN PAUL;;SAVAYA BONNIE ELIAS,,https://lens.org/146-988-137-482-053,Patent Application,no,0,1,3,3,0,B60H1/004;;B60L58/26;;B60H1/004;;B60H1/0075;;B60H1/0075;;B60J1/00;;B60J7/02;;B60J7/0573;;B60J7/0573;;B60K1/04;;B60L58/26;;E05F15/695;;E05F15/695;;E05F15/71;;E05F15/71;;Y02T10/70,H01M10/625,,0,0,,,,DISCONTINUED
391,US,A1,US 2017/0146267 A1,165-812-162-821-184,2017-05-25,2017,US 201715423961 A,2017-02-03,US 201715423961 A;;US 2015/0037993 W;;US 201462045112 P;;US 201462060234 P;;US 201414542150 A,2014-09-03,CRYOCOOLER CONTAINING ADDITIVELY-MANUFACTURED HEAT EXCHANGER,"An apparatus includes a heat exchanger configured to transfer heat to a fluid and to absorb heat from the fluid as the fluid flows between a warm end and a cold end of a cryocooler. The heat exchanger includes at least one section having a substrate of at least one allotropic form of carbon and a layer of nanoparticles on or over the substrate. The heat exchanger could include multiple sections, and each section could include one of multiple substrates and one of multiple layers of nanoparticles. The heat exchanger can further include pores through the multiple sections of the heat exchanger, where the pores are configured to allow the fluid to flow through the heat exchanger and to contact the substrates and the layers of nanoparticles. The nanoparticles could include at least one lanthanide element or alloy, and the substrate could include carbon nanotubes or graphene.",RAYTHEON CO,CONRAD THEODORE J;;CHOW JAMES R;;AMIENTO CRAIG A;;ELIAS WILLIAM E,,https://lens.org/165-812-162-821-184,Patent Application,yes,5,5,23,23,0,F25B9/00;;F25B2309/1412;;F25B2309/1415;;B22F2999/00;;F28F13/185;;F28F21/02;;F28F2255/20;;C09D11/037;;C09D11/322;;F28F2245/00;;C09D11/52;;F28F13/18;;F28F19/02;;B22F2202/11;;F28D2021/0033;;B22F9/24;;F25B9/145;;B22F1/054;;B01J19/123;;B22F9/24;;B22F2202/11;;B22F2999/00;;B41J2/01;;C09D11/037;;C09D11/322;;F25B9/00;;F25B9/145;;F25B2309/1412;;F25B2309/1415;;F28F13/185;;F28F21/02;;F28F2255/20;;B22F1/054;;B22F9/24;;B01J19/123;;F28F13/185;;F28F21/02;;F28F2255/20;;F25B2309/1415;;B22F2202/11;;B22F2999/00;;C09D11/037;;C09D11/322;;C09D11/52;;F25B9/00;;F25B2309/1412;;F28D2021/0033;;F28F13/18;;F28F19/02;;F28F2245/00;;B22F1/054;;B41J2/01;;F25B9/145;;B33Y10/00;;B33Y80/00,F25B9/14;;B22F1/054;;B22F9/24;;B33Y10/00;;B33Y80/00;;B41J2/01;;F28F13/18;;F28F21/02,,0,0,,,,ACTIVE
392,EP,B1,EP 0314778 B1,137-396-028-143-057,1991-06-19,1991,EP 88906239 A,1988-03-18,US 4601387 A,1987-05-05,SUBSTITUTED AROMATIC SILANE COMPOUNDS AND METHOD FOR PREPARATION OF SAME,,HUGHES AIRCRAFT COMPANY,"LAU, KREISLER, S., Y.;;OLDHAM, SUSAN, L.;;ELIAS, WILLIAM, E.;;BIGUS, STEPHEN, J.",,https://lens.org/137-396-028-143-057,Granted Patent,yes,1,0,7,12,0,C07F7/0812;;C08F30/08;;C08G59/306;;C07F7/081;;C08F30/08;;C07F7/0812;;C08G59/306;;C07F7/081,C07F7/08;;C08F30/08;;C08G59/30,,0,0,,,,EXPIRED
393,WO,A1,WO 2016/172065 A1,015-213-198-682-397,2016-10-27,2016,US 2016/0028208 W,2016-04-19,US 201562151006 P,2015-04-22,GLASS MANUFACTURING APPARATUS FACILITATING SEPARATION OF A GLASS RIBBON,"A glass manufacturing apparatus may be configured to facilitate a process of separating a glass ribbon along a separation path extending across a width of the glass ribbon. In one example, the glass manufacturing apparatus comprises at least one anvil-side vacuum port defined by an elongated nose and an elongated anvil member. The anvil-side vacuum port is configured to remove glass debris during the process of separating the glass ribbon. In another example, the glass manufacturing apparatus comprises a scoring device and a score-side vacuum port configured to remove glass debris generated during the process of separating the glass ribbon.",CORNING INC,BROWN JAMES WILLIAM;;LUO WEIWEI;;PANIDES ELIAS;;QI LING;;ZHMAYEV EDWARD;;ZHOU NAIYUE,,https://lens.org/015-213-198-682-397,Patent Application,yes,5,4,12,12,0,C03B33/0215;;C03B33/033;;C03B33/0215;;B65G2249/045;;C03B33/033;;B65G49/063;;C03B33/0215;;B65G2249/045;;Y02P40/57;;B65G2249/045;;C03B33/0215;;C03B33/033;;C03B17/067;;C03B33/03,C03B33/02;;C03B33/03;;C03B33/037;;C03B35/20,,0,0,,,,PENDING
394,DE,A1,DE 4028947 A1,054-589-915-098-362,1991-03-28,1991,DE 4028947 A,1990-09-12,US 40751589 A,1989-09-15,NUKLEARREAKTOR,,BABCOCK & WILCOX CO,BINGHAM BILLY ELIAS;;COINER JUN JOHN ROBSON;;PETTUS WILLIAM GOWER;;SHORT BARRETT JOHN,,https://lens.org/054-589-915-098-362,Patent Application,no,2,1,9,9,0,G21C1/10;;G21C1/10;;G21C15/02;;G21C15/02;;Y02E30/30;;Y02E30/30,G21C1/00;;G21C1/10;;G21C15/02,,0,0,,,,EXPIRED
395,KR,A,KR 20170139616 A,187-631-716-637-238,2017-12-19,2017,KR 20177033707 A,2016-04-19,US 201562151006 P;;US 2016/0028208 W,2015-04-22,유리 리본의 분리를 용이하게 하는 유리 제조 기기,"유리 제조 기기는 유리 리본의 폭을 가로질러 연장된 분리 경로를 따라 유리 리본을 분리하는 공정을 용이하게 하도록 구성될 수 있다. 하나의 예시에서, 유리 제조 기기는 세장형 노즈 및 세장형 앤빌 부재에 의해 형성된 적어도 하나의 앤빌-측 진공 포트를 포함한다. 앤빌-측 진공 포트는 유리 리본을 분리하는 공정 중 유리 파편을 제거하도록 구성된다. 다른 예시에서, 유리 제조 기기는 유리 리본을 분리하는 공정 중 발생된 유리 파편을 제거하도록 구성된 스코어링 장치와 스코어-측 진공 포트를 포함한다.",CORNING INC,BROWN JAMES WILLIAM;;LUO WEIWEI;;PANIDES ELIAS;;QI LING;;ZHMAYEV EDWARD;;ZHOU NAIYUE,,https://lens.org/187-631-716-637-238,Patent Application,no,7,0,12,12,0,C03B33/0215;;C03B33/033;;C03B33/0215;;B65G2249/045;;C03B33/033;;B65G49/063;;C03B33/0215;;B65G2249/045;;Y02P40/57;;B65G2249/045;;C03B33/0215;;C03B33/033;;C03B17/067;;C03B33/03,C03B33/02;;B65G49/06,,0,0,,,,ACTIVE
396,EP,A3,EP 0626529 A3,022-582-772-340-138,1996-08-14,1996,EP 94302940 A,1994-04-25,US 6684793 A,1993-05-25,Automotive transmission.,"An automatic transmission mechanism having multiple ratio gearing and clutch and brake elements operated by fluid pressure operated servos for changing speed ratio in the transmission and a controller for actuating and releasing the clutches and brakes in response to operating demands determined by sensed variables such as vehicle speed, engine torque, manual valve position, transmission turbine speed, and engine temperature, and means for achieving improved control of a synchronous downshift event by electronically regulating the exhaust pressure from an off-going friction element of the clutch and brake structure, thus controlling the torque-carrying capacity of that off-going element during the downshift interval.",FORD MOTOR CO;;FORD WERKE AG;;FORD FRANCE,EL-KHOURY JOSEPH ELIAS;;TIMTE FRANK WILLIAM;;KUCHTA GERARD PATRICK;;LEAGUE EDMOND RICHARD,,https://lens.org/022-582-772-340-138,Search Report,yes,4,0,6,6,0,F16H59/14;;F16H59/44;;F16H59/78;;F16H61/061;;F16H2059/385;;F16H2061/0444;;F16H61/061;;F16H2059/385;;F16H59/44;;F16H2061/0444;;F16H59/14;;F16H59/78,F16H59/14;;F16H59/38;;F16H59/44;;F16H59/78;;F16H61/04;;F16H61/06;;F16H61/08,,0,0,,,,EXPIRED
397,DE,C2,DE 4028947 C2,063-655-599-086-990,1995-02-09,1995,DE 4028947 A,1990-09-12,US 40751589 A,1989-09-15,Nuklearreaktor,,BABCOCK & WILCOX CO,BINGHAM BILLY ELIAS;;COINER JUN JOHN ROBSON;;PETTUS WILLIAM GOWER;;SHORT BARRETT JOHN,,https://lens.org/063-655-599-086-990,Granted Patent,no,0,0,9,9,0,G21C1/10;;G21C1/10;;G21C15/02;;G21C15/02;;Y02E30/30;;Y02E30/30,G21C1/00;;G21C1/10;;G21C15/02,,0,0,,,,EXPIRED
398,EP,B1,EP 0492827 B1,067-799-448-273-877,1995-05-10,1995,EP 91311213 A,1991-12-03,US 63130690 A;;US 63130890 A;;US 74267191 A;;US 74267291 A,1990-12-21,Encapsulated aluminum compositions.,,DOW CORNING,CONWAY LORI JEAN;;SMITH JANET MARY;;KATSOULIS DIMITRIS ELIAS;;SCHULZ WILLIAM JAMES JR,,https://lens.org/067-799-448-273-877,Granted Patent,yes,4,0,5,9,0,A61K8/28;;A61K8/11;;A61K8/26;;A61K2800/412;;A61Q15/00,A61K8/26;;A61K8/11;;A61K8/20;;A61K8/28;;A61K8/36;;A61K8/37;;A61Q15/00,,0,0,,,,EXPIRED
399,TW,A,TW 201722568 A,128-184-386-308-818,2017-07-01,2017,TW 105126581 A,2016-08-19,US 201562208317 P;;US 201662279194 P;;US 201662346175 P,2015-08-21,Methods and apparatus for processing glass,"Methods and apparatus for processing a glass ribbon can include a glass former to draw a glass ribbon from a quantity of molten material in a draw direction along a draw plane of the glass former. In some embodiments, the apparatus can include a baffle with an inner surface facing the draw plane and an elongated gas port oriented to distribute an outer curtain of gas to pass over an outer surface of the baffle before passing over a downstream edge of the baffle. In some embodiments, the apparatus can include a gas dispenser including a gas outlet oriented to dispense a gas stream in the draw direction along the draw plane and a glass separator oriented to separate a glass sheet from the glass ribbon along a separation path transverse to the draw direction along a width of the glass ribbon.",CORNING INC,BROWN JAMES WILLIAM;;LUO WEI-WEI;;PANIDES ELIAS;;ZHANG JING-RU;;ZHOU NAIYUE,,https://lens.org/128-184-386-308-818,Patent of Addition,no,0,0,9,28,0,B08B3/022;;C03B33/0215;;C03B33/033;;C03B33/093;;C03B35/167;;C03B35/246;;C03B17/064;;C03B17/067;;B65G2249/04;;C03B17/064;;C03B5/182;;C03B18/20;;Y02P40/57,B08B3/02;;B05D1/00;;B08B3/04;;B23K26/062;;B23K26/064;;B32B17/10,,0,0,,,,ACTIVE
400,WO,A1,WO 1988/008846 A1,156-302-271-772-450,1988-11-17,1988,US 8800846 W,1988-03-18,US 4601387 A,1987-05-05,SUBSTITUTED AROMATIC SILANE COMPOUNDS AND METHOD FOR PREPARATION OF SAME,"A new group of silane compounds in which silicon atoms are linked together by a hydrocarbon chain and which comprise phenyl groups substituted with an epoxy group or an ethenyl group. The compounds of the present invention have formula (I), where R1 is selected from the group consisting of: (a) an aliphatic hydrocarbon group containing 2 to 10 carbon atoms, and (b) a group having formula (II), where n = 1 to 3; m = 0 to 5; R2 and R2', are each selected from the group consisting of an alkyl group containing 1 to 4 carbon atoms, an unsubstituted aryl group, and a substituted aryl group; and R3 is selected from the group consisting of formula (III) and formula (IV) where R4, R5, and R6 are each selected from the group consisting of H, an alkyl group containing 1 to 4 carbon atoms, and an aryl group; and n = 0 to 10.",HUGHES AIRCRAFT CO,LAU KREISLER S Y;;OLDHAM SUSAN L;;ELIAS WILLIAM E;;BIGUS STEPHEN J,,https://lens.org/156-302-271-772-450,Patent Application,yes,1,1,7,12,0,C07F7/0812;;C08F30/08;;C08G59/306;;C07F7/081;;C08F30/08;;C07F7/0812;;C08G59/306;;C07F7/081,C07F7/08;;C08F30/08;;C08G59/30,C2R RSGA          RSGA;;C2R RSGA          RSGBX;;C2R RSGA          RSPD;;C2R RSGA          RSPE;;C2R RSGBX         RSGA;;C2R RSGBX         RSGBX;;C2R RSGBX         RSPD;;C2R RSGBX         RSPE;;C2R RSPD          RSGA;;C2R RSPD          RSGBX;;C2R RSPD          RSPD;;C2R RSPD          RSPE;;C2R RSPE          RSGA;;C2R RSPE          RSGBX;;C2R RSPE          RSPD;;C2R RSPE          RSPE;;C2R RS201         RSGA;;C2R RS201         RSGBX;;C2R RS201         RSPD;;C2R RS201         RSPE;;C2R RS207         RSGA;;C2R RS207         RSGBX;;C2R RS207         RSPD;;C2R RS207         RSPE;;C2R RS210         RSGA;;C2R RS210         RSGBX;;C2R RS210         RSPD;;C2R RS210         RSPE;;C2R RS212         RSGA;;C2R RS212         RSGBX;;C2R RS212         RSPD;;C2R RS212         RSPE;;C2R RS219         RSGA;;C2R RS219         RSGBX;;C2R RS219         RSPD;;C2R RS219         RSPE;;C2R RS221         RSGA;;C2R RS221         RSGBX;;C2R RS221         RSPD;;C2R RS221         RSPE;;C2R RS322         RSGA;;C2R RS322         RSGBX;;C2R RS322         RSPD;;C2R RS322         RSPE;;C2R RS430         RSGA;;C2R RS430         RSGBX;;C2R RS430         RSPD;;C2R RS430         RSPE;;C2R RS440         RSGA;;C2R RS440         RSGBX;;C2R RS440         RSPD;;C2R RS440         RSPE,0,0,,,,PATENTED
401,US,A,US 5681547 A,093-343-727-525-384,1997-10-28,1997,US 74267291 A,1991-08-07,US 74267291 A;;US 63130690 A,1990-12-21,Encapsulated aluminum compositions,"Encapsulated aluminum salts are produced by combining and heating an aqueous aluminum salt selected from aluminum halohydrate, aluminum nitrohydrate and mixtures thereof; a hydrophobic liquid; and a carboxylate. The mixture is heated until substantially all of the free water has been removed. The encapsulated aluminum salts precipitate out after the removal of the water. The encapsulated aluminum salts are useful in deodorant and antiperspirant compositions.",DOW CORNING,CONWAY LORI JEAN;;KATSOULIS DIMITRIS ELIAS;;SCHULZ JR WILLIAM JAMES;;SMITH JANET MARY,DOW CORNING CORPORATION A CORPORATION OF MI (1991-08-01),https://lens.org/093-343-727-525-384,Granted Patent,yes,7,0,1,9,0,A61K8/11;;A61K8/26;;A61K8/28;;A61K2800/412;;A61Q15/00;;Y10S424/05;;A61Q15/00;;A61K8/11;;A61K8/26;;A61K2800/412;;A61K8/28,A61K8/11;;A61K8/26;;A61K8/28;;A61K9/12;;A61Q15/00,424/47;;424/65;;424/68;;424/401;;X424DIG  5,2,2,034-635-440-487-207;;021-137-538-456-00X,10.1021/ja00177a074;;10.1021/cen-v068n043.p028,"S. Cohen, et al; J. Am. Chem. Soc. 1990; Ionically Cross Linkable Polyphosphazene: A Novel Polymer for Microencapsulation; 112, pp. 7832 7833.;;R. Dagani; C&EN; Polyphosphazene Encapsulates Living Cells ; Oct. 22, 1990, p. 28.",EXPIRED
402,CA,C,CA 1310329 C,105-808-340-702-789,1992-11-17,1992,CA 564148 A,1988-04-14,US 4601387 A,1987-05-05,SUBSTITUTED AROMATIC SILANE COMPOUNDS AND METHOD FOR PREPARATION OF SAME,"SUBSTITUTED AROMATIC SILANE COMPOUNDS AND METHOD FOR PREPARATION OF SAME A new group of silane compounds in which silicon atoms are linked together by a hydrocarbon chain and which comprise phenyl groups substituted with an epoxy group or an ethenyl group. The compounds of the present invention have the formula <IMG> where R1 is selected from the group consisting of: (a) an aliphatic hydrocarbon group containing 2 to 10 carbon atoms, and (b) a group having the formula <IMG> where n = 1 to 3 m = 0 to 5; R2 and R2' are each selected from the group consisting of an alkyl group containing 1 to 4 carbon atoms, an unsubstituted aryl group, and a substituted aryl group; and R3 is selected from the group consisting of: and <IMG> where R4, R5, and R6 are each selected from the group consiting of H, an alkyl group containing 1 to 4 carbon atoms, and an aryl group; and n = 0 to 10. The compounds of the present invention are useful as encapsulants, primers, topcoats and adhesives.",HUGHES AIRCRAFT CO,LAU KREISLER S Y;;OLDHAM SUSAN L;;ELIAS WILLIAM E;;BIGUS STEPHEN J,,https://lens.org/105-808-340-702-789,Granted Patent,no,0,0,7,12,0,C07F7/0812;;C08F30/08;;C08G59/306;;C07F7/081;;C08F30/08;;C07F7/0812;;C08G59/306;;C07F7/081,C07F7/08;;C08F30/08;;C08G59/30,D12600369    M;;26004481   S;;26004489   S;;4020011    S,0,0,,,,EXPIRED
403,CN,A,CN 107787307 A,024-350-824-551-878,2018-03-09,2018,CN 201680036166 A,2016-04-19,US 201562151006 P;;US 2016/0028208 W,2015-04-22,Glass manufacturing apparatus facilitating separation of a glass ribbon,"A glass manufacturing apparatus may be configured to facilitate a process of separating a glass ribbon along a separation path extending across a width of the glass ribbon. In one example, the glass manufacturing apparatus comprises at least one anvil-side vacuum port defined by an elongated nose and an elongated anvil member. The anvil-side vacuum port is configured to remove glass debris duringthe process of separating the glass ribbon. In another example, the glass manufacturing apparatus comprises a scoring device and a score-side vacuum port configured to remove glass debris generated during the process of separating the glass ribbon.",CORNING INC,BROWN JAMES WILLIAM;;LUO WEIWEI;;PANIDES ELIAS;;QI LING;;ZHMAYEV EDWARD;;ZHOU NAIYUE,,https://lens.org/024-350-824-551-878,Patent Application,no,6,0,12,12,0,C03B33/0215;;C03B33/033;;C03B33/0215;;B65G2249/045;;C03B33/033;;B65G49/063;;C03B33/0215;;B65G2249/045;;Y02P40/57;;B65G2249/045;;C03B33/0215;;C03B33/033;;C03B17/067;;C03B33/03,C03B33/02;;C03B33/033,,0,0,,,,ACTIVE
404,EP,A2,EP 0626529 A2,065-780-285-556-537,1994-11-30,1994,EP 94302940 A,1994-04-25,US 6684793 A,1993-05-25,Automotive transmission.,"An automatic transmission mechanism having multiple ratio gearing and clutch and brake elements operated by fluid pressure operated servos for changing speed ratio in the transmission and a controller for actuating and releasing the clutches and brakes in response to operating demands determined by sensed variables such as vehicle speed, engine torque, manual valve position, transmission turbine speed, and engine temperature, and means for achieving improved control of a synchronous downshift event by electronically regulating the exhaust pressure from an off-going friction element of the clutch and brake structure, thus controlling the torque-carrying capacity of that off-going element during the downshift interval.",FORD MOTOR CO;;FORD WERKE AG;;FORD FRANCE,EL-KHOURY JOSEPH ELIAS;;TIMTE FRANK WILLIAM;;KUCHTA GERARD PATRICK;;LEAGUE EDMOND RICHARD,,https://lens.org/065-780-285-556-537,Patent Application,yes,0,8,6,6,0,F16H59/14;;F16H59/44;;F16H59/78;;F16H61/061;;F16H2059/385;;F16H2061/0444;;F16H61/061;;F16H2059/385;;F16H59/44;;F16H2061/0444;;F16H59/14;;F16H59/78,F16H59/14;;F16H59/38;;F16H59/44;;F16H59/78;;F16H61/04;;F16H61/06;;F16H61/08,,0,0,,,,EXPIRED
405,FR,A1,FR 2652190 A1,071-928-982-809-216,1991-03-22,1991,FR 9011209 A,1990-09-11,US 40751589 A,1989-09-15,PERFECTIONNEMENTS APPORTES AUX REACTEURS NUCLEAIRES.,"<P>Réacteur nucléaire (10) utilisant un gaz en tant que refrigérant primaire et un liquide en tant que modérateur et/ou réflecteur. Le réfrigérant gazeux s'écoule à travers des passages d'admission autour de la chambre de sortie (14) vers une plaque de distributeur. Le gaz est dirigé entre des gaines (36) d'élément de combustible et les éléments de combustible (18) à l'intérieur, à travers les éléments de combustible, et dans la chambre de sortie du réacteur. Des ailettes sur les gaines transfèrent la chaleur au gaz depuis un modérateur liquide circulant dans le cœur. L'utilisation d'un modérateur liquide accroît la sécurité, permet de réduire la quantité de matière fissile et la masse du réacteur et élimine les problèmes associés à un refroidissement d'un modérateur solide.</P>",BABCOCK & WILCOX CO,ELIAS BINGHAM BILLY;;ROBSON COINER JR JOHN;;GOWER PETTUS WILLIAM;;JOHN SHORT BARRETT,,https://lens.org/071-928-982-809-216,Patent Application,no,8,0,9,9,0,G21C1/10;;G21C1/10;;G21C15/02;;G21C15/02;;Y02E30/30;;Y02E30/30,G21C1/00;;G21C1/10;;G21C15/02,,0,0,,,,EXPIRED
406,EP,B1,EP 0626529 B1,171-622-566-204-019,1999-08-04,1999,EP 94302940 A,1994-04-25,US 6684793 A,1993-05-25,Automotive transmission,,FORD MOTOR CO;;FORD WERKE AG;;FORD FRANCE,EL-KHOURY JOSEPH ELIAS;;TIMTE FRANK WILLIAM;;KUCHTA GERARD PATRICK;;LEAGUE EDMOND RICHARD,,https://lens.org/171-622-566-204-019,Granted Patent,yes,4,0,6,6,0,F16H59/14;;F16H59/44;;F16H59/78;;F16H61/061;;F16H2059/385;;F16H2061/0444;;F16H61/061;;F16H2059/385;;F16H59/44;;F16H2061/0444;;F16H59/14;;F16H59/78,F16H59/14;;F16H59/38;;F16H59/44;;F16H59/78;;F16H61/04;;F16H61/06;;F16H61/08,,0,0,,,,EXPIRED
407,TW,B,TW I703098 B,001-407-440-690-22X,2020-09-01,2020,TW 105112675 A,2016-04-22,US 201562151006 P,2015-04-22,Glass manufacturing apparatus facilitating separation of a glass ribbon,,CORNING INC,BROWN JAMES WILLIAM;;LUO WEIWEI;;PANIDES ELIAS;;QI LING;;ZHMAYEV EDWARD;;ZHOU NAIYUE,,https://lens.org/001-407-440-690-22X,Granted Patent,no,4,0,12,12,0,C03B33/0215;;C03B33/033;;C03B33/0215;;B65G2249/045;;C03B33/033;;B65G49/063;;C03B33/0215;;B65G2249/045;;Y02P40/57;;B65G2249/045;;C03B33/0215;;C03B33/033;;C03B17/067;;C03B33/03,,,0,0,,,,ACTIVE
408,EP,A1,EP 0492827 A1,065-162-497-161-109,1992-07-01,1992,EP 91311213 A,1991-12-03,US 63130690 A;;US 63130890 A;;US 74267191 A;;US 74267291 A,1990-12-21,Encapsulated aluminum compositions.,"Encapsulated aluminum salts are produced by combining and heating an aqueous aluminum salt selected from aluminum halohydrate, aluminum nitrohydrate and mixtures thereof, or aluminum-zirconium halohydrates and mixtures thereof; a hydrophobic liquid; and a carboxylate. The mixture is heated until substantially all of the free water has been removed. The encapsulated aluminum salts precipitate out after the removal of the water. The encapsulated aluminum salts are useful in deodorant and antiperspirant compositions.",DOW CORNING,CONWAY LORI JEAN;;SMITH JANET MARY;;KATSOULIS DIMITRIS ELIAS;;SCHULZ WILLIAM JAMES JR,,https://lens.org/065-162-497-161-109,Patent Application,yes,4,7,5,9,0,A61K8/28;;A61K8/11;;A61K8/26;;A61K2800/412;;A61Q15/00,A61K8/26;;A61K8/11;;A61K8/20;;A61K8/28;;A61K8/36;;A61K8/37;;A61Q15/00,,0,0,,,,EXPIRED
409,US,A1,US 2018/0148365 A1,139-153-757-928-766,2018-05-31,2018,US 201615567521 A,2016-04-19,US 201615567521 A;;US 201562151006 P;;US 2016/0028208 W,2015-04-22,GLASS MANUFACTURING APPARATUS FACILITATING SEPARATION OF A GLASS RIBBON,"A glass manufacturing apparatus may be configured to facilitate a process of separating a glass ribbon along a separation path extending across a width of the glass ribbon. In one example, the glass manufacturing apparatus comprises at least one anvil-side vacuum port defined by an elongated nose and an elongated anvil member. The anvil-side vacuum port is configured to remove glass debris during the process of separating the glass ribbon. In another example, the glass manufacturing apparatus comprises a scoring device and a score-side vacuum port configured to remove glass debris generated during the process of separating the glass ribbon.",CORNING INC,BROWN JAMES WILLIAM;;LUO WEIWIE;;PANIDES ELIAS;;QI LING;;ZHMAYEV EDWARD;;ZHOU NAIYUE,CORNING INCORPORATED (2017-08-07),https://lens.org/139-153-757-928-766,Patent Application,yes,0,3,12,12,0,C03B33/0215;;C03B33/033;;C03B33/0215;;B65G2249/045;;C03B33/033;;B65G49/063;;C03B33/0215;;B65G2249/045;;Y02P40/57;;B65G2249/045;;C03B33/0215;;C03B33/033;;C03B17/067;;C03B33/03,C03B33/033;;C03B17/06;;C03B33/03,,0,0,,,,DISCONTINUED
410,US,A,US 4874643 A,163-465-057-363-656,1989-10-17,1989,US 21817788 A,1988-07-13,US 21817788 A;;US 4601387 A,1987-05-05,Aromatic silane polymer coatings,"A method for rendering a substrate resistant to erosion by a plasma comprising oxygen by providing on the surface of the substrate a layer of a cured polymer of a compound having the formula ##STR1## where: R.sub.1 is selected from the group consisting of: (a) an aliphatic hydrocarbon group containing 2 to 10 carbon atoms, and (b) a group having the formula ##STR2## wherein n=1 to 3 m=0 to 5 R.sub.2 and R.sub.2 ' are each selected from the group consisting of an alkyl group containing 1 to 4 carbon atoms, an unsubstituted aryl group, and a substituted aryl group; and R.sub.3 comprises: ##STR3## n=0 to 10",HUGHES AIRCRAFT CO,OLDHAM SUSAN L;;ELIAS WILLIAM E;;BIGUS STEPHEN J;;LAU KREISLER S Y,HUGHES AIRCRAFT COMPANY LOS ANGELES CA. A DE. CORP (1988-06-28),https://lens.org/163-465-057-363-656,Granted Patent,yes,1,9,1,12,0,C07F7/0812;;C07F7/0812;;C07F7/081;;C07F7/081;;C08F30/08;;C08F30/08;;C08G59/306;;C08G59/306;;Y10T428/31663;;Y10T428/31663,C07F7/08;;C08F30/08;;C08G59/30,427/340;;427/387;;428/447;;528/33;;528/38,0,0,,,,EXPIRED
411,US,A,US 5356242 A,018-485-250-079-64X,1994-10-18,1994,US 95826092 A,1992-10-09,US 95826092 A,1992-10-09,System and method for adjustably connecting wall facing panels to the soldier beams of a tie-back or anchored wall,"A system and method for adjustably connecting pre-cast wall facing panels to the soldier beams of a tie-back or anchor wall is provided, wherein the system comprises an array of panels stacked in rows having mutually adjacent side edge portions which are spaced apart from one of the soldier beams, a connecting column cast-in-place between the beam and the adjacent side edge portions of the panels for structurally interconnecting both of the panels to the beam, and an adjustable array of reinforcing members within the column for interconnecting the adjacent side edge portions of each of the panels with the beam and for reinforcing the resulting column. The depth of the cast-in-place connecting column advantageously accommodates variations in the distances between the beams and panels. In the method of the invention, a first row of wall facing panels is stacked in front of the soldier beams, and a first section of the connecting column is cast therebetween. Thereafter, a second row of panels is stacked on top of the first, and the process repeated until the wall achieves its desired height. Both the system and the method are particularly applicable to tie-back walls employing piles since the cast-in-place connecting column automatically adjusts for misalignments between the piles and the wall facing panels.",JTE INC,ELMORE J THOMAS;;VEATCH ALAN;;CLEMENTS WILLIAM C;;ELIAS VICTOR;;WOJCIECHOWSKI LONGINE J,JET INC (1993-01-04),https://lens.org/018-485-250-079-64X,Granted Patent,yes,11,19,1,2,0,E02D29/0283;;E02D29/0283,E02D29/02,405/262;;405/285;;405/287,0,0,,,,EXPIRED
412,TW,B,TW I739251 B,035-099-714-075-286,2021-09-11,2021,TW 108147294 A,2016-04-22,US 201562151006 P,2015-04-22,GLASS MANUFACTURING APPARATUS FACILITATING SEPARATION OF A GLASS RIBBON,,CORNING INC,BROWN JAMES WILLIAM;;LUO WEIWEI;;PANIDES ELIAS;;QI LING;;ZHMAYEV EDWARD;;ZHOU NAIYUE,,https://lens.org/035-099-714-075-286,Granted Patent,no,1,0,12,12,0,C03B33/0215;;C03B33/033;;C03B33/0215;;B65G2249/045;;C03B33/033;;B65G49/063;;C03B33/0215;;B65G2249/045;;Y02P40/57;;B65G2249/045;;C03B33/0215;;C03B33/033;;C03B17/067;;C03B33/03,,,0,0,,,,ACTIVE
413,BR,A2,BR 102020023100 A2,080-330-105-604-227,2022-05-24,2022,BR 102020023100 A,2020-11-12,BR 102020023100 A,2020-11-12,Estação meteorológica aerotransportável (ema) com registro remoto de dados,"estação meteorológica aerotransportável (ema) com registro remoto de dados. dispositivo de medição e transmissão de dados meteorológicos composto por: sistema aerotransportável de dimensões e peso reduzido para medição e transmissão, por rádio frequência, da velocidade do vento, umidade e temperatura; e receptor, verificador e registrador de dados. o aerotransporte pode ser realizado por drone em alturas de até 120 metros. os dados meteorológicos obtidos auxiliam na avaliação do local e condições atmosféricas para instalação de torre e gerador eólico.",INST FEDERAL DE EDUCACAO CIENCIA E TECNOLOGIA FLUMINENSE,CAIO PEIXOTO GOMES;;JOSÉ CARLOS MENDONÇA;;JOÃO ELIAS MOTHÉ;;WILLIAM DA SILVA VIANNA,,https://lens.org/080-330-105-604-227,Patent Application,no,0,0,1,1,0,G01W1/08,G01W1/08,,0,0,,,,DISCONTINUED
414,DE,D1,DE 69419825 D1,150-666-125-967-523,1999-09-09,1999,DE 69419825 T,1994-04-25,US 6684793 A,1993-05-25,Kraftfahrzeuggetriebe,,FORD WERKE AG,EL-KHOURY JOSEPH ELIAS;;TIMTE FRANK WILLIAM;;KUCHTA GERARD PATRICK;;LEAGUE EDMOND RICHARD,"FORD-WERKE GMBH, 50735 KOELN, DE (2005-05-25)",https://lens.org/150-666-125-967-523,Granted Patent,no,0,0,6,6,0,F16H59/14;;F16H59/44;;F16H59/78;;F16H61/061;;F16H2059/385;;F16H2061/0444;;F16H61/061;;F16H2059/385;;F16H59/44;;F16H2061/0444;;F16H59/14;;F16H59/78,F16H59/14;;F16H59/38;;F16H59/44;;F16H59/78;;F16H61/04;;F16H61/06;;F16H61/08,,0,0,,,,EXPIRED
415,US,A,US 4861901 A,080-551-808-261-477,1989-08-29,1989,US 4601387 A,1987-05-05,US 4601387 A,1987-05-05,Substituted aromatic silane compounds and method for preparation of same,"A new group of silane compounds in which silicon atoms are linked together by a hydrocarbon chain and which comprise phenyl groups substituted with an epoxy group or an ethenyl group. The compounds of the present invention have the formula ##STR1## where R.sub.1 is selected from the group consisting of: (a) an aliphatic hydrocarbon group containing 2 to 10 carbon atoms, and (b) a group having the formula ##STR2## where n=1 to 3 m=0 to 5; R.sub.2 and R.sub.2 ' are each selected from the group consisting of an alkyl group containing 1 to 4 carbon atoms, an unsubstituted aryl group, and a substituted aryl group; and R.sub.3 is selected from the group consisting of: ##STR3## where R.sub.4, R.sub.5, and R.sub.6 are each selected from the group consisting of H, an alkyl group containing 1 to 4 carbon atoms, and an aryl group; and n=0 to 10.",HUGHES AIRCRAFT CO,LAU KREISLER S Y;;OLDHAM SUSAN L;;ELIAS WILLIAM E;;BIGUS STEPHEN J,HUGHES AIRCRAFT COMPANY LOS ANGELES CALIFORNIA A DE. CORP (1987-04-30),https://lens.org/080-551-808-261-477,Granted Patent,yes,6,7,7,12,0,C07F7/0812;;C08F30/08;;C08G59/306;;C07F7/081;;C08F30/08;;C07F7/0812;;C08G59/306;;C07F7/081,C07F7/08;;C08F30/08;;C08G59/30,549/215;;556/432;;556/435;;556/431,0,0,,,,EXPIRED
416,FR,B1,FR 2652190 B1,106-673-015-709-515,1994-04-08,1994,FR 9011209 A,1990-09-11,US 40751589 A,1989-09-15,PERFECTIONNEMENTS APPORTES AUX REACTEURS NUCLEAIRES.,,BABCOCK ET WILCOX CY,"BINGHAM BILLY ELIAS;;COINER, JR. JOHN ROBSON;;PETTUS WILLIAM GOWER;;SHORT BARRETT JOHN",,https://lens.org/106-673-015-709-515,Granted Patent,no,0,0,9,9,0,G21C1/10;;G21C1/10;;G21C15/02;;G21C15/02;;Y02E30/30;;Y02E30/30,G21C1/00;;G21C1/10;;G21C15/02,,0,0,,,,EXPIRED
417,WO,A1,WO 2014/106785 A1,173-985-874-150-687,2014-07-10,2014,IB 2013060980 W,2013-12-16,US 201313735380 A,2013-01-07,IN-LINE EDITING OF WEBPAGES,"A method, computer program product, and system for editing webpages is described. An editable region of a dynamically rendered webpage is identified. An indicator associated with the editable region is provided, wherein the indicator identifies the editable region as available for editing. An in-line edit, made by a user, to a portion of the editable region is identified. Commitment of the in-line edit for rendering is identified. A first portion of the webpage is rendered based upon, at least in part, the commitment of the in-line edit for rendering, wherein the first portion of the webpage is affected by the in-line edit and one or more portions of the webpage that are not affected by the in-line edit are not rendered concurrently with the first portion of the webpage.",IBM;;IBM UK;;IBM JAPAN,HAMPTON MARK CARL;;MARTINEZ DE MORENTIN ERIC;;IZARD WILLIAM JOHN;;JORDAN ELIAS KANE,,https://lens.org/173-985-874-150-687,Patent Application,yes,2,2,5,5,0,G06F16/958;;G06F40/143;;G06F16/958;;G06F40/166;;G06F40/143,G06F13/00;;G06F40/143,,0,0,,,,PENDING
418,US,A1,US 2014/0195892 A1,000-532-617-385-56X,2014-07-10,2014,US 201314069620 A,2013-11-01,US 201314069620 A;;US 201313735380 A,2013-01-07,IN-LINE EDITING OF WEBPAGES,"A method, computer program product, and system for editing webpages is described. An editable region of a dynamically rendered webpage is identified. An indicator associated with the editable region is provided, wherein the indicator identifies the editable region as available for editing. An in-line edit, made by a user, to a portion of the editable region is identified. Commitment of the in-line edit for rendering is identified. A first portion of the webpage is rendered based upon, at least in part, the commitment of the in-line edit for rendering, wherein the first portion of the webpage is affected by the in-line edit and one or more portions of the webpage that are not affected by the in-line edit are not rendered concurrently with the first portion of the webpage.",IBM,HAMPTON MARK C;;IZARD WILLIAM J;;JORDAN ELIAS K;;MARTINEZ DE MORENTIN ERIC,INTERNATIONAL BUSINESS MACHINES CORPORATION (2013-01-03),https://lens.org/000-532-617-385-56X,Patent Application,yes,16,18,5,5,0,G06F16/958;;G06F40/143;;G06F16/958;;G06F40/166;;G06F40/143,G06F40/143,715/234,0,0,,,,ACTIVE
419,US,B2,US 11113454 B2,034-763-401-808-502,2021-09-07,2021,US 201314069620 A,2013-11-01,US 201314069620 A;;US 201313735380 A,2013-01-07,In-line editing of webpages,"A method, computer program product, and system for editing webpages is described. An editable region of a dynamically rendered webpage is identified. An indicator associated with the editable region is provided, wherein the indicator identifies the editable region as available for editing. An in-line edit, made by a user, to a portion of the editable region is identified. Commitment of the in-line edit for rendering is identified. A first portion of the webpage is rendered based upon, at least in part, the commitment of the in-line edit for rendering, wherein the first portion of the webpage is affected by the in-line edit and one or more portions of the webpage that are not affected by the in-line edit are not rendered concurrently with the first portion of the webpage.",IBM,HAMPTON MARK C;;IZARD WILLIAM J;;JORDAN ELIAS K;;MARTINEZ DE MORENTIN ERIC,INTERNATIONAL BUSINESS MACHINES CORPORATION (2013-01-03),https://lens.org/034-763-401-808-502,Granted Patent,yes,21,0,5,5,0,G06F16/958;;G06F40/143;;G06F16/958;;G06F40/166;;G06F40/143,G06F40/143;;G06F16/958;;G06F40/166,,3,0,,,"Madhusudan Pagadala, “Partial Page Rendering Using Hidden Iframe”, www.htmlgoodies.com, Apr. 8, 2008, pp. 1-14. (Year: 2008).;;Refresh, http://computerhope.com/jargon/r/refresh.htm, Oct. 13, 2006, p. 1. (Year: 2006).;;International Search Report and Written Opinion dated Apr. 28, 2014 Received in International Application No. PCT/IB2013/060980, pp. 1-6.",ACTIVE
420,DE,T2,DE 69419825 T2,068-503-213-640-629,1999-12-09,1999,DE 69419825 T,1994-04-25,US 6684793 A,1993-05-25,Kraftfahrzeuggetriebe,,FORD WERKE AG,EL-KHOURY JOSEPH ELIAS;;TIMTE FRANK WILLIAM;;KUCHTA GERARD PATRICK;;LEAGUE EDMOND RICHARD,"FORD-WERKE GMBH, 50735 KOELN, DE (2005-05-25)",https://lens.org/068-503-213-640-629,Granted Patent,no,0,0,6,6,0,F16H59/14;;F16H59/44;;F16H59/78;;F16H61/061;;F16H2059/385;;F16H2061/0444;;F16H61/061;;F16H2059/385;;F16H59/44;;F16H2061/0444;;F16H59/14;;F16H59/78,F16H59/14;;F16H59/38;;F16H59/44;;F16H59/78;;F16H61/04;;F16H61/06;;F16H61/08,,0,0,,,,EXPIRED
421,US,A1,US 2023/0275809 A1,095-703-364-175-467,2023-08-31,2023,US 202318309957 A,2023-05-01,US 202318309957 A;;US 202117164769 A,2021-02-01,UNOBSERVABLE NODE IDENTIFICATION,"The disclosed technology is generally directed to the identification of unobservable nodes. In one example of the technology, a set of monitored machines are monitored. Each of the monitored machines includes associated monitoring logic. Monitoring the set of monitored machines includes receiving the machine information from the monitoring logic. A total inventory list of the set of monitored machines is generated in a manner that is independent of the monitoring of the monitored machines. An agent inventory list is generated such that the agent inventory list is a list of machines that, based on the monitoring of the monitored machine, are determined to have been running monitoring logic during a particular time period. Unobservable machine information that is associated with a set of unobservable machines is determined based on a comparison of the total inventory list with the agent inventory list.",MICROSOFT TECHNOLOGY LICENSING LLC,STOLZ HENRY ELIAS;;YAKKALI NAGA MARUTHI KUMARI;;BUTLER WILLIAM CANDLER;;STAVROU EVAN ROLAND,,https://lens.org/095-703-364-175-467,Patent Application,yes,3,0,3,3,0,H04L41/12;;H04L41/0853;;H04L41/046;;H04L41/0893;;H04L43/0876;;H04L43/20;;H04L41/0895;;H04L43/10;;H04L43/028;;H04L41/22;;G06F11/3051;;G06F9/45558;;G06F2009/45562;;H04L41/12;;G06F2009/45562;;G06F9/45558,H04L41/12,,0,0,,,,PENDING
422,US,B2,US 11200368 B2,104-082-530-264-71X,2021-12-14,2021,US 201313735380 A,2013-01-07,US 201313735380 A,2013-01-07,In-line editing of webpages,"An in-line webpage editing system includes identifying an editable region of a dynamically rendered webpage. Providing an indicator, wherein the indicator is associated with the editable region of the dynamically rendered webpage, and identifies the editable region as available for editing. Further, identifying an in-line edit, made by a user, to a portion of the editable region, and commitment of the in-line edit for rendering. Rendering a first portion of the webpage is rendered based upon, at least in part, the commitment of the in-line edit for rendering, wherein the first portion of the webpage is affected by the in-line edit, and one or more portions of the webpage that are not affected by the in-line edit are not rendered concurrently with the first portion of the webpage.",IBM,HAMPTON MARK C;;IZARD WILLIAM J;;JORDAN ELIAS K;;MARTINEZ DE MORENTIN ERIC,INTERNATIONAL BUSINESS MACHINES CORPORATION (2013-01-03),https://lens.org/104-082-530-264-71X,Granted Patent,yes,35,0,5,5,0,G06F16/958;;G06F40/143;;G06F16/958;;G06F40/166;;G06F40/143,G06F40/143;;G06F16/958;;G06F40/166,,6,2,059-875-051-907-917;;092-867-413-536-735,10.1016/s0169-7552(98)00118-4;;10.1109/auic.2000.822071,"Microsoft Press, Microsoft Computer Dictionary, Mar. 15, 2002, Microsoft Press, 5th Edition, p. 563.;;ComputerHope.com, http://computerhope.com/jargon/r/refresh.htm, Oct. 13, 2006.;;HTML Goodies, http://www.htmlgoodies.com/beyond/webmaster/article.php/3739471/Partial-Page-Rendering-Using-Hidden-IFrame.htm, Jun. 29, 2010.;;Chang, Bay-Wei. “In-place editing of Web pages: Sparrow community-shared documents”, 1998 Elsevier. (Year: 1998).;;Rees, Michael J. “User Interfaces for Lightweight In-line Editing of Web Pages”, Aug. 6, 2002, IEEE. (Year: 2002).;;International Search Report and Written Opinion dated Apr. 28, 14 Received in International Application No. PCT/IB2013/060980, pp. 1-6.",ACTIVE
423,US,A,US 5558470 A,196-743-068-889-527,1996-09-24,1996,US 32373294 A,1994-10-17,US 32373294 A;;US 95826092 A,1992-10-09,System and method for adjustably anchoring traffic barriers and wall facing panels to the soldier beams of a wall,"A system and method for adjustably connecting traffic barriers and pre-cast wall facing panels to the soldier beams of a pile wall is provided, which includes a connecting structure cast-in-place between the upper ends of the beam and the panels for structurally interconnecting both a traffic barrier and the upper ends of the panels to the beam. The system further includes an anchor member projecting from the upper end of the soldier beam for securing the connecting structure to the beam, as well as a depth-adjustable array of reinforcing members that are cast within the structure for accommodating variations in the distances between the beams and panels. At least one of the array of reinforcing members projects upwardly out of the connecting structure to link the traffic barrier to the connecting structure. In the method of the invention, the connecting structure is cast-in-place on top of a connecting column that secures the wall panels to the soldier beams, and the traffic barrier is in turn cast over the connecting structure after it sets.",JTE INC,ELMORE J THOMAS;;VEATCH ALAN;;CLEMENTS WILLIAM C;;ELIAS VICTOR;;WOJCIECHOWSKI LONGINE J,JTE INC (1995-01-03),https://lens.org/196-743-068-889-527,Granted Patent,yes,11,8,1,2,0,E02D29/0283;;E02D29/0283,E02D29/02,405/262;;405/285;;405/287,0,0,,,,EXPIRED
424,EP,A1,EP 0314778 A1,069-309-655-218-211,1989-05-10,1989,EP 88906239 A,1988-03-18,US 4601387 A,1987-05-05,SUBSTITUTED AROMATIC SILANE COMPOUNDS AND METHOD FOR PREPARATION OF SAME.,"Un nouveau groupe de composés de silane, dans lequel les atomes de silicium sont liés les uns aux autres par une chaîne d'hydrocarbure et qui comprend des groupes phényle substitués par un groupe époxy ou un groupe éthényle, est représenté par la formule (I), dans laquelle R1 est choisi dans le groupe se composant: (a) d'un groupe d'hydrocarbure aliphatique contenant 2 à 10 atomes de carbone et (b) d'un groupe représenté par la formule (II) (où n est égal à un nombre compris entre 1 et 3 et m est égal à un nombre compris entre 0 et 5); R2 et R2' sont choisis dans le groupe se composant d'un groupe alkyle contenant 1 à 4 atomes de carbone, d'un groupe aryle non substitué ainsi que d'un groupe aryle substitué; et R3 est choisi dans le groupe se composant des composés représentés par les formules (III) et (IV), dans lesquelles R4, R5 et R6 sont choisis dans le groupe se composant d'hydrogène, d'un groupe alkyle contenant 1 à 4 atomes de carbone et d'un groupe aryle; et n est compris entre 0 et 10.",HUGHES AIRCRAFT CO,LAU KREISLER S Y;;OLDHAM SUSAN L;;ELIAS WILLIAM E;;BIGUS STEPHEN J,,https://lens.org/069-309-655-218-211,Patent Application,yes,0,1,7,12,0,C07F7/0812;;C08F30/08;;C08G59/306;;C07F7/081;;C08F30/08;;C07F7/0812;;C08G59/306;;C07F7/081,C07F7/08;;C08F30/08;;C08G59/30,,0,0,,,,EXPIRED
425,US,A,US 4916038 A,016-319-413-512-289,1990-04-10,1990,US 23781688 A,1988-08-29,US 23781688 A;;US 4601387 A,1987-05-05,Substituted aromatic silane compounds and method for preparation of same,"A new group of silane compounds in which silicon atoms are linked together by a hydrocarbon chain and which comprise phenyl groups substituted with an epoxy group or an ethenyl group. The compounds of the present invention have the formula ##STR1## where R.sub.1 is selected from the group consisting of: (a) an aliphatic hydrocarbon group containing 2 to 10 carbon atoms, and (b) a group having the formula ##STR2## where n=1 to 3 m=0 to 5; R.sub.2 and R.sub.2 ' are each selected from the group consisting of an alkyl group containing 1 to 4 carbon atoms, an unsubstituted aryl group, and a substituted aryl group; and R.sub.3 is selected from the group consisting of: ##STR3## where R.sub.4, R.sub.5, and R.sub.6 ae each selected from the group consisting of H, an alkyl group containing 1 to 4 carbon atoms, and an aryl group; and n=0 to 10.",HUGHES AIRCRAFT CO,LAU KREISLER S Y;;OLDHAM SUSAN L;;ELIAS WILLIAM E;;BIGUS STEPHEN J,,https://lens.org/016-319-413-512-289,Granted Patent,yes,3,6,1,12,0,C08G59/306;;C08G59/306;;C07F7/081;;C07F7/081;;C07F7/0812;;C07F7/0812;;C08F30/08;;C08F30/08;;Y10T428/31663;;Y10T428/31663,C07F7/08;;C08F30/08;;C08G59/30,428/447;;528/32;;528/35;;528/43;;526/279;;427/387,0,0,,,,EXPIRED
426,US,B2,US 11677629 B2,030-191-686-883-111,2023-06-13,2023,US 202117164769 A,2021-02-01,US 202117164769 A,2021-02-01,Unobservable node identification,"The disclosed technology is generally directed to the identification of unobservable nodes. In one example of the technology, a set of monitored machines are monitored. Each of the monitored machines includes associated monitoring logic. Monitoring the set of monitored machines includes receiving the machine information from the monitoring logic. A total inventory list of the set of monitored machines is generated in a manner that is independent of the monitoring of the monitored machines. An agent inventory list is generated such that the agent inventory list is a list of machines that, based on the monitoring of the monitored machine, are determined to have been running monitoring logic during a particular time period. Unobservable machine information that is associated with a set of unobservable machines is determined based on a comparison of the total inventory list with the agent inventory list.",MICROSOFT TECHNOLOGY LICENSING LLC,STOLZ HENRY ELIAS;;YAKKALI NAGA MARUTHI KUMARI;;BUTLER WILLIAM CANDLER;;STAVROU EVAN ROLAND,MICROSOFT TECHNOLOGY LICENSING LLC (2021-01-28),https://lens.org/030-191-686-883-111,Granted Patent,yes,5,1,3,3,0,H04L41/12;;H04L41/0853;;H04L41/046;;H04L41/0893;;H04L43/0876;;H04L43/20;;H04L41/0895;;H04L43/10;;H04L43/028;;H04L41/22;;G06F11/3051;;G06F9/45558;;G06F2009/45562;;H04L41/12;;G06F2009/45562;;G06F9/45558,G06F15/173;;G06F9/455;;H04L41/12,,0,0,,,,ACTIVE
427,US,A1,US 2022/0247641 A1,034-933-775-995-102,2022-08-04,2022,US 202117164769 A,2021-02-01,US 202117164769 A,2021-02-01,UNOBSERVABLE NODE IDENTIFICATION,"The disclosed technology is generally directed to the identification of unobservable nodes. In one example of the technology, a set of monitored machines are monitored. Each of the monitored machines includes associated monitoring logic. Monitoring the set of monitored machines includes receiving the machine information from the monitoring logic. A total inventory list of the set of monitored machines is generated in a manner that is independent of the monitoring of the monitored machines. An agent inventory list is generated such that the agent inventory list is a list of machines that, based on the monitoring of the monitored machine, are determined to have been running monitoring logic during a particular time period. Unobservable machine information that is associated with a set of unobservable machines is determined based on a comparison of the total inventory list with the agent inventory list.",MICROSOFT TECHNOLOGY LICENSING LLC,STOLZ HENRY ELIAS;;YAKKALI NAGA MARUTHI KUMARI;;BUTLER WILLIAM CANDLER;;STAVROU EVAN ROLAND,MICROSOFT TECHNOLOGY LICENSING LLC (2021-01-28),https://lens.org/034-933-775-995-102,Patent Application,yes,5,1,3,3,0,H04L41/12;;H04L41/0853;;H04L41/046;;H04L41/0893;;H04L43/0876;;H04L43/20;;H04L41/0895;;H04L43/10;;H04L43/028;;H04L41/22;;G06F11/3051;;G06F9/45558;;G06F2009/45562;;H04L41/12;;G06F2009/45562;;G06F9/45558,H04L12/24,,0,0,,,,ACTIVE
428,US,A,US 5814082 A,096-744-425-296-615,1998-09-29,1998,US 84154297 A,1997-04-23,US 84154297 A,1997-04-23,Layered capacitor with alignment elements for an implantable cardiac defibrillator,"A capacitor for an implantable cardiac defibrillator with a housing defining a chamber. A plurality of flat, stacked, charge storing layers reside within the chamber. Each of the layers includes at least a first and a second electrically conductive sheets separated by a sheet in between. The first sheet is electrically connected to the housing, and the second sheet is electrically isolated from the housing. The layers each have a periphery having at least one alignment element, with the second sheet extending to the periphery along at least a portion of the alignment element, such that the layers may be engaged at the alignment element to register the layers during assembly.",PACESETTER INC,FAYRAM TIMOTHY A;;PLESS BENJAMIN D;;PARLER SAMUEL;;ELIAS WILLIAM H;;MCCALL SCOTT,PACESETTER INC (1997-05-15);;VENTRITEX INC (1997-04-21),https://lens.org/096-744-425-296-615,Granted Patent,yes,7,127,1,1,0,A61N1/375;;A61N1/3956;;A61N1/375;;A61N1/3956,A61N1/375;;A61N1/39,607/5;;607/4;;361/301.4,0,0,,,,EXPIRED
429,US,A1,US 2014/0195889 A1,166-005-491-228-707,2014-07-10,2014,US 201313735380 A,2013-01-07,US 201313735380 A,2013-01-07,IN-LINE EDITING OF WEBPAGES,"A method, computer program product, and system for editing webpages is described. An editable region of a dynamically rendered webpage is identified. An indicator associated with the editable region is provided, wherein the indicator identifies the editable region as available for editing. An in-line edit, made by a user, to a portion of the editable region is identified. Commitment of the in-line edit for rendering is identified. A first portion of the webpage is rendered based upon, at least in part, the commitment of the in-line edit for rendering, wherein the first portion of the webpage is affected by the in-line edit and one or more portions of the webpage that are not affected by the in-line edit are not rendered concurrently with the first portion of the webpage.",IBM,HAMPTON MARK C;;IZARD WILLIAM J;;JORDAN ELIAS K;;MARTINEZ DE MORENTIN ERIC,INTERNATIONAL BUSINESS MACHINES CORPORATION (2013-01-03),https://lens.org/166-005-491-228-707,Patent Application,yes,22,7,5,5,0,G06F16/958;;G06F40/143;;G06F16/958;;G06F40/166;;G06F40/143,G06F40/143,715/234,3,0,,,"Microsoft Press, Microsoft Computer Dictionary, 03/15/2002, Microsoft Press, 5th Edition, Page 563;;ComputerHope.com, http://computerhope.com/jargon/r/refresh.htm, 10/13/2006;;HTML Goodies, http://www.htmlgoodies.com/beyond/webmaster/article.php/3739471/Partial-Page-Rendering-Using-Hidden-IFrame.htm, 06/29/2010",ACTIVE
430,DE,D1,DE 602005008667 D1,069-211-675-911-456,2008-09-18,2008,DE 602005008667 T,2005-05-11,US 84933004 A,2004-05-19,Schleifenantenne für zwei Frequenzbereiche,"An antenna assembly (10, 100, 200, 300) is disclosed. The antenna assembly (10, 100, 200, 300) includes a dual band vertical loop wire antenna (12, 102, 202, 302) extending from a printed circuit board (16, 106, 206, 306) positioned over a ground plane (24), wherein the wire antenna (12, 102, 202, 302) includes: at least one coiled section (12a, 12b, 102a-102e, 202a-202c, 302a-302c), at least one straight wire section (18, 20, 108-114), and at least one feeding post section (22, 122, 210, 310). <IMAGE>",DELPHI TECH INC,YEGIN KORGUT;;SNOEYINK RANDALL J;;MORRIS DANIEL G;;LIVENGOOD WILLIAM R;;GHAFARI ELIAS H,,https://lens.org/069-211-675-911-456,Granted Patent,no,0,0,6,6,0,H01Q1/3275;;H01Q7/00;;H01Q5/357;;H01Q7/00;;H01Q1/3275;;H01Q5/357,H01Q7/00;;H01Q1/32;;H01Q5/00;;H01Q5/357,,0,0,,,,ACTIVE
431,US,B2,US 7710335 B2,136-083-256-582-680,2010-05-04,2010,US 84933004 A,2004-05-19,US 84933004 A,2004-05-19,Dual band loop antenna,"An antenna assembly is disclosed. The antenna assembly includes a dual band vertical loop wire antenna extending from a printed circuit board positioned over a ground plane, wherein the wire antenna includes: at least one coiled section, at least one straight wire section, and at least one feeding post section.",DELPHI TECH INC,YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;SNOEYINK RANDALL J;;LIVENGOOD WILLIAM R,DELPHI TECHNOLOGIES INC (2004-04-27),https://lens.org/136-083-256-582-680,Granted Patent,yes,23,1,6,6,0,H01Q1/3275;;H01Q7/00;;H01Q5/357;;H01Q7/00;;H01Q1/3275;;H01Q5/357,H01Q21/00;;H01Q1/32;;H01Q5/00;;H01Q5/357;;H01Q7/00,343/728;;343/711;;343/713;;343/741,1,0,,,"EP 05 07 6081, European Search Report dated Aug. 11, 2005.",INACTIVE
432,AT,T1,AT E412260 T1,150-530-298-200-459,2008-11-15,2008,AT 05076333 T,2005-06-08,US 86963504 A,2004-06-16,PATCH-ANTENNE MIT SIE UMGEBENDE PARASITÄRE ELEMENTE FÜR VERBESSERTE STRAHLUNGSCHARAKTERISTIK,"An antenna unit (10, 100, 200) is disclosed. The antenna unit (100, 200, 300) includes a patch antenna element (12, 102, 202) with a dielectric substrate (14, 104, 204) positioned on a circuit board (16, 106, 206). A parasitically enhanced perimeter (18, 108, 208) extends from the circuit board (16, 106, 206) and encompasses the patch antenna (12, 102, 202) to utilize surface waves in order to enhance low-elevation terrestrial antenna performance. <IMAGE>",DELPHI TECH INC,YEGIN KORKUT;;SNOEYINK RANDALL J;;MORRIS DANIEL G;;LIVENGOOD WILLIAM R;;GHAFARI ELIAS H,,https://lens.org/150-530-298-200-459,Granted Patent,no,0,0,6,6,0,H01Q9/0407;;H01Q3/446;;H01Q9/0407,H01Q9/04,,0,0,,,,INACTIVE
433,EP,A1,EP 1662681 A1,098-719-858-055-540,2006-05-31,2006,EP 05077604 A,2005-11-15,US 99938604 A,2004-11-30,Receiver integrated satellite digital audio radio antenna system,A receiver system for receiving a satellite digital audio radio signal having an antenna module and a receiver. The antenna module is permanently coupled thereto and/or integrated with the receiver.,DELPHI TECH INC,YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;THOMPSON LOREN M;;LIVENGOOD WILLIAM R,,https://lens.org/098-719-858-055-540,Patent Application,yes,2,1,3,3,0,H01Q1/22;;H01Q11/08;;H01Q21/28;;H01Q21/28;;H01Q11/08;;H01Q1/22,H04H20/00;;H01Q1/22;;H01Q11/08;;H01Q21/28,,4,2,130-749-177-747-678;;106-352-919-252-792,10.1049/el:20020275;;10.1109/aero.2002.1035232,"ANONYMOUS: ""Portable AM/FM/ADARS antenna"", RESEARCH DISCLOSURE, MASON PUBLICATIONS, HAMPSHIRE, GB, vol. 487, no. 55, 12 November 2004 (2004-11-12), XP007134497, ISSN: 0374-4353;;ANONYMOUS: ""Portable AM/FM/SDARS diversity antenna"", RESEARCH DISCLOSURE, MASON PUBLICATIONS, HAMPSHIRE, GB, vol. 487, no. 49, 12 November 2004 (2004-11-12), XP007134491, ISSN: 0374-4353;;NOTTER M ET AL: ""Impedance matching arrangement for quadrifilar helix antennas"", ELECTRONICS LETTERS, IEE STEVENAGE, GB, vol. 38, no. 8, 11 April 2002 (2002-04-11), pages 354 - 354, XP006018208, ISSN: 0013-5194;;HALE A ET AL: ""Military applications for digital audio radio service (DARS)"", AEROSPACE CONFERENCE PROCEEDINGS, 2002. IEEE MAR 9-16, 2002, PISCATAWAY, NJ, USA,IEEE, vol. 3, 9 March 2002 (2002-03-09), pages 1039 - 1050, XP010604233, ISBN: 0-7803-7231-X",DISCONTINUED
434,EP,B1,EP 1601049 B1,088-611-194-170-708,2008-08-06,2008,EP 05076081 A,2005-05-11,US 84933004 A,2004-05-19,Dual band loop antenna,"An antenna assembly (10, 100, 200, 300) is disclosed. The antenna assembly (10, 100, 200, 300) includes a dual band vertical loop wire antenna (12, 102, 202, 302) extending from a printed circuit board (16, 106, 206, 306) positioned over a ground plane (24), wherein the wire antenna (12, 102, 202, 302) includes: at least one coiled section (12a, 12b, 102a-102e, 202a-202c, 302a-302c), at least one straight wire section (18, 20, 108-114), and at least one feeding post section (22, 122, 210, 310). <IMAGE>",DELPHI TECH INC,YEGIN KORGUT;;SNOEYINK RANDALL J;;MORRIS DANIEL G;;LIVENGOOD WILLIAM R;;GHAFARI ELIAS H,,https://lens.org/088-611-194-170-708,Granted Patent,yes,6,0,6,6,0,H01Q1/3275;;H01Q7/00;;H01Q5/357;;H01Q7/00;;H01Q1/3275;;H01Q5/357,H01Q7/00;;H01Q1/32;;H01Q5/00;;H01Q5/357,,0,0,,,,ACTIVE
435,US,A1,US 2016/0336565 A1,042-852-471-480-762,2016-11-17,2016,US 201615224074 A,2016-07-29,US 201615224074 A;;US 201213445866 A,2012-04-12,EMBEDDED OPTICS IN MODULAR ASSEMBLIES,"An enhanced multi object potting fixture for exposure to a curing modality that sets an adhesive includes a fixture housing supporting a plurality of objects, the fixture housing having a wall defining a plurality of bonding wells with each the bonding well receiving a first portion of one of the objects, each the bonding well including an aperture in the wall proximate the first portion wherein each bonding well includes a target zone for selective cure of the adhesive to inhibit the adhesive from exiting the aperture; and a fixture enhancement structure integrated into the wall concentrating the curing modality in each the target zone.",TESLA MOTORS INC,HACHTMANN BRIAN DEAN;;RIEGEL MARK;;HEGEMAN DAVID ELIAS;;BISHOP WILIAM CHRISTOPHER;;BEECHER WILLIAM VUCICH,TESLA INC (2012-04-10),https://lens.org/042-852-471-480-762,Patent Application,yes,2,1,8,8,0,B29C2035/0827;;B29C35/0894;;Y02E60/10;;H01M50/213;;H01M50/264;;H01M50/227;;B32B3/26;;H01M2220/20;;B29C2035/0827;;H01M50/213;;H01M50/227;;H01M50/264;;B29C35/0894;;B29C65/4845;;B29C66/301;;B29C66/5324;;B29C66/73343;;B29L2031/3468,B29C65/00;;B29C65/48;;H01M50/213;;H01M50/227;;H01M50/264,,0,0,,,,ACTIVE
436,US,A1,US 2005/0280592 A1,125-377-555-812-516,2005-12-22,2005,US 86963504 A,2004-06-16,US 86963504 A,2004-06-16,Patch antenna with parasitically enhanced perimeter,An antenna unit is disclosed. The antenna unit includes a patch antenna element with a dielectric substrate positioned on a circuit board. A parasitically enhanced perimeter extends from the circuit board and encompasses the patch antenna to utilize surface waves in order to enhance low-elevation terrestrial antenna performance.,YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;SNOEYINK RANDALL J;;LIVENGOOD WILLIAM R,YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;SNOEYINK RANDALL J;;LIVENGOOD WILLIAM R,DELPHI TECHNOLOGIES INC (2004-02-18),https://lens.org/125-377-555-812-516,Patent Application,yes,15,11,6,6,0,H01Q9/0407;;H01Q3/446;;H01Q9/0407,H01Q9/04,343/725;;343/833;;343/834,0,0,,,,ACTIVE
437,EP,A1,EP 1608037 A1,115-906-187-688-352,2005-12-21,2005,EP 05076333 A,2005-06-08,US 86963504 A,2004-06-16,Patch antenna with parasitic fense perimeter for improved radiation characteristics,"An antenna unit (10, 100, 200) is disclosed. The antenna unit (100, 200, 300) includes a patch antenna element (12, 102, 202) with a dielectric substrate (14, 104, 204) positioned on a circuit board (16, 106, 206). A parasitically enhanced perimeter (18, 108, 208) extends from the circuit board (16, 106, 206) and encompasses the patch antenna (12, 102, 202) to utilize surface waves in order to enhance low-elevation terrestrial antenna performance.",DELPHI TECH INC,YEGIN KORKUT;;SNOEYINK RANDALL J;;MORRIS DANIEL G;;LIVENGOOD WILLIAM R;;GHAFARI ELIAS H,,https://lens.org/115-906-187-688-352,Patent Application,yes,3,2,6,6,0,H01Q9/0407;;H01Q3/446;;H01Q9/0407,H01Q9/04,,0,0,,,,ACTIVE
438,TW,A,TW 201700414 A,157-044-391-689-261,2017-01-01,2017,TW 105112675 A,2016-04-22,US 201562151006 P,2015-04-22,Glass manufacturing apparatus facilitating separation of a glass ribbon,"A glass manufacturing apparatus may be configured to facilitate a process of separating a glass ribbon along a separation path extending across a width of the glass ribbon. In one example, the glass manufacturing apparatus comprises at least one anvil-side vacuum port defined by an elongated nose and an elongated anvil member. The anvil-side vacuum port is configured to remove glass debris during the process of separating the glass ribbon. In another example, the glass manufacturing apparatus comprises a scoring device and a score-side vacuum port configured to remove glass debris generated during the process of separating the glass ribbon.",CORNING INC,BROWN JAMES WILLIAM;;LUO WEI-WEI;;PANIDES ELIAS;;QI LING;;ZHMAYEV EDWARD;;ZHOU NAIYUE,,https://lens.org/157-044-391-689-261,Patent of Addition,no,0,0,12,12,0,C03B33/0215;;C03B33/033;;C03B33/0215;;B65G2249/045;;C03B33/033;;B65G49/063;;C03B33/0215;;B65G2249/045;;Y02P40/57;;B65G2249/045;;C03B33/0215;;C03B33/033;;C03B17/067;;C03B33/03,C03B17/04,,0,0,,,,ACTIVE
439,TW,A,TW 201720611 A,007-623-507-214-178,2017-06-16,2017,TW 105139381 A,2016-11-30,US 201562260867 P,2015-11-30,Method and system for making articles from preformed materials,"A method of making articles from preformed materials includes placing a preformed material on a mold such that a non-quality region of the preformed material contacts the mold and a quality region of the preformed material is free of contact with the mold. A non-contact support is provided to the quality region to control sagging of the quality region. A reformable area of the preformed material is formed into a select shape by contacting the reformable area with a forming tool while restricting contact between the forming tool and the reformable area to the non-quality region. After the forming of the reformable area, an article is extracted from the quality region.",CORNING INC,DABOUINEAU JEAN-LUC;;PANIDES ELIAS;;POWELL WILLIAM ROBERT;;SLATER IRENE MARJORIE;;ZOUBI SAM SAMER,,https://lens.org/007-623-507-214-178,Patent of Addition,no,0,0,3,3,0,C03B23/035;;C03B23/0235;;C03B40/04;;C03B23/0258;;C03B23/0235;;C03B40/04;;C03B23/0305;;C03B23/0307;;C03B23/0355;;C03B23/035,B29C33/18;;B29C33/24;;B29C51/06;;B29C51/10,,0,0,,,,PENDING
440,DE,C3,DE 1454857 C3,178-715-126-115-693,1974-04-04,1974,DE 1454857 A,1964-09-15,US 31000763 A,1963-09-19,DE 1454857 C3,,"PENNSALT CHEMICALS CORP., PHILADELPHIA, PA. (V.ST.A.)","BLACK, MATTHEW BAXTER, DELAWARE COUNTY;;FAUST, ELLSWORTH ELIAS, PHOENIXVILLE;;BARNHART, WILLIAM SIDDAL;;NERSCH, RAYMOND",,https://lens.org/178-715-126-115-693,Granted Patent,no,0,0,6,7,0,B29B9/00;;B29B9/00;;C08J3/12;;C08J3/12;;C08J3/124;;C08J3/124;;C08J2327/18;;C08J2327/18;;Y10T428/2982;;Y10T428/2982,B29B9/00;;C08J3/12,,0,0,,,,EXPIRED
441,EP,A1,EP 1601049 A1,191-332-090-927-413,2005-11-30,2005,EP 05076081 A,2005-05-11,US 84933004 A,2004-05-19,Dual band loop antenna,"An antenna assembly (10, 100, 200, 300) is disclosed. The antenna assembly (10, 100, 200, 300) includes a dual band vertical loop wire antenna (12, 102, 202, 302) extending from a printed circuit board (16, 106, 206, 306) positioned over a ground plane (24), wherein the wire antenna (12, 102, 202, 302) includes: at least one coiled section (12a, 12b, 102a-102e, 202a-202c, 302a-302c), at least one straight wire section (18, 20, 108-114), and at least one feeding post section (22, 122, 210, 310).",DELPHI TECH INC,YEGIN KORGUT;;SNOEYINK RANDALL J;;MORRIS DANIEL G;;LIVENGOOD WILLIAM R;;GHAFARI ELIAS H,,https://lens.org/191-332-090-927-413,Patent Application,yes,6,2,6,6,0,H01Q1/3275;;H01Q7/00;;H01Q5/357;;H01Q7/00;;H01Q1/3275;;H01Q5/357,H01Q1/32;;H01Q5/00;;H01Q5/357;;H01Q7/00,,0,0,,,,ACTIVE
442,WO,A1,WO 2017/095767 A1,145-823-119-968-891,2017-06-08,2017,US 2016/0063902 W,2016-11-29,US 201562260867 P,2015-11-30,METHOD AND SYSTEM FOR MAKING ARTICLES FROM PREFORMED MATERIALS,"A method of making articles from preformed materials includes placing a preformed material on a mold such that a non-quality region of the preformed material contacts the mold and a quality region of the preformed material is free of contact with the mold. A non-contact support is provided to the quality region to control sagging of the quality region. A reformable area of the preformed material is formed into a select shape by contacting the reformable area with a forming tool while restricting contact between the forming tool and the reformable area to the non-quality region. After the forming of the reformable area, an article is extracted from the quality region.",CORNING INC,DABOUINEAU JEAN-LUC;;PANIDES ELIAS;;POWELL WILLIAM ROBERT;;SLATER IRENE MARJORIE;;ZOUBI SAM SAMER,,https://lens.org/145-823-119-968-891,Patent Application,yes,10,1,3,3,0,C03B23/035;;C03B23/0235;;C03B40/04;;C03B23/0258;;C03B23/0235;;C03B40/04;;C03B23/0305;;C03B23/0307;;C03B23/0355;;C03B23/035,C03B23/023;;C03B23/035;;C03B40/04,,0,0,,,,PENDING
443,US,A1,US 2005/0259017 A1,148-871-480-125-778,2005-11-24,2005,US 84933004 A,2004-05-19,US 84933004 A,2004-05-19,Dual band loop antenna,"An antenna assembly is disclosed. The antenna assembly includes a dual band vertical loop wire antenna extending from a printed circuit board positioned over a ground plane, wherein the wire antenna includes: at least one coiled section, at least one straight wire section, and at least one feeding post section.",YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;SNOEYINK RANDALL J;;LIVENGOOD WILLIAM R,YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;SNOEYINK RANDALL J;;LIVENGOOD WILLIAM R,DELPHI TECHNOLOGIES INC (2004-04-27),https://lens.org/148-871-480-125-778,Patent Application,yes,21,9,6,6,0,H01Q1/3275;;H01Q7/00;;H01Q5/357;;H01Q7/00;;H01Q1/3275;;H01Q5/357,H01Q1/32;;H01Q5/00;;H01Q5/357;;H01Q7/00,343/728;;343/866;;343/725,0,0,,,,INACTIVE
444,US,B2,US 11725987 B2,135-794-931-201-656,2023-08-15,2023,US 202017435052 A,2020-03-02,SE 1950273 A;;SE 2020050229 W,2019-03-02,Assembly for spectrophotometric measurements,"An assembly for measurements of one or more optical parameters of a medium is disclosed. The assembly comprises a light sheet generator, a light intensity modulator, a holder for a sample, and an optical sensor. A method of using the assembly for measuring one or more optical parameters of a medium is also disclosed.",SPEC IMAGING AB,BERROCAL EDOUARD JEAN JACQUES;;CHAZE WILLIAM RENÉ SERGE;;KRISTENSSON ELIAS VIKTOR;;ZOUEU JÉRÉMIE THOUAKESSEH,SPEC-IMAGING AB (2021-09-02),https://lens.org/135-794-931-201-656,Granted Patent,yes,14,0,11,11,0,G01N21/255;;G01N21/49;;G01N21/645;;G01N2021/6463;;G01N2201/0691;;G01N2201/0635;;G01N2201/0675;;G01N21/4738;;G01N21/4795;;G01N21/49;;G01N21/532;;G01N21/255;;G01N21/31;;G01J3/0229;;G01J3/2846;;G01J3/433;;G01J3/0229;;G01J3/433;;G01N21/31;;G01N21/4738;;G01N2021/6463;;G01N2201/0635,G01J3/433;;G01J3/02;;G01N21/31;;G01N21/47;;G01N21/64,,6,3,017-912-618-493-265;;021-303-731-950-991;;055-986-766-744-783,10.1088/1361-6501/aa6361;;10.1063/1.2825462;;18248042;;10.1038/s41598-018-30233-y;;pmc6079086;;30082685,"Patent Cooperation Treaty (PCT), International Search Report and Written Opinion for Application PCT/SE2020/050229 filed Mar. 2, 2020, dated Apr. 24, 2020, International Searching Authority, SE.;;Swedish Search Report for Application 1950273-1, dated Sep. 11, 2019, 9 pgs., Swedish Patent Office, Sweden.;;Supplementary European Search Report dated Sep. 2, 2022; European Patent Application No. 20765897.2 filed Mar. 2, 2020.;;JOHANNES KIEFER: ""Using a supercontinuum light source for instantaneous excitation-emission fluorescence mapping"", MEASUREMENT SCIENCE AND TECHNOLOGY., IOP, BRISTOL., GB, vol. 28, no. 6, 7 April 2017 (2017-04-07), GB , pages 067001, XP020316697, ISSN: 0957-0233, DOI: 10.1088/1361-6501/aa6361;;MCGREGOR T.; SPENCE D.; COUTTS D.: ""Laser-based volumetric flow visualization by digital color imaging of a spectrally coded volume"", REVIEW OF SCIENTIFIC INSTRUMENTS, AMERICAN INSTITUTE OF PHYSICS, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747, vol. 79, no. 1, 30 January 2008 (2008-01-30), 2 Huntington Quadrangle, Melville, NY 11747, pages 013710 - 013710-7, XP012114558, ISSN: 0034-6748, DOI: 10.1063/1.2825462;;ELIAS KRISTENSSON, EDOUARD BERROCAL: ""Crossed patterned structured illumination for the analysis and velocimetry of transient turbid media"", SCIENTIFIC REPORTS, vol. 8, no. 1, 1 December 2018 (2018-12-01), XP055581732, DOI: 10.1038/s41598-018-30233-y",ACTIVE
445,US,A1,US 2006/0116071 A1,125-097-512-174-917,2006-06-01,2006,US 99938604 A,2004-11-30,US 99938604 A,2004-11-30,Receiver integrated satellite digital audio radio antenna system,A receiver system for receiving a satellite digital audio radio signal having an antenna module and a receiver. The antenna module is permanently coupled thereto and/or integrated with the receiver.,YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;THOMPSON LOREN M;;LIVENGOOD WILLIAM R,YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;THOMPSON LOREN M;;LIVENGOOD WILLIAM R,DELPHI TECHNOLOGIES INC (2004-11-16),https://lens.org/125-097-512-174-917,Patent Application,yes,3,2,3,3,0,H01Q1/22;;H01Q11/08;;H01Q21/28;;H01Q21/28;;H01Q11/08;;H01Q1/22,H04H20/00;;H04M1/00,455/3.02;;455/575.7,0,0,,,,DISCONTINUED
446,EP,A3,EP 1662681 A3,153-162-999-862-896,2007-08-01,2007,EP 05077604 A,2005-11-15,US 99938604 A,2004-11-30,Receiver integrated satellite digital audio radio antenna system,A receiver system for receiving a satellite digital audio radio signal having an antenna module and a receiver. The antenna module is permanently coupled thereto and/or integrated with the receiver.,DELPHI TECH INC,YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;THOMPSON LOREN M;;LIVENGOOD WILLIAM R,,https://lens.org/153-162-999-862-896,Search Report,yes,0,0,3,3,0,H01Q1/22;;H01Q11/08;;H01Q21/28;;H01Q21/28;;H01Q11/08;;H01Q1/22,H04H20/00;;H01Q1/22;;H01Q11/08;;H01Q21/28,,0,0,,,,DISCONTINUED
447,US,A1,US 2018/0370839 A1,184-073-360-329-871,2018-12-27,2018,US 201615778819 A,2016-11-29,US 201615778819 A;;US 201562260867 P;;US 2016/0063902 W,2015-11-30,METHOD AND SYSTEM FOR MAKING ARTICLES FROM PREFORMED MATERIALS,"A method of making articles from preformed materials includes placing a preformed material on a mold such that a non-quality region of the preformed material contacts the mold and a quality region of the preformed material is free of contact with the mold. A non-contact support is provided to the quality region to control sagging of the quality region. A reformable area of the preformed material is formed into a select shape by contacting the reformable area with a forming tool while restricting contact between the forming tool and the reformable area to the non-quality region. After the forming of the reformable area, an article is extracted from the quality region.",CORNING INC,DABOUINEAU JEAN-LUC;;PANIDES ELIAS;;POWELL WILLIAM ROBERT;;SLATER IRENE MARJORIE;;ZOUBI SAM SAMER,CORNING INCORPORATED (2018-05-24),https://lens.org/184-073-360-329-871,Patent Application,yes,3,0,3,3,0,C03B23/035;;C03B23/0235;;C03B40/04;;C03B23/0258;;C03B23/0235;;C03B40/04;;C03B23/0305;;C03B23/0307;;C03B23/0355;;C03B23/035,C03B23/025;;C03B23/023;;C03B23/03;;C03B23/035;;C03B40/04,,0,0,,,,DISCONTINUED
448,TW,A,TW 202028134 A,131-602-086-560-71X,2020-08-01,2020,TW 108147294 A,2016-04-22,US 201562151006 P,2015-04-22,Glass manufacturing apparatus facilitating separation of a glass ribbon,"A glass manufacturing apparatus may be configured to facilitate a process of separating a glass ribbon along a separation path extending across a width of the glass ribbon. In one example, the glass manufacturing apparatus comprises at least one anvil-side vacuum port defined by an elongated nose and an elongated anvil member. The anvil-side vacuum port is configured to remove glass debris during the process of separating the glass ribbon. In another example, the glass manufacturing apparatus comprises a scoring device and a score-side vacuum port configured to remove glass debris generated during the process of separating the glass ribbon.",CORNING INC,BROWN JAMES WILLIAM;;LUO WEI-WEI;;PANIDES ELIAS;;QI LING;;ZHMAYEV EDWARD;;ZHOU NAIYUE,,https://lens.org/131-602-086-560-71X,Patent of Addition,no,0,0,12,12,0,C03B33/0215;;C03B33/033;;C03B33/0215;;B65G2249/045;;C03B33/033;;B65G49/063;;C03B33/0215;;B65G2249/045;;Y02P40/57;;B65G2249/045;;C03B33/0215;;C03B33/033;;C03B17/067;;C03B33/03,C03B33/04,,0,0,,,,ACTIVE
449,US,A1,US 2022/0136900 A1,185-395-209-784-140,2022-05-05,2022,US 202017435052 A,2020-03-02,SE 1950273 A;;SE 2020050229 W,2019-03-02,ASSEMBLY FOR SPECTROPHOTOMETRIC MEASUREMENTS,"An assembly for measurements of one or more optical parameters of a medium is disclosed. The assembly comprises a light sheet generator, a light intensity modulator, a holder for a sample, and an optical sensor. The light sheet generator is configured to provide a polychromatic light sheet comprising a light spectrum extending in a first spatial dimension, wherein the polychromatic light sheet has a propagation path in a second spatial dimension. The light sheet generator comprises a light source configured to provide white light, a dispersive element configured to spread the white light in the first spatial dimension to provide the light spectrum, and an optical slit extending in the first spatial dimension configured to provide the polychromatic light sheet by limitation of the spread white light. The light intensity modulator is configured to provide an intensity modulated polychromatic light sheet by applying—to the polychromatic light sheet—an intensity modulation having a periodical (or substantially periodical) pattern in the first spatial dimension. The holder for a sample of the medium is configured to enable the intensity modulated polychromatic light sheet to illuminate the sample. The optical sensor is configured to record intensity of light exiting the sample over the light spectrum for provision of the one or more optical parameters. A method of using the assembly for measuring one or more optical parameters of a medium is also disclosed.",SPEC IMAGING AB,BERROCAL EDOUARD JEAN JACQUES;;CHAZE WILLIAM RENÉ SERGE;;KRISTENSSON ELIAS VIKTOR;;ZOUEU JÉRÉMIE THOUAKESSEH,SPEC-IMAGING AB (2021-09-02),https://lens.org/185-395-209-784-140,Patent Application,yes,2,1,11,11,0,G01N21/255;;G01N21/49;;G01N21/645;;G01N2021/6463;;G01N2201/0691;;G01N2201/0635;;G01N2201/0675;;G01N21/4738;;G01N21/4795;;G01N21/49;;G01N21/532;;G01N21/255;;G01N21/31;;G01J3/0229;;G01J3/2846;;G01J3/433;;G01J3/0229;;G01J3/433;;G01N21/31;;G01N21/4738;;G01N2021/6463;;G01N2201/0635,G01J3/433;;G01J3/02;;G01N21/31;;G01N21/47,,0,0,,,,ACTIVE
450,EP,B1,EP 1608037 B1,148-672-897-233-078,2008-10-22,2008,EP 05076333 A,2005-06-08,US 86963504 A,2004-06-16,Patch antenna with parasitic fense perimeter for improved radiation characteristics,"An antenna unit (10, 100, 200) is disclosed. The antenna unit (100, 200, 300) includes a patch antenna element (12, 102, 202) with a dielectric substrate (14, 104, 204) positioned on a circuit board (16, 106, 206). A parasitically enhanced perimeter (18, 108, 208) extends from the circuit board (16, 106, 206) and encompasses the patch antenna (12, 102, 202) to utilize surface waves in order to enhance low-elevation terrestrial antenna performance. <IMAGE>",DELPHI TECH INC,YEGIN KORKUT;;SNOEYINK RANDALL J;;MORRIS DANIEL G;;LIVENGOOD WILLIAM R;;GHAFARI ELIAS H,,https://lens.org/148-672-897-233-078,Granted Patent,yes,3,3,6,6,0,H01Q9/0407;;H01Q3/446;;H01Q9/0407,H01Q9/04,,0,0,,,,ACTIVE
451,US,B2,US 7038624 B2,018-097-386-475-217,2006-05-02,2006,US 86963504 A,2004-06-16,US 86963504 A,2004-06-16,Patch antenna with parasitically enhanced perimeter,An antenna unit is disclosed. The antenna unit includes a patch antenna element with a dielectric substrate positioned on a circuit board. A parasitically enhanced perimeter extends from the circuit board and encompasses the patch antenna to utilize surface waves in order to enhance low-elevation terrestrial antenna performance.,DELPHI TECH INC,YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;SNOEYINK RANDALL J;;LIVENGOOD WILLIAM R,DELPHI TECHNOLOGIES INC (2004-02-18),https://lens.org/018-097-386-475-217,Granted Patent,yes,17,3,6,6,0,H01Q9/0407;;H01Q3/446;;H01Q9/0407,H01Q1/38;;H01Q1/24;;H01Q9/04;;H01Q13/10,343700MS;;343/767,1,0,,,"EP 05 07 6333 European Search Report dated Aug. 4, 2005.",ACTIVE
452,AT,T1,AT E403950 T1,158-377-910-836-000,2008-08-15,2008,AT 05076081 T,2005-05-11,US 84933004 A,2004-05-19,SCHLEIFENANTENNE FÜR ZWEI FREQUENZBEREICHE,"An antenna assembly (10, 100, 200, 300) is disclosed. The antenna assembly (10, 100, 200, 300) includes a dual band vertical loop wire antenna (12, 102, 202, 302) extending from a printed circuit board (16, 106, 206, 306) positioned over a ground plane (24), wherein the wire antenna (12, 102, 202, 302) includes: at least one coiled section (12a, 12b, 102a-102e, 202a-202c, 302a-302c), at least one straight wire section (18, 20, 108-114), and at least one feeding post section (22, 122, 210, 310). <IMAGE>",DELPHI TECH INC,YEGIN KORGUT;;SNOEYINK RANDALL J;;MORRIS DANIEL G;;LIVENGOOD WILLIAM R;;GHAFARI ELIAS H,,https://lens.org/158-377-910-836-000,Granted Patent,no,0,0,6,6,0,H01Q1/3275;;H01Q7/00;;H01Q5/357;;H01Q7/00;;H01Q1/3275;;H01Q5/357,H01Q1/32;;H01Q5/00;;H01Q5/357;;H01Q7/00,,0,0,,,,INACTIVE
453,US,A1,US 2005/0266875 A1,138-789-840-492-796,2005-12-01,2005,US 99938404 A,2004-11-30,US 99938404 A;;US 57448004 P,2004-05-26,Integrated SDARS headphone system,"An integrated antenna module includes an antenna element configured to receive satellite digital audio radio signals, an amplifier, and a ground plane. The antenna module may be integrated into a headphone assembly configured to receive satellite digital audio radio signals.",YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;THOMPSON LOREN M;;LIVENGOOD WILLIAM R,YEGIN KORKUT;;MORRIS DANIEL G;;GHAFARI ELIAS H;;THOMPSON LOREN M;;LIVENGOOD WILLIAM R,DELPHI TECHNOLOGIES INC (2004-11-16),https://lens.org/138-789-840-492-796,Patent Application,yes,7,26,1,1,0,H01Q1/273;;H01Q1/44;;H01Q1/273;;H01Q1/44,H01Q1/27;;H01Q1/44;;H04B1/38,455/552.1,0,0,,,,DISCONTINUED
454,DE,D1,DE 602005010508 D1,174-668-264-461-67X,2008-12-04,2008,DE 602005010508 T,2005-06-08,US 86963504 A,2004-06-16,Patch-Antenne mit sie umgebende parasitäre Elemente für verbesserte Strahlungscharakteristik,"An antenna unit (10, 100, 200) is disclosed. The antenna unit (100, 200, 300) includes a patch antenna element (12, 102, 202) with a dielectric substrate (14, 104, 204) positioned on a circuit board (16, 106, 206). A parasitically enhanced perimeter (18, 108, 208) extends from the circuit board (16, 106, 206) and encompasses the patch antenna (12, 102, 202) to utilize surface waves in order to enhance low-elevation terrestrial antenna performance. <IMAGE>",DELPHI TECH INC,YEGIN KORKUT;;SNOEYINK RANDALL J;;MORRIS DANIEL G;;LIVENGOOD WILLIAM R;;GHAFARI ELIAS H,,https://lens.org/174-668-264-461-67X,Granted Patent,no,0,0,6,6,0,H01Q9/0407;;H01Q3/446;;H01Q9/0407,H01Q9/04,,0,0,,,,INACTIVE
455,US,A1,US 2021/0377147 A1,176-095-079-539-428,2021-12-02,2021,US 202016889651 A,2020-06-01,US 202016889651 A,2020-06-01,INFRASTRUCTURE LINK PATH ARRANGEMENT DETERMINATION METHOD AND SYSTEM,"A computer-implemented method and system for determining a path arrangement of an infrastructure link. The method includes receiving one or more inputs each indicative of a constraint; and processing the one or more inputs and a set of data based on a path arrangement determination model. The set of data includes data representing one or more factors affecting the path arrangement. The method also includes determining, based on the processing, the path arrangement of the infrastructure link.",UNIV CITY HONG KONG,ZUKERMAN MOSHE;;WANG ZENGFU;;WANG QING;;MORAN WILLIAM;;WANG XINYU;;TAHCHI ELIAS;;LEUNG FU CHU,CITY UNIVERSITY OF HONG KONG (2020-05-27),https://lens.org/176-095-079-539-428,Patent Application,yes,0,2,2,2,0,H04L45/24;;H04L47/125;;H04L45/02;;H04L45/122;;H04L45/124;;H04L45/02;;H04L45/125;;H04L45/124;;H04L45/04;;H04L45/122,H04L45/02;;H04L45/122;;H04L45/125,,0,0,,,,ACTIVE
456,WO,A2,WO 2008/057758 A2,172-264-585-820-481,2008-05-15,2008,US 2007/0082249 W,2007-10-23,US 55358306 A,2006-10-27,METHOD AND DEVICE FOR CLEANING A LIQUID ASPIRATION AND DISPENSE PROBE,"Cleaning a liquid sample probe with a cleansing station having sources of air, cleansing solution, bath and shower water in a two-weil cleansing body. The cleansing body comprises a multifunctional plate having features to provide both a wall of shower water and thin sheets of high velocity air that provide thorough cleaning of the sample probe.",DADE BEHRING INC;;DUNFEE WILLIAM DAVID;;ZHANG RICHARD RENRONG;;HADDAD ANTOINE ELIAS;;MYERS ROBERT EUGENE;;HAZELWOOD ROBERT FRANKLIN,DUNFEE WILLIAM DAVID;;ZHANG RICHARD RENRONG;;HADDAD ANTOINE ELIAS;;MYERS ROBERT EUGENE;;HAZELWOOD ROBERT FRANKLIN,,https://lens.org/172-264-585-820-481,Patent Application,yes,0,0,5,5,0,B08B3/022;;B08B3/04;;B08B9/00;;G01N35/1004;;B08B3/022;;B08B9/00;;B08B3/04;;G01N35/1004,B08B3/00,,0,0,,,,PENDING
457,WO,A3,WO 2008/057758 A3,009-515-694-617-451,2008-07-03,2008,US 2007/0082249 W,2007-10-23,US 55358306 A,2006-10-27,METHOD AND DEVICE FOR CLEANING A LIQUID ASPIRATION AND DISPENSE PROBE,"Cleaning a liquid sample probe with a cleansing station having sources of air, cleansing solution, bath and shower water in a two-weil cleansing body. The cleansing body comprises a multifunctional plate having features to provide both a wall of shower water and thin sheets of high velocity air that provide thorough cleaning of the sample probe.",SIEMENS HEALTHCARE DIAGNOSTICS;;DUNFEE WILLIAM DAVID;;ZHANG RICHARD RENRONG;;HADDAD ANTOINE ELIAS;;MYERS ROBERT EUGENE;;HAZELWOOD ROBERT FRANKLIN,DUNFEE WILLIAM DAVID;;ZHANG RICHARD RENRONG;;HADDAD ANTOINE ELIAS;;MYERS ROBERT EUGENE;;HAZELWOOD ROBERT FRANKLIN,,https://lens.org/009-515-694-617-451,Search Report,yes,3,0,5,5,0,B08B3/022;;B08B3/04;;B08B9/00;;G01N35/1004;;B08B3/022;;B08B9/00;;B08B3/04;;G01N35/1004,B01D29/58,,0,0,,,,PENDING
458,US,B2,US 11228523 B2,108-903-886-596-388,2022-01-18,2022,US 202016889651 A,2020-06-01,US 202016889651 A,2020-06-01,Infrastructure link path arrangement determination method and system,"A computer-implemented method and system for determining a path arrangement of an infrastructure link. The method includes receiving one or more inputs each indicative of a constraint; and processing the one or more inputs and a set of data based on a path arrangement determination model. The set of data includes data representing one or more factors affecting the path arrangement. The method also includes determining, based on the processing, the path arrangement of the infrastructure link.",UNIV CITY HONG KONG,ZUKERMAN MOSHE;;WANG ZENGFU;;WANG QING;;MORAN WILLIAM;;WANG XINYU;;TAHCHI ELIAS;;LEUNG FU CHU,CITY UNIVERSITY OF HONG KONG (2020-05-27),https://lens.org/108-903-886-596-388,Granted Patent,yes,13,0,2,2,0,H04L45/24;;H04L47/125;;H04L45/02;;H04L45/122;;H04L45/124;;H04L45/02;;H04L45/125;;H04L45/124;;H04L45/04;;H04L45/122,H04L45/02;;H04L45/122;;H04L45/125,,5,5,027-711-687-373-867;;027-968-064-447-843;;090-181-079-506-194;;031-787-479-905-107;;092-101-002-972-242,10.1109/access.2018.2854581;;10.1109/jlt.2017.2711658;;10.1111/mice.12287;;10.1364/oe.27.008221;;31052644;;10.1109/access.2019.2915125,"Wang, Z., et al., “Application of the Fast Marching Method for Path Planning of Long-haul Optical Fiber Cables With Shielding” IEEE Access, vol. 6, 2018, pp. 41367-41378.;;Wang, Z., et al., “A Seismic Resistant Design Algorithm for Laying and Shielding of Optical Fiber Cables” IEEE/OSA Journal of Lightwave Technology, vol. 35, 2017, No. 14, pp. 3060-3074.;;Wang, Z., et al., “Multiobjective Path Optimization for Critical Infrastructure Links with Consideration to Seismic Resilience” Computer-Aided Civil and Infrastructure Engineering, vol. 32, 2017, pp. 836-855.;;Wang, Z., et al., “Terrain Constrained Path Planning for Long-haul Cables,” Optics Express, vol. 27, No. 6, 2019, pp. 8221-8235.;;Wang, Q., et al., “Cost-Effective Path Planning for Submarine Cable Network Extension,” IEEE Access, vol. 7, 2019, pp. 61883-61895.",ACTIVE
459,EP,A1,EP 2366964 A1,027-275-264-909-297,2011-09-21,2011,EP 10380035 A,2010-03-15,EP 10380035 A,2010-03-15,Solar field cleaning system and cleaning method used by said system,"Cleaning system for solar fields, formed by heliostats or photovoltaic solar trackers, which is formed by a plurality of mobile autonomous robots (2), and at least one transport vehicle (7), which transports the robots (2), deposits them on the heliostats or on photovoltaic solar trackers for the robots to clean them, and collects them once they have finished the cleaning. The robots (2) have a chassis (3) in which there are arranged means for the displacement along all the reflective surfaces (1) of the heliostats or photovoltaic modules (1) of the solar trackers, cleaning means arranged on the front part (4) of the chassis (3), for the cleaning of reflective surfaces (1) or the photovoltaic modules (1), and navigation means, connected to the displacement means, which orient and direct the robot (2) in its displacement along the reflective surfaces (1) or of the photovoltaic modules (1).
",SENER ING & SIST,GONZALEZ ELIAS ANTONIO;;ESCALERA PINA JUAN ANTONIO;;HARDT GONZALEZ MICHAEL WILLIAM;;VILLA NAVARRO JOSE RAMON,,https://lens.org/027-275-264-909-297,Patent Application,yes,12,19,3,3,0,F24S40/20;;Y02E10/40,F24J2/46,,0,0,,,,DISCONTINUED
460,EP,A4,EP 2076323 A4,050-804-056-992-406,2012-05-02,2012,EP 07844540 A,2007-10-23,US 2007/0082249 W;;US 55358306 A,2006-10-27,METHOD AND DEVICE FOR CLEANING A LIQUID ASPIRATION AND DISPENSE PROBE,,SIEMENS HEALTHCARE DIAGNOSTICS,DUNFEE WILLIAM DAVID;;ZHANG RICHARD RENRONG;;HADDAD ANTOINE ELIAS;;MYERS ROBERT EUGENE;;HAZELWOOD ROBERT FRANKLIN,,https://lens.org/050-804-056-992-406,Search Report,no,5,0,5,5,0,B08B3/022;;B08B3/04;;B08B9/00;;G01N35/1004;;B08B3/022;;B08B9/00;;B08B3/04;;G01N35/1004,B01D29/58,,0,0,,,,DISCONTINUED
461,US,A1,US 2014/0018655 A1,092-021-919-360-299,2014-01-16,2014,US 201213549636 A,2012-07-16,US 201213549636 A,2012-07-16,BLOOD GLUCOSE METER INTEGRATED WITH A COMPUTING OR COMMUNICATION DEVICE,"A blood glucose meter integrated with a computing or communication device that includes a test strip receiving device that is coupled to and powered by the communication port or jack of the computing or communication device and utilizes a blood glucose meter application that resides in the memory and is operated by the microprocessor of the computing or communication device. Advantageously, blood glucose meter data can be transmitted by the computing or communication device to a memory storage “cloud” for later review and/or manipulation by a user, a doctor, and/or the like.",ABULHAJ RAMZI;;BAXTER WILLIAM;;SHEHAB AMR YEHIA MOHAMED;;KO MOO NAM;;MAROUF SAID;;MAHFOUD ELIAS;;PRODIGY DIABETES CARE LLC,ABULHAJ RAMZI;;BAXTER WILLIAM;;SHEHAB AMR YEHIA MOHAMED;;KO MOO NAM;;MAROUF SAID;;MAHFOUD ELIAS,PRODIGY DIABETES CARE LLC (2012-07-13),https://lens.org/092-021-919-360-299,Patent Application,yes,1,3,1,1,0,A61B5/14532;;A61B2560/0431;;A61B5/157;;A61B5/150854;;A61B5/150022;;A61B5/14532;;A61B2560/0431;;A61B5/157;;A61B5/150854;;A61B5/150022,A61B5/145,600/365,0,0,,,,DISCONTINUED
462,WO,A2,WO 2011/113555 A2,087-479-375-344-04X,2011-09-22,2011,EP 2011001213 W,2011-03-11,EP 10380035 A,2010-03-15,SOLAR FIELD CLEANING SYSTEM AND CLEANING METHOD USED BY SAID SYSTEM,"Cleaning system for solar fields, formed by heliostats or photovoltaic solar trackers, which is formed by a plurality of mobile autonomous robots (2), and at least one transport vehicle (7), which transports the robots (2), deposits them on the heliostats or on photovoltaic solar trackers for the robots to clean them, and collects them once they have finished the cleaning. The robots (2) have a chassis (3) in which there are arranged means for the displacement along all the reflective surfaces (1) of the heliostats or photovoltaic modules (1) of the solar trackers, cleaning means arranged on the front part (4) of the chassis (3), for the cleaning of reflective surfaces (1) or the photovoltaic modules (1), and navigation means, connected to the displacement means, which orient and direct the robot (2) in its displacement along the reflective surfaces (1) or of the photovoltaic modules (1).",SENER ING & SIST;;GONZALEZ ELIAS ANTONIO;;ESCALERA PINA JUAN ANTONIO;;HARDT GONZALEZ MICHAEL WILLIAM;;VILLA NAVARRO JOSE RAMON,GONZALEZ ELIAS ANTONIO;;ESCALERA PINA JUAN ANTONIO;;HARDT GONZALEZ MICHAEL WILLIAM;;VILLA NAVARRO JOSE RAMON,,https://lens.org/087-479-375-344-04X,Patent Application,yes,3,3,3,3,0,F24S40/20;;Y02E10/40,F24J2/46,,0,0,,,,PENDING
463,EP,A2,EP 2076323 A2,009-355-117-286-058,2009-07-08,2009,EP 07844540 A,2007-10-23,US 2007/0082249 W;;US 55358306 A,2006-10-27,METHOD AND DEVICE FOR CLEANING A LIQUID ASPIRATION AND DISPENSE PROBE,,SIEMENS HEALTHCARE DIAGNOSTICS,DUNFEE WILLIAM DAVID;;ZHANG RICHARD RENRONG;;HADDAD ANTOINE ELIAS;;MYERS ROBERT EUGENE;;HAZELWOOD ROBERT FRANKLIN,,https://lens.org/009-355-117-286-058,Patent Application,yes,0,0,5,5,0,B08B3/022;;B08B3/04;;B08B9/00;;G01N35/1004;;B08B3/022;;B08B9/00;;B08B3/04;;G01N35/1004,B01D29/58,,0,0,,,,DISCONTINUED
464,WO,A3,WO 2011/113555 A3,146-569-050-887-481,2012-03-08,2012,EP 2011001213 W,2011-03-11,EP 10380035 A,2010-03-15,SOLAR FIELD CLEANING SYSTEM AND CLEANING METHOD USED BY SAID SYSTEM,"Cleaning system for solar fields, formed by heliostats or photovoltaic solar trackers, which is formed by a plurality of mobile autonomous robots (2), and at least one transport vehicle (7), which transports the robots (2), deposits them on the heliostats or on photovoltaic solar trackers for the robots to clean them, and collects them once they have finished the cleaning. The robots (2) have a chassis (3) in which there are arranged means for the displacement along all the reflective surfaces (1) of the heliostats or photovoltaic modules (1) of the solar trackers, cleaning means arranged on the front part (4) of the chassis (3), for the cleaning of reflective surfaces (1) or the photovoltaic modules (1), and navigation means, connected to the displacement means, which orient and direct the robot (2) in its displacement along the reflective surfaces (1) or of the photovoltaic modules (1).",SENER ING & SIST;;GONZALEZ ELIAS ANTONIO;;ESCALERA PINA JUAN ANTONIO;;HARDT GONZALEZ MICHAEL WILLIAM;;VILLA NAVARRO JOSE RAMON,GONZALEZ ELIAS ANTONIO;;ESCALERA PINA JUAN ANTONIO;;HARDT GONZALEZ MICHAEL WILLIAM;;VILLA NAVARRO JOSE RAMON,,https://lens.org/146-569-050-887-481,Search Report,yes,10,0,3,3,0,F24S40/20;;Y02E10/40,F24J2/46,,0,0,,,,PENDING
465,US,A1,US 2008/0099057 A1,049-653-873-782-424,2008-05-01,2008,US 55358306 A,2006-10-27,US 55358306 A,2006-10-27,Method and Device for Cleaning a Liquid Aspiration and Dispense Probe,"Cleaning a liquid sample probe with a cleansing station having sources of air, cleansing solution, bath and shower water in a two-well cleansing body. The cleansing body comprises a multifunctional plate having features to provide both a wall of shower water and thin sheets of high velocity air that provide thorough cleaning of the sample probe",DADE BEHRING INC,DUNFEE WILLIAM DAVID;;HADDAD ANTOINE ELIAS;;HAZELWOOD ROBERT FRANKLIN;;MYERS ROBERT EUGENE;;ZHANG RICHARD RENRONG,DADE BEHRING INC (2006-10-23);;SIEMENS HEALTHCARE DIAGNOSTICS INC (2007-12-31),https://lens.org/049-653-873-782-424,Patent Application,yes,20,27,5,5,0,B08B3/022;;B08B3/04;;B08B9/00;;G01N35/1004;;B08B3/022;;B08B9/00;;B08B3/04;;G01N35/1004,B08B3/00,134/94.1;;134/198,0,0,,,,DISCONTINUED
466,BR,A2,BR 102019009574 A2,117-894-042-014-960,2020-11-24,2020,BR 102019009574 A,2019-05-10,BR 102019009574 A,2019-05-10,dispositivo e método de controle para mortalhas térmicas de uma câmara termo vácuo,"dispositivo e método de controle para mortalhas térmicas de uma câmara termo vácuo dispositivo e método de controle, através de uma interface homem-máquina de um software de controle e supervisão, controlam as temperaturas das múltiplas mortalhas à uma pressão negativa (vácuo), facilitando e atendendo aos padrões rigorosos exigidos pelos testes aeroespaciais referentes aos equipamentos que serão submetidos às missões espaciais.",INST FEDERAL DE EDUCACAO CIENCIA E TECNOLOGIA FLUMINENSE,CEDRIC SALOTTO CORDEIRO;;JOÃO ELIAS MOTHÉ;;ROGERIO ATEM DE CARVALHO;;RONNAN SEIJI TATIBANA;;WILLIAM DA SILVA VIANNA;;WILLIAM DOS SANTOS OLIVEIRA,,https://lens.org/117-894-042-014-960,Patent Application,no,0,0,1,1,0,,B64G1/50;;G05D23/19,,0,0,,,,DISCONTINUED
467,US,A1,US 2009/0087234 A1,022-358-783-653-766,2009-04-02,2009,US 86222307 A,2007-09-27,US 86222307 A,2007-09-27,ENHANCED FUSER STRIPPING SYSTEM,"An improved fuser includes a fuser member, a pressure member that forms a nip with the fuser member through which copy sheets pass to have images fused thereon and an air knife to assist in peeling copy sheets from the fuser member. The air knife has a device connected to it that blocks entrained airflow between the fuser and air knife to reduce fuser cooling and power loss.",XEROX CORP,ROOF BRYAN J;;PANIDES ELIAS;;KLADIAS NICHOLAS;;DOMOTO GERALD A;;BURTON WILLIAM A;;RUSSEL STEVEN M,XEROX CORPORATION (2007-09-19),https://lens.org/022-358-783-653-766,Patent Application,yes,9,9,2,2,0,G03G15/2028;;G03G15/2028,G03G15/20,399/323,0,0,,,,INACTIVE
468,US,B2,US 7676187 B2,099-419-402-151-405,2010-03-09,2010,US 86222307 A,2007-09-27,US 86222307 A,2007-09-27,Enhanced fuser stripping system,"An improved fuser includes a fuser member, a pressure member that forms a nip with the fuser member through which copy sheets pass to have images fused thereon and an air knife to assist in peeling copy sheets from the fuser member. The air knife has a device connected to it that blocks entrained airflow between the fuser and air knife to reduce fuser cooling and power loss.",XEROX CORP,ROOF BRYAN J;;PANIDES ELIAS;;KLADIAS NICHOLAS;;DOMOTO GERALD A;;BURTON WILLIAM A;;RUSSEL STEVEN M,XEROX CORPORATION (2007-09-19),https://lens.org/099-419-402-151-405,Granted Patent,yes,11,0,2,2,0,G03G15/2028;;G03G15/2028,G03G15/20,399/323,0,0,,,,INACTIVE
469,CA,A,CA 552934 A,180-475-402-951-13X,1958-02-11,1958,CA 552934D A,,CA 552934T A,,PENICILLIN COMPOSITIONS,,AMERICAN HOME PROD,BRUCE WILLIAM F;;SHAW DANIEL L JR;;BARNETT JOHN O;;ELIAS WILLIAM F;;EDWARDS CHARLES D;;APAT JOSEPH K;;MERRION HOWARD J,,https://lens.org/180-475-402-951-13X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
470,CH,A,CH 331049 A,184-007-384-498-316,1958-06-30,1958,CH 331049D A,1953-10-29,US 331049X A;;US 34616253 A;;US 328076X A,1952-10-29,Verfahren zur Herstellung eines Penicillinsalzes,,AMERICAN HOME PROD,WILLIAM FAUSSET BRUCE;;CHARLES DAVID EDWARDS;;JOSEPH KLARENCE APAT;;WILLIAM FRANK ELIAS;;HOWARD JOSEPH MERRION;;OSWALD BARNETT J;;DANIEL LEONARD JR SHAW,,https://lens.org/184-007-384-498-316,Granted Patent,no,0,0,1,18,0,C07D499/00,C07D499/00;;C07D499/24,116H,0,0,,,,EXPIRED
471,KR,A,KR 20190109604 A,062-369-242-065-149,2019-09-25,2019,KR 20197027514 A,2017-05-03,US 201615148574 A;;US 201615178812 A;;US 2017/0030772 W,2016-05-06,PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF,"약학적 안과용 조성물이 기재되며, 상기 조성물은 치료적 유효량의 항균제 (예컨대 목시플록사신), 치료적 유효량의 항염증제 (예컨대 프레드니솔론), 적어도 둘의 가용화 및 현탁화제의 조합 (그 중 하나는 비이온성 폴리옥시에틸렌-폴리옥시프로필렌 블록 공중합체임), 및 담체로 본질적으로 이루어진다. 조성물의 제조 및 사용 방법이 또한 기재된다.",HARROW HEALTH INC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS;;LIEGNER JEFFREY T;;KAROLCHYK JOHN SCOTT;;COVALESKY BERNARD;;PETERS KALLAN,,https://lens.org/062-369-242-065-149,Patent Application,no,0,2,11,52,0,A61K31/196;;A61K31/4709;;A61K9/0048;;A61K47/10;;A61K47/26;;A61K9/10;;A61K47/38;;A61K31/47;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61P27/02;;A61P27/02;;A61K9/0048;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61K2300/00,A61K9/00;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61P27/02,,0,0,,,,DISCONTINUED
472,CN,U,CN 216424291 U,171-821-899-900-081,2022-05-03,2022,CN 202120849552 U,2021-04-23,US 202063014401 P,2020-04-23,Bent glass article,"Embodiments of curved glass articles are disclosed herein. The curved glass article includes a glass sheet having a first major surface and a second major surface. The glass sheet is bent to define a bending region disposed between the flat sections. The curved glass article also includes a carrier adhered to the glass sheet. The carrier includes longitudinal strips and lateral strips. The longitudinal strip defines a radius of curvature of the curved region. The lateral strips extend between the longitudinal strips. In the flat section, the glass sheet deviates from the plane by 0.3 mm or less. Each longitudinal strip has a width Wlong of 2 mm or less. Each first lateral strip has a width Wlat of 20 mm or less. At least a portion of the width Wlat of each lateral strip is located in the curved region and the flat section.",CORNING COMPANY,DAVE GAURAV;;RAYOUNI KHALED;;LIU MINCONG;;MERY ELIAS;;PIERON QUENTIN JEAN ANDRE;;PRICE MICHAEL WILLIAM;;TAHIR FARAZ,,https://lens.org/171-821-899-900-081,Limited Patent,no,0,0,8,8,0,B32B37/12;;B32B38/1866;;B32B2457/20;;B32B17/061;;B32B17/067;;B32B17/10;;C03C21/002;;C03C27/00;;C03C27/00;;C03C17/00;;C03C21/002;;C03B23/023;;B32B7/12;;B32B17/061;;B32B17/10;;B32B37/12;;B32B38/0012;;B32B2307/732;;B32B2457/20;;C03B23/023;;C03C27/04,B60R13/02,,0,0,,,,ACTIVE
473,EP,A4,EP 3452033 A4,007-667-715-674-800,2020-02-12,2020,EP 17793224 A,2017-05-03,US 201615148574 A;;US 201615178812 A;;US 2017/0030772 W,2016-05-06,PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF,,HARROW IP LLC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS;;LIEGNER JEFFREY T;;KAROLCHYK JOHN SCOTT;;COVALESKY BERNARD;;PETERS KALLAN,"HARROW HEALTH, INC. (2019-03-20);;HARROW IP, LLC (2020-01-08)",https://lens.org/007-667-715-674-800,Search Report,no,3,0,11,52,0,A61K31/196;;A61K31/4709;;A61K9/0048;;A61K47/10;;A61K47/26;;A61K9/10;;A61K47/38;;A61K31/47;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61P27/02;;A61P27/02;;A61K9/0048;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61K2300/00,A61K31/196;;A61K9/10;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61P27/02,,1,0,,,See also references of WO 2017192675A1,DISCONTINUED
474,US,A1,US 2002/0194052 A1,064-544-139-521-108,2002-12-19,2002,US 87851801 A,2001-06-11,US 87851801 A,2001-06-11,Method and system for analyzing application needs of an entity,"
   A method and system for analyzing application needs on an entity. Specifically, the present invention presents an entity with sets of questions and weighted responses pertaining to the entity's applications. The sets of questions and weighted responses are formulated based upon the entity's business strategy. The entity's responses to the questions are analyzed. Based on the analysis, recommendations regarding the entity's applications are made. 
",IBM,DELANO PAULA F;;DUGGINS WENDELL L;;OLSON ELIAS;;PARRIS CYNTHIA L;;TRUMBLE JOHN L;;WESTBERRY WILLIAM A,INTERNATIONAL BUSINESS MACHINES CORPORATION (2001-06-01),https://lens.org/064-544-139-521-108,Patent Application,yes,17,9,1,1,0,G06Q10/06;;G06Q10/06;;G06Q10/0637;;G06Q10/0637;;G06Q30/02;;G06Q30/02;;G06Q30/0203;;G06Q30/0203,G06Q10/06;;G06Q30/02,705 1,0,0,,,,DISCONTINUED
475,US,A1,US 2018/0340395 A1,169-483-637-466-341,2018-11-29,2018,US 201715605716 A,2017-05-25,US 201715605716 A,2017-05-25,Flow Back Retrieval Method for Borehole Plug with a Lower Slip Assembly,"A borehole plug or packer for treating is designed to be flowed back to a surface location after use. When the treatment is concluded pressure from above is relieved or lowered, and well fluid is flowed back, so that the plug or plugs disengages at slips designed to resist differential pressure from above. The application of differential pressure from below causes the lower slips to release one or more of such plugs in the hole into specialized sub surface or surface capture equipment so that well pressure is relieved before removal of the plugs from specialized subsurface or surface capture equipment.",BAKER HUGHES A GE CO LLC,WISE TRISTAN R;;SILVA ZACHARY S;;PENA ELIAS;;CASANOVA GABRIEL F;;GONZALEZ HECTOR O;;HANDY WILLIAM B,BAKER HUGHES HOLDINGS LLC (2017-05-23),https://lens.org/169-483-637-466-341,Patent Application,yes,0,0,3,12,0,E21B33/129;;E21B33/1291;;E21B23/01;;E21B33/129,E21B33/129;;E21B23/01;;E21B23/04,,0,0,,,,ACTIVE
476,EP,A1,EP 3452033 A1,093-872-115-781-778,2019-03-13,2019,EP 17793224 A,2017-05-03,US 201615148574 A;;US 201615178812 A;;US 2017/0030772 W,2016-05-06,PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF,,IMPRIMIS PHARMACEUTICALS INC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS;;LIEGNER JEFFREY T;;KAROLCHYK JOHN SCOTT;;COVALESKY BERNARD;;PETERS KALLAN,"HARROW HEALTH, INC. (2019-03-20);;HARROW IP, LLC (2020-01-08)",https://lens.org/093-872-115-781-778,Patent Application,yes,0,0,11,52,0,A61K31/196;;A61K31/4709;;A61K9/0048;;A61K47/10;;A61K47/26;;A61K9/10;;A61K47/38;;A61K31/47;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61P27/02;;A61P27/02;;A61K9/0048;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61K2300/00,A61K31/196;;A61K31/4709;;A61K31/593,,0,0,,,,DISCONTINUED
477,US,A1,US 2019/0111045 A1,028-411-036-084-799,2019-04-18,2019,US 201715552450 A,2017-05-03,US 201715552450 A;;US 201615178812 A;;US 201615148574 A;;US 2017/0030772 W,2016-05-06,PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF,"Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.",HARROW HEALTH INC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS;;LIEGNER JEFFREY T;;KAROLCHYK JOHN SCOTT;;COVALESKY BERNARD;;PETERS KALLAN,HARROW HEALTH INC (2018-12-27);;HARROW IP LLC (2019-11-01),https://lens.org/028-411-036-084-799,Patent Application,yes,0,9,1,52,0,A61K9/0051;;A61K47/10;;A61K47/183;;A61K31/4709;;A61K9/0048;;A61P31/04;;A61P27/02;;A61K31/196;;A61K47/26;;A61K38/14;;A61K31/573;;A61K38/12;;A61K31/4709;;A61K9/0048;;A61P31/04;;A61P27/02;;A61K31/196;;A61K47/34;;A61K47/26;;A61K38/14;;A61K31/573;;A61K47/10;;A61K38/12;;A61K47/183;;A61K9/0051,A61K31/4709;;A61K9/00;;A61K31/196;;A61K31/573;;A61K38/14;;A61K47/26;;A61K47/34;;A61P27/02;;A61P31/04,,0,0,,,,DISCONTINUED
478,KR,A,KR 20230008100 A,148-598-258-785-236,2023-01-13,2023,KR 20227039828 A,2021-04-13,US 202063014401 P;;US 2021/0026996 W,2020-04-23,최소화된 형상 편차 및 작은 베젤 폭을 위해 구성된 프레임을 갖는 유리 물품,만곡된 유리 물품의 구현 예가 개시된다. 상기 만곡된 유리 물품은 유리 시트의 제1 및 제2 주표면을 포함한다. 상기 유리 시트는 평면 섹션들 사이에 배치된 만곡된 영역을 정의하도록 구부러진다. 상기 만곡된 유리 물품은 또한 상기 유리 시트에 접착된 캐리어를 포함한다. 상기 캐리어는 세로 스트립 및 가로 스트립을 포함한다. 상기 세로 스트립은 만곡된 영역의 곡률 반경을 정의한다. 상기 가로 스트립은 세로 스트립들 사이에 연장된다. 상기 유리 시트는 평면 섹션에서 평면으로부터 0.3 mm 이하로 벗어난다. 상기 세로 스트립들은 각각 2 mm 이하의 폭(Wlong)을 갖는다. 상기 제1 가로 스트립들은 각각 20 mm 이하의 폭(Wlat)을 갖는다. 각각의 가로 스트립의 폭(Wlat)의 적어도 일부는 만곡된 영역 및 평면 섹션에 위치된다.,CORNING INC,DAVE GAURAV;;LAYOUNI KHALED;;LIU MINCONG;;MERHY ELIAS;;PIERRON QUENTIN JEAN ANDRE;;PRICE MICHAEL WILLIAM;;TAHIR FRAAZ,,https://lens.org/148-598-258-785-236,Patent Application,no,0,0,8,8,0,B32B37/12;;B32B38/1866;;B32B2457/20;;B32B17/061;;B32B17/067;;B32B17/10;;C03C21/002;;C03C27/00;;C03C27/00;;C03C17/00;;C03C21/002;;C03B23/023;;B32B7/12;;B32B17/061;;B32B17/10;;B32B37/12;;B32B38/0012;;B32B2307/732;;B32B2457/20;;C03B23/023;;C03C27/04,C03C27/00;;C03B23/023;;C03C17/00;;C03C21/00,,0,0,,,,PENDING
479,US,B2,US 10392897 B2,054-360-073-170-958,2019-08-27,2019,US 201715605716 A,2017-05-25,US 201715605716 A,2017-05-25,Flow back retrieval method for borehole plug with a lower slip assembly,"A borehole plug or packer for treating is designed to be flowed back to a surface location after use. When the treatment is concluded pressure from above is relieved or lowered, and well fluid is flowed back, so that the plug or plugs disengages at slips designed to resist differential pressure from above. The application of differential pressure from below causes the lower slips to release one or more of such plugs in the hole into specialized sub surface or surface capture equipment so that well pressure is relieved before removal of the plugs from specialized subsurface or surface capture equipment.",BAKER HUGHES A GE CO LLC,WISE TRISTAN R;;SILVA ZACHARY S;;PENA ELIAS;;CASANOVA GABRIEL F;;GONZALEZ HECTOR O;;HANDY WILLIAM B,BAKER HUGHES HOLDINGS LLC (2017-05-23),https://lens.org/054-360-073-170-958,Granted Patent,yes,10,0,3,12,0,E21B33/129;;E21B33/1291;;E21B23/01;;E21B33/129,E21B33/129;;E21B23/01;;E21B23/04,,0,0,,,,ACTIVE
480,EP,A1,EP 4139130 A1,025-275-121-243-19X,2023-03-01,2023,EP 21723074 A,2021-04-13,US 202063014401 P;;US 2021/0026996 W,2020-04-23,GLASS ARTICLE HAVING FRAME CONFIGURED FOR MINIMAL SHAPE DEVIATION AND HAVING SMALL BEZEL WIDTH,,CORNING INC,DAVE GAURAV;;LAYOUNI KHALED;;LIU MINCONG;;MERHY ELIAS;;PIERRON QUENTIN JEAN ANDRÉ;;PRICE MICHAEL WILLIAM;;TAHIR FRAAZ,,https://lens.org/025-275-121-243-19X,Patent Application,yes,0,0,8,8,0,B32B37/12;;B32B38/1866;;B32B2457/20;;B32B17/061;;B32B17/067;;B32B17/10;;C03C21/002;;C03C27/00;;C03C27/00;;C03C17/00;;C03C21/002;;C03B23/023;;B32B7/12;;B32B17/061;;B32B17/10;;B32B37/12;;B32B38/0012;;B32B2307/732;;B32B2457/20;;C03B23/023;;C03C27/04,B32B37/12;;B32B38/18;;C03C27/10;;G02F1/1333,,0,0,,,,PENDING
481,US,A1,US 2023/0182459 A1,109-614-046-304-94X,2023-06-15,2023,US 202117920887 A,2021-04-13,US 202117920887 A;;US 202063014401 P;;US 2021/0026996 W,2020-04-23,GLASS ARTICLE HAVING FRAME CONFIGURED FOR MINIMAL SHAPE DEVIATION AND HAVING SMALL BEZEL WIDTH,Emobidments of a curved glass article are disclosed herein. The curved glass article includes a glass sheet first and second major surfaces. The glass sheet is bent to define a curved region disposed between flat sections. The curved glass article also includes a carrier adhered to the glass sheet. The carrier includes longitudinal strips and lateral strips. The longitudinal strips define the radius of curvature of the curved region. The lateral strips extend between the longitudinal strips. The glass sheet deviates 0.3 mm or less from planar in the flat sections. The longitudinal strips each have a width W long of 2 mm or less. The first lateral strips each have a width W lat of 20 mm or less. At least a portion of the width W lat of each lateral strip is located in the curved region and a flat section.,CORNING INC,DAVE GAURAV;;LAYOUNI KHALED;;LIU MINCONG;;MERHY ELIAS;;PIERRON QUENTIN JEAN ANDRÉ;;PRICE MICHAEL WILLIAM;;TAHIR FRAAZ,,https://lens.org/109-614-046-304-94X,Patent Application,yes,5,0,8,8,0,B32B37/12;;B32B38/1866;;B32B2457/20;;B32B17/061;;B32B17/067;;B32B17/10;;C03C21/002;;C03C27/00;;C03C27/00;;C03C17/00;;C03C21/002;;C03B23/023;;B32B7/12;;B32B17/061;;B32B17/10;;B32B37/12;;B32B38/0012;;B32B2307/732;;B32B2457/20;;C03B23/023;;C03C27/04,B32B37/12;;B32B7/12;;B32B17/06;;B32B17/10;;B32B38/00;;C03C27/04,,0,0,,,,PENDING
482,CA,A1,CA 3005588 A1,107-653-797-533-371,2018-11-25,2018,CA 3005588 A,2018-05-22,US 201715605716 A,2017-05-25,FLOW BACK RETRIEVAL METHOD FOR BOREHOLE PLUG WITH A LOWER SLIP ASSEMBLY,"A borehole plug or packer for treating is designed to be flowed back to a surface location after use. When the treatment is concluded pressure from above is relieved or lowered, and well fluid is flowed back, so that the plug or plugs disengages at slips designed to resist differential pressure from above. The application of differential pressure from below causes the lower slips to release one or more of such plugs in the hole into specialized sub surface or surface capture equipment so that well pressure is relieved before removal of the plugs from specialized subsurface or surface capture equipment.",BAKER HUGHES A GE CO LLC,WISE TRISTAN R;;SILVA ZACHARY S;;PENA ELIAS;;CASANOVA GABRIEL F;;GONZALEZ HECTOR O;;HANDY WILLIAM B,,https://lens.org/107-653-797-533-371,Patent Application,no,0,1,3,12,0,E21B33/129;;E21B33/1291;;E21B23/01;;E21B33/129,E21B23/00;;E21B23/06;;E21B33/068;;E21B33/129,,0,0,,,,PENDING
483,AU,A1,AU 2017/260327 A1,145-986-611-252-47X,2018-11-29,2018,AU 2017/260327 A,2017-05-03,US 201615178812 A;;US 201615148574 A;;US 2017/0030772 W,2016-05-06,Pharmaceutical Ophthalmic compositions and methods for fabricating thereof,"Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.",IMPRIMIS PHARMACEUTICALS INC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS;;LIEGNER JEFFREY T;;KAROLCHYK JOHN SCOTT;;COVALESKY BERNARD;;PETERS KALLAN,"HARROW HEALTH, INC. (2019-01-31);;HARROW IP, LLC (2019-11-21)",https://lens.org/145-986-611-252-47X,Patent Application,no,0,0,11,52,0,A61K31/196;;A61K31/4709;;A61K9/0048;;A61K47/10;;A61K47/26;;A61K9/10;;A61K47/38;;A61K31/47;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61P27/02;;A61P27/02;;A61K9/0048;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61K2300/00,A61K31/196;;A61K31/4709;;A61K31/593,,0,0,,,,INACTIVE
484,CA,C,CA 3023243 C,058-371-926-718-575,2020-01-21,2020,CA 3023243 A,2017-05-03,US 201615148574 A;;US 201615178812 A;;US 2017/0030772 W,2016-05-06,PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF,"Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.",IMPRIMIS PHARMACEUTICALS INC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS;;LIEGNER JEFFREY T;;KAROLCHYK JOHN SCOTT;;COVALESKY BERNARD;;PETERS KALLAN,,https://lens.org/058-371-926-718-575,Granted Patent,no,0,0,11,52,0,A61K31/196;;A61K31/4709;;A61K9/0048;;A61K47/10;;A61K47/26;;A61K9/10;;A61K47/38;;A61K31/47;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61P27/02;;A61P27/02;;A61K9/0048;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61K2300/00,A61K31/196;;A61K31/4709;;A61K31/593,,0,0,,,,INACTIVE
485,KR,A,KR 20180126087 A,116-398-764-209-031,2018-11-26,2018,KR 20187033036 A,2017-05-03,US 201615148574 A;;US 201615178812 A;;US 2017/0030772 W,2016-05-06,약학적 안과용 조성물 및 그의 제조 방법,"약학적 안과용 조성물이 기재되며, 상기 조성물은 치료적 유효량의 항균제 (예컨대 목시플록사신), 치료적 유효량의 항염증제 (예컨대 프레드니솔론), 적어도 둘의 가용화 및 현탁화제의 조합 (그 중 하나는 비이온성 폴리옥시에틸렌-폴리옥시프로필렌 블록 공중합체임), 및 담체로 본질적으로 이루어진다. 조성물의 제조 및 사용 방법이 또한 기재된다.",IMPRIMIS PHARMACEUTICALS INC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS;;LIEGNER JEFFREY T;;KAROLCHYK JOHN SCOTT;;COVALESKY BERNARD;;PETERS KALLAN,,https://lens.org/116-398-764-209-031,Patent Application,no,0,0,11,52,0,A61K31/196;;A61K31/4709;;A61K9/0048;;A61K47/10;;A61K47/26;;A61K9/10;;A61K47/38;;A61K31/47;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61P27/02;;A61P27/02;;A61K9/0048;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61K2300/00,A61K9/00;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K47/10;;A61K47/26;;A61K47/38,,0,0,,,,DISCONTINUED
486,CA,A1,CA 3023243 A1,019-357-114-065-446,2017-11-09,2017,CA 3023243 A,2017-05-03,US 201615148574 A;;US 201615178812 A;;US 2017/0030772 W,2016-05-06,PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF,"Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.",IMPRIMIS PHARMACEUTICALS INC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS;;LIEGNER JEFFREY T;;KAROLCHYK JOHN SCOTT;;COVALESKY BERNARD;;PETERS KALLAN,,https://lens.org/019-357-114-065-446,Patent Application,no,0,0,11,52,0,A61K31/196;;A61K31/4709;;A61K9/0048;;A61K47/10;;A61K47/26;;A61K9/10;;A61K47/38;;A61K31/47;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61P27/02;;A61P27/02;;A61K9/0048;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61K2300/00,A61K31/196;;A61K31/4709;;A61K31/593,,0,0,,,,INACTIVE
487,WO,A1,WO 2021/216317 A1,192-849-515-241-029,2021-10-28,2021,US 2021/0026996 W,2021-04-13,US 202063014401 P,2020-04-23,GLASS ARTICLE HAVING FRAME CONFIGURED FOR MINIMAL SHAPE DEVIATION AND HAVING SMALL BEZEL WIDTH,Emobidments of a curved glass article are disclosed herein. The curved glass article includes a glass sheet first and second major surfaces. The glass sheet is bent to define a curved region disposed between flat sections. The curved glass article also includes a carrier adhered to the glass sheet. The carrier includes longitudinal strips and lateral strips. The longitudinal strips define the radius of curvature of the curved region. The lateral strips extend between the longitudinal strips. The glass sheet deviates 0.3 mm or less from planar in the flat sections. The longitudinal strips each have a width W long of 2 mm or less. The first lateral strips each have a width W lat of 20 mm or less. At least a portion of the width W lat of each lateral strip is located in the curved region and a flat section.,CORNING INC,DAVE GAURAV;;LAYOUNI KHALED;;LIU MINCONG;;MERHY ELIAS;;PIERRON QUENTIN JEAN ANDRÉ;;PRICE MICHAEL WILLIAM;;TAHIR FRAAZ,,https://lens.org/192-849-515-241-029,Patent Application,yes,3,0,8,8,0,B32B37/12;;B32B38/1866;;B32B2457/20;;B32B17/061;;B32B17/067;;B32B17/10;;C03C21/002;;C03C27/00;;C03C27/00;;C03C17/00;;C03C21/002;;C03B23/023;;B32B7/12;;B32B17/061;;B32B17/10;;B32B37/12;;B32B38/0012;;B32B2307/732;;B32B2457/20;;C03B23/023;;C03C27/04,B32B37/12;;B32B38/18;;C03C27/10;;G02F1/1333,,0,0,,,,PENDING
488,CN,A,CN 115666947 A,040-340-024-973-299,2023-01-31,2023,CN 202180036948 A,2021-04-13,US 202063014401 P;;US 2021/0026996 W,2020-04-23,GLASS ARTICLE HAVING FRAME FOR MINIMAL SHAPE DEFINITIES AND HAVING,"Embodiments of curved glass articles are disclosed herein. The curved glass article includes a glass sheet having a first major surface and a second major surface. The glass sheet is bent to define a bending region disposed between the flat sections. The curved glass article also includes a carrier adhered to the glass sheet. The carrier includes longitudinal strips and lateral strips. The longitudinal strip defines a radius of curvature of the curved region. The lateral strips extend between the longitudinal strips. In the flat section, the glass sheet deviates from the plane by 0.3 mm or less. Each longitudinal strip has a width Wlong of 2 mm or less. Each first lateral strip has a width Wlat of 20 mm or less. At least a portion of the width Wlat of each lateral strip is located in the curved region and the flat section.",CORNING INC,DAVE GAURAV;;RAYOUNI KHALED;;LIU MINCONG;;MERY ELIAS;;PIERON QUENTIN JEAN ANDRE;;PRICE MICHAEL WILLIAM;;TAHIR FARAZ,,https://lens.org/040-340-024-973-299,Patent Application,no,0,0,8,8,0,B32B37/12;;B32B38/1866;;B32B2457/20;;B32B17/061;;B32B17/067;;B32B17/10;;C03C21/002;;C03C27/00;;C03C27/00;;C03C17/00;;C03C21/002;;C03B23/023;;B32B7/12;;B32B17/061;;B32B17/10;;B32B37/12;;B32B38/0012;;B32B2307/732;;B32B2457/20;;C03B23/023;;C03C27/04,B32B37/12;;B32B38/18;;C03C27/10;;G02F1/1333,,0,0,,,,PENDING
489,WO,A1,WO 2017/192675 A1,196-731-977-500-381,2017-11-09,2017,US 2017/0030772 W,2017-05-03,US 201615148574 A;;US 201615178812 A,2016-05-06,PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF,"Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.",IMPRIMIS PHARMACEUTICALS INC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS;;LIEGNER JEFFREY T;;KAROLCHYK JOHN SCOTT;;COVALESKY BERNARD;;PETERS KALLAN,,https://lens.org/196-731-977-500-381,Patent Application,yes,5,4,11,52,0,A61K31/196;;A61K31/4709;;A61K9/0048;;A61K47/10;;A61K47/26;;A61K9/10;;A61K47/38;;A61K31/47;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61P27/02;;A61P27/02;;A61K9/0048;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61K2300/00,A61K31/196;;A61K31/4709;;A61K31/593,,1,0,,,See also references of EP 3452033A4,PENDING
490,AU,B2,AU 2017/260327 B2,187-155-011-270-531,2018-12-20,2018,AU 2017/260327 A,2017-05-03,US 201615178812 A;;US 201615148574 A;;US 2017/0030772 W,2016-05-06,Pharmaceutical Ophthalmic compositions and methods for fabricating thereof,"Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.",HARROW IP LLC,WILEY WILLIAM;;DILZER RICHARD;;SAADEH DENNIS ELIAS;;LIEGNER JEFFREY T;;KAROLCHYK JOHN SCOTT;;COVALESKY BERNARD;;PETERS KALLAN,"HARROW HEALTH, INC. (2019-01-31);;HARROW IP, LLC (2019-11-21)",https://lens.org/187-155-011-270-531,Granted Patent,no,5,0,11,52,0,A61K31/196;;A61K31/4709;;A61K9/0048;;A61K47/10;;A61K47/26;;A61K9/10;;A61K47/38;;A61K31/47;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61P27/02;;A61P27/02;;A61K9/0048;;A61K9/10;;A61K31/196;;A61K31/47;;A61K31/4709;;A61K31/496;;A61K31/573;;A61K38/14;;A61K45/06;;A61K47/10;;A61K47/26;;A61K47/38;;A61K2300/00,A61K31/196;;A61K31/4709;;A61K31/593,,0,0,,,,INACTIVE
491,WO,A1,WO 2014/130656 A1,105-038-560-613-456,2014-08-28,2014,US 2014/0017363 W,2014-02-20,US 201313772061 A,2013-02-20,RECOVERABLE DATA ACQUISITION SYSTEM AND METHOD OF SENSING AT LEAST ONE PARAMETER OF A SUBTERRANEAN BORE,A recoverable data acquisition system includes at least one sensor positionable within a tubular of a completion system that is recoverable therefrom.,BAKER HUGHES INC,MILLER II JAMES L;;MAILAND JASON;;PENA ELIAS;;SANCHEZ JAMES SCOTT;;HANDY WILLIAM B;;ELLIOTT CHRISTOPHER;;MATTHEWS DANIEL,,https://lens.org/105-038-560-613-456,Patent Application,yes,5,0,7,7,0,E21B47/01;;Y10T29/49819;;E21B47/26;;Y10T29/49819;;E21B47/01;;E21B47/26,E21B47/01;;E21B47/12,,0,0,,,,PENDING
492,EP,A1,EP 3734483 A1,177-316-254-038-333,2020-11-04,2020,EP 20163792 A,2020-03-18,US 201916403296 A,2019-05-03,"SYSTEMS AND METHODS FOR INTELLECTUAL PROPERTY-SECURED, REMOTE DEBUGGING","Systems and techniques of the present disclosure may provide remote debugging of an integrated circuit (IC) device while preventing unauthorized access of device intellectual property (IP). A system may include an IC device that generates an encrypted session key and an interface that enables communication between the IC device and a remote debugging site. The interface may enable the IC device to send the encrypted the encrypted session key to initiate a remote debug process, receive an acknowledgement from the remote debugging session, and authenticate the acknowledgement. Further, the interface may enable to the IC device to initiate a secure debug session between the IC device and the remote debugging site.
",INTEL CORP,KURTS TSVIKA;;DOLGUNOV BORIS;;MLADENTSEV VLADISLAV;;ANATI ITTAI;;KHOURY ELIAS;;KIMA MAOR;;SHLOMO ERAN;;GUERON SHAY;;PENNER WILLIAM,,https://lens.org/177-316-254-038-333,Patent Application,yes,0,0,6,6,0,H04L63/0428;;H04L63/06;;H04L63/12;;G06F21/602;;G06F21/606;;H04L67/025;;H04L63/0428;;H04L63/0435;;G06F11/3656;;G06F16/22;;G01R31/31705;;G01R31/31719;;G01R31/3177;;G06F11/263;;H04L9/0631;;H04L9/0819;;H04L9/0894;;H04L9/321,G06F21/60;;G06F11/36;;H04L29/06;;H04L29/08,,4,3,107-330-287-134-948;;056-385-921-619-61X;;140-175-321-643-738,10.1109/mdt.2010.9;;10.1109/ddecs.2019.8724654;;10.1007/s10836-013-5369-9,"ROSENFELD K ET AL: ""Attacks and Defenses for JTAG"", IEEE DESIGN & TEST OF COMPUTERS, IEEE SERVICE CENTER, NEW YORK, NY, US, vol. 27, no. 1, 1 January 2010 (2010-01-01), pages 36 - 47, XP011301526, ISSN: 0740-7475;;VALEA EMANUELE ET AL: ""Encryption-Based Secure JTAG"", 2019 IEEE 22ND INTERNATIONAL SYMPOSIUM ON DESIGN AND DIAGNOSTICS OF ELECTRONIC CIRCUITS & SYSTEMS (DDECS), IEEE, 24 April 2019 (2019-04-24), pages 1 - 6, XP033553843, DOI: 10.1109/DDECS.2019.8724654;;IONA TECHNOLOGIES PLC: ""iPortal Application Server Developer's Guide"", INTERNET CITATION, 1 October 2001 (2001-10-01), XP007901784, Retrieved from the Internet <URL:http://www.iona.com/support/docs/iportal_application_server/3.0/DevelopGuide/pdf/ipas30_developguide.pdf> [retrieved on 20070226];;AMITABH DAS ET AL: ""Secure JTAG Implementation Using Schnorr Protocol"", JOURNAL OF ELECTRONIC TESTING, vol. 29, no. 2, 1 April 2013 (2013-04-01), pages 193 - 209, XP055166528, ISSN: 0923-8174, DOI: 10.1007/s10836-013-5369-9",PENDING
493,US,B2,US 9359887 B2,007-239-501-497-262,2016-06-07,2016,US 201313772061 A,2013-02-20,US 201313772061 A,2013-02-20,Recoverable data acquisition system and method of sensing at least one parameter of a subterranean bore,"A recoverable data acquisition system includes at least a portion of at least one sensor be positionable within a tubular of a completion system, the at least a portion being recoverable therefrom and a retainer movably disposed at the tubular between at least a first position and a second position, a cavity being defined between the tubular and the retainer when the retainer is in the first position, the at least a portion of the at least one sensor being removable from the cavity in response to movement of the retainer from the first position to the second position.",MILLER II JAMES L;;MAILAND JASON;;PENA ELIAS;;SANCHEZ JAMES SCOTT;;HANDY WILLIAM B;;ELLIOTT CHRISTOPHER;;MATTHEWS DANIEL;;BAKER HUGHES INC,MILLER II JAMES L;;MAILAND JASON;;PENA ELIAS;;SANCHEZ JAMES SCOTT;;HANDY WILLIAM B;;ELLIOTT CHRISTOPHER;;MATTHEWS DANIEL,BAKER HUGHES INCORPORATED (2013-03-07),https://lens.org/007-239-501-497-262,Granted Patent,yes,6,3,7,7,0,E21B47/01;;Y10T29/49819;;E21B47/26;;Y10T29/49819;;E21B47/01;;E21B47/26,E21B47/12;;E21B47/00;;E21B47/01,,3,2,007-145-818-382-415;;007-145-818-382-415,10.2118/147298-ms;;10.2118/147298-ms,"Liu and Home, ""Interpreting Pressure and Flow Rate Data from Permanent Downhole Gauges Using Data Mining Approaches""; Society of Petroleum Engineers; Conference Paper SPE147298; 2011; 16 pages.;;Liu and Home, ""Interpreting Pressure and Flow-Rate Data From Permanent Downhole Gauges by Use of Data-Mining Approaches""; Society of Petroleum Engineers; Feb. 2013 SPE Journal; 14 pages.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; PCT/US2014/017363; Jun. 20, 2014; 12 pages.",ACTIVE
494,CA,C,CA 2962978 C,159-716-339-553-182,2023-03-21,2023,CA 2962978 A,2015-11-13,US 201414548135 A;;US 2015/0060526 W,2014-11-19,"MULTI-LAYER ADVANCED CARBON NANOTUBE BLACKBODY FOR COMPACT, LIGHTWEIGHT, AND ON-DEMAND INFRARED CALIBRATION","An apparatus, method and thin-film structure for producing a blackbody spectrum is disclosed. A first layer (302) of the apparatus is configured to generate heat in response to an applied voltage. A second layer (306) is configured to emit the blackbody radiation spectrum in response to the heat from the first layer. A thermal spreading layer (304) is disposed between the first layer and the second layer. The thermal spreading layer includes a graphene sheet for reducing a spatial variation of the heat in a plane of the thermal spreading layer. The first layer may be a carbon nanotube layer.",RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LAKOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,,https://lens.org/159-716-339-553-182,Granted Patent,no,0,0,14,25,0,G01J5/53;;B82Y20/00;;G01J5/53;;G01J5/52;;H01L29/06,G01J5/53,,0,0,,,,PENDING
495,CA,A1,CA 2900683 A1,152-489-203-658-40X,2014-08-28,2014,CA 2900683 A,2014-02-20,US 201313772061 A;;US 2014/0017363 W,2013-02-20,RECOVERABLE DATA ACQUISITION SYSTEM AND METHOD OF SENSING AT LEAST ONE PARAMETER OF A SUBTERRANEAN BORE,A recoverable data acquisition system includes at least one sensor positionable within a tubular of a completion system that is recoverable therefrom.,BAKER HUGHES INC,MILLER JAMES L II;;MAILAND JASON;;PENA ELIAS;;SANCHEZ JAMES SCOTT;;HANDY WILLIAM B;;ELLIOTT CHRISTOPHER;;MATTHEWS DANIEL,,https://lens.org/152-489-203-658-40X,Patent Application,no,0,0,7,7,0,E21B47/01;;Y10T29/49819;;E21B47/26;;Y10T29/49819;;E21B47/01;;E21B47/26,E21B47/12;;E21B47/01,,0,0,,,,ACTIVE
496,US,A1,US 2020/0348361 A1,167-801-686-136-873,2020-11-05,2020,US 201916403296 A,2019-05-03,US 201916403296 A,2019-05-03,"SYSTEMS AND METHODS FOR INTELLECTUAL PROPERTY-SECURED, REMOTE DEBUGGING","Systems and techniques of the present disclosure may provide remote debugging of an integrated circuit (IC) device while preventing unauthorized access of device intellectual property (IP). A system may include an IC device that generates an encrypted session key and an interface that enables communication between the IC device and a remote debugging site. The interface may enable the IC device to send the encrypted the encrypted session key to initiate a remote debug process, receive an acknowledgement from the remote debugging session, and authenticate the acknowledgement. Further, the interface may enable to the IC device to initiate a secure debug session between the IC device and the remote debugging site.",KURTS TSVIKA;;DOLGUNOV BORIS;;MLADENTSEV VLADISLAV;;ANATI ITTAI;;KHOURY ELIAS;;KIMA MAOR;;SHLOMO ERAN;;GUERON SHAY;;PENNER WILLIAM,KURTS TSVIKA;;DOLGUNOV BORIS;;MLADENTSEV VLADISLAV;;ANATI ITTAI;;KHOURY ELIAS;;KIMA MAOR;;SHLOMO ERAN;;GUERON SHAY;;PENNER WILLIAM,INTEL CORPORATION (2020-02-26),https://lens.org/167-801-686-136-873,Patent Application,yes,7,11,6,6,0,H04L63/0428;;H04L63/06;;H04L63/12;;G06F21/602;;G06F21/606;;H04L67/025;;H04L63/0428;;H04L63/0435;;G06F11/3656;;G06F16/22;;G01R31/31705;;G01R31/31719;;G01R31/3177;;G06F11/263;;H04L9/0631;;H04L9/0819;;H04L9/0894;;H04L9/321,G01R31/3177;;G01R31/317;;G06F11/263;;G06F16/22;;H04L9/06;;H04L9/08;;H04L9/32,,1,0,,,"GOOGLE translation of CN108011883A (2018-05-08 Publication of CN108011883A, 8 pages) (Year: 2018)",ACTIVE
497,US,B2,US 11085964 B2,062-435-088-525-495,2021-08-10,2021,US 201916403296 A,2019-05-03,US 201916403296 A,2019-05-03,"Systems and methods for intellectual property-secured, remote debugging","Systems and techniques of the present disclosure may provide remote debugging of an integrated circuit (IC) device while preventing unauthorized access of device intellectual property (IP). A system may include an IC device that generates an encrypted session key and an interface that enables communication between the IC device and a remote debugging site. The interface may enable the IC device to send the encrypted the encrypted session key to initiate a remote debug process, receive an acknowledgement from the remote debugging session, and authenticate the acknowledgement. Further, the interface may enable to the IC device to initiate a secure debug session between the IC device and the remote debugging site.",INTEL CORP,KURTS TSVIKA;;DOLGUNOV BORIS;;MLADENTSEV VLADISLAV;;ANATI ITTAI;;KHOURY ELIAS;;KIMA MAOR;;SHLOMO ERAN;;GUERON SHAY;;PENNER WILLIAM,INTEL CORPORATION (2020-02-26),https://lens.org/062-435-088-525-495,Granted Patent,yes,8,0,6,6,0,H04L63/0428;;H04L63/06;;H04L63/12;;G06F21/602;;G06F21/606;;H04L67/025;;H04L63/0428;;H04L63/0435;;G06F11/3656;;G06F16/22;;G01R31/31705;;G01R31/31719;;G01R31/3177;;G06F11/263;;H04L9/0631;;H04L9/0819;;H04L9/0894;;H04L9/321,G01R31/317;;G01R31/3177;;G06F11/263;;G06F16/22;;H04L9/06;;H04L9/08;;H04L9/32,,6,2,107-330-287-134-948;;056-385-921-619-61X,10.1109/mdt.2010.9;;10.1109/ddecs.2019.8724654,"GOOGLE translation of CN108011883A (May 8, 2018 Publication of CN108011883A, 8 pages) (Year: 2018).;;Extended European Search Report for EP20163972.3 dated Sep. 24, 2020.;;Rosenfeld, K., et al., “Attacks and Defenses for JTAG,” IEEE Design & Test of Computers, IEEE Service Center, New York, NY, US, vol. 27, No. 1, Jan. 1, 2020.;;Valea Emanuele et al., “Encryption-Based Secure JTAG,” 2019 IEEE 22nd International Symposium on Design and Diagnostics of Electronic Circuits and Systems (DDECS), IEEE, Apr. 24, 2019.;;IONA Technologies PLC, “iPortal Application Server Developer's Guide,” Internet Citation, Oct. 1, 2001, retrieved from: http://www.iona.com/support/docs/iportal_application_server/3.0/DevelopGuide/pdf/ipas30_developguide.pdf.;;Amitabh Das et al., “Secure JTAG Implementation Using Schnorr Protocol,” Journal of Electronic Testing, vol. 29, No. 2, Apr. 1, 2013.",ACTIVE
498,US,B2,US 11754623 B2,157-924-885-239-135,2023-09-12,2023,US 202117397951 A,2021-08-09,US 202117397951 A;;US 201916403296 A,2019-05-03,"Systems and methods for intellectual property-secured, remote debugging","Systems and techniques of the present disclosure may provide remote debugging of an integrated circuit (IC) device while preventing unauthorized access of device intellectual property (IP). A system may include an IC device that generates an encrypted session key and an interface that enables communication between the IC device and a remote debugging site. The interface may enable the IC device to send the encrypted the encrypted session key to initiate a remote debug process, receive an acknowledgement from the remote debugging session, and authenticate the acknowledgement. Further, the interface may enable to the IC device to initiate a secure debug session between the IC device and the remote debugging site.",INTEL CORP,KURTS TSVIKA;;DOLGUNOV BORIS;;MLADENTSEV VLADISLAV;;ANATI ITTAI;;KHOURY ELIAS;;KIMA MAOR;;SHLOMO ERAN;;GUERON SHAY;;PENNER WILLIAM,,https://lens.org/157-924-885-239-135,Granted Patent,yes,11,0,6,6,0,H04L63/0428;;H04L63/06;;H04L63/12;;G06F21/602;;G06F21/606;;H04L67/025;;H04L63/0428;;H04L63/0435;;G06F11/3656;;G06F16/22;;G01R31/31705;;G01R31/31719;;G01R31/3177;;G06F11/263;;H04L9/0631;;H04L9/0819;;H04L9/0894;;H04L9/321,G01R31/317;;G01R31/3177;;G06F11/263;;G06F16/22;;H04L9/06;;H04L9/08;;H04L9/32,,8,3,107-330-287-134-948;;056-385-921-619-61X;;046-482-975-169-732,10.1109/mdt.2010.9;;10.1109/ddecs.2019.8724654;;10.1109/dexa.2002.1045871,"NPL “Tamper proof certification system based on secure non-volatile FPGAs, Thesis, Nov. 2017, 84 pages” by Diogo Alcoforado da Gama de Oliveira Parrinha (Year: 2017).;;Extended European Search Report for EP20163972.3 dated Sep. 24, 2020.;;Rosenfeld, K., et al., “Attacks and Defenses for JTAG,” IEEE Design & Test of Computers, IEEE Service Center, New York, NY, US, vol. 27, No. 1, Jan. 1, 2020.;;Valea Emanuele et al., “Encryption-Based Secure JTAG,” 2019 IEEE 22nd International Symposium on Design and Diagnostics of Electronic Circuits and Systems (DDECS), IEEE, Apr. 24, 2019.;;IONA Technologies PLC, “iPortal Application Server Developer's Guide,” Internet Citation, Oct. 1, 2001, retrieved from: http://www.iona.eom/support/docs/iportal_application_server/3.0/DevelopGuide/pdf/ipas30_developguide.pdf.;;Amitabh Das et al., “Secure JTAG Implementation Using Schnorr Protocol,” Journal of Electronic Testing, vol. 29, No. 2, Apr. 1, 2013.;;Extended European Search Report for EP20163792.3 dated Mar. 20, 2023.;;SAITO T., KITO T., UMESAWA K., MIZOGUCHI F.: ""Architectural defects of the secure shell"", DATABASE AND EXPERT SYSTEMS APPLICATIONS, 2002. PROCEEDINGS. 13TH INTE RNATIONAL WORKSHOP ON 2-6 SEPT. 2002, PISCATAWAY, NJ, USA,IEEE, 2 September 2002 (2002-09-02) - 6 September 2002 (2002-09-06), pages 18 - 24, XP010611981, ISBN: 978-0-7695-1668-4",ACTIVE
499,CA,A1,CA 2962978 A1,087-982-422-027-820,2016-05-26,2016,CA 2962978 A,2015-11-13,US 201414548135 A;;US 2015/0060526 W,2014-11-19,"MULTI-LAYER ADVANCED CARBON NANOTUBE BLACKBODY FOR COMPACT, LIGHTWEIGHT, AND ON-DEMAND INFRARED CALIBRATION","An apparatus, method and thin-film structure for producing a blackbody spectrum is disclosed. A first layer (302) of the apparatus is configured to generate heat in response to an applied voltage. A second layer (306) is configured to emit the blackbody radiation spectrum in response to the heat from the first layer. A thermal spreading layer (304) is disposed between the first layer and the second layer. The thermal spreading layer includes a graphene sheet for reducing a spatial variation of the heat in a plane of the thermal spreading layer. The first layer may be a carbon nanotube layer.",RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LAKOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,,https://lens.org/087-982-422-027-820,Patent Application,no,0,0,14,25,0,G01J5/53;;B82Y20/00;;G01J5/53;;G01J5/52;;H01L29/06,G01J5/02,,0,0,,,,PENDING
500,US,B1,US 8989951 B1,025-177-292-856-266,2015-03-24,2015,US 201213664121 A,2012-10-30,US 201213664121 A,2012-10-30,Maintaining the airworthiness configuration of aircraft,"A method and apparatus for maintaining the airworthiness configuration of an aircraft. Airworthiness configuration information for an aircraft is identified by a data processing system. The airworthiness configuration information identifies an airworthiness configuration of the aircraft comprising a number of components of the aircraft. A number of automated identification technology devices are attached to the aircraft. The number of automated identification technology devices include component information for the number of components. The component information is read from the number of automated identification technology devices by a reader. The component information read from the number of automated identification technology devices is compared, by a processor unit, to the airworthiness configuration information to determine whether the aircraft complies with the airworthiness configuration.",BOEING CO,COOP WILLIAM P;;ELIAS JOSE R;;HILL LOIS;;KNOLL SHELLA A;;TILZER DAVID ROBERT;;BAUTZ JR CHARLES K,THE BOEING COMPANY (2012-10-17),https://lens.org/025-177-292-856-266,Granted Patent,yes,15,5,1,1,0,B64D25/00;;B64F5/60;;G01C23/005;;B64D25/00;;B64F5/60,G01M17/00;;G01C23/00,701/31.4;;701/29.1;;701/29.4,6,0,,,"Coop et al., ""Aircraft Rework Management,"" U.S. Appl. No. 13/644,827, filed Oct. 4, 2012, 42 pages.;;Knox et al., ""Aircraft Interior Component Maintenance,"" U.S. Appl. No. 13/782,475, filed Mar. 1, 2013, 47 pages.;;Office Action, dated May 30, 2014, regarding U.S. Appl. No. 13/644,827, 19 pages.;;Office Action, dated May 30, 2014, regarding U.S. Appl. No. 13/782,475, 15 pages.;;Notice of Allowance, dated Aug. 12, 2014, regarding U.S. Appl. No. 13/644,827, 9 pages.;;Notice of Allowance, dated Aug. 13, 2014, regarding U.S. Appl. No. 13/782,475, 9 pages.",ACTIVE
501,TW,A,TW 202202339 A,059-105-889-561-672,2022-01-16,2022,TW 110114679 A,2021-04-23,US 202063014401 P,2020-04-23,Glass article having frame configured for minimal shape deviation and having small bezel width,Emobidments of a curved glass article are disclosed herein. The curved glass article includes a glass sheet first and second major surfaces. The glass sheet is bent to define a curved region disposed between flat sections. The curved glass article also includes a carrier adhered to the glass sheet. The carrier includes longitudinal strips and lateral strips. The longitudinal strips define the radius of curvature of the curved region. The lateral strips extend between the longitudinal strips. The glass sheet deviates 0.3 mm or less from planar in the flat sections. The longitudinal strips each have a width Wlong of 2 mm or less. The first lateral strips each have a width Wlat of 20 mm or less. At least a portion of the width Wlat of each lateral strip is located in the curved region and a flat section.,CORNING INC,DAVE GAURAV;;LAYOUNI KHALED;;LIU MIN-CONG;;MERHY ELIAS;;PIERRON QUENTIN JEAN ANDRE;;PRICE MICHAEL WILLIAM;;TAHIR FRAAZ,,https://lens.org/059-105-889-561-672,Patent of Addition,no,0,0,8,8,0,B32B37/12;;B32B38/1866;;B32B2457/20;;B32B17/061;;B32B17/067;;B32B17/10;;C03C21/002;;C03C27/00;;C03C27/00;;C03C17/00;;C03C21/002;;C03B23/023;;B32B7/12;;B32B17/061;;B32B17/10;;B32B37/12;;B32B38/0012;;B32B2307/732;;B32B2457/20;;C03B23/023;;C03C27/04,B32B17/06;;B60K35/00;;B60R13/02,,0,0,,,,PENDING
502,US,A1,US 2021/0364571 A1,149-525-454-684-300,2021-11-25,2021,US 202117397951 A,2021-08-09,US 202117397951 A;;US 201916403296 A,2019-05-03,"SYSTEMS AND METHODS FOR INTELLECTUAL PROPERTY-SECURED, REMOTE DEBUGGING","Systems and techniques of the present disclosure may provide remote debugging of an integrated circuit (IC) device while preventing unauthorized access of device intellectual property (IP). A system may include an IC device that generates an encrypted session key and an interface that enables communication between the IC device and a remote debugging site. The interface may enable the IC device to send the encrypted the encrypted session key to initiate a remote debug process, receive an acknowledgement from the remote debugging session, and authenticate the acknowledgement. Further, the interface may enable to the IC device to initiate a secure debug session between the IC device and the remote debugging site.",INTEL CORP,KURTS TSVIKA;;DOLGUNOV BORIS;;MLADENTSEV VLADISLAV;;ANATI ITTAI;;KHOURY ELIAS;;KIMA MAOR;;SHLOMO ERAN;;GUERON SHAY;;PENNER WILLIAM,,https://lens.org/149-525-454-684-300,Patent Application,yes,2,0,6,6,0,H04L63/0428;;H04L63/06;;H04L63/12;;G06F21/602;;G06F21/606;;H04L67/025;;H04L63/0428;;H04L63/0435;;G06F11/3656;;G06F16/22;;G01R31/31705;;G01R31/31719;;G01R31/3177;;G06F11/263;;H04L9/0631;;H04L9/0819;;H04L9/0894;;H04L9/321,G01R31/317;;G01R31/3177;;G06F11/263;;G06F16/22;;H04L9/06;;H04L9/08;;H04L9/32,,1,0,,,"NPL “Tamper proof certification system based on secure non-volatile FPGAs, Thesis, November 2017, 84 pages” by Diogo Alcoforado da Gama de Oliveira Parrinha (Year: 2017)",ACTIVE
503,US,A1,US 2019/0116090 A1,108-892-430-978-002,2019-04-18,2019,US 201715785793 A,2017-10-17,US 201715785793 A,2017-10-17,METHOD FOR DETERMINING OPTIMAL LAYING ARRANGEMENT OF INFRASTRUCTURE LINK,"A method for determining an optimal laying arrangement of a new infrastructure link for connection from a new site to an existing infrastructure network includes modeling a terrain of a region around and at the new site and the existing infrastructure network near the new site; modeling each factor affecting the laying arrangement as a respective cost function; applying a respective weighting to each of the cost function to determine a life-cycle cost function; and determining, based on the determined life-cycle cost function, an optimized laying arrangement with minimal life-cycle cost from the new site to a connection point in the existing infrastructure network.",UNIV CITY HONG KONG,ZUKERMAN MOSHE;;WANG ZENGFU;;WANG QING;;WANG YU;;WANG GANG;;MORAN WILLIAM;;CUCKER FELIPE;;GUO JUN;;TAHCHI ELIAS,CITY UNIVERSITY OF HONG KONG (2017-11-21),https://lens.org/108-892-430-978-002,Patent Application,yes,0,10,2,2,0,G06Q50/08;;G06Q10/06313;;H04L41/0836;;H04L41/145;;G06Q50/08;;H04L45/124;;G06Q10/06313;;H04L41/0826,H04L12/24;;G06Q10/06;;G06Q50/08;;H04L12/721,,0,0,,,,ACTIVE
504,AU,B2,AU 2014/218975 B2,137-207-045-968-784,2016-12-01,2016,AU 2014/218975 A,2014-02-20,US 201313772061 A;;US 2014/0017363 W,2013-02-20,Recoverable data acquisition system and method of sensing at least one parameter of a subterranean bore,A recoverable data acquisition system includes at least one sensor positionable within a tubular of a completion system that is recoverable therefrom.,BAKER HUGHES A GE COMPANY,MILLER II JAMES L;;MAILAND JASON;;PENA ELIAS;;SANCHEZ JAMES SCOTT;;HANDY WILLIAM B;;ELLIOTT CHRISTOPHER;;MATTHEWS DANIEL,"BAKER HUGHES, A GE COMPANY, LLC (2018-05-17)",https://lens.org/137-207-045-968-784,Granted Patent,no,1,0,7,7,0,E21B47/01;;Y10T29/49819;;E21B47/26;;Y10T29/49819;;E21B47/01;;E21B47/26,E21B47/12;;E21B47/01,,0,0,,,,ACTIVE
505,GB,A,GB 2383783 A,196-687-791-668-711,2003-07-09,2003,GB 0200303 A,2002-01-08,GB 0200303 A,2002-01-08,Motion simulator,"A motion simulator, replicating the movements experienced in a motor vehicle or aeroplane, for example, comprises four pivotally-mounted jack arrangements, two under each side of a seat portion 27, differential operation of which in pairs on each side of the seat by actuators (19c, 19d, Fig. 6) causes the seat to pivot about a fore-and aft axis below the level of the seat portion 27. Operating the jack arrangements together causes the seat to rise or ""heave"". Two further actuators (19a, 19b, Fig. 6) to cause the seat to move forwards or backwards, one actuator for each direction, whilst pivoting about a transverse axis above the level of the portion 27 of the seat. The actuators may be ""air muscles"", comprising air-pressurisable rubber tubes which shorten when expanded, these acting through pulleys. The actuators are controlled electronically through a computer and in response to controls, e.g. 107, 111, controlled by the operator of the simulator.",GENTILE WILLIAMS MARC DE,BROWN PAUL MICHAEL;;WALLIS ALEXANDER GUY;;SMITH DAVID WILLIAM;;GREENHILL RICHARD MARTIN;;ELIAS HUGO;;GODDEN MATTHEW;;WALKER RICHARD,,https://lens.org/196-687-791-668-711,Patent Application,no,3,10,2,2,0,A63F2300/302;;A63F2300/8082;;A63G31/16;;G09B9/12;;A47C7/723;;A63F13/28;;A63F2300/1043;;A63F13/24;;A63F13/24;;A47C15/004;;A63G31/16;;A47C7/723,A47C7/72;;A63F13/08;;A63G31/16;;G09B9/12,B7H HQA           HQA,0,0,,,,DISCONTINUED
506,CN,A,CN 112235232 A,115-051-079-465-484,2021-01-15,2021,CN 202010218179 A,2020-03-25,US 201916403296 A,2019-05-03,"SYSTEMS AND METHODS FOR INTELLECTUAL PROPERTY-SECURED, REMOTE DEBUGGING","Systems and techniques of the present disclosure may provide remote debugging of an integrated circuit (IC) device while preventing unauthorized access of device intellectual property (IP). The systemmay include an IC device that generates an encrypted session key and an interface that enables communication between the IC device and a remote debugging site. The interface may enable the IC deviceto send the encrypted the encrypted session key to initiate a remote debug process, receive an acknowledgement from the remote debugging session, and authenticate the acknowledgement. Further, the interface may enable to the IC device to initiate a secure debug session between the IC device and the remote debugging site.",INTEL CORP,KURTS TSVIKA;;DOLGUNOV BORIS;;MLADENTSEV VLADISLAV;;ANATI ITTAI;;KHOURY ELIAS;;KIMA MAOR;;SHLOMO ERAN;;GUERON SHAY;;PENNER WILLIAM,,https://lens.org/115-051-079-465-484,Patent Application,no,0,2,6,6,0,H04L63/0428;;H04L63/06;;H04L63/12;;G06F21/602;;G06F21/606;;H04L67/025;;H04L63/0428;;H04L63/0435;;G06F11/3656;;G06F16/22;;G01R31/31705;;G01R31/31719;;G01R31/3177;;G06F11/263;;H04L9/0631;;H04L9/0819;;H04L9/0894;;H04L9/321,H04L29/06,,0,0,,,,PENDING
507,DE,C2,DE 3227997 C2,031-852-258-729-224,1987-03-05,1987,DE 3227997 A,1982-07-23,US 29787481 A,1981-08-31,DE 3227997 C2,,"GENERAL MOTORS CORP., DETROIT, MICH., US","RAZINSKY, ELIAS HIRSH, TOLEDO, OHIO, US;;ROBERTS, WILLIAM BYRON, FREMONT, CALIF., US;;LONGHOUSE, RICHARD EDWARD, DAYTON, OHIO, US",,https://lens.org/031-852-258-729-224,Granted Patent,no,0,0,6,7,0,F04D29/384,F04D29/38;;F04D29/68,,0,0,,,,EXPIRED
508,AU,A1,AU 2014/218975 A1,058-906-768-828-223,2015-08-20,2015,AU 2014/218975 A,2014-02-20,US 201313772061 A;;US 2014/0017363 W,2013-02-20,Recoverable data acquisition system and method of sensing at least one parameter of a subterranean bore,A recoverable data acquisition system includes at least one sensor positionable within a tubular of a completion system that is recoverable therefrom.,BAKER HUGHES INC,MILLER II JAMES L;;MAILAND JASON;;PENA ELIAS;;SANCHEZ JAMES SCOTT;;HANDY WILLIAM B;;ELLIOTT CHRISTOPHER;;MATTHEWS DANIEL,"BAKER HUGHES, A GE COMPANY, LLC (2018-05-17)",https://lens.org/058-906-768-828-223,Patent Application,no,0,0,7,7,0,E21B47/01;;Y10T29/49819;;E21B47/26;;Y10T29/49819;;E21B47/01;;E21B47/26,E21B47/12;;E21B47/01,,0,0,,,,ACTIVE
509,US,A1,US 2014/0236485 A1,055-025-014-797-855,2014-08-21,2014,US 201313772061 A,2013-02-20,US 201313772061 A,2013-02-20,RECOVERABLE DATA ACQUISITION SYSTEM AND METHOD OF SENSING AT LEAST ONE PARAMETER OF A SUBTERRANEAN BORE,A recoverable data acquisition system includes at least one sensor positionable within a tubular of a completion system that is recoverable therefrom,MILLER II JAMES L;;MAILAND JASON;;PENA ELIAS;;SANCHEZ JAMES SCOTT;;HANDY WILLIAM B;;ELLIOTT CHRISTOPHER;;MATTHEWS DANIEL;;BAKER HUGHES INC,MILLER II JAMES L;;MAILAND JASON;;PENA ELIAS;;SANCHEZ JAMES SCOTT;;HANDY WILLIAM B;;ELLIOTT CHRISTOPHER;;MATTHEWS DANIEL,BAKER HUGHES INCORPORATED (2013-03-07),https://lens.org/055-025-014-797-855,Patent Application,yes,0,1,7,7,0,E21B47/01;;Y10T29/49819;;E21B47/26;;Y10T29/49819;;E21B47/01;;E21B47/26,E21B47/12,702/6;;29/426.3,0,0,,,,ACTIVE
510,BR,A2,BR 102014028116 A2,084-118-500-137-240,2016-05-31,2016,BR 102014028116 A,2014-11-10,BR 102014028116 A,2014-11-10,ignitor para sistema de cocção baseado em queima de gás e conjunto queimador de gás provido de ignitor para sistema de cocção baseado em queima de gás,"ignitor para sistema de cocção baseado em queima de gás e conjunto queimador de gás provido de ignitor para sistema de cocção baseado em queima de gás. a presente invenção pertence ao campo tecnológico de equipamentos e componentes relacionados à sistemas de cocção baseados em queima de gás, como por exemplo, fogões tradicionais. problema a ser resolvido: almeja-se otimizar a montagem e limpeza de ignitores, reduzir os problemas com ignição devido ao espaçamento demasiado entre capa do queimador e queimador, e reduzir o diâmetro do anel metálico, buscando também uma melhoria estética do produto. resolução do problema: é descrito um ignitor cuja capa isolante compreende duas extremidades distais e um segmento intermediário, sendo as referidas duas extremidades distais paralelamente alinhas entre si, longitudinalmente espaçadas entre si pelo referido segmento intermediário, e opostamente dispostas uma em relação à outra.",WHIRLPOOL SA,SCHMIDT ANDRE CARLOS;;CAVALET ELIAS ROQUE;;ALCANTARA GUILHERME MOREIRA DE FILHO;;IBAÑEZ WILLIAM ALEXANDER CARRILLO;;LEONARDO ÁRION CLAYTON,,https://lens.org/084-118-500-137-240,Patent Application,no,0,0,1,1,0,,F23D14/00;;F23Q3/00;;F24C3/10,,0,0,,,,DISCONTINUED
511,US,B2,US 10425280 B2,010-172-423-275-588,2019-09-24,2019,US 201715785793 A,2017-10-17,US 201715785793 A,2017-10-17,Method for determining optimal laying arrangement of infrastructure link,"A method for determining an optimal laying arrangement of a new infrastructure link for connection from a new site to an existing infrastructure network includes modeling a terrain of a region around and at the new site and the existing infrastructure network near the new site; modeling each factor affecting the laying arrangement as a respective cost function; applying a respective weighting to each of the cost function to determine a life-cycle cost function; and determining, based on the determined life-cycle cost function, an optimized laying arrangement with minimal life-cycle cost from the new site to a connection point in the existing infrastructure network.",UNIV CITY HONG KONG,ZUKERMAN MOSHE;;WANG ZENGFU;;WANG QING;;WANG YU;;WANG GANG;;MORAN WILLIAM;;CUCKER FELIPE;;GUO JUN;;TAHCHI ELIAS,CITY UNIVERSITY OF HONG KONG (2017-11-21),https://lens.org/010-172-423-275-588,Granted Patent,yes,9,2,2,2,0,G06Q50/08;;G06Q10/06313;;H04L41/0836;;H04L41/145;;G06Q50/08;;H04L45/124;;G06Q10/06313;;H04L41/0826,H04L12/24;;G06Q10/06;;G06Q50/08;;H04L12/721,,0,0,,,,ACTIVE
512,DE,C,DE 947826 C,198-037-910-179-83X,1956-08-23,1956,DE A0019070 A,1953-10-30,US 331049X A,1952-10-29,"Verfahren zur Herstellung eines N, N'-disubstituierten Alkylendiaminsalzes des Penicillins",,AMERICAN HOME PROD,BRUCE WILLIAM FAUSSET;;EDWARDS CHARLES DAVID;;APAT JOSEPH KLARENCE;;ELIAS WILLIAM FRANK;;MERRION HOWARD JOSEPH;;BARNETT JOHN OSWALD;;DR MED DANIEL LEONHARD SHAW JU,,https://lens.org/198-037-910-179-83X,Granted Patent,no,0,0,1,18,0,C07D499/00,C07D499/00,,0,0,,,,EXPIRED
513,CA,C,CA 2900683 C,104-323-018-692-12X,2018-02-27,2018,CA 2900683 A,2014-02-20,US 201313772061 A;;US 2014/0017363 W,2013-02-20,RECOVERABLE DATA ACQUISITION SYSTEM AND METHOD OF SENSING AT LEAST ONE PARAMETER OF A SUBTERRANEAN BORE,A recoverable data acquisition system includes at least one sensor positionable within a tubular of a completion system that is recoverable therefrom.,BAKER HUGHES INC,MILLER JAMES L II;;MAILAND JASON;;PENA ELIAS;;SANCHEZ JAMES SCOTT;;HANDY WILLIAM B;;ELLIOTT CHRISTOPHER;;MATTHEWS DANIEL,,https://lens.org/104-323-018-692-12X,Granted Patent,no,0,0,7,7,0,E21B47/01;;Y10T29/49819;;E21B47/26;;Y10T29/49819;;E21B47/01;;E21B47/26,E21B47/12;;E21B47/01,,0,0,,,,ACTIVE
514,CN,A,CN 107076617 A,135-244-363-876-113,2017-08-18,2017,CN 201580060128 A,2015-11-13,US 201414548135 A;;US 2015/0060526 W,2014-11-19,"Multi-layer advanced carbon nanotube blackbody for compact, lightweight, and on-demand infrared calibration","An apparatus, method and thin-film structure for producing a blackbody spectrum is disclosed. A first layer (302) of the apparatus is configured to generate heat in response to an applied voltage. A second layer (306) is configured to emit the blackbody radiation spectrum in response to the heat from the first layer. A thermal spreading layer (304) is disposed between the first layer and the second layer. The thermal spreading layer includes a graphene sheet for reducing a spatial variation of the heat in a plane of the thermal spreading layer. The first layer may be a carbon nanotube layer.",RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LA KOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,,https://lens.org/135-244-363-876-113,Patent Application,no,6,3,14,25,0,G01J5/53;;B82Y20/00;;G01J5/53;;G01J5/52;;H01L29/06,G01J5/52,,1,0,,,"W. KONZ, J. ET AL.: ""Micromachined IR-source with excellent blackbody like behaviour"", 《SPIE SMART SENSORS, ACTUATORS, AND MEMS II》",ACTIVE
515,AU,A1,AU 2018/319545 A1,184-021-764-419-190,2020-01-23,2020,AU 2018/319545 A,2018-02-22,US 201762548059 P;;US 2018/0019179 W,2017-08-21,Dose detection module for a medication delivery device,The present disclosure relates to a dose detection system for use with a medication delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system comprises a module including a rotation sensor attached to the actuator during dose delivery. A sensed element is attached to the dose setting member and includes first gear teeth. The rotation sensor comprises a driven gear including second gear teeth. The second gear teeth are operatively received by the first gear teeth and are driven in rotation as the first gear teeth rotate during dose delivery. The rotation sensor is responsive to the rotation of the second gear teeth to detect the rotation of the dose setting member.,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,,https://lens.org/184-021-764-419-190,Patent Application,no,0,0,13,14,0,A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584,A61M5/315;;A61M5/24,,0,0,,,,ACTIVE
516,DE,T1,DE 192659 T1,129-621-738-023-031,1986-12-18,1986,DE 85903956 T,1985-07-31,US 8501450 W;;US 64049084 A,1984-08-13,"VERTEILTER, GEMAESS RAUMAUFLOESUNG AUFGESTELLTER DEHNUNGSMESSER MIT OPTISCHER FASER.",,"UNITED TECHNOLOGIES CORP., HARTFORD, CONN., US","MELTZ, GERALD, AVON, CT 06001, US;;GLENN, H., WILLIAM, VERNON, CT 06066, US;;SNITZER, ELIAS, WELLESLEY, MA 02181, US",,https://lens.org/129-621-738-023-031,Patent Application,no,0,0,1,11,0,,G01B11/16;;G01J5/08;;G01J5/38,,0,0,,,,DISCONTINUED
517,US,B2,US 9459154 B2,197-365-705-769-837,2016-10-04,2016,US 201414548135 A,2014-11-19,US 201414548135 A;;US 201313894953 A,2013-05-15,"Multi-layer advanced carbon nanotube blackbody for compact, lightweight, and on-demand infrared calibration","An apparatus, method and thin-film structure for producing a blackbody spectrum is disclosed. A first layer of the apparatus is configured to generate heat in response to an applied voltage. A second layer is configured to emit the blackbody radiation spectrum in response to the heat from the first layer. A thermal spreading layer is disposed between the first layer and the second layer. The thermal spreading layer includes a graphene sheet for reducing a spatial variation of the heat in a plane of the thermal spreading layer.",RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LA KOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,RAYTHEON COMPANY (2014-11-24),https://lens.org/197-365-705-769-837,Granted Patent,yes,27,1,2,25,0,Y10S977/949;;G01J5/53;;Y10S977/949;;H01L29/0673;;G01J5/53;;H10K85/221,G01D18/00;;G01J5/52;;H01L29/06;;H01L51/00,,6,2,089-824-829-812-010;;026-504-678-326-614,10.1557/mrs.2012.203;;10.1007/s12274-011-0109-x,"""Thermal properties of graphene: Fundamentals and applications"", MRS Bulletin, vol. 37, Dec. 2012, p. 1273-1281 to Pop et al.;;""Synthesis of Large Area, Homogeneous, Single Layer Graphene Films by Annealing Amorphous Carbon on Co and Ni"", Nano Res. 2011, 4(6): 531-540 to Orofeo et al.;;International Search Report for International Application No. PCT/US2014/018928; International Filing Date Feb. 27, 2014; Mail Date Aug. 11, 2014. (7 pages).;;Written Opinion for International Application No. PCT/US2014/018928; International Filing Date Feb. 27, 2014; Mail Date Aug. 11, 2014. (7 pages).;;Konz et al.; ""Micromachined IR-source with excellent blackbody like behaviour"", Invited Paper, Proceedings of SPIE vol. 5836, Jul. 1, 2005, pp. 540-548.;;PCT International Search Report and Written Opinion; International Application No. PCT/US2015/060526; International Filing Date: Nov. 13, 2015; Date of Mailing: Mar. 7, 2016; pp. 1-15.",ACTIVE
518,TW,A,TW 201625937 A,068-448-903-917-331,2016-07-16,2016,TW 104134192 A,2015-10-19,US 201414548135 A,2014-11-19,"Apparatus, film and method for producing a blackbody spectrum","An apparatus, method and thin-film structure for producing a blackbody spectrum is disclosed. A first layer of the apparatus is configured to generate heat in response to an applied voltage. A second layer is configured to emit the blackbody radiation spectrum in response to the heat from the first layer. A thermal spreading layer is disposed between the first layer and the second layer. The thermal spreading layer includes a graphene sheet for reducing a spatial variation of the heat in a plane of the thermal spreading layer.",RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LA KOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,,https://lens.org/068-448-903-917-331,Patent of Addition,no,0,12,14,25,0,G01J5/53;;B82Y20/00;;G01J5/53;;G01J5/52;;H01L29/06,G01N23/08;;B32B9/04;;C01B31/02,,0,0,,,,ACTIVE
519,WO,A1,WO 2009/094761 A1,110-580-118-101-512,2009-08-06,2009,CA 2009000089 W,2009-01-23,US 2513108 P,2008-01-31,APPARATUS AND METHOD FOR URINALYSIS,"A urinalysis apparatus operates in an automated fashion to determine at least one user characteristic from at least one measured parameter of a urine sample that is provided directly by a user. The urinalysis apparatus includes an inlet for receiving the urine sample and at least one sensor unit having at least one sensor configured to measure at least one parameter from at least a portion of the urine sample. The urinalysis aparatus also has a urine transport assembly for transporting the urine sample from the inlet to a sensor unit during a measurement mode, and a cleansing fluid transport assembly for disposing of the urine sample after the measurement mode and cleansing the apparatus during a cleanse mode. The urinalysis apparatus can also include other sensor units and a flow meter unit.",EXCELTION MEDICAL INNOVATIONS;;KIANI FARSAD;;DEKKER EDWARD WILLIAM;;SHERMAN FELIX;;SONG FAYI;;KISENKO EDUARD YURIYOUY;;KOIKAS ELIAS;;BRIKIS SAULIUS PETER;;XIONG HUI,KIANI FARSAD;;DEKKER EDWARD WILLIAM;;SHERMAN FELIX;;SONG FAYI;;KISENKO EDUARD YURIYOUY;;KOIKAS ELIAS;;BRIKIS SAULIUS PETER;;XIONG HUI,,https://lens.org/110-580-118-101-512,Patent Application,yes,3,16,1,1,0,A61B10/007;;G01N21/553;;G01F1/80;;G01N21/27;;G01T1/003,G01F1/10;;G01F1/06;;G01N1/20;;G01N21/75;;G01N33/48;;G01N35/00;;G01T1/167;;G01T1/20,,0,0,,,,PENDING
520,AU,B2,AU 2018/319545 B2,128-402-576-309-697,2021-02-25,2021,AU 2018/319545 A,2018-02-22,US 201762548059 P;;US 2018/0019179 W,2017-08-21,Dose detection module for a medication delivery device,The present disclosure relates to a dose detection system for use with a medication delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system comprises a module including a rotation sensor attached to the actuator during dose delivery. A sensed element is attached to the dose setting member and includes first gear teeth. The rotation sensor comprises a driven gear including second gear teeth. The second gear teeth are operatively received by the first gear teeth and are driven in rotation as the first gear teeth rotate during dose delivery. The rotation sensor is responsive to the rotation of the second gear teeth to detect the rotation of the dose setting member.,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,,https://lens.org/128-402-576-309-697,Granted Patent,no,4,0,13,14,0,A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584,A61M5/315;;A61M5/24,,0,0,,,,ACTIVE
521,EP,B1,EP 3221673 B1,195-281-335-273-939,2019-05-29,2019,EP 15801592 A,2015-11-13,US 201414548135 A;;US 2015/0060526 W,2014-11-19,"MULTI-LAYER ADVANCED CARBON NANOTUBE BLACKBODY FOR COMPACT, LIGHTWEIGHT, AND ON-DEMAND INFRARED CALIBRATION",,RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LA KOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,,https://lens.org/195-281-335-273-939,Granted Patent,yes,6,0,14,25,0,G01J5/53;;B82Y20/00;;G01J5/53;;G01J5/52;;H01L29/06,B82Y20/00,,1,0,,,"W. KONZ ET AL: ""<title>Micromachined IR-source with excellent blackbody like behaviour (Invited Paper)</title>"", MEDICAL IMAGING 2002: PACS AND INTEGRATED MEDICAL INFORMATION SYSTEMS: DESIGN AND EVALUATION, vol. 5836, 1 July 2005 (2005-07-01), pages 540-548, XP055250167, 1000 20th St. Bellingham WA 98225-6705 USA ISSN: 0277-786X, DOI: 10.1117/12.608712 ISBN: 978-1-5106-0167-3",ACTIVE
522,EP,A1,EP 3672667 A1,195-822-594-336-964,2020-07-01,2020,EP 18709859 A,2018-02-22,US 201762548059 P;;US 2018/0019179 W,2017-08-21,DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE,,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,,https://lens.org/195-822-594-336-964,Patent Application,yes,0,0,13,14,0,A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584,A61M5/315;;A61M5/24,,0,0,,,,PENDING
523,US,A1,US 2023/0001095 A1,113-895-706-191-687,2023-01-05,2023,US 202217942481 A,2022-09-12,US 202217942481 A;;US 202016633630 A;;US 2018/0019179 W;;US 201762548059 P,2017-08-21,MEDICATION DELIVERY DEVICE WITH ROTATION SENSOR,The present disclosure relates to a dose detection system for use with a medication delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system comprises a module including a rotation sensor attached to the actuator during dose delivery. A sensed element is attached to the dose setting member and includes first gear teeth. The rotation sensor comprises a driven gear including second gear teeth. The second gear teeth are operatively received by the first gear teeth and are driven in rotation as the first gear teeth rotate during dose delivery. The rotation sensor is responsive to the rotation of the second gear teeth to detect the rotation of the dose setting member.,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,,https://lens.org/113-895-706-191-687,Patent Application,yes,0,2,1,14,0,A61M5/31551;;A61M5/31585;;A61M5/20;;A61M5/31593;;A61M2205/3569;;A61M2205/3584;;A61M2205/581;;A61M2205/582;;A61M2205/583;;A61M5/14248;;A61M5/31585;;A61M5/31551,A61M5/315,,0,0,,,,PENDING
524,TW,B,TW I684002 B,162-329-086-296-197,2020-02-01,2020,TW 104134192 A,2015-10-19,US 201414548135 A,2014-11-19,"Apparatus, film and method for producing a blackbody spectrum",,RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LA KOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,,https://lens.org/162-329-086-296-197,Granted Patent,no,6,0,14,25,0,G01J5/53;;B82Y20/00;;G01J5/53;;G01J5/52;;H01L29/06,,,0,0,,,,ACTIVE
525,US,A1,US 2020/0206431 A1,134-737-123-076-300,2020-07-02,2020,US 201816633630 A,2018-02-22,US 201816633630 A;;US 201762548059 P;;US 2018/0019179 W,2017-08-21,DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE,The present disclosure relates to a dose detection system for use with a medication delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system comprises a module including a rotation sensor attached to the actuator during dose delivery. A sensed element is attached to the dose setting member and includes first gear teeth. The rotation sensor comprises a driven gear including second gear teeth. The second gear teeth are operatively received by the first gear teeth and are driven in rotation as the first gear teeth rotate during dose delivery. The rotation sensor is responsive to the rotation of the second gear teeth to detect the rotation of the dose setting member.,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,ELI LILLY AND COMPANY (2018-01-22);;COOPER PERKINS INC (2018-01-17),https://lens.org/134-737-123-076-300,Patent Application,yes,0,3,13,14,0,A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584,A61M5/315;;A61M5/24,,0,0,,,,ACTIVE
526,US,B2,US 11439766 B2,172-427-143-209-072,2022-09-13,2022,US 201816633630 A,2018-02-22,US 201816633630 A;;US 201762548059 P;;US 2018/0019179 W,2017-08-21,Dose detection module for a medication delivery device,The present disclosure relates to a dose detection system for use with a medication delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system comprises a module including a rotation sensor attached to the actuator during dose delivery. A sensed element is attached to the dose setting member and includes first gear teeth. The rotation sensor comprises a driven gear including second gear teeth. The second gear teeth are operatively received by the first gear teeth and are driven in rotation as the first gear teeth rotate during dose delivery. The rotation sensor is responsive to the rotation of the second gear teeth to detect the rotation of the dose setting member.,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,ELI LILLY AND COMPANY (2018-01-22);;COOPER PERKINS INC (2018-01-17),https://lens.org/172-427-143-209-072,Granted Patent,yes,19,0,13,14,0,A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584,A61M5/315;;A61M5/24,,2,0,,,"Patent Cooperation Treaty International Search Report pertaining to International Application No. PCT/US2018/019179; International Filing Date: Feb. 22, 2018; dated May 15, 2018.;;Patent Cooperation Treaty Written Opinion of the International Searching Authority pertaining to International Application No. PCT/US2018/019179; International Filing Date: Feb. 22, 2018; dated May 15, 2018.",ACTIVE
527,EP,A1,EP 3221673 A1,016-264-493-268-953,2017-09-27,2017,EP 15801592 A,2015-11-13,US 201414548135 A;;US 2015/0060526 W,2014-11-19,"MULTI-LAYER ADVANCED CARBON NANOTUBE BLACKBODY FOR COMPACT, LIGHTWEIGHT, AND ON-DEMAND INFRARED CALIBRATION",,RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LA KOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,,https://lens.org/016-264-493-268-953,Patent Application,yes,0,0,14,25,0,G01J5/53;;B82Y20/00;;G01J5/53;;G01J5/52;;H01L29/06,G01J5/52;;H01L29/06,,0,0,,,,ACTIVE
528,US,B2,US 8086158 B2,018-594-032-102-664,2011-12-27,2011,US 76922507 A,2007-06-27,US 76922507 A,2007-06-27,Method and apparatus for enhanced sheet stripping,An enhanced sheet stripping method and apparatus for stripping toner image carrying copy sheets from a surface of a moving heated fusing member forming a fusing nip. The apparatus includes (a) a moving assembly for moving a cut sheet towards the fusing nip; (b) a sheet curling device positioned upstream of the fusing nip relative to movement of the cut sheet for inducing a desired pre-curl in the cut sheet before the cut sheet enters the fusing nip; and (c) a sheet stripping device positioned downstream of the fusing nip for stripping the cut sheet from contact with the surface of the moving heated fusing member as the cut sheet exits the fusing nip. The method includes inducing a desired curl in the cut sheet before the cut sheet enters the fusing nip and enhanced stripping the cut sheet from contact with the surface of the fuser roll as the cut sheet exits the fusing nip.,DOMOTO GERALD A;;PANIDES ELIAS;;CASTILLO RUDDY;;ROOF BRYAN J;;BURTON WILLIAM A;;RUSSEL STEVEN M;;BOTT DONALD M;;XEROX CORP,DOMOTO GERALD A;;PANIDES ELIAS;;CASTILLO RUDDY;;ROOF BRYAN J;;BURTON WILLIAM A;;RUSSEL STEVEN M;;BOTT DONALD M,XEROX CORPORATION (2007-06-20),https://lens.org/018-594-032-102-664,Granted Patent,yes,37,3,2,2,0,G03G15/657;;G03G15/657;;G03G15/2028;;G03G15/2028,G03G15/20,399/323;;399/332;;399/337;;399/390;;399/400;;399/406,2,0,,,"English translation of Japanese reference, Yamada (JP 57-111550A).;;English machine translation of Japanese reference, Suzuki (JP 09-152802 A).",INACTIVE
529,WO,A1,WO 2016/081293 A1,033-382-033-920-967,2016-05-26,2016,US 2015/0060526 W,2015-11-13,US 201414548135 A,2014-11-19,"MULTI-LAYER ADVANCED CARBON NANOTUBE BLACKBODY FOR COMPACT, LIGHTWEIGHT, AND ON-DEMAND INFRARED CALIBRATION","An apparatus, method and thin-film structure for producing a blackbody spectrum is disclosed. A first layer (302) of the apparatus is configured to generate heat in response to an applied voltage. A second layer (306) is configured to emit the blackbody radiation spectrum in response to the heat from the first layer. A thermal spreading layer (304) is disposed between the first layer and the second layer. The thermal spreading layer includes a graphene sheet for reducing a spatial variation of the heat in a plane of the thermal spreading layer. The first layer may be a carbon nanotube layer.",RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LA KOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,,https://lens.org/033-382-033-920-967,Patent Application,yes,6,6,14,25,0,G01J5/53;;B82Y20/00;;G01J5/53;;G01J5/52;;H01L29/06,G01J5/52;;H01L29/06,,1,1,139-767-984-439-977,10.1117/12.608712,"W. KONZ ET AL: ""<title>Micromachined IR-source with excellent blackbody like behaviour (Invited Paper)</title>"", MEDICAL IMAGING 2002: PACS AND INTEGRATED MEDICAL INFORMATION SYSTEMS: DESIGN AND EVALUATION, vol. 5836, 1 July 2005 (2005-07-01), 1000 20th St. Bellingham WA 98225-6705 USA, pages 540 - 548, XP055250167, ISSN: 0277-786X, ISBN: 978-1-5106-0167-3, DOI: 10.1117/12.608712",PENDING
530,US,A1,US 2015/0076373 A1,085-536-805-221-142,2015-03-19,2015,US 201414548135 A,2014-11-19,US 201414548135 A;;US 201313894953 A,2013-05-15,"MULTI-LAYER ADVANCED CARBON NANOTUBE BLACKBODY FOR COMPACT, LIGHTWEIGHT, AND ON-DEMAND INFRARED CALIBRATION","An apparatus, method and thin-film structure for producing a blackbody spectrum is disclosed. A first layer of the apparatus is configured to generate heat in response to an applied voltage. A second layer is configured to emit the blackbody radiation spectrum in response to the heat from the first layer. A thermal spreading layer is disposed between the first layer and the second layer. The thermal spreading layer includes a graphene sheet for reducing a spatial variation of the heat in a plane of the thermal spreading layer.",RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LA KOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,RAYTHEON COMPANY (2014-11-24),https://lens.org/085-536-805-221-142,Patent Application,yes,4,12,2,25,0,Y10S977/949;;G01J5/53;;Y10S977/949;;H01L29/0673;;G01J5/53;;H10K85/221,G01J3/10,250504 R,2,2,089-824-829-812-010;;026-504-678-326-614,10.1557/mrs.2012.203;;10.1007/s12274-011-0109-x,"""Thermal properties of graphene: Fundamentals and applications"", MRS Bulletin, Vol. 37, December 2012, p. 1273- 1281 to Pop et al.;;""Synthesis of Large Area, Homogeneous, Single Layer Graphene Films by Annealing Amorphous Carbon on Co and Ni"", Nano Res. 2011, 4(6): 531-540 to Orofeo et al.",ACTIVE
531,KR,A,KR 20170086578 A,090-541-334-827-136,2017-07-26,2017,KR 20177016443 A,2015-11-13,US 201414548135 A;;US 2015/0060526 W,2014-11-19,- MULTI-LAYER ADVANCED CARBON NANOTUBE BLACKBODY FOR COMPACT LIGHTWEIGHT AND ON-DEMAND INFRARED CALIBRATION,"흑체 스펙트럼을 생성하기 위한 장치, 방법 및 얇은 필름 구조물이 개시된다. 장치의 제 1 층(302)은 적용된 전압에 응답하여 열을 발생시키도록 구성된다. 제 2 층(306)은 제 1 층으로부터의 열에 응답하여 흑체 방사 스펙트럼을 방출하도록 구성된다. 열 확산 층(304)은 제 1 층과 제 2 층 사이에 배치된다. 열 확산 층은 열 확산 층의 평면에서 열의 공간적 변화를 감소시키기 위한 그래핀 시이트를 포함한다. 제 1 층은 탄소 나노튜브 층일 수 있다.",RAYTHEON CO,CHOW JAMES R;;KETOLA KURT S;;LA KOMSKI DAVID M;;TOWNSEND CARL W;;ELIAS WILLIAM E;;MARBLE STUART J,,https://lens.org/090-541-334-827-136,Patent Application,no,11,0,14,25,0,G01J5/53;;B82Y20/00;;G01J5/53;;G01J5/52;;H01L29/06,G01J5/52;;H01L29/06,,1,0,,,"KONZ, W., et al. Micromachined IR-source with excellent blackbody like behaviour. In: Smart Sensors, Actuators, and MEMS II. International Society for Optics and Photonics, 2005. p. 540-549.",ACTIVE
532,CA,A1,CA 3073603 A1,047-004-122-706-671,2019-02-28,2019,CA 3073603 A,2018-02-22,US 201762548059 P;;US 2018/0019179 W,2017-08-21,DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE,The present disclosure relates to a dose detection system for use with a medication delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system comprises a module including a rotation sensor attached to the actuator during dose delivery. A sensed element is attached to the dose setting member and includes first gear teeth. The rotation sensor comprises a driven gear including second gear teeth. The second gear teeth are operatively received by the first gear teeth and are driven in rotation as the first gear teeth rotate during dose delivery. The rotation sensor is responsive to the rotation of the second gear teeth to detect the rotation of the dose setting member.,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,,https://lens.org/047-004-122-706-671,Patent Application,no,0,0,13,14,0,A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584,A61M5/315;;A61M5/24,,0,0,,,,ACTIVE
533,CA,C,CA 3073603 C,064-009-177-215-545,2022-06-07,2022,CA 3073603 A,2018-02-22,US 201762548059 P;;US 2018/0019179 W,2017-08-21,DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE,The present disclosure relates to a dose detection system for use with a medication delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system comprises a module including a rotation sensor attached to the actuator during dose delivery. A sensed element is attached to the dose setting member and includes first gear teeth. The rotation sensor comprises a driven gear including second gear teeth. The second gear teeth are operatively received by the first gear teeth and are driven in rotation as the first gear teeth rotate during dose delivery. The rotation sensor is responsive to the rotation of the second gear teeth to detect the rotation of the dose setting member.,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,,https://lens.org/064-009-177-215-545,Granted Patent,no,0,0,13,14,0,A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584,A61M5/315;;A61M5/24,,0,0,,,,ACTIVE
534,US,A1,US 2009/0003896 A1,010-904-040-462-010,2009-01-01,2009,US 76922507 A,2007-06-27,US 76922507 A,2007-06-27,METHOD AND APPARATUS FOR ENHANCED SHEET STRIPPING,An enhanced sheet stripping method and apparatus for stripping toner image carrying copy sheets from a surface of a moving heated fusing member forming a fusing nip. The apparatus includes (a) a moving assembly for moving a cut sheet towards the fusing nip; (b) a sheet curling device positioned upstream of the fusing nip relative to movement of the cut sheet for inducing a desired pre-curl in the cut sheet before the cut sheet enters the fusing nip; and (c) a sheet stripping device positioned downstream of the fusing nip for stripping the cut sheet from contact with the surface of the moving heated fusing member as the cut sheet exits the fusing nip. The method includes inducing a desired curl in the cut sheet before the cut sheet enters the fusing nip and enhanced stripping the cut sheet from contact with the surface of the fuser roll as the cut sheet exits the fusing nip.,XEROX CORP,DOMOTO GERALD A;;PANIDES ELIAS;;CASTILLO RUDDY;;ROOF BRYAN J;;BURTON WILLIAM A;;RUSSEL STEVEN M;;BOTT DONALD M,XEROX CORPORATION (2007-06-20),https://lens.org/010-904-040-462-010,Patent Application,yes,35,13,2,2,0,G03G15/657;;G03G15/657;;G03G15/2028;;G03G15/2028,G03G15/20,399/323,0,0,,,,INACTIVE
535,CN,A,CN 115252969 A,026-130-195-397-852,2022-11-01,2022,CN 202210862772 A,2018-02-22,US 201762548059 P;;CN 201880054593 A;;US 2018/0019179 W,2017-08-21,Dose detection module for drug delivery device,The present disclosure relates to a dose detection system for use with a drug delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system includes a module including a rotation sensor attached to an actuator during dose delivery. The sensed element is attached to the dose setting member and includes a first gear tooth. The rotation sensor includes a driven gear including second gear teeth. The second gear tooth is operatively received by the first gear tooth and is driven in rotation as the first gear tooth rotates during dose delivery. A rotation sensor is responsive to rotation of the second gear teeth to detect rotation of the dose setting member.,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,,https://lens.org/026-130-195-397-852,Patent Application,no,6,0,13,14,0,A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584,A61M5/24;;A61M5/315,,0,0,,,,PENDING
536,DE,T1,DE 191063 T1,153-563-348-674-282,1987-01-15,1987,DE 85904033 T,1985-07-31,US 8501451 W;;US 64048984 A,1984-08-13,VERFAHREN ZUM EINLAGERN OPTISCHER GITTER IN FASEROPTIK.,,"UNITED TECHNOLOGIES CORP., HARTFORD, CONN., US","GLENN, H., WILLIAM, VERNON, CT 06066, US;;MELTZ, GERALD, AVON, CT 06001, US;;SNITZER, ELIAS, WELLESLEY, MA 02181, US",,https://lens.org/153-563-348-674-282,Patent Application,no,0,0,10,10,0,G02B5/18;;G02B5/18;;G02B6/02133;;G02B6/02133;;G02B6/022;;G02B6/022;;G02B6/02204;;G02B6/02204;;G02B6/124;;G02B6/124;;Y10S359/90;;Y10S359/90,G01J1/02;;G01K11/12;;G01L1/00;;G02B5/18;;G02B6/00;;G02B6/02;;G02B6/124;;G02B6/34,,0,0,,,,DISCONTINUED
537,CN,A,CN 110958897 A,171-686-472-979-73X,2020-04-03,2020,CN 201880054593 A,2018-02-22,US 201762548059 P;;US 2018/0019179 W,2017-08-21,DOSE DETECTION MODULE FOR MEDICATION DELIVERY DEVICE,The present disclosure relates to a dose detection system for use with a medication delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system comprises a module including a rotation sensor attached to the actuator during dose delivery. A sensed element is attached to the dose setting member and includes first gear teeth. The rotation sensor comprises a driven gear including second gear teeth. The second gear teeth are operatively received by the first gear teeth and are driven in rotation as the first gear teeth rotate duringdose delivery. The rotation sensor is responsive to the rotation of the second gear teeth to detect the rotation of the dose setting member.,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,,https://lens.org/171-686-472-979-73X,Patent Application,no,13,1,13,14,0,A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584,A61M5/315;;A61M5/24,,0,0,,,,ACTIVE
538,WO,A1,WO 2019/040118 A1,190-379-822-455-514,2019-02-28,2019,US 2018/0019179 W,2018-02-22,US 201762548059 P,2017-08-21,DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE,The present disclosure relates to a dose detection system for use with a medication delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system comprises a module including a rotation sensor attached to the actuator during dose delivery. A sensed element is attached to the dose setting member and includes first gear teeth. The rotation sensor comprises a driven gear including second gear teeth. The second gear teeth are operatively received by the first gear teeth and are driven in rotation as the first gear teeth rotate during dose delivery. The rotation sensor is responsive to the rotation of the second gear teeth to detect the rotation of the dose setting member.,LILLY CO ELI,ANTONELLI MATTHEW THOMAS;;BURKE WILLIAM CHURCHILL TALIAFERRO;;BYERLY ROY HOWARD;;PERKINS RUSSELL WAYNE;;RITSHER KENNETH ALAN;;SAMIA ELIAS RAAD,,https://lens.org/190-379-822-455-514,Patent Application,yes,5,14,13,14,0,A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584;;A61M5/24;;A61M5/3155;;A61M5/31551;;A61M5/31568;;A61M5/31585;;A61M2205/3584,A61M5/315;;A61M5/24,,0,0,,,,PENDING
539,CA,C,CA 2995077 C,154-785-386-338-933,2020-04-21,2020,CA 2995077 A,2016-08-05,GB 201514021 A;;US 2016/0045731 W,2015-08-07,PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3, R4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNER ELIAS SET JENO;;US HEALTH,ARNER ELIAS SET JENO;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS,,https://lens.org/154-785-386-338-933,Granted Patent,no,0,0,20,20,0,C07D213/71;;A61P35/00;;A61P35/02;;A61P43/00;;A61P35/00;;A61K31/44;;A61K45/06;;C07D213/71;;A61K31/435;;A61P35/00;;C07D213/71;;A61P35/00;;A61K45/06;;C07D213/71,C07D213/71;;A61K31/435;;A61P35/00,,0,0,,,,ACTIVE
540,EP,A3,EP 0608549 A3,195-069-402-075-29X,1996-12-04,1996,EP 93120591 A,1993-12-21,US 949893 A,1993-01-26,FLEX CIRCUIT CARD ELASTOMERIC CABLE CONNECTOR ASSEMBLY.,"A flex circuit card with an elastomeric cable connector assembly is provided for for transmitting high speed signals between two or more printed circuit boards in a high performance computer system. The flex circuit card connects a cable assembly to a printed circuit board. A conductor trace in the flex circuit card extends into an elastomeric end and terminates with a ball shaped contact (16)which is angled to wipe against mating pads (51) on the printed circuit card (50) for making electrical contact. The cable assembly uses multiple wires attached to a plurality of elastomeric connectors. At least one elastomeric connector is attached to each end of the cable assembly and each elastomeric connector has a plurality of contacts which are used to mate with a plurality of pads on the surface of the printed circuit board. The elastomeric connector described in the present invention provides a high density, cable-to-board interconnection that is perpendicular to the surface of the printed circuit board.",IBM,BEAMAN BRIAN SAMUEL;;DOANY FUAD ELIAS;;DUDEK THOMAS JOHN;;LANZETTA ALPHONSO PHILIP;;SHIH DA-YUAN;;TKAZYIK WILLIAM JOHN;;WALKER GEORGE FREDERICK,,https://lens.org/195-069-402-075-29X,Search Report,yes,3,0,6,6,0,H01R12/714;;H01R12/714;;H01R12/79;;H01R12/79,H01R12/71;;H01R12/79;;H01R24/00,,0,0,,,,DISCONTINUED
541,EP,A2,EP 0608549 A2,083-458-659-355-535,1994-08-03,1994,EP 93120591 A,1993-12-21,US 949893 A,1993-01-26,Flex circuit card elastomeric cable connector assembly.,"A flex circuit card with an elastomeric cable connector assembly is provided for for transmitting high speed signals between two or more printed circuit boards in a high performance computer system. The flex circuit card connects a cable assembly to a printed circuit board. A conductor trace in the flex circuit card extends into an elastomeric end and terminates with a ball shaped contact (16)which is angled to wipe against mating pads (51) on the printed circuit card (50) for making electrical contact. The cable assembly uses multiple wires attached to a plurality of elastomeric connectors. At least one elastomeric connector is attached to each end of the cable assembly and each elastomeric connector has a plurality of contacts which are used to mate with a plurality of pads on the surface of the printed circuit board. The elastomeric connector described in the present invention provides a high density, cable-to-board interconnection that is perpendicular to the surface of the printed circuit board.",IBM,BEAMAN BRIAN SAMUEL;;DOANY FUAD ELIAS;;DUDEK THOMAS JOHN;;LANZETTA ALPHONSO PHILIP;;SHIH DA-YUAN;;TKAZYIK WILLIAM JOHN;;WALKER GEORGE FREDERICK,,https://lens.org/083-458-659-355-535,Patent Application,yes,0,1,6,6,0,H01R12/714;;H01R12/714;;H01R12/79;;H01R12/79,H01R12/71;;H01R12/79;;H01R24/00,,0,0,,,,DISCONTINUED
542,US,A,US 5301681 A,183-977-921-936-344,1994-04-12,1994,US 76837391 A,1991-09-27,US 76837391 A,1991-09-27,Device for detecting cancerous and precancerous conditions in a breast,"The present invention relates to a device for detecting and monitoring physiological conditions in mammalian tissue, and method for using the same. The device includes sensors for sensing physiological conditions and generating signals in response thereto and processor operatively associated with the sensors for receiving and manipulating the signals to produce a generalization indicative of normal and abnormal physiological condition of mammalian tissue. The processor is characterized to include a neural network having a predetermined solution spaced memory, the solution space memory including regions indicative of two (2) or more physiological conditions, wherein the generalization is characterized by the signals projected into the regions.",DEBAN ABDOU F;;TUMEY DAVID M;;REEVES JONATHON W;;MCQUAIN DAVID B;;REEVES WILLIAM H;;REEVES CAROLE C;;ABOUJAOUDE ELIAS D,DEBAN ABDOU F;;TUMEY DAVID M;;REEVES JONATHON W;;MCQUAIN DAVID B;;REEVES WILLIAM H;;REEVES CAROLE C;;ABOUJAOUDE ELIAS D,,https://lens.org/183-977-921-936-344,Granted Patent,yes,19,64,1,3,0,A61B5/7267;;A61B5/7267;;A61B5/015;;A61B5/015;;G16H50/70;;Y10S128/925;;Y10S128/925,A61B5/00,128/736;;364/413.03,2,1,080-832-185-268-517,10.1109/massp.1987.1165576,"Nerves of Silicon by T. A. Heppedheimer, Discover, Feb. 1988, pp. 70 79.;;An Introduction to Computing With Neural Nets by Richard P. Lippmann, IEEE ASSP Magazine, Apr., 1987, pp. 4 22.",EXPIRED
543,CA,C,CA 2790985 C,041-144-648-877-471,2017-01-17,2017,CA 2790985 A,2011-02-25,US 30820810 P;;GB 201009606 A;;EP 2011052855 W,2010-02-25,SOFTWARE APPLICATION DEVELOPMENT TOOL,"A software development tool for use with external systems and services uses a common code base and defines all data and messages using XML Schema System components are defined which include a device abstraction layer which handles interactions between the application and devices. A host abstraction layer handles interactions between a host system and the application. A graphical tool models the work flow of the application and includes screens and services defined by Schema. The application is assembled using the graphical tool, declarative XML rules and customisations of system components without the user having to generate any coding.",SITA INFORMATION NETWORKING COMPUTING IRELAND LTD,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,,https://lens.org/041-144-648-877-471,Granted Patent,no,0,0,14,14,0,G06F8/34;;G06F8/34;;G06F9/44;;G06F8/34,G06F9/44,,0,0,,,,ACTIVE
544,CN,A,CN 103109266 A,002-457-650-806-229,2013-05-15,2013,CN 201180020916 A,2011-02-25,EP 2011052855 W;;GB 201009606 A;;US 30820810 P,2010-02-25,Software application development tool,"A software development tool for use with external systems and services uses a common code base and defines all data and messages using XML Schema System components are defined which include a device abstraction layer which handles interactions between the application and devices. A host abstraction layer handles interactions between a host system and the application. A graphical tool models the work flow of the application and includes screens and services defined by Schema. The application is assembled using the graphical tool, declarative XML rules and customisations of system components without the user having to generate any coding.",SITA INFORMATION NETWORKING COMPUTING IRELAND LTD,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,,https://lens.org/002-457-650-806-229,Patent Application,no,1,2,14,14,0,G06F8/34;;G06F8/34;;G06F8/34;;G06F9/44,G06F9/44,,1,0,,,"JÜRGEN DUNKEL，RALF BRUNS: ""Model-Driven Architecture for Mobile Applications"", 《BUSINESS INFORMATION SYSTEMS》, 25 April 2007 (2007-04-25)",DISCONTINUED
545,US,B2,US 10095486 B2,079-083-539-454-456,2018-10-09,2018,US 201113581182 A,2011-02-25,US 201113581182 A;;GB 201009606 A;;US 30820810 P;;EP 2011052855 W,2010-02-25,Software application development tool,"A software development tool for use with external systems and services uses a common code base and defines all data and messages using XML Schema System components are defined which include a device abstraction layer which handles interactions between the application and devices. A host abstraction layer handles interactions between a host system and the application. A graphical tool models the work flow of the application and includes screens and services defined by Schema. The application is assembled using the graphical tool, declarative XML rules and customizations of system components without the user having to generate any coding.",FINDLAY DENISE;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;FLENLEY JOHN MARTIN;;SITA INFORMATION NETWORKING COMPUTING IRELAND LTD,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,SITA INFORMATION NETWORKING COMPUTING IRELAND LIMITED (2010-04-15),https://lens.org/079-083-539-454-456,Granted Patent,yes,289,3,14,14,0,G06F8/34;;G06F8/34;;G06F8/34;;G06F9/44,G06F9/44;;G06F8/34,,51,9,087-615-737-309-713;;006-600-790-573-863;;113-458-102-712-108;;128-556-045-184-030;;096-599-170-382-184;;002-480-107-967-261;;069-139-877-692-120;;004-495-125-916-024;;122-335-673-152-34X,10.1016/j.datak.2007.09.008;;10.1109/icsssm.2008.4598477;;10.1109/mc.2003.1231193;;10.1002/9780470744734.ch4;;10.2139/ssrn.1679788;;10.1109/dasc.2015.7311532;;10.1109/dasc.2004.1391265;;10.1109/milcom.2008.4753368;;10.1109/dasc.2004.1391238,"Kinneging, T., Machine Readable Travel Documents—Technical Report: PKI for Machine Readable Travel Documents Offering ICC Read-Only Access, PKI Task Force, International Civil Aviation Organization, Version 1.1, Oct. 1, 2004.;;International Search Report and the Written Opinion of the International Search Authority (EPO) for PCT/EP2013/057497 dated Jun. 27, 2013.;;Susan Stellin, “Automation is Considered for Checking IDs in Airports”, Business Day, The New York Times, Mar. 19, 2012, 3 pages, retrieved Sep. 4, 2014, http://www.nytimes.com/2012/03/20/business/tsa-is-considering-automating-id-checks.html.;;Robert Longley, “TSA's New ID, Boarding Pass Scanning System Draws Criticism”, US Government, About.com, Aug. 2, 2012, 2 pages, retrieved online on Jul. 30, 2014, http://usgovinfo.about.com/od/defenseandsecurity/a/Tsa-Boarding-Pass-Scanning-System-Draws-Criticism.htm#&newsissues&newsissues.;;Search Report of Application No. GB 1403967.1, received from the UK Intellectual Property Office dated Aug. 4, 2014.;;Examination Opinion of Application No. GB 1403967.1, received from the UK Intellectual Property Office dated Aug. 5, 2014.;;Search Report of Singapore Application No. 201306353-2, received from the Danish Patent and Trademark Office dated Jun. 16, 2014.;;Written Opinion of Singapore Application No. 201306353-2, received from the Danish Patent and Trademark Office dated Jun. 16, 2014.;;Sam Schechner, “Airlines Entertain Tablet Ideas—Rather Than Wiring Planes for In-Flight Movies, Some Hand Out iPads”, http://online.wsj.com/articles/SB10000872396390443916104578020601759253578, Sep. 2012.;;Mary Kirby, “Personal Services—In-flight connectivity poised to change the passenger experience for ever”, http://www.flightglobal.com/news/articles/personal-services-in-flight-connectivity-poised-to-change-the-passenger-experience-for-332765/, Sep. 2009.;;Lawrence Kitson, “The Future of In-flight: Part Two—The Concierge Concept”, http://ustwo.com/blog/the-future-of-in-flight-part-two-the-concierge-concept/, Apr. 2012.;;Examination Report of Malaysian Application No. 2013001405, received from the Intellectual Property Corporation of Malaysia dated Oct. 28, 2014.;;International Civil Aviation Organization, Machine Readable Travel Documents, Part 1, Machine Readable Passports—vol. 1, Specifications for Electronically Enabled Passports with Biometric Identification Capability, Sixth Edition, 99 pages, 2006.;;International Civil Aviation Organization, Machine Readable Travel Documents, Part 1, Machine Readable Passports—vol. 2, Passports with Machine Readable Data Stored in Optical Character Recognition Format, Sixth Edition, 131 pages, 2006.;;International Civil Aviation Organization, Machine Readable Travel Documents, Part 3, Machine Readable Official Travel Documents—vol. 1, MRtds with Machine Readable Data Stored in Optical Character Recognition Text International Civil Aviation Organization, Third Edition, 122 pages, 2008.;;International Civil Aviation Organization, Machine Readable Travel Documents, Part 3, Machine Readable Official Travel Documents—vol. 2, Specifications for Electronically Enabled MRtds with Biometric Identification Capability, Third Edition, 149 pages, 2008.;;Dunkel, Jürgen, et al., Model-Driven Architecture for Mobile Applications, pp. 464-477, 2007, Hannover University of Applied Sciences and Arts, Department of Computer Sciences, Hannover Germany.;;Glushko, Robert J., et al., Bridging the “Front Stage” and “Back Stage” in Service System Design, pp. 1-10, 2008, University of California, Berkely, School of Information, Proceedings of the 41st Hawaii International Conference on System Sciences, Institute of Electrical and Electronics Engineers (IEEE).;;Li, Quanzhong, et al., XVM: A Bridge Between XML Data and Its Behavior, 9 pages, May 17-22, 2004, 13th International Conference on World Wide Web, New York, New York, USA.;;Madria, Sanjay, An XML Schema Integration and Query Mechanism System, pp. 266-303, 2007, Elsevier B.V., Science Direct, Data & Knowledge Engineering 65 (2008).;;McGuire, Kelly A., et al., The Future of Revenue Management, 5 pages, 2009, SAS Global Forum 2009, SAS Institute, Inc.;;Smith, Barry C., et al., Yield Management at American Airlines, pp. 8-31, 1992, American Airlines Decision Technologies, Dallas/Fort Worth Airport, Texas, USA.;;Xu, Liping, et al., A Model of Capacity Control with Overbooking for a Two-leg Airlines Network, 5 pages, 2008, Institute of Electrical and Electronics Engineers (IEEE).;;AIRCOM Server Administrator Guide, SITA Airline Telecommunications and Information Services, Feb. 19, 2013, pp. 1-280.;;AIRCOM Server User Guide, SITA Airline Telecommunications and Information Services, Jan. 24, 2013, pp. 1-153.;;International Search Report and the Written Opinion mailed in International Application No. PCT/EP2013/052590 filed Aug. 2, 2013.;;International Search Report and Written Opinion mailed in International Application No. PCT/EP2011/070551 filed Nov. 21, 2011.;;International Search Report and Written Opinion mailed in International Application No. PCT/EP2014/062464 filed Jun. 13, 2014.;;International Search Report and Written Opinion mailed in International Application No. PCT/EP2015/053319 filed Feb. 17, 2015.;;International Search Report mailed in International Application No. PCT/EP2011/072286 filed on Sep. 12, 2011.;;Search Report and Written Opinion of Singapore Application No. 201301980-7, dated Sep. 3, 2013.;;Written Opinion mailed in Singapore Application No. 201301978-1, dated Oct. 15, 2013.;;Marmesse, M., et al., Location-aware Information Delivery with comMotion, MIT Media Laboratory, Cambridge, MA, HUC 2000 Proceedings, pp. 157-171, Springer-Verlag.;;Munoz, M., et al., Context-Aware Mobile Communication in Hospitals, IEEE Computer Society, Sep. 2003.;;Schwinger, W., et al., Context-Aware in Mobile Tourism Guides—A Comprehensive Survey, Austrian Federal Ministry for Education, Science, and Culture, and the European Social Fund, 2002.;;Russian Search Report for 2013133853/08(050668) dated Feb. 20, 2015. Receipt date: Jun. 16, 2015.;;Belobaba, Fundamentals of Pricing and Revenue Management, The Global Airline Industry, 2009.;;Caliendo, et al., Social Networks, Job Search Methods and Reservation Wages: Evidence for Germany, IZA, Sep. 2010, Germany.;;Glaser-Opitz, et al., Evaluation of CPDLC and Voice Communication During Approach Phase, Digital Avionics Conference, Sep. 13-17, 2015.;;Hull, et al., Technology-Enabled Airborne Spacing and Merging, Digital Avionics Systems Conference, 2004.;;International Examination Report mailed in Australian Application No. 2011347893 dated Sep. 11, 2015.;;International Search Report and Written Opinion mailed in International Application No. PCT/EP2014/055037 filed Mar. 13, 2014.;;International Search Report and Written Opinion mailed in International Application PCT/EP2015/068682 dated Oct. 29, 2015.;;International Search Report and Written Opinion mailed in Singapore Application No. 11201404575U dated Jun. 16, 2015.;;Kenney, et al., Secure ATC Surveillance for Military Applications, Military Communications Conference, 2008.;;Lee, et al., Effectiveness of the Ground-Based Transceiver (GBT) Parrot System for Monitoring GPS Integrity for Alaska ATC “Radar-Like Services” Using ADS-B, Digital Avionics Systems Conference, 2004.;;Search Report and Written Opinion dated Apr. 2, 2014 in GB Application No. 1317659.9.;;Johnston, et al., Multimodal Applications from Mobile to Kiosk, 2004, pp. 1-4.;;Kindervater, Revenue Management in the Airline Passenger Industry, 2007, pp. 1-24, Lunteren.;;Search Report and Examination Opinion dated May 19, 2015 in International Application No. GB1421313.6.;;Examination Report dated Apr. 28, 2014 in Malaysian Application No. PI 2013000936.",ACTIVE
546,AU,A1,AU 2015/203437 A1,134-116-225-050-222,2015-07-16,2015,AU 2015/203437 A,2015-06-22,AU 2011/219701 A;;AU 2015/203437 A,2011-02-25,Software application development tool,"5 A software development tool for use with external systems and services uses a common code base and defines all data and messages using XML Schema System components are defined which include a device abstraction layer which handles interactions between the application and devices. A host abstraction layer handles interactions between a host system and the application. A graphical tool models the work flow of the application and 10 includes screens and services defined by Schema. The application is assembled using the graphical tool, declarative XML rules and customisations of system components without the user having to generate any coding.",SITA INFORMATION NETWORKING COMPUTING IRELAND LTD,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,,https://lens.org/134-116-225-050-222,Patent Application,no,0,0,1,1,0,,G06F9/44,,0,0,,,,DISCONTINUED
547,US,S,US D0665672 S,030-670-711-502-703,2012-08-21,2012,US 37586310 F,2010-09-28,US 37586310 F,2010-09-28,Bottle,,RANDQUIST WILLIAM;;FELICI JOHN;;KRUGER CONRAD;;MANDERFIELD GROVER JOHN;;WELLS PETER C;;SPARTIS ELIAS PHILIP;;BASILE JOSEPH;;BASILE ANTHONY J;;BASILE ROBERT;;CATANIA SPAGNA CORP,RANDQUIST WILLIAM;;FELICI JOHN;;KRUGER CONRAD;;MANDERFIELD GROVER JOHN;;WELLS PETER C;;SPARTIS ELIAS PHILIP;;BASILE JOSEPH;;BASILE ANTHONY J;;BASILE ROBERT,CATANIA-SPAGNA CORPORATION (2010-08-27),https://lens.org/030-670-711-502-703,Design Right,no,0,7,1,1,0,,,0901;;D 9531;;D9/543;;D9/552,0,0,,,,ACTIVE
548,WO,A2,WO 2011/104367 A2,147-469-706-144-102,2011-09-01,2011,EP 2011052855 W,2011-02-25,GB 201009606 A;;US 30820810 P,2010-02-25,SOFTWARE APPLICATION DEVELOPMENT TOOL,"A software development tool for use with external systems and services uses a common code base and defines all data and messages using XML Schema System components are defined which include a device abstraction layer which handles interactions between the application and devices. A host abstraction layer handles interactions between a host system and the application. A graphical tool models the work flow of the application and includes screens and services defined by Schema. The application is assembled using the graphical tool, declarative XML rules and customisations of system components without the user having to generate any coding.",SITA INFORMATION NETWORKING COMPUTING IRELAND LTD;;FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,,https://lens.org/147-469-706-144-102,Patent Application,yes,0,8,14,14,0,G06F8/34;;G06F8/34;;G06F8/34;;G06F9/44,G06F9/44,,0,0,,,,PENDING
549,CA,A1,CA 2790985 A1,046-063-674-133-844,2011-09-01,2011,CA 2790985 A,2011-02-25,US 30820810 P;;GB 201009606 A;;EP 2011052855 W,2010-02-25,SOFTWARE APPLICATION DEVELOPMENT TOOL,"A software development tool for use with external systems and services uses a common code base and defines all data and messages using XML Schema System components are defined which include a device abstraction layer which handles interactions between the application and devices. A host abstraction layer handles interactions between a host system and the application. A graphical tool models the work flow of the application and includes screens and services defined by Schema. The application is assembled using the graphical tool, declarative XML rules and customisations of system components without the user having to generate any coding.",SITA INFORMATION NETWORKING COMPUTING IRELAND LTD,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,,https://lens.org/046-063-674-133-844,Patent Application,no,0,0,14,14,0,G06F8/34;;G06F8/34;;G06F8/34;;G06F9/44,G06F9/44,,0,0,,,,ACTIVE
550,AU,A1,AU 2011/219701 A1,068-158-989-763-867,2012-09-13,2012,AU 2011/219701 A,2011-02-25,US 30820810 P;;GB 201009606 A;;EP 2011052855 W,2010-02-25,Software application development tool,"A software development tool for use with external systems and services uses a common code base and defines all data and messages using XML Schema System components are defined which include a device abstraction layer which handles interactions between the application and devices. A host abstraction layer handles interactions between a host system and the application. A graphical tool models the work flow of the application and includes screens and services defined by Schema. The application is assembled using the graphical tool, declarative XML rules and customisations of system components without the user having to generate any coding.",SITA INFORMATION NETWORKING COMPUTING IRELAND LTD,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,,https://lens.org/068-158-989-763-867,Patent Application,no,0,0,14,14,0,G06F8/34;;G06F8/34;;G06F8/34;;G06F9/44,G06F9/44,,0,0,,,,DISCONTINUED
551,US,A1,US 2015/0309770 A1,053-211-479-759-388,2015-10-29,2015,US 201113581182 A,2011-02-25,US 201113581182 A;;GB 201009606 A;;US 30820810 P;;EP 2011052855 W,2010-02-25,Software Application Development Tool,"A software development tool for use with external systems and services uses a common code base and defines all data and messages using XML Schema System components are defined which include a device abstraction layer which handles interactions between the application and devices. A host abstraction layer handles interactions between a host system and the application. A graphical tool models the work flow of the application and includes screens and services defined by Schema. The application is assembled using the graphical tool, declarative XML rules and customisations of system components without the user having to generate any coding.",FINDLAY DENISE;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;FLENLEY JOHN MARTIN;;SITA INFORMATION NETWORKING COMPUTING IRELAND LTD,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,SITA INFORMATION NETWORKING COMPUTING IRELAND LIMITED (2010-04-15),https://lens.org/053-211-479-759-388,Patent Application,yes,5,18,14,14,0,G06F8/34;;G06F8/34;;G06F8/34;;G06F9/44,G06F9/44,,0,0,,,,ACTIVE
552,EP,A2,EP 2539811 A2,117-581-163-592-858,2013-01-02,2013,EP 11709892 A,2011-02-25,GB 201009606 A;;US 30820810 P;;EP 2011052855 W,2010-02-25,SOFTWARE APPLICATION DEVELOPMENT TOOL,,SITA INFORMATION NETWORKING COMPUTING IRELAND LTD,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,,https://lens.org/117-581-163-592-858,Patent Application,yes,0,0,14,14,0,G06F8/34;;G06F8/34;;G06F8/34;;G06F9/44,G06F9/44,,1,0,,,See references of WO 2011104367A3,DISCONTINUED
553,GB,A,GB 2481191 A,132-567-524-835-230,2011-12-21,2011,GB 201009606 A,2010-06-08,US 30820810 P,2010-02-25,Graphical development tool for software application development,"A method of using a graphical development tool to assemble a software application is disclosed. The method uses a common code base. A declarative data description language is then used to describe data and messages used by the application. A library of system components is also provided and includes a device abstraction layer which maps interactions between devices and the application. A further abstraction layer is provided for mapping interactions between the host and the application. A graphical tool is used to model the workflow of the application including screens and services and then to assemble the application using the rules and customizations of the system components from the library. In use the graphical tool makes use of drag and drop. Messages, data, screens and services may be described using an XML schema. In a particular embodiment the system is used to develop an air passenger check-in client.",SITA INFORMATION NETWORKING COMPUTING IRELAND LTD,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,,https://lens.org/132-567-524-835-230,Patent Application,no,0,4,14,14,0,G06F8/34;;G06F8/34;;G06F8/34;;G06F9/44,G06F9/44,,1,0,,,None,DISCONTINUED
554,WO,A3,WO 2011/104367 A3,173-848-797-619-742,2011-11-17,2011,EP 2011052855 W,2011-02-25,GB 201009606 A;;US 30820810 P,2010-02-25,SOFTWARE APPLICATION DEVELOPMENT TOOL,"A software development tool for use with external systems and services uses a common code base and defines all data and messages using XML Schema System components are defined which include a device abstraction layer which handles interactions between the application and devices. A host abstraction layer handles interactions between a host system and the application. A graphical tool models the work flow of the application and includes screens and services defined by Schema. The application is assembled using the graphical tool, declarative XML rules and customisations of system components without the user having to generate any coding.",SITA INFORMATION NETWORKING COMPUTING IRELAND LTD;;FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,FINDLAY DENISE;;ATTAR MICHAEL JOSEPH;;EULER ERIC WILLIAM;;SERRATORE CORY ALLAN;;ELIAS LISSY;;VALENTE LEONARDO GRANADO;;LESTYAN GABOR JANOS;;FLENLEY JOHN MARTIN,,https://lens.org/173-848-797-619-742,Search Report,yes,3,0,14,14,0,G06F8/34;;G06F8/34;;G06F8/34;;G06F9/44,G06F9/44,,1,1,090-490-195-543-530,10.1007/978-3-540-72035-5_36,"DUNKEL J, BRUNS R: ""Model-Driven Architecture for Mobile Applications"", 25 April 2007, BUSINESS INFORMATION SYSTEMS; [LECTURE NOTES IN COMPUTER SCIENCE;LNCS], SPRINGER BERLIN HEIDELBERG, BERLIN, HEIDELBERG, PAGE(S) 464 - 477, ISBN: 978-3-540-72034-8, XP019079208",PENDING
555,MA,A,MA 42915 A,172-279-335-186-803,2018-08-01,2018,MA 42915 A,2016-08-05,GB 201514021 A,2015-08-07,PYRIDINES ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER,,ARNER ELIAS SET JENOE;;US HEALTH,ARNÉR ELIAS SET JENÖ;;COUSSENS NATHAN PATRICK;;DEXHEIMER THOMAS S;;JADHAV AJIT;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;STAFFORD WILLIAM CHESTER,,https://lens.org/172-279-335-186-803,Unknown,no,0,0,20,20,0,A61K31/435;;A61K31/44;;A61K45/06;;A61K45/06;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/02;;A61P43/00;;C07D213/71;;C07D213/71;;C07D213/71;;C07D213/71,A61K31/435;;A61P35/00;;C07D213/71,,0,0,,,,PENDING
556,AU,A1,AU 2016/306276 A1,173-924-306-252-045,2018-02-22,2018,AU 2016/306276 A,2016-08-05,GB 201514021 A;;US 2016/0045731 W,2015-08-07,Pyridines and their use in the treatment of cancer,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein L, R",ARNER ELIAS;;US HEALTH,ARNER ELIAS SET JENOE;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/173-924-306-252-045,Patent Application,no,0,0,20,20,0,A61K31/435;;A61K31/44;;A61K45/06;;A61K45/06;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/02;;A61P43/00;;C07D213/71;;C07D213/71;;C07D213/71;;C07D213/71,C07D213/71;;A61K31/435;;A61P35/00,,0,0,,,,INACTIVE
557,WO,A8,WO 2017/027358 A8,095-081-652-182-043,2017-04-20,2017,US 2016/0045730 W,2016-08-05,GB 201514018 A,2015-08-07,TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein X, Y, Z, R 1 and R 2 have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNER ELIAS SET JENÖ;;THE UNITED STATES OF AMERICA AS REPESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES,ARNER ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/095-081-652-182-043,Amended Application,yes,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61P35/00,,0,0,,,,PENDING
558,CA,A1,CA 2995077 A1,043-127-679-035-371,2017-02-16,2017,CA 2995077 A,2016-08-05,GB 201514021 A;;US 2016/0045731 W,2015-08-07,PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3, R4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNER ELIAS SET JENO;;US HEALTH,ARNER ELIAS SET JENO;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/043-127-679-035-371,Patent Application,no,0,0,20,20,0,A61K31/435;;A61K31/44;;A61K45/06;;A61K45/06;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/02;;A61P43/00;;C07D213/71;;C07D213/71;;C07D213/71;;C07D213/71,C07D213/71;;A61K31/435;;A61P35/00,,0,0,,,,ACTIVE
559,RU,C2,RU 2730505 C2,011-544-043-113-502,2020-08-24,2020,RU 2018107879 A,2016-08-05,GB 201514021 A;;US 2016/0045731 W,2015-08-07,PYRIDINES AND USE THEREOF IN TREATING CANCER,"FIELD: medicine; pharmaceuticals.SUBSTANCE: invention relates to compounds of formula I, as well as to use thereof as a pharmaceutical agent for treating cancer and a method for production thereof.(I).EFFECT: obtaining compounds capable of inhibiting cytosolic thioredoxin reductase applicable in treating mediated diseases, such as cancer.12 cl, 17 ex, 3 dwg",ARNER ELIAS SET JENO,ARNER ELIAS SET JENO;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/011-544-043-113-502,Granted Patent,no,3,0,20,20,0,A61K31/435;;A61K31/44;;A61K45/06;;A61K45/06;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/02;;A61P43/00;;C07D213/71;;C07D213/71;;C07D213/71;;C07D213/71,C07D213/71;;A61K31/435;;A61P35/00,,2,0,,,"I-LIN LU et al., Structure-Based Drug Design And Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease, J. MED. CHEM, т. 49, стр.:5154 - 5161, 2006.;;WANG J et al, Discovery of nitropyridine",ACTIVE
560,WO,A8,WO 2017/027357 A8,039-160-704-382-114,2017-04-20,2017,US 2016/0045729 W,2016-08-05,GB 201514015 A,2015-08-07,PYRIDAZINONES AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein W, X, Y, Z, R 1 , R 2 and R 3 have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNÉR ELIAS SET JENÖ;;US HEALTH,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/039-160-704-382-114,Amended Application,yes,0,0,7,7,0,C07D413/06;;A61P35/00;;A61K31/501;;A61K45/06;;C07D413/06,C07D413/06;;A61K31/501;;A61P35/00,,0,0,,,,PENDING
561,US,B2,US 10899710 B2,080-240-382-192-997,2021-01-26,2021,US 201615750805 A,2016-08-05,GB 201514021 A;;US 2016/0045731 W,2015-08-07,Pyridines and their use in the treatment of cancer,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein L, R 1 , R 2 , R 3 , R 4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.",US HEALTH;;ARNER ELIAS SET JENOE,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2016-11-15);;ARNÉR ELIAS SET JENÖ (2016-08-05),https://lens.org/080-240-382-192-997,Granted Patent,yes,49,4,20,20,0,A61K31/435;;A61K31/44;;A61K45/06;;A61K45/06;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/02;;A61P43/00;;C07D213/71;;C07D213/71;;C07D213/71;;C07D213/71,C07D213/71;;A61K45/06;;A61P35/00,,47,27,007-866-411-448-224;;044-376-130-292-200;;014-252-764-931-163;;027-629-217-527-021;;091-849-816-773-182;;031-578-877-323-70X;;034-656-244-271-073;;000-782-866-783-149;;045-555-859-711-633;;102-334-263-768-520;;025-212-543-652-454;;000-017-079-794-318;;046-213-631-913-139;;100-931-763-922-89X;;051-814-634-260-30X;;031-130-677-713-716;;034-715-939-510-592;;068-662-469-835-081;;003-628-570-362-410;;019-923-883-143-334;;088-609-498-068-080;;132-374-543-815-541;;039-432-356-150-005;;100-269-788-422-927;;035-909-375-232-196;;099-433-905-208-961;;127-840-627-323-899,11012661;;10.1046/j.1432-1327.2000.01701.x;;19364476;;10.1016/j.bbagen.2009.01.014;;11012663;;10.1046/j.1432-1327.2000.01703.x;;10.1016/j.bcp.2008.08.021;;18789312;;10.1002/(sici)1097-0231(19970215)11:3<316::aid-rcm746>3.0.co;2-a;;10.1158/1078-0432.ccr-11-0736;;pmc3186854;;21844013;;10.1016/j.ccell.2014.11.019;;25620030;;10.1074/jbc.m511373200;;16481328;;10.1021/jm800101w;;18605719;;18621099;;19269363;;pmc2894612;;10.1016/j.cell.2009.02.024;;5890622;;10.1248/yakushi1947.85.5_429;;21126054;;10.1021/ol102629c;;21045148;;10.1158/0008-5472.can-10-1509;;10.1016/j.freeradbiomed.2011.11.025;;pmc3267845;;22198266;;16036347;;10.1080/10715760500135391;;10.1021/ja01512a058;;13585510;;10.1248/cpb.6.369;;10.1038/nrd2803;;19478820;;10.1021/op700060e;;16913704;;10.1021/jm060207o.s001;;10.1021/jm060207o;;10.1016/j.ejmech.2014.02.047;;24602795;;10.1021/cb500789h;;25402598;;6625479;;1206454;;10.3987/r-1986-08-2137;;10.1080/13543776.2017.1272576;;27977313,"Arnér et al., Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. Oct. 2000;267(20):6102-9.;;Arnér, Focus on mammalian thioredoxin reductases—important selenoproteins with versatile functions. Biochim Biophys Acta. Jun. 2009;1790(6):495-526.;;Becker et al., Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem. Oct. 2000;267(20):6118-25.;;Cox et al., The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochemical Pharmacology. 2008;76:1097-1109.;;El-Zahara et al., Mass Spectral Study of Some Phenyl-mono and Dinitropyridyl Sulfide, Ether, Amine and Sulfone Derivatives. Rapid Communications in Mass Spectrometry. 1997;11:316-320.;;Fath et al., Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism. Clin Cancer Res. Oct. 1, 2011;17(19):6206-17.;;Harris et al., Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell. Feb. 9, 2015;27(2)211-22.;;Hashemy et al., Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J Biol Chem. Apr. 21, 2006;281(16):10691-7.;;Krishnamurthy et al., Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study. J Med Chem. Aug. 14, 2008;51(15):4790-5.;;Lillig et al., Glutaredoxin systems. Biochim Biophys Acta. Nov. 2008;1780(11):1304-17.;;Luo et al., Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. Mar. 6, 2009;136(5):823-37.;;Maki et al., Studies of Rearrangement Reaction XIII. Smiles Rearrangement on Pyridine Derivatives. Gifu Yakka Daigaku Kiyo. 1965;15:31-33.;;Maki et al., Studies of rearrangement reactions. X. Smiles rearrangement on pyridine derivatives. 7. Yakugaku Zasshi. May 1965;85(5):429-36.;;Maloney et al., A practical, one-pot synthesis of sulfonylated pyridines. Org Lett. Jan. 7, 2011;13(1):102-5.;;Mandal et al., Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation. Cancer Res. Nov. 15, 2010;70(22):9505-14.;;Prigge et al., Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1. Free Radic Biol Med. Feb. 15, 2012;52(4):803-10.;;Rigobello et al., Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase. Free Radic Res. Jul. 2005;39(7):687-95.;;Robison et al., 7-Azaindole. VI. Preparation of 5- and 6-Substituted 7-azaindoles. J Am Chem Soc. 1959;81:743-747.;;STN RN 1087745-45-6, Pyridine, 5-methyl-3-nitro-2-(phenylsulfonyl)—5 pages, Dec. 21, 2008.;;STN RN 1258786-29-6, 6-Methoxy-2-[ (4-methylphenyl)sulfonyl]-3-nitropyridine, 6 pages, Jan. 7, 2011.;;STN RN 188429-02-9, Pyridine, 3-nitro-2-(phenylsulfonyl)—5 pages, Apr. 18, 1997.;;STN RN 246020-68-8, Pyridine, 2[(4-chlorophenyl/sulfonyl]-6-methoxy-3-nitro—2 pages, Nov. 3, 1999.;;STN RN 3573-15-7, Acetamide, N-[2-[(5-chloro-3-nitro-2-pyridinyl)sulfonyl]phenyl]—5 pages, Nov. 16, 1984.;;STN RN 477871-39-9, Pyridine, 2[(4-methylphenyl)sulfonyl]-3-nitro—2 pages, Dec. 31, 2002.;;STN RN 97420-49-0, Pyridine, 2-methyl-3, 5-dinitro-6-(phenylsulfonyl)—3 pages, Aug. 4, 1985.;;Takahashi et al., Sulfur-containing pyridine derivatives. LVI. Smiles rearrangement of pyridine derivatives and synthesis of benzopyrido- and dipyrido-1, 4-thiazine derivatives. 4. Chem Pharm Bull (Tokyo). Aug. 1958;6(4):369-73.;;Talik et al., Synteza Niektorych Siarkowych Pochodnych 3,5-Dinitro-6-Metylopirydyny. Prace Naukowe Akademii Ekonomicznej We Wroclawiu. 1984;255:137-144.;;Trachootham et al., Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. Jul. 2009;8(7):579-91.;;Trankle et al., Green Chemical Synthesis of 2-Benzenesulfonyl-pyridine and Related Derivatives. Organic Process Research & Development. 2007;11:913-917.;;Lu et al., “Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease” J. Med. Chem., vol. 49:5154-5161, Jan. 8, 2006.;;Wang et al., “Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via structure-based core refining approach” Eur. J. of Med. Chem., vol. 76:531-538, Feb. 19, 2014.;;International Search Report and Written Opinion, PCT/US2016/045731, dated Oct. 28, 2016.;;Belikov, Pharmaceutical Chemistry. Medpress-inform. pp. 27-29, (2007).;;Braun et al., Synthesis and biological evaluation of optimized inhibitors of the mitotic kinesin Kif18A. ACS Chem Biol. Feb. 20, 2015; 10(2):554-60.;;Jamoulle et al., Preparation et proprietes protozoocides de sulfures et sulfones heterocycliques. Ann Pharmaceutiques francaises. 1983; 41(1):61-8.;;Jamoulle et al., Synthese de Quelques Alkylsulfonyl-2 Pyridines Substituees en Position 3. J Pharm Belg. 1975;30 (2):114-20.;;Moshchitskii et al., Competitive Nucleophilic Substitution Reactions of Methysulfonyl and Nitro Derivatives of Khimiya Geterotsiklicheskikh Soedinenii. Jun. 1975; 6:802-6. Polychloropyridines.;;Moss, Iupac, Pure and Applied Chemistry. 1995; 67:1314, 1330.;;Storey, Benzyl Alcohol. Handbook of Pharmaceutical Excipients, Sixth Edition. Pharmaceutical Press, London. Raymond C. Rowe (Ed.). pp. 64-66, (2009).;;Takayama et al., Diels-Alder Reaction of 3-(2-Pyridylsulfinyl)Acrylates—The Enhancement of the Reactivity and the Diastereoelectivity by the Introduction of Electron-withdrawing Substituents on the Pyridine Ring. Hetercycles. 1986; 24(8):2137-40.;;Talik et al., Synthesis of Some Sulfoderivatives of Pyridine. Polish Journal of Chemistry. 1978;52:163-70.;;Zhang et al., Thioredoxin reductase inhibitors: a patent review. Expert Opin Ther Pat. May 2017; 27(5):547-556.;;Russian Office Action for Application No. 2018107879, dated Feb. 25, 2020, 7 pages.;;U.S. Appl. No. 16/484,039, filed Aug. 6, 2019, Publication No. 2020-0223819.;;U.S. Appl. No. 16/484,057, filed Aug. 6, 2019, Publication No. 2020-0239417.;;U.S. Appl. No. 16/483,961, filed Aug. 6, 2019, Publication No. 2020-0024255.;;U.S. Appl. No. 16/484,074, filed Aug. 6, 2019, Publication No. 2020-0024233.",ACTIVE
562,CA,C,CA 2995075 C,193-461-341-921-440,2022-05-31,2022,CA 2995075 A,2016-08-05,GB 201514018 A;;US 2016/0045730 W,2015-08-07,TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein X, Y, Z, R1 and R2 have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNER ELIAS SET JENO;;US HEALTH,ARNER ELIAS SET JENO;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/193-461-341-921-440,Granted Patent,no,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61P35/00,,0,0,,,,ACTIVE
563,RU,C2,RU 2736501 C2,021-422-876-684-841,2020-11-17,2020,RU 2018107941 A,2016-08-05,GB 201514018 A;;US 2016/0045730 W,2015-08-07,TRICYCLIC COMPOUNDS AND USE THEREOF FOR TREATING CANCER,"FIELD: pharmaceuticals.SUBSTANCE: invention relates to use of compounds of formula I, or pharmaceutically acceptable salts thereof, where X, Y, Z, R1and R2have values given in the claim, as a pharmaceutical agent acting by inhibiting cytosolic thioredoxin reductase, and which can be used for treating cancer diseases.(I)EFFECT: tricyclic compounds and use thereof for treating cancer are disclosed.10 cl, 69 ex, 3 dwg",ARNER ELIAS SET JENO,ARNER ELIAS SET JENO;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/021-422-876-684-841,Granted Patent,no,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61P35/00,,0,0,,,,ACTIVE
564,US,B2,US 11110089 B2,157-553-624-620-501,2021-09-07,2021,US 201615750817 A,2016-08-05,GB 201514015 A;;US 2016/0045729 W,2015-08-07,Pyridazinones and their use in the treatment of cancer,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein W, X, Y, Z, R 1 , R 2 and R 3 have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNER ELIAS SET JENOE;;US HEALTH;;ELIAS SET JENOE ARNER,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2016-11-15);;ARNÉR ELIAS SET JENÖ (2016-08-05),https://lens.org/157-553-624-620-501,Granted Patent,yes,6,0,7,7,0,C07D413/06;;A61P35/00;;A61K31/501;;A61K45/06;;C07D413/06,C07D413/06;;A61K31/501;;A61K45/06,,17,15,007-866-411-448-224;;044-376-130-292-200;;014-252-764-931-163;;027-629-217-527-021;;031-578-877-323-70X;;034-656-244-271-073;;000-782-866-783-149;;045-555-859-711-633;;102-334-263-768-520;;025-212-543-652-454;;100-931-763-922-89X;;051-814-634-260-30X;;031-130-677-713-716;;003-628-570-362-410;;042-407-756-186-385,11012661;;10.1046/j.1432-1327.2000.01701.x;;19364476;;10.1016/j.bbagen.2009.01.014;;11012663;;10.1046/j.1432-1327.2000.01703.x;;10.1016/j.bcp.2008.08.021;;18789312;;10.1158/1078-0432.ccr-11-0736;;pmc3186854;;21844013;;10.1016/j.ccell.2014.11.019;;25620030;;10.1074/jbc.m511373200;;16481328;;10.1021/jm800101w;;18605719;;18621099;;19269363;;pmc2894612;;10.1016/j.cell.2009.02.024;;21045148;;10.1158/0008-5472.can-10-1509;;10.1016/j.freeradbiomed.2011.11.025;;pmc3267845;;22198266;;16036347;;10.1080/10715760500135391;;10.1038/nrd2803;;19478820;;10.1002/jhet.2182,"Abdel-Hakeem et al., Synthesis and Antimicrobial Activity of Some 6-(4-Fluorophenyl) Pyridazine Derivatives. Bull Fac Pharm Cairo Univ. 2007;45:39-46.;;Arnér et al., Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. Oct. 2000;267(20):6102-9.;;Arnér, Focus on mammalian thioredoxin reductases—important selenoproteins with versatile functions. Biochim Biophys Acta. Jun. 2009;1790(6):495-526.;;Becker et al., Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem. Oct. 2000;267(20):6118-25.;;Cox et al., The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochemical Pharmacology. 2008;76:1097-1109.;;Fath et al., Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism. Clin Cancer Res. Oct. 1, 2011;17(19):6206-17.;;Harris et al., Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell. Feb. 9, 2015;27(2):211-22.;;Hashemy et al., Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J Biol Chem. Apr. 21, 2006;281(16):10691-7.;;Krisfinamurthy et al., Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study. J Med Chem. Aug. 14, 2008;51(15):4790-5.;;Lillig et al., Glutaredoxin systems. Biochim Biophys Acta. Nov. 2008;1780(11):1304-17.;;Luo et al., Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. Mar. 6, 2009;136(5):823-37.;;Mandal et al., Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation. Cancer Res. Nov. 15, 2010;70(22):9505-14.;;Prigge et al., Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1. Free Radic Biol Med. Feb. 15, 2012;52(4):803-10.;;Rigobello et al., Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase. Free Radic Res. Jul. 2005;39(7):687-95.;;Trachootham et al., Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. Jul. 2009;8(7):579-91.;;El-Hashash et al., “Synthesis of novel heterocyclic compounds with expected antibacterial activities from 4-(4-bromophenyl) . . . ” J. Hetero. Chem, vol. 52:732-743, May 31, 2014.;;International Search Report and Written Opinion, PCT/US2016/045729, dated Oct. 21, 2016.",ACTIVE
565,WO,A8,WO 2017/027359 A8,194-733-839-888-695,2017-04-20,2017,US 2016/0045731 W,2016-08-05,GB 201514021 A,2015-08-07,PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein L, R 1 , R 2 , R 3 , R 4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNÉR ELIAS SET JENÖ;;US HEALTH,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/194-733-839-888-695,Amended Application,yes,0,0,20,20,0,A61K31/435;;A61K31/44;;A61K45/06;;A61K45/06;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/02;;A61P43/00;;C07D213/71;;C07D213/71;;C07D213/71;;C07D213/71,C07D213/71;;A61K31/435;;A61P35/00,,0,0,,,,PENDING
566,WO,A1,WO 2017/027359 A1,044-409-852-078-124,2017-02-16,2017,US 2016/0045731 W,2016-08-05,GB 201514021 A,2015-08-07,PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein L, R 1 , R 2 , R 3 , R 4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNÉR ELIAS SET JENÖ;;US HEALTH,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/044-409-852-078-124,Patent Application,yes,3,13,20,20,0,C07D213/71;;A61P35/00;;A61P35/02;;A61P43/00;;A61P35/00;;A61K31/44;;A61K45/06;;C07D213/71;;A61K31/435;;A61P35/00;;C07D213/71;;A61P35/00;;A61K45/06;;C07D213/71,C07D213/71;;A61K31/435;;A61P35/00,,2,2,088-609-498-068-080;;132-374-543-815-541,16913704;;10.1021/jm060207o.s001;;10.1021/jm060207o;;10.1016/j.ejmech.2014.02.047;;24602795,"I-LIN LU ET AL.: ""Structure-Based Drug Design And Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease"", J. MED. CHEM., vol. 49, 8 January 2006 (2006-01-08), pages 5154 - 5161, XP002763179;;J. WANG ET AL.: ""Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a strcuture-based core refining approach"", EUROPEAN JOURANL OF MEDICINAL CHEMISTRY, vol. 76, 19 February 2014 (2014-02-19), pages 531 - 538, XP002763180",PENDING
567,KR,A,KR 20180035904 A,059-608-467-447-68X,2018-04-06,2018,KR 20187006536 A,2016-08-05,GB 201514021 A;;US 2016/0045731 W,2015-08-07,피리딘 및 암의 치료에서의 이의 용도,"하기 화학식 I의 화합물, 또는 이의 약제학적으로-허용 가능한 염이 제공되며, 이 화합물은 암의 치료에서 유용하다:식 중, L, R, R, R, R및 n은 명세서에서 제공되는 의미를 갖는다.",ARNER ELIAS SET JENOE;;US HEALTH,ARNER ELIAS SET JENOE;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/059-608-467-447-68X,Patent Application,no,1,0,20,20,0,A61K31/435;;A61K31/44;;A61K45/06;;A61K45/06;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/02;;A61P43/00;;C07D213/71;;C07D213/71;;C07D213/71;;C07D213/71,C07D213/71;;A61K31/44;;A61K45/06;;A61P35/00,,0,0,,,,ACTIVE
568,EP,A1,EP 3331858 A1,154-038-915-462-069,2018-06-13,2018,EP 16759907 A,2016-08-05,GB 201514021 A;;US 2016/0045731 W,2015-08-07,PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER,,ARNER ELIAS SET JENOE;;US HEALTH,STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S;;ARNÉR ELIAS SET JENÖ,,https://lens.org/154-038-915-462-069,Patent Application,yes,0,0,20,20,0,A61K31/435;;A61K31/44;;A61K45/06;;A61K45/06;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/02;;A61P43/00;;C07D213/71;;C07D213/71;;C07D213/71;;C07D213/71,C07D213/71;;A61K31/435;;A61P35/00,,1,0,,,See references of WO 2017027359A1,DISCONTINUED
569,AU,A1,AU 2016/307438 A1,172-248-371-229-653,2018-02-22,2018,AU 2016/307438 A,2016-08-05,GB 201514018 A;;US 2016/0045730 W,2015-08-07,Tricyclic compounds and their use in the treatment of cancer,"There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein X, Y, Z, R",ARNER ELIAS;;THE UNITED STATES OF AMERICA AS REPESENTED BY THE SECRETARY,ARNER ELIAS SET JENOE;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/172-248-371-229-653,Patent Application,no,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61P35/00,,0,0,,,,INACTIVE
570,US,A1,US 2020/0113889 A1,161-026-744-490-350,2020-04-16,2020,US 201615750819 A,2016-08-05,GB 201514018 A;;US 2016/0045730 W,2015-08-07,TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein X, Y, Z, R 1 and R 2 have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNER ELIAS SET JENOE;;THE US SECREATARY DEPARTMENT OF HEALTH AND HUMAN SERVI,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2016-11-15);;ARNÉR ELIAS SET JENÖ (2016-08-05),https://lens.org/161-026-744-490-350,Patent Application,yes,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,A61K31/46;;A61P35/00;;C07D451/00,,0,0,,,,ACTIVE
571,CA,A1,CA 2995075 A1,170-648-212-474-942,2017-02-16,2017,CA 2995075 A,2016-08-05,GB 201514018 A;;US 2016/0045730 W,2015-08-07,TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein X, Y, Z, R1 and R2 have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNER ELIAS SET JENO;;US HEALTH,ARNER ELIAS SET JENO;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/170-648-212-474-942,Patent Application,no,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61P35/00,,0,0,,,,ACTIVE
572,KR,A,KR 20180032647 A,188-767-471-535-792,2018-03-30,2018,KR 20187006528 A,2016-08-05,GB 201514018 A;;US 2016/0045730 W,2015-08-07,삼환식 화합물 및 암의 치료에서의 이의 용도,"하기 화학식 I의 화합물, 또는 이의 약제학적으로-허용 가능한 염이 제공되며, 이 화합물은 암의 치료에서 유용하다:식 중 X, Y, Z, R및 R는 명세서에서 제공되는 의미를 갖는다.",ARNER ELIAS SET JENOE;;US HEALTH,ARNER ELIAS SET JENOE;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/188-767-471-535-792,Patent Application,no,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61K31/46;;A61P35/00,,0,0,,,,DISCONTINUED
573,US,A1,US 2020/0087260 A1,130-110-332-561-99X,2020-03-19,2020,US 201615750805 A,2016-08-05,GB 201514021 A;;US 2016/0045731 W,2015-08-07,PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein L, R 1 , R 2 , R 3 , R 4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.",THE USA AS REPRESENTED BY THE SECRETRY DEPT OF HEALTH AND HUMAN SERVICES;;THE USA AS REPRESENTED BY THE SEC DEP PF HEALTH AND HUMAN SERVICES,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2016-11-15);;ARNÉR ELIAS SET JENÖ (2016-08-05),https://lens.org/130-110-332-561-99X,Patent Application,yes,0,3,20,20,0,A61K31/435;;A61K31/44;;A61K45/06;;A61K45/06;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/02;;A61P43/00;;C07D213/71;;C07D213/71;;C07D213/71;;C07D213/71,C07D213/71;;A61P35/00,,0,0,,,,ACTIVE
574,US,A1,US 2020/0113897 A1,175-149-510-896-348,2020-04-16,2020,US 201615750817 A,2016-08-05,GB 201514015 A;;US 2016/0045729 W,2015-08-07,PYRIDAZINONES AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein W, X, Y, Z, R 1 , R 2 and R 3 have meanings provided in the description, which compounds are useful in the treatment of cancers.",AMER ELIAS SET JENOE;;THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2016-11-15);;ARNÉR ELIAS SET JENÖ (2016-08-05),https://lens.org/175-149-510-896-348,Patent Application,yes,0,0,7,7,0,C07D413/06;;A61P35/00;;A61K31/501;;A61K45/06;;C07D413/06,A61K31/501;;A61K45/06;;C07D413/06,,0,0,,,,ACTIVE
575,US,B2,US 10881653 B2,188-781-603-124-671,2021-01-05,2021,US 201615750819 A,2016-08-05,GB 201514018 A;;US 2016/0045730 W,2015-08-07,Tricyclic compounds and their use in the treatment of cancer,"There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein X, Y, Z, R 1 and R 2 have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNER ELIAS SET JENOE;;US HEALTH,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2016-11-15);;ARNÉR ELIAS SET JENÖ (2016-08-05),https://lens.org/188-781-603-124-671,Granted Patent,yes,3,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,A61K31/46;;A61P35/00;;C07D451/00,,46,32,075-152-078-478-842;;067-178-194-417-049;;007-866-411-448-224;;044-376-130-292-200;;003-269-490-584-038;;014-252-764-931-163;;027-629-217-527-021;;058-114-658-588-518;;163-324-827-037-701;;120-094-053-483-773;;031-578-877-323-70X;;034-656-244-271-073;;000-782-866-783-149;;037-858-111-853-234;;044-532-793-951-846;;038-226-478-142-763;;165-234-223-367-148;;029-533-827-653-259;;029-342-555-214-41X;;082-653-894-301-577;;097-591-863-941-065;;052-042-042-497-206;;045-555-859-711-633;;102-334-263-768-520;;025-212-543-652-454;;021-819-705-751-590;;100-931-763-922-89X;;161-069-676-513-564;;093-557-062-189-112;;051-814-634-260-30X;;031-130-677-713-716;;003-628-570-362-410,10.1039/p19790002535;;10.1016/s0040-4020(01)00740-2;;11012661;;10.1046/j.1432-1327.2000.01701.x;;19364476;;10.1016/j.bbagen.2009.01.014;;10.1039/p19760002334;;11012663;;10.1046/j.1432-1327.2000.01703.x;;10.1016/j.bcp.2008.08.021;;18789312;;10.1039/p19770001930;;10.1039/p19740001883;;10.1039/p19740000746;;10.1158/1078-0432.ccr-11-0736;;pmc3186854;;21844013;;10.1016/j.ccell.2014.11.019;;25620030;;10.1074/jbc.m511373200;;16481328;;10.1039/p19790000399;;10.1039/p19800000331;;10.1039/p19800000343;;10.1039/p19800000362;;10.1002/chin.198047222;;10.1002/chin.198144089;;10.1039/j39710000874;;10.1021/ja00716a066;;10.1039/c39780000316;;10.1021/jm800101w;;18605719;;18621099;;19269363;;pmc2894612;;10.1016/j.cell.2009.02.024;;10.1021/ol000288x;;11101451;;21045148;;10.1158/0008-5472.can-10-1509;;10.1002/chin.199732026;;10.1080/00397919808004823;;10.1016/j.freeradbiomed.2011.11.025;;pmc3267845;;22198266;;16036347;;10.1080/10715760500135391;;10.1038/nrd2803;;19478820,"A.R.KATRITZKY ET AL.: ""1,3-Dipolar character of six-membered aromatic rings. Part 45."", JOURNAL CHEM. SOC., PERKIN TRANS. 1, 1 January 1979 (1979-01-01), pages 2535 - 2541, XP002762644;;Fielding et al., “Seqeuential oxopyridinium betaine cycloaddition-palladium catalysed cyclisation-anion capture processes” Tetrahedron, Elsevier Science Publ., Amsterdam NL, vol. 57(36):7737-7748, Sep. 3, 2001.;;Database CAPLUS Accession No: 1990:235247 (The whole document: El-abbady et al., “Cycloadditions of 1-(6-arylpyridazin-3-yl)-3-oxidopyridinum betaines with . . . ”, Indian J. Chem., vol. 28B(11):923-927, Jan. 1, 1989).;;Database CAPLUS Accession No. 1980:532333 (The whole document: Katritzky et al., “1,3 Dipolar character of six-membnered aromatic rings”, J. Chem. Soc. Perkin Trans. 1, vol. 2, pp. 362-371, Jan. 1, 1980).;;International Search Report and Written Opinion, PCT/US2016/045730, dated Oct. 21, 2016.;;Arnér et al., Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. Oct. 2000;267 (20):6102-9.;;Arnér, Focus on mammalian thioredoxin reductases—important selenoproteins with versatile functions. Biochim Biophys Acta. Jun. 2009;1790(6):495-526.;;Banerji et al., 1,3-Dipolar Character of Six-membered Aromatic Rings. Part XXVI. 3-Hydroxypyridine and 1-Benzyl-3-oxidopyridinium. J Chem Soc Perkin Trans I. 1976;2334-2338.;;Becker et al., Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem. Oct. 2000;267(20):6118-25.;;Chen et al., A Convenient Synthesis of N-substituted 1,6-Dihydro-3(2H)-Pyridinones. J Chin Chem Soc. 1984;31:281-6.;;Cox et al., The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochemical Pharmacology. 2008;76:1097-1109.;;Dennis et al., 1,3-Dipolar CHaracter of Six-Membered Aromatic Rings. Part 33. Transformations of Cycloadducts derived from 3-Oxido-1-triazinylpyridiniums. J Chem Soc Perkin Trans I. 1977;1930-1940.;;Dennis et al., 1,3-Dipolar CHaracter of Six-Membered Aromatic Rings. Part IX. Re-arrangement of Additions of 1-(2,4-Dinitrophenyl)-3-oxidopyridinium. J Chem Soc Perkin Trans I. 1974;1883-1887.;;Dennis et al., 1,3-Dipolar CHaracter of Six-Membered Aromatic Rings. Part VII. 1-Phenyl-3-oxidopyridinium. J Chem Soc Perkin Trans I. 1974;746-750.;;Dennis et al., 1,3-Dipolar Character of Six-membered Aronatic Rings. Part 39. 1,omega-Bis-(3-oxidopyridinio) alkanes. J Chem Res. 1978:102-103.;;El-Abbady et al., [4n=2]pi-Cycloadditions of 1-(6-arylpyridazin-3-yl)-3-oxidopyridinium betaines with 2pi-1,3-dipolarophiles. Indian Journal of Chemistry. 1989;28B:923-927.;;Fath et al., Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism. Clin Cancer Res. Oct. 1, 2011;17(19):6206-17.;;Harris et al., Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell. Feb. 9, 2015;27(2):211-22.;;Hashemy et al., Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J Biol Chem. Apr. 21, 2006;281(16):10691-7.;;Katritzky et al., 1,3-Dipolar Character of Six-membered Aromatic Rings. Part 34. The Search for Superior 1-Substituents to Facilitate Cycloadditions of 3-Oxidopyridinium. J Chem Soc Perkin Trans I. 1979;399-407.;;Katritzky et al., 1,3-Dipolar Character of Six-membered Aromatic Rings. Part 48. Novel Conversions of PYridines to Isoquinolines. J Chem Soc Perkin Trans I. 1980;331-342.;;Katritzky et al., 1,3-Dipolar Character of Six-membered Aromatic Rings. Part 49. 3-Oxido-1-(4-pyridyl)pyridinium, 3-Oxido-1-(5,6-diphenyl-1,2,4-triazin-3-yl)pyridinium, and 3-Oxido-1-(5-phenyl-1,2,4-triazin-3-yl)pyridinium. J Chem Soc Perkin Trans I. 1980;343-353.;;Katritzky et al., 1,3-Dipolar Character of Six-membered Aromatic Rings. Part 51. Cycloadditions of 1-(beta-Benzoylvinyl)-3-oxidopyridiniums and Subsequent Transformations. J Chem Soc Perkin Trans I. 1980;362-371.;;Katritzky et al., 1,3-Dipolar Character of Six-membered Aromatic Rings. Part 53. 1-(1-Oxido-4-pyridyl)-3-oxidopyridinium, 2-(5-Nitro-2-pyridyl)-4-oxidoisoquinolinium, and 2-[trans-3-(4-Chloropheny1)-3-oxoprop-1-enyl)-4-oxidoisoquinolinium. J Chem Research. 1980:249.;;Katritzky et al., 1,3-Dipolar Character of Six-membered Aromatic Rings. Part 55. 3-Hydroxypyridine-2-thiones: Betaines, Cycloadditions, and Other Reactions. J Chem Research. 1981;208-209.;;Katritzky et al., 1,3-Dipolar Character of Six-membered Aromatic Rings. Part I. 1-Methyl-3-oxidopyridinium. J Chem Soc (C). 1971;874-877.;;Katritzky et al., 1,3-Dipolar Character of Six-membered Aromatic Rings. Part LIV. 1(a-p-Nitrophenyl-beta-mu-Nitrophenylvinyl)-3-Oxidopyridinium. Polish Journal of Chemistry. 1981;55(6):1352-1362.;;Katritzky et al., 1,3-Dipolar Character of Six-membered Heteroaromatic Rings. Part XLVII. Betanes Derived from 3-Hydroxypyridine and beta-chloro-alpha,beta-unsaturated ketones. Polish Journal of Chemistry. 1979;53(11:57-65, 130.;;Katritzky et al., A New Route to Tropones Based on the 1,3-Dipolar Reactivity of Heteroaromatic Betaines. Journal of the American Chemical Society. Jul. 1, 1970;92(13):4134-6.;;Katritzky et al., Novel Conversion of a 3-Oxidopyridinium into a 4-Oxidoisoquinolinium. J Chem Soc Chem Commun. 1978;316-318.;;Krishnamurthy et al., Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study. J Med Chem. Aug. 14, 2008;51(15):4790-5.;;Lillig et al., Glutaredoxin systems. Biochim Biophys Acta. Nov. 2008;1780(11):1304-17.;;Luo et al., Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. Mar. 6, 2009;136(5):823-37.;;Malinakova et al., Enantiocontrolled synthesis of highly functionalized tropanes via [5+2] cycloaddition to eta(3)-pyridinylmolybdenum pi-complexes. Org Lett. Nov. 30, 2000;2(24):3909-11.;;Mandal et al., Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation. Cancer Res. Nov. 15, 2010;70(22):9505-14.;;Moustafa et al., Dipolar Additions with1-(6-Chloropyridazin-3-yl)pyridinium-3-olate and1,1?-(Pyridazine-3,6-diyl)di (pyridinium-3-olate). J Chem Res, Synopses. 1997;4:138-139.;;Nair et al., ZnCl2 Catalysed Diels-Alder Reactions of Oxa and Aza Bicyclo[3.2.1]systems with Dienes: Formation of Some Novel Heterocyclic Systems. Synthetic Communications. 1998;28(14):2549-2557.;;Prigge et al., Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1. Free Radic Biol Med. Feb. 15, 2012;52(4):803-10.;;Rigobello et al., Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin-reductase. Free Radic Res. Jul. 2005;39(7):687-95.;;Trachootham et al., Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. Jul. 2009;8(7):579-91.;;Cycloaddition Reactions, [4n+2]pi-Cycloadditions of 1-(6-Arylpyridazin-3-yl)-3-oxidopyridinium Betaines with 2pi-1,3-Dipolarophiles. ChemInform. 1990;21(9):17-18. Abstract 045.;;CAS Registry No. 74780-63-5, 4,8-Iminocyclohepta[c]pyrrole-1,3,5(2H)-trione, 9-[3-{2-chloro-5-nitrophenyl)-3-oxo,1-propenyl]-3a,4,8,8a-tetrahydro-2-phenyl-,[3aalpha,4beta,8beta,8aalpha,9(E)]-(9Cl). 3 page.;;CAS Registry No. 484647-00-9, 4,8-Iminocyclohepta(c)pyrrole-1,3,5(2H)-trione, 3a,4,8,8a-tetrohydro-2,9-diphenyl. 4 pages.;;CAS Registry No. 127200-09-3, 4,8-Iminocyclohepta[c]pyrrole-1,3,5(2H)-trione, 3a,4,8,8a-tetrahydro-9-[6-{4-methylphenyl}-3-pyridazinyl]-2-phenyl-, (3aalpha,4alpha,8alpha,8aalpha)-(9Cl). 3 pages.;;Dyson et al., Chemistry of Synthetic Drugs. pp. 12-19, (1964).;;Russian Office Action for Application No. 2018107941, dated May 16, 2019, 6 pages.",ACTIVE
576,CN,A,CN 108026044 A,195-166-967-054-626,2018-05-11,2018,CN 201680046606 A,2016-08-05,GB 201514021 A;;US 2016/0045731 W,2015-08-07,PYRIDINES AND THEIR USE IN TREATMENT OF CANCER,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3, R4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNER ELIAS SET JENO;;US HEALTH,ARNER ELIAS SET JENO;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/195-166-967-054-626,Patent Application,no,3,1,20,20,0,A61K31/435;;A61K31/44;;A61K45/06;;A61K45/06;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/00;;A61P35/02;;A61P43/00;;C07D213/71;;C07D213/71;;C07D213/71;;C07D213/71,C07D213/71;;A61K31/435;;A61P35/00,,4,0,,,"JOACHIM BRAUN等: ""Synthesis and Biological Evaluation of Optimized Inhibitors of the Mitotic Kinesin Kif18A"", 《ACS CHEM. BIOL.》;;I-LIN LU等: ""Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease"", 《J. MED. CHEM.》;;WILLIAM G. TRANKLE等: ""Green Chemical Synthesis of 2-Benzenesulfonyl-pyridine and Related Derivatives"", 《ORGANIC PROCESS RESEARCH & DEVELOPMENT》;;MAKI, YOSHIFUMI等: ""REARRANGEMENT REACTIONS .X.SMILES REARRANGEMENT OF PTRIDINE DERIVATIVES.7"", 《YAKUGAKU ZASSHI》",PENDING
577,US,A,US 5941832 A,027-267-578-518-993,1999-08-24,1999,US 88430797 A,1997-06-27,US 88430797 A;;US 68102796 A;;US 16852493 A;;US 16808193 A;;US 76837391 A,1991-09-27,Method and apparatus for detection of cancerous and precancerous conditions in a breast,"An apparatus for detection of precancerous and cancerous conditions in a breast is provided and includes a computer for digitizing at least one of a mammogram image data and a (scinti)mammogram image data of a breast, computer-based software operably associated with the computer based means for manipulating at least one of said digitized mammogram image data and said digitized (scinti)mammogram image data and generating at least one of a mammogram ROI image and a (scinti)mammogram ROI image data indicative of precancerous and cancerous condition, and monitor operably associated with the computer based means for concurrently visually displaying at least one of said digitized mammogram image data and said digitized (scinti)mammogram image data and said mammogram ROI image and said (scinti)mammogram ROI image data in a superimposed manner.",TUMEY; DAVID M.;;XU; TONY;;DEBAN; ABDOU F.;;REEVES; JONATHON W.;;MCQUAIN; DAVID B.;;REEVES; WILLIAM H.;;REEVES; CAROLE C.;;ABOUJAOUDE; ELIAS D.,TUMEY DAVID M;;XU TONY;;DEBAN ABDOU F;;REEVES JONATHON W;;MCQUAIN DAVID B;;REEVES WILLIAM H;;REEVES CAROLE C;;ABOUJAOUDE ELIAS D,CYRCADIA INC (2017-04-14);;LIFELINE BIOTECHNOLOGIES INC (1997-06-24),https://lens.org/027-267-578-518-993,Granted Patent,yes,12,91,1,3,0,A61B5/015;;A61B5/015,A61B5/00,600/549;;600/382,2,0,,,The Diagnosis of Breast Cancer By The ChonoBra Simpson et al. 1989.;;Computer Aided Breast Cancer Detection usinng differentces of Gaussians and Derivative Based Features Palokowski et al. Apr. 1997.,EXPIRED
578,MA,A,MA 42913 A,126-490-922-906-356,2018-08-01,2018,MA 42913 A,2016-08-05,GB 201514015 A,2015-08-07,PYRIDAZINONES ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER,,ARNER ELIAS SET JENOE;;US HEALTH,ARNÉR ELIAS SET JENÖ;;COUSSENS NATHAN PATRICK;;DEXHEIMER THOMAS S;;JADHAV AJIT;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;STAFFORD WILLIAM CHESTER,,https://lens.org/126-490-922-906-356,Unknown,no,0,0,7,7,0,C07D413/06;;A61P35/00;;A61K31/501;;A61K45/06;;C07D413/06,A61K31/501;;A61P35/00;;C07D413/06,,0,0,,,,PENDING
579,AU,B2,AU 2016/306276 B2,180-687-216-531-769,2019-08-01,2019,AU 2016/306276 A,2016-08-05,GB 201514021 A;;US 2016/0045731 W,2015-08-07,Pyridines and their use in the treatment of cancer,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein L, R",ARNER ELIAS SET JENOE;;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/180-687-216-531-769,Granted Patent,no,1,0,20,20,0,C07D213/71;;A61P35/00;;A61P35/02;;A61P43/00;;A61P35/00;;A61K31/44;;A61K45/06;;C07D213/71;;A61K31/435;;A61P35/00;;C07D213/71;;A61P35/00;;A61K45/06;;C07D213/71,C07D213/71;;A61K31/435;;A61P35/00,,8,1,088-609-498-068-080,16913704;;10.1021/jm060207o.s001;;10.1021/jm060207o,"CAS Registry Number 1087745-45-6; STN Entry Date 21 December 2008;;CAS Registry Number 477871-39-9; STN Entry Date 31 December 2002;;CAS Registry Number 246020-68-8; STN Entry Date 3 November 1999;;CAS Registry Number 188429-02-9; STN Entry Date 18 April 1997;;CAS Registry Number 97420-49-0; STN Entry Date 4 August 1985;;CAS Registry Number 3573-15-7; STN Entry Date 16 November 1984;;I-LIN LU ET AL., ""Structure-Based Drug Design And Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease"", J. MED. CHEM., 2006, vol. 49, pages 5154 - 5161;;CAS Registry Number 1258786-29-6; STN Entry Date 7 January 2011",INACTIVE
580,KR,A,KR 20200102529 A,037-720-228-251-358,2020-08-31,2020,KR 20207024002 A,2016-08-05,GB 201514018 A;;KR 20187006528 A;;US 2016/0045730 W,2015-08-07,TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER,"하기 화학식 I의 화합물, 또는 이의 약제학적으로-허용 가능한 염이 제공되며, 이 화합물은 암의 치료에서 유용하다:식 중 X, Y, Z, R및 R는 명세서에서 제공되는 의미를 갖는다.",ARNER ELIAS SET JENOE;;US HEALTH,ARNER ELIAS SET JENOE;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/037-720-228-251-358,Patent Application,no,2,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61K31/46;;A61P35/00,,0,0,,,,ACTIVE
581,WO,A8,WO 2017/027358 A8,053-661-871-163-878,2017-05-11,2017,US 2016/0045730 W,2016-08-05,GB 201514018 A,2015-08-07,TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein X, Y, Z, R 1 and R 2 have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNÉR ELIAS SET JENÖ;;THE UNITED STATES OF AMERICA AS REPESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/053-661-871-163-878,Amended Application,yes,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61P35/00,,0,0,,,,PENDING
582,WO,A1,WO 2017/027357 A1,093-631-572-327-864,2017-02-16,2017,US 2016/0045729 W,2016-08-05,GB 201514015 A,2015-08-07,PYRIDAZINONES AND THEIR USE IN THE TREATMENT OF CANCER,"There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein W, X, Y, Z, R 1 , R 2 and R 3 have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNÉR ELIAS SET JENÖ;;US HEALTH,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/093-631-572-327-864,Patent Application,yes,4,5,7,7,0,C07D413/06;;A61P35/00;;A61K31/501;;A61K45/06;;C07D413/06,C07D413/06;;A61K31/501;;A61P35/00,,1,1,042-407-756-186-385,10.1002/jhet.2182,"M.A.EL-HASHASH ET AL.: ""Synthesis of novel heterocyclic compounds with expected antibacterial activities from 4-(4-bromophenyl)-4-oxobut-2-enoic acid."", J. HETERO.CHEM., vol. 52, 31 May 2014 (2014-05-31), pages 732 - 743, XP002762729",PENDING
583,MA,A,MA 42914 A,169-722-676-791-388,2018-08-01,2018,MA 42914 A,2016-08-05,GB 201514018 A,2015-08-07,COMPOSÉS TRICYCLIQUES ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER,,ARNER ELIAS SET JENOE;;US HEALTH,ARNÉR ELIAS SET JENÖ;;COUSSENS NATHAN PATRICK;;DEXHEIMER THOMAS S;;JADHAV AJIT;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;STAFFORD WILLIAM CHESTER,,https://lens.org/169-722-676-791-388,Unknown,no,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,A61K31/407;;A61P35/00;;C07D471/18,,0,0,,,,PENDING
584,EP,A1,EP 3331883 A1,185-188-599-094-820,2018-06-13,2018,EP 16751126 A,2016-08-05,GB 201514018 A;;US 2016/0045730 W,2015-08-07,TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER,,ARNER ELIAS SET JENOE;;US HEALTH,STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S;;ARNÉR ELIAS SET JENÖ,,https://lens.org/185-188-599-094-820,Patent Application,yes,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61P35/00,,0,0,,,,DISCONTINUED
585,AU,B2,AU 2016/307438 B2,189-349-670-513-240,2019-07-11,2019,AU 2016/307438 A,2016-08-05,GB 201514018 A;;US 2016/0045730 W,2015-08-07,Tricyclic compounds and their use in the treatment of cancer,"There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein X, Y, Z, R",ARNER ELIAS SET JENOE;;THE UNITED STATES OF AMERICA AS REPESENTED BY THE SECRETARY,ARNÉR ELIAS SET JENÖ;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/189-349-670-513-240,Granted Patent,no,0,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61P35/00,,1,0,,,"EL-ABBADY ET AL, ""[4n+2]#-Cycloadditions of 1-(6-arylpyridazin-3-y)-3oxopyridinium betaines with 2#-1,3-dipolarophiles"", INDIAN J.CHEM., B: ORG.CHEM.MED.CHEM., 1989, vol. 28B, no. 11, pages 923 -927",INACTIVE
586,CN,A,CN 108026096 A,136-888-590-956-236,2018-05-11,2018,CN 201680046578 A,2016-08-05,GB 201514018 A;;US 2016/0045730 W,2015-08-07,TRICYCLIC COMPOUNDS AND THEIR USE IN TREATMENT OF CANCER,"There is provided compounds of formula (I), or pharmaceutically-acceptable salts thereof, wherein X, Y, Z, R1 and R2 have meanings provided in the description, which compounds are useful in the treatment of cancers.",ARNER ELIAS SET JENO;;THE UNITED STATES OF AMERICA AS REPESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES,ARNER ELIAS SET JENO;;STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S,,https://lens.org/136-888-590-956-236,Patent Application,no,3,0,22,22,0,C07D471/18;;A61P35/00;;A61P35/02;;A61P43/00;;A61K31/439;;A61K31/46;;A61K31/407;;A61P35/00;;A61K31/407;;A61K31/46;;C07D471/18;;A61K31/407;;A61P35/00;;C07D471/18;;A61P35/00;;A61K31/46;;C07D451/00,C07D471/18;;A61K31/407;;A61P35/00,,3,1,067-178-194-417-049,10.1016/s0040-4020(01)00740-2,"CHEMINFORM: ""Reaction and Process"", 《CHEMINFORM》;;REGISTRY: ""RN 484647-00-9"", 《STN COLUMBUS》;;MARK R.FIELDING ET AL.: ""Sequential oxopyridinium betaine cycloaddition-palladium catalysed cyclisation-antion capture processes"", 《TETRAHEDRON》",PENDING
587,EP,A1,EP 3331878 A1,017-493-619-882-891,2018-06-13,2018,EP 16751125 A,2016-08-05,GB 201514015 A;;US 2016/0045729 W,2015-08-07,PYRIDAZINONES AND THEIR USE IN THE TREATMENT OF CANCER,,ARNER ELIAS SET JENOE;;US HEALTH,STAFFORD WILLIAM CHESTER;;COUSSENS NATHAN PATRICK;;LUCI DIANE KAREN;;MALONEY DAVID JOSEPH;;SIMEONOV ANTON;;JADHAV AJIT;;DEXHEIMER THOMAS S;;ARNÉR ELIAS SET JENÖ,,https://lens.org/017-493-619-882-891,Patent Application,yes,0,0,7,7,0,C07D413/06;;A61P35/00;;A61K31/501;;A61K45/06;;C07D413/06,C07D413/06;;A61K31/501;;A61P35/00,,0,0,,,,DISCONTINUED
588,US,S,US D1000322 S,185-681-743-117-628,2023-10-03,2023,US 202129772545 F,2021-03-02,US 202129772545 F,2021-03-02,Vehicle suspension assembly,,ZOOX INC,STOFFEL CHRISTOPHER JOHN;;BATTAGLIA NAHUEL ELIAS;;DELOS SANTOS HERMAN FRANCISCO;;EARL CHRISTL CLEBALD;;KRAUS ALEXANDER;;LABADIE CHRISTOPHER WILLIAM;;OSELLAME RICHARD LUKE;;RUDD ANDREW DAVID,ZOOX INC (2021-06-16),https://lens.org/185-681-743-117-628,Design Right,no,12,0,1,1,0,,,1216;;D12/159,2,0,,,"Amazon, posted Sep. 28, 2020 [online], [retrieved Apr. 14, 2023]. Retrieved from internet, https://www.amazon.com/MOSTPLUS-1643206113-Suspension-Compatible-Mercedes-Benz/dp/B08KCV52MZ/ref (Year: 2020).;;FCP Euro Strut, posting date N/A [online], [retrieved Apr. 14, 2023]. Retrieved from internet, https://www.fcpeuro.com/products/saab-suspension-strut-assembly-front-9-5-bilstein-bil-22147080 (Year: 2023).",ACTIVE
589,BR,A2,BR 102019017747 A2,118-307-249-908-985,2021-03-09,2021,BR 102019017747 A,2019-08-26,BR 102019017747 A,2019-08-26,dispositivo autônomo e automatizado para gerenciamento de irrigação,"dispositivo autônomo e automatizado para gerenciamento de irrigação. sistema autônomo de gerenciamento de irrigação composto por: dispositivo microcontrolado para o cálculo automático da evapotranspiração, módulo real time clock, sensores de temperatura do ar, umidade relativa do ar, precipitação pluviométrica, radiação solar e velocidade do vento, sistema de transferência de água para irrigação, sistema de alimentação por placas fotovoltaicas e baterias e interface de parametrização via web. por meio da interface, o usuário define informações necessárias ao funcionamento do sistema referentes às especificações da cultura e características do solo, e a invenção determina a dosagem necessária de água que a cultura carece tendo um melhor aproveitamento dos recursos hídricos e otimização das metas de produções agrícolas. após, aciona o sistema de transferência de água pelo tempo necessário para repor a quantidade de água perdida durante o processo de evapotranspiração.",INST FEDERAL DE EDUCACAO CIENCIA E TECNOLOGIA FLUMINENSE,BRUNA LEONARDO DE JESUS RABELO DE BARROS;;BRUNO RAMOS MACIEL;;JOSÉ CARLOS MENDONÇA;;JOÃO ELIAS MOTHÉ;;KÉSSILA DA SILVA MENEZES PERDOMO;;WILLIAM DA SILVA VIANNA,,https://lens.org/118-307-249-908-985,Patent Application,no,0,0,1,1,0,A01G25/167;;Y02P60/12,A01G25/16,,0,0,,,,DISCONTINUED
590,WO,A2,WO 2007/047519 A2,129-264-300-365-544,2007-04-26,2007,US 2006/0040225 W,2006-10-16,US 25219805 A,2005-10-17,HOT RUNNER NOZZLE HEATER AND METHODS OF MANUFACTURE THEREOF,"A hot runner nozzle heater is provided that includes a sleeve defining a slot extending along a length of the sleeve. A first dielectric layer is disposed over an outer surface of the sleeve, and a resistive element layer is disposed over the first dielectric layer, wherein the resistive element layer defines a resistive circuit pattern that is preferably formed by a laser trimming process. A pair of terminal leads are secured to a portion of the resistive element layer thus defining a termination area, and the termination area is positioned proximate the slot and away from the proximal end and the distal end of the sleeve. A second dielectric layer is disposed over the resistive element layer but not over the termination area, a third dielectric layer is disposed over the termination area, and a protective layer disposed over the second dielectric layer and the third dielectric layer.",WATLOW ELECTRIC MFG;;RUSSEGGER ELIAS;;SCHEFBANKER GERHARD;;ANTOSCH GERNOT;;POSCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL WILLIAM A;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,RUSSEGGER ELIAS;;SCHEFBANKER GERHARD;;ANTOSCH GERNOT;;POSCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL WILLIAM A;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,,https://lens.org/129-264-300-365-544,Patent Application,yes,0,3,14,14,0,B29C45/2737;;B29C45/2737;;B29C2045/2746;;B29C2045/2746;;H05B3/56;;H05B3/56;;H05B3/565;;H05B3/565;;Y10T137/6416;;Y10T137/6416,H05B3/58;;B67D7/80,,0,0,,,,PENDING
591,US,B1,US 8897949 B1,053-765-266-646-683,2014-11-25,2014,US 201213644827 A,2012-10-04,US 201213644827 A,2012-10-04,Aircraft rework management,A method and apparatus for reworking a component on a vehicle. An inconsistency on the component is identified. The component is reworked to remove the inconsistency. Component rework information is stored on an automated identification technology tag attached to the vehicle. The component rework information comprises information describing the reworking of the component to remove the inconsistency.,BOEING CO,COOP WILLIAM P;;ELIAS JOSE R;;SEEGER PAUL F;;SHORE REBECCA J;;NGUYEN TOMMY T;;RINER EDWIN KEITH;;KNOX JAMES DON;;HILL LOIS T;;ALLEN DAVID W,THE BOEING COMPANY (2012-10-01),https://lens.org/053-765-266-646-683,Granted Patent,yes,15,3,1,1,0,G06Q10/20;;G07C5/006;;G06Q10/20;;G07C5/006,G01M17/00,701/29.1;;701/29.4;;701/31.4,6,0,,,"Knox et al., ""Aircraft Interior Component Maintenance,"" U.S. Appl. No. 13/782,475, filed Mar. 1, 2013, 47 pages.;;Coop et al., ""Maintaining the Airworthiness Configuration of Aircraft,"" U.S. Appl. No. 13/664,121, filed Oct. 30, 2012, 44 pages.;;Office Action, dated May 30, 2014, regarding U.S. Appl. No. 13/664,121, 18 pages.;;Office Action, dated May 30, 2014, regarding U.S. Appl. No. 13/782,475, 15 pages.;;Final Office Action, dated Aug. 8, 2014, regarding U.S. Appl. No. 13/664,121, 13 pages.;;Notice of Allowance, dated Aug. 13, 2014, regarding U.S. Appl. No. 13/782,475, 9 pages.",ACTIVE
592,US,A1,US 2008/0138053 A1,106-243-955-707-51X,2008-06-12,2008,US 85044707 A,2007-09-05,US 85044707 A;;US 25219805 A,2005-10-17,HOT RUNNER NOZZLE HEATER AND METHODS OF MANUFACTURE THEREOF,"An instrumented heater sleeve is provided that has a plurality of zones, a dielectric layer disposed over an outer surface of the sleeve, a resistive element layer disposed over the first dielectric layer, and a plurality of pairs of lead wires secured to a portion of the resistive element layer. Each pair of lead wires is connected to and corresponds with each of the zones and a protective layer is disposed over the dielectric layer. An amount of power is supplied to each of the zones and adjusted during a test run, or multiple test runs, to achieve a desired temperature profile along a heating target such as a hot runner nozzle. Methods of designing a hot runner nozzle heater using the instrumented heater sleeve are also provided.",WATLOW ELECTRIC MFG,RUSSEGGER ELIAS;;SCHEFBANKER GERHARD;;ANTOSCH GERNOT;;POSCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL WILLIAM A;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,WATLOW ELECTRIC MANUFACTURING COMPANY (2005-11-18),https://lens.org/106-243-955-707-51X,Patent Application,yes,20,5,14,14,0,B29C45/2737;;B29C45/2737;;B29C2045/2746;;B29C2045/2746;;H05B3/56;;H05B3/56;;H05B3/565;;H05B3/565;;Y10T137/6416;;Y10T137/6416,B05B1/24;;B67D7/80,392/473,0,0,,,,ACTIVE
593,WO,A3,WO 2007/047519 A3,181-328-679-261-285,2007-06-07,2007,US 2006/0040225 W,2006-10-16,US 25219805 A,2005-10-17,HOT RUNNER NOZZLE HEATER AND METHODS OF MANUFACTURE THEREOF,"A hot runner nozzle heater is provided that includes a sleeve defining a slot extending along a length of the sleeve. A first dielectric layer is disposed over an outer surface of the sleeve, and a resistive element layer is disposed over the first dielectric layer, wherein the resistive element layer defines a resistive circuit pattern that is preferably formed by a laser trimming process. A pair of terminal leads are secured to a portion of the resistive element layer thus defining a termination area, and the termination area is positioned proximate the slot and away from the proximal end and the distal end of the sleeve. A second dielectric layer is disposed over the resistive element layer but not over the termination area, a third dielectric layer is disposed over the termination area, and a protective layer disposed over the second dielectric layer and the third dielectric layer.",WATLOW ELECTRIC MFG;;RUSSEGGER ELIAS;;SCHEFBANKER GERHARD;;ANTOSCH GERNOT;;POSCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL WILLIAM A;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,RUSSEGGER ELIAS;;SCHEFBANKER GERHARD;;ANTOSCH GERNOT;;POSCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL WILLIAM A;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,,https://lens.org/181-328-679-261-285,Search Report,yes,5,0,14,14,0,B29C45/2737;;B29C45/2737;;B29C2045/2746;;B29C2045/2746;;H05B3/56;;H05B3/56;;H05B3/565;;H05B3/565;;Y10T137/6416;;Y10T137/6416,H05B3/58;;B67D7/80,,0,0,,,,PENDING
594,EP,B1,EP 1946614 B1,112-387-314-591-633,2013-12-18,2013,EP 06825966 A,2006-10-16,US 2006/0040225 W;;US 25219805 A,2005-10-17,HOT RUNNER NOZZLE HEATER AND METHODS OF MANUFACTURE THEREOF,,WATLOW ELECTRIC MFG,RUSSEGGER ELIAS;;SCHEFBANKER GERHARD;;ANTOSCH GERNOT;;POSCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL WILLIAM A;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,,https://lens.org/112-387-314-591-633,Granted Patent,yes,5,0,14,14,0,B29C45/2737;;B29C45/2737;;B29C2045/2746;;B29C2045/2746;;H05B3/56;;H05B3/56;;H05B3/565;;H05B3/565;;Y10T137/6416;;Y10T137/6416,H05B3/58;;B67D7/80,,0,0,,,,ACTIVE
595,EP,A2,EP 1946614 A2,041-615-834-939-996,2008-07-23,2008,EP 06825966 A,2006-10-16,US 2006/0040225 W;;US 25219805 A,2005-10-17,HOT RUNNER NOZZLE HEATER AND METHODS OF MANUFACTURE THEREOF,,WATLOW ELECTRIC MFG,RUSSEGGER ELIAS;;SCHEFBANKER GERHARD;;ANTOSCH GERNOT;;POSCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL WILLIAM A;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,,https://lens.org/041-615-834-939-996,Patent Application,yes,0,0,14,14,0,B29C45/2737;;B29C45/2737;;B29C2045/2746;;B29C2045/2746;;H05B3/56;;H05B3/56;;H05B3/565;;H05B3/565;;Y10T137/6416;;Y10T137/6416,H05B3/58;;B67D7/80,,1,0,,,See references of WO 2007047519A3,ACTIVE
596,US,A1,US 2007/0086759 A1,198-990-632-080-966,2007-04-19,2007,US 25219805 A,2005-10-17,US 25219805 A,2005-10-17,Hot runner nozzle heater and methods of manufacture thereof,"A hot runner nozzle heater is provided that includes a sleeve defining a slot extending along a length of the sleeve. A first dielectric layer is disposed over an outer surface of the sleeve, and a resistive element layer is disposed over the first dielectric layer, wherein the resistive element layer defines a resistive circuit pattern that is preferably formed by a laser trimming process. A pair of terminal leads are secured to a portion of the resistive element layer thus defining a termination area, and the termination area is positioned proximate the slot and away from the proximal end and the distal end of the sleeve. A second dielectric layer is disposed over the resistive element layer but not over the termination area, a third dielectric layer is disposed over the termination area, and a protective layer disposed over the second dielectric layer and the third dielectric layer.",WATLOW ELECTRIC MFG CO,RUSSEGGER ELIAS;;SCHEFBANKER GERHARD;;ANTOSCH GERNOT;;POSCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL WILLIAM A III;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,WATLOW ELECTRIC MANUFACTURING COMPANY (2005-11-18),https://lens.org/198-990-632-080-966,Patent Application,yes,16,22,14,14,0,B29C45/2737;;B29C45/2737;;B29C2045/2746;;B29C2045/2746;;H05B3/56;;H05B3/56;;H05B3/565;;H05B3/565;;Y10T137/6416;;Y10T137/6416,F24H1/10;;B05B1/24;;B05B7/22;;B67D7/80,392/473,0,0,,,,ACTIVE
597,CA,A1,CA 2626263 A1,037-004-276-538-129,2007-04-26,2007,CA 2626263 A,2006-10-16,US 25219805 A;;US 2006/0040225 W,2005-10-17,HOT RUNNER NOZZLE HEATER AND METHODS OF MANUFACTURE THEREOF,,WATLOW ELECTRIC MFG,LEHNERT REINHARDT;;POSCHL WOLFGANG;;PTASIENSKI KEVIN;;MCMILLIN JAMES;;BOLDT ALLEN;;SCHEFBANKER GERHARD;;FENNEWALD KENNETH F;;RUSSEGGER ELIAS;;MCDOWELL WILLIAM A III;;ANTOSCH GERNOT;;LANHAM CHRISTOPHER C;;ZIMMERMANN FREDERIC,,https://lens.org/037-004-276-538-129,Patent Application,no,0,0,14,14,0,B29C45/2737;;B29C45/2737;;B29C2045/2746;;B29C2045/2746;;H05B3/56;;H05B3/56;;H05B3/565;;H05B3/565;;Y10T137/6416;;Y10T137/6416,H05B3/58;;B67D7/80,,0,0,,,,INACTIVE
598,US,B2,US 8175446 B2,141-920-580-744-959,2012-05-08,2012,US 85044707 A,2007-09-05,US 85044707 A;;US 25219805 A,2005-10-17,Hot runner nozzle heater and methods of manufacture thereof,"An instrumented heater sleeve is provided that has a plurality of zones, a dielectric layer disposed over an outer surface of the sleeve, a resistive element layer disposed over the first dielectric layer, and a plurality of pairs of lead wires secured to a portion of the resistive element layer. Each pair of lead wires is connected to and corresponds with each of the zones and a protective layer is disposed over the dielectric layer. An amount of power is supplied to each of the zones and adjusted during a test run, or multiple test runs, to achieve a desired temperature profile along a heating target such as a hot runner nozzle. Methods of designing a hot runner nozzle heater using the instrumented heater sleeve are also provided.",RUSSEGGER ELIAS;;SCHEFBAENKER GERHARD;;ANTOSCH GERNOT;;POESCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL III WILLIAM A;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN;;WALLOW ELECTRIC MFG COMPANY,RUSSEGGER ELIAS;;SCHEFBAENKER GERHARD;;ANTOSCH GERNOT;;POESCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL III WILLIAM A;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,WATLOW ELECTRIC MANUFACTURING COMPANY (2005-11-18),https://lens.org/141-920-580-744-959,Granted Patent,yes,25,4,14,14,0,B29C45/2737;;B29C45/2737;;B29C2045/2746;;B29C2045/2746;;H05B3/56;;H05B3/56;;H05B3/565;;H05B3/565;;Y10T137/6416;;Y10T137/6416,B05B1/24;;B67D7/80;;F16K49/00,392/473;;137/334,0,0,,,,ACTIVE
599,CN,B,CN 101322436 B,139-471-841-559-856,2010-12-22,2010,CN 200680045496 A,2006-10-16,US 2006/0040225 W;;US 25219805 A,2005-10-17,Hot runner nozzle heater and methods of manufacture thereof,"A hot runner nozzle heater is provided that includes a sleeve defining a slot extending along a length of the sleeve. A first dielectric layer is disposed over an outer surface of the sleeve, and a resistive element layer is disposed over the first dielectric layer, wherein the resistive element layer defines a resistive circuit pattern that is preferably formed by a laser trimming process. A pair of terminal leads are secured to a portion of the resistive element layer thus defining a termination area, and the termination area is positioned proximate the slot and away from the proximal end and the distal end of the sleeve. A second dielectric layer is disposed over the resistive element layer but not over the termination area, a third dielectric layer is disposed over the termination area, and a protective layer disposed over the second dielectric layer and the third dielectric layer.",WATLOW ELECTRIC MFG CO,JAMES MCMILLIN;;LANHAM CHRISTOPHER C;;ELIAS RUSSEGGER;;GERHARD SCHEFBANKER;;REINHARDT LEHNERT;;MCDOWELL WILLIAM A III;;FENNEWALD KENNETH F;;ALLEN BOLDT;;KEVIN PTASIENSKI;;GERNOT ANTOSCH;;WOLFGANG POSCHL;;FREDERIC ZIMMERMANN,,https://lens.org/139-471-841-559-856,Granted Patent,no,0,0,14,14,0,B29C45/2737;;B29C45/2737;;B29C2045/2746;;B29C2045/2746;;H05B3/56;;H05B3/56;;H05B3/565;;H05B3/565;;Y10T137/6416;;Y10T137/6416,B29C45/27;;B67D7/80;;H05B3/58,,0,0,,,,INACTIVE
600,WO,A1,WO 2021/102340 A1,097-907-694-438-220,2021-05-27,2021,US 2020/0061626 W,2020-11-20,US 201962938646 P;;US 202063081253 P,2019-11-21,INTEGRATED ENERGY STORAGE SYSTEM,"An integrated, unitary battery pack may be formed and used as part of the structural support for a vehicle frame. The unitary battery pack includes arrays cells having all positive and negative electrical terminals aligned in-plane on a common face of the product assembly. The unitary battery pack includes cooling components for passively or actively cooling the cell arrays. The unitary battery pack is encased in a potting material that allows that forms part of the structure support for the unitary battery pack. The unitary batter pack may be integrated into the vehicle with or without additional support structures.",TESLA INC,SUMPF JR;;PIRES ANDREW;;STOCKTON WILLIAM B;;SPOONER COLE;;PRODAN COLE;;GORASIA JAYESH BHARAT;;HARRIS KENTON;;BURKE DAN;;SZAFER DANFNA GABRIELA;;PATEL KRUPAL;;PARKER BENJAMIN;;HEGEMAN DAVID ELIAS,,https://lens.org/097-907-694-438-220,Patent Application,yes,5,3,9,9,0,H01M50/273;;H01M50/242;;H01M50/24;;H01M50/213;;H01M2220/20;;H01M10/659;;H01M10/658;;H01M10/6567;;H01M10/6561;;H01M10/643;;H01M10/625;;H01M10/613;;H01M2220/10;;Y02E60/10;;H01M10/658;;H01M10/659;;H01M10/643;;H01M10/6557;;H01M10/6565;;H01M10/6567;;H01M10/625;;H01M10/613;;H01M50/213;;H01M50/249;;H01M50/24;;H01M50/273;;H01M50/291;;H01M50/293;;H01M50/502;;H01M2220/20;;H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6556;;H01M10/658;;B60L50/64;;H01M50/249;;H01M50/213;;H01M50/271;;H01M2220/20,H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6561;;H01M10/6567;;H01M10/658;;H01M10/659;;H01M50/213;;H01M50/24;;H01M50/242;;H01M50/273,,0,0,,,,PENDING
601,CA,C,CA 2626263 C,166-307-035-937-44X,2013-07-02,2013,CA 2626263 A,2006-10-16,US 25219805 A;;US 2006/0040225 W,2005-10-17,HOT RUNNER NOZZLE HEATER AND METHODS OF MANUFACTURE THEREOF,"A hot runner nozzle heater is provided that includes a sleeve defining a slot extending along a length of the sleeve. A first dielectric layer is disposed over an outer surface of the sleeve, and a resistive element layer is disposed over the first dielectric layer, wherein the resistive element layer defines a resistive circuit pattern that is preferably formed by a laser trimming process. A pair of terminal leads are secured to a portion of the resistive element layer thus defining a termination area, and the termination area is positioned proximate the slot and away from the proximal end and the distal end of the sleeve. A second dielectric layer is disposed over the resistive element layer but not over the termination area, a third dielectric layer is disposed over the termination area, and a protective layer disposed over the second dielectric layer and the third dielectric layer.",WATLOW ELECTRIC MFG,RUSSEGGER ELIAS;;SCHEFBANKER GERHARD;;ANTOSCH GERNOT;;POSCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL WILLIAM A III;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,,https://lens.org/166-307-035-937-44X,Granted Patent,no,0,0,14,14,0,B29C45/2737;;B29C2045/2746;;H05B3/56;;H05B3/565;;Y10T137/6416;;Y10T137/6416;;B29C45/2737;;H05B3/565;;H05B3/56;;B29C2045/2746,H05B3/58;;B67D7/80,,0,0,,,,INACTIVE
602,US,B2,US 7280750 B2,106-190-536-402-846,2007-10-09,2007,US 25219805 A,2005-10-17,US 25219805 A,2005-10-17,Hot runner nozzle heater and methods of manufacture thereof,"A hot runner nozzle heater is provided that includes a sleeve defining a slot extending along a length of the sleeve. A first dielectric layer is disposed over an outer surface of the sleeve, and a resistive element layer is disposed over the first dielectric layer, wherein the resistive element layer defines a resistive circuit pattern that is preferably formed by a laser trimming process. A pair of terminal leads are secured to a portion of the resistive element layer thus defining a termination area, and the termination area is positioned proximate the slot and away from the proximal end and the distal end of the sleeve. A second dielectric layer is disposed over the resistive element layer but not over the termination area, a third dielectric layer is disposed over the termination area, and a protective layer disposed over the second dielectric layer and the third dielectric layer.",WATLOW ELECTRIC MFG,RUSSEGGER ELIAS;;SCHEFBAENKER GERHARD;;ANTOSCH GERNOT;;POESCHL WOLFGANG;;LANHAM CHRISTOPHER C;;MCMILLIN JAMES;;MCDOWELL III WILLIAM A;;FENNEWALD KENNETH F;;BOLDT ALLEN;;ZIMMERMANN FREDERIC;;LEHNERT REINHARDT;;PTASIENSKI KEVIN,WATLOW ELECTRIC MANUFACTURING COMPANY (2005-11-18),https://lens.org/106-190-536-402-846,Granted Patent,yes,18,8,14,14,0,B29C45/2737;;B29C45/2737;;B29C2045/2746;;B29C2045/2746;;H05B3/56;;H05B3/56;;H05B3/565;;H05B3/565;;Y10T137/6416;;Y10T137/6416,B05B1/24;;B67D7/80,392/473;;392/465,0,0,,,,ACTIVE
603,KR,A,KR 20220105652 A,115-962-967-973-767,2022-07-27,2022,KR 20227020152 A,2020-11-20,US 201962938646 P;;US 202063081253 P;;US 2020/0061626 W,2019-11-21,통합 에너지 저장 시스템,통합된 단일 배터리 팩이 형성되어 차량 프레임의 구조적 지지의 일부로 사용될 수 있다. 단일 배터리 팩은 제품 어셈블리의 공통 면 상의 평면 내 정렬된 모든 양극 및 음극 전기 단자를 갖는 어레이 셀들을 포함한다. 단일 배터리 팩에는 셀 어레이들을 수동적으로 또는 능동적으로 냉각하기 위한 냉각 부품들을 포함한다. 단일 배터리 팩은 단일 배터리 팩에 대한 구조적 지지의 일부를 형성할 수 있는 포팅 재료로 둘러싸여 있다. 단일 배터리 팩은 추가적인 지지 구조가 있거나 없어도 차량에 통합될 수 있다.,TESLA INC,SUMPF JR ROBERT DAVID;;PIRES ANDREW;;STOCKTON WILLIAM B;;SPOONER COLE;;PRODAN COLE;;GORASIA JAYESH BHARAT;;HARRIS KENTON;;BURKE DAN;;SZAFER DAFNA GABRIELA;;PATEL KRUPAL;;PARKER BENJAMIN;;HEGEMAN DAVID ELIAS,,https://lens.org/115-962-967-973-767,Patent Application,no,0,0,9,9,0,H01M50/273;;H01M50/242;;H01M50/24;;H01M50/213;;H01M2220/20;;H01M10/659;;H01M10/658;;H01M10/6567;;H01M10/6561;;H01M10/643;;H01M10/625;;H01M10/613;;H01M2220/10;;Y02E60/10;;H01M10/658;;H01M10/659;;H01M10/643;;H01M10/6557;;H01M10/6565;;H01M10/6567;;H01M10/625;;H01M10/613;;H01M50/213;;H01M50/249;;H01M50/24;;H01M50/273;;H01M50/291;;H01M50/293;;H01M50/502;;H01M2220/20;;H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6556;;H01M10/658;;B60L50/64;;H01M50/249;;H01M50/213;;H01M50/271;;H01M2220/20,H01M10/658;;H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6557;;H01M10/6565;;H01M10/6567;;H01M10/659;;H01M50/213;;H01M50/24;;H01M50/249,,0,0,,,,PENDING
604,US,A1,US 2021/0159567 A1,185-009-676-083-265,2021-05-27,2021,US 202017100700 A,2020-11-20,US 202017100700 A;;US 201962938646 P;;US 202063081253 P,2019-11-21,INTEGRATED ENERGY STORAGE SYSTEM,"An integrated, unitary battery pack may be formed and used as part of the structural support for a vehicle frame. The unitary battery pack includes arrays cells having all positive and negative electrical terminals aligned in-plane on a common face of the product assembly. The unitary battery pack includes cooling components for passively or actively cooling the cell arrays. The unitary battery pack is encased in a potting material that allows that forms part of the structure support for the unitary battery pack. The unitary batter pack may be integrated into the vehicle with or without additional support structures.",TESLA INC,PIRES ANDREW;;SUMPF JR ROBERT DAVID;;STOCKTON WILLIAM B;;SPOONER COLE;;PRODAN COLE;;GORASIA JAYESH BHARAT;;HARRIS KENTON;;BURKE DAN;;SZAFER DAFNA GABRIELA;;PATEL KRUPAL;;PARKER BENJAMIN;;HEGEMAN DAVID ELIAS,TESLA INC (2021-08-16),https://lens.org/185-009-676-083-265,Patent Application,yes,11,5,9,9,0,H01M50/273;;H01M50/242;;H01M50/24;;H01M50/213;;H01M2220/20;;H01M10/659;;H01M10/658;;H01M10/6567;;H01M10/6561;;H01M10/643;;H01M10/625;;H01M10/613;;H01M2220/10;;Y02E60/10;;H01M10/658;;H01M10/659;;H01M10/643;;H01M10/6557;;H01M10/6565;;H01M10/6567;;H01M10/625;;H01M10/613;;H01M50/213;;H01M50/249;;H01M50/24;;H01M50/273;;H01M50/291;;H01M50/293;;H01M50/502;;H01M2220/20;;H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6556;;H01M10/658;;B60L50/64;;H01M50/249;;H01M50/213;;H01M50/271;;H01M2220/20,H01M50/249;;B60L50/64;;H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6556;;H01M10/658;;H01M50/213;;H01M50/271,,0,0,,,,PENDING
605,EP,A1,EP 4062477 A1,071-238-774-610-124,2022-09-28,2022,EP 20825326 A,2020-11-20,US 201962938646 P;;US 202063081253 P;;US 2020/0061626 W,2019-11-21,INTEGRATED ENERGY STORAGE SYSTEM,,TESLA INC,SUMPF JR ROBERT DAVID;;PIRES ANDREW;;STOCKTON WILLIAM B;;SPOONER COLE;;PRODAN COLE;;GORASIA JAYESH BHARAT;;HARRIS KENTON;;BURKE DAN;;SZAFER DAFNA GABRIELA;;PATEL KRUPAL;;PARKER BENJAMIN;;HEGEMAN DAVID ELIAS,,https://lens.org/071-238-774-610-124,Patent Application,yes,0,0,9,9,0,H01M50/273;;H01M50/242;;H01M50/24;;H01M50/213;;H01M2220/20;;H01M10/659;;H01M10/658;;H01M10/6567;;H01M10/6561;;H01M10/643;;H01M10/625;;H01M10/613;;H01M2220/10;;Y02E60/10;;H01M10/658;;H01M10/659;;H01M10/643;;H01M10/6557;;H01M10/6565;;H01M10/6567;;H01M10/625;;H01M10/613;;H01M50/213;;H01M50/249;;H01M50/24;;H01M50/273;;H01M50/291;;H01M50/293;;H01M50/502;;H01M2220/20;;H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6556;;H01M10/658;;B60L50/64;;H01M50/249;;H01M50/213;;H01M50/271;;H01M2220/20,H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6561;;H01M10/6567;;H01M10/658;;H01M10/659;;H01M50/213;;H01M50/24;;H01M50/242;;H01M50/273,,0,0,,,,PENDING
606,US,B2,US 7934751 B2,083-111-280-401-936,2011-05-03,2011,US 59040906 A,2006-10-31,US 59040906 A;;US 79923806 P,2006-05-09,"Label sheet assembly, application kit and method of using the same","An improved label sheet assembly and application kit including an optional liner sheet, a carrier strip, and a removably attached label facestock sheet. The application kit further includes a stacked group of tabbed sheets and an alignment guide. The label facestock sheet assembly includes a plurality of cut lines defining a perimeter of a plurality of facestock labels spaced from one another in an offset manner that substantially corresponds to a set of staggered tabs extending outwardly from a stacked group of divider sheets. The carrier strip is defined by a plurality of cuts having substantially the same shape as a portion of the perimeters of the facestock labels, but with slightly smaller dimensions as its respective label. The user may separate the carrier strip from the liner sheet, exposing an adhesive back of the precut labels and place and align the carrier strip across the divider sheets such that the precut labels are placed on the tabs of the divider sheets. The user then pulls the carrier strip upwardly and away from the divider sheets such that a portion of each of the perimeters of the precut labels flexes to separate from the carrier strip and remain on the staggered tabs.",AVERY DENNISON CORP,CASTILLO ARTHUR G;;HONG LE HOA;;MARTIN DOUGLAS WILLIAM;;SANCHEZ ELIZABETH MARIE;;URBINA MORIEL JESUS ANGEL;;RAMON CARLOS LOBATO;;MUNOZ JOSE ELIAS PINTO;;UGOLICK RONALD;;HODSDON JERRY GRANT;;TATARYAN ANAHIT,CCL LABEL INC (2013-07-01);;AVERY DENNISON CORPORATION (2006-10-16),https://lens.org/083-111-280-401-936,Granted Patent,yes,45,12,12,28,0,B42F21/00;;B42F21/02;;B42F21/02;;B42F21/00,B42F15/00;;B42F21/00,283/37;;283/36;;283/39;;283/41;;283/81,3,0,,,"Pollman; Index Divider Label Application and Alignment Kit and Method of Using Same; PCT/US98/07326; WO 98/47771; Oct. 29, 1998.;;Wein; Label Applicator, Method and Label Therefor; PCT/US02/11512; WO 02/083403; Oct. 24, 2002.;;International Search Report, PCT/US2006/042604, May 7, 2007.",ACTIVE
607,AU,A1,AU 2020/388682 A1,189-194-211-745-049,2022-06-09,2022,AU 2020/388682 A,2020-11-20,US 201962938646 P;;US 202063081253 P;;US 2020/0061626 W,2019-11-21,Integrated energy storage system,"An integrated, unitary battery pack may be formed and used as part of the structural support for a vehicle frame. The unitary battery pack includes arrays cells having all positive and negative electrical terminals aligned in-plane on a common face of the product assembly. The unitary battery pack includes cooling components for passively or actively cooling the cell arrays. The unitary battery pack is encased in a potting material that allows that forms part of the structure support for the unitary battery pack. The unitary batter pack may be integrated into the vehicle with or without additional support structures.",TESLA INC,SUMPF JR ROBERT DAVID;;PIRES ANDREW;;STOCKTON WILLIAM B;;SPOONER COLE;;PRODAN COLE;;GORASIA JAYESH BHARAT;;HARRIS KENTON;;BURKE DAN;;SZAFER DAFNA GABRIELA;;PATEL KRUPAL;;PARKER BENJAMIN;;HEGEMAN DAVID ELIAS,,https://lens.org/189-194-211-745-049,Patent Application,no,0,0,9,9,0,H01M50/273;;H01M50/242;;H01M50/24;;H01M50/213;;H01M2220/20;;H01M10/659;;H01M10/658;;H01M10/6567;;H01M10/6561;;H01M10/643;;H01M10/625;;H01M10/613;;H01M2220/10;;Y02E60/10;;H01M10/658;;H01M10/659;;H01M10/643;;H01M10/6557;;H01M10/6565;;H01M10/6567;;H01M10/625;;H01M10/613;;H01M50/213;;H01M50/249;;H01M50/24;;H01M50/273;;H01M50/291;;H01M50/293;;H01M50/502;;H01M2220/20;;H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6556;;H01M10/658;;B60L50/64;;H01M50/249;;H01M50/213;;H01M50/271;;H01M2220/20,H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6561;;H01M10/6567;;H01M10/658;;H01M10/659;;H01M50/213;;H01M50/24;;H01M50/242;;H01M50/273,,0,0,,,,PENDING
608,US,A1,US 2007/0262578 A1,126-292-382-933-398,2007-11-15,2007,US 59040906 A,2006-10-31,US 59040906 A;;US 79923806 P,2006-05-09,"Label sheet assembly, application kit and method of using the same","An improved label sheet assembly and application kit including an optional liner sheet, a carrier strip, and a removably attached label facestock sheet. The application kit further includes a stacked group of tabbed sheets and an alignment guide. The label facestock sheet assembly includes a plurality of cut lines defining a perimeter of a plurality of facestock labels spaced from one another in an offset manner that substantially corresponds to a set of staggered tabs extending outwardly from a stacked group of divider sheets. The carrier strip is defined by a plurality of cuts having substantially the same shape as a portion of the perimeters of the facestock labels, but with slightly smaller dimensions as its respective label. The user may separate the carrier strip from the liner sheet, exposing an adhesive back of the precut labels and place and align the carrier strip across the divider sheets such that the precut labels are placed on the tabs of the divider sheets. The user then pulls the carrier strip upwardly and away from the divider sheets such that a portion of each of the perimeters of the precut labels flexes to separate from the carrier strip and remain on the staggered tabs.",AVERY DENNISON CORP,CASTILLO ARTHUR G;;HONG LE HOA;;MARTIN DOUGLAS WILLIAM;;SANCHEZ ELIZABETH MARIE;;URBINA MORIEL JESUS ANGEL;;RAMON CARLOS LOBATO;;PINTO MUNOZ JOSE ELIAS;;UGOLICK RONALD;;HODSDON JERRY GRANT;;TATARYAN ANAHIT,CCL LABEL INC (2013-07-01);;AVERY DENNISON CORPORATION (2006-10-16),https://lens.org/126-292-382-933-398,Patent Application,yes,19,10,12,28,0,B42F21/00;;B42F21/02;;B42F21/02;;B42F21/00,B42D15/00,283/81,0,0,,,,ACTIVE
609,CA,A1,CA 3158596 A1,077-375-493-790-519,2021-05-27,2021,CA 3158596 A,2020-11-20,US 201962938646 P;;US 202063081253 P;;US 2020/0061626 W,2019-11-21,INTEGRATED ENERGY STORAGE SYSTEM,"An integrated, unitary battery pack may be formed and used as part of the structural support for a vehicle frame. The unitary battery pack includes arrays cells having all positive and negative electrical terminals aligned in-plane on a common face of the product assembly. The unitary battery pack includes cooling components for passively or actively cooling the cell arrays. The unitary battery pack is encased in a potting material that allows that forms part of the structure support for the unitary battery pack. The unitary batter pack may be integrated into the vehicle with or without additional support structures.",TESLA INC,SUMPF JR ROBERT DAVID;;PIRES ANDREW;;STOCKTON WILLIAM B;;SPOONER COLE;;PRODAN COLE;;GORASIA JAYESH BHARAT;;HARRIS KENTON;;BURKE DAN;;SZAFER DANFNA GABRIELA;;PATEL KRUPAL;;PARKER BENJAMIN;;HEGEMAN DAVID ELIAS,,https://lens.org/077-375-493-790-519,Patent Application,no,0,0,9,9,0,H01M50/273;;H01M50/242;;H01M50/24;;H01M50/213;;H01M2220/20;;H01M10/659;;H01M10/658;;H01M10/6567;;H01M10/6561;;H01M10/643;;H01M10/625;;H01M10/613;;H01M2220/10;;Y02E60/10;;H01M10/658;;H01M10/659;;H01M10/643;;H01M10/6557;;H01M10/6565;;H01M10/6567;;H01M10/625;;H01M10/613;;H01M50/213;;H01M50/249;;H01M50/24;;H01M50/273;;H01M50/291;;H01M50/293;;H01M50/502;;H01M2220/20;;H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6556;;H01M10/658;;B60L50/64;;H01M50/249;;H01M50/213;;H01M50/271;;H01M2220/20,H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6561;;H01M10/6567;;H01M10/658;;H01M10/659;;H01M50/213;;H01M50/24;;H01M50/242;;H01M50/273,,0,0,,,,PENDING
610,MX,A,MX 2022005982 A,123-937-141-503-879,2022-09-02,2022,MX 2022005982 A,2020-11-20,US 201962938646 P;;US 202063081253 P;;US 2020/0061626 W,2019-11-21,INTEGRATED ENERGY STORAGE SYSTEM.,"An integrated, unitary battery pack may be formed and used as part of the structural support for a vehicle frame. The unitary battery pack includes arrays cells having all positive and negative electrical terminals aligned in-plane on a common face of the product assembly. The unitary battery pack includes cooling components for passively or actively cooling the cell arrays. The unitary battery pack is encased in a potting material that allows that forms part of the structure support for the unitary battery pack. The unitary batter pack may be integrated into the vehicle with or without additional support structures.",TESLA INC,SUMPF JR ROBERT DAVID;;PIRES ANDREW;;STOCKTON WILLIAM B;;SPOONER COLE;;PRODAN COLE;;GORASIA JAYESH BHARAT;;HARRIS KENTON;;BURKE DAN;;SZAFER DAFNA GABRIELA;;PATEL KRUPAL;;PARKER BENJAMIN;;HEGEMAN DAVID ELIAS,,https://lens.org/123-937-141-503-879,Patent Application,no,0,0,9,9,0,H01M50/273;;H01M50/242;;H01M50/24;;H01M50/213;;H01M2220/20;;H01M10/659;;H01M10/658;;H01M10/6567;;H01M10/6561;;H01M10/643;;H01M10/625;;H01M10/613;;H01M2220/10;;Y02E60/10;;H01M10/658;;H01M10/659;;H01M10/643;;H01M10/6557;;H01M10/6565;;H01M10/6567;;H01M10/625;;H01M10/613;;H01M50/213;;H01M50/249;;H01M50/24;;H01M50/273;;H01M50/291;;H01M50/293;;H01M50/502;;H01M2220/20;;H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6556;;H01M10/658;;B60L50/64;;H01M50/249;;H01M50/213;;H01M50/271;;H01M2220/20,H01M10/613;;H01M10/625;;H01M10/643;;H01M10/6561;;H01M10/6567;;H01M10/658;;H01M10/659;;H01M50/213;;H01M50/24;;H01M50/242;;H01M50/273,,0,0,,,,PENDING
611,US,B1,US 8897951 B1,001-488-992-163-935,2014-11-25,2014,US 201313782475 A,2013-03-01,US 201313782475 A,2013-03-01,Aircraft interior component maintenance,"A method and apparatus for maintaining a component on a vehicle. Component maintenance information is read from an automated identification technology tag on the vehicle, wherein the automated identification technology tag is associated with an interior component on the vehicle. A remaining portion of a maintenance period for the interior component is determined using the component maintenance information. An indication of the remaining portion of the maintenance period is displayed on a user interface.",BOEING CO,KNOX JAMES DON;;ALLEN DAVID W;;ELIAS JOSE R;;SHORE REBECCA J;;NGUYEN TOMMY T;;HILL LOIS T;;SEEGER PAUL F;;RINER EDWIN KEITH;;KINNEY DAVID SCOTT;;BUCKLEY MICHAEL J;;COOP WILLIAM P,THE BOEING COMPANY (2013-02-25),https://lens.org/001-488-992-163-935,Granted Patent,yes,15,7,1,1,0,B64F5/40;;B64F5/40,G01M17/00;;B64F5/00,701/29.1;;701/29.4;;701/31.4,6,0,,,"Coop et al., ""Maintaining the Airworthiness Configuration of Aircraft,"" U.S. Appl. No. 13/664,121, filed Oct. 30, 2012, 44 pages.;;Coop et al., ""Aircraft Rework Management,"" U.S. Appl. No. 13/644,827, filed Oct. 4, 2012, 42 pages.;;Office Action, dated May 30, 2014, regarding U.S. Appl. No. 13/664,121, 18 pages.;;Office Action, dated May 30, 2014, regarding U.S. Appl. No. 13/644,827, 19 pages.;;Final Office Action, dated Aug. 8, 2014, regarding U.S. Appl. No. 13/664,121, 13 pages.;;Notice of Allowance, dated Aug. 12, 2014, regarding U.S. Appl. No. 13/644,827, 9 pages.",ACTIVE
612,WO,A1,WO 2011/119404 A1,196-919-574-151-679,2011-09-29,2011,US 2011/0028806 W,2011-03-17,US 31791110 P,2010-03-26,PORTABLE SYSTEMS AND METHODS FOR AMPLIFYING NUCLEOTIDES AND DETECTING NUCLEOTIDE SEQUENCES,Portable systems and methods for amplifying nucleotides and for detecting nucleotide sequences in a sample are provided. The portable instruments and methods use RPA techniques for DNA amplification and detect sample fluorescence in response to amplification and/or to the presence of specific DNA sequences.,MONSANTO TECHNOLOGY LLC;;CARGILL EDWARD J;;DEPPERMANN KEVIN L;;WHITE BRAD D;;GROTE WILLIAM A;;YANNAKAKIS ELIAS J;;SINGLETON ANDREW M;;GROTHAUS DAVID;;STEPHANS TIFFANY L;;CHRISTIAN ALLEN T;;MITTANCK DONALD W;;DUDIN YELENA A;;GOVINTHASAMY RAMESH,CARGILL EDWARD J;;DEPPERMANN KEVIN L;;WHITE BRAD D;;GROTE WILLIAM A;;YANNAKAKIS ELIAS J;;SINGLETON ANDREW M;;GROTHAUS DAVID;;STEPHANS TIFFANY L;;CHRISTIAN ALLEN T;;MITTANCK DONALD W;;DUDIN YELENA A;;GOVINTHASAMY RAMESH,,https://lens.org/196-919-574-151-679,Patent Application,yes,7,4,3,3,0,G01N21/645;;G01N2021/6421;;G01N2021/6432;;G01N2021/6441;;G01N2201/0221;;G01N2201/024;;G01N2201/0627;;G01N21/645;;G01N2021/6421;;G01N2021/6432;;G01N2021/6441;;G01N2201/0221;;G01N2201/024;;G01N2201/0627;;C12Q1/6844;;C12Q1/6895;;C12Q2600/13;;G01N21/643;;G01N2201/062,G01N31/00,,0,0,,,,PENDING
613,US,B2,US 9464329 B2,116-881-203-940-22X,2016-10-11,2016,US 201113637303 A,2011-03-17,US 201113637303 A;;US 31791110 P;;US 2011/0028806 W,2010-03-26,Portable systems and methods for amplifying nucleotides and detecting nucleotide sequences,Portable systems and methods for amplifying nucleotides and for detecting nucleotide sequences in a sample are provided. The portable instruments and methods use RPA techniques for DNA amplification and detect sample fluorescence in response to amplification and/or to the presence of specific DNA sequences.,CARGILL EDWARD J;;DEPPERMANN KEVIN L;;WHITE BRAD D;;GROTE WILLIAM A;;YANNAKAKIS ELIAS J;;SINGLETON ANDREW M;;GROTHAUS G DAVID;;STEPHANS TIFFANY L;;CHRISTIAN ALLEN T;;MITTANCK DONALD W;;DUDIN YELENA A;;MONSANTO TECHNOLOGY LLC,CARGILL EDWARD J;;DEPPERMANN KEVIN L;;WHITE BRAD D;;GROTE WILLIAM A;;YANNAKAKIS ELIAS J;;SINGLETON ANDREW M;;GROTHAUS G DAVID;;STEPHANS TIFFANY L;;CHRISTIAN ALLEN T;;MITTANCK DONALD W;;DUDIN YELENA A;;GOVINTHASAMY RAMESH,MONSANTO TECHNOLOGY LLC (2008-09-19),https://lens.org/116-881-203-940-22X,Granted Patent,yes,7,1,3,3,0,G01N21/645;;G01N2021/6421;;G01N2021/6432;;G01N2021/6441;;G01N2201/0221;;G01N2201/024;;G01N2201/0627;;G01N21/645;;G01N2021/6421;;G01N2021/6432;;G01N2021/6441;;G01N2201/0221;;G01N2201/024;;G01N2201/0627;;C12Q1/6844;;C12Q1/6895;;C12Q2600/13;;G01N21/643;;G01N2201/062,C12Q1/68;;G01N21/64,,1,0,,,"PCT International Search Report and Written Opinion of the International Searching Authority mailed on May 20, 2011 regarding PCT/US2011/028806; pp. 9.",ACTIVE
614,US,A1,US 2015/0203922 A1,059-242-400-612-771,2015-07-23,2015,US 201113637303 A,2011-03-17,US 201113637303 A;;US 31791110 P;;US 2011/0028806 W,2010-03-26,Portable Systems and Methods for Amplifying Nucleotides and Detecting Nucleotide Sequences,Portable systems and methods for amplifying nucleotides and for detecting nucleotide sequences in a sample are provided. The portable instruments and methods use RPA techniques for DNA amplification and detect sample fluorescence in response to amplification and/or to the presence of specific DNA sequences.,CARGILL EDWARD J;;DEPPERMANN KEVIN L;;WHITE BRAD D;;GROTE WILLIAM A;;YANNAKAKIS ELIAS J;;SINGLETON ANDREW M;;GROTHAUS D DAVID;;STEPHANS TIFFANY L;;CHRISTIAN ALLEN T;;MITTANCK DONALD W;;DUDIN YELENA A;;GOVINTHASAMY RAMESH;;MONSANTO TECHNOLOGY LLC,CARGILL EDWARD J;;DEPPERMANN KEVIN L;;WHITE BRAD D;;GROTE WILLIAM A;;YANNAKAKIS ELIAS J;;SINGLETON ANDREW M;;GROTHAUS D DAVID;;STEPHANS TIFFANY L;;CHRISTIAN ALLEN T;;MITTANCK DONALD W;;DUDIN YELENA A;;GOVINTHASAMY RAMESH,MONSANTO TECHNOLOGY LLC (2008-09-19),https://lens.org/059-242-400-612-771,Patent Application,yes,0,0,3,3,0,G01N21/645;;G01N2021/6421;;G01N2021/6432;;G01N2021/6441;;G01N2201/0221;;G01N2201/024;;G01N2201/0627;;G01N21/645;;G01N2021/6421;;G01N2021/6432;;G01N2021/6441;;G01N2201/0221;;G01N2201/024;;G01N2201/0627;;C12Q1/6844;;C12Q1/6895;;C12Q2600/13;;G01N21/643;;G01N2201/062,G01N21/64;;C12Q1/68,,0,0,,,,ACTIVE
615,US,B1,US 6594530 B1,030-281-055-375-70X,2003-07-15,2003,US 16009402 A,2002-06-04,US 16009402 A;;US 91617897 A;;US 2434696 P,1996-08-23,Block-oriented control system,"
    The present invention is a block oriented control system that allows interoperability between devices made by different manufacturers. A block oriented control system is a system which includes a plurality of field devices incorporating a physical layer, communication stack, and user layer, with the field devices being connected by a transmission medium, such as a bus. The physical layer receives signals from the bus and translates the signals into a message for the communications stack, and receives messages from the communications stack and translates the messages into signals for the bus. The communication stack controls the communications between devices operating in the control system. The user layer is a block oriented approach to the system's control functions, and includes function blocks and system management. The function blocks are standardized encapsulations of control functions, such as analog input or proportional/derivative. The system management allows synchronization of the device applications and the network processing. 
",FIELDBUS FOUNDATION,GLANZER DAVID A;;BLEVINS TERRENCE L;;RAMACHANDRAN RAM;;KRIVOSHEIN KENNETH D;;BRETT PATRICIA E;;ELIAS JACK;;HODSON WILLIAM R;;LYNCH FRANK;;GUPTA ASHOK K;;NEITZEL LEE A;;KINNEY THOMAS B;;AKIYAMA CHUJI;;KUMEDA YASUO;;MORI HIROSHI;;TANAKA MITSUGU,FIELDCOMM GROUP INC (2014-12-18),https://lens.org/030-281-055-375-70X,Granted Patent,yes,4,123,2,61,0,G05B19/4185;;G05B19/4185;;G05B15/02;;G05B15/02;;G05B2219/31118;;G05B2219/31118;;H04L41/06;;H04L41/06;;Y02P90/02;;Y02P90/02,G05B15/02;;G05B19/418;;H04L12/24,700/18;;700/4;;700/17;;700/83;;700/86;;709/224;;709/227;;709/230;;709/201;;710/15;;710/72;;710/105;;714/10;;714/11,0,0,,,,EXPIRED
616,US,B1,US 6424872 B1,058-548-644-370-006,2002-07-23,2002,US 91617897 A,1997-08-21,US 91617897 A;;US 2434696 P,1996-08-23,Block oriented control system,"
    The present invention is a block oriented control system that allows interoperability between devices made by different manufacturers. A block oriented control system is a system which includes a plurality of field devices incorporating a physical layer, communication stack, and user layer, with the field devices being connected by a transmission medium, such as a bus. The physical layer receives signals from the bus and translates the signals into a message for the communications stack, and receives messages from the communications stack and translates the messages into signals for the bus. The communication stack controls the communications between devices operating in the control system. The user layer is a block oriented approach to the system's control functions, and includes function blocks and system management. The function blocks are standardized encapsulations of control functions, such as analog input or proportional/derivative. The system management allows synchronization of the device applications and the network processing. 
",FIELDBUS FOUNDATION,GLANZER DAVID A;;BLEVINS TERRANCE L;;RAMACHANDRAN RAM;;KRIVOSHEIN KENNETH D;;BRETT PATRICIA E;;ELIAS JACK;;HODSON WILLIAM R;;LYNCH FRANK;;GUPTA ASHOK K;;NEITZEL LEE A;;KINNEY THOMAS B;;AKIYAMA CHUJI;;KUMEDA YASUO;;MORI HIROSHI;;TANAKA MITSUGU,FIELDCOMM GROUP INC (2014-12-18);;FIELDBUS FOUNDATION (1998-04-27),https://lens.org/058-548-644-370-006,Granted Patent,yes,89,171,2,61,0,G05B19/4185;;G05B19/4185;;G05B15/02;;G05B15/02;;G05B2219/31118;;G05B2219/31118;;H04L41/06;;H04L41/06;;Y02P90/02;;Y02P90/02,G05B15/02;;G05B19/418;;H04L12/24,700/18;;700/17;;700/4;;700/83;;700/86;;709/224;;709/227;;709/230;;709/201;;710/15;;710/72;;710/105;;714/10;;714/11,4,0,,,"File History: Peer-to-Peer Register Exchange Controller for Industrial Programmable Controllers; U.S. Patent No. 4,992,926, Application Serial No. 07/258,779, Feb. 12, 1991; Janke et al., filed Oct. 17, 1988.;;File History: Distributed Interface Architecture for Programmable Industrial Control Systems; U.S. Patent No. 5,805,442, Application Serial No. 08/655,469, Sep. 8, 1998; Crater et al., filed May 30, 19.;;File History: Distributed Interface Architecture for Programmable Industrial Control Systems; U.S. Patent No. 5,975,737, Application Serial No. 09/112,583, Nov. 2, 1999; Crater et al., filed Jul. 9, 1998.;;Disclosure Statement of Invention by Inventor, Patricia Brett.",EXPIRED
617,BR,A2,BR PI0703065 A2,091-943-199-806-989,2009-03-10,2009,BR PI0703065 A,2007-07-26,BR PI0703065 A,2007-07-26,sistema e processo de testes de dispositivos eletrânicos,"SISTEMA E PROCESSO DE TESTES DE DISPOSITIVOS ELETRâNICOS. A presente invenção refere-se a um sistema e processo de testes de dispositivos eletrônicos (1), particularmente para ser utilizado em testes de módulos de tela de cristal líquido (10) de celulares, onde dito sistema (1) é modi.ilar e compreende um módulo fonte (2) de alimentação, um módulo mecânico (4) para acomodação de um dispositivo de teste (10), um módulo de interface homem-máquina (5) de entrada de dados e acionamento do sistema (1), e um módulo de instrumentação e controle (3) responsável pela conexão entre todos os módulos (2, 3, 4, 5).",FUNDACAO UNIVERSIDADE DO AMAZONAS,FERREIRA FERNANDES COSTA CICERO JR;;FERREIRA OSMIDIO LIMA HILLERMANN;;DA SILVA MELO ORLENS;;SILVA DE MORAES WILLIAM;;DA COSTA ANDRADE BRAZ JR;;CARVALHO DIAS FABIAN;;COLLYER DA SILVEIRA MARCIO DAVID;;CARDOSO LITAIFF ELIAS JR;;DUARTE CAVALCANTE ANDRE LUIZ;;SILVA DE SOUZA FRANKLIN,,https://lens.org/091-943-199-806-989,Patent Application,no,0,0,1,1,0,,G01R31/28,,0,0,,,,DISCONTINUED
618,US,A1,US 2009/0148342 A1,185-879-361-557-576,2009-06-11,2009,US 92728807 A,2007-10-29,US 92728807 A,2007-10-29,Hypochlorite Technology,"This invention generally relates to compositions and method of producing diluted hypohalous acid and hypohalous acid vapor. These compositions can be used to treat allergen containing surfaces, hard surfaces, food contact surfaces, hospital surfaces, food surfaces, kitchen surfaces, bathroom surfaces, human surfaces, animal surfaces, children's items, outdoor surfaces, soft surfaces, and medical instruments. These compositions can be converted to solid particulate or granular compositions. These compositions can be put into a variety of containers which preserve the stability. These compositions can be used to treat allergens and molds and as part of a mold detection system. These compositions can be dispersed into the air to enable microbiological control.",BROMBERG STEVEN E;;BITOWFT BRUCE K;;CRANE ELIZABETH;;EL-SAYED MAHA;;HUITT DANIEL A;;NGUYEN ANDREAS;;GOPEGUI RICARDO RUIZ DE;;SHIEH DORIS S;;SMITH WILLIAM L;;TIMBERMAN JULIE;;GARABEDIAN ARAM;;ARNT LACHELLE;;SHAHEEN ELIAS A;;BROMBERG STEVEN;;FRIEDMAN VICKI;;FUNG JENNIFER;;JULIAN JENNIFER C;;VIEIRA KENNETH;;WIESMAN JULIE;;KENNEDY TIMOTHY;;CHIANG CHIH;;VIEIRA KENNETH L;;OCHOMOGO MARIA G;;CUMBERLAND SCOTT;;HUITT DANIEL AARON;;MELLETT DIANE;;DANI NIKHIL;;EL-SAYED MAHA Y;;FOLAND LAFAYETTE D;;ROBLES JORGE;;SHAHEEN ELIAS A,BROMBERG STEVEN E;;BITOWFT BRUCE K;;CRANE ELIZABETH;;EL-SAYED MAHA;;HUITT DANIEL A;;NGUYEN ANDREAS;;GOPEGUI RICARDO RUIZ DE;;SHIEH DORIS S;;SMITH WILLIAM L;;TIMBERMAN JULIE;;GARABEDIAN ARAM;;ARNT LACHELLE;;SHAHEEN ELIAS A;;BROMBERG STEVEN;;FRIEDMAN VICKI;;FUNG JENNIFER;;JULIAN JENNIFER C;;VIEIRA KENNETH;;WIESMAN JULIE;;KENNEDY TIMOTHY;;CHIANG CHIH;;VIEIRA KENNETH L;;OCHOMOGO MARIA G;;CUMBERLAND SCOTT;;HUITT DANIEL AARON;;MELLETT DIANE;;DANI NIKHIL;;EL-SAYED MAHA Y;;FOLAND LAFAYETTE D;;ROBLES JORGE;;SHAHEEN ELIAS A,,https://lens.org/185-879-361-557-576,Patent Application,yes,99,181,1,1,0,A61L2/18;;A61L2/18;;A01N59/00;;A01N59/00;;A23L3/358;;A23L3/358;;A61L2/20;;A61L2/20;;A61L2/22;;A61L2/22;;A61L2/23;;A61L2/23;;A61L9/01;;A61L9/01;;A61L9/05;;A61L9/05;;A61L9/12;;A61L9/12;;A61L9/14;;A61L9/14;;A61L2202/24;;A61L2202/24;;C11D3/124;;C11D3/124;;C11D3/3953;;C11D3/3953;;C11D3/3956;;C11D3/3956;;C11D3/48;;C11D3/48;;C11D17/041;;C11D17/041,A61L2/20,422/37;;424/661;;422/123,0,0,,,,DISCONTINUED
619,US,A1,US 2020/0105364 A1,021-602-653-629-835,2020-04-02,2020,US 201916713528 A,2019-12-13,US 201916713528 A;;US 2018/0036084 W;;US 201762519728 P,2017-06-14,METHOD FOR DETERMINING LYMPHOMA TYPE,"In embodiments of the invention, the invention provides a method for distinguishing between lymphoma types based on gene expression measurements. In embodiments, the invention distinguishes between PMBCL and DLBCL based on gene expression signatures, and can further distinguish between DLBCL subtypes. In embodiments of the invention, the distinctions are used in methods of treatment.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;MAYO FOUND MEDICAL EDUCATION & RES;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;UNIV NEBRASKA;;OSLO UNIV HOSPITAL HF;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;INST DINVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER IDIBAPS;;ROBERT BOSCH GES FUER MEDIZINISCHE FORSCHUNG MBH;;UNIV OREGON HEALTH & SCIENCE;;HOPE CITY;;CLEVELAND CLINIC FOUND;;INSTITUT D? INVESTIG BIOMEDIQUES AUGUST PI I SUNYER IDIBAPS,STAUDT LOUIS M;;STEIDL CHRISTIAN;;MOTTOK ANJA;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;RIMSZA LISA M;;ROSENWALD ANDREAS;;GASCOYNE RANDY;;GREINER TIMOTHY;;WEISENBURGER DENNIS;;SMELAND ERLEND B;;DELABIE JAN;;CAMPO GUERRI ELIAS;;OTT GERMAN;;BRAZIEL RITA;;JAFFE ELAINE S;;FU KAI;;CHAN WING C;;SONG JOO;;COOK JAMES R,BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2020-05-22);;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2020-06-18);;OREGON HEALTH & SCIENCE UNIVERSITY (2020-07-10);;ROBERT BOSCH GESELLSCHAFT FUER MEDIZINISCHE FORSCHUNG MBH (2020-05-25);;JULIUS-MAXIMILIANS-UNIVERSITY OF WÜRZBURG (2020-05-28);;CITY OF HOPE (2020-06-18);;INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER (IDIBAPS) (2020-06-05);;HOSPITAL CLINIC DE BARCELONA (2020-06-05);;OSLO UNIVERSITY HOSPITAL HF (2020-06-19);;THE CLEVELAND CLINIC FOUNDATION (2020-07-14);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2020-07-14);;MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (2020-06-15);;UNIVERSITAT DE BARCELONA (2020-06-05),https://lens.org/021-602-653-629-835,Patent Application,yes,0,0,6,6,58,C12Q1/6886;;C12Q2600/112;;C12Q2600/158;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/112;;C12Q2600/158,G16B5/00;;C12Q1/6886;;G16B25/10,,0,0,,,,ACTIVE
620,EP,B1,EP 3638814 B1,031-439-243-676-909,2023-05-10,2023,EP 18733500 A,2018-06-05,US 201762519728 P;;US 2018/0036084 W,2017-06-14,METHOD FOR DETERMINING LYMPHOMA TYPE,,US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;MAYO FOUND MEDICAL EDUCATION & RES;;UNIV WUERZBURG J MAXIMILIANS;;UNIV NEBRASKA;;OSLO UNIV HOSPITAL HF;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;INST DINVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER IDIBAPS;;ROBERT BOSCH GES FUER MEDIZINISCHE FORSCHUNG MBH;;UNIV OREGON HEALTH & SCIENCE;;HOPE CITY;;CLEVELAND CLINIC FOUND,STAUDT LOUIS M;;STEIDL CHRISTIAN;;MOTTOK ANJA;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;RIMSZA LISA M;;ROSENWALD ANDREAS;;GASCOYNE RANDY;;GREINER TIMOTHY;;WEISENBURGER DENNIS;;SMELAND ERLEND B;;DELABIE JAN;;CAMPO GUERRI ELIAS;;OTT GERMAN;;BRAZIEL RITA;;JAFFE ELAINE S;;FU KAI;;CHAN WING C;;SONG JOO;;COOK JAMES R,"BRITISH COLUMBIA CANCER AGENCY BRANCH, VANCOUV, CA (2023-11-13);;CITY OF HOPE, DUARTE, US (2023-11-13);;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (2023-12-06);;OREGON HEALTH & SCIENCE UNIVERSITY (2023-12-06);;JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG - KO, DE (2023-11-13);;HOSPITAL CLINIC DE BARCELONA, ES (2023-11-13);;INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER - IDIBAPS (2023-05-24);;CITY OF HOPE (2023-12-06);;FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (FRCB-IDIBAPS) (2023-12-06);;HOSPITAL CLINIC DE BARCELONA (2023-12-06);;THE UNITED STATES OF AMERICA, AS REPRESENTED B, US (2023-11-13);;MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESE, US (2023-11-13);;OSLO UNIVERSITY HOSPITAL HF (2023-12-06);;THE CLEVELAND CLINIC FOUNDATION (2023-12-06);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2023-12-06);;MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (2023-12-06);;THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBR, US (2023-11-13);;ROBERT BOSCH GESELLSCHAFT FUER MEDIZINISCHE FORSCHUNG MBH (2023-12-06);;OREGON HEALTH & SCIENCE UNIVERSITY, PORTLAND, US (2023-11-13);;OSLO UNIVERSITY HOSPITAL HF, NO (2023-11-13);;THE CLEVELAND CLINIC FOUNDATION, CLEVELAND, US (2023-11-13);;FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT , ES (2023-11-13);;ROBERT BOSCH GESELLSCHAFT FUER MEDIZINISCHE FO, DE (2023-11-13);;UNIVERSITAT DE BARCELONA, ES (2023-11-13);;UNIVERSITAT DE BARCELONA (2023-12-06);;THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2023-12-06);;JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG (2023-12-06)",https://lens.org/031-439-243-676-909,Granted Patent,yes,2,0,6,6,0,C12Q1/6886;;C12Q2600/112;;C12Q2600/158;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/112;;C12Q2600/158,C12Q1/6886,,5,0,,,"A. MOTTOK ET AL: ""MOLECULAR CLASSIFICATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA USING FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUE SPECIMENS - AN LLMPP PROJECT"", HEMATOLOGICAL ONCOLOGY, vol. 35, 7 June 2017 (2017-06-07), pages 59-60, XP055495961, US ISSN: 0278-0232, DOI: 10.1002/hon.2437_46;;D. W. SCOTT ET AL: ""Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue"", BLOOD, vol. 123, no. 8, 20 February 2014 (2014-02-20), pages 1214-1217, XP055495536, US ISSN: 0006-4971, DOI: 10.1182/blood-2013-11-536433;;ROSENWALD A ET AL: ""Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma"", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 198, no. 6, 15 September 2003 (2003-09-15), pages 851-862, XP002396795, ISSN: 0022-1007, DOI: 10.1084/JEM.20031074;;LENZ G ET AL: ""Stromal gene signatures in large-B-cell lymphomas"", NEW ENGLAND JOURNAL OF MEDICINE, THE - NEJM, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 359, no. 22, 27 November 2008 (2008-11-27), pages 2313-2323, XP002551776, ISSN: 1533-4406, DOI: 10.1056/NEJMOA0802885;;M. H. VELDMAN-JONES ET AL: ""Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter System"", CLINICAL CANCER RESEARCH, vol. 21, no. 10, 9 October 2014 (2014-10-09), pages 2367-2378, XP055495781, US ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-14-0357 & Veldman-Jones ET AL: ""Supplemental Table 1"", Clinical Cancer Research 21(10): 2367-2378 (2014), 9 January 2014 (2014-01-09), XP055495789, Retrieved from the Internet: URL:http://clincancerres.aacrjournals.org/ highwire/filestream/131853/field_highwire_ adjunct_files/5/126978_2_supp_2633385_nfzh bv.pptx [retrieved on 2018-07-27]",ACTIVE
621,EP,B8,EP 3638814 B8,077-414-601-883-931,2023-06-21,2023,EP 18733500 A,2018-06-05,US 201762519728 P;;US 2018/0036084 W,2017-06-14,METHOD FOR DETERMINING LYMPHOMA TYPE,,US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;MAYO FOUND MEDICAL EDUCATION & RES;;UNIV WUERZBURG J MAXIMILIANS;;UNIV NEBRASKA;;OSLO UNIV HOSPITAL HF;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;INST DINVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER IDIBAPS;;ROBERT BOSCH GES FUER MEDIZINISCHE FORSCHUNG MBH;;UNIV OREGON HEALTH & SCIENCE;;HOPE CITY;;CLEVELAND CLINIC FOUND,STAUDT LOUIS M;;STEIDL CHRISTIAN;;MOTTOK ANJA;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;RIMSZA LISA M;;ROSENWALD ANDREAS;;GASCOYNE RANDY;;GREINER TIMOTHY;;WEISENBURGER DENNIS;;SMELAND ERLEND B;;DELABIE JAN;;CAMPO GUERRI ELIAS;;OTT GERMAN;;BRAZIEL RITA;;JAFFE ELAINE S;;FU KAI;;CHAN WING C;;SONG JOO;;COOK JAMES R,"BRITISH COLUMBIA CANCER AGENCY BRANCH, VANCOUV, CA (2023-11-13);;CITY OF HOPE, DUARTE, US (2023-11-13);;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (2023-12-06);;OREGON HEALTH & SCIENCE UNIVERSITY (2023-12-06);;JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG - KO, DE (2023-11-13);;HOSPITAL CLINIC DE BARCELONA, ES (2023-11-13);;INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER - IDIBAPS (2023-05-24);;CITY OF HOPE (2023-12-06);;FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (FRCB-IDIBAPS) (2023-12-06);;HOSPITAL CLINIC DE BARCELONA (2023-12-06);;MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESE, US (2023-11-13);;THE UNITED STATES OF AMERICA, AS REPRESENTED B, US (2023-11-13);;OSLO UNIVERSITY HOSPITAL HF (2023-12-06);;THE CLEVELAND CLINIC FOUNDATION (2023-12-06);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2023-12-06);;MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (2023-12-06);;THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBR, US (2023-11-13);;ROBERT BOSCH GESELLSCHAFT FUER MEDIZINISCHE FORSCHUNG MBH (2023-12-06);;OREGON HEALTH & SCIENCE UNIVERSITY, PORTLAND, US (2023-11-13);;OSLO UNIVERSITY HOSPITAL HF, NO (2023-11-13);;THE CLEVELAND CLINIC FOUNDATION, CLEVELAND, US (2023-11-13);;FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT , ES (2023-11-13);;ROBERT BOSCH GESELLSCHAFT FUER MEDIZINISCHE FO, DE (2023-11-13);;UNIVERSITAT DE BARCELONA, ES (2023-11-13);;THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2023-12-06);;UNIVERSITAT DE BARCELONA (2023-12-06);;JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG (2023-12-06)",https://lens.org/077-414-601-883-931,Amended Patent,yes,2,0,6,6,0,C12Q1/6886;;C12Q2600/112;;C12Q2600/158;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/112;;C12Q2600/158,C12Q1/6886,,5,0,,,"A. MOTTOK ET AL: ""MOLECULAR CLASSIFICATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA USING FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUE SPECIMENS - AN LLMPP PROJECT"", HEMATOLOGICAL ONCOLOGY, vol. 35, 7 June 2017 (2017-06-07), pages 59-60, XP055495961, US ISSN: 0278-0232, DOI: 10.1002/hon.2437_46;;D. W. SCOTT ET AL: ""Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue"", BLOOD, vol. 123, no. 8, 20 February 2014 (2014-02-20), pages 1214-1217, XP055495536, US ISSN: 0006-4971, DOI: 10.1182/blood-2013-11-536433;;ROSENWALD A ET AL: ""Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma"", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 198, no. 6, 15 September 2003 (2003-09-15), pages 851-862, XP002396795, ISSN: 0022-1007, DOI: 10.1084/JEM.20031074;;LENZ G ET AL: ""Stromal gene signatures in large-B-cell lymphomas"", NEW ENGLAND JOURNAL OF MEDICINE, THE - NEJM, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 359, no. 22, 27 November 2008 (2008-11-27), pages 2313-2323, XP002551776, ISSN: 1533-4406, DOI: 10.1056/NEJMOA0802885;;M. H. VELDMAN-JONES ET AL: ""Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter System"", CLINICAL CANCER RESEARCH, vol. 21, no. 10, 9 October 2014 (2014-10-09), pages 2367-2378, XP055495781, US ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-14-0357 & Veldman-Jones ET AL: ""Supplemental Table 1"", Clinical Cancer Research 21(10): 2367-2378 (2014), 9 January 2014 (2014-01-09), XP055495789, Retrieved from the Internet: URL:http://clincancerres.aacrjournals.org/ highwire/filestream/131853/field_highwire_ adjunct_files/5/126978_2_supp_2633385_nfzh bv.pptx [retrieved on 2018-07-27]",ACTIVE
622,EP,A1,EP 3638814 A1,137-619-281-723-253,2020-04-22,2020,EP 18733500 A,2018-06-05,US 201762519728 P;;US 2018/0036084 W,2017-06-14,METHOD FOR DETERMINING LYMPHOMA TYPE,,THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;MAYO FOUND MEDICAL EDUCATION & RES;;UNIV WUERZBURG J MAXIMILIANS;;UNIV NEBRASKA;;OSLO UNIV HOSPITAL HF;;UNIV OF HEALTH NETWORK;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;INST DINVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER IDIBAPS;;ROBERT BOSCH GES FUER MEDIZINISCHE FORSCHUNG MBH;;UNIV OREGON HEALTH & SCIENCE;;HOPE CITY;;CLEVELAND CLINIC FOUND,STAUDT LOUIS M;;STEIDL CHRISTIAN;;MOTTOK ANJA;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;RIMSZA LISA M;;ROSENWALD ANDREAS;;GASCOYNE RANDY;;GREINER TIMOTHY;;WEISENBURGER DENNIS;;SMELAND ERLEND B;;DELABIE JAN;;CAMPO GUERRI ELIAS;;OTT GERMAN;;BRAZIEL RITA;;JAFFE ELAINE S;;FU KAI;;CHAN WING C;;SONG JOO;;COOK JAMES R,"BRITISH COLUMBIA CANCER AGENCY BRANCH, VANCOUV, CA (2023-11-13);;CITY OF HOPE, DUARTE, US (2023-11-13);;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (2023-12-06);;OREGON HEALTH & SCIENCE UNIVERSITY (2023-12-06);;JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG - KO, DE (2023-11-13);;HOSPITAL CLINIC DE BARCELONA, ES (2023-11-13);;INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER - IDIBAPS (2023-05-24);;CITY OF HOPE (2023-12-06);;FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (FRCB-IDIBAPS) (2023-12-06);;HOSPITAL CLINIC DE BARCELONA (2023-12-06);;MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESE, US (2023-11-13);;THE UNITED STATES OF AMERICA, AS REPRESENTED B, US (2023-11-13);;OSLO UNIVERSITY HOSPITAL HF (2023-12-06);;THE CLEVELAND CLINIC FOUNDATION (2023-12-06);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2023-12-06);;MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (2023-12-06);;THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBR, US (2023-11-13);;ROBERT BOSCH GESELLSCHAFT FUER MEDIZINISCHE FORSCHUNG MBH (2023-12-06);;OREGON HEALTH & SCIENCE UNIVERSITY, PORTLAND, US (2023-11-13);;OSLO UNIVERSITY HOSPITAL HF, NO (2023-11-13);;THE CLEVELAND CLINIC FOUNDATION, CLEVELAND, US (2023-11-13);;FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT , ES (2023-11-13);;UNIVERSITAT DE BARCELONA, ES (2023-11-13);;ROBERT BOSCH GESELLSCHAFT FUER MEDIZINISCHE FO, DE (2023-11-13);;THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2023-12-06);;UNIVERSITAT DE BARCELONA (2023-12-06);;JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG (2023-12-06)",https://lens.org/137-619-281-723-253,Patent Application,yes,0,0,6,6,0,C12Q1/6886;;C12Q2600/112;;C12Q2600/158;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/112;;C12Q2600/158,C12Q1/6886,,0,0,,,,ACTIVE
623,US,B2,US 11646099 B2,118-176-185-785-527,2023-05-09,2023,US 201916713528 A,2019-12-13,US 201916713528 A;;US 2018/0036084 W;;US 201762519728 P,2017-06-14,Method for determining lymphoma type and providing treatment,"In embodiments of the invention, the invention provides a method for distinguishing between lymphoma types based on gene expression measurements. In embodiments, the invention distinguishes between PMBCL and DLBCL based on gene expression signatures, and can further distinguish between DLBCL subtypes. In embodiments of the invention, the distinctions are used in methods of treatment.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;MAYO FOUND MEDICAL EDUCATION & RES;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;UNIV NEBRASKA;;OSLO UNIV HOSPITAL HF;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;INST DINVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER IDIBAPS;;ROBERT BOSCH GES FUER MEDIZINISCHE FORSCHUNG MBH;;UNIV OREGON HEALTH & SCIENCE;;HOPE CITY;;CLEVELAND CLINIC FOUND;;BRITISH COLUMBIA CANCER AGENCY;;BOATD OF REGENTS OF THE UNIV OF NEBRASKA;;UNIV DE BARCELOA;;INST DINVESTIGACIONS BIOMEDIQUES PI I SUNYER IDIBAPS;;ROBERT BOSCH GES FEUER MEDIZINISCHE FORSHUNG MBH,STAUDT LOUIS M;;STEIDL CHRISTIAN;;MOTTOK ANJA;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;RIMSZA LISA M;;ROSENWALD ANDREAS;;GASCOYNE RANDY;;GREINER TIMOTHY;;WEISENBURGER DENNIS;;SMELAND ERLEND B;;DELABIE JAN;;CAMPO GUERRI ELIAS;;OTT GERMAN;;BRAZIEL RITA;;JAFFE ELAINE S;;FU KAI;;CHAN WING C;;SONG JOO;;COOK JAMES R,BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2020-05-22);;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2020-06-18);;OREGON HEALTH & SCIENCE UNIVERSITY (2020-07-10);;ROBERT BOSCH GESELLSCHAFT FUER MEDIZINISCHE FORSCHUNG MBH (2020-05-25);;JULIUS-MAXIMILIANS-UNIVERSITY OF WÜRZBURG (2020-05-28);;CITY OF HOPE (2020-06-18);;INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER (IDIBAPS) (2020-06-05);;HOSPITAL CLINIC DE BARCELONA (2020-06-05);;OSLO UNIVERSITY HOSPITAL HF (2020-06-19);;THE CLEVELAND CLINIC FOUNDATION (2020-07-14);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2020-07-14);;MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (2020-06-15);;UNIVERSITAT DE BARCELONA (2020-06-05),https://lens.org/118-176-185-785-527,Granted Patent,yes,9,0,6,6,58,C12Q1/6886;;C12Q2600/112;;C12Q2600/158;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/112;;C12Q2600/158,G01N33/48;;C12Q1/6886;;G16B5/00;;G16B25/10,,19,16,040-694-135-115-041;;000-127-456-789-192;;024-527-436-840-118;;037-047-957-053-389;;014-557-082-098-140;;126-705-824-845-073;;076-494-546-067-072;;016-315-892-068-657;;035-839-847-512-823;;089-821-514-441-856;;001-476-207-579-575;;035-255-900-380-462;;001-018-672-231-808;;135-267-805-607-167;;009-549-896-452-232;;026-589-581-583-417,10.1038/35000501;;10676951;;23574119;;10.1056/nejmoa1214561;;pmc4568999;;10.1038/nbt0308-293;;18327237;;10.1038/nbt1385;;18278033;;pmc9103713;;10.1056/nejmoa0802885;;19038878;;31292115;;10.1182/blood.2019001126;;pmc6265647;;10.1182/blood-2018-05-851154;;30257882;;10.1002/hon.2437_46;;10.1158/1078-0432.ccr-10-2573;;pmc3107869;;21364035;;10.1182/blood.2019002493;;31488455;;10.1084/jem.20031074;;12975453;;pmc2194208;;12075054;;10.1056/nejmoa012914;;pmc3931191;;10.1182/blood-2013-11-536433;;24398326;;pmc4554747;;10.3410/f.725696264.793521331;;10.1200/jco.2014.60.2383;;26240231;;10.1158/1078-0432.ccr-14-0357;;25301847;;12900505;;10.1073/pnas.1732008100;;pmc187912,"Alizadeh et al., “Distinct Types of Diffuse Large B-cell Lymphoma Identified by Gene Expression Profiing,” Nature 403: 503-511 (2000).;;Dunleavy et al., “Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma,” N Engl J Med. 368(15): 1408-1416 (2003), “Author Manuscript” as published in PubMed, with Supplementary Appendix.;;European Patent Office, Written Opinion of the International Searching Authority, European Patent Office PCT/US2018/036084, dated Sep. 11, 2018, 10 pages.;;European Patent Office, International Search Report, European Patent Office PCT/US2018/036084, dated Sep. 11, 2018, 8 pages.;;Fortina et al., “Digital mRNA Profiling,” Nature Biotechnology, 26(3): 293-294 (Mar. 2008).;;Geiss et al., “Direct Multiplexed Measurement of Gene Expression with Color-coded Probe Pairs,” Nature Biotechnology 26(3): 317-325 (Mar. 2008).;;International Bureau of WIPO, International Preliminary Report on Patentability, PCT/US2018/036084 dated Dec. 26, 2019, 9 pages.;;Lenz et al., “Stromal Gene Signatures in Large-Cell Lymphomas,” N Engl J Med. 359(22): 2313-2323 (Nov. 27, 2008).;;Mottok et al., “Integrative Genomic Analysis Identifies Key Pathogenic Mechanisms in Primary Mediastinal Large B-cell Lymphoma,” Blood 134(10): 802-813 (ePub Jul. 10, 2019).;;Mottok et al., “Molecular Classification of Primary Mediastinal Large B-cell Lymphoma Using Routinely Available Tissue Specimens,” Blood 134(10): 2401-2405 (Nov. 29, 2018) published online Sep. 26, 2018.;;Mottok et al., “Molecular Classification of Primary Mediastinal Large B-cell Lymphoma Using Formalin-fixed, Paraffin-embedded Tissue Specimens—An LLMPP Project,” Abstract 47, Hematol Oncol, 35: 59-60 (Jun. 7, 2017).;;Rimsza et al., “Accurate Classification of Diffuse Large B Cell Lymphoma into Germinal Center and Activated B Cell Subtypes Using a Nuclease Protection Assay on Formalin Fixed Paraffin Embedded Tissues,” Clin Cancer Res 17(11): 3727-3732 (Jun. 1, 2011) “Author Manuscript” as published in PubMed.;;Rimsza, “PMBL: Flying Under the Immune Radar,” Blood 134(10): 788-789 (Sep. 5, 2019).;;Rosenwald et al., “Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma,” J Experimental Medicine 198(6): 851-862 (Sep. 15, 2003).;;Rosenwald et al., “The Use of Molecular Profiling to Predict Survival After Chemotherapy for Diffuse Large B-Cell Lymphoma,” New England of Journal of Medicine, 346(25): 1937-1947 (Jun. 20, 2002).;;Scott et al., “Determining Cell-of-Origin Subtypes of Diffuse Large B-cell Lymphoma Using Gene Expression in Formalin-fixed Paraffin-embedded Tissue,” Blood, 123(8): 1214-1217 (Feb. 20, 2014).;;Scott et al., “Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies,” Journal of Clinical Oncology 33(26): 2848-2856 (Sep. 10, 2015).;;Veldman-Jones et al., “Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter System,” Clinical Cancer Research, 21(10): 2367-2378 (2015) epublished Oct. 9, 2014.;;Wright et al., “A Gene Expression-based Method to Diagnose Clinically Distinct Subgroups of Diffuse Large B Cell Lymphoma,” PNAS 100(17): 9991-9996 (Aug. 19, 2003).",ACTIVE
624,WO,A1,WO 2018/231589 A1,190-491-397-066-832,2018-12-20,2018,US 2018/0036084 W,2018-06-05,US 201762519728 P,2017-06-14,METHOD FOR DETERMINING LYMPHOMA TYPE,"In embodiments of the invention, the invention provides a method for distinguishing between lymphoma types based on gene expression measurements. In embodiments, the invention distinguishes between PMBCL and DLBCL based on gene expression signatures, and can further distinguish between DLBCL subtypes.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;MAYO FOUND MEDICAL EDUCATION & RES;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;UNIV NEBRASKA;;OSLO UNIV HOSPITAL HF;;UNIV HEALTH NETWORK;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;INST DINVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER IDIBAPS;;ROBERT BOSCH HEALTHCARE SYSTEMS INC;;UNIV OREGON HEALTH & SCIENCE;;HOPE CITY;;CLEVELAND CLINIC FOUND;;STAUDT LOUIS M;;STEIDL CHRISTIAN;;MOTTOK ANJA;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;RIMSZA LISA M;;ROSENWALD ANDREAS;;GASCOYNE RANDY;;GREINER TIMOTHY;;WEISENBURGER DENNIS;;SMELAND ERLEND B;;DELABIE JAN;;CAMPO GUERRI ELIAS;;OTT GERMAN;;BRAZIEL RITA;;JAFFE ELAINE S;;FU KAI;;CHAN WING C;;SONG JOO;;COOK JAMES R,STAUDT LOUIS M;;STEIDL CHRISTIAN;;MOTTOK ANJA;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;RIMSZA LISA M;;ROSENWALD ANDREAS;;GASCOYNE RANDY;;GREINER TIMOTHY;;WEISENBURGER DENNIS;;SMELAND ERLEND B;;DELABIE JAN;;CAMPO GUERRI ELIAS;;OTT GERMAN;;BRAZIEL RITA;;JAFFE ELAINE S;;FU KAI;;CHAN WING C;;SONG JOO;;COOK JAMES R,,https://lens.org/190-491-397-066-832,Patent Application,yes,44,0,6,6,58,C12Q1/6886;;C12Q2600/112;;C12Q2600/158;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/112;;C12Q2600/158,C12Q1/6886,,45,43,016-315-892-068-657;;001-018-672-231-808;;001-476-207-579-575;;014-557-082-098-140;;009-549-896-452-232;;005-952-510-626-477;;093-992-351-106-367;;000-705-324-102-258;;160-631-360-016-499;;046-044-728-292-565;;051-346-920-381-327;;083-926-915-990-672;;014-065-259-226-128;;071-699-049-017-661;;041-085-398-221-48X;;081-376-983-952-92X;;023-425-205-244-323;;053-141-431-021-519;;085-467-264-451-562;;079-336-969-276-20X;;031-538-684-093-737;;003-117-956-540-879;;043-885-019-636-545;;078-147-429-983-57X;;012-855-494-804-729;;068-614-447-896-338;;046-635-580-964-007;;001-018-672-231-808;;135-267-805-607-167;;012-379-833-792-853;;134-527-041-082-111;;001-476-207-579-575;;061-990-723-525-723;;115-496-463-132-125;;037-047-957-053-389;;047-322-007-088-891;;035-255-900-380-462;;014-557-082-098-140;;003-192-760-764-15X;;001-018-672-231-808;;014-557-082-098-140;;040-694-135-115-041;;135-267-805-607-167,10.1002/hon.2437_46;;pmc3931191;;10.1182/blood-2013-11-536433;;24398326;;10.1084/jem.20031074;;12975453;;pmc2194208;;pmc9103713;;10.1056/nejmoa0802885;;19038878;;10.1158/1078-0432.ccr-14-0357;;25301847;;10.1158/1055-9965.epi-10-0091;;20332269;;pmc2864144;;1380482;;10.1016/0888-7543(92)90014-j;;7514785;;10.1093/nar/22.8.1368;;pmc307992;;8895530;;8828038;;10.1101/gr.6.6.492;;10.1126/science.270.5235.467;;7569999;;10.1038/ng1296-457;;8944026;;8855227;;pmc38202;;10.1073/pnas.93.20.10614;;8796352;;10.1101/gr.6.7.639;;10.1126/science.278.5338.680;;9381177;;pmc20056;;9122163;;10.1073/pnas.94.6.2150;;pmc24262;;9371799;;10.1073/pnas.94.24.13057;;8197176;;10.1073/pnas.91.11.5022;;pmc43922;;7495558;;10.1126/science.274.5287.610;;8849452;;10.1038/nbt1296-1675;;9634850;;9415887;;10.1038/nbt1297-1359;;10.1126/science.270.5235.484;;7570003;;14676315;;pmc307634;;10.1073/pnas.2536670100;;10.1186/bcr2189;;18954444;;pmc2614499;;10.1038/nmeth.1226;;18516045;;10.1200/jco.2012.43.4589;;pmc3574267;;23182984;;pmc3931191;;10.1182/blood-2013-11-536433;;24398326;;pmc4554747;;10.3410/f.725696264.793521331;;10.1200/jco.2014.60.2383;;26240231;;pmc4626253;;26307535;;10.1182/blood-2015-06-649905;;28291392;;pmc5455765;;10.1200/jco.2016.70.7901;;10.1084/jem.20031074;;12975453;;pmc2194208;;10.1182/blood-2003-06-1841;;12933571;;10.1002/0471142727.mb25b10s94;;10.1038/nbt1385;;18278033;;11567628;;10.1016/s1074-7613(01)00194-7;;12075054;;10.1056/nejmoa012914;;pmc9103713;;10.1056/nejmoa0802885;;19038878;;10.1182/blood-2014-04-570937;;pmc4224196;;25150293;;pmc3931191;;10.1182/blood-2013-11-536433;;24398326;;pmc9103713;;10.1056/nejmoa0802885;;19038878;;10.1038/35000501;;10676951;;pmc4554747;;10.3410/f.725696264.793521331;;10.1200/jco.2014.60.2383;;26240231,"A. MOTTOK ET AL: ""MOLECULAR CLASSIFICATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA USING FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUE SPECIMENS - AN LLMPP PROJECT"", HEMATOLOGICAL ONCOLOGY, vol. 35, 7 June 2017 (2017-06-07), US, pages 59 - 60, XP055495961, ISSN: 0278-0232, DOI: 10.1002/hon.2437_46;;D. W. SCOTT ET AL: ""Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue"", BLOOD, vol. 123, no. 8, 20 February 2014 (2014-02-20), US, pages 1214 - 1217, XP055495536, ISSN: 0006-4971, DOI: 10.1182/blood-2013-11-536433;;ROSENWALD A ET AL: ""Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma"", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 198, no. 6, 15 September 2003 (2003-09-15), pages 851 - 862, XP002396795, ISSN: 0022-1007, DOI: 10.1084/JEM.20031074;;LENZ G ET AL: ""Stromal gene signatures in large-B-cell lymphomas"", NEW ENGLAND JOURNAL OF MEDICINE, THE - NEJM, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 359, no. 22, 27 November 2008 (2008-11-27), pages 2313 - 2323, XP002551776, ISSN: 1533-4406, DOI: 10.1056/NEJMOA0802885;;M. H. VELDMAN-JONES ET AL: ""Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter System"", CLINICAL CANCER RESEARCH, vol. 21, no. 10, 9 October 2014 (2014-10-09), US, pages 2367 - 2378, XP055495781, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-14-0357;;""Histological and Histochemical Methods: Theory and Practice"", 2008, COLD SPRING HARBOR LABORATORY PRESS;;HUANG ET AL., CANCER EPIDEMIOL BIOMARKERS PREV., vol. 19, 2010, pages 973 - 977;;SOUTHERN ET AL., GENOMICS, vol. 13, 1992, pages 1008 - 1017;;SOUTHERN ET AL., NUCL. ACIDS. RES., vol. 22, 1994, pages 1368 - 1373;;GRESS ET AL., ONCOGENE, vol. 13, 1996, pages 1819 - 1830;;PIETU ET AL., GENOME RES., vol. 6, 1996, pages 492 - 503;;SCHENA ET AL., SCIENCE, vol. 270, 1995, pages 467 - 470;;DERISI ET AL., NAT. GENET., vol. 14, 1996, pages 457 - 460;;SCHENA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 10614 - 10619;;SHALON ET AL., GENOME RES., vol. 6, 1996, pages 639 - 645;;DERISI ET AL., SCIENCE, vol. 278, 1997, pages 680 - 686;;HELLER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 2150 - 2155;;LASHKARI ET AL., PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 13057 - 13062;;PEASE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 5022 - 5026;;LIPSHUTZ ET AL., BIOTECHNIQUES, vol. 19, 1995, pages 442 - 447;;CHEE ET AL., SCIENCE, vol. 274, 1996, pages 610 - 14;;LOCKHART ET AL., NAT. BIOTECHNOL., vol. 14, 1996, pages 1675 - 1680;;WODICKA ET AL., NAT. BIOTECHNOL., vol. 15, 1997, pages 1359 - 1367;;VELCULESCU ET AL., SCIENCE, vol. 270, no. 5235, 1995, pages 484 - 487;;MATSUMURA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 100, no. 26, 2003, pages 15718 - 15723;;CAO ET AL., BREAST CANCER RESEARCH, vol. 10, 2008, pages R91;;MORTAZAVI ET AL., NAT METHODS, vol. 5, no. 7, 2008, pages 621 - 628;;SCOTT ET AL., J. CLIN. ONCOL., vol. 31, no. 6, 2013, pages 692 - 700;;SCOTT ET AL., BLOOD, vol. 123, no. 8, 2014, pages 1214 - 1217;;SCOTT; MOTTOK ET AL., J. CLIN. ONCOL., vol. 33, no. 26, 2015, pages 2848 - 2856;;KRIDEL; MOTTOK ET AL., BLOOD, vol. 126, no. 18, 2015, pages 21118 - 2127;;SCOTT; ABRISQUETA ET AL., J. CLIN. ONCOL., vol. 35, no. 15, pages 1668 - 1677;;ROSENWALD ET AL., J. EXPER. MED., vol. 198, no. 6, 2003, pages 851 - 862;;SAVAGE ET AL., BLOOD, vol. 102, no. 12, 2003, pages 3871 - 3879;;KULKARNI, M. M.: ""Digital Multiplexed Gene Expression Analysis Using the NanoString Technologies nCounter ° System"", CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, vol. 94, 2011;;GEISS ET AL., NATURE BIOTECHNOLOGY, vol. 26, 2008, pages 317 - 325;;SHAFFER ET AL., IMMUNITY, vol. 15, 2001, pages 375 - 385;;ROSENWALD ET AL., NEW ENGL. J. MED., vol. 346, 2002, pages 1937 - 1947;;LENZ ET AL., N. ENGL. J. MED., vol. 359, 2008, pages 2313 - 2323;;SCOTT ET AL., BLOOD, vol. 124, 2014, pages 3016 - 3019;;SCOTT ET AL., BLOOD, vol. 123, 2014, pages 1214 - 1217;;ROSENWALD ET AL., J. EXP. MED., vol. 198, 2003, pages 851 - 861;;LENZ ET AL., N. ENG. J. MED., vol. 359, 2008, pages 2313 - 2323;;ALIZADEH ET AL., NATURE, vol. 403, 2000, pages 503 - 511;;SCOTT ET AL., J. CLIN. ONCOL., vol. 33, 2015, pages 2848 - 2856",PENDING
625,BR,A2,BR 102019002844 A2,180-021-791-432-766,2020-09-29,2020,BR 102019002844 A,2019-02-12,BR 102019002844 A,2019-02-12,órtese ortopédica para animais diabéticos,"trata-se de um modelo de órtese ortopédica para um modelo de roedores diabéticos submetidos ao treinamento de corrida desenvolvida para aplicação laboratorial e confeccionada com quatro tipos diferentes de materiais comerciais: podadur, borracha de silicone, etileno acetato de vinila (eva) e o látex pré-vulcanizado (hevea brasiliensis). as referidas órteses apresentam as seguintes dimensões (3,5 x 1,0 cm) com textura homogênea, superfície plana e lisa, resistente à deformação e flexível ao manuseio e movimentação com formato similar a pata do animal abrangendo o calcâneo até as falanges distais incluindo o formato do arco longitudinal. as principais vantagens da órtese inclui o amortecimento durante o impacto da pisada, distribuir melhor as pressões impostas pelas patas dos animais, absorver a umidade, serem flexíveis e duráveis proporcionando maior conforto e evitando possíveis ulcerações oriundas de complicações do diabetes.",FUNDACAO UNIV ESTADUAL DO CEARA FUNECE,ANTONIO NADSON MODESTO FILHO;;CARLA ANDRESSA ANDRADE DOS SANTOS;;CASSIANO OLIVEIRA MOREIRA;;FRANCISCO FLEURY UCHOA SANTOS JÚNIOR;;JEFFERSON PACHECO AMARAL FORTES;;JONATHAN ELIAS RODRIGUES MARTINS;;JOSÉ WILLIAM GIRÃO DIAS;;KARLA CAMILA LIMA DE SOUZA;;NATHÁLIA MARIA RODRIGUES DE ANDRADE;;PEDRO CUNHA LOPES;;VÂNIA MARILANDE CECCATTO;;YARA CARLIANE DE ABREU MESQUITA,,https://lens.org/180-021-791-432-766,Patent Application,no,0,0,1,1,0,,A61D9/00;;A01K13/00;;A61F5/01,,0,0,,,,PENDING
626,WO,A1,WO 2021/236946 A1,186-380-904-118-398,2021-11-25,2021,US 2021/0033438 W,2021-05-20,US 202063028289 P,2020-05-21,WINCH SYSTEMS FOR CHILD CONTAINMENT DEVICES,"A winch reel system is provided for use in child containment devices. The winch reel systems can include a one-way winch reel, a two-way winch reel, a multi-cord winch reel, and/or a drawstring winch reel. The winch reel systems can be included in various child containment devices, including strollers, infant rockers, children's car seats, playards, infant swings, baby carriers, bouncers, jumpers, high chairs, play mats, baby gates, children's booster seats, and/or other types of infant carrier or containment systems and devices. Each winch reel system can include one or more wires that are engaged with a winch reel in order to adjust at least one feature of a child containment device. In other embodiments, the one or more wires can be replaced with one or more lines, cables, or straps. In some embodiments, each winch reel system can include at least one toothed pawl to engage the winch reel.",GRACO CHILDRENS PRODUCTS INC,BACHNER JOHN DAVID;;CROSS BRANDON SETH;;HOTARD DAVID THOMAS;;WOLF MELISSA ANN;;KITCHENS ANDREW PHILLIP;;CONWAY WILLIAM ELIAS;;BURKHOLDER BRANDON MICHAEL;;HU GUOZHEN;;SHIBATA YUJI;;SAVILLE DEREK DUANE;;HEWSON KARL;;STEARN THOMAS;;WILKINSON CLAIRE GEORGINA RADHA;;HOGAN CLODAGH;;WILSON NATASHA;;CRUNDWELL BEN;;WYNNE ANDREW;;CAMPBELL NEIL LESTER;;HOPKINSON PAUL EDWARD;;DEVINE CONOR MARK,,https://lens.org/186-380-904-118-398,Patent Application,yes,7,0,4,4,0,B62B9/12;;B62B2206/003;;B60N2/26;;B62B9/104;;B62B9/12;;B62B9/245;;B62B2206/003,B62B9/12,,0,0,,,,PENDING
627,AU,B2,AU 2014/346788 B2,104-524-004-403-842,2020-09-24,2020,AU 2014/346788 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,Method for subtyping lymphoma types by means of expression profiling,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNVIERSITY OF ARIZONA;;UNIV NEBRASKA;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;CLEVELAND CLINIC;;HOSPITAL CLINIC BARCELONA;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;UNIV OREGON HEALTH & SCIENCE;;OSLO UNIV HOSPITAL HF;;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY;;UNIV BARCELONA,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;FU KAI;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS,,https://lens.org/104-524-004-403-842,Granted Patent,no,1,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,2,2,101-841-825-225-801;;026-589-581-583-417,19455257;;pmc2675856;;10.1177/117693510700300004;;12900505;;10.1073/pnas.1732008100;;pmc187912,"S Blenk ET AL, ""Cancer Informatics 2007:3 399-420: Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival"", (2007-12-12), URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675856/pdf/cin-03-399.pdf, (2015-02-24);;WRIGHT G ET AL, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (2003-08-19), vol. 100, no. 17, doi:10.1073/PNAS.1732008100, ISSN 0027-8424, pages 9991 - 9996",ACTIVE
628,AU,A1,AU 2014/346788 A1,127-102-256-431-887,2016-05-26,2016,AU 2014/346788 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,Method for subtyping lymphoma types by means expression profiling,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",UNIV OREGON HEALTH & SCIENCE;;OSLO UNIVERSITY HOSPITAL HF;;CLEVELAND CLINIC;;UNIV NEBRASKA;;BRITISH COLUMBIA CANCER AGENCY;;US HEALTH;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;UNIV ARIZONA STATE;;JULIUS MAXIMILIANS UNIVERSITY OF WUERZBURG,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS,,https://lens.org/127-102-256-431-887,Patent Application,no,0,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,0,0,,,,ACTIVE
629,AU,A8,AU 2014/346788 A8,079-228-541-636-261,2016-06-16,2016,AU 2014/346788 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,Method for subtyping lymphoma types by means of expression profiling,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNVIERSITY OF ARIZONA;;UNIV NEBRASKA;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;CLEVELAND CLINIC;;HOSPITAL CLINIC BARCELONA;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;UNIV OREGON HEALTH & SCIENCE;;OSLO UNIV HOSPITAL HF;;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY;;UNIV BARCELONA,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS,,https://lens.org/079-228-541-636-261,Patent Application,no,1,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,2,2,101-841-825-225-801;;026-589-581-583-417,19455257;;pmc2675856;;10.1177/117693510700300004;;12900505;;10.1073/pnas.1732008100;;pmc187912,"S Blenk ET AL, ""Cancer Informatics 2007:3 399-420: Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival"", (2007-12-12), URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675856/pdf/cin-03-399.pdf, (2015-02-24);;WRIGHT G ET AL, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (2003-08-19), vol. 100, no. 17, doi:10.1073/PNAS.1732008100, ISSN 0027-8424, pages 9991 - 9996",ACTIVE
630,AU,B8,AU 2014/346788 B8,085-727-661-637-916,2021-01-28,2021,AU 2014/346788 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,Method for subtyping lymphoma types by means of expression profiling,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNVIERSITY OF ARIZONA;;UNIV NEBRASKA;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;CLEVELAND CLINIC;;HOSPITAL CLINIC BARCELONA;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;UNIV OREGON HEALTH & SCIENCE;;OSLO UNIV HOSPITAL HF;;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY;;UNIV BARCELONA,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;TUBBS RAYMOND;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS,,https://lens.org/085-727-661-637-916,Amended Patent,no,1,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,2,2,101-841-825-225-801;;026-589-581-583-417,19455257;;pmc2675856;;10.1177/117693510700300004;;12900505;;10.1073/pnas.1732008100;;pmc187912,"S Blenk ET AL, ""Cancer Informatics 2007:3 399-420: Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival"", (2007-12-12), URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675856/pdf/cin-03-399.pdf, (2015-02-24);;WRIGHT G ET AL, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (2003-08-19), vol. 100, no. 17, doi:10.1073/PNAS.1732008100, ISSN 0027-8424, pages 9991 - 9996",ACTIVE
631,JP,A,JP 2020078323 A,153-028-985-328-062,2020-05-28,2020,JP 2020018323 A,2020-02-05,US 201361900553 P,2013-11-06,METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING,"To provide methods for identifying and classifying lymphomas based on their molecular characteristics to qualify patients for clinical trials that use targeted agents.SOLUTION: The invention discloses a method for selecting the treatment for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject, by analyzing digital gene expression data obtained from a biopsy sample and the like.SELECTED DRAWING: None",US GOVERNMENT;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;UNIV ARIZONA STATE;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC FOUND;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;OSLO UNIV HOSPITAL HF,LOUIS M STAUDT;;GEORGE W WRIGHT;;DAVID WILLIAM SCOTT;;JOSEPH M CONNORS;;RANDY D GASCOYNE;;LISA RIMSZA;;ELIAS CAMPO GUERRI;;RAYMOND TUBBS;;TIMOTHY C GREINER;;JAMES ROBERT COOK;;FU KAI;;PAUL MICHAEL WILLIAMS;;LIH CHIH-JIAN;;ELAINE S JAFFE;;RITA M BRAZIEL;;ANDREAS ROSENWALD;;ERLEND B SMELAND;;WING C CHAN;;GERMAN OTT;;JAN DELABIE;;DENNIS WEISENBURGER,,https://lens.org/153-028-985-328-062,Patent Application,no,7,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/6816;;C12Q1/6837;;G16B25/10;;G16B5/00,,2,0,,,"PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. VOL:100, NR:17, JPN5016011262, 19 August 2003 (2003-08-19), pages 9991 - 9996, ISSN: 0004488332;;CANCER INFORMATICS, vol. V3, JPN5016011261, 12 December 2007 (2007-12-12), pages 399 - 420, ISSN: 0004488333",ACTIVE
632,CA,A1,CA 2929826 A1,185-692-606-989-458,2015-05-14,2015,CA 2929826 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,METHOD FOR SELECTING AND TREATING LYMPHOMA TYPES,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;UNIV ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS-MAXIMILIANS-UNIVERSITY OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;GREINER TIMOTHY C;;TUBBS RAYMOND,,https://lens.org/185-692-606-989-458,Patent Application,no,0,0,27,27,2460,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,0,0,,,,PENDING
633,EP,B1,EP 3066215 B1,012-784-064-884-081,2019-04-24,2019,EP 14803288 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING,,US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;ARIZONA BOARD OF REGENTS ON BEHALF OF UNIV OF ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;TUBBS RAYMOND,"BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2018-07-25);;CLEVELAND CLINIC (2018-07-25);;OREGON HEALTH & SCIENCE UNIVERSITY (2018-07-25);;THE UNITED STATES OF AMERICA, REPRESENTED BY THE S (2018-07-25);;HOSPITAL CLINIC DE BARCELONA (2018-07-25);;OSLO UNIVERSITY HOSPITAL HF (2018-07-25);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2018-07-25);;JULIUS-MAXIMILIANS-UNIVERSITY OF WUERZBURG (2018-07-25);;UNIVERSITAT DE BARCELONA (2018-07-25);;ARIZONA BOARD OF REGENTS ON BEHALF OF UNIVERSITY O (2018-07-25)",https://lens.org/012-784-064-884-081,Granted Patent,yes,5,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,6,0,,,"S Blenk ET AL: ""Cancer Informatics 2007:3 399-420 Germinal Center B Cell-Like (GCB) and Activated B Cell-Like (ABC) Type of Diffuse Large B Cell Lymphoma (DLBCL): Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival"", , 12 December 2007 (2007-12-12), XP055171680, Retrieved from the Internet: URL:http://www.ncbi.nlm.nih.gov/pmc/articl es/PMC2675856/pdf/cin-03-399.pdf [retrieved on 2015-02-24];;WRIGHT G ET AL: ""A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 100, no. 17, 19 August 2003 (2003-08-19), pages 9991-9996, XP002322638, ISSN: 0027-8424, DOI: 10.1073/PNAS.1732008100;;LING-HUA ZHANG ET AL: ""Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression"", BRITISH JOURNAL OF HAEMATOLOGY, vol. 160, no. 4, 18 December 2012 (2012-12-18), pages 487-502, XP055171665, ISSN: 0007-1048, DOI: 10.1111/bjh.12172;;L BRAULT ET AL: ""PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma"", BRITISH JOURNAL OF CANCER, vol. 107, no. 3, 21 June 2012 (2012-06-21) , pages 491-500, XP055171664, ISSN: 0007-0920, DOI: 10.1038/bjc.2012.272;;S. J. DEEB ET AL: ""Super-SILAC Allows Classification of Diffuse Large B-cell Lymphoma Subtypes by Their Protein Expression Profiles"", MOLECULAR & CELLULAR PROTEOMICS, vol. 11, no. 5, 21 March 2012 (2012-03-21) , pages 77-89, XP055171662, ISSN: 1535-9476, DOI: 10.1074/mcp.M111.015362;;GU XIA ET AL: ""[Analysis of survivin expression in subtypes of lymphoma]."", AI ZHENG = AIZHENG = CHINESE JOURNAL OF CANCER JUN 2004, vol. 23, no. 6, June 2004 (2004-06), pages 655-661, XP055171538,",ACTIVE
634,WO,A1,WO 2020/245710 A1,172-498-734-192-143,2020-12-10,2020,IB 2020055092 W,2020-05-28,US 201962857045 P,2019-06-04,METHODS AND SYSTEMS OF PATH-BASED MAPPING AND ROUTING,"Systems and methods of path-based mapping and routing are provided. Translation information and absolute orientation information of mobile objects in environments are determined based on a fusion of sensing data from a radar and an inertial measurement unit (IMU) including a gyroscope and an accelerometer, from which path-based maps and optimal routes can be generated.",3M INNOVATIVE PROPERTIES CO,SINGH GAUTAM;;KRUSE JOHN M;;JESME RONALD D;;KELLIHER WILLIAM J;;ODOM JACOB E;;NYLAND ADAM C;;GABRIEL NICHOLAS T;;AVELDSON JASON L;;HAGH-SHENAS HALEH;;HERFORT FRANK T;;GJERE MICHAEL L;;KAUR RACHNEET;;WILKEN-RESMAN ELIAS;;LEE JAE YONG;;ADDLEMAN DOUGLAS A;;CASNER GLENN E;;CARLSON JAMES D;;TUNGJUNYATHAM JUSTIN;;BATTLE KARL;;LUCHT STEVEN G,,https://lens.org/172-498-734-192-143,Patent Application,yes,3,0,5,5,0,G01C21/1652;;G01C21/206;;G01S13/86;;G01S13/876;;G01S13/723;;G01S13/89;;G01S13/426;;G01C21/206;;G01C21/1652;;G01S13/86;;G01S13/89;;G01S13/876;;G01S13/723;;G01S13/426;;G01C21/1652;;G01C21/206;;G01S13/426;;G01S13/867;;G01S13/89,G01C21/16;;G01C21/20;;G01S13/86,,1,0,,,"MCCROSKEY R ET AL: ""GLANSER - An Emergency Responder Locator System for Indoor and GPS-Denied Applica"", GNSS 2010 - PROCEEDINGS OF THE 23RD INTERNATIONAL TECHNICAL MEETING OF THE SATELLITE DIVISION OF THE INSTITUTE OF NAVIGATION (ION GNSS 2010), THE INSTITUTE OF NAVIGATION, 8551 RIXLEW LANE SUITE 360 MANASSAS, VA 20109, USA, 24 September 2010 (2010-09-24), pages 2901 - 2909, XP056000394",PENDING
635,WO,A9,WO 2015/069790 A9,040-359-114-060-741,2016-06-02,2016,US 2014/0064161 W,2014-11-05,US 201361900553 P,2013-11-06,METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY;;UNIV ARIZONA STATE;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIVERSITY OF WUERZBURG;;OSLO UNIVERSITY HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;TUBBS RAYMOND,,https://lens.org/040-359-114-060-741,Search Report,yes,0,1,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,0,0,,,,PENDING
636,AU,A8,AU 2014/346788 A8,094-106-245-864-399,2021-01-21,2021,AU 2014/346788 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,Method for subtyping lymphoma types by means of expression profiling,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",UNIV OREGON HEALTH & SCIENCE;;OSLO UNIV HOSPITAL HF;;CLEVELAND CLINIC;;UNIV NEBRASKA;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNVIERSITY OF ARIZONA;;JULIUS MAXIMILIANS UNIV OF WUERZBURG,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;TUBBS RAYMOND;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS,,https://lens.org/094-106-245-864-399,Patent Application,no,0,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68,,0,0,,,,ACTIVE
637,WO,A1,WO 2015/069790 A1,075-621-776-233-315,2015-05-14,2015,US 2014/0064161 W,2014-11-05,US 201361900553 P,2013-11-06,METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS EXPRESSION PROFILING,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY;;UNIV ARIZONA STATE;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIVERSITY OF WUERZBURG;;OSLO UNIVERSITY HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;TUBBS RAYMOND,,https://lens.org/075-621-776-233-315,Patent Application,yes,5,24,27,27,2460,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,6,6,101-841-825-225-801;;026-589-581-583-417;;008-161-966-545-470;;080-261-677-082-739;;005-967-436-046-627;;139-742-950-119-640,19455257;;pmc2675856;;10.1177/117693510700300004;;12900505;;10.1073/pnas.1732008100;;pmc187912;;23252516;;10.1111/bjh.12172;;10.1038/bjc.2012.272;;22722314;;pmc3405213;;pmc3418848;;22442255;;10.1074/mcp.m111.015362;;10.1007/s10330-004-0351-8,"S BLENK ET AL: ""Cancer Informatics 2007:3 399-420 Germinal Center B Cell-Like (GCB) and Activated B Cell-Like (ABC) Type of Diffuse Large B Cell Lymphoma (DLBCL): Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival"", 12 December 2007 (2007-12-12), XP055171680, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675856/pdf/cin-03-399.pdf> [retrieved on 20150224];;WRIGHT G ET AL: ""A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 100, no. 17, 19 August 2003 (2003-08-19), pages 9991 - 9996, XP002322638, ISSN: 0027-8424, DOI: 10.1073/PNAS.1732008100;;LING-HUA ZHANG ET AL: ""Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression"", BRITISH JOURNAL OF HAEMATOLOGY, vol. 160, no. 4, 18 December 2012 (2012-12-18), pages 487 - 502, XP055171665, ISSN: 0007-1048, DOI: 10.1111/bjh.12172;;L BRAULT ET AL: ""PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma"", BRITISH JOURNAL OF CANCER, vol. 107, no. 3, 21 June 2012 (2012-06-21), pages 491 - 500, XP055171664, ISSN: 0007-0920, DOI: 10.1038/bjc.2012.272;;S. J. DEEB ET AL: ""Super-SILAC Allows Classification of Diffuse Large B-cell Lymphoma Subtypes by Their Protein Expression Profiles"", MOLECULAR & CELLULAR PROTEOMICS, vol. 11, no. 5, 21 March 2012 (2012-03-21), pages 77 - 89, XP055171662, ISSN: 1535-9476, DOI: 10.1074/mcp.M111.015362;;GU XIA ET AL: ""[Analysis of survivin expression in subtypes of lymphoma]."", AI ZHENG = AIZHENG = CHINESE JOURNAL OF CANCER JUN 2004, vol. 23, no. 6, June 2004 (2004-06-01), pages 655 - 661, XP055171538",PENDING
638,EP,A1,EP 3066215 A1,119-275-787-390-856,2016-09-14,2016,EP 14803288 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING,,US HEALTH;;BRITISH COLUMBIA CANCER AGENCY;;UNIV ARIZONA STATE;;UNIV BARCELONA;;HOSPITAL CLÍNIC DE BARCELONA;;CLEVELAND CLINIC;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIVERSITY OF WUERZBURG;;OSLO UNIVERSITY HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;TUBBS RAYMOND,"CLEVELAND CLINIC (2018-07-25);;BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2018-07-25);;OREGON HEALTH & SCIENCE UNIVERSITY (2018-07-25);;THE UNITED STATES OF AMERICA, REPRESENTED BY THE S (2018-07-25);;HOSPITAL CLINIC DE BARCELONA (2018-07-25);;OSLO UNIVERSITY HOSPITAL HF (2018-07-25);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2018-07-25);;JULIUS-MAXIMILIANS-UNIVERSITY OF WUERZBURG (2018-07-25);;UNIVERSITAT DE BARCELONA (2018-07-25);;ARIZONA BOARD OF REGENTS ON BEHALF OF UNIVERSITY O (2018-07-25)",https://lens.org/119-275-787-390-856,Patent Application,yes,0,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,0,0,,,,ACTIVE
639,ES,T3,ES 2923942 T3,033-651-481-396-970,2022-10-03,2022,ES 19170689 T,2014-11-05,US 201361900553 P,2013-11-06,Procedimiento para el subtipado de tipos de linfoma por medio de perfiles de expresión,"La invención está dirigida a métodos para seleccionar una opción de tratamiento para un sujeto con linfoma difuso de células B grandes similar a células B activadas (ABC DLBCL), un sujeto con linfoma difuso de células B grandes similar a células B del centro germinal (GCB DLBCL), un sujeto con linfoma primario de células B sujeto con linfoma de células B (PMBL), un sujeto con linfoma de Burkitt (BL) o un sujeto con linfoma de células del manto (MCL) analizando los datos de expresión génica digital obtenidos del sujeto, por ejemplo, de una muestra de biopsia. (Traducción automática con Google Translate, sin valor legal)",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;ARIZONA BOARD OF REGENTS ON BEHALF OF UNIV OF ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC FOUND;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;TUBBS RAYMOND,,https://lens.org/033-651-481-396-970,Granted Patent,no,0,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,0,0,,,,ACTIVE
640,EP,A1,EP 3980721 A1,062-465-330-405-596,2022-04-13,2022,EP 20731222 A,2020-05-28,US 201962857045 P;;IB 2020055092 W,2019-06-04,METHODS AND SYSTEMS OF PATH-BASED MAPPING AND ROUTING,,3M INNOVATIVE PROPERTIES CO,SINGH GAUTAM;;KRUSE JOHN M;;JESME RONALD D;;KELLIHER WILLIAM J JR;;ODOM JACOB E;;NYLAND ADAM C;;GABRIEL NICHOLAS T;;AVELDSON JASON L;;HAGH-SHENAS HALEH;;HERFORT FRANK T;;GJERE MICHAEL L;;KAUR RACHNEET;;WILKEN-RESMAN ELIAS;;LEE JAE YONG;;ADDLEMAN DOUGLAS A;;CASNER GLENN E;;CARLSON JAMES D;;TUNGJUNYATHAM JUSTIN;;BATTLE KARL;;LUCHT STEVEN G,,https://lens.org/062-465-330-405-596,Patent Application,yes,0,0,5,5,0,G01C21/1652;;G01C21/206;;G01S13/86;;G01S13/876;;G01S13/723;;G01S13/89;;G01S13/426;;G01C21/206;;G01C21/1652;;G01S13/86;;G01S13/89;;G01S13/876;;G01S13/723;;G01S13/426;;G01C21/1652;;G01C21/206;;G01S13/426;;G01S13/867;;G01S13/89,G01C21/16;;G01C21/20;;G01S13/86,,0,0,,,,PENDING
641,CA,C,CA 2929826 C,093-730-074-354-679,2022-08-16,2022,CA 2929826 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,METHOD FOR SELECTING AND TREATING LYMPHOMA TYPES,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g. from a biopsy sample, the digital gene expression data comprising data for a prescribed list of genes; calculating a predictor score from the digital gene expression data using an equation and a prescribed list of normalization weights; classifying the subject using the predictor score; and selecting a treatment option for the subject based on the classification.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;UNIV ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;GREINER TIMOTHY C;;TUBBS RAYMOND,,https://lens.org/093-730-074-354-679,Granted Patent,no,0,0,27,27,2460,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,G16B25/10;;C12Q1/6809;;G16B5/00;;G16B20/00,,0,0,,,,PENDING
642,US,A1,US 2019/0153539 A1,101-006-283-163-933,2019-05-23,2019,US 201716094965 A,2017-04-20,US 201716094965 A;;US 201662325213 P;;US 2017/0028628 W,2016-04-20,EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO,The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.,THE US SECRETARY DEP OF HEALTH AND HUMAN SERVICE;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;UNIV OREGON HEALTH & SCIENCE;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;OSLO UNIV HOSPITAL HF;;UNIV NEBRASKA;;CLEVELAND CLINIC FOUND;;MAYO FOUND MEDICAL EDUCATION & RES,STAUDT LOUIS M;;SCOTT DAVID WILLIAM;;WRIGHT GEORGE W;;ROSENWALD ANDREAS;;ABRISQUETA PAU;;BRAZIEL RITA;;CAMPO GUERRI ELIAS;;CHAN WING C;;CONNORS JOSEPH M;;DELABIE JAN;;VILLA DIEGO;;FU KAI;;GASCOYNE RANDY D;;GREINER TIMOTHY;;JAFFE ELAINE S;;JARES PEDRO;;MOTTOK ANJA;;OTT GERMAN;;RIMSZA LISA M;;SLACK GRAHAM;;WEISENBURGER DENNIS;;SMELAND ERLEND B;;COOK JAMES ROBERT,BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2019-01-18);;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2019-01-25);;OREGON HEALTH & SCIENCE UNIVERSITY (2019-01-23);;JULIUS-MAXIMILIANS-UNIVERSITY OF WÜRZBURG (2019-01-22);;HOSPITAL CLINIC DE BARCELONA (2019-01-21);;THE CLEVELAND CLINIC FOUNDATION (2019-01-22);;OSLO UNIVERSITY HOSPITAL HF (2019-03-27);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2018-01-03);;MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (2019-03-14);;UNIVERSITAT DE BARCELONA (2019-01-21),https://lens.org/101-006-283-163-933,Patent Application,yes,0,0,11,11,165,C12Q2600/106;;C12Q2600/118;;C12Q2600/158;;C12Q1/6886;;A61P35/00;;A61P35/02;;A61P7/00;;C12Q2600/118;;C12Q2600/158;;C12Q2600/106;;C12Q1/6886,C12Q1/6886,,0,0,,,,ACTIVE
643,US,B2,US 11725248 B2,038-583-318-174-77X,2023-08-15,2023,US 201716094965 A,2017-04-20,US 201716094965 A;;US 201662325213 P;;US 2017/0028628 W,2016-04-20,Evaluation of mantle cell lymphoma and methods related thereto,The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.,US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;JULIUS MAXIMILIANS—UNIVERSITY OF WUERZBURG;;UNIV OREGON HEALTH & SCIENCE;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;OSLO UNIV HOSPITAL HF;;UNIV NEBRASKA;;CLEVELAND CLINIC FOUND;;MAYO FOUND MEDICAL EDUCATION & RES;;JULIUS MAXIMILIANS UNIV OF WUERZBURG,STAUDT LOUIS M;;SCOTT DAVID WILLIAM;;WRIGHT GEORGE W;;ROSENWALD ANDREAS;;ABRISQUETA PAU;;BRAZIEL RITA;;CAMPO GUERRI ELIAS;;CHAN WING C;;CONNORS JOSEPH M;;DELABIE JAN;;VILLA DIEGO;;FU KAI;;GASCOYNE RANDY D;;GREINER TIMOTHY;;JAFFE ELAINE S;;JARES PEDRO;;MOTTOK ANJA;;OTT GERMAN;;RIMSZA LISA M;;SLACK GRAHAM;;WEISENBURGER DENNIS;;SMELAND ERLEND B;;COOK JAMES ROBERT,BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2019-01-18);;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2019-01-25);;OREGON HEALTH & SCIENCE UNIVERSITY (2019-01-23);;JULIUS-MAXIMILIANS-UNIVERSITY OF WÜRZBURG (2019-01-22);;HOSPITAL CLINIC DE BARCELONA (2019-01-21);;THE CLEVELAND CLINIC FOUNDATION (2019-01-22);;OSLO UNIVERSITY HOSPITAL HF (2019-03-27);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2018-01-03);;MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (2019-03-14);;UNIVERSITAT DE BARCELONA (2019-01-21),https://lens.org/038-583-318-174-77X,Granted Patent,yes,16,0,11,11,165,C12Q2600/106;;C12Q2600/118;;C12Q2600/158;;C12Q1/6886;;A61P35/00;;A61P35/02;;A61P7/00;;C12Q2600/118;;C12Q2600/158;;C12Q2600/106;;C12Q1/6886,C12Q1/6886,,72,66,038-019-739-715-928;;031-728-020-891-354;;001-878-227-881-642;;085-510-114-198-152;;040-694-135-115-041;;023-684-991-899-058;;074-137-886-505-202;;012-855-494-804-729;;017-380-251-267-055;;022-159-965-474-089;;037-836-837-269-988;;003-374-645-325-642;;012-102-630-702-772;;166-928-472-179-298;;033-971-166-966-681;;008-479-304-060-255;;017-055-508-520-150;;024-527-436-840-118;;037-076-313-885-430;;024-527-436-840-118;;054-277-353-896-06X;;166-832-177-257-760;;006-606-201-561-766;;104-557-009-702-690;;018-978-940-212-079;;055-111-537-100-00X;;059-431-894-450-428;;005-952-510-626-477;;131-905-544-919-039;;022-393-675-280-070;;014-997-943-354-61X;;037-914-332-518-855;;096-603-188-929-757;;037-474-607-752-557;;056-119-365-062-942;;056-491-763-273-738;;115-496-463-132-125;;114-138-749-753-22X;;178-935-842-768-083;;078-147-429-983-57X;;039-781-158-431-16X;;068-614-447-896-338;;024-463-910-146-183;;014-661-635-997-366;;048-325-804-402-273;;092-830-555-362-495;;055-691-371-341-340;;038-246-842-310-750;;004-162-318-388-875;;035-255-900-380-462;;015-395-832-493-244;;074-128-110-532-508;;018-364-083-825-391;;040-439-415-810-331;;027-657-011-129-499;;001-018-672-231-808;;087-051-173-456-513;;134-527-041-082-111;;047-322-007-088-891;;019-595-273-525-116;;111-837-502-058-915;;057-959-241-615-654;;046-330-045-125-124;;086-474-226-374-65X;;043-885-019-636-545;;026-589-581-583-417,10.1038/s41598-020-74996-9;;pmc7591483;;33110110;;22446084;;10.1016/j.jmoldx.2012.01.008;;10.1002/ajh.24094;;26103436;;19243299;;10.2217/14796694.5.1.63;;10.1038/35000501;;10676951;;10.1182/blood.v89.6.2067;;9058729;;10.1182/blood.v126.23.701.701;;10.1186/bcr2189;;18954444;;pmc2614499;;10.1200/jco.2015.63.5904;;26755518;;17327602;;10.1200/jco.2006.09.4490;;15229187;;10.1093/hmg/ddh195;;18077791;;10.1182/blood-2007-10-117010;;25320369;;10.1158/1078-0432.ccr-14-0836;;10.1038/leu.2014.171;;24854989;;18645603;;10.2174/138920207780833801;;pmc2435353;;10.1158/0008-5472.can-09-3419;;20124476;;10.1158/1078-0432.ccr-13-1845;;24520097;;10.1038/nbt0308-293;;18327237;;10.1111/j.1365-2141.2012.09174.x;;22640180;;10.1038/nbt0308-293;;18327237;;10.1200/jco.2007.12.0410;;18606985;;20421449;;pmc2924229;;10.1182/blood-2010-01-263806;;10.1016/j.acthis.2010.11.001;;21145576;;pmc4657859;;10.1182/blood.v98.3.787;;11468180;;17962512;;10.1182/blood-2007-06-095331;;24687837;;10.1200/jco.2013.52.2466;;26926679;;10.3410/f.726183219.793548359;;10.1200/jco.2015.63.8387;;10.1158/1055-9965.epi-10-0091;;20332269;;pmc2864144;;10.1093/annonc/mdf155;;12123339;;10.1016/j.beha.2009.05.001;;19698928;;10.1158/0008-5472.can-06-3597;;17363572;;10.1172/jci61272;;pmc3461905;;23023712;;17891190;;10.1038/nrc2230;;16597597;;10.1182/blood-2005-10-4079;;10.1200/jco.2006.08.7999;;17563396;;19669190;;10.1007/s12308-009-0036-x;;pmc2725281;;10.1002/0471142727.mb25b10s94;;10.1097/00000478-199008000-00007;;2198813;;14678979;;14676315;;pmc307634;;10.1073/pnas.2536670100;;24515757;;10.1309/ajcp3cp6vfzjymtk;;10.1038/nmeth.1226;;18516045;;pmc4282019;;24684350;;10.1111/bjh.12854;;12609845;;10.1182/blood-2002-06-1864;;10.1182/blood-2007-02-068791;;18024791;;19049489;;10.2202/1544-6115.1404;;pmc4485451;;24080457;;10.1016/j.cancergen.2013.07.003;;16098065;;10.1111/j.1365-2141.2005.05630.x;;pmc1906980;;10.1016/s1525-1578(10)60693-9;;12169673;;12075054;;10.1056/nejmoa012914;;12620412;;10.1016/s1535-6108(03)00028-x;;14723013;;10.1182/blood-2004-10-3907;;15718413;;23433739;;10.3410/f.717980688.793474808;;10.1016/s0140-6736(12)61763-2;;pmc2366164;;10.1200/jco.2006.08.4251;;17296973;;pmc3931191;;10.1182/blood-2013-11-536433;;24398326;;10.1200/jco.2016.34.15_suppl.7510;;28291392;;pmc5455765;;10.1200/jco.2016.70.7901;;11567628;;10.1016/s1074-7613(01)00194-7;;pmc1351148;;10.1016/s0065-2776(05)87005-1;;16102574;;10.1182/blood-2016-01-643569;;pmc4874220;;26980727;;14630827;;10.1182/blood-2003-06-2160;;10.1111/j.1365-2141.2005.05716.x;;16173960;;10.1182/blood-2013-10-533869;;24891323;;10.1126/science.270.5235.484;;7570003;;12900505;;10.1073/pnas.1732008100;;pmc187912,"Kwak, M. etal; “Gene expression analysis in formalin fixed paraffin embedded melanomas is associated with density of corresponding immune cells in those tissues”. Sci Rep 10, 18336 (2020), pp. 1-8 (Year: 2020).;;Linton, K. et al; “Microarray Gene Expression Analysis of Fixed Archival Tissue Permits Molecular Classification and Identification of Potential Therapeutic Targets in Diffuse Large B-Cell Lymphoma”, The Journal of Molecular Diagnostics, vol. 14, Issue 3, 2012, pp. 223-232 (Year: 2012).;;Vose, Julie M. “Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.” American journal of hematology 90.8 (2015): 739-745 (Year: 2015).;;Hartmann, Elena M., German Ott, and Andreas Rosenwald. “Molecular outcome prediction in mantle cell lymphoma.” (2009): 63-73 (Year: 2009).;;Alizadeh et al., “Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling,” Nature, 403 (6769), 503-511 (2000).;;Argatoff et al., “Mantle cell lymphoma: A clinicopathologic study of 80 cases,” Blood, 89 (6), 2067-2078 (1997).;;Bomben et al., “701 Identification of a Novel Gene Expression Signature in Mantle Cell Lymphoma from the Fondazione Italiana Linfomi (FIL)-MCL-0208 Trial: A Focus on the B Cell Receptor Pathway,” ASH 57th Annual Meeting & Exposition, Dec. 5-8, 2015 (2 pages).;;Campo, “Mantle Cell Lymphoma,” Presentation, Mar. 3, 2013 at 102nd Annual Meeting USCAP (6 pages).;;Cao et al., “Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9,” Breast Cancer Research, 10 (5), R91 (2008) (10 pages).;;Cheah et al., “Mantle cell lymphoma,” J. Clin. Oncol., 34 (11), 1256-1269 (2016).;;De Jong et al., “Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: Validation of tissue microarray as a prerequisite for broad clinical applications—A study from the Lunenburg Lymphoma Biomarker Consortium,” J. Clin. Oncol., 25 (7), 805-812 (2007).;;De Leeuw et al., “Comprehensive whole genome array CGH profiling of mantle-cell lymphoma model genomes” Human Molecular Genetics, 13 (17), 1827-1837 (2004).;;Determann et al., “Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group,” Blood, 111 (4), 2385-2387 (2008).;;Dreyling et al., “New paradigms in mantle cell lymphoma: Is it time to risk-stratify treatment based on the proliferative signature?” Ciin. Cancer Res., 20 (20), 5194-5206 (2014).;;Dreyling et al., “How to manage mantle cell lymphoma,” Leukemia, 28 (11), 2117-2130 (2014).;;Ek et al., “Parallel Gene Expression Profiling of Mantle Cell Lymphoma—How Do we Transform Omics Data into Clinical Practice,” Current Genomics, 8, 171-179 (2007).;;Fern{dot over (a)}ndez et al., “Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma,” Cancer Res., 70 (4), 1408-1418 (2010).;;Filipits et al., “The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer,” Clin. Cancer Res., 20 (5), 1298-1305 (2014).;;Fortina et al., “Digital mRNA profiling,” Nat. Biotechnol., 26 (3), 293-294 (2008).;;Geisler et al., “Nordic MCL2 trial update: Six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: Still very long survival but late relapses do occur,” Br. J. Haematol., 158 (3), 355-362 (2012).;;Geiss et al., “Direct multiplexed measurement of gene expression with color-coded probe pairs,” Nature Biotechnol , 26 (3), 317-325 (2008) (with comment by Fortina et al., “Digital mRNA profiling,” Nature Biotechnol., 26 (3), 293-294 (2008).;;Gene Expression Omnibus, GEO Accession No. GSE93291. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi, public Mar. 17, 2017 (2 pages).;;Hartmann et al., “Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue,” J. Clin. Oncol., 26 (30), 4966-4972 (2008).;;Hartmann et al., “Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling,” Blood, 116 (6), 953-961 (2010).;;Henson et al., “Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma,” Acta Histochem., 113 (7), 729-742 (2011) author manuscript.;;Hofmann et al., “Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray,” Blood, 98 (3), 787-794 (2001).;;Hoster et al., “A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma,” Blood, 111 (2), 558-565 (2008).;;Hoster et al., “Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network,” J. Clin. Oncol., 32 (13), 1338-1346 (2014).;;Hoster et al., “Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: Results from randomized trials of the European Mantle Cell Lymphoma Network,” J. Clin. Oncol., 34 (12), 1386-1394 (2016).;;Huang et al., “Simultaneous recovery of DNA and RNA from formalin-fixed paraffin-embedded tissue and application in epidemiologic studies,” Cancer Epidemiol. Biomarkers Prev., 19 (4), 973-977 (2010) (retracted May 1, 2014).;;Igarashi et al., “Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study,” Ann. Oncol., 13 (6), 928-943 (2002).;;International Preliminary Report on Patentability, Application No. PCT/US2017/028628, dated Oct. 23, 2018 (7 pages).;;Iqbal et al., “Gene expression profiling in lymphoma diagnosis and management,” Best Pract. Res. Clin. Haematol., 22 (2), 191-210 (2009).;;International Search Report, Application No. PCT/US2017/028628, dated Jul. 18, 2017 (5 pages).;;Jacobs et al., “Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays,” Cancer Res., 67 (6), 2544-2551 (2007).;;Jares et al., “Molecular pathogenesis of mantle cell lymphoma,” J. Clin. Invest., 122 (10), 3416-3423 (2012).;;Jares et al., “Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics,” Nat. Rev. Cancer, 7 (10), 750-762 (2007).;;Katzenberger et al., “The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma,” Blood, 107 (8), 3407 (2006), (1 page).;;Kienle et al, “Quantitative gene expression deregulation in mantle-cell lymphoma: Correlation with clinical and biologic factors,” J. Ciin. Oncol., 25 (19), 2770-2777 (2007).;;Klapper et al., “Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network,” J. Hematop., 2(2), 103-111 (2009).;;Kulkarni, “Digital Multiplexed Gene Expression Analysis Using the NanoString nCounter System,” Curr. Protac. Mol. Biol., Unit 25B.10. Supplement 94 (2011) (17 pages).;;Lardelli et al., “Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations,” Am. J. Surg. Pathol., 14 (8), 752-763 (1990).;;Martinez et al., “The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival,” Cancer Res., 63 (23), 8226-8232 (2003).;;Matsumura et al., “Gene expression analysis of plant host-pathogen interactions by SuperSAGE,” Proc. Natl. Acad. Sci. USA, 100 (26), 15718-15723 (2003).;;Montgomery et al., “Pathology consultation on intermediate-to-large B-cell lymphomas,” Am. J. Clin. Pathol., 141 (3), 305-317 (2014).;;Mortazavi et al. “Mapping and quantifying mammalian transcriptomes by RNA-Seq,” Nat. Methods, 5 (7), 621-628 (2008).;;Nordström et al., “SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma—A Nordic Lymphoma Group study,” Br. J. Haematol., 166 (1), 98-108 (2014).;;Orchard et al., “A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease,” Blood, 101 (12), 4975-4981 (2003).;;Ortega-Paino et al., “Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference,” Blood, 111 (3), 1617-1624 (2008).;;Pollard et al., “Supervised Distance Matrices: Theory and Applications to Genomics,” Paper 238 (2008) (32 pages).;;Puvvada et al., “Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma,” Cancer Genet , 206 (7-8), 257-265 (2013) author manuscript.;;Rizzatti et al., “Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways,” Br. J. Haematol., 130 (4), 516-526 (2005).;;Robetorye et al., “Microarray analysis of B-cell lymphoma cell lines with the t(14;18),” J. Mol Diagn., 4 (3), 123-136 (2002).;;Rosenwald et al., “The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma,” N. Engl. J. Med., 346 (25), 1937-1947 (2002).;;Rosenwald et al. “The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma,” Cancer Cell, 3 (2), 185-197 (2003).;;Rosenwald, “DNA microarrays in lymphoid malignancies,” Oncology Journal, 17 (12), 1743-1748 (2003).;;Rubio-Moscardo et al., “Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome,” Blood, 105 (11), 4445-4454 (2005).;;Rummel et al., “Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial,” Lancet, 381 (9873), 1203-1210 (2013).;;Saba et al., Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma, Blood, 128 (1), 82-92 (2016).;;Salaverria et al., “Specific secondary genetic alterations in mantle cell lymphoma provide prognostic in formation independent of the gene expression-based proliferation signature,” J. Clin. Oncol., 25 (10), 1216-1222 (2007).;;Scott et al., “Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue,” Blood, 123 (8), 1214-1217 (2014).;;Scott et al., “Prognostic significance of the proliferation signature in mantle cell lymphoma measured using digital gene expression in formalin-fixed paraffin-embedded tissue biopsies,” abstract No. 7510 (previously No. 163878) and presentation at the 2016 annual meeting of the American Society of Clinical Oncology, J. Clin. Oncol., 34 (15 suppl.), May 20, 2016 abstract title published Apr. 20, 2016, (2 pages).;;Scott et al., “New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies,” J. Ciin. Oncol., 35 (15), 1668-1677 (2017).;;Shaffer et al., “Signatures of the immune response,” Immunity, 15 (3), 375-385 (2001).;;Staudt et al., “The biology of human lymphoid malignancies revealed by gene expression profiling,” Adv. Immunol., 87, 163-208 (2005) author manuscript.;;Swerdlow et al., “The 2016 revision of the World Health Organization classification of lymphoid neoplasms,” Blood, 127 (20), 2375-2390 (2016).;;Thieblemont et al., “Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis” Blood, 103 (7), 2727-2737 (2004).;;Tiemann et al., “Hislopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): A clinicopathological study from the European MCL Network,” Br. J. Haematol., 131 (1), 29-38 (2005).;;Van Der Velden et al., “B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma” Blood, 124 (3), 412-419 (2014).;;Velculescu et al., “Serial analysis of gene expression,” Science, 270 (5235), 484-487 (1995).;;Wright et al., “A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma,” Proc. Natl. Acad. Sci. USA, 100 (17), 9991-9996 (2003).;;Written Opinion of the International Searching Authority, Application No. PCT/US2017/028628, (6 pages).",ACTIVE
644,US,B1,US 7941520 B1,026-950-910-039-960,2011-05-10,2011,US 96445101 A,2001-09-28,US 96445101 A,2001-09-28,System and method for tracking telephone network capacity and equipment,"A system and method of managing telephone network facilities. A telephone network facilities database, such as LEIS, is accessed and selected information, including wire center location, equipment and slot information stored therein, is extracted and re-stored in a relational database. Additional fields in the relational database are populated based on the information extracted from the telephone network facilities database. The additional fields represent working ADSL and T1 facilities, ADSL and T1 capacity, and ADSL and T1 availability. A graphical user interface is provided that displays several views of the data in the relational database. Color coding aspects of the graphical user interface indicates capacity levels.",BELLSOUTH INTELLECT PTY CORP,KITE JOSHUA W;;BROWN ELLEN W;;ASKEW PATRICIA RANKINS;;QUINN RICK;;ZICKEFOOSE MARK K;;WOMACK JAMES P;;COWART GREG;;PFISTER WILLIAM L;;CARLSON TED J;;RAY GARY P;;LILLIE JOSEPH V;;BRATTON LAWRENCE C;;CHAMPION CAROLYN F;;BREARD JOHN KENNETH;;DABNEY ROBERT E;;HORTON LYNN BAINBRIDGE;;LAKE GREG;;DORN JR WATSON;;RODRIGUEZ ELIAS;;SMITH RUSSELL T,BELLSOUTH INTELLECTUAL PROPERTY CORPORATION (2002-02-05),https://lens.org/026-950-910-039-960,Granted Patent,yes,29,4,1,1,0,H04M3/2245;;H04M3/2245;;H04M2201/42;;H04M2201/42,G06F15/173,709/224;;709/217;;709/218;;709/219;;709/223;;379/247;;707/1;;707/2;;707/104.1;;715/736,1,0,,,"Crawford, Sharon. Windows 2000 Pro: The Missing Manual. Nov. 2000. O'Reilly. First Edition.",INACTIVE
645,CN,A,CN 113906270 A,066-506-033-125-188,2022-01-07,2022,CN 202080041139 A,2020-05-28,US 201962857045 P;;IB 2020055092 W,2019-06-04,METHODS AND SYSTEMS OF PATH-BASED MAPPING AND ROUTING,"Systems and methods of path-based mapping and routing are provided. Translation information and absolute orientation information of mobile objects in environments are determined based on a fusion of sensing data from a radar and an inertial measurement unit (IMU) including a gyroscope and an accelerometer, from which path-based maps and optimal routes can be generated.",3M INNOVATIVE PROPERTIES CO,SINGH GAUTAM;;KRUSE JOHN M;;JESME RONALD D;;KELLIHER WILLIAM J;;ODOM JACOB E;;NYLAND ADAM C;;GABRIEL NICHOLAS T;;AVELDSON JASON L;;HAGH-SHENAS HALEH;;HERFORT FRANK T;;GJERE MICHAEL L;;KAUR RACHNEET;;WILKEN-RESMAN ELIAS;;LEE JAE-YONG;;ADDLEMAN DOUGLAS A;;CASNER GLENN E;;CARLSON JAMES D;;TUNGJUNYATHAM JUSTIN;;BATTLE KARL;;LUCHT STEVEN G,,https://lens.org/066-506-033-125-188,Patent Application,no,0,0,5,5,0,G01C21/1652;;G01C21/206;;G01S13/86;;G01S13/876;;G01S13/723;;G01S13/89;;G01S13/426;;G01C21/206;;G01C21/1652;;G01S13/86;;G01S13/89;;G01S13/876;;G01S13/723;;G01S13/426;;G01C21/1652;;G01C21/206;;G01S13/426;;G01S13/867;;G01S13/89,G01C21/16;;G01C21/20;;G01S13/42;;G01S13/72;;G01S13/86;;G01S13/87;;G01S13/89,,0,0,,,,DISCONTINUED
646,US,B2,US 10607717 B2,003-601-739-196-797,2020-03-31,2020,US 201415035101 A,2014-11-05,US 201415035101 A;;US 201361900553 P;;US 2014/0064161 W,2013-11-06,Method for subtyping lymphoma types by means of expression profiling,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;UNIV ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC FOUND;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;GUERRI ELIAS CAMPO;;TUBBS RAYMOND;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS,BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2016-08-15);;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2015-03-27);;OREGON HEALTH & SCIENCE UNIVERSITY (2016-09-08);;JULIUS-MAXIMILIANS-UNIVERSITY OF WÜRZBURG (2016-09-07);;HOSPITAL CLINIC DE BARCELONA (2016-09-02);;THE CLEVELAND CLINIC FOUNDATION (2015-03-24);;OSLO UNIVERSITY HOSPITAL HF (2016-08-16);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2016-09-06);;ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (2015-03-16);;UNIVERSITAT DE BARCELONA (2016-09-02),https://lens.org/003-601-739-196-797,Granted Patent,yes,80,2,27,27,2460,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,G01N33/48;;G16B25/10;;C12Q1/6886;;G16B5/00;;G16B25/00,,179,165,008-555-947-606-655;;116-351-259-268-93X;;044-611-856-177-401;;040-694-135-115-041;;016-596-651-939-443;;016-006-028-791-093;;008-419-113-437-385;;056-453-977-117-995;;034-452-195-533-57X;;060-759-207-536-364;;053-932-758-603-87X;;051-786-486-516-995;;101-841-825-225-801;;024-946-492-182-494;;080-261-677-082-739;;012-855-494-804-729;;079-336-969-276-20X;;081-079-559-532-247;;024-490-999-993-98X;;068-584-499-536-196;;047-262-184-051-895;;004-727-308-938-832;;030-896-154-936-42X;;054-078-060-931-86X;;090-176-895-315-998;;033-968-074-794-870;;070-747-278-744-464;;090-064-710-132-858;;021-650-522-587-897;;005-967-436-046-627;;037-836-837-269-988;;032-611-541-376-312;;041-085-398-221-48X;;083-926-915-990-672;;057-287-836-052-142;;166-928-472-179-298;;013-529-949-265-243;;033-916-592-216-662;;033-971-166-966-681;;008-479-304-060-255;;037-236-591-728-945;;025-520-775-172-251;;056-464-372-256-072;;024-527-436-840-118;;010-838-505-357-69X;;037-047-957-053-389;;069-311-247-178-567;;029-742-983-481-795;;160-631-360-016-499;;107-296-031-742-505;;083-931-891-231-212;;016-533-931-410-773;;008-066-052-380-31X;;166-832-177-257-760;;081-376-983-952-92X;;099-803-524-269-475;;006-606-201-561-766;;104-557-009-702-690;;013-402-932-169-492;;047-817-434-820-973;;017-934-499-413-775;;005-952-510-626-477;;081-031-514-300-626;;029-974-412-724-477;;087-871-690-717-906;;026-225-449-299-526;;131-905-544-919-039;;003-583-041-937-112;;022-393-675-280-070;;000-322-118-693-394;;096-603-188-929-757;;068-762-846-278-363;;034-506-218-618-076;;033-627-282-704-547;;007-974-316-902-490;;083-330-301-419-474;;014-280-105-584-733;;023-425-205-244-323;;004-773-466-896-807;;014-557-082-098-140;;050-502-569-231-297;;085-467-264-451-562;;031-538-684-093-737;;016-150-622-242-94X;;178-935-842-768-083;;078-147-429-983-57X;;075-838-748-885-137;;039-385-706-948-676;;102-508-786-930-192;;039-781-158-431-16X;;006-530-638-049-054;;068-614-447-896-338;;024-500-130-167-872;;019-138-428-462-268;;028-569-460-877-835;;023-599-464-062-049;;062-366-341-744-610;;028-925-425-329-938;;048-325-804-402-273;;098-721-574-391-14X;;037-717-936-973-653;;053-141-431-021-519;;046-044-728-292-565;;069-185-424-344-964;;055-691-371-341-340;;095-208-239-623-138;;040-382-367-616-74X;;036-274-890-235-324;;051-186-934-591-472;;014-565-650-855-999;;078-452-543-920-848;;084-282-120-664-916;;089-264-099-925-423;;038-246-842-310-750;;004-162-318-388-875;;043-042-357-918-339;;074-128-110-532-508;;052-672-767-581-401;;001-476-207-579-575;;015-395-832-493-244;;035-255-900-380-462;;018-364-083-825-391;;040-439-415-810-331;;027-657-011-129-499;;061-990-723-525-723;;014-065-259-226-128;;051-346-920-381-327;;009-793-691-951-016;;044-412-429-345-691;;001-018-672-231-808;;055-831-640-840-407;;190-172-199-061-514;;007-669-468-009-211;;047-322-007-088-891;;071-699-049-017-661;;021-104-159-501-594;;079-667-051-092-518;;041-898-993-227-665;;000-705-324-102-258;;020-914-368-965-430;;019-595-273-525-116;;009-118-554-603-358;;061-643-519-956-079;;026-677-172-273-32X;;025-569-223-928-169;;101-346-478-869-486;;108-298-116-795-433;;098-335-021-363-434;;072-928-593-005-990;;030-100-080-719-126;;057-959-241-615-654;;050-723-935-789-629;;031-846-362-071-660;;086-474-226-374-65X;;043-885-019-636-545;;019-693-630-289-481;;026-266-975-077-828;;003-117-956-540-879;;026-589-581-583-417;;047-836-705-919-603;;139-742-950-119-640;;013-322-445-914-037;;006-958-690-304-873;;109-942-379-781-827;;008-161-966-545-470,20167839;;10.1634/theoncologist.2009-0304;;pmc3227958;;pmc3342980;;10.3324/haematol.2011.056531;;22133772;;10.1101/sqb.1999.64.71;;11232339;;10.1038/35000501;;10676951;;pmc21986;;10.1073/pnas.96.12.6745;;10359783;;pmc5926895;;12460461;;10.1111/j.1349-7006.2002.tb01225.x;;10.1016/s0165-4608(97)00291-4;;9530346;;15331443;;10.1182/blood-2003-12-4291;;15337798;;10.1200/jco.2004.11.025;;12181265;;10.1097/01.mp.0000024375.04135.2b;;10.1034/j.1600-065x.2003.00052.x;;12846810;;10923106;;10.3109/07357900009012197;;19455257;;pmc2675856;;10.1177/117693510700300004;;11607812;;10.1038/sj.onc.1204595;;10.1038/bjc.2012.272;;22722314;;pmc3405213;;10.1186/bcr2189;;18954444;;pmc2614499;;10.1126/science.274.5287.610;;8849452;;10.1182/blood.v95.2.619;;10627471;;9702192;;10.1016/s1097-2765(00)80114-8;;10.1158/1078-0432.ccr-09-0113;;19706817;;pmc7289055;;10.1126/science.282.5389.699;;9784122;;10.1002/(sici)1098-2264(199906)25:2<123::aid-gcc8>3.3.co;2-w;;10337996;;10.1002/(sici)1098-2264(199906)25:2<123::aid-gcc8>3.0.co;2-4;;11807147;;10.1056/nejmoa011795;;pmc4174364;;10.1245/s10434-013-3240-y;;24046106;;10.1097/01.mp.0000032534.81894.b3;;12429796;;11850073;;10.1016/s0165-4608(01)00548-9;;10.1056/nejmoa055759;;16760443;;pmc2193582;;10.1084/jem.194.12.1861;;11748286;;12042708;;10.1097/00062752-200207000-00011;;pmc3418848;;22442255;;10.1074/mcp.m111.015362;;15229187;;10.1093/hmg/ddh195;;10.1182/blood.v85.10.2870.bloodjournal85102870;;7742549;;10.1126/science.278.5338.680;;9381177;;10.1038/ng1296-457;;8944026;;10.1002/(sici)1096-9896(199806)185:2<159::aid-path73>3.0.co;2-0;;9713342;;10.1038/leu.2014.171;;24854989;;15245604;;10.3816/clm.2004.n.006;;9843981;;10.1073/pnas.95.25.14863;;pmc24541;;18645603;;10.2174/138920207780833801;;pmc2435353;;10.1158/0008-5472.can-09-3419;;20124476;;23152841;;10.1371/journal.pone.0049010;;pmc3494663;;15870177;;10.1182/blood-2004-12-4901;;7680764;;10.1056/nejm199304083281404;;10.1038/nbt0308-293;;18327237;;pmc1895253;;16123218;;10.1182/blood-2005-04-1753;;10.1038/nbt1385;;18278033;;11122110;;10.1046/j.1365-2141.2000.02352.x;;10.1126/science.286.5439.531;;10521349;;8895530;;14504078;;10.1182/blood-2003-05-1545;;10.1038/modpathol.3800434;;15920548;;10.1097/01.pas.0000168176.71405.e5;;16006805;;7805040;;20421449;;pmc2924229;;10.1182/blood-2010-01-263806;;pmc20056;;9122163;;10.1073/pnas.94.6.2150;;17265723;;10.1007/978-0-387-39978-2_13;;10.1016/j.acthis.2010.11.001;;21145576;;pmc4657859;;10.1182/blood.v98.3.787;;11468180;;10.1016/s0092-8674(00)81641-4;;9845373;;11895757;;10.1182/blood.v99.7.2285;;24789858;;10.1158/1055-9965.epi-14-0395;;pmc4394836;;10.1158/1055-9965.epi-10-0091;;20332269;;pmc2864144;;10.1186/1476-4598-12-13;;23409773;;pmc3626580;;16760442;;10.1056/nejmoa055351;;12414653;;10.1038/nrc2775;;20383180;;10.1093/annonc/mdf155;;12123339;;pmc1618550;;10.1016/s0002-9440(10)63284-1;;15215171;;10.1016/j.beha.2009.05.001;;19698928;;8623927;;pmc1861570;;17891190;;10.1038/nrc2230;;10.1038/89044;;pmc1282521;;11385503;;9850025;;10.1200/jco.1998.16.12.3803;;pmc279815;;2894030;;10.1073/pnas.85.5.1571;;9787151;;10.1182/blood.v92.9.3152;;16006802;;10.1097/01.pas.0000167362.06148.95;;2676601;;10.1016/0014-5793(89)81066-x;;pmc24262;;9371799;;10.1073/pnas.94.24.13057;;10.1126/science.1153629;;18323416;;pmc9103713;;10.1056/nejmoa0802885;;19038878;;10.1093/bioinformatics/bti824;;16339281;;7495558;;10.1038/nbt1296-1675;;9634850;;10.1158/1535-7163.mct-05-0146;;16373702;;14678979;;14676315;;pmc307634;;10.1073/pnas.2536670100;;10.1200/jco.2010.30.0368;;pmc3058275;;21135273;;10.3892/ijo.24.3.497;;14767533;;10.1182/blood.v87.12.5269.bloodjournal87125269;;8652842;;24515757;;10.1309/ajcp3cp6vfzjymtk;;15550490;;10.1182/blood-2004-07-2947;;10.1038/nmeth.1226;;18516045;;10.1182/blood-2002-11-3442;;12576316;;2833750;;10.1073/pnas.85.8.2748;;pmc280076;;16572121;;10.1038/nature04687;;22057785;;pmc3306784;;10.1007/s00401-011-0899-7;;10.1182/blood-2006-09-047068;;17299093;;10.1158/0008-5472.can-04-0756;;15374954;;10.1182/blood-2007-02-068791;;18024791;;9376597;;10.1182/blood.v90.8.3154;;pmc2689138;;10.1172/jci38248;;19451695;;8197176;;10.1073/pnas.91.11.5022;;pmc43922;;8828038;;10.1101/gr.6.6.492;;12898595;;10.1002/path.1384;;pmc4485451;;24080457;;10.1016/j.cancergen.2013.07.003;;pmc3447789;;10.1371/journal.pone.0045656;;23029164;;pmc1852938;;9665478;;10.1016/s0002-9440(10)65558-7;;12162889;;10.1089/106652702760138592;;pmc3953419;;24140199;;10.1016/s1470-2045(13)70449-2;;11742071;;10.1073/pnas.211566398;;pmc64998;;10.1038/nrc1322;;15057290;;10.1182/blood.v92.1.234.413k22_234_240;;9639522;;14976040;;10.1182/blood-2003-07-2365;;16098065;;10.1111/j.1365-2141.2005.05630.x;;pmc1906980;;10.1016/s1525-1578(10)60693-9;;12169673;;14600649;;14723013;;15202524;;10.1080/10428190310001623775;;10.1084/jem.20031074;;12975453;;pmc2194208;;12620412;;10.1016/s1535-6108(03)00028-x;;12075054;;10.1056/nejmoa012914;;10.1182/blood-2004-10-3907;;15718413;;23433739;;10.3410/f.717980688.793474808;;10.1016/s0140-6736(12)61763-2;;pmc2366164;;10.1200/jco.2006.08.4251;;17296973;;10.1182/blood-2003-06-1841;;12933571;;8855227;;pmc38202;;10.1073/pnas.93.20.10614;;10.1126/science.270.5235.467;;7569999;;14961037;;10.1038/sj.leu.2403293;;12719886;;10.1007/s00277-003-0649-6;;pmc3931191;;10.1182/blood-2013-11-536433;;24398326;;17105812;;10.1182/blood-2006-08-038257;;10.1111/j.0105-2896.2006.00373.x;;12461565;;10.1038/nri953;;11567628;;10.1016/s1074-7613(01)00194-7;;8796352;;10.1101/gr.6.7.639;;10.1056/nejm199309303291402;;8141877;;10.1038/nm0102-68;;10.1038/news011227-7;;11786909;;11675358;;10.1182/blood.v98.9.2837;;7514785;;10.1093/nar/22.8.1368;;pmc307992;;10.1091/mbc.9.12.3273;;9843569;;pmc25624;;pmc1351148;;10.1016/s0065-2776(05)87005-1;;16102574;;12450791;;10.1016/s1535-6108(02)00178-2;;10.1146/annurev.med.53.082901.103941;;11818476;;10.1146/annurev.immunol.18.1.829;;10837077;;10.1056/nejmra020067;;12724484;;12086866;;10.1016/s1535-6108(02)00036-3;;10.1073/pnas.0506580102;;16199517;;pmc1239896;;10.1182/blood-2005-02-0542;;15886317;;10.1073/pnas.96.6.2907;;10077610;;pmc15868;;10.1038/10343;;10391217;;14630827;;10.1182/blood-2003-06-2160;;12011421;;10.1073/pnas.082099299;;pmc124443;;10.1158/0008-5472.can-12-4331;;24019381;;10.1182/blood-2013-10-533869;;24891323;;10.1126/science.270.5235.484;;7570003;;10.1016/s0037-1963(03)00194-x;;14582080;;10.1182/blood-2005-10-4222;;16449523;;pmc1895783;;9415887;;10.1038/nbt1297-1359;;12900505;;10.1073/pnas.1732008100;;pmc187912;;10.1038/ki.1990.46;;2407890;;10.1007/s10330-004-0351-8;;10733493;;10.1182/blood-2002-11-3502;;12676782;;10.1186/gb-2003-4-10-r69;;pmc328458;;14519204;;23252516;;10.1111/bjh.12172,"Castillo, et al. “Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma,” The oncologist, vol. 15 (2010) pp. 293-299.;;Wilson et al., “A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype,” Haematologica, vol. 97 (2012) pp. 758-765.;;Alizadeh et al., “The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes,” Cold Spring Harbor Symp. Quant. Biol., 64, 71-78 (1999).;;Alizadeh et al., “Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling,” Nature, 403 (6769), 503-511 (2000).;;Alon et al., “Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays,” Proc. Natl. Acad. Sci. USA, 96 (12), 6745-6750 (1999).;;Ando et al., “Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell lymphoma,” Jpn. J. Cancer Res., 93, 1207-1212 (2002).;;Andreasson et al., “Genomic amplification of CCND2 is rare in non-Hodgkin lymphomas,” Cancer Genet. Cytogenet., 102 (1), 81-82 (1998).;;Basso et al., “Tracking CD40 signaling during germinal center development,” Blood, 104 (13), 4088-4096 (2004).;;Bea et al., “Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas,” J. Clin. Oncol., 22 (17), 3498-3506 (2004).;;Berglund et al., “Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization,” Mod. Pathol., 15 (8), 807-816 (2002).;;Bergsagel et al., “Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma,” Immunol. Rev., 194, 96-104 (2003).;;Bishop et al., “Burkitt's lymphoma: molecular pathogenesis and treatment,” Cancer Invest., 18 (6), 574-583 (2000).;;Blenk et al., “Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival,” Cancer Inform., 3, 399-420 (2007).;;Boxer et al., “Translocations involving c-myc and c-myc function,” Oncogene, 20 (40), 5595-5610 (2001).;;Brault et al., “PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma,” Br. J. Canc., 107 (3), 491-500 (2012).;;Cao et al., “Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9,” Breast Cancer Res., 10 (5), 10 pp. (2008).;;Chee et al., “Accessing genetic information with high-density DNA arrays,” Science, 274 (5287), 610-614 (1996).;;Chiarle et al., “Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma,” Blood, 95 (2), 619-626 (2000).;;Cho et al., “A genome-wide transcriptional analysis of the mitotic cell cycle,” Mol. Cell., 2 (1), 65-73 (1998).;;Choi et al., “A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy,” Clin. Cancer Res., 15 (17), 5494-5502 (2009).;;Chu et al., “The transcriptional program of sporulation in budding yeast,” Science, 282 (5389), 699-705 (1998).;;Cigudosa et al., “Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas,” Genes Chromosomes Cancer, 25 (2), 123-133 (1999).;;Coiffier et al., “CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma,” N. Engl. J. Med., 346 (4), 235-242 (2002).;;Collins et al., “A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma,” Ann. Surg. Oncol., 21 (1), 133-138 (2014) Author Manuscript.;;Copie-Bergman et al., “MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas,” Mod Pathol., 15 (11), 1172-1180 (2002).;;Dave et al., “Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization,” Cancer Genet. Cytogenet., 132 (2), 125-132 (2002).;;Dave et al., “Molecular diagnosis of Burkitt's lymphoma,” N. Engl. J. Med., 354 (23), 2431-2442 (2006).;;Davis et al., “Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells,” J. Exp. Med., 194 (12), 1861-1874 (2001).;;Davis et al., “Molecular diagnosis of lymphoid malignancies by gene expression profiling,” Curr. Opin. Hematol., 9 (4), 333-338 (2002).;;Deeb et al., “Super-SILAC Allows Classification of Diffuse Large B-cell Lymphoma Subtypes by Their Protein Expression Profiles,” Mol. Cell. Proteomics, 11(5), 77-89 (2012).;;De Leeuw et al., “Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes,” Hum. Mol. Genet., 13 (17), 1827-1837 (2004).;;Delmer et al., “Overexpression of cyclin D2 in chronic B-cell malignancies,” Blood, 85 (10), 2870-2876 (1995).;;Derisi et al., “Exploring the metabolic and genetic control of gene expression on a genomic scale,” Science, 278 (5338), 680-686 (1997).;;Derisi et al., “Use of a cDNA microarray to analyse gene expression patterns in human cancer,” Nat. Genet., 14 (4), 457-460 (1996).;;Doglioni et al., “Cyclin D3 expression in normal, reactive and neoplastic tissues,” J. Pathol., 185 (2), 159-166 (1998).;;Dreyling et al., “How to manage mantle cell lymphoma,” Leukemia, 28 (11), 2117-2130 (2014).;;Dudoit et al., “Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data,” J. Am. Stat. Assoc., 97 (457), 77-87 (2002).;;Dybkaer et al., “Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma,” Clinical Lymphoma, 5 (1), 19-28 (2004).;;Eisen et al., “Cluster analysis and display of genome-wide expression patterns,” Proc. Natl. Acad. Sci. USA, 95 (25), 14863-14868 (1998).;;Ek et al., “Parallel gene expression profiling of mantle cell lymphoma—how do we transform 'omics data into clinical practice,” Curr. Genomics, 8 (3), 171-179 (2007).;;Fernandez et al., “Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma,” Cancer Res., 70 (4), 1408-1418 (2010).;;Fernandez et al., “Using digital RNA counting and flow cytometry to compare mRNA with protein expression in acute leukemias,” PLoS One, 7(11), e49010 (2012).;;Feuerhake et al., “NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes,” Blood, 106 (4), 1392-1399 (2005).;;Fisher et al., “Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma,” N. Engl. J. Med., 328 (14), 1002-1006 (1993).;;Fortina et al., “Digital mRNA profiling,” Nat. Biotechnol., 26 (3), 293-294 (2008).;;Fu et al., “Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling,” Blood, 106 (13), 4315-4321 (2005).;;Geiss et al., “Direct multiplexed measurement of gene expression with color-coded probe pairs,” Nat. Biotechnol., 26 (3), 317-325 (2008).;;Goff et al., “The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma,” Br. J. Haematol., 111 (2), 618-625 (2000).;;Golub et al., “Molecular classification of cancer: class discovery and class prediction by gene expression monitoring,” Science, 286 (5439), 531-537 (1999).;;Gress et al., “A pancreatic cancer-specific expression profile,” Oncogene, 13 (8), 1819-1830 (1996).;;Hans et al., “Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray,” Blood, 103 (1), 275-82 (2004).;;Hans et al., “Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma,” Mod. Pathol., 18 (10), 1377-1384 (2005).;;Haralambieva et al., “Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma,” Am. J. Surg. Pathol., 29 (8), 1086-1094 (2005).;;Harpole et al., “A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression,” Cancer Res., 55 (1), 51-56 (1995).;;Hartmann et al., “Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling,” Blood, 116 (6), 953-961 (2010).;;Heller et al., “Discovery and analysis of inflammatory disease-related genes using cDNA microarrays,” Proc. Natl. Acad. Sci. USA, 94 (6), 2150-2155 (1997).;;Henrickson et al., “Gene expression profiling in malignant lymphomas,” Adv. Exp. Med. Biol., 593, 134-146 (2007).;;Henson et al., “Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma,” Acta Histochem, 113 (7), 729-742 (2011), Author Manuscript.;;Hofmann et al., “Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray,” Blood, 98 (3), 787-794 (2001).;;Holstege et al., “Dissecting the regulatory circuitry of a eukaryotic genome,” Cell, 95 (5), 717-728 (1998).;;Huang et al., “The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile,” Blood, 99 (7), 2285-2290 (2002).;;Huang et al., “Retraction: Simultaneous recovery of DNA and RNA from formalin-fixed paraffin-embedded tissue and application in epidemiologic studies,” Cancer Epidemiol Biomarkers Prev, 23 (6), 1132 (2014).;;Huang et al., “Simultaneous recovery of DNA and RNA from formalin-fixed paraffin-embedded tissue and application in epidemiologic studies,” Cancer Epidemiol Biomarkers Prev., 19 (4), 973-977 (2010), retracted May 1, 2014.;;Hudson et al., “Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer,” Mol. Cancer, 12, 13 pp. (2013).;;Hummel et al., “A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling,” N. Engl. J. Med., 354 (23), 2419-2430 (2006).;;Hyman et al., “Impact of DNA amplification on gene expression patterns in breast cancer,” Cancer Res., 62 (21), 6240-6245 (2002).;;Hymowitz et al., “A20: from ubiquitin editing to tumour suppression,” Nat. Rev. Cancer, 10 (5), 332-340 (2010).;;Igarashi et al., “Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study,” Ann. Oncol., 13 (6), 928-943 (2002).;;International Preliminary Report on Patentability, Application No. PCT/US2014/064161, dated May 10, 2016, 11 pp.;;International Search Report, Application No. PCT/US2014/064161, dated Mar. 5, 2015, 7 pp.;;Iqbal et al., “BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma,” Am. J. Pathol., 165 (1), 159-166 (2004).;;Iqbal et al., “Gene expression profiling in lymphoma diagnosis and management,” Best Pract. Res. Clin. Haematol., 22 (2), 191-210 (2009).;;Jares et al., “Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity,” Am. J. Pathol., 148 (5), 1591-1600 (1996).;;Jares et al., “Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics,” Nat. Rev. Cancer, 7 (10), 750-762 (2007).;;Khan et al., “Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks,” Nat. Med., 7 (6), 673-679 (2001).;;Khouri et al., “Hyper-CVAD and high-dose methotrexate/cytarbine followed by stem cell transplantation: an active regimen for aggressive mantle cell lymphoma,” J. Clin. Oncol 16 (12), 3803-3809 (1998).;;Kovacs, “Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma,” Proc. Natl. Acad. Sci. USA, 85 (5), 1571-1573 (1988).;;Kramer et al., “Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma,” Blood, 92 (9), 3152-3162 (1998).;;Kusumoto et al., “Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a ‘non-germinal center phenotype’,” Am. J. Surg. Pathol., 29 (8), 1063-1073 (2005).;;Lafage-Pochitaloff-Huvale et al., “The gene for human thioredoxin maps on the short arm of chromosome 3 at bands 3p11-p12,” FEBS Lett., 255 (1), 89-91 (1989).;;Lashkari et al., “Yeast microarrays for genome wide parallel genetic and gene expression analysis,” Proc. Natl. Acad. Sci. USA, 94 (24), 13057-13062 (1997).;;Lenz et al., “Oncogenic CARD11 mutations in human diffuse large B cell lymphoma,” Science, 319 (5870), 1676-1679 (2008).;;Lenz et al., “Stromal gene signatures in large-B-cell lymphomas,” N. Engl. J. Med., 359 (22), 2313-2323 (2008).;;Li, “Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression information,” Bioinformatics, 22 (4), 466-471 (2006).;;Lipshutz et al., “Using oligonucleotide probe arrays to access genetic diversity,” Biotechniques, 19 (3), 442-447 (1995).;;Lockhart et al., “Expression monitoring by hybridization to high-density oligonucleotide arrays,” Nat. Biotechnol., 14 (13), 1675-1680 (1996).;;Mahadevan et al., “Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures,” Mol. Cancer. Ther., 4 (12), 1867-1879 (2005).;;Martinez et al., “The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival,” Cancer Res., 63 (23), 8226-8232 (2003).;;Matsumura et al., “Gene expression analysis of plant host-pathogen interactions by SuperSAGE,” Proc. Natl. Acad. Sci. USA, 100 (26), 15718-15723 (2003).;;Meyer et al., “Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab,” J. Clin. Oncol., 29 (2), 200-207 (2011).;;Mircean et al., “Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas,” Int. J. Oncol., 24 (3), 497-504 (2004).;;Monni et al., “DNA copy number changes in diffuse large B-cell lymphoma—comparative genomic hybridization study,” Blood, 87 (12), 5269-5278 (1996).;;Montgomery et al., “Pathology consultation on intermediate-to-large B-cell lymphomas,” Am. J. Clin. Pathol., 141 (3), 305-317 (2014).;;Monti et al., “Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response,” Blood, 105 (5), 1851-1861 (2005).;;Mortazavi et al., “Mapping and quantifying mammalian transcriptomes by RNA-Seq,” Nat Methods, 5 (7), 621-628 (2008).;;Mounier et al., “Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL),” Blood, 101 (11), 4279-4284 (2003).;;Neri et al., “Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma,” Proc. Natl. Acad. Sci. USA, 85 (8), 2748-2752 (1988).;;Ngo et al., “A loss-of-function RNA interference screen for molecular targets in cancer,” Nature, 441 (7089), 106-110 (2006).;;Northcott et al., “Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples,” Acta Neruopathol., 123 (4), 615-626 (2012).;;Nyman et al., “Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy,” Blood, 109 (11), 4930-4935 (2007).;;Orsetti et al., “Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes,” Cancer Res., 64 (18), 6453-6460 (2004).;;Ortega-Paino et al., “Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference,” Blood, 111 (3), 1617-1624 (2008).;;Ott et al., “Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity,” Blood, 90 (8), 3154-3159 (1997).;;Payton et al., “High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples,” J. Clin. Invest., 119 (6), 1714-1726 (2009).;;Pease et al., “Light-generated oligonucleotide arrays for rapid DNA sequence analysis,” Proc. Natl. Acad. Sci. USA, 91 (11), 5022-5026 (1994).;;Pietu et al., “Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array,” Genome Res., 6 (6), 492-503 (1996).;;Pruneri et al., “Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocation,” J. Pathol., 200 (5), 596-601 (2003).;;Puvvada et al., “Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B-cell lymphoma,” Cancer Genet., 206, 257-265 (2013), Author Manuscript.;;Quek et al., “A multiplex assay to measure RNA transcripts of prostate cancer in urine,” PLoS One, 7 (9), e45656 (2012).;;Quintanilla-Martinez et al., “Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor,” Am. J. Pathol., 153 (1), 175-182 (1998).;;Radmacher et al., “A paradigm for class prediction using gene expression profiles,” J. Comput. Biol., 9 (3), 505-511 (2002).;;Ramaswamy et al., “Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis,” Lancet Oncol., 14 (12), 1200-1207 (2013), Author Manuscript.;;Ramaswamy et al., “Multiclass cancer diagnosis using tumor gene expression signatures,” Proc. Natl. Acad. Sci. USA, 98 (26), 15149-15154 (2001).;;Ransohoff, “Rules of evidence for cancer molecular-marker discovery and validation,” Nat. Rev. Cancer, 4 (4), 309-314 (2004).;;Rao et al., “Chromosomal and gene amplification in diffuse large B-cell lymphoma,” Blood, 92 (1), 234-240 (1998).;;Rimsza et al., “Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project,” Blood, 103 (11), 4251-4258 (2004).;;Rizzatti et al., “Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways,” Br. J. Haematol., 130 (4), 516-526 (2005).;;Robetorye et al., “Microarray analysis of b-cell lymphoma cell lines with the t(14;18),” J. Mol. Diag., 4 (3), 123-136 (2002).;;Rogge et al., “Gene Profiling of Lymphoma, myeloma, and AML,” Medscape from WebMed, 5 (3), 1-8 (2003).;;Rosenwald, “DNA microarrays in lymphoid malignancies,” Oncology, 8 pp. (2003), Web.;;Rosenwald et al., “Gene expression profiling of diffuse large B-cell lymphoma,” Leukemia & Lymphoma, 44 (Supp. 3), S41-S47 (2003).;;Rosenwald et al., “Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma,” J. Exp. Med., 198 (6), 851-862 (2003).;;Rosenwald et al., “The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma,” Cancer Cell, 3 (2), 185-197 (2003).;;Rosenwald et al., “The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma,” N. Engl. J. Med., 346 (25), 1937-1947 (2002).;;Rubio-Moscardo et al., “Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome,” Blood, 105 (11), 4445-4454 (2005).;;Rummel et al., “Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial,” Lancet, 381 (9873), 1203-1210 (2013).;;Salaverria et al., “Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature,” J. Clin. Oncol., 25 (10), 1216-1222 (2007).;;Savage et al., “The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma,” Blood, 102 (12), 3871-3879 (2003).;;Schena et al., “Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes,” Proc. Natl. Acad. Sci. USA, 93, 10614-1061 9 (1996).;;Schena et al., “Quantitative monitoring of gene expression patterns with a complementary DNA microarray,” Science, 270 (5235), 467-470 (1995).;;Schmechel et al., “Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma,” Leukemia, 18, 841-855 (2004).;;Schwaenen et al., “DNA microarray analysis in malignant lymphomas,” Ann Hematol., 82 (6), 323-332 (2003).;;Scott et al., “Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue,” Blood, 123 (8), 1214-1217 (2014).;;Sehn et al., “The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP,” Blood, 109 (5), 1857-1861 (2007).;;Shaffer et al., “A library of gene expression signatures to illuminate normal and pathological lymphoid biology,” Immunol. Rev., 210, 67-85 (2006).;;Shaffer et al., “Lymphoid malignancies: the dark side of B-cell differentiation,” Nat. Rev. Immunol., 2 (12), 920-932 (2002).;;Shaffer et al., “Signatures of the immune response,” Immunity, 15 (3), 375-385 (2001).;;Shalon et al., “A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization,” Genome Res., 6 (7), 639-645 (1996).;;Shipp et al., “A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project,” N. Engl. J. Med., 329 (14), 987-994 (1993).;;Shipp et al., “Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning,” Nat. Med, 8 (1), 68-74 (2002).;;Sonoki et al., “Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies,” Blood, 98 (9), 2837-2844 (2001).;;Southern et al., “Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids,” Nucleic Acids. Res., 22 (8), 1368-1373 (1994).;;Spellman et al., “Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization,” Mol. Biol. Cell, 9 (12), 3273-3297 (1998).;;Staudt et al., “The biology of human lymphoid malignancies revealed by gene expression profiling,” Adv. Immunol., 87, 163-208 (2005), Author Manuscript.;;Staudt et al., “Focus on lymphomas,” Cancer Cell, 2 (5), 363-366 (2002).;;Staudt, “Gene expression profiling of lymphoid malignancies,” Annu. Rev. Med., 53, 303-318 (2002).;;Staudt et al., “Genomic views of the immune system*,” Annu. Rev. Immunol., 18, 829-859 (2000).;;Staudt et al., “Molecular diagnosis of the hematologic cancers,” N. Engl. J. Med., 348 (18), 1777-1785 (2003).;;Staudt, “Its All in the diagnosis,” Cancer Cell, 1 (2), 109-110 (2002).;;Subramanian et al., “Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,” Proc. Natl. Acad. Sci. USA, 102 (43), 15545-15550 (2005).;;Tagawa et al., “Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma,” Blood, 106 (5), 1770-1777 (2005).;;Tamayo et al., “Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation,” Proc. Natl. Acad. Sci. USA, 96 (6), 2907-2912 (1999).;;Tavazoie et al., “Systematic determination of genetic network architecture,” Nature Genet., 22 (3), 281-285 (1999).;;Thieblemont et al., “Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis,” Blood, 103 (7), 2727-2737 (2004).;;Tibshirani et al., “Diagnosis of multiple cancer types by shrunken centroids of gene expression,” Proc. Natl. Acad. Sci. USA, 99 (10), 6567-6572 (2002).;;Triscott et al., “Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children,” Cancer Res., 73 (22), 6734-6744 (2013).;;Van Der Velden et al., “B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma,” Blood, 124 (3), 412-419 (2014).;;Velculescu et al., “Serial analysis of gene expression,” Science, 270 (5235), 484-487 (1995).;;Wells, “Lymphoma microenvironment impacts therapy and prognosis,” Hematology Times, 3 pp. (2008), http://www.hematologytimes.com/ht/p_article_print.do?id=437&section.;;Wiestner et al., “Towards molecular diagnosis and targeted therapy of lymphoid malignancies,” Semin. Hematol., 40 (4), 296-307 (2003).;;Winter et al., “Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study,” Blood, 107 (11), 4207-4213 (2006).;;Wodicka et al., “Genome-wide expression monitoring in Saccharomyces cerevisiae,” Nat. Biotechnol., 15 (13), 1359-1367 (1997).;;Wright et al., “A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma,” Proc. Natl. Acad. Sci. USA, 100 (17), 9991-9996 (2003).;;Written Opinion of the International Searching Authority, Application No. PCT/US2014/064161, dated Jul. 2009, 10 pp.;;Wuthrich et al., “MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells,” Kidney Int., 37 (2), 783-792 (1990).;;Xiu et al., “Analysis of survivin expression in subtypes of lymphoma,” Chinese J. Can., 23 (6), 655-661 (2004).;;Yatabe et al., “Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma,” Blood, 95 (7), 2253-2261 (2000).;;Ye et al., “Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma,” Blood, 102 (3), 1012-1018 (2003).;;Zeller et al., “An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets,” Genome Biol., 4 (10), 10 pp. (2003).;;Zhang et al., “Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression,” Br. J. Haemotology, 160 (4), 487-502 (2012).;;Japanese Patent Office, Office Action dated Oct. 16, 2018 in Application No. 2016-553231, with English translation, 15 pages.;;U.S. Appl. No. 10/934,930, filed Sep. 3, 2004.;;U.S. Appl. No. 11/493,387, filed Jul. 25, 2006.;;U.S. Appl. No. 12/592,778, filed Dec. 2, 2009.;;U.S. Appl. No. 12/996,489, filed Feb. 24, 2011.;;U.S. Appl. No. 13/008,403, filed Jan. 18, 2011.;;U.S. Appl. No. 13/409,416, filed Mar. 1, 2012.;;U.S. Appl. No. 14/540,302, filed Nov. 13, 2014.;;U.S. Appl. No. 14/570,316, filed Dec. 15, 2014.",ACTIVE
647,US,A1,US 2016/0283653 A1,108-719-237-331-507,2016-09-29,2016,US 201415035101 A,2014-11-05,US 201415035101 A;;US 201361900553 P;;US 2014/0064161 W,2013-11-06,METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNINVERSITY OF ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC;;BORD OF REGENTS ON THE UNIV OF NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS-MAXIMILIANS-UNIVERSITY OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;GUERRI ELIAS CAMPO;;TUBBS RAYMOND;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS,BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2016-08-15);;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2015-03-27);;OREGON HEALTH & SCIENCE UNIVERSITY (2016-09-08);;JULIUS-MAXIMILIANS-UNIVERSITY OF WÜRZBURG (2016-09-07);;HOSPITAL CLINIC DE BARCELONA (2016-09-02);;THE CLEVELAND CLINIC FOUNDATION (2015-03-24);;OSLO UNIVERSITY HOSPITAL HF (2016-08-16);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2016-09-06);;ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (2015-03-16);;UNIVERSITAT DE BARCELONA (2016-09-02),https://lens.org/108-719-237-331-507,Patent Application,yes,3,11,27,27,2460,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,G16B25/10;;C12Q1/68;;G16B5/00,,2,2,008-555-947-606-655;;116-351-259-268-93X,20167839;;10.1634/theoncologist.2009-0304;;pmc3227958;;pmc3342980;;10.3324/haematol.2011.056531;;22133772,"Castillo, et al. ""Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma,"" The oncologist, vol. 15 (2010) pp.293-299.;;Wilson et al., ""A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype,"" Haematologica, vol. 97 (2012) pp.758-765",ACTIVE
648,ES,T3,ES 2738289 T3,132-324-619-791-713,2020-01-21,2020,ES 14803288 T,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,Procedimiento para el subtipado de tipos de linfoma por medio de perfiles de expresión,"Un procedimiento para seleccionar una opción de tratamiento para un sujeto con linfoma difuso de linfocitos B grandes similares a linfocitos B activados (ABC DLBCL), un sujeto con linfoma difuso de linfocitos B grandes similares a linfocitos B del centro germinal (GCB DLBCL), un sujeto con linfoma primario mediastínico de linfocitos B (PMBL), un sujeto con linfoma de Burkitt (BL) o un sujeto con linfoma de células del manto (MCL), que comprende las etapas de: (a) aislar un producto de expresión génica de una muestra de biopsia de un sujeto con linfoma; (b) obtener datos de expresión génica digital a partir del producto de expresión génica aislado, en el que los datos de expresión génica digital comprenden datos para genes en una firma de expresión génica, y en el que la firma de expresión génica comprende al menos uno de los genes enumerados en la tabla 2; (c) obtener opcionalmente datos de expresión génica digital de un primer y segundo conjunto de sondas de referencia, el segundo conjunto de sondas de referencia conocido para clasificar ABC DLBCL, GCB DLBCL, PMBL, BL o MCL; (d) generar un promedio ponderado de los niveles de expresión de los genes a partir de la firma de expresión génica para obtener de este modo un valor de firma de expresión génica; (e) calcular una puntuación predictiva basada en el valor de la firma de expresión génica usando la ecuación: **Fórmula** en la que yi es una puntuación predictiva, xi son los recuentos para el gen i para el conjunto de sondas i, el conjunto de sondas i es de la muestra que se está sometiendo a análisis, xj es el recuento para el gen j para el conjunto de sondas j, el conjunto de sondas j es el conjunto de genes de normalización de la muestra que se está sometiendo a prueba, hj es el peso de normalización para el conjunto de sondas j como se enumera en la tabla 4, ri es el recuento para el gen i para el conjunto de sondas i en el primer conjunto de sondas de referencia, 30 y gi es el recuento de gen i para el conjunto de sondas i en el segundo conjunto de sondas de referencia, siendo los términos matemáticos con ri y gi igual a cero si no se obtienen datos de expresión génica digital de un primer y segundo conjunto de sondas de referencia; (f) clasificar el sujeto como perteneciente a uno de los siguientes en base a la puntuación predictiva de (e): (i) ABC DLBCL, (ii) GCB DLBCL, (iii) PMBL, (iv) BL o (v) MCL; (g) seleccionar una opción de tratamiento para el sujeto basada en la clasificación del sujeto en (f);",HOSPITAL CLINIC BARCELONA;;US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;ARIZONA BOARD OF REGENTS ON BEHALF OF UNIV OF ARIZONA;;UNIV BARCELONA;;UNIV NEBRASKA;;CLEVELAND CLINIC;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;TUBBS RAYMOND,,https://lens.org/132-324-619-791-713,Granted Patent,no,0,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,0,0,,,,ACTIVE
649,EP,A1,EP 3594359 A1,136-418-381-765-162,2020-01-15,2020,EP 19170689 A,2014-11-05,US 201361900553 P;;EP 14803288 A;;US 2014/0064161 W,2013-11-06,METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.
",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;ARIZONA BOARD OF REGENTS ON BEHALF OF UNIV OF ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;TUBBS RAYMOND,"BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2022-05-04);;ARIZONA BOARD OF REGENTS ON BEHALF OF UNIVERSITY OF ARIZONA (2022-05-04);;CLEVELAND CLINIC (2022-01-05);;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (2022-05-04);;OREGON HEALTH & SCIENCE UNIVERSITY (2022-05-04);;HOSPITAL CLINIC DE BARCELONA (2022-05-04);;THE CLEVELAND CLINIC FOUNDATION (2022-05-04);;OSLO UNIVERSITY HOSPITAL HF (2022-05-04);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2022-05-04);;JULIUS-MAXIMILIANS-UNIVERSITY OF WUERZBURG (2022-05-04);;UNIVERSITAT DE BARCELONA (2022-05-04)",https://lens.org/136-418-381-765-162,Patent Application,yes,46,0,27,27,2460,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,44,37,101-841-825-225-801;;026-589-581-583-417;;008-161-966-545-470;;080-261-677-082-739;;005-967-436-046-627;;139-742-950-119-640;;040-694-135-115-041;;005-952-510-626-477;;043-885-019-636-545;;093-992-351-106-367;;000-705-324-102-258;;160-631-360-016-499;;046-044-728-292-565;;051-346-920-381-327;;083-926-915-990-672;;014-065-259-226-128;;071-699-049-017-661;;041-085-398-221-48X;;081-376-983-952-92X;;023-425-205-244-323;;053-141-431-021-519;;085-467-264-451-562;;079-336-969-276-20X;;031-538-684-093-737;;003-117-956-540-879;;043-885-019-636-545;;078-147-429-983-57X;;012-855-494-804-729;;068-614-447-896-338;;115-496-463-132-125;;037-047-957-053-389;;047-322-007-088-891;;035-255-900-380-462;;014-557-082-098-140;;056-464-372-256-072;;034-506-218-618-076;;068-584-499-536-196,19455257;;pmc2675856;;10.1177/117693510700300004;;12900505;;10.1073/pnas.1732008100;;pmc187912;;23252516;;10.1111/bjh.12172;;10.1038/bjc.2012.272;;22722314;;pmc3405213;;pmc3418848;;22442255;;10.1074/mcp.m111.015362;;10.1007/s10330-004-0351-8;;10.1038/35000501;;10676951;;10.1158/1055-9965.epi-10-0091;;20332269;;pmc2864144;;10.1126/science.270.5235.484;;7570003;;1380482;;10.1016/0888-7543(92)90014-j;;7514785;;10.1093/nar/22.8.1368;;pmc307992;;8895530;;8828038;;10.1101/gr.6.6.492;;10.1126/science.270.5235.467;;7569999;;10.1038/ng1296-457;;8944026;;8855227;;pmc38202;;10.1073/pnas.93.20.10614;;8796352;;10.1101/gr.6.7.639;;10.1126/science.278.5338.680;;9381177;;pmc20056;;9122163;;10.1073/pnas.94.6.2150;;pmc24262;;9371799;;10.1073/pnas.94.24.13057;;8197176;;10.1073/pnas.91.11.5022;;pmc43922;;7495558;;10.1126/science.274.5287.610;;8849452;;10.1038/nbt1296-1675;;9634850;;9415887;;10.1038/nbt1297-1359;;10.1126/science.270.5235.484;;7570003;;14676315;;pmc307634;;10.1073/pnas.2536670100;;10.1186/bcr2189;;18954444;;pmc2614499;;10.1038/nmeth.1226;;18516045;;10.1002/0471142727.mb25b10s94;;10.1038/nbt1385;;18278033;;11567628;;10.1016/s1074-7613(01)00194-7;;12075054;;10.1056/nejmoa012914;;pmc9103713;;10.1056/nejmoa0802885;;19038878;;7680764;;10.1056/nejm199304083281404;;9850025;;10.1200/jco.1998.16.12.3803;;10.1158/1078-0432.ccr-09-0113;;19706817;;pmc7289055,"S BLENK ET AL: ""Cancer Informatics 2007:3 399-420 Germinal Center B Cell-Like (GCB) and Activated B Cell-Like (ABC) Type of Diffuse Large B Cell Lymphoma (DLBCL): Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival"", 12 December 2007 (2007-12-12), XP055171680, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675856/pdf/cin-03-399.pdf> [retrieved on 20150224];;WRIGHT G ET AL: ""A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 100, no. 17, 19 August 2003 (2003-08-19), pages 9991 - 9996, XP002322638, ISSN: 0027-8424, DOI: 10.1073/PNAS.1732008100;;LING-HUA ZHANG ET AL: ""Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression"", BRITISH JOURNAL OF HAEMATOLOGY, vol. 160, no. 4, 18 December 2012 (2012-12-18), pages 487 - 502, XP055171665, ISSN: 0007-1048, DOI: 10.1111/bjh.12172;;L BRAULT ET AL: ""PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma"", BRITISH JOURNAL OF CANCER, vol. 107, no. 3, 21 June 2012 (2012-06-21), pages 491 - 500, XP055171664, ISSN: 0007-0920, DOI: 10.1038/bjc.2012.272;;S. J. DEEB ET AL: ""Super-SILAC Allows Classification of Diffuse Large B-cell Lymphoma Subtypes by Their Protein Expression Profiles"", MOLECULAR & CELLULAR PROTEOMICS, vol. 11, no. 5, 21 March 2012 (2012-03-21), pages 77 - 89, XP055171662, ISSN: 1535-9476, DOI: 10.1074/mcp.M111.015362;;GU XIA ET AL: ""[Analysis of survivin expression in subtypes of lymphoma]."", AI ZHENG = AIZHENG = CHINESE JOURNAL OF CANCER JUN 2004, vol. 23, no. 6, June 2004 (2004-06-01), pages 655 - 661, XP055171538;;""WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"", 2008, INTERNATIONAL AGENCY FOR RESEARCH ON CANCER ; WORLD HEALTH ORGANIZATION;;JAFFE, E.S.: ""Classification of Tumours, Pathology and Genetics series"", 2001, WHO, article ""Pathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues"";;SEE ALIZADEH ET AL., NATURE, vol. 403, 2000, pages 503 - 511;;""Histological and Histochemical Methods: Theory and Practice"", 2008, COLD SPRING HARBOR LABORATORY PRESS;;HUANG ET AL., CANCER EPIDEMIOL BIOMARKERS PREV., vol. 19, 2010, pages 973 - 977;;VELCULESCU ET AL., SCIENCE, vol. 270, 1995, pages 484 - 487;;SOUTHERN ET AL., GENOMICS, vol. 13, 1992, pages 1008 - 1017;;SOUTHERN ET AL., NUCL. ACIDS. RES., vol. 22, 1994, pages 1368 - 1373;;GRESS ET AL., ONCOGENE, vol. 13, 1996, pages 1819 - 1830;;PIETU ET AL., GENOME RES.,, vol. 6, 1996, pages 492 - 503;;SCHENA ET AL., SCIENCE, vol. 270, 1995, pages 467 - 470;;DERISI ET AL., NAT. GENET.,, vol. 14, 1996, pages 457 - 460;;SCHENA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 10614 - 10619;;SHALON ET AL., GENOME RES., vol. 6, 1996, pages 639 - 645;;DERISI ET AL., SCIENCE, vol. 278, 1997, pages 680 - 686;;HELLER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 2150 - 2155;;LASHKARI ET AL., PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 13057 - 13062;;PEASE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 5022 - 5026;;LIPSHUTZ ET AL., BIOTECHNIQUES, vol. 19, 1995, pages 442 - 447;;CHEE ET AL., SCIENCE, vol. 274, 1996, pages 610 - 14;;LOCKHART ET AL., NAT. BIOTECHNOL., vol. 14, 1996, pages 1675 - 1680;;WODICKA ET AL., NAT. BIOTECHNOL., vol. 15, 1997, pages 1359 - 1367;;VELCULESCU ET AL., SCIENCE, vol. 270, no. 5235, 1995, pages 484 - 487;;MATSUMURA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 100, no. 26, 2003, pages 15718 - 15723;;CAO ET AL., BREAST CANCER RESEARCH, vol. 10, 2008, pages R91;;MORTAZAVI ET AL., NAT METHODS,, vol. 5, no. 7, 2008, pages 621 - 628;;KULKARNI, M. M.: ""Digital Multiplexed Gene Expression Analysis Using the NANOSTRINGTM NCOUNTERTM System"", CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, vol. 94, 2011, pages 25B.10.1 - 25B.10.17;;GEISS ET AL., NATURE BIOTECHNOLOGY, vol. 26, 2008, pages 317 - 325;;SHAFFER ET AL., IMMUNITY, vol. 15, 2001, pages 375 - 385;;ROSENWALD ET AL., NEW ENGL. J. MED., vol. 346, 2002, pages 1937 - 1947;;LENZ ET AL., N. ENGL. J. MED.,, vol. 359, 2008, pages 2313 - 2323;;FISHER ET AL., N. ENGL. J. MED., vol. 328, 1993, pages 1002 - 1006;;KHOURI ET AL., J. CLIN. ONCOL.,, vol. 12, 1998, pages 3803 - 3809;;LENZ ET AL., N. ENGL. J. MED., vol. 359, 2008, pages 2313 - 2323;;ANS ET AL., BLOOD, vol. 103, no. 1, 2004, pages 275 - 82;;MEYER ET AL., J. CLIN. ONCOL.,, vol. 29, no. 2, 2011, pages 200 - 207;;CHOI ET AL., CLIN. CANCER RES., vol. 15, no. 17, 2009, pages 5494 - 502;;SCOTT ET AL., BLOOD, January 2014 (2014-01-01)",ACTIVE
650,EP,B1,EP 3594359 B1,100-915-615-967-877,2022-05-18,2022,EP 19170689 A,2014-11-05,US 201361900553 P;;EP 14803288 A;;US 2014/0064161 W,2013-11-06,METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING,,US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;ARIZONA BOARD OF REGENTS ON BEHALF OF UNIV OF ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC FOUND;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;TUBBS RAYMOND,"BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (2022-05-04);;CLEVELAND CLINIC (2022-01-05);;ARIZONA BOARD OF REGENTS ON BEHALF OF UNIVERSITY OF ARIZONA (2022-05-04);;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (2022-05-04);;OREGON HEALTH & SCIENCE UNIVERSITY (2022-05-04);;HOSPITAL CLINIC DE BARCELONA (2022-05-04);;THE CLEVELAND CLINIC FOUNDATION (2022-05-04);;OSLO UNIVERSITY HOSPITAL HF (2022-05-04);;BRITISH COLUMBIA CANCER AGENCY BRANCH (2022-05-04);;JULIUS-MAXIMILIANS-UNIVERSITY OF WUERZBURG (2022-05-04);;UNIVERSITAT DE BARCELONA (2022-05-04)",https://lens.org/100-915-615-967-877,Granted Patent,yes,0,0,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,5,4,013-477-384-917-90X;;149-160-133-704-041;;137-639-038-744-87X;;163-155-617-270-295,10.1369/0022155411417309;;21832150;;pmc3201129;;19029149;;10.3324/haematol.12986;;pmc2625430;;24117687;;10.1111/his.12223;;10.1038/modpathol.2009.73;;19448593,"SALAH A AL-HUMOOD ET AL: ""Genotypic and Phenotypic Differences between Nodal and Extranodal Diffuse Large B-Cell Lymphomas"", JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1 October 2011 (2011-10-01), Sage CA: Los Angeles, CA, pages 918 - 931, XP055171675, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pubmed/21832150> DOI: 10.1369/0022155411417309;;I. TAKEUCHI ET AL: ""The potential of copy number gains and losses, detected by array-based comparative genomic hybridization, for computational differential diagnosis of B-cell lymphomas and genetic regions involved in lymphomagenesis"", HAEMATOLOGICA, vol. 94, no. 1, 1 January 2009 (2009-01-01), pages 61 - 69, XP055171424, ISSN: 0390-6078, DOI: 10.3324/haematol.12986;;RACHEL E CULPIN ET AL: ""Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients"", HISTOPATHOLOGY, vol. 63, no. 6, 1 October 2013 (2013-10-01), pages 788 - 801, XP055171666, ISSN: 0309-0167, DOI: 10.1111/his.12223;;GU X AND LIN HL: ""[Analysis of survivin expression in subtypes of lymphoma]. - PubMed - NCBI"", 1 June 2004 (2004-06-01), XP055171448, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pubmed/15191665> [retrieved on 20150223];;HEIDI NYMAN ET AL: ""Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP"", MODERN PATHOLOGY, vol. 22, no. 8, 15 May 2009 (2009-05-15), pages 1094 - 1101, XP055171669, ISSN: 0893-3952, DOI: 10.1038/modpathol.2009.73",ACTIVE
651,KR,A,KR 20160127713 A,151-061-530-472-959,2016-11-04,2016,KR 20167014876 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING,"본 발명은 대상로부터, 예를 들어 생검 샘플로부터 획득된 디지털 유전자 발현 데이터를 분석함으로써, 활성화된 B 세포-형 미만성 거대 B 세포 림프종(ABC DLBCL) 대상, 배중심 B 세포-형 미만성 거대 B 세포 림프종(GCB DLBCL) 대상, 원발성 종격동 B 세포 림프종(PMBL) 대상, 버킷 림프종(BL) 대상, 또는 외투세포 림프종(MCL) 대상에 대한 치료 옵션을 선택하는 방법에 관한 것이다.",US HEALTH;;UNIV BARCELONA;;UNIV OREGON HEALTH & SCIENCE;;ARIZONA BOARD OF REGENTS ON BEHALF OF UNIV OF ARIZONA;;HOSPITAL CLINIC BARCELONA;;JULIUS-MAXIMILIANS UNIV WUERZBURG;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;OSLO UNIV HOSPITAL HF;;UNIV NEBRASKA;;CLEVELAND CLINIC FOUND,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;TUBBS RAYMOND;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS,,https://lens.org/151-061-530-472-959,Patent Application,no,3,0,27,27,4920,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,0,0,,,,ACTIVE
652,US,B2,US 11574704 B2,172-955-720-792-237,2023-02-07,2023,US 202016746347 A,2020-01-17,US 202016746347 A;;US 201615035101 A;;US 2014/0064161 W;;US 201361900553 P,2013-11-06,Method for subtyping lymphoma types by means of expression profiling,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;UNIV ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC FOUND;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS—UNIVERSITY OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;GUERRI ELIAS CAMPO;;TUBBS RAYMOND;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS,,https://lens.org/172-955-720-792-237,Granted Patent,yes,81,0,27,27,2460,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,G01N33/48;;G16B25/10;;C12Q1/6886;;G16B5/00;;G16B25/00,,185,170,044-611-856-177-401;;040-694-135-115-041;;016-596-651-939-443;;016-006-028-791-093;;008-419-113-437-385;;056-453-977-117-995;;034-452-195-533-57X;;060-759-207-536-364;;053-932-758-603-87X;;051-786-486-516-995;;101-841-825-225-801;;024-946-492-182-494;;080-261-677-082-739;;012-855-494-804-729;;008-555-947-606-655;;079-336-969-276-20X;;081-079-559-532-247;;024-490-999-993-98X;;068-584-499-536-196;;047-262-184-051-895;;004-727-308-938-832;;030-896-154-936-42X;;054-078-060-931-86X;;090-176-895-315-998;;033-968-074-794-870;;070-747-278-744-464;;090-064-710-132-858;;021-650-522-587-897;;005-967-436-046-627;;037-836-837-269-988;;032-611-541-376-312;;041-085-398-221-48X;;083-926-915-990-672;;057-287-836-052-142;;166-928-472-179-298;;013-529-949-265-243;;033-916-592-216-662;;033-971-166-966-681;;008-479-304-060-255;;037-236-591-728-945;;025-520-775-172-251;;056-464-372-256-072;;024-527-436-840-118;;010-838-505-357-69X;;037-047-957-053-389;;069-311-247-178-567;;029-742-983-481-795;;160-631-360-016-499;;107-296-031-742-505;;083-931-891-231-212;;016-533-931-410-773;;008-066-052-380-31X;;166-832-177-257-760;;081-376-983-952-92X;;099-803-524-269-475;;006-606-201-561-766;;104-557-009-702-690;;013-402-932-169-492;;047-817-434-820-973;;017-934-499-413-775;;005-952-510-626-477;;081-031-514-300-626;;029-974-412-724-477;;087-871-690-717-906;;026-225-449-299-526;;131-905-544-919-039;;003-583-041-937-112;;022-393-675-280-070;;000-322-118-693-394;;096-603-188-929-757;;068-762-846-278-363;;034-506-218-618-076;;033-627-282-704-547;;007-974-316-902-490;;083-330-301-419-474;;014-280-105-584-733;;023-425-205-244-323;;004-773-466-896-807;;014-557-082-098-140;;050-502-569-231-297;;085-467-264-451-562;;031-538-684-093-737;;016-150-622-242-94X;;178-935-842-768-083;;078-147-429-983-57X;;075-838-748-885-137;;039-385-706-948-676;;102-508-786-930-192;;039-781-158-431-16X;;006-530-638-049-054;;068-614-447-896-338;;024-500-130-167-872;;019-138-428-462-268;;028-569-460-877-835;;023-599-464-062-049;;062-366-341-744-610;;028-925-425-329-938;;048-325-804-402-273;;098-721-574-391-14X;;037-717-936-973-653;;053-141-431-021-519;;046-044-728-292-565;;069-185-424-344-964;;055-691-371-341-340;;095-208-239-623-138;;040-382-367-616-74X;;036-274-890-235-324;;051-186-934-591-472;;014-565-650-855-999;;078-452-543-920-848;;084-282-120-664-916;;089-264-099-925-423;;038-246-842-310-750;;004-162-318-388-875;;043-042-357-918-339;;074-128-110-532-508;;052-672-767-581-401;;001-476-207-579-575;;015-395-832-493-244;;035-255-900-380-462;;018-364-083-825-391;;040-439-415-810-331;;027-657-011-129-499;;061-990-723-525-723;;014-065-259-226-128;;051-346-920-381-327;;009-793-691-951-016;;044-412-429-345-691;;001-018-672-231-808;;055-831-640-840-407;;190-172-199-061-514;;007-669-468-009-211;;047-322-007-088-891;;071-699-049-017-661;;021-104-159-501-594;;079-667-051-092-518;;041-898-993-227-665;;000-705-324-102-258;;020-914-368-965-430;;019-595-273-525-116;;009-118-554-603-358;;061-643-519-956-079;;026-677-172-273-32X;;025-569-223-928-169;;101-346-478-869-486;;108-298-116-795-433;;098-335-021-363-434;;072-928-593-005-990;;030-100-080-719-126;;057-959-241-615-654;;050-723-935-789-629;;031-846-362-071-660;;086-474-226-374-65X;;043-885-019-636-545;;019-693-630-289-481;;116-351-259-268-93X;;026-266-975-077-828;;003-117-956-540-879;;026-589-581-583-417;;047-836-705-919-603;;139-742-950-119-640;;013-322-445-914-037;;006-958-690-304-873;;109-942-379-781-827;;008-161-966-545-470;;013-477-384-917-90X;;137-639-038-744-87X;;163-155-617-270-295;;149-160-133-704-041;;139-742-950-119-640,10.1101/sqb.1999.64.71;;11232339;;10.1038/35000501;;10676951;;pmc21986;;10.1073/pnas.96.12.6745;;10359783;;pmc5926895;;12460461;;10.1111/j.1349-7006.2002.tb01225.x;;10.1016/s0165-4608(97)00291-4;;9530346;;15331443;;10.1182/blood-2003-12-4291;;15337798;;10.1200/jco.2004.11.025;;12181265;;10.1097/01.mp.0000024375.04135.2b;;10.1034/j.1600-065x.2003.00052.x;;12846810;;10923106;;10.3109/07357900009012197;;19455257;;pmc2675856;;10.1177/117693510700300004;;11607812;;10.1038/sj.onc.1204595;;10.1038/bjc.2012.272;;22722314;;pmc3405213;;10.1186/bcr2189;;18954444;;pmc2614499;;20167839;;10.1634/theoncologist.2009-0304;;pmc3227958;;10.1126/science.274.5287.610;;8849452;;10.1182/blood.v95.2.619;;10627471;;9702192;;10.1016/s1097-2765(00)80114-8;;10.1158/1078-0432.ccr-09-0113;;19706817;;pmc7289055;;10.1126/science.282.5389.699;;9784122;;10.1002/(sici)1098-2264(199906)25:2<123::aid-gcc8>3.3.co;2-w;;10337996;;10.1002/(sici)1098-2264(199906)25:2<123::aid-gcc8>3.0.co;2-4;;11807147;;10.1056/nejmoa011795;;pmc4174364;;10.1245/s10434-013-3240-y;;24046106;;10.1097/01.mp.0000032534.81894.b3;;12429796;;11850073;;10.1016/s0165-4608(01)00548-9;;10.1056/nejmoa055759;;16760443;;pmc2193582;;10.1084/jem.194.12.1861;;11748286;;12042708;;10.1097/00062752-200207000-00011;;pmc3418848;;22442255;;10.1074/mcp.m111.015362;;15229187;;10.1093/hmg/ddh195;;10.1182/blood.v85.10.2870.bloodjournal85102870;;7742549;;10.1126/science.278.5338.680;;9381177;;10.1038/ng1296-457;;8944026;;10.1002/(sici)1096-9896(199806)185:2<159::aid-path73>3.0.co;2-0;;9713342;;10.1038/leu.2014.171;;24854989;;15245604;;10.3816/clm.2004.n.006;;9843981;;10.1073/pnas.95.25.14863;;pmc24541;;18645603;;10.2174/138920207780833801;;pmc2435353;;10.1158/0008-5472.can-09-3419;;20124476;;23152841;;10.1371/journal.pone.0049010;;pmc3494663;;15870177;;10.1182/blood-2004-12-4901;;7680764;;10.1056/nejm199304083281404;;10.1038/nbt0308-293;;18327237;;pmc1895253;;16123218;;10.1182/blood-2005-04-1753;;10.1038/nbt1385;;18278033;;11122110;;10.1046/j.1365-2141.2000.02352.x;;10.1126/science.286.5439.531;;10521349;;8895530;;14504078;;10.1182/blood-2003-05-1545;;10.1038/modpathol.3800434;;15920548;;10.1097/01.pas.0000168176.71405.e5;;16006805;;7805040;;20421449;;pmc2924229;;10.1182/blood-2010-01-263806;;pmc20056;;9122163;;10.1073/pnas.94.6.2150;;17265723;;10.1007/978-0-387-39978-2_13;;10.1016/j.acthis.2010.11.001;;21145576;;pmc4657859;;10.1182/blood.v98.3.787;;11468180;;10.1016/s0092-8674(00)81641-4;;9845373;;11895757;;10.1182/blood.v99.7.2285;;24789858;;10.1158/1055-9965.epi-14-0395;;pmc4394836;;10.1158/1055-9965.epi-10-0091;;20332269;;pmc2864144;;10.1186/1476-4598-12-13;;23409773;;pmc3626580;;16760442;;10.1056/nejmoa055351;;12414653;;10.1038/nrc2775;;20383180;;10.1093/annonc/mdf155;;12123339;;pmc1618550;;10.1016/s0002-9440(10)63284-1;;15215171;;10.1016/j.beha.2009.05.001;;19698928;;8623927;;pmc1861570;;17891190;;10.1038/nrc2230;;10.1038/89044;;pmc1282521;;11385503;;9850025;;10.1200/jco.1998.16.12.3803;;pmc279815;;2894030;;10.1073/pnas.85.5.1571;;9787151;;10.1182/blood.v92.9.3152;;16006802;;10.1097/01.pas.0000167362.06148.95;;2676601;;10.1016/0014-5793(89)81066-x;;pmc24262;;9371799;;10.1073/pnas.94.24.13057;;10.1126/science.1153629;;18323416;;pmc9103713;;10.1056/nejmoa0802885;;19038878;;10.1093/bioinformatics/bti824;;16339281;;7495558;;10.1038/nbt1296-1675;;9634850;;10.1158/1535-7163.mct-05-0146;;16373702;;14678979;;14676315;;pmc307634;;10.1073/pnas.2536670100;;10.1200/jco.2010.30.0368;;pmc3058275;;21135273;;10.3892/ijo.24.3.497;;14767533;;10.1182/blood.v87.12.5269.bloodjournal87125269;;8652842;;24515757;;10.1309/ajcp3cp6vfzjymtk;;15550490;;10.1182/blood-2004-07-2947;;10.1038/nmeth.1226;;18516045;;10.1182/blood-2002-11-3442;;12576316;;2833750;;10.1073/pnas.85.8.2748;;pmc280076;;16572121;;10.1038/nature04687;;22057785;;pmc3306784;;10.1007/s00401-011-0899-7;;10.1182/blood-2006-09-047068;;17299093;;10.1158/0008-5472.can-04-0756;;15374954;;10.1182/blood-2007-02-068791;;18024791;;9376597;;10.1182/blood.v90.8.3154;;pmc2689138;;10.1172/jci38248;;19451695;;8197176;;10.1073/pnas.91.11.5022;;pmc43922;;8828038;;10.1101/gr.6.6.492;;12898595;;10.1002/path.1384;;pmc4485451;;24080457;;10.1016/j.cancergen.2013.07.003;;pmc3447789;;10.1371/journal.pone.0045656;;23029164;;pmc1852938;;9665478;;10.1016/s0002-9440(10)65558-7;;12162889;;10.1089/106652702760138592;;pmc3953419;;24140199;;10.1016/s1470-2045(13)70449-2;;11742071;;10.1073/pnas.211566398;;pmc64998;;10.1038/nrc1322;;15057290;;10.1182/blood.v92.1.234.413k22_234_240;;9639522;;14976040;;10.1182/blood-2003-07-2365;;16098065;;10.1111/j.1365-2141.2005.05630.x;;pmc1906980;;10.1016/s1525-1578(10)60693-9;;12169673;;14600649;;14723013;;15202524;;10.1080/10428190310001623775;;10.1084/jem.20031074;;12975453;;pmc2194208;;12620412;;10.1016/s1535-6108(03)00028-x;;12075054;;10.1056/nejmoa012914;;10.1182/blood-2004-10-3907;;15718413;;23433739;;10.3410/f.717980688.793474808;;10.1016/s0140-6736(12)61763-2;;pmc2366164;;10.1200/jco.2006.08.4251;;17296973;;10.1182/blood-2003-06-1841;;12933571;;8855227;;pmc38202;;10.1073/pnas.93.20.10614;;10.1126/science.270.5235.467;;7569999;;14961037;;10.1038/sj.leu.2403293;;12719886;;10.1007/s00277-003-0649-6;;pmc3931191;;10.1182/blood-2013-11-536433;;24398326;;17105812;;10.1182/blood-2006-08-038257;;10.1111/j.0105-2896.2006.00373.x;;12461565;;10.1038/nri953;;11567628;;10.1016/s1074-7613(01)00194-7;;8796352;;10.1101/gr.6.7.639;;10.1056/nejm199309303291402;;8141877;;10.1038/nm0102-68;;10.1038/news011227-7;;11786909;;11675358;;10.1182/blood.v98.9.2837;;7514785;;10.1093/nar/22.8.1368;;pmc307992;;10.1091/mbc.9.12.3273;;9843569;;pmc25624;;pmc1351148;;10.1016/s0065-2776(05)87005-1;;16102574;;12450791;;10.1016/s1535-6108(02)00178-2;;10.1146/annurev.med.53.082901.103941;;11818476;;10.1146/annurev.immunol.18.1.829;;10837077;;10.1056/nejmra020067;;12724484;;12086866;;10.1016/s1535-6108(02)00036-3;;10.1073/pnas.0506580102;;16199517;;pmc1239896;;10.1182/blood-2005-02-0542;;15886317;;10.1073/pnas.96.6.2907;;10077610;;pmc15868;;10.1038/10343;;10391217;;14630827;;10.1182/blood-2003-06-2160;;12011421;;10.1073/pnas.082099299;;pmc124443;;10.1158/0008-5472.can-12-4331;;24019381;;10.1182/blood-2013-10-533869;;24891323;;10.1126/science.270.5235.484;;7570003;;10.1016/s0037-1963(03)00194-x;;14582080;;pmc3342980;;10.3324/haematol.2011.056531;;22133772;;10.1182/blood-2005-10-4222;;16449523;;pmc1895783;;9415887;;10.1038/nbt1297-1359;;12900505;;10.1073/pnas.1732008100;;pmc187912;;10.1038/ki.1990.46;;2407890;;10.1007/s10330-004-0351-8;;10733493;;10.1182/blood-2002-11-3502;;12676782;;10.1186/gb-2003-4-10-r69;;pmc328458;;14519204;;23252516;;10.1111/bjh.12172;;10.1369/0022155411417309;;21832150;;pmc3201129;;24117687;;10.1111/his.12223;;10.1038/modpathol.2009.73;;19448593;;19029149;;10.3324/haematol.12986;;pmc2625430;;10.1007/s10330-004-0351-8,"U.S. Appl. No. 10/934,930, filed Sep. 3, 2004.;;U.S. Appl. No. 11/493,387, filed Jul. 25, 2006.;;U.S. Appl. No. 12/592,778, filed Dec. 2, 2009.;;U.S. Appl. No. 12/996,489, filed Feb. 24, 2011.;;U.S. Appl. No. 13/008,403, filed Jan. 18, 2011.;;U.S. Appl. No. 13/409,416, filed Mar. 1, 2012.;;U.S. Appl. No. 14/540,302, filed Nov. 13, 2014.;;U.S. Appl. No. 14/570,316, filed Dec. 15, 2014.;;U.S. Appl. No. 15/035,101, filed May 6, 2016.;;Alizadeh et al., “The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes,” Cold Spring Harbor Symp. Quant. Biol., 64, 71-78 (1999).;;Alizadeh et al., “Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling,” Nature, 403 (6769), 503-511 (2000).;;Alon et al., “Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays,” Proc. Natl. Acad. Sci. USA, 96 (12), 6745-6750 (1999).;;Ando et al., “Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell lymphoma,” Jpn. J. Cancer Res., 93, 1207-1212 (2002).;;Andreasson et al., “Genomic amplification of CCND2 is rare in non-Hodgkin lymphomas,” Cancer Genet. Cytogenet., 102 (1), 81-82 (1998).;;Basso et al., “Tracking CD40 signaling during germinal center development,” Blood, 104 (13), 4088-4096 (2004).;;Bea et al., “Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas,” J. Clin. Oncol., 22 (17), 3498-3506 (2004).;;Berglund et al., “Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization,” Mod. Pathol., 15 (8), 807-816 (2002).;;Bergsagel et al., “Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma,” Immunol. Rev., 194, 96-104 (2003).;;Bishop et al., “Burkitt's lymphoma: molecular pathogenesis and treatment,” Cancer Invest., 18 (6), 574-583 (2000).;;Blenk et al., “Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival,” Cancer Inform., 3, 399-420 (2007).;;Boxer et al., “Translocations involving c-myc and c-myc function,” Oncogene, 20 (40), 5595-5610 (2001).;;Brault et al., “PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma,” Br. J. Canc., 107 (3), 491-500 (2012).;;Cao et al., “Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9,” Breast Cancer Res., 10 (5), 10 pp. (2008).;;Castillo et al., “Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma,” The oncologist, 15:293-299 (2010).;;Chee et al., “Accessing genetic information with high-density DNA arrays,” Science, 274 (5287), 610-614 (1996).;;Chiarle et al., “Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma,” Blood, 95 (2), 619-626 (2000).;;Cho et al., “A genome-wide transcriptional analysis of the mitotic cell cycle,” Mol. Cell., 2 (1), 65-73 (1998).;;Choi et al., “A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy,” Clin. Cancer Res., 15 (17), 5494-5502 (2009).;;Chu et al., “The transcriptional program of sporulation in budding yeast,” Science, 282 (5389), 699-705 (1998).;;Cigudosa et al., “Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas,” Genes Chromosomes Cancer, 25 (2), 123-133 (1999).;;Coiffier et al., “CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma,” N. Engl. J. Med., 346 (4), 235-242 (2002).;;Collins et al., “A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma,” Ann. Surg. Oncol., 21 (1), 133-138 (2014) Author Manuscript.;;Copie-Bergman et al., “MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas,” Mod Pathol., 15 (11), 1172-1180 (2002).;;Dave et al., “Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization,” Cancer Genet. Cytogenet., 132 (2), 125-132 (2002).;;Dave et al., “Molecular diagnosis of Burkitt's lymphoma,” N. Engl. J. Med., 354 (23), 2431-2442 (2006).;;Davis et al., “Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells,” J. Exp. Med., 194 (12), 1861-1874 (2001).;;Davis et al., “Molecular diagnosis of lymphoid malignancies by gene expression profiling,” Curr. Opin. Hematol., 9 (4), 333-338 (2002).;;Deeb et al., “Super-SILAC Allows Classification of Diffuse Large B-cell Lymphoma Subtypes by Their Protein Expression Profiles,” Mol. Cell. Proteomics, 11(5), 77-89 (2012).;;De Leeuw et al., “Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes,” Hum. Mol. Genet., 13 (17), 1827-1837 (2004).;;Delmer et al., “Overexpression of cyclin D2 in chronic B-cell malignancies,” Blood, 85 (10), 2870-2876 (1995).;;Derisi et al., “Exploring the metabolic and genetic control of gene expression on a genomic scale,” Science, 278 (5338), 680-686 (1997).;;Derisi et al., “Use of a cDNA microarray to analyse gene expression patterns in human cancer,” Nat. Genet., 14 (4), 457-460 (1996).;;Doglioni et al., “Cyclin D3 expression in normal, reactive and neoplastic tissues,” J. Pathol., 185 (2), 159-166 (1998).;;Dreyling et al., “How to manage mantle cell lymphoma,” Leukemia, 28 (11), 2117-2130 (2014).;;Dudoit et al., “Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data,” J. Am. Stat. Assoc., 97 (457), 77-87 (2002).;;Dybkaer et al., “Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma,” Clinical Lymphoma, 5 (1), 19-28 (2004).;;Eisen et al., “Cluster analysis and display of genome-wide expression patterns,” Proc. Natl. Acad. Sci. USA, 95 (25), 14863-14868 (1998).;;Ek et al., “Parallel gene expression profiling of mantle cell lymphoma—how do we transform 'omics data into clinical practice,” Curr. Genomics, 8 (3), 171-179 (2007).;;Fernandez et al., “Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma,” Cancer Res., 70 (4), 1408-1418 (2010).;;Fernandez et al., “Using digital RNA counting and flow cytometry to compare mRNA with protein expression in acute leukemias,” PLoS One, 7(11), e49010 (2012), 10 pp.;;Feuerhake et al., “NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes,” Blood, 106 (4), 1392-1399 (2005).;;Fisher et al., “Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma,” N. Engl. J. Med., 328 (14), 1002-1006 (1993).;;Fortina et al., “Digital mRNA profiling,” Nat. Biotechnol., 26 (3), 293-294 (2008).;;Fu et al., “Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling,” Blood, 106 (13), 4315-4321 (2005).;;Geiss et al., “Direct multiplexed measurement of gene expression with color-coded probe pairs,” Nat. Biotechnol., 26 (3), 317-325 (2008).;;Goff et al., “The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma,” Br. J. Haematol., 111 (2), 618-625 (2000).;;Golub et al., “Molecular classification of cancer: class discovery and class prediction by gene expression monitoring,” Science, 286 (5439), 531-537 (1999).;;Gress et al., “A pancreatic cancer-specific expression profile,” Oncogene, 13 (8), 1819-1830 (1996).;;Hans et al., “Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray,” Blood, 103 (1), 275-82 (2004).;;Hans et al., “Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma,” Mod. Pathol., 18 (10), 1377-1384 (2005).;;Haralambieva et al., “Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma,” Am. J. Surg. Pathol., 29 (8), 1086-1094 (2005).;;Harpole et al., “A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression,” Cancer Res., 55 (1), 51-56 (1995).;;Hartmann et al., “Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling,” Blood, 116 (6), 953-961 (2010).;;Heller et al., “Discovery and analysis of inflammatory disease-related genes using cDNA microarrays,” Proc. Natl. Acad. Sci. USA, 94 (6), 2150-2155 (1997).;;Henrickson et al., “Gene expression profiling in malignant lymphomas,” Adv. Exp. Med. Biol., 593, 134-146 (2007).;;Henson et al., “Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma,” Acta Histochem, 113 (7), 729-742 (2011), Author Manuscript.;;Hofmann et al., “Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray,” Blood, 98 (3), 787-794 (2001).;;Holstege et al., “Dissecting the regulatory circuitry of a eukaryotic genome,” Cell, 95 (5), 717-728 (1998).;;Huang et al., “The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile,” Blood, 99 (7), 2285-2290 (2002).;;Huang et al., “Retraction: Simultaneous recovery of DNA and RNA from formalin-fixed paraffin-embedded tissue and application in epidemiologic studies,” Cancer Epidemiol Biomarkers Prev, 23 (6), 1132 (2014).;;Huang et al., “Simultaneous recovery of DNA and RNA from formalin-fixed paraffin-embedded tissue and application in epidemiologic studies,” Cancer Epidemiol Biomarkers Prev., 19 (4), 973-977 (2010), retracted May 1, 2014.;;Hudson et al., “Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer,” Mol. Cancer, 12, 13 pp. (2013).;;Hummel et al., “A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling,” N. Engl. J. Med., 354 (23), 2419-2430 (2006).;;Hyman et al., “Impact of DNA amplification on gene expression patterns in breast cancer,” Cancer Res., 62 (21), 6240-6245 (2002).;;Hymowitz et al., “A20: from ubiquitin editing to tumour suppression,” Nat. Rev. Cancer, 10 (5), 332-340 (2010).;;Igarashi et al., “Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study,” Ann. Oncol., 13 (6), 928-943 (2002).;;International Preliminary Report on Patentability, Application No. PCT/US2014/064161, dated May 10, 2016, 11 pp.;;International Search Report, Application No. PCT/US2014/064161, dated Mar. 5, 2015, 7 pp.;;Iqbal et al., “BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma,” Am. J. Pathol., 165 (1), 159-166 (2004).;;Iqbal et al., “Gene expression profiling in lymphoma diagnosis and management,” Best Pract. Res. Clin. Haematol., 22 (2), 191-210 (2009).;;Japanese Patent Office, Office Action dated Oct. 16, 2018 in Application No. 2016-553231, with English translation, 15 pages.;;Jares et al., “Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity,” Am. J. Pathol., 148 (5), 1591-1600 (1996).;;Jares et al., “Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics,” Nat. Rev. Cancer, 7 (10), 750-762 (2007).;;Khan et al., “Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks,” Nat. Med., 7 (6), 673-679 (2001).;;Khouri et al., “Hyper-CVAD and high-dose methotrexate/cytarbine followed by stem cell transplantation: an active regimen for aggressive mantle cell lymphoma,” J. Clin. Oncol 16 (12), 3803-3809 (1998).;;Kovacs, “Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma,” Proc. Natl. Acad. Sci. USA, 85 (5), 1571-1573 (1988).;;Kramer et al., “Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma,” Blood, 92 (9), 3152-3162 (1998).;;Kusumoto et al., “Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a ‘non-germinal center phenotype’,”Am. J. Surg. Pathol., 29 (8), 1063-1073 (2005).;;Lafage-Pochitaloff-Huvale et al., “The gene for human thioredoxin maps on the short arm of chromosome 3 at bands 3p11-p12,” FEBS Lett., 255 (1), 89-91 (1989).;;Lashkari et al., “Yeast microarrays for genome wide parallel genetic and gene expression analysis,” Proc. Natl. Acad. Sci. USA, 94 (24), 13057-13062 (1997).;;Lenz et al., “Oncogenic CARD11 mutations in human diffuse large B cell lymphoma,” Science, 319 (5870), 1676-1679 (2008).;;Lenz et al., “Stromal gene signatures in large-B-cell lymphomas,” N. Engl. J. Med., 359 (22), 2313-2323 (2008).;;Li, “Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression information,” Bioinformatics, 22 (4), 466-471 (2006).;;Lipshutz et al., “Using oligonucleotide probe arrays to access genetic diversity,” Biotechniques, 19 (3), 442-447 (1995).;;Lockhart et al., “Expression monitoring by hybridization to high-density oligonucleotide arrays,” Nat. Biotechnol., 14 (13), 1675-1680 (1996).;;Mahadevan et al., “Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures,” Mol. Cancer. Ther., 4 (12), 1867-1879 (2005).;;Martinez et al., “The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival,” Cancer Res., 63 (23), 8226-8232 (2003).;;Matsumura et al., “Gene expression analysis of plant host-pathogen interactions by SuperSAGE,” Proc. Natl. Acad. Sci. USA, 100 (26), 15718-15723 (2003).;;Meyer et al., “Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab,” J. Clin. Oncol., 29 (2), 200-207 (2011).;;Mircean et al., “Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas,” Int. J. Oncol., 24 (3), 497-504 (2004).;;Monni et al., “DNA copy number changes in diffuse large B-cell lymphoma—comparative genomic hybridization study,” Blood, 87 (12), 5269-5278 (1996).;;Montgomery et al., “Pathology consultation on intermediate-to-large B-cell lymphomas,” Am. J. Clin. Pathol., 141 (3), 305-317 (2014).;;Monti et al., “Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response,” Blood, 105 (5), 1851-1861 (2005).;;Mortazavi et al., “Mapping and quantifying mammalian transcriptomes by RNA-Seq,” Nat Methods, 5 (7), 621-628 (2008).;;Mounier et al., “Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL),” Blood, 101 (11), 4279-4284 (2003).;;Neri et al., “Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma,” Proc. Natl. Acad. Sci. USA, 85 (8), 2748-2752 (1988).;;Ngo et al., “A loss-of-function RNA interference screen for molecular targets in cancer,” Nature, 441 (7089), 106-110 (2006).;;Northcott et al., “Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples,” Acta Neruopathol., 123 (4), 615-626 (2012).;;Nyman et al., “Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy,” Blood, 109 (11), 4930-4935 (2007).;;Orsetti et al., “Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes,” Cancer Res., 64 (18), 6453-6460 (2004).;;Ortega-Paino et al., “Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference,” Blood, 111 (3), 1617-1624 (2008).;;Ott et al., “Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity,” Blood, 90 (8), 3154-3159 (1997).;;Payton et al., “High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples,” J. Clin. Invest., 119 (6), 1714-1726 (2009).;;Pease et al., “Light-generated oligonucleotide arrays for rapid DNA sequence analysis,” Proc. Natl. Acad. Sci. USA, 91 (11), 5022-5026 (1994).;;Pietu et al., “Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array,” Genome Res., 6 (6), 492-503 (1996).;;Pruneri et al., “Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocation,” J. Pathol., 200 (5), 596-601 (2003).;;Puvvada et al., “Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B-cell lymphoma,” Cancer Genet., 206, 257-265 (2013), Author Manuscript.;;Quek et al., “A multiplex assay to measure RNA transcripts of prostate cancer in urine,” PLoS One, 7 (9), e45656 (2012), 9 pp.;;Quintanilla-Martinez et al., “Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor,” Am. J. Pathol., 153 (1), 175-182 (1998).;;Radmacher et al., “A paradigm for class prediction using gene expression profiles,” J. Comput. Biol., 9 (3), 505-511 (2002).;;Ramaswamy et al., “Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis,” Lancet Oncol., 14 (12), 1200-1207 (2013), Author Manuscript.;;Ramaswamy et al., “Multiclass cancer diagnosis using tumor gene expression signatures,” Proc. Natl. Acad. Sci. USA, 98 (26), 15149-15154 (2001).;;Ransohoff, “Rules of evidence for cancer molecular-marker discovery and validation,” Nat. Rev. Cancer, 4 (4), 309-314 (2004).;;Rao et al., “Chromosomal and gene amplification in diffuse large B-cell lymphoma,” Blood, 92 (1), 234-240 (1998).;;Rimsza et al., “Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project,” Blood, 103 (11), 4251-4258 (2004).;;Rizzatti et al., “Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways,” Br. J. Haematol., 130 (4), 516-526 (2005).;;Robetorye et al., “Microarray analysis of b-cell lymphoma cell lines with the t(14;18),” J. Mol. Diag., 4 (3), 123-136 (2002).;;Rogge et al., “Gene Profiling of Lymphoma, myeloma, and AML,” Medscape from WebMed, 5 (3), 1-8 (2003).;;Rosenwald, “DNA microarrays in lymphoid malignancies,” Oncology, 8 pp. (2003), Web.;;Rosenwald et al., “Gene expression profiling of diffuse large B-cell lymphoma,” Leukemia & Lymphoma, 44 (Supp. 3), S41-S47 (2003).;;Rosenwald et al., “Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma,” J. Exp. Med., 198 (6), 851-862 (2003).;;Rosenwald et al., “The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma,” Cancer Cell, 3 (2), 185-197 (2003).;;Rosenwald et al., “The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma,” N. Engl. J. Med., 346 (25), 1937-1947 (2002).;;Rubio-Moscardo et al., “Mantle-cell lymphoma genotypes identified with CGH to BAG microarrays define a leukemic subgroup of disease and predict patient outcome,” Blood, 105 (11), 4445-4454 (2005).;;Rummel et al., “Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial,” Lancet, 381 (9873), 1203-1210 (2013).;;Salaverria et al., “Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature,” J. Clin. Oncol., 25 (10), 1216-1222 (2007).;;Savage et al., “The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma,” Blood, 102 (12), 3871-3879 (2003).;;Schena et al., “Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes,” Proc. Natl. Acad. Sci. USA, 93, 10614-10619 (1996).;;Schena et al., “Quantitative monitoring of gene expression patterns with a complementary DNA microarray,” Science, 270 (5235), 467-470 (1995).;;Schmechel et al., “Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma,” Leukemia, 18, 841-855 (2004).;;Schwaenen et al., “DNA microarray analysis in malignant lymphomas,” Ann Hematol., 82 (6), 323-332 (2003).;;Scott et al., “Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue,” Blood, 123 (8), 1214-1217 (2014).;;Sehn et al., “The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP,” Blood, 109 (5), 1857-1861 (2007).;;Shaffer et al., “A library of gene expression signatures to illuminate normal and pathological lymphoid biology,” Immunol. Rev., 210, 67-85 (2006).;;Shaffer et al., “Lymphoid malignancies: the dark side of B-cell differentiation,” Nat. Rev. Immunol., 2 (12), 920-932 (2002).;;Shaffer et al., “Signatures of the immune response,” Immunity, 15 (3), 375-385 (2001).;;Shalon et al., “A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization,” Genome Res., 6 (7), 639-645 (1996).;;Shipp et al., “A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project,” N. Engl. J. Med., 329 (14), 987-994 (1993).;;Shipp et al., “Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning,” Nat. Med, 8 (1), 68-74 (2002).;;Sonoki et al., “Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies,” Blood, 98 (9), 2837-2844 (2001).;;Southern et al., “Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids,” Nucleic Acids. Res., 22 (8), 1368-1373 (1994).;;Spellman et al., “Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization,” Mol. Biol. Cell, 9 (12), 3273-3297 (1998).;;Staudt et al., “The biology of human lymphoid malignancies revealed by gene expression profiling,” Adv. Immunol., 87, 163-208 (2005), Author Manuscript.;;Staudt et al., “Focus on lymphomas,” Cancer Cell, 2 (5), 363-366 (2002).;;Staudt, “Gene expression profiling of lymphoid malignancies,” Annu. Rev. Med., 53, 303-318 (2002).;;Staudt et al., “Genomic views of the immune system*,” Annu. Rev. Immunol., 18, 829-859 (2000).;;Staudt et al., “Molecular diagnosis of the hematologic cancers,” N. Engl. J. Med., 348 (18), 1777-1785 (2003).;;Staudt, “It's All in the diagnosis,” Cancer Cell, 1 (2), 109-110 (2002).;;Subramanian et al., “Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,” Proc. Natl. Acad. Sci. USA, 102 (43), 15545-15550 (2005).;;Tagawa et al., “Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma,” Blood, 106 (5), 1770-1777 (2005).;;Tamayo et al., “Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation,” Proc. Natl. Acad. Sci. USA, 96 (6), 2907-2912 (1999).;;Tavazoie et al., “Systematic determination of genetic network architecture,” Nature Genet., 22 (3), 281-285 (1999).;;Thieblemont et al., “Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis,” Blood, 103 (7), 2727-2737 (2004).;;Tibshirani et al., “Diagnosis of multiple cancer types by shrunken centroids of gene expression,” Proc. Natl. Acad. Sci. USA, 99 (10), 6567-6572 (2002).;;Triscott et al., “Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children,” Cancer Res., 73 (22), 6734-6744 (2013).;;Van Der Velden et al., “B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma,” Blood, 124 (3), 412-419 (2014).;;Velculescu et al., “Serial analysis of gene expression,” Science, 270 (5235), 484-487 (1995).;;Wells, “Lymphoma microenvironment impacts therapy and prognosis,” Hematology Times, 3 pp. (2008), http://www.hematologytimes.com/ht/p_article_print.do?id=437&section.;;Wiestner et al., “Towards molecular diagnosis and targeted therapy of lymphoid malignancies,” Semin. Hematol., 40 (4), 296-307 (2003).;;Wilson et al., “A cancer and leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype,” Haeatologica, 97:758-765 (2012).;;Winter et al., “Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study,” Blood, 107 (11), 4207-4213(2006).;;Wodicka et al., “Genome-wide expression monitoring in Saccharomyces cerevisiae,” Nat. Biotechnol., 15 (13), 1359-1367 (1997).;;Wright et al., “A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma,” Proc. Natl. Acad. Sci. USA, 100 (17), 9991-9996 (2003).;;Written Opinion of the International Searching Authority, Application No. PCT/US2014/064161, dated Jul. 2009, 10 pp.;;Wuthrich et al., “MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells,” Kidney Int., 37 (2), 783-792 (1990).;;Xiu et al., “Analysis of survivin expression in subtypes of lymphoma,” Chinese J. Can., 23 (6), 655-661 (2004).;;Yatabe et al., “Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma,” Blood, 95 (7), 2253-2261 (2000).;;Ye et al., “Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma,” Blood, 102 (3), 1012-1018 (2003).;;Zeller et al., “An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets,” Genome Biol., 4 (10), 10 pp. (2003).;;Zhang et al., “Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression,” Br. J. Haemotology, 160 (4), 487-502 (2012).;;Al-Humood et al., “Genotypic and Phenotypic Differences between Nodal and Extranodal Diffuse Large B-Cell Lymphomas,” J Histochem Cytochem., 59 (10), 918-31 (Oct. 2011).;;Culpin et al., “Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients,” Histopathology, 63 (6), 788-801 (Dec. 2013).;;Nyman et al., “Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated in R-CHOP,” Modern Pathology, 22 (8), 1094-1101 (Aug. 2009).;;Takeuchi et al., “The potential of copy number gains and losses, detected by array-based comparative genomic hybridization, for computational differential diagnosis of B-cell lymphomas and genetic regions involved in lymphomagenesis,” Haematologica, 94 (1), 61-69 (Jan. 2009).;;Zheng, “Analysis ofsurvivin expression in subtypes of lymphoma,” Chinese Journal of Cancer, 23 (6), 655-661 (Jun. 2004).",ACTIVE
653,US,A1,US 2022/0228868 A1,085-443-752-169-260,2022-07-21,2022,US 202017596012 A,2020-05-28,US 202017596012 A;;US 201962857045 P;;IB 2020055092 W,2019-06-04,METHODS AND SYSTEMS FOR PATH-BASED MAPPING AND ROUTING,"Systems and methods of path-based mapping and routing are provided. Translation information and absolute information of mobile objects in environments are determined based on a fusion of sensing data from a radar and an inertial measurement unit (IMU) including a gyroscope and an accelerometer, from which path-based maps and optimal routes can be generated.",3M INNOVATIVE PROPERTIES CO,SINGH GAUTAM;;KRUSE JOHN M;;JESME RONALD D;;KELLIHER JR WILLIAM J;;ODOM JACOB E;;NYLAND ADAM C;;GABRIEL NICHOLAS T;;AVELDSON JASON L;;HAGH-SHENAS HALEH;;HERFORT FRANK T;;GJERE MICHAEL L;;KAUR RACHNEET;;WILKEN-RESMAN ELIAS;;LEE JAE YONG;;ADDLEMAN DOUG A;;CASNER GLENN E;;CARLSON JAMES D;;TUNGJUNYATHAM JUSTIN;;BATTLE KARL;;LUCHT STEVEN G,3M INNOVATIVE PROPERTIES COMPANY (2021-03-01),https://lens.org/085-443-752-169-260,Patent Application,yes,0,2,5,5,0,G01C21/1652;;G01C21/206;;G01S13/86;;G01S13/876;;G01S13/723;;G01S13/89;;G01S13/426;;G01C21/206;;G01C21/1652;;G01S13/86;;G01S13/89;;G01S13/876;;G01S13/723;;G01S13/426;;G01C21/1652;;G01C21/206;;G01S13/426;;G01S13/867;;G01S13/89,G01C21/20;;G01C21/16;;G01S13/42;;G01S13/86;;G01S13/89,,0,0,,,,PENDING
654,CN,A,CN 106232831 A,041-859-066-113-083,2016-12-14,2016,CN 201480072382 A,2014-11-05,US 201361900553 P;;US 2014/0064161 W,2013-11-06,Method for subtyping lymphoma types by means expression profiling,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNVIERSITY OF ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS-MAXIMILIANS-UNIVERSITY OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;CAMPO GUERRI ELIAS;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS;;TUBBS RAYMOND,,https://lens.org/041-859-066-113-083,Patent Application,no,0,10,27,27,0,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,C12Q1/68;;G16B25/10;;G16B5/00,,2,0,,,"S. BLENK等: ""Germinal Center B Cell-Like (GCB) and Activated B Cell-Like (ABC) Type of Diffuse Large B Cell Lymphoma (DLBCL): Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival"", 《CANCER INFORMATICS》;;GEORGE WRIGHT等: ""A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma"", 《PNAS》",ACTIVE
655,US,A1,US 2020/0143906 A1,194-066-474-619-188,2020-05-07,2020,US 202016746347 A,2020-01-17,US 202016746347 A;;US 201615035101 A;;US 2014/0064161 W;;US 201361900553 P,2013-11-06,METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING,"The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;UNIV ARIZONA;;UNIV BARCELONA;;HOSPITAL CLINIC BARCELONA;;CLEVELAND CLINIC FOUND;;UNIV NEBRASKA;;UNIV OREGON HEALTH & SCIENCE;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;OSLO UNIV HOSPITAL HF,STAUDT LOUIS M;;WRIGHT GEORGE W;;SCOTT DAVID WILLIAM;;CONNORS JOSEPH M;;GASCOYNE RANDY D;;RIMSZA LISA;;GUERRI ELIAS CAMPO;;TUBBS (DECEASED) RAYMOND;;GREINER TIMOTHY C;;COOK JAMES ROBERT;;FU KAI;;WILLIAMS PAUL MICHAEL;;LIH CHIH-JIAN;;JAFFE ELAINE S;;BRAZIEL RITA M;;ROSENWALD ANDREAS;;SMELAND ERLEND B;;CHAN WING C;;OTT GERMAN;;DELABIE JAN;;WEISENBURGER DENNIS,,https://lens.org/194-066-474-619-188,Patent Application,yes,0,1,27,27,2460,C12Q1/6886;;C12Q2600/166;;G16B25/00;;G16B5/00;;G16B25/10;;C12Q1/6886;;C12Q2600/158;;C12Q2600/106;;C12Q2600/112;;G16B25/10;;C12Q2600/166;;G16B25/00;;G16B5/00;;C12Q1/6886;;C12Q2600/166;;G16B25/10;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158,G16B25/00;;G16B25/10;;C12Q1/6886;;G16B5/00,,0,0,,,,ACTIVE
656,CA,A1,CA 3021569 A1,019-731-577-523-332,2017-10-26,2017,CA 3021569 A,2017-04-20,US 201662325213 P;;US 2017/0028628 W,2016-04-20,EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO,The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.,US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;JULIUS MAXIMILIANS UNIV OF WURZBURG;;UNIV OREGON HEALTH & SCIENCE;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;OSLO UNIV HOSPITAL HF;;UNIV NEBRASKA;;CLEVELAND CLINIC FOUND;;MAYO FOUND MEDICAL EDUCATION & RES,STAUDT LOUIS M;;SCOTT DAVID WILLIAM;;WRIGHT GEORGE W;;ROSENWALD ANDREAS;;ABRISQUETA PAU;;BRAZIEL RITA M;;CAMPO GUERRI ELIAS;;CHAN WING C;;CONNORS JOSEPH M;;DELABIE JAN;;VILLA DIEGO;;FU KAI;;GASCOYNE RANDY D;;GREINER TIMOTHY C;;JAFFE ELAINE S;;JARES PEDRO;;MOTTOK ANJA;;OTT GERMAN;;RIMSZA LISA M;;SLACK GRAHAM;;WEISENBURGER DENNIS D;;SMELAND ERLEND B;;COOK JAMES ROBERT,,https://lens.org/019-731-577-523-332,Patent Application,no,0,0,11,11,165,C12Q2600/106;;C12Q2600/118;;C12Q2600/158;;C12Q1/6886;;A61P35/00;;A61P35/02;;A61P7/00;;C12Q2600/118;;C12Q2600/158;;C12Q2600/106;;C12Q1/6886,C12Q1/68,,0,0,,,,PENDING
657,ES,T3,ES 2859423 T3,199-051-668-490-482,2021-10-04,2021,ES 17724960 T,2017-04-20,US 201662325213 P;;US 2017/0028628 W,2016-04-20,Evaluación del linfoma de células del manto y procedimientos relacionados con el mismo,"Un procedimiento para predecir el resultado de supervivencia de un sujeto humano que tiene linfoma de células del manto (LCM), cuyo procedimiento comprende: (1) determinar una puntuación del indicador predictivo de supervivencia del sujeto (a) aislando el producto de expresión génica de ARN de una muestra de biopsia fijada con formol e incluida en parafina (FFPE) del sujeto; (b) obteniendo datos de expresión génica del producto de expresión génica de ARN, en el que los datos de expresión génica comprenden valores de señal que representan niveles de expresión para cada gen de la tabla 1; y (c) determinando una puntuación del indicador predictivo de supervivencia a partir de los datos de expresión génica, en el que la puntuación del indicador predictivo de supervivencia se determina calculando un producto de multiplicación para cada gen de la tabla 1, en el que el producto de multiplicación es el producto matemático de la transformación logarítmica del valor de señal de un gen y un valor de coeficiente para ese gen, el valor del coeficiente para el gen enumerado en la tabla 1, y sumando los productos de la multiplicación; y (2) clasificar al sujeto como perteneciente a uno de los siguientes grupos en base a la puntuación del indicador predictivo de supervivencia: (i) buen pronóstico, (ii) pronóstico intermedio y (iii) mal pronóstico.",US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;UNIV OREGON HEALTH & SCIENCE;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;OSLO UNIV HOSPITAL HF;;UNIV NEBRASKA;;CLEVELAND CLINIC FOUND;;MAYO FOUND MEDICAL EDUCATION & RES,STAUDT LOUIS M;;SCOTT DAVID WILLIAM;;WRIGHT GEORGE W;;ROSENWALD ANDREAS;;ABRISQUETA PAU;;BRAZIEL RITA M;;CAMPO GUERRI ELIAS;;CHAN WING C;;CONNORS JOSEPH M;;DELABIE JAN;;VILLA DIEGO;;FU KAI;;GASCOYNE RANDY D;;GREINER TIMOTHY C;;JAFFE ELAINE S;;JARES PEDRO;;MOTTOK ANJA;;OTT GERMAN;;RIMSZA LISA M;;SLACK GRAHAM;;WEISENBURGER DENNIS D;;SMELAND ERLEND B;;COOK JAMES ROBERT,,https://lens.org/199-051-668-490-482,Granted Patent,no,0,0,11,11,0,C12Q2600/106;;C12Q2600/118;;C12Q2600/158;;C12Q1/6886;;A61P35/00;;A61P35/02;;A61P7/00;;C12Q2600/118;;C12Q2600/158;;C12Q2600/106;;C12Q1/6886,A61P7/00;;A61P35/00;;A61P35/02;;C12Q1/6886,,0,0,,,,ACTIVE
658,AU,B2,AU 2017/254645 B2,062-221-143-629-710,2023-02-09,2023,AU 2017/254645 A,2017-04-20,US 201662325213 P;;US 2017/0028628 W,2016-04-20,Evaluation of mantle cell lymphoma and methods related thereto,The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.,UNIV NEBRASKA;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;HOSPITAL CLINIC BARCELONA;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;MAYO FOUND MEDICAL EDUCATION & RES;;UNIV OREGON HEALTH & SCIENCE;;OSLO UNIV HOSPITAL HF;;CLEVELAND CLINIC FOUND;;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY;;UNIV BARCELONA,STAUDT LOUIS M;;SCOTT DAVID WILLIAM;;WRIGHT GEORGE W;;ROSENWALD ANDREAS;;ABRISQUETA PAU;;BRAZIEL RITA M;;CAMPO GUERRI ELIAS;;CHAN WING C;;CONNORS JOSEPH M;;DELABIE JAN;;VILLA DIEGO;;FU KAI;;GASCOYNE RANDY D;;GREINER TIMOTHY C;;JAFFE ELAINE S;;JARES PEDRO;;MOTTOK ANJA;;OTT GERMAN;;RIMSZA LISA M;;SLACK GRAHAM;;WEISENBURGER DENNIS D;;SMELAND ERLEND B;;COOK JAMES ROBERT,,https://lens.org/062-221-143-629-710,Granted Patent,no,0,0,11,11,0,C12Q2600/106;;C12Q2600/118;;C12Q2600/158;;C12Q1/6886;;A61P35/00;;A61P35/02;;A61P7/00;;C12Q2600/118;;C12Q2600/158;;C12Q2600/106;;C12Q1/6886,C12Q1/68,,1,1,054-277-353-896-06X,10.1200/jco.2007.12.0410;;18606985,"ELENA HARTMANN ET AL: ""Five-Gene Model to Predict Survival in Mantle-Cell Lymphoma Using Frozen or Formalin-Fixed, Paraffin-Embedded Tissue"", JOURNAL OF CLINICAL ONCOLOGY, vol. 26, no. 30, 20 October 2008 DOI: 10.1200/JCO.2007.12.0410",ACTIVE
659,WO,A1,WO 2017/184861 A1,010-638-782-670-08X,2017-10-26,2017,US 2017/0028628 W,2017-04-20,US 201662325213 P,2016-04-20,EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO,The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.,US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;JULIUS-MAXIMILIANS-UNIVERSITY OF WÜRZBURG;;UNIV OREGON HEALTH & SCIENCE;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;OSLO UNIV HOSPITAL HF;;UNIV NEBRASKA;;CLEVELAND CLINIC FOUND;;MAYO FOUNDATION,STAUDT LOUIS M;;SCOTT DAVID WILLIAM;;WRIGHT GEORGE W;;ROSENWALD ANDREAS;;ABRISQUETA PAU;;BRAZIEL RITA M;;CAMPO GUERRI ELIAS;;CHAN WING C;;CONNORS JOSEPH M;;DELABIE JAN;;VILLA DIEGO;;FU KAI;;GASCOYNE RANDY D;;GREINER TIMOTHY C;;JAFFE ELAINE S;;JARES PEDRO;;MOTTOK ANJA;;OTT GERMAN;;RIMSZA LISA M;;SLACK GRAHAM;;WEISENBURGER DENNIS D;;SMELAND ERLEND B;;COOK JAMES ROBERT,,https://lens.org/010-638-782-670-08X,Patent Application,yes,45,1,11,11,165,C12Q2600/106;;C12Q2600/118;;C12Q2600/158;;C12Q1/6886;;A61P35/00;;A61P35/02;;A61P7/00;;C12Q2600/118;;C12Q2600/158;;C12Q2600/106;;C12Q1/6886,C12Q1/68,,38,34,054-277-353-896-06X;;005-952-510-626-477;;093-992-351-106-367;;000-705-324-102-258;;160-631-360-016-499;;046-044-728-292-565;;051-346-920-381-327;;083-926-915-990-672;;014-065-259-226-128;;071-699-049-017-661;;041-085-398-221-48X;;081-376-983-952-92X;;023-425-205-244-323;;053-141-431-021-519;;085-467-264-451-562;;079-336-969-276-20X;;031-538-684-093-737;;003-117-956-540-879;;043-885-019-636-545;;078-147-429-983-57X;;012-855-494-804-729;;068-614-447-896-338;;115-496-463-132-125;;037-047-957-053-389;;047-322-007-088-891;;035-255-900-380-462;;040-439-415-810-331;;056-491-763-273-738;;115-127-987-199-386;;056-119-365-062-942;;054-277-353-896-06X;;056-119-365-062-942;;015-395-832-493-244;;003-374-645-325-642,10.1200/jco.2007.12.0410;;18606985;;10.1158/1055-9965.epi-10-0091;;20332269;;pmc2864144;;1380482;;10.1016/0888-7543(92)90014-j;;7514785;;10.1093/nar/22.8.1368;;pmc307992;;8895530;;8828038;;10.1101/gr.6.6.492;;10.1126/science.270.5235.467;;7569999;;10.1038/ng1296-457;;8944026;;8855227;;pmc38202;;10.1073/pnas.93.20.10614;;8796352;;10.1101/gr.6.7.639;;10.1126/science.278.5338.680;;9381177;;pmc20056;;9122163;;10.1073/pnas.94.6.2150;;pmc24262;;9371799;;10.1073/pnas.94.24.13057;;8197176;;10.1073/pnas.91.11.5022;;pmc43922;;7495558;;10.1126/science.274.5287.610;;8849452;;10.1038/nbt1296-1675;;9634850;;9415887;;10.1038/nbt1297-1359;;10.1126/science.270.5235.484;;7570003;;14676315;;pmc307634;;10.1073/pnas.2536670100;;10.1186/bcr2189;;18954444;;pmc2614499;;10.1038/nmeth.1226;;18516045;;10.1002/0471142727.mb25b10s94;;10.1038/nbt1385;;18278033;;11567628;;10.1016/s1074-7613(01)00194-7;;12075054;;10.1056/nejmoa012914;;23433739;;10.3410/f.717980688.793474808;;10.1016/s0140-6736(12)61763-2;;19669190;;10.1007/s12308-009-0036-x;;pmc2725281;;8889347;;10.1016/0197-2456(96)00075-x;;10.1200/jco.2006.08.7999;;17563396;;10.1200/jco.2007.12.0410;;18606985;;10.1200/jco.2006.08.7999;;17563396;;12620412;;10.1016/s1535-6108(03)00028-x;;18077791;;10.1182/blood-2007-10-117010,"ELENA HARTMANN ET AL: ""Five-Gene Model to Predict Survival in Mantle-Cell Lymphoma Using Frozen or Formalin-Fixed, Paraffin-Embedded Tissue"", JOURNAL OF CLINICAL ONCOLOGY, vol. 26, no. 30, 20 October 2008 (2008-10-20), US, pages 4966 - 4972, XP055388995, ISSN: 0732-183X, DOI: 10.1200/JCO.2007.12.0410;;ROSENWALD ET AL., CANCER CELL, vol. 3, 2003, pages 185 - 197;;""Histological and Histochemical Methods: Theory and Practice"", 2008, COLD SPRING HARBOR LABORATORY PRESS;;HUANG ET AL., CANCER EPIDEMIO/ BIOMARKERS PREV, vol. 19, 2010, pages 973 - 977;;SOUTHERN ET AL., GENOMICS, vol. 1.3, 1992, pages 1008 - 1017;;SOUTHERN, NUC/. ACIDS. RES., vol. 22, 1994, pages 1368 - 1373;;GRESS ET AL., ONCOGENE, vol. 13, 1996, pages 1819 - 1830;;PIETU ET AL., GENOME RES., vol. 6, 1996, pages 492 - 503;;SCHENA ET AL., SCIENCE, vol. 270, 1995, pages 467 - 470;;DERISI ET AL., NAT. GENET., vol. 14, 1996, pages 457 - 460;;SCHENA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 10614 - 10619;;SHALON ET AL., GENOME RES., vol. 6, 1996, pages 639 - 645;;DERISI ET AL., SCIENCE, vol. 278, 1997, pages 680 - 686;;HELLER ET AL., PROC. NAIL ACAD. SCI. USA, vol. 94, 1997, pages 2150 - 2155;;LASHKARI ET AL., PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 13057 - 13062;;PEASE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 5022 - 5026;;LIPSHUTZ ET AL., BIOTECHNIQUES, vol. 19, 1995, pages 442 - 447;;CHEE ET AL., SCIENCE, vol. 274, 1996, pages 610 - 14;;LOCKHAIT ET AL., NAT. BIOTECHNOL., vol. 14, 1996, pages 1675 - 1680;;WODICKA ET AL., NAT. BIOTECHNOL., vol. 15, 1997, pages 1359 - 1367;;VELCULESCU ET AL., SCIENCE, vol. 270, no. 5235, 1995, pages 484 - 487;;MATSUMURA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 100, no. 26, 2003, pages 15718 - 15723;;CAO ET AL., BREAST CANCER RESEARCH, vol. 10, 2008, pages R91;;MORTAZAVI ET AL., NAT METHODS, vol. 5, no. 7, 2008, pages 621 - 628;;KULKARNI, M. M.: ""Digital Multiplexed Gene Expression Analysis Using the NanoString Technologies® nCounter® System"", CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, vol. 94, 2011;;GEISS ET AL., NATURE BIOTECHNOLOGY, vol. 26, 2008, pages 317 - 325;;SHAFFER ET AL., IMMUNITY, vol. 15, 2001, pages 375 - 385;;ROSENWALD ET AL., NEW ENGL. J. MED., vol. 346, 2002, pages 1937 - 1947;;RUMMEL ET AL., LANCET, vol. 381, no. 9873, 2013, pages 1203 - 10;;SWERDLOW ET AL.: ""World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues"", 2008, IARC PRESS;;KLAPPER ET AL., J. HEMATOP., vol. 2, 2009, pages 103 - 11;;HOSTER ET AL., BLOOD, vol. 11, no. 1, 2008, pages 558 - 565;;SCHEMPER ET AL., CONTROLLED CLINICAL TRIALS, vol. 17, 1996, pages 343 - 346;;KIENLE ET AL., J. CLIN. ONCOL., vol. 25, 2007, pages 2770 - 2777;;HARTMANN ET AL., J. CLIN. ONCOL., vol. 26, 2008, pages 4966 - 4972;;KIENIE ET AL., J. CLIN. ONCOL., vol. 25, 2007, pages 2770 - 2777;;ROSENWALD, CANCER CELL, vol. 3, 2003, pages 185 - 197;;DETERMANN ET AL., BLOOD, vol. 111, 2008, pages 2385 - 2387",PENDING
660,AU,A1,AU 2017/254645 A1,047-480-549-493-588,2018-10-25,2018,AU 2017/254645 A,2017-04-20,US 201662325213 P;;US 2017/0028628 W,2016-04-20,Evaluation of mantle cell lymphoma and methods related thereto,The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.,UNIV NEBRASKA;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;HOSPITAL CLINIC BARCELONA;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;MAYO FOUND MEDICAL EDUCATION & RES;;UNIV OREGON HEALTH & SCIENCE;;OSLO UNIV HOSPITAL HF;;CLEVELAND CLINIC FOUND;;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY;;UNIV BARCELONA,STAUDT LOUIS M;;SCOTT DAVID WILLIAM;;WRIGHT GEORGE W;;ROSENWALD ANDREAS;;ABRISQUETA PAU;;BRAZIEL RITA M;;CAMPO GUERRI ELIAS;;CHAN WING C;;CONNORS JOSEPH M;;DELABIE JAN;;VILLA DIEGO;;FU KAI;;GASCOYNE RANDY D;;GREINER TIMOTHY C;;JAFFE ELAINE S;;JARES PEDRO;;MOTTOK ANJA;;OTT GERMAN;;RIMSZA LISA M;;SLACK GRAHAM;;WEISENBURGER DENNIS D;;SMELAND ERLEND B;;COOK JAMES ROBERT,,https://lens.org/047-480-549-493-588,Patent Application,no,0,0,11,11,0,C12Q2600/106;;C12Q2600/118;;C12Q2600/158;;C12Q1/6886;;A61P35/00;;A61P35/02;;A61P7/00;;C12Q2600/118;;C12Q2600/158;;C12Q2600/106;;C12Q1/6886,C12Q1/68,,0,0,,,,ACTIVE
661,EP,A1,EP 3445873 A1,040-353-062-782-146,2019-02-27,2019,EP 17724960 A,2017-04-20,US 201662325213 P;;US 2017/0028628 W,2016-04-20,EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO,,US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;UNIV OREGON HEALTH & SCIENCE;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;OSLO UNIV HOSPITAL HF;;UNIV NEBRASKA;;CLEVELAND CLINIC FOUND;;MAYO FOUND MEDICAL EDUCATION & RES,STAUDT LOUIS M;;SCOTT DAVID WILLIAM;;WRIGHT GEORGE W;;ROSENWALD ANDREAS;;ABRISQUETA PAU;;BRAZIEL RITA M;;CAMPO GUERRI ELIAS;;CHAN WING C;;CONNORS JOSEPH M;;DELABIE JAN;;VILLA DIEGO;;FU KAI;;GASCOYNE RANDY D;;GREINER TIMOTHY C;;JAFFE ELAINE S;;JARES PEDRO;;MOTTOK ANJA;;OTT GERMAN;;RIMSZA LISA M;;SLACK GRAHAM;;WEISENBURGER DENNIS D;;SMELAND ERLEND B;;COOK JAMES ROBERT,,https://lens.org/040-353-062-782-146,Patent Application,yes,0,0,11,11,0,C12Q2600/106;;C12Q2600/118;;C12Q2600/158;;C12Q1/6886;;A61P35/00;;A61P35/02;;A61P7/00;;C12Q2600/118;;C12Q2600/158;;C12Q2600/106;;C12Q1/6886,C12Q1/68,,0,0,,,,ACTIVE
662,EP,B1,EP 3445873 B1,098-521-268-754-372,2020-11-04,2020,EP 17724960 A,2017-04-20,US 201662325213 P;;US 2017/0028628 W,2016-04-20,EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO,,US HEALTH;;BRITISH COLUMBIA CANCER AGENCY BRANCH;;JULIUS MAXIMILIANS UNIV OF WUERZBURG;;UNIV OREGON HEALTH & SCIENCE;;HOSPITAL CLINIC BARCELONA;;UNIV BARCELONA;;OSLO UNIV HOSPITAL HF;;UNIV NEBRASKA;;CLEVELAND CLINIC FOUND;;MAYO FOUND MEDICAL EDUCATION & RES,CONNORS JOSEPH M;;STAUDT LOUIS M;;SCOTT DAVID WILLIAM;;WRIGHT GEORGE W;;ROSENWALD ANDREAS;;ABRISQUETA PAU;;BRAZIEL RITA M;;CAMPO GUERRI ELIAS;;CHAN WING C;;DELABIE JAN;;VILLA DIEGO;;FU KAI;;GASCOYNE RANDY D;;GREINER TIMOTHY C;;JAFFE ELAINE S;;JARES PEDRO;;MOTTOK ANJA;;OTT GERMAN;;RIMSZA LISA M;;SLACK GRAHAM;;WEISENBURGER DENNIS D;;SMELAND ERLEND B;;COOK JAMES ROBERT,,https://lens.org/098-521-268-754-372,Granted Patent,yes,1,0,11,11,0,C12Q2600/106;;C12Q2600/118;;C12Q2600/158;;C12Q1/6886;;A61P35/00;;A61P35/02;;A61P7/00;;C12Q2600/118;;C12Q2600/158;;C12Q2600/106;;C12Q1/6886,A61P7/00;;A61P35/00;;A61P35/02;;C12Q1/6886,,1,1,015-395-832-493-244,12620412;;10.1016/s1535-6108(03)00028-x,"ROSENWALD A ET AL: ""THE PROLIFERATION GENE EXPRESSION SIGNATURE IS A QUANTITATIVE INTEGRATOR OF ONCOGENIC EVENTS THAT PREDICTS SURVIVAL IN MANTLE CELL LYMPHOMA"", CANCER CELL, CELL PRESS, US, vol. 3, no. 2, 1 February 2003 (2003-02-01), pages 185 - 197, XP001191077, ISSN: 1535-6108, DOI: 10.1016/S1535-6108(03)00028-X",ACTIVE
